Clustering O 0 0.07961113750934601
of O 0 0.03105071932077408
missense O 0 0.04978721961379051
mutations O 0 0.020122751593589783
in O 0 0.013729440048336983
the O 0 0.03452116250991821
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999994039535522
telangiectasia I-Disease 1 0.9999996423721313
gene O 0 0.015549508854746819
in O 0 0.011752834543585777
a O 0 0.016780933365225792
sporadic B-Disease 1 0.9782140254974365
T I-Disease 1 0.9999996423721313
- I-Disease 1 0.999988317489624
cell I-Disease 1 0.9991694688796997
leukaemia I-Disease 1 0.999998927116394
. O 0 0.06085510551929474

Ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999845027923584
telangiectasia I-Disease 1 0.9999974966049194
( O 0 0.0467679537832737
A B-Disease 1 0.9999141693115234
- I-Disease 1 0.9999997615814209
T I-Disease 1 0.9999992847442627
) O 0 0.010297729633748531
is O 0 0.008199736475944519
a O 0 0.010086334310472012
recessive B-Disease 1 0.8396409153938293
multi I-Disease 1 0.9999673366546631
- I-Disease 1 0.9999996423721313
system I-Disease 1 0.9999343156814575
disorder I-Disease 1 1.0
caused O 1 0.9427289962768555
by O 0 0.00986260175704956
mutations O 0 0.010238372720777988
in O 0 0.00690076220780611
the O 0 0.010237057693302631
ATM O 0 0.04818617179989815
gene O 0 0.010742547921836376
at O 0 0.012672423385083675
11q22 O 1 0.8416669964790344
- O 1 0.9515276551246643
q23 O 1 0.9383185505867004
( O 0 0.021001683548092842
ref O 1 0.8468636870384216
. O 0 0.022144336253404617
3 O 0 0.032861270010471344
) O 0 0.030825624242424965
. O 0 0.04586902633309364

The O 0 0.03148245811462402
risk O 0 0.06986265629529953
of O 0 0.4955315589904785
cancer B-Disease 1 1.0
, O 0 0.16590085625648499
especially O 1 0.6405894160270691
lymphoid B-Disease 1 0.9999996423721313
neoplasias I-Disease 1 0.999992847442627
, O 0 0.011726167984306812
is O 0 0.00862911343574524
substantially O 0 0.014223715290427208
elevated O 0 0.025836361572146416
in O 0 0.008497313596308231
A B-Disease 1 0.9921615719795227
- I-Disease 1 0.9999996423721313
T I-Disease 1 1.0
patients O 1 0.9888303875923157
and O 0 0.009565459564328194
has O 0 0.009239624254405499
long O 0 0.010699480772018433
been O 0 0.0097338343039155
associated O 0 0.014664226211607456
with O 0 0.019600648432970047
chromosomal O 1 0.9999117851257324
instability O 1 0.9999617338180542
. O 0 0.06721801310777664

By O 0 0.037922874093055725
analysing O 0 0.09451090544462204
tumour B-Disease 1 0.9999691247940063
DNA O 0 0.024071957916021347
from O 0 0.014893841929733753
patients O 0 0.04007212072610855
with O 0 0.013420922681689262
sporadic B-Disease 1 0.5686236023902893
T I-Disease 1 0.9999901056289673
- I-Disease 1 0.9984847903251648
cell I-Disease 1 0.8842918872833252
prolymphocytic I-Disease 1 0.9999746084213257
leukaemia I-Disease 1 1.0
( O 1 0.9178740382194519
T B-Disease 1 0.9999994039535522
- I-Disease 1 0.9999713897705078
PLL I-Disease 1 0.9999790191650391
) O 0 0.016546625643968582
, O 0 0.013066725805401802
a O 0 0.01402478851377964
rare O 0 0.03041345626115799
clonal B-Disease 1 0.9891530275344849
malignancy I-Disease 1 0.9999562501907349
with O 0 0.01006839144974947
similarities O 0 0.012462468817830086
to O 0 0.008276751264929771
a O 0 0.0114304069429636
mature B-Disease 0 0.46832019090652466
T I-Disease 1 0.9999243021011353
- I-Disease 1 0.9983596205711365
cell I-Disease 1 0.5513988137245178
leukaemia I-Disease 1 0.9999877214431763
seen O 0 0.013038377277553082
in O 0 0.010231513530015945
A B-Disease 1 0.9987414479255676
- I-Disease 1 0.9999951124191284
T I-Disease 1 0.9999908208847046
, O 0 0.011011768132448196
we O 0 0.00997831579297781
demonstrate O 0 0.013437146320939064
a O 0 0.01209462434053421
high O 0 0.01536476518958807
frequency O 0 0.015110191889107227
of O 0 0.01487763412296772
ATM O 0 0.0631752759218216
mutations O 0 0.02895139716565609
in O 0 0.02769354358315468
T B-Disease 1 0.9999178647994995
- I-Disease 1 0.9912776947021484
PLL I-Disease 1 0.9969649910926819
. O 0 0.08246351778507233

In O 0 0.032415661960840225
marked O 0 0.03159918636083603
contrast O 0 0.020954523235559464
to O 0 0.012262186966836452
the O 0 0.013320892117917538
ATM O 0 0.036777328699827194
mutation O 0 0.015674717724323273
pattern O 0 0.012175663374364376
in O 0 0.010601119138300419
A B-Disease 1 0.9787887334823608
- I-Disease 1 0.9999923706054688
T I-Disease 1 0.9999805688858032
, O 0 0.009471306577324867
the O 0 0.008569857105612755
most O 0 0.007731209509074688
frequent O 0 0.012843545526266098
nucleotide O 0 0.012772937305271626
changes O 0 0.009062639437615871
in O 0 0.011252887547016144
this O 0 0.01443231850862503
leukaemia B-Disease 1 0.9999868869781494
were O 0 0.02214072272181511
missense O 0 0.42315545678138733
mutations O 0 0.043582845479249954
. O 0 0.03913211449980736

These O 0 0.021807346493005753
clustered O 0 0.025842158123850822
in O 0 0.01002818625420332
the O 0 0.00965045765042305
region O 0 0.010682472959160805
corresponding O 0 0.008435450494289398
to O 0 0.007511555217206478
the O 0 0.010202483274042606
kinase O 0 0.028477678075432777
domain O 0 0.013766111806035042
, O 0 0.009265019558370113
which O 0 0.0060558198019862175
is O 0 0.006784593220800161
highly O 0 0.009234121069312096
conserved O 0 0.010587846860289574
in O 0 0.008867062628269196
ATM O 0 0.14351500570774078
- O 0 0.07427655160427094
related O 0 0.012315335683524609
proteins O 0 0.011881559155881405
in O 0 0.010304457508027554
mouse O 0 0.03738861903548241
, O 0 0.016196025535464287
yeast O 0 0.03907717764377594
and O 0 0.025685224682092667
Drosophila O 0 0.07723928987979889
. O 0 0.051659341901540756

The O 0 0.03665059804916382
resulting O 0 0.032306745648384094
amino O 0 0.03013910911977291
- O 1 0.9663380980491638
acid O 0 0.03245185688138008
substitutions O 0 0.02219582535326481
are O 0 0.008030053228139877
predicted O 0 0.013290110044181347
to O 0 0.009470161981880665
interfere O 0 0.017307480797171593
with O 0 0.012715277262032032
ATP O 1 0.9979665279388428
binding O 0 0.021416470408439636
or O 0 0.01901300810277462
substrate O 0 0.04651224985718727
recognition O 0 0.041398752480745316
. O 0 0.04501182585954666

Two O 0 0.026351291686296463
of O 0 0.024566365405917168
seventeen O 0 0.045983389019966125
mutated O 1 0.9671180844306946
T B-Disease 1 0.9999812841415405
- I-Disease 1 0.9930413961410522
PLL I-Disease 1 0.9974270462989807
samples O 0 0.017282795161008835
had O 0 0.012225360609591007
a O 0 0.01090241502970457
previously O 0 0.01420882809907198
reported O 0 0.017713412642478943
A B-Disease 1 0.9868488311767578
- I-Disease 1 0.9999828338623047
T I-Disease 1 0.9999945163726807
allele O 0 0.08382298052310944
. O 0 0.053369928151369095

In O 0 0.02695341594517231
contrast O 0 0.023758795112371445
, O 0 0.013766946271061897
no O 0 0.011098998598754406
mutations O 0 0.011614248156547546
were O 0 0.006547038909047842
detected O 0 0.009581312537193298
in O 0 0.006857912987470627
the O 0 0.0095356535166502
p53 O 0 0.07869363576173782
gene O 0 0.009493817575275898
, O 0 0.007530098780989647
suggesting O 0 0.008746449835598469
that O 0 0.006321716587990522
this O 0 0.01058456115424633
tumour B-Disease 1 1.0
suppressor O 1 0.9999622106552124
is O 0 0.010969138704240322
not O 0 0.008795127272605896
frequently O 0 0.012800933793187141
altered O 0 0.017350321635603905
in O 0 0.014997783116996288
this O 0 0.020550118759274483
leukaemia B-Disease 1 0.9999953508377075
. O 0 0.05285118520259857

Occasional O 0 0.08082295209169388
missense O 0 0.07406674325466156
mutations O 0 0.027884269133210182
in O 0 0.016311688348650932
ATM O 0 0.04769379273056984
were O 0 0.009436886757612228
also O 0 0.009225430898368359
found O 0 0.00950265396386385
in O 0 0.01019991748034954
tumour B-Disease 1 0.9999407529830933
DNA O 0 0.012287439778447151
from O 0 0.009543078951537609
patients O 0 0.017145736142992973
with O 0 0.009516515769064426
B B-Disease 1 0.9670559763908386
- I-Disease 1 0.8733389973640442
cell I-Disease 0 0.03293628990650177
non I-Disease 1 0.7087222337722778
- I-Disease 1 0.9999977350234985
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 1 0.9999998807907104
( O 0 0.05741206556558609
B B-Disease 1 0.9963468909263611
- I-Disease 1 0.5610595345497131
NHL I-Disease 0 0.05985265225172043
) O 0 0.012775451876223087
and O 0 0.012257971800863743
a O 0 0.01785408891737461
B B-Disease 1 0.9926053285598755
- I-Disease 1 0.966605544090271
NHL I-Disease 1 0.9349363446235657
cell O 0 0.07880312204360962
line O 0 0.0562131404876709
. O 0 0.04852138087153435

The O 0 0.028513122349977493
evidence O 0 0.017479224130511284
of O 0 0.012248554266989231
a O 0 0.010826922953128815
significant O 0 0.010143769904971123
proportion O 0 0.009420977905392647
of O 0 0.007927997037768364
loss O 0 0.35823896527290344
- O 1 0.7894607782363892
of O 0 0.013736880384385586
- O 1 0.9961470365524292
function O 0 0.010770794935524464
mutations O 0 0.009551573544740677
and O 0 0.005915699526667595
a O 0 0.007924806326627731
complete O 0 0.010349102318286896
absence O 0 0.010710862465202808
of O 0 0.008123736828565598
the O 0 0.008839529938995838
normal O 0 0.008825216442346573
copy O 0 0.013782648369669914
of O 0 0.010528167709708214
ATM O 0 0.02261715941131115
in O 0 0.008267580531537533
the O 0 0.008904947899281979
majority O 0 0.010104265064001083
of O 0 0.01473854761570692
mutated O 1 0.8290116190910339
tumours B-Disease 1 0.9999978542327881
establishes O 1 0.9772093296051025
somatic O 1 0.9071069955825806
inactivation O 1 0.9956979751586914
of O 0 0.013693083077669144
this O 0 0.008940448053181171
gene O 0 0.009896432980895042
in O 0 0.007922421209514141
the O 0 0.01126386970281601
pathogenesis O 1 0.9836724400520325
of O 0 0.01412722747772932
sporadic B-Disease 1 0.9765974879264832
T I-Disease 1 0.9999996423721313
- I-Disease 1 0.999963641166687
PLL I-Disease 1 0.9999778270721436
and O 0 0.01194132212549448
suggests O 0 0.01363969687372446
that O 0 0.009570792317390442
ATM O 0 0.03144703060388565
acts O 0 0.013198858126997948
as O 0 0.015165258198976517
a O 0 0.44375303387641907
tumour B-Disease 1 1.0
suppressor O 1 0.9999587535858154
. O 0 0.0555335208773613

As O 0 0.026287121698260307
constitutional O 0 0.02568734996020794
DNA O 0 0.019692009314894676
was O 0 0.013220489025115967
not O 0 0.00702098710462451
available O 0 0.008558984845876694
, O 0 0.008659097366034985
a O 0 0.012725649401545525
putative O 1 0.7427423596382141
hereditary O 1 0.9999768733978271
predisposition O 1 0.9999853372573853
to O 0 0.22105926275253296
T B-Disease 1 0.9999988079071045
- I-Disease 1 0.9998667240142822
PLL I-Disease 1 0.999708354473114
will O 0 0.019182756543159485
require O 0 0.01839819736778736
further O 0 0.02240724302828312
investigation O 0 0.03457219526171684
. O 0 0.031515054404735565
. O 0 0.04849260300397873

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 1 0.9824122786521912
kinase O 1 0.6365110278129578
is O 0 0.012600908987224102
involved O 0 0.009646380320191383
in O 0 0.007648026570677757
the O 0 0.0083091976121068
modulation O 0 0.016607346013188362
of O 0 0.010535387322306633
the O 0 0.018774906173348427
Ca2 O 1 0.9998290538787842
+ O 1 0.9628058671951294
homeostasis O 1 0.9995599389076233
in O 0 0.18169055879116058
skeletal O 1 0.999998927116394
muscle O 1 0.9999939203262329
cells O 0 0.4775456488132477
. O 0 0.0468452125787735

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999725818634033
DM B-Disease 1 1.0
) O 0 0.019614828750491142
, O 0 0.012377428822219372
the O 0 0.011597930453717709
most O 0 0.013693825341761112
prevalent O 1 0.9999134540557861
muscular B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 1 0.5322629809379578
adults O 1 0.8490279316902161
, O 0 0.01242743618786335
is O 0 0.008400996215641499
caused O 0 0.01954790949821472
by O 0 0.00899876281619072
( O 0 0.016158852726221085
CTG O 1 0.9988186955451965
) O 0 0.01422506757080555
n O 0 0.022029053419828415
- O 0 0.02433205209672451
repeat O 0 0.01908113993704319
expansion O 0 0.016578687354922295
in O 0 0.009802507236599922
a O 0 0.010533945634961128
gene O 0 0.010712060146033764
encoding O 0 0.011874609626829624
a O 0 0.01264297217130661
protein O 0 0.018566148355603218
kinase O 0 0.038114696741104126
( O 0 0.022640414535999298
DM B-Disease 1 0.9999995231628418
protein O 0 0.03261733055114746
kinase O 0 0.11730930954217911
; O 0 0.021133722737431526
DMPK O 1 0.998840868473053
) O 0 0.01246736478060484
and O 0 0.01191013865172863
involves O 0 0.015756456181406975
changes O 0 0.012059135362505913
in O 0 0.016831446439027786
cytoarchitecture O 1 0.9834302663803101
and O 0 0.03504924848675728
ion O 1 0.9544731974601746
homeostasis O 1 0.9875916242599487
. O 0 0.06314564496278763

To O 0 0.02844070829451084
obtain O 0 0.025820137932896614
clues O 0 0.022560235112905502
to O 0 0.011336077004671097
the O 0 0.010834770277142525
normal O 0 0.01312995608896017
biological O 0 0.015428599901497364
role O 0 0.012693936005234718
of O 0 0.013817860744893551
DMPK O 1 0.9964093565940857
in O 0 0.015137202106416225
cellular O 1 0.947537362575531
ion O 1 0.9740105271339417
homeostasis O 1 0.976407527923584
, O 0 0.011512245051562786
we O 0 0.007362228352576494
have O 0 0.005777438171207905
compared O 0 0.00823110993951559
the O 0 0.009529396891593933
resting O 1 0.8976107835769653
[ O 0 0.14764538407325745
Ca2 O 1 0.9838483929634094
+ O 0 0.12615977227687836
] O 0 0.02535264566540718
i O 0 0.01535654254257679
, O 0 0.009277593344449997
the O 0 0.008543615229427814
amplitude O 0 0.01692403480410576
and O 0 0.009290260262787342
shape O 0 0.014047588221728802
of O 0 0.014334834180772305
depolarization O 1 0.9999852180480957
- O 1 0.9999948740005493
induced O 1 0.9999988079071045
Ca2 O 1 0.9999884366989136
+ O 1 0.975658118724823
transients O 0 0.13108651340007782
, O 0 0.012610216625034809
and O 0 0.0084729278460145
the O 0 0.007720820140093565
content O 0 0.009697585366666317
of O 0 0.010673658922314644
ATP O 1 0.9944751858711243
- O 1 0.6828062534332275
driven O 0 0.028938211500644684
ion O 0 0.045906826853752136
pumps O 0 0.043675560504198074
in O 0 0.016645392403006554
cultured O 1 0.8529564142227173
skeletal O 1 0.9999433755874634
muscle O 1 0.9923985600471497
cells O 0 0.01526648923754692
of O 0 0.012280682101845741
wild O 0 0.01585591770708561
- O 1 0.7733888626098633
type O 0 0.016895124688744545
and O 0 0.013372110202908516
DMPK O 1 0.9998365640640259
[ O 1 0.6271023750305176
- O 1 0.9998351335525513
/ O 1 0.9998517036437988
- O 1 0.999711811542511
] O 1 0.8682785034179688
knockout O 1 0.9948731064796448
mice O 0 0.08111224323511124
. O 0 0.05972358584403992

In O 0 0.039005279541015625
vitro O 0 0.059481628239154816
- O 0 0.06733367592096329
differentiated O 0 0.07244695723056793
DMPK O 1 0.9990785121917725
[ O 0 0.35178419947624207
- O 1 0.999263346195221
/ O 1 0.9992893934249878
- O 1 0.9893994927406311
] O 0 0.033113159239292145
myotubes O 0 0.05520806089043617
exhibit O 0 0.022954756394028664
a O 0 0.014636465348303318
higher O 0 0.015787703916430473
resting O 1 0.8760672211647034
[ O 0 0.35260653495788574
Ca2 O 1 0.9983041286468506
+ O 0 0.3832398056983948
] O 0 0.024032192304730415
i O 0 0.01354848500341177
than O 0 0.007585492916405201
do O 0 0.008470379747450352
wild O 0 0.014996880665421486
- O 1 0.8557606935501099
type O 0 0.12722958624362946
myotubes O 1 0.6949853897094727
because O 0 0.007800406776368618
of O 0 0.007797835394740105
an O 0 0.007292142137885094
altered O 0 0.01170305348932743
open O 0 0.01173015870153904
probability O 0 0.011031520552933216
of O 0 0.010225396603345871
voltage O 0 0.020804207772016525
- O 0 0.10259975492954254
dependent O 0 0.019276192411780357
l O 1 0.5204958319664001
- O 1 0.8719388246536255
type O 0 0.3365139067173004
Ca2 O 1 0.9704758524894714
+ O 0 0.09312141686677933
and O 0 0.03142827749252319
Na O 1 0.9995679259300232
+ O 0 0.06969853490591049
channels O 0 0.05513051152229309
. O 0 0.05712617188692093

The O 0 0.047281473875045776
mutant O 0 0.08245504647493362
myotubes O 1 0.8099596500396729
exhibit O 0 0.03711705282330513
smaller O 0 0.02160390093922615
and O 0 0.016556233167648315
slower O 0 0.031111644580960274
Ca2 O 1 0.7913288474082947
+ O 0 0.03202952817082405
responses O 0 0.018080230802297592
upon O 0 0.015273544937372208
triggering O 0 0.024490950629115105
by O 0 0.011864016763865948
acetylcholine O 0 0.1372494101524353
or O 0 0.012184257619082928
high O 0 0.033734019845724106
external O 1 0.6411985158920288
K O 1 0.9793534874916077
+ O 0 0.08507474511861801
. O 0 0.04804673418402672

In O 0 0.02861892804503441
addition O 0 0.02087295614182949
, O 0 0.012436546385288239
we O 0 0.009718320332467556
observed O 0 0.009802533313632011
that O 0 0.0078956363722682
these O 0 0.010726486332714558
Ca2 O 1 0.9468916654586792
+ O 1 0.6108208894729614
transients O 1 0.5871492028236389
partially O 0 0.02391032502055168
result O 0 0.011146514676511288
from O 0 0.008809329941868782
an O 0 0.009557032957673073
influx O 0 0.01954309456050396
of O 0 0.0153302988037467
extracellular O 0 0.05709061771631241
Ca2 O 0 0.2649565041065216
+ O 0 0.023842206224799156
through O 0 0.013836321420967579
the O 0 0.015737758949398994
l O 1 0.9529631733894348
- O 1 0.9936617612838745
type O 1 0.843040943145752
Ca2 O 1 0.9924870729446411
+ O 0 0.0682675912976265
channel O 0 0.06032067909836769
. O 0 0.05832061916589737

Neither O 0 0.04657358303666115
the O 0 0.02304365299642086
content O 0 0.019262585788965225
nor O 0 0.017703242599964142
the O 0 0.012130667455494404
activity O 0 0.0129183204844594
of O 0 0.017102662473917007
Na O 1 0.9999808073043823
+ O 1 0.8875876069068909
/ O 1 0.8506985902786255
K O 0 0.17674820125102997
+ O 0 0.06478291004896164
ATPase O 1 0.5941342711448669
and O 0 0.03690348565578461
sarcoplasmic O 1 0.9999216794967651
reticulum O 1 0.9999518394470215
Ca2 O 1 0.9997755885124207
+ O 1 0.9616102576255798
- O 1 0.9558754563331604
ATPase O 1 0.6841864585876465
are O 0 0.016888480633497238
affected O 0 0.026746459305286407
by O 0 0.025248205289244652
DMPK O 1 0.9996180534362793
absence O 0 0.25143852829933167
. O 0 0.06374894827604294

In O 0 0.029577257111668587
conclusion O 0 0.028324641287326813
, O 0 0.016147999092936516
our O 0 0.012841966934502125
data O 0 0.011055287905037403
suggest O 0 0.011817023158073425
that O 0 0.009632469154894352
DMPK O 1 0.9848774671554565
is O 0 0.010107834823429585
involved O 0 0.010551230981945992
in O 0 0.009431620128452778
modulating O 0 0.025418635457754135
the O 0 0.01016053557395935
initial O 0 0.012728817760944366
events O 0 0.012742110528051853
of O 0 0.012951183132827282
excitation O 0 0.32842305302619934
- O 1 0.990836501121521
contraction O 1 0.8846216797828674
coupling O 0 0.16089506447315216
in O 0 0.03417878597974777
skeletal O 1 0.9999947547912598
muscle O 1 0.9997813105583191
. O 0 0.03364328294992447
. O 0 0.051911722868680954

Constitutional O 0 0.1316584348678589
RB1 O 1 0.9999958276748657
- O 1 0.9937071204185486
gene O 0 0.02879134565591812
mutations O 0 0.023795530200004578
in O 0 0.01611821912229061
patients O 1 0.9705395102500916
with O 0 0.020038463175296783
isolated O 1 0.7131929397583008
unilateral B-Disease 1 0.9878830313682556
retinoblastoma I-Disease 1 0.9999974966049194
. O 0 0.08042161911725998

In O 0 0.024329714477062225
most O 0 0.01628476195037365
patients O 0 0.06798943877220154
with O 0 0.00957238394767046
isolated O 0 0.09984219074249268
unilateral B-Disease 1 0.9881921410560608
retinoblastoma I-Disease 1 1.0
, O 1 0.9995569586753845
tumor B-Disease 1 0.9999997615814209
development O 0 0.0792355015873909
is O 0 0.01067945547401905
initiated O 0 0.024596886709332466
by O 0 0.012020430527627468
somatic O 0 0.07744703441858292
inactivation O 1 0.9076847434043884
of O 0 0.015705734491348267
both O 0 0.014482316561043262
alleles O 0 0.022876480594277382
of O 0 0.017949046567082405
the O 0 0.0456976480782032
RB1 O 1 0.9999971389770508
gene O 0 0.04591558873653412
. O 0 0.05228982865810394

However O 0 0.02023688144981861
, O 0 0.012226466089487076
some O 0 0.007829645648598671
of O 0 0.009086045436561108
these O 0 0.008045623078942299
patients O 1 0.8835904598236084
can O 0 0.012879342772066593
transmit O 1 0.9553973078727722
retinoblastoma B-Disease 1 0.9999977350234985
predisposition O 1 0.9999496936798096
to O 0 0.02212725393474102
their O 0 0.024825582280755043
offspring O 0 0.06358121335506439
. O 0 0.04655390605330467

To O 0 0.024165058508515358
determine O 0 0.020249785855412483
the O 0 0.013950055465102196
frequency O 0 0.013275116682052612
and O 0 0.009934894740581512
nature O 0 0.010526001453399658
of O 0 0.009617715142667294
constitutional O 0 0.028260070830583572
RB1 O 1 0.999998927116394
- O 1 0.9988007545471191
gene O 0 0.016956932842731476
mutations O 0 0.012668236158788204
in O 0 0.010143856517970562
patients O 0 0.25722983479499817
with O 0 0.010210365056991577
isolated O 0 0.08376403898000717
unilateral B-Disease 1 0.7696929574012756
retinoblastoma I-Disease 1 0.9999865293502808
, O 0 0.012307405471801758
we O 0 0.00955713726580143
analyzed O 0 0.013215954415500164
DNA O 0 0.013034358620643616
from O 0 0.011218532919883728
peripheral O 1 0.9995384216308594
blood O 1 0.8208357691764832
and O 0 0.022418340668082237
from O 0 0.35041797161102295
tumor B-Disease 1 0.9999997615814209
tissue O 1 0.9997420907020569
. O 0 0.05140117555856705

The O 0 0.026265650987625122
analysis O 0 0.02075900323688984
of O 0 0.01783020608127117
tumors B-Disease 1 0.998487114906311
from O 0 0.012119324877858162
54 O 0 0.025702761486172676
( O 0 0.011669370345771313
71 O 0 0.02295347861945629
% O 0 0.010502096265554428
) O 0 0.009972924366593361
of O 0 0.010577487759292126
76 O 0 0.03646678104996681
informative O 0 0.03549801930785179
patients O 0 0.2226969450712204
showed O 0 0.013716892339289188
loss O 0 0.017612144351005554
of O 0 0.01271320041269064
constitutional O 0 0.3290860652923584
heterozygosity O 1 0.9999992847442627
( O 1 0.9740455746650696
LOH O 1 1.0
) O 0 0.03416783735156059
at O 0 0.04652673751115799
intragenic O 1 0.9361792802810669
loci O 0 0.08401612937450409
. O 0 0.057598013430833817

Three O 0 0.02916889265179634
of O 0 0.02791675738990307
13 O 0 0.04431203752756119
uninformative O 1 0.9998643398284912
patients O 1 0.9968878626823425
had O 0 0.03458013758063316
constitutional O 0 0.07405852526426315
deletions O 1 0.8434590697288513
. O 0 0.06108018755912781

For O 0 0.03345874696969986
39 O 0 0.040440384298563004
randomly O 0 0.03212294727563858
selected O 0 0.03494827449321747
tumors B-Disease 1 0.9992033839225769
, O 0 0.024046489968895912
SSCP O 1 0.9994660019874573
, O 0 0.02799135074019432
hetero O 1 0.9998972415924072
- O 1 0.9817222952842712
duplex O 0 0.33360061049461365
analysis O 0 0.01445082575082779
, O 0 0.011395174078643322
sequencing O 0 0.0194130577147007
, O 0 0.011652758345007896
and O 0 0.010919715277850628
Southern O 0 0.01788789965212345
blot O 0 0.10884255915880203
analysis O 0 0.01369263231754303
were O 0 0.010622110217809677
used O 0 0.010952426120638847
to O 0 0.01418689638376236
identify O 0 0.028002990409731865
mutations O 0 0.03320613503456116
. O 0 0.03867832571268082

Mutations O 0 0.044110942631959915
were O 0 0.017940398305654526
detected O 0 0.019617469981312752
in O 0 0.012375587597489357
21 O 0 0.01788382977247238
( O 0 0.012024088762700558
91 O 0 0.02289375476539135
% O 0 0.010892310179769993
) O 0 0.011977373622357845
of O 0 0.015699023380875587
23 O 0 0.19702309370040894
tumors B-Disease 1 0.9999967813491821
with O 0 0.17577369511127472
LOH O 1 0.9999998807907104
. O 0 0.07026410847902298

In O 0 0.029586346819996834
6 O 0 0.031512513756752014
( O 0 0.016900550574064255
38 O 0 0.0233367457985878
% O 0 0.012709460221230984
) O 0 0.009873999282717705
of O 0 0.011091291904449463
16 O 0 0.029718071222305298
tumors B-Disease 1 0.9999902248382568
without O 0 0.018340786918997765
LOH O 1 0.9999995231628418
, O 0 0.012559624388813972
one O 0 0.010663894936442375
mutation O 0 0.011301257647573948
was O 0 0.012210904620587826
detected O 0 0.011204930953681469
, O 0 0.0064715975895524025
and O 0 0.00610515009611845
in O 0 0.006226763594895601
9 O 0 0.011116376146674156
( O 0 0.008083443157374859
56 O 0 0.01285926066339016
% O 0 0.007383351214230061
) O 0 0.006691247224807739
of O 0 0.00864313542842865
the O 0 0.013019816018640995
tumors B-Disease 1 0.9999959468841553
without O 0 0.07007720321416855
LOH O 1 1.0
, O 0 0.01760348305106163
both O 0 0.012155154719948769
mutations O 0 0.0166896004229784
were O 0 0.011888491921126842
found O 0 0.01794140785932541
. O 0 0.02899010479450226

Thus O 0 0.027695920318365097
, O 0 0.014358884654939175
a O 0 0.011288734152913094
total O 0 0.010098605416715145
of O 0 0.00900648720562458
45 O 0 0.013324721716344357
mutations O 0 0.010093310847878456
were O 0 0.007075480185449123
identified O 0 0.008899235166609287
in O 0 0.010819623246788979
tumors B-Disease 1 0.9999395608901978
of O 0 0.02096954546868801
36 O 0 0.48927637934684753
patients O 1 0.9944222569465637
. O 0 0.043538086116313934

Thirty O 0 0.06549583375453949
- O 0 0.03606787323951721
nine O 0 0.01746314764022827
of O 0 0.012600861489772797
the O 0 0.011726698838174343
mutations O 0 0.011691388674080372
- O 0 0.01599397324025631
including O 0 0.00898595992475748
34 O 0 0.013991161249577999
small O 0 0.008984965272247791
mutations O 0 0.009577176533639431
, O 0 0.007679859641939402
2 O 0 0.010917800478637218
large O 0 0.009354939684271812
structural O 0 0.16095833480358124
alterations O 0 0.021803492680191994
, O 0 0.009853832423686981
and O 0 0.010298963636159897
hypermethylation O 1 0.8640966415405273
in O 0 0.011762591078877449
3 O 0 0.2554604411125183
tumors O 1 0.9999971389770508
- O 0 0.22044764459133148
were O 0 0.0074210879392921925
not O 0 0.006328531540930271
detected O 0 0.012056902050971985
in O 0 0.00903069507330656
the O 0 0.011776854284107685
corresponding O 0 0.024933407083153725
peripheral O 1 0.999948263168335
blood O 1 0.9442586898803711
DNA O 0 0.04441514611244202
. O 0 0.03947184979915619

In O 0 0.027178578078746796
6 O 0 0.026809385046362877
( O 0 0.015553523786365986
17 O 0 0.017629187554121017
% O 0 0.01058624405413866
) O 0 0.007814202457666397
of O 0 0.008091016672551632
the O 0 0.008846338838338852
36 O 0 0.018717734143137932
patients O 0 0.10455921292304993
, O 0 0.008451619185507298
a O 0 0.009729155339300632
mutation O 0 0.012241529300808907
was O 0 0.00957120768725872
detected O 0 0.010522818192839622
in O 0 0.007181609980762005
constitutional O 0 0.010736357420682907
DNA O 0 0.009508714079856873
, O 0 0.0072527797892689705
and O 0 0.0065317535772919655
1 O 0 0.009139389730989933
of O 0 0.006946383509784937
these O 0 0.005632113199681044
mutations O 0 0.008111661300063133
is O 0 0.0062605030834674835
known O 0 0.007692367769777775
to O 0 0.0075830742716789246
be O 0 0.007476967293769121
associated O 0 0.011896461248397827
with O 0 0.015764305368065834
reduced O 0 0.04004292190074921
expressivity O 1 0.9993507266044617
. O 0 0.054614387452602386

The O 0 0.0235898420214653
presence O 0 0.015337858349084854
of O 0 0.010549347847700119
a O 0 0.011017373763024807
constitutional O 0 0.016999807208776474
mutation O 0 0.017380785197019577
was O 0 0.01131548173725605
not O 0 0.005224842112511396
associated O 0 0.006000659894198179
with O 0 0.005190650466829538
an O 0 0.006344405002892017
early O 0 0.012672369368374348
age O 0 0.05105981230735779
at O 0 0.12942291796207428
treatment O 1 0.9944730401039124
. O 0 0.04051565006375313

In O 0 0.03156933933496475
1 O 0 0.03206685930490494
patient O 1 0.7375845909118652
, O 0 0.02147943712770939
somatic O 1 0.8827357888221741
mosaicism O 1 0.9998626708984375
was O 0 0.027592357248067856
demonstrated O 0 0.020120512694120407
by O 0 0.009671421721577644
molecular O 0 0.01429230161011219
analysis O 0 0.010114663280546665
of O 0 0.00941463466733694
DNA O 0 0.014198391698300838
and O 0 0.01132870838046074
RNA O 0 0.025943981483578682
from O 0 0.020883075892925262
peripheral O 1 0.9999042749404907
blood O 1 0.7499976754188538
. O 0 0.042883679270744324

In O 0 0.026091214269399643
2 O 0 0.030159737914800644
patients O 0 0.025496477261185646
without O 0 0.010557794012129307
a O 0 0.013082348741590977
detectable O 0 0.20070874691009521
mutation O 0 0.01640072464942932
in O 0 0.012224589474499226
peripheral O 1 0.9999939203262329
blood O 1 0.99787437915802
, O 0 0.07022105157375336
mosaicism O 1 0.9999293088912964
was O 0 0.016130123287439346
suggested O 0 0.00854593887925148
because O 0 0.006644989363849163
1 O 0 0.009041116572916508
of O 0 0.008030261844396591
the O 0 0.0113237164914608
patients O 1 0.9997556805610657
showed O 1 0.9982993006706238
multifocal O 1 1.0
tumors B-Disease 1 1.0
and O 0 0.012384168803691864
the O 0 0.010118636302649975
other O 0 0.010350045748054981
later O 0 0.019167564809322357
developed O 0 0.06786433607339859
bilateral B-Disease 1 0.7104899883270264
retinoblastoma I-Disease 1 0.9999164342880249
. O 0 0.06843607872724533

In O 0 0.029639529064297676
conclusion O 0 0.026325462386012077
, O 0 0.015928784385323524
our O 0 0.014191905967891216
results O 0 0.01242605596780777
emphasize O 0 0.01793191023170948
that O 0 0.006705003324896097
the O 0 0.010316948406398296
manifestation O 1 0.9473772644996643
and O 0 0.015759779140353203
transmissibility O 1 0.9999181032180786
of O 0 0.12724505364894867
retinoblastoma B-Disease 1 0.9999884366989136
depend O 0 0.010882159695029259
on O 0 0.007893078029155731
the O 0 0.007347811944782734
nature O 0 0.007629541680216789
of O 0 0.006429451983422041
the O 0 0.006660710088908672
first O 0 0.00879480317234993
mutation O 0 0.009081942960619926
, O 0 0.005487376824021339
its O 0 0.005254159215837717
time O 0 0.005033254157751799
in O 0 0.005375690292567015
development O 0 0.006424394436180592
, O 0 0.005204336252063513
and O 0 0.0047442433424293995
the O 0 0.0053042941726744175
number O 0 0.0047200932167470455
and O 0 0.005166613031178713
types O 0 0.005542689468711615
of O 0 0.006427512038499117
cells O 0 0.009538567624986172
that O 0 0.006217962130904198
are O 0 0.007258268538862467
affected O 0 0.015310912393033504
. O 0 0.02016574889421463
. O 0 0.0343908853828907

Hereditary B-Disease 1 0.9999997615814209
deficiency I-Disease 1 0.9999998807907104
of I-Disease 0 0.036835167557001114
the I-Disease 0 0.1776372492313385
fifth I-Disease 1 0.9993926286697388
component I-Disease 1 0.8953403830528259
of I-Disease 0 0.020860906690359116
complement I-Disease 0 0.047667745500802994
in O 0 0.02532353065907955
man O 0 0.04956828057765961
. O 0 0.042776428163051605

I O 0 0.2031102180480957
. O 0 0.08676604926586151

Clinical O 1 0.9920601844787598
, O 0 0.03826050087809563
immunochemical O 1 0.9948740601539612
, O 0 0.026887863874435425
and O 0 0.026645082980394363
family O 0 0.03599114343523979
studies O 0 0.033549122512340546
. O 0 0.046200282871723175

The O 0 0.02715231105685234
first O 0 0.020453091710805893
recognized O 0 0.02022533118724823
human O 0 0.017336677759885788
kindred O 1 0.9999761581420898
with O 1 0.9717126488685608
hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.7918516397476196
the I-Disease 0 0.13724195957183838
fifth I-Disease 1 0.9943628311157227
component I-Disease 1 0.6979424953460693
of I-Disease 0 0.017845511436462402
complement I-Disease 1 0.9891381859779358
( O 0 0.4052390456199646
C5 O 1 0.9999948740005493
) O 0 0.020780829712748528
is O 0 0.02021600678563118
described O 0 0.03448669984936714
. O 0 0.04147127643227577

The O 0 0.04386962577700615
proband O 0 0.10362578183412552
, O 0 0.016499970108270645
a O 0 0.014171479269862175
20 O 0 0.015639036893844604
- O 0 0.02143077179789543
year O 0 0.013536643236875534
- O 0 0.15154027938842773
old O 0 0.02108517661690712
black O 0 0.02224532514810562
female O 0 0.16346776485443115
with O 1 0.9755488634109497
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 1 0.9810487031936646
age O 1 0.9308438897132874
11 O 0 0.0394756980240345
, O 0 0.031439408659935
lacked O 1 0.9997158646583557
serum O 1 0.9999994039535522
hemolytic O 1 1.0
complement O 1 0.9415178894996643
activity O 0 0.022208325564861298
, O 0 0.018889769911766052
even O 0 0.019796842709183693
during O 0 0.035705000162124634
remission O 1 0.9980995059013367
. O 0 0.05499380826950073

C5 O 1 0.9998373985290527
was O 0 0.18773384392261505
undetectable O 1 0.9255461692810059
in O 0 0.018097640946507454
her O 0 0.02954816073179245
serum O 1 0.9333528876304626
by O 0 0.013793502002954483
both O 0 0.017542416229844093
immunodiffusion O 1 0.9999202489852905
and O 1 0.8404695987701416
hemolytic O 1 1.0
assays O 1 0.603425920009613
. O 0 0.06100368872284889

Other O 0 0.02751758322119713
complement O 0 0.0367513969540596
components O 0 0.02277226746082306
were O 0 0.010546183213591576
normal O 0 0.012316931039094925
during O 0 0.013705382123589516
remission O 1 0.9995846152305603
of O 1 0.9263759255409241
lupus O 1 1.0
, O 0 0.2655428349971771
but O 0 0.015934227034449577
C1 O 1 0.9999986886978149
, O 0 0.023985089734196663
C4 O 1 0.999884843826294
, O 0 0.025864776223897934
C2 O 1 0.9999945163726807
, O 0 0.01779874600470066
and O 0 0.020632833242416382
C3 O 1 0.9999947547912598
levels O 0 0.03522133454680443
fell O 1 0.9661375284194946
during O 0 0.0997016504406929
exacerbations O 1 0.9999678134918213
. O 0 0.07114125788211823

A O 0 0.03568435087800026
younger O 0 0.031038733199238777
half O 0 0.01736791431903839
- O 1 0.7830552458763123
sister O 0 0.02427489310503006
, O 0 0.00828541349619627
who O 0 0.007638308685272932
had O 0 0.008042742498219013
no O 0 0.011658184230327606
underlying O 1 0.9999681711196899
disease O 1 1.0
, O 0 0.17331890761852264
was O 0 0.2589161992073059
also O 0 0.00802250113338232
found O 0 0.007493623998016119
to O 0 0.01118897832930088
lack O 0 0.029073892161250114
immunochemically O 1 0.9998831748962402
detectable O 1 0.9996263980865479
C5 O 1 0.9998884201049805
. O 0 0.06593002378940582

By O 0 0.05747749283909798
hemolytic O 1 0.9999998807907104
assay O 0 0.4924432337284088
, O 0 0.021765805780887604
she O 0 0.020350154489278793
exhibited O 0 0.0257091261446476
1 O 0 0.018962303176522255
- O 0 0.024220306426286697
2 O 0 0.015400825999677181
% O 0 0.009188470430672169
of O 0 0.009073304012417793
the O 0 0.011299324221909046
normal O 0 0.01769639551639557
serum O 1 0.9978259205818176
C5 O 1 0.9996254444122314
level O 0 0.016470499336719513
and O 0 0.011715336702764034
normal O 0 0.013000870123505592
concentrations O 0 0.017440514639019966
of O 0 0.0137669388204813
other O 0 0.015604786574840546
complement O 0 0.046489618718624115
components O 0 0.05164940282702446
. O 0 0.04755081981420517

C5 O 1 0.996884286403656
levels O 0 0.028002575039863586
of O 0 0.01674727164208889
other O 0 0.01143867988139391
family O 0 0.012725991196930408
members O 0 0.008215131238102913
were O 0 0.006052385549992323
either O 0 0.00643311720341444
normal O 0 0.006969439331442118
or O 0 0.005300124175846577
approximately O 0 0.006842121481895447
half O 0 0.009374518878757954
- O 0 0.02151438407599926
normal O 0 0.009986380115151405
, O 0 0.00917130708694458
consistent O 0 0.011223025619983673
with O 0 0.011562769301235676
autosomal O 1 0.9785042405128479
codominant O 1 0.998729407787323
inheritance O 0 0.06369408220052719
of O 0 0.013506500981748104
the O 0 0.01965413987636566
gene O 0 0.09432332217693329
determining O 1 0.9567008018493652
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.19682864844799042

Normal O 0 0.4836364686489105
hemolytic O 1 0.9999995231628418
titers O 1 0.9982594847679138
were O 0 0.017714913934469223
restored O 0 0.022257167845964432
to O 0 0.011035187169909477
both O 0 0.012583503499627113
homozygous O 0 0.15382932126522064
C5 B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999990463256836
deficient I-Disease 1 0.9999997615814209
( O 1 0.9052789211273193
C5D B-Disease 1 0.9999998807907104
) O 0 0.022396691143512726
sera O 1 0.5155825018882751
by O 0 0.014639772474765778
addition O 0 0.016482742503285408
of O 0 0.017923958599567413
highly O 0 0.03660902380943298
purified O 1 0.8289753794670105
human O 0 0.07092432677745819
C5 O 1 0.9997352957725525
. O 0 0.07712823152542114

In O 0 0.03460202366113663
specific O 0 0.029094917699694633
C5 O 1 0.9999740123748779
titrations O 1 0.9971721768379211
, O 0 0.01547233946621418
however O 0 0.009323792532086372
, O 0 0.008623265661299229
it O 0 0.007212857715785503
was O 0 0.010261567309498787
noted O 0 0.008955932222306728
that O 0 0.00570741156116128
when O 0 0.007237664423882961
limited O 0 0.008819317445158958
amounts O 0 0.009130164980888367
of O 0 0.010995764285326004
C5 O 1 0.9819101691246033
were O 0 0.010029967874288559
assayed O 0 0.02219214290380478
in O 0 0.008439511992037296
the O 0 0.007472789380699396
presence O 0 0.00880368147045374
of O 0 0.008629602380096912
low O 0 0.014462796971201897
dilutions O 0 0.11040490865707397
of O 0 0.013315019197762012
either O 0 0.018424198031425476
C5D B-Disease 1 0.9999994039535522
serum O 1 0.9992809891700745
, O 0 0.016264332458376884
curving O 0 0.027533331885933876
rather O 0 0.010315166786313057
than O 0 0.01000598631799221
linear O 0 0.01629895344376564
dose O 1 0.7485719919204712
- O 0 0.14743773639202118
response O 0 0.015299958176910877
plots O 0 0.019281700253486633
were O 0 0.010195263661444187
consistently O 0 0.01769273728132248
obtained O 0 0.016804900020360947
, O 0 0.01611521653831005
suggesting O 0 0.022911064326763153
some O 0 0.01762368157505989
inhibitory O 0 0.05461772903800011
effect O 0 0.03271302953362465
. O 0 0.045809630304574966

Further O 0 0.029518654569983482
studies O 0 0.02292591519653797
suggested O 0 0.019378861412405968
that O 0 0.011007801629602909
low O 0 0.017723575234413147
dilutions O 0 0.23170866072177887
of O 0 0.01880587823688984
C5D B-Disease 1 0.9999992847442627
serum O 1 0.9971230626106262
contain O 0 0.015412217006087303
a O 0 0.01449528057128191
factor O 0 0.08014059066772461
( O 0 0.010271549224853516
or O 0 0.008690869435667992
factors O 0 0.009235777892172337
) O 0 0.008867397904396057
interfering O 0 0.013122468255460262
at O 0 0.008316793479025364
some O 0 0.006246653385460377
step O 0 0.010903277434408665
in O 0 0.009069835767149925
the O 0 0.014675358310341835
hemolytic O 1 0.9999998807907104
assay O 1 0.5632807016372681
of O 0 0.02641412615776062
C5 O 1 0.9999547004699707
, O 0 0.012817556038498878
rather O 0 0.01121995598077774
than O 0 0.01036518719047308
a O 0 0.016411112621426582
true O 0 0.11836708337068558
C5 O 1 0.9999970197677612
inhibitor O 1 0.9997380375862122
or O 0 0.04141906648874283
inactivator O 1 0.9827759265899658
. O 0 0.05863518640398979

Of O 0 0.03241918236017227
clinical O 1 0.8783336281776428
interest O 0 0.015520943328738213
are O 0 0.007136957719922066
( O 0 0.008553998544812202
a O 0 0.008919809944927692
) O 0 0.007672711741179228
the O 0 0.008079628460109234
documentation O 0 0.01731022261083126
of O 0 0.04740539938211441
membranous O 1 1.0
glomerulonephritis B-Disease 1 1.0
, O 1 0.9999673366546631
vasculitis B-Disease 1 1.0
, O 1 0.9988759160041809
and O 1 0.9997095465660095
arthritis B-Disease 1 1.0
in O 0 0.013840504921972752
an O 0 0.012128462083637714
individual O 0 0.016149085015058517
lacking O 1 0.9993768334388733
C5 O 1 0.9999990463256836
( O 0 0.011581231839954853
and O 0 0.008201236836612225
its O 0 0.009615571238100529
biologic O 1 0.9759911894798279
functions O 0 0.009873597882688046
) O 0 0.008094814606010914
, O 0 0.007899077609181404
and O 0 0.007449211552739143
( O 0 0.010709513910114765
b O 0 0.0172234196215868
) O 0 0.008351440541446209
a O 0 0.009710035286843777
remarkable O 0 0.01769918017089367
propensity O 1 0.7193123698234558
to O 0 0.026031700894236565
bacterial B-Disease 1 0.9999997615814209
infections I-Disease 1 0.9999984502792358
in O 0 0.012445016764104366
the O 0 0.017312023788690567
proband O 1 0.9977654218673706
, O 0 0.010279438458383083
even O 0 0.008304990828037262
during O 0 0.00978032872080803
periods O 0 0.011814461089670658
of O 0 0.009780763648450375
low O 0 0.018992818892002106
- O 0 0.10401542484760284
dose O 0 0.036584850400686264
or O 0 0.011924591846764088
alternate O 0 0.025711664929986
- O 1 0.9720475673675537
day O 0 0.18748076260089874
corticosteroid O 1 0.9999948740005493
therapy O 1 0.9998183846473694
. O 0 0.054786477237939835

Other O 0 0.024055365473031998
observations O 0 0.025349518284201622
indicate O 0 0.014458081685006618
that O 0 0.0084821917116642
the O 0 0.012899314984679222
C5D B-Disease 1 0.9983713030815125
state O 0 0.01065670233219862
is O 0 0.009769750759005547
compatible O 0 0.016784513369202614
with O 0 0.009652642533183098
normal O 0 0.01735803671181202
coagulation O 1 0.9906678795814514
function O 0 0.010614895261824131
and O 0 0.00863309483975172
the O 0 0.009377495385706425
capacity O 0 0.01408162247389555
to O 0 0.013105369172990322
mount O 0 0.36732786893844604
a O 0 0.039257071912288666
neutrophilic O 1 0.9999997615814209
leukocytosis O 1 0.9999997615814209
during O 1 0.9997530579566956
pyogenic B-Disease 1 0.9999998807907104
infection I-Disease 1 0.9999995231628418
. O 0 0.0385647676885128
. O 0 0.05228472501039505

Susceptibility O 1 0.9989469647407532
to O 1 0.7128458023071289
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 0 0.20769256353378296
twins O 1 0.9330762028694153
: O 0 0.016341393813490868
the O 0 0.011911840178072453
role O 0 0.012065737508237362
of O 0 0.011380203068256378
genes O 0 0.01428358443081379
, O 0 0.09931006282567978
HLA O 1 0.9999996423721313
, O 0 0.015090804547071457
and O 0 0.01427143719047308
the O 0 0.019712870940566063
environment O 0 0.035346727818250656
. O 0 0.040825892239809036

OBJECTIVE O 0 0.04912716895341873
To O 0 0.01881151832640171
determine O 0 0.014113115146756172
the O 0 0.011276531033217907
relative O 0 0.013029733672738075
effects O 0 0.01212890725582838
of O 0 0.008353202603757381
genetic O 0 0.011493885889649391
and O 0 0.007461091503500938
environmental O 0 0.019348176196217537
factors O 0 0.009901097044348717
in O 0 0.011226397007703781
susceptibility O 1 0.9999724626541138
to O 1 0.9973152279853821
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 1 0.9997398257255554
AS B-Disease 1 0.9989516735076904
) O 0 0.03940226137638092
. O 0 0.049091193825006485

METHODS O 0 0.04267848655581474
Twins O 0 0.058278072625398636
with O 0 0.012979833409190178
AS B-Disease 0 0.014953982084989548
were O 0 0.008056913502514362
identified O 0 0.007550667505711317
from O 0 0.005649861413985491
the O 0 0.007898314855992794
Royal O 1 0.7807210683822632
National O 1 0.998561441898346
Hospital O 1 1.0
for O 1 0.9999550580978394
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 1.0
database O 1 0.9990938901901245
. O 0 0.07020806521177292

Clinical O 1 0.9840989708900452
and O 0 0.03175125643610954
radiographic O 1 0.9993751645088196
examinations O 0 0.10466980189085007
were O 0 0.010971803218126297
performed O 0 0.01229424774646759
to O 0 0.009346122853457928
establish O 0 0.017270313575863838
diagnoses O 1 0.9999794960021973
, O 0 0.27743223309516907
and O 1 0.9495638012886047
disease O 1 1.0
severity O 1 0.9999958276748657
was O 1 0.634558379650116
assessed O 0 0.01630946807563305
using O 0 0.01149989664554596
a O 0 0.01262859907001257
combination O 0 0.016634872183203697
of O 0 0.015003024600446224
validated O 0 0.038966499269008636
scoring O 0 0.03437681123614311
systems O 0 0.053769901394844055
. O 0 0.05001288279891014

HLA O 1 0.9979324340820312
typing O 0 0.08763602375984192
for O 0 0.03678121417760849
HLA O 1 0.9999955892562866
- O 1 0.9938010573387146
B27 O 1 0.9840813875198364
, O 0 0.03649952635169029
HLA O 1 0.9999980926513672
- O 1 0.9559023380279541
B60 O 1 0.8459339141845703
, O 0 0.017110005021095276
and O 0 0.02246515266597271
HLA O 1 1.0
- O 1 0.999895453453064
DR1 O 1 0.9999336004257202
was O 0 0.024292733520269394
performed O 0 0.017257895320653915
by O 0 0.012603817507624626
polymerase O 0 0.03120403178036213
chain O 0 0.021847398951649666
reaction O 0 0.01261090487241745
with O 0 0.008456284180283546
sequence O 0 0.01110030710697174
- O 0 0.020433058962225914
specific O 0 0.01223104540258646
primers O 0 0.030491188168525696
, O 0 0.011828632093966007
and O 0 0.01392186526209116
zygosity O 1 0.5935079455375671
was O 0 0.023325737565755844
assessed O 0 0.03696637973189354
using O 0 0.032691288739442825
microsatellite O 1 0.9822152256965637
markers O 0 0.09169532358646393
. O 0 0.062133610248565674

Genetic O 0 0.04241323843598366
and O 0 0.017448149621486664
environmental O 0 0.02181513048708439
variance O 0 0.0168863907456398
components O 0 0.016346903517842293
were O 0 0.007883965037763119
assessed O 0 0.012527501210570335
with O 0 0.008007205091416836
the O 0 0.010368234477937222
program O 0 0.01969178393483162
Mx O 1 0.9956254959106445
, O 0 0.008583618327975273
using O 0 0.006086856126785278
data O 0 0.005490692798048258
from O 0 0.005172609351575375
this O 0 0.0047570280730724335
and O 0 0.00557989114895463
previous O 0 0.007794430945068598
studies O 0 0.009703444316983223
of O 0 0.011492060497403145
twins O 0 0.47415876388549805
with O 0 0.01758730225265026
AS B-Disease 1 0.6242635846138
. O 0 0.0420660525560379

RESULTS O 0 0.04449117183685303
Six O 0 0.02538302168250084
of O 0 0.018519489094614983
8 O 0 0.031190374866127968
monozygotic O 1 0.9931579232215881
( O 0 0.06702619791030884
MZ O 1 0.999998927116394
) O 0 0.02287512645125389
twin O 0 0.07034328579902649
pairs O 0 0.02390887401998043
were O 0 0.014729568734765053
disease O 1 0.9999517202377319
concordant O 1 0.9372883439064026
, O 0 0.010403992608189583
compared O 0 0.009886919520795345
with O 0 0.006647387985140085
4 O 0 0.011447613127529621
of O 0 0.009431620128452778
15 O 0 0.01777937449514866
B27 O 0 0.26475992798805237
- O 0 0.0348857156932354
positive O 0 0.02167493849992752
dizygotic O 1 0.9649654626846313
( O 0 0.026502298191189766
DZ O 1 0.9999085664749146
) O 0 0.01921270415186882
twin O 0 0.03807341679930687
pairs O 0 0.016560569405555725
( O 0 0.011703455820679665
27 O 0 0.016650933772325516
% O 0 0.010684868320822716
) O 0 0.00845785066485405
and O 0 0.008039196953177452
4 O 0 0.013286408968269825
of O 0 0.013107522390782833
32 O 0 0.026848405599594116
DZ O 1 0.9983933568000793
twin O 0 0.10768331587314606
pairs O 0 0.019688881933689117
overall O 0 0.01868545636534691
( O 0 0.012080462649464607
12 O 0 0.01535585056990385
. O 0 0.014027731493115425
5 O 0 0.023257659748196602
% O 0 0.021517300978302956
) O 0 0.02917954884469509
. O 0 0.03883013129234314

Nonsignificant O 1 0.9160978198051453
increases O 0 0.031066566705703735
in O 0 0.013966587372124195
similarity O 0 0.015625977888703346
with O 0 0.007887541316449642
regard O 0 0.009753742255270481
to O 0 0.008406663313508034
age O 0 0.20948180556297302
at O 1 0.9910430908203125
disease O 1 1.0
onset O 1 0.9999995231628418
and O 0 0.007884811609983444
all O 0 0.006336993537843227
of O 0 0.008563592098653316
the O 0 0.3363597095012665
disease O 1 0.9999995231628418
severity O 1 0.9996607303619385
scores O 0 0.015498359687626362
assessed O 0 0.014365063048899174
were O 0 0.00888571422547102
noted O 0 0.013760000467300415
in O 0 0.017260408028960228
disease O 1 0.9999985694885254
- O 1 0.9998642206192017
concordant O 1 0.9999063014984131
MZ O 1 0.9999997615814209
twins O 1 0.8724501132965088
compared O 0 0.03614519536495209
with O 0 0.031674206256866455
concordant O 1 0.9982596039772034
DZ O 1 0.9999929666519165
twins O 1 0.9773592352867126
. O 0 0.07954423129558563

HLA O 1 0.9999988079071045
- O 1 0.9965975880622864
B27 O 1 0.8697875738143921
and O 0 0.017947329208254814
B60 O 0 0.18170645833015442
were O 0 0.008617258630692959
associated O 0 0.009056051261723042
with O 0 0.006864911876618862
the O 0 0.05012567341327667
disease O 1 0.9999986886978149
in O 0 0.044903844594955444
probands O 1 0.9999792575836182
, O 0 0.00809496734291315
and O 0 0.006550907623022795
the O 0 0.006497805006802082
rate O 0 0.008494265377521515
of O 0 0.011485178023576736
disease O 1 0.9999814033508301
concordance O 1 0.8758419752120972
was O 0 0.014750240370631218
significantly O 0 0.012352785095572472
increased O 0 0.011797104962170124
among O 0 0.014032255858182907
DZ O 1 0.9999551773071289
twin O 0 0.4079138934612274
pairs O 0 0.012077879160642624
in O 0 0.007067692466080189
which O 0 0.006079864222556353
the O 0 0.008959989063441753
co O 1 0.9620316624641418
- O 1 0.9928277134895325
twin O 1 0.7877383232116699
was O 0 0.014490596018731594
positive O 0 0.010995660908520222
for O 0 0.010016463696956635
both O 0 0.015880491584539413
B27 O 1 0.9318830370903015
and O 0 0.035122714936733246
DR1 O 1 0.9992035031318665
. O 0 0.06201764568686485

Additive O 0 0.0906047374010086
genetic O 0 0.04161665588617325
effects O 0 0.02456878311932087
were O 0 0.010812178254127502
estimated O 0 0.012937762774527073
to O 0 0.01171834021806717
contribute O 0 0.017433390021324158
97 O 0 0.029216745868325233
% O 0 0.013583466410636902
of O 0 0.012794028967618942
the O 0 0.01564430072903633
population O 0 0.017763733863830566
variance O 0 0.03662169352173805
. O 0 0.045804694294929504

CONCLUSION O 0 0.059512123465538025
Susceptibility O 0 0.3135313391685486
to O 0 0.017671668902039528
AS B-Disease 0 0.0197360310703516
is O 0 0.009452522732317448
largely O 0 0.010277303867042065
genetically O 0 0.012007281184196472
determined O 0 0.009877757169306278
, O 0 0.007216744124889374
and O 0 0.00644549448043108
the O 0 0.008344643749296665
environmental O 0 0.01579667069017887
trigger O 0 0.061621151864528656
for O 0 0.012608766555786133
the O 1 0.723457932472229
disease O 1 0.9999998807907104
is O 0 0.10743455588817596
probably O 1 0.5255997180938721
ubiquitous O 1 0.9497169852256775
. O 0 0.049151211977005005

HLA O 1 0.9999946355819702
- O 1 0.9414007067680359
B27 O 0 0.07344108819961548
accounts O 0 0.01761074922978878
for O 0 0.010712716728448868
a O 0 0.011208165436983109
minority O 0 0.011015030555427074
of O 0 0.00825060810893774
the O 0 0.011203853413462639
overall O 1 0.8513859510421753
genetic O 1 0.8067995309829712
susceptibility O 1 0.9980533123016357
to O 0 0.020307306200265884
AS B-Disease 0 0.1308429092168808
. O 0 0.0403912216424942

Cell O 0 0.1105768084526062
cycle O 0 0.04102419316768646
- O 0 0.0523749515414238
dependent O 0 0.026403341442346573
colocalization O 1 0.5173429846763611
of O 0 0.02322647161781788
BARD1 O 1 0.9999768733978271
and O 0 0.12206452339887619
BRCA1 O 1 0.9998114705085754
proteins O 0 0.017884718254208565
in O 0 0.01441502571105957
discrete O 0 0.03248218446969986
nuclear O 0 0.0474511943757534
domains O 0 0.0679129883646965
. O 0 0.054490093141794205

Germ O 1 0.999653697013855
- O 1 0.6030782461166382
line O 0 0.03183325380086899
mutations O 0 0.019181743264198303
of O 0 0.012428062036633492
the O 0 0.016399169340729713
BRCA1 O 1 0.9996612071990967
gene O 0 0.01720036007463932
predispose O 0 0.039435818791389465
women O 0 0.00970565713942051
to O 0 0.007468090858310461
early O 0 0.012418637983500957
- O 1 0.9999816417694092
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 1 0.9999959468841553
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 0.012307096272706985
compromising O 1 0.991459846496582
the O 0 0.03972344100475311
genes O 0 0.03194897249341011
presumptive O 1 0.9999847412109375
function O 0 0.015511940233409405
as O 0 0.016584916040301323
a O 0 0.3102857172489166
tumor B-Disease 1 0.9999959468841553
suppressor O 1 0.9994206428527832
. O 0 0.055949073284864426

Although O 0 0.027801066637039185
the O 0 0.022030353546142578
biochemical O 0 0.03442472964525223
properties O 0 0.01842719130218029
of O 0 0.01655358076095581
BRCA1 O 1 0.9999520778656006
polypeptides O 0 0.0421191081404686
are O 0 0.0065353563986718655
not O 0 0.006431487388908863
understood O 0 0.009194266982376575
, O 0 0.007682981435209513
their O 0 0.006484747864305973
expression O 0 0.00929996371269226
pattern O 0 0.012208246625959873
and O 0 0.011364664882421494
subcellular O 0 0.05913562700152397
localization O 0 0.026014231145381927
suggest O 0 0.012143176048994064
a O 0 0.01168170664459467
role O 0 0.012624473311007023
in O 0 0.013143956661224365
cell O 0 0.24240374565124512
- O 1 0.7665185928344727
cycle O 0 0.03699091821908951
regulation O 0 0.045477695763111115
. O 0 0.04607267677783966

When O 0 0.06176196411252022
resting O 1 0.9945372939109802
cells O 0 0.02779921516776085
are O 0 0.010237965732812881
induced O 0 0.17890824377536774
to O 0 0.013848935253918171
proliferate O 0 0.030447151511907578
, O 0 0.011937442235648632
the O 0 0.010801916942000389
steady O 0 0.017806541174650192
- O 0 0.015804264694452286
state O 0 0.007897814735770226
levels O 0 0.008319837972521782
of O 0 0.00904474500566721
BRCA1 O 0 0.34541812539100647
increase O 0 0.009309472516179085
in O 0 0.009913576766848564
late O 0 0.020658621564507484
G1 O 1 0.9974472522735596
and O 0 0.011165806092321873
reach O 0 0.016499817371368408
a O 0 0.014712332747876644
maximum O 0 0.022977862507104874
during O 0 0.03066755272448063
S O 1 0.6632617712020874
phase O 0 0.07046040892601013
. O 0 0.05702539160847664

Moreover O 0 0.04436695575714111
, O 0 0.01968437060713768
in O 0 0.016160884872078896
S O 1 0.990019679069519
phase O 1 0.7171571850776672
cells O 0 0.024856898933649063
, O 0 0.020645873621106148
BRCA1 O 1 0.9977117776870728
polypeptides O 0 0.0337073877453804
are O 0 0.01164642721414566
hyperphosphorylated O 1 0.6717637181282043
and O 0 0.01626458577811718
accumulate O 0 0.030362524092197418
into O 0 0.020123446360230446
discrete O 0 0.03740392252802849
subnuclear O 1 0.9819179773330688
foci O 1 0.9858309626579285
termed O 1 0.7042034268379211
" O 0 0.04419219121336937
BRCA1 O 1 0.9994747042655945
nuclear O 0 0.07398391515016556
dots O 0 0.10444145649671555
. O 0 0.0582486130297184

" O 0 0.05524327978491783
BRCA1 O 1 0.9964331388473511
associates O 0 0.18285080790519714
in O 0 0.01773490384221077
vivo O 0 0.04209926724433899
with O 0 0.014630855061113834
a O 0 0.022697871550917625
structurally O 0 0.4814590513706207
related O 0 0.031849466264247894
protein O 0 0.03904328867793083
termed O 0 0.48354122042655945
BARD1 O 1 0.9996070265769958
. O 0 0.06195838376879692

Here O 0 0.027056889608502388
we O 0 0.014290481805801392
show O 0 0.013067868538200855
that O 0 0.006818811874836683
the O 0 0.00916507001966238
steady O 0 0.016437595710158348
- O 0 0.015902727842330933
state O 0 0.006679093930870295
levels O 0 0.008267933502793312
of O 0 0.009847540408372879
BARD1 O 1 0.977071225643158
, O 0 0.010194522328674793
unlike O 0 0.009964383207261562
those O 0 0.006457037758082151
of O 0 0.011078272014856339
BRCA1 O 1 0.9948017597198486
, O 0 0.011147378012537956
remain O 0 0.012344969436526299
relatively O 0 0.012268069200217724
constant O 0 0.01695876009762287
during O 0 0.0225595161318779
cell O 0 0.4297128915786743
cycle O 0 0.11753720790147781
progression O 1 0.8504076600074768
. O 0 0.05167310684919357

However O 0 0.036751825362443924
, O 0 0.02623262256383896
immunostaining O 1 0.5780067443847656
revealed O 0 0.025096993893384933
that O 0 0.015179643407464027
BARD1 O 1 0.989696741104126
resides O 0 0.04050936922430992
within O 0 0.016756853088736534
BRCA1 O 1 0.9992964267730713
nuclear O 0 0.02417304366827011
dots O 0 0.029510458931326866
during O 0 0.016735464334487915
S O 0 0.07769130915403366
phase O 0 0.018389243632555008
of O 0 0.011175538413226604
the O 0 0.011306981556117535
cell O 0 0.06835711002349854
cycle O 0 0.013284839689731598
, O 0 0.008447759784758091
but O 0 0.007388735190033913
not O 0 0.006493576802313328
during O 0 0.01321055181324482
the O 0 0.02130058780312538
G1 O 1 0.9999390840530396
phase O 0 0.08362533152103424
. O 0 0.053889673203229904

Nevertheless O 0 0.07638084888458252
, O 0 0.035797253251075745
BARD1 O 1 0.9983002543449402
polypeptides O 0 0.042756903916597366
are O 0 0.008592046797275543
found O 0 0.008761283941566944
exclusively O 0 0.011390657164156437
in O 0 0.007537557277828455
the O 0 0.009081813506782055
nuclear O 0 0.01164028700441122
fractions O 0 0.015575171448290348
of O 0 0.00971153937280178
both O 0 0.01096438430249691
G1 O 1 0.9998557567596436
- O 1 0.9203269481658936
and O 0 0.020108770579099655
S O 1 0.9996356964111328
- O 1 0.9948015213012695
phase O 1 0.5007331371307373
cells O 0 0.051288262009620667
. O 0 0.053836189210414886

Therefore O 0 0.03998710960149765
, O 0 0.023786146193742752
progression O 0 0.06383741647005081
to O 0 0.016163036227226257
S O 1 0.9687172770500183
phase O 0 0.029619785025715828
is O 0 0.012728135101497173
accompanied O 0 0.0185992531478405
by O 0 0.009308134205639362
the O 0 0.011493008583784103
aggregation O 0 0.020990446209907532
of O 0 0.016021132469177246
nuclear O 0 0.032471489161252975
BARD1 O 1 0.9978691339492798
polypeptides O 0 0.05661548301577568
into O 0 0.03219524398446083
BRCA1 O 1 0.9971601963043213
nuclear O 0 0.061679162085056305
dots O 0 0.09098446369171143
. O 0 0.05856256186962128

This O 0 0.02702481299638748
cell O 0 0.03525669500231743
cycle O 0 0.03132714703679085
- O 0 0.057702697813510895
dependent O 0 0.023489654064178467
colocalization O 0 0.31796446442604065
of O 0 0.017902113497257233
BARD1 O 1 0.9999898672103882
and O 0 0.05538159981369972
BRCA1 O 1 0.9998276233673096
indicates O 0 0.016234606504440308
a O 0 0.011453880928456783
role O 0 0.011713940650224686
for O 0 0.0119323143735528
BARD1 O 1 0.9990484118461609
in O 0 0.02185397408902645
BRCA1 O 1 0.9999943971633911
- O 1 0.9999774694442749
mediated O 1 0.9999812841415405
tumor B-Disease 1 0.9999996423721313
suppression O 1 0.9998866319656372
. O 0 0.06447111070156097

Ethnic O 0 0.04332998767495155
differences O 0 0.0321047343313694
in O 0 0.022301120683550835
the O 0 0.025159325450658798
HFE O 1 0.9989142417907715
codon O 0 0.06700223684310913
282 O 1 0.9425539970397949
( O 0 0.24196594953536987
Cys O 1 0.9999969005584717
/ O 1 0.9998762607574463
Tyr O 1 0.9999837875366211
) O 0 0.058137197047472
polymorphism O 0 0.10657807439565659
. O 0 0.06436962634325027

Recent O 0 0.02570200152695179
studies O 0 0.01487864088267088
have O 0 0.008489569649100304
shown O 0 0.00956127792596817
that O 0 0.011221003718674183
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 1 0.9999994039535522
HH B-Disease 1 1.0
) O 0 0.02331915684044361
is O 0 0.009220559149980545
likely O 0 0.008659109473228455
to O 0 0.007132138125598431
be O 0 0.006834116764366627
caused O 0 0.01013143453747034
by O 0 0.007454480975866318
homozygosity O 0 0.358661025762558
for O 0 0.010768462903797626
a O 0 0.01596307009458542
Cys282Tyr O 1 0.9517872333526611
mutation O 0 0.020555371418595314
in O 0 0.013515469618141651
the O 0 0.02064126543700695
HFE O 1 0.9999316930770874
gene O 0 0.03289526328444481
located O 0 0.03784601017832756
4 O 0 0.0440090037882328
. O 0 0.047525182366371155

5 O 0 0.07879619300365448
Mb O 1 0.9584761261940002
telomeric O 1 0.9758716225624084
to O 0 0.053897012025117874
HLA O 1 0.9999983310699463
- O 1 0.9781474471092224
A O 0 0.08079862594604492
. O 0 0.06369443237781525

Population O 0 0.022833144292235374
studies O 0 0.01706663891673088
of O 0 0.01162134949117899
this O 0 0.008995710872113705
polymorphism O 0 0.01882159151136875
are O 0 0.006670330185443163
facilitated O 0 0.012879875488579273
by O 0 0.006628108210861683
the O 0 0.007886524312198162
fact O 0 0.007937566377222538
that O 0 0.007416172418743372
the O 0 0.014147311449050903
Cys282Tyr O 1 0.9922491312026978
mutation O 0 0.027206523343920708
creates O 0 0.030681926757097244
a O 0 0.025212407112121582
Rsal O 1 0.9937660694122314
restriction O 0 0.04709520936012268
site O 0 0.05431913584470749
. O 0 0.04957783594727516

We O 0 0.02866688184440136
have O 0 0.016054783016443253
studied O 0 0.021749049425125122
the O 0 0.016633210703730583
codon O 0 0.03429236263036728
282 O 0 0.1622968316078186
( O 0 0.04225722327828407
Cys O 1 0.9999984502792358
/ O 1 0.9998207688331604
Tyr O 1 0.999931812286377
) O 0 0.02528628148138523
polymorphism O 0 0.03359689190983772
in O 0 0.016149325296282768
different O 0 0.012748068198561668
ethnic O 0 0.019201571121811867
groups O 0 0.024880383163690567
. O 0 0.041262321174144745

In O 0 0.024396292865276337
agreement O 0 0.017936432734131813
with O 0 0.013374829664826393
previous O 0 0.01548631303012371
observations O 0 0.02283126302063465
the O 0 0.01968425139784813
Tyr O 1 0.9999295473098755
allele O 0 0.027318835258483887
appeared O 0 0.014720472507178783
to O 0 0.009498453699052334
be O 0 0.007423550356179476
rare O 0 0.011406799778342247
or O 0 0.009516398422420025
absent O 0 0.017297664657235146
in O 0 0.011581367813050747
Asiatic O 1 0.9992794394493103
( O 0 0.01470380648970604
Indian O 0 0.02205588109791279
, O 0 0.016171995550394058
Chinese O 0 0.02633635140955448
) O 0 0.02399650402367115
populations O 0 0.030746588483452797
. O 0 0.0420665480196476

The O 0 0.030504662543535233
highest O 0 0.0353759340941906
allele O 0 0.026518655940890312
frequency O 0 0.016151396557688713
( O 0 0.011163871735334396
7 O 0 0.015291326679289341
. O 0 0.008430063724517822
5 O 0 0.01242811419069767
% O 0 0.011139453388750553
) O 0 0.010995122604072094
was O 0 0.015969285741448402
found O 0 0.013522426597774029
in O 0 0.019081924110651016
Swedes O 0 0.06314001977443695
. O 0 0.04345500469207764

Saamis O 1 0.8806347846984863
( O 0 0.026093333959579468
2 O 0 0.024973157793283463
% O 0 0.014141653664410114
) O 0 0.012305954471230507
and O 0 0.011447607539594173
Mordvinians O 1 0.6310948133468628
( O 0 0.010988770984113216
1 O 0 0.012520972639322281
. O 0 0.008629626594483852
8 O 0 0.013593032956123352
% O 0 0.010476883500814438
) O 0 0.010578630492091179
had O 0 0.013735046610236168
significantly O 0 0.015963450074195862
lower O 0 0.016143349930644035
frequencies O 0 0.01853940449655056
of O 0 0.01868949644267559
the O 0 0.03369669243693352
Tyr O 1 0.9999376535415649
allele O 0 0.10036373138427734
. O 0 0.06101292371749878

Comparisons O 0 0.05358858034014702
with O 0 0.023937541991472244
allele O 0 0.0333755686879158
frequencies O 0 0.01969224028289318
based O 0 0.015106418170034885
on O 0 0.01276762317866087
prevalence O 0 0.03752603754401207
estimates O 0 0.01687765307724476
of O 0 0.0183689147233963
HH B-Disease 1 0.9999998807907104
showed O 0 0.020493019372224808
some O 0 0.010600932873785496
disagreements O 0 0.020233945921063423
with O 0 0.011681883595883846
the O 0 0.01395214069634676
RFLP O 1 0.8774209022521973
data O 0 0.014549083076417446
, O 0 0.01565653271973133
particularly O 0 0.019255205988883972
in O 0 0.023473836481571198
Finns O 0 0.13311046361923218
. O 0 0.0558837428689003

The O 0 0.043235428631305695
newly O 0 0.049108196049928665
described O 0 0.04062286391854286
HFE O 1 0.9999902248382568
marker O 1 0.5092035531997681
provides O 0 0.015523687936365604
a O 0 0.010039963759481907
new O 0 0.00913447979837656
approach O 0 0.008744444698095322
to O 0 0.007881821133196354
the O 0 0.00821327418088913
screening O 0 0.016002802178263664
of O 0 0.015619346871972084
HH B-Disease 1 0.9999998807907104
as O 0 0.009779801592230797
well O 0 0.0071498635224998
as O 0 0.006581779103726149
studies O 0 0.006616019178181887
of O 0 0.0063737607561051846
the O 0 0.006989294663071632
relationship O 0 0.009024031460285187
between O 0 0.008506865240633488
the O 0 0.015313023701310158
HFE O 1 0.9999997615814209
Tyr O 1 0.9999995231628418
allele O 0 0.399874210357666
and O 0 0.01850150153040886
different O 0 0.01934448443353176
disorders O 1 0.9999980926513672
including O 1 0.9372555017471313
cancer B-Disease 1 0.9999998807907104

Autosomal B-Disease 1 0.9999040365219116
dominant I-Disease 1 0.999975323677063
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
associated O 0 0.13240568339824677
with O 0 0.012925715185701847
a O 0 0.01756582036614418
missense O 0 0.037038836628198624
mutation O 0 0.0190107524394989
encoding O 0 0.02177933230996132
Gly23 O 1 0.9993576407432556
- O 1 0.99945467710495
- O 1 0.99957674741745
> O 1 0.9930739402770996
Val O 1 0.9919277429580688
in O 0 0.03137090802192688
neurophysin O 1 0.9995551705360413
II O 1 0.9998971223831177
. O 0 0.07244031876325607

Autosomal B-Disease 1 0.9993721842765808
dominant I-Disease 1 0.9998586177825928
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 1 0.9979466795921326
ADNDI B-Disease 1 0.9999995231628418
) O 0 0.014585277996957302
is O 0 0.010856418870389462
an O 1 0.6267086267471313
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 1 0.9999910593032837
by O 1 0.5061786770820618
progressive O 1 0.9999998807907104
degeneration O 1 1.0
of O 1 0.6722776889801025
the O 1 0.658561646938324
magnocellular O 1 0.9999951124191284
neurons O 0 0.029054885730147362
of O 0 0.01142987422645092
the O 0 0.013660033233463764
hypothalamus O 1 0.8544318675994873
leading O 0 0.03381643444299698
to O 0 0.01018358301371336
decreased O 0 0.01602734439074993
ability O 0 0.010794215835630894
to O 0 0.009821820072829723
produce O 0 0.012975258752703667
the O 0 0.016259940341114998
hormone O 1 0.8486540913581848
arginine O 0 0.3859998285770416
vasopressin O 1 0.9883085489273071
( O 0 0.06376875936985016
AVP O 1 0.9999077320098877
) O 0 0.05311287194490433
. O 0 0.05602812394499779

Affected O 0 0.0384274460375309
individuals O 0 0.01559748686850071
are O 0 0.008328547701239586
not O 0 0.00935888197273016
symptomatic O 1 0.9998981952667236
at O 0 0.050331320613622665
birth O 0 0.3033386766910553
, O 0 0.008792310021817684
but O 0 0.007651806343346834
usually O 0 0.010473260655999184
develop O 1 0.9422523379325867
diabetes B-Disease 1 1.0
insipidus I-Disease 1 0.9999992847442627
at O 0 0.05086401104927063
1 O 0 0.05224660411477089
- O 1 0.9541727900505066
6 O 0 0.0351351723074913
yr O 1 0.9703202843666077
of O 0 0.030401496216654778
age O 0 0.044467322528362274
. O 0 0.052916303277015686

The O 0 0.03221071884036064
genetic O 0 0.026909656822681427
locus O 0 0.036364179104566574
of O 0 0.014382395893335342
the O 0 0.06087367236614227
disease O 1 0.9999750852584839
is O 0 0.009579646401107311
the O 0 0.016065243631601334
AVP O 1 0.9999994039535522
- O 1 0.99988853931427
neurophysin O 1 0.999993085861206
II O 1 0.9999996423721313
( O 0 0.030608737841248512
NPII O 1 0.9999392032623291
) O 0 0.012249903753399849
gene O 0 0.011516808532178402
, O 0 0.00841846875846386
and O 0 0.008837566711008549
mutations O 0 0.00995299220085144
that O 0 0.0071053639985620975
cause O 1 0.8932686448097229
ADNDI B-Disease 1 0.9999817609786987
have O 0 0.006689263507723808
been O 0 0.006356190890073776
found O 0 0.006106677930802107
in O 0 0.005800653714686632
both O 0 0.006336717400699854
the O 0 0.008985241875052452
signal O 0 0.015251792035996914
peptide O 0 0.02034260705113411
of O 0 0.011351269669830799
the O 0 0.014300540089607239
prepro O 1 0.9990468621253967
- O 1 0.9998416900634766
AVP O 1 0.9999992847442627
- O 1 0.9996343851089478
NPII O 1 0.999940037727356
precursor O 0 0.13697999715805054
and O 0 0.023047570139169693
within O 0 0.03206108510494232
NPII O 1 0.9990065693855286
itself O 0 0.05649442970752716
. O 0 0.05480549857020378

An O 0 0.02979137748479843
affected O 0 0.026708871126174927
girl O 0 0.029547715559601784
who O 0 0.013038291595876217
presented O 0 0.013811671175062656
at O 0 0.010892469435930252
9 O 0 0.011802438646554947
months O 0 0.0076643615029752254
of O 0 0.007718920242041349
age O 0 0.009682745672762394
and O 0 0.006867272779345512
her O 0 0.010673562996089458
similarly O 0 0.01393527165055275
affected O 0 0.016160452738404274
younger O 1 0.5401037335395813
brother O 1 0.565211832523346
and O 0 0.00914040394127369
father O 0 0.014955876395106316
were O 0 0.005598012823611498
all O 0 0.005056921858340502
found O 0 0.0057153296656906605
to O 0 0.00572205102071166
have O 0 0.005184727720916271
a O 0 0.008616842329502106
novel O 0 0.01534806564450264
missense O 0 0.02300488017499447
mutation O 0 0.014491364359855652
( O 0 0.012260442599654198
G1758 O 1 0.9930639863014221
- O 1 0.9997621178627014
- O 1 0.9998501539230347
> O 1 0.9984985589981079
T O 1 0.9280149340629578
) O 0 0.01676139421761036
encoding O 0 0.019082192331552505
the O 0 0.017193276435136795
amino O 0 0.02329678274691105
acid O 0 0.0287608802318573
substitution O 0 0.040304530411958694
Gly23 O 1 0.9955162405967712
- O 1 0.9988284707069397
- O 1 0.9959654808044434
> O 1 0.9522634744644165
Val O 1 0.9523276686668396
within O 0 0.048559434711933136
NPII O 1 0.9986274242401123
. O 0 0.06357237696647644

The O 0 0.04335535317659378
mutation O 0 0.039568088948726654
was O 0 0.026677248999476433
confirmed O 0 0.021833350881934166
by O 0 0.01762072555720806
restriction O 0 0.037935927510261536
endonuclease O 0 0.4280419647693634
analysis O 0 0.044901441782712936
. O 0 0.05234519764780998

A O 0 0.09528867900371552
T1 O 1 0.9995741248130798
- O 0 0.08813158422708511
weighted O 0 0.039713092148303986
magnetic O 0 0.03361409157514572
resonance O 0 0.03367398679256439
imaging O 0 0.03712846338748932
of O 0 0.018708035349845886
the O 0 0.0229854267090559
fathers O 1 0.8612643480300903
pituitary O 1 0.9999977350234985
gland O 1 0.9999815225601196
demonstrates O 1 0.8987077474594116
an O 1 0.5749755501747131
attenuated O 1 0.9999978542327881
posterior O 1 0.9999970197677612
pituitary O 1 0.9999998807907104
bright O 1 0.9998586177825928
spot O 1 0.9215759038925171
. O 0 0.06708630919456482

This O 0 0.026537809520959854
mutation O 0 0.028071846812963486
may O 0 0.012016047723591328
be O 0 0.007967137731611729
valuable O 0 0.012363518588244915
for O 0 0.008169992826879025
developing O 0 0.011775955557823181
models O 0 0.015352316200733185
of O 0 0.017332494258880615
dominantly B-Disease 1 0.9999988079071045
inherited I-Disease 1 1.0
neurodegeneration I-Disease 1 1.0
, O 0 0.013845236971974373
as O 0 0.007694787345826626
the O 0 0.00721977511420846
early O 0 0.008094606921076775
age O 0 0.009186694398522377
of O 0 0.009473221376538277
onset O 1 0.9999984502792358
of O 1 0.8780410289764404
symptoms O 1 0.9999994039535522
suggests O 0 0.044168807566165924
that O 0 0.006482529919594526
this O 0 0.007181853521615267
mutation O 0 0.013276561163365841
may O 0 0.007797522004693747
be O 0 0.007237651385366917
particularly O 0 0.011320113204419613
deleterious O 0 0.021434668451547623
to O 0 0.014816057868301868
the O 0 0.025598451495170593
magnocellular O 1 0.9999792575836182
neuron O 1 0.9996882677078247
. O 0 0.036707501858472824
. O 0 0.050190236419439316

Frequent O 0 0.07355942577123642
inactivation O 1 0.9869368672370911
of O 0 0.09421961009502411
PTEN O 1 0.9999986886978149
/ O 1 0.9998559951782227
MMAC1 O 1 0.9999840259552002
in O 0 0.34067341685295105
primary O 1 0.9999940395355225
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.4492703378200531

Sporadic B-Disease 1 0.9999921321868896
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 0.02178656868636608
the O 0 0.013456635177135468
most O 0 0.010396032594144344
common O 0 0.02465944178402424
male B-Disease 1 0.9195687770843506
cancer I-Disease 1 0.9999967813491821
in O 0 0.007187108974903822
the O 0 0.008084123022854328
Western O 0 0.011506510898470879
world O 0 0.014071635901927948
, O 0 0.00742845656350255
yet O 0 0.006941638421267271
many O 0 0.004537828266620636
of O 0 0.0057166568003594875
the O 0 0.007047292310744524
major O 0 0.010453685186803341
genetic O 0 0.008106686174869537
events O 0 0.006936371326446533
involved O 0 0.006093601230531931
in O 0 0.005610583815723658
the O 0 0.00706448033452034
progression O 0 0.08673799782991409
of O 0 0.00706403236836195
this O 0 0.007620961405336857
often O 0 0.015408158302307129
fatal O 1 0.9999977350234985
cancer B-Disease 1 0.9999996423721313
remain O 0 0.019727010279893875
to O 0 0.015622501261532307
be O 0 0.021177880465984344
elucidated O 1 0.5650763511657715
. O 0 0.04840335249900818

Numerous O 0 0.046960584819316864
cytogenetic O 1 0.9759355187416077
and O 0 0.021303877234458923
allelotype O 1 0.9120034575462341
studies O 0 0.01425777468830347
have O 0 0.00847281888127327
reported O 0 0.012489458546042442
frequent O 0 0.014049974270164967
loss O 0 0.026843208819627762
of O 0 0.014652400277554989
heterozygosity O 1 0.999161958694458
on O 0 0.017153194174170494
chromosomal O 1 0.8602094054222107
arm O 1 0.996444046497345
10q O 1 0.9987599849700928
in O 0 0.15299545228481293
sporadic B-Disease 1 0.9999887943267822
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.40782204270362854

Deletion O 0 0.08468062430620193
mapping O 0 0.045292213559150696
studies O 0 0.021085884422063828
have O 0 0.011789681389927864
unambiguously O 0 0.025767141953110695
identified O 0 0.012324207462370396
a O 0 0.010040578432381153
region O 0 0.011572364717721939
of O 0 0.01070932112634182
chromosome O 0 0.03471110016107559
10q23 O 1 0.6229611039161682
to O 0 0.007784365676343441
be O 0 0.006185367237776518
the O 0 0.007788476999849081
minimal O 0 0.015353715978562832
area O 0 0.014851017855107784
of O 0 0.018612854182720184
loss O 1 0.9301404356956482
. O 0 0.040362101048231125

A O 0 0.040479402989149094
new O 0 0.036944083869457245
tumor B-Disease 1 0.999967098236084
suppressor O 1 0.998428463935852
gene O 0 0.028019333258271217
, O 0 0.025660034269094467
PTEN O 1 0.9999853372573853
/ O 1 0.9998162388801575
MMAC1 O 1 0.9999464750289917
, O 0 0.01661532185971737
was O 0 0.018543316051363945
isolated O 0 0.0154851283878088
recently O 0 0.013334402814507484
at O 0 0.009667517617344856
this O 0 0.00679357023909688
region O 0 0.009833931922912598
of O 0 0.01045367494225502
chromosome O 0 0.03542337194085121
10q23 O 1 0.7784262895584106
and O 0 0.00768158957362175
found O 0 0.006759191397577524
to O 0 0.006456563714891672
be O 0 0.006406336557120085
inactivated O 0 0.029819106683135033
by O 0 0.006572341546416283
mutation O 0 0.010110152885317802
in O 0 0.009220235981047153
three O 1 0.6988539099693298
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.9998685121536255
lines O 0 0.057685963809490204
. O 0 0.04801665619015694

We O 0 0.03203808516263962
screened O 0 0.058926086872816086
80 O 1 0.9646361470222473
prostate B-Disease 1 1.0
tumors I-Disease 1 0.999997615814209
by O 0 0.01381546352058649
microsatellite O 1 0.9539326429367065
analysis O 0 0.012627546675503254
and O 0 0.011138350702822208
found O 0 0.01195556577295065
chromosome O 0 0.01963471807539463
10q23 O 0 0.03255070000886917
to O 0 0.011180044151842594
be O 0 0.010015825740993023
deleted O 0 0.022521499544382095
in O 0 0.015291140414774418
23 O 0 0.03063010796904564
cases O 0 0.02767646126449108
. O 0 0.03941261023283005

We O 0 0.02847839705646038
then O 0 0.020427513867616653
proceeded O 0 0.02305491268634796
with O 0 0.009915369562804699
sequence O 0 0.009210823103785515
analysis O 0 0.007689069956541061
of O 0 0.006945504806935787
the O 0 0.009200281463563442
entire O 0 0.02597968280315399
PTEN O 1 0.9999980926513672
/ O 1 0.9995393753051758
MMAC1 O 1 0.9999527931213379
coding O 0 0.0389954075217247
region O 0 0.016498161479830742
and O 0 0.011810572817921638
tested O 0 0.01774480938911438
for O 0 0.010561320930719376
homozygous O 0 0.021511519327759743
deletion O 0 0.02059197425842285
with O 0 0.010060273110866547
new O 0 0.014172738417983055
intragenic O 1 0.9275988936424255
markers O 0 0.019939105957746506
in O 0 0.008511178195476532
these O 0 0.007176561746746302
23 O 0 0.015379702672362328
cases O 0 0.01257284265011549
with O 0 0.014777894131839275
10q23 O 1 0.9718842506408691
loss O 1 0.8770330548286438
of O 0 0.04798014089465141
heterozygosity O 1 0.9997813105583191
. O 0 0.06324761360883713

The O 0 0.027094338089227676
identification O 0 0.02160285785794258
of O 0 0.013343843631446362
the O 0 0.013437467627227306
second O 0 0.01821988634765148
mutational O 1 0.8846428394317627
event O 0 0.015800390392541885
in O 0 0.00848541222512722
10 O 0 0.010577622801065445
( O 0 0.00937766395509243
43 O 0 0.017155759036540985
% O 0 0.014467787928879261
) O 0 0.018861521035432816
tumors B-Disease 1 0.9998229146003723
establishes O 1 0.9964873790740967
PTEN O 1 0.9999994039535522
/ O 1 0.9994244575500488
MMAC1 O 1 0.9952730536460876
as O 0 0.016458075493574142
a O 0 0.017389794811606407
main O 0 0.021572476252913475
inactivation O 0 0.26950326561927795
target O 0 0.017627215012907982
of O 0 0.01467316597700119
10q O 0 0.26090574264526367
loss O 0 0.14580325782299042
in O 0 0.025851521641016006
sporadic B-Disease 1 0.9999957084655762
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.2563144862651825
. O 0 0.051656607538461685

Risk O 0 0.085157610476017
reversals O 0 0.05852962285280228
in O 0 0.019606441259384155
predictive O 0 0.06968238204717636
testing O 0 0.3068283796310425
for O 1 0.7956984639167786
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.12866899371147156

The O 0 0.025393184274435043
first O 0 0.018691914156079292
predictive O 0 0.024186566472053528
testing O 0 0.02014383114874363
for O 0 0.3361763656139374
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.8658183813095093
HD B-Disease 1 0.9996706247329712
) O 0 0.01277290191501379
was O 0 0.013691872358322144
based O 0 0.010278968140482903
on O 0 0.00884124357253313
analysis O 0 0.009265360422432423
of O 0 0.011503245681524277
linked O 0 0.017384376376867294
polymorphic O 0 0.03840801864862442
DNA O 0 0.0182148739695549
markers O 0 0.017638711258769035
to O 0 0.010925577022135258
estimate O 0 0.013511844910681248
the O 0 0.010824930854141712
likelihood O 0 0.01653924211859703
of O 0 0.013632305897772312
inheriting O 1 0.5929468870162964
the O 0 0.0189238078892231
mutation O 0 0.032144464552402496
for O 0 0.026158824563026428
HD B-Disease 1 0.8491470217704773
. O 0 0.05709802731871605

Limits O 0 0.03568194806575775
to O 0 0.01946190372109413
accuracy O 0 0.02370649017393589
included O 0 0.01683906279504299
recombination O 0 0.02011970616877079
between O 0 0.008875489234924316
the O 0 0.011130076833069324
DNA O 0 0.013625845313072205
markers O 0 0.015241676941514015
and O 0 0.009010184556245804
the O 0 0.010569253005087376
mutation O 0 0.01330497581511736
, O 0 0.009721191599965096
pedigree O 0 0.33850783109664917
structure O 0 0.012286849319934845
, O 0 0.007576072122901678
and O 0 0.007052709814161062
whether O 0 0.007850873284041882
DNA O 0 0.00950965378433466
samples O 0 0.007859520614147186
were O 0 0.007000264246016741
available O 0 0.008802542462944984
from O 0 0.011783115565776825
family O 0 0.019488003104925156
members O 0 0.021945001557469368
. O 0 0.033685579895973206

With O 0 0.021329086273908615
direct O 0 0.017321499064564705
tests O 0 0.012184051796793938
for O 0 0.009010949172079563
the O 0 0.012925686314702034
HD B-Disease 1 0.9954580068588257
mutation O 0 0.015818629413843155
, O 0 0.007800491061061621
we O 0 0.0059262607246637344
have O 0 0.004789899569004774
assessed O 0 0.010114950127899647
the O 0 0.006343362387269735
accuracy O 0 0.008947395719587803
of O 0 0.006559070199728012
results O 0 0.006741891615092754
obtained O 0 0.007311408407986164
by O 0 0.006324083544313908
linkage O 0 0.015810783952474594
approaches O 0 0.01295537780970335
when O 0 0.009366649203002453
requested O 0 0.012162193655967712
to O 0 0.00832230132073164
do O 0 0.008471068926155567
so O 0 0.0072584026493132114
by O 0 0.008193201385438442
the O 0 0.01167119201272726
test O 0 0.02030576579272747
individuals O 0 0.019450940191745758
. O 0 0.03810618072748184

For O 0 0.021221961826086044
six O 0 0.015734681859612465
such O 0 0.008952301926910877
individuals O 0 0.006573018152266741
, O 0 0.007498627062886953
there O 0 0.0067238397896289825
was O 0 0.011506972834467888
significant O 0 0.011955334804952145
disparity O 0 0.03256792202591896
between O 0 0.011865944601595402
the O 0 0.018328934907913208
tests O 0 0.029759446159005165
. O 0 0.038342997431755066

Three O 0 0.0249840896576643
went O 0 0.021873505786061287
from O 0 0.012495812028646469
a O 0 0.014590118080377579
decreased O 0 0.033171042799949646
risk O 0 0.011238952167332172
to O 0 0.006933333817869425
an O 0 0.007289174012839794
increased O 0 0.012288456782698631
risk O 0 0.1410689353942871
, O 0 0.006486597005277872
while O 0 0.005779333878308535
in O 0 0.005362331867218018
another O 0 0.00785244069993496
three O 0 0.007477965671569109
the O 0 0.011722555384039879
risk O 1 0.5240593552589417
was O 1 0.6581404805183411
decreased O 0 0.45924121141433716
. O 0 0.04619154334068298

Knowledge O 0 0.035489145666360855
of O 0 0.019413361325860023
the O 0 0.015990490093827248
potential O 0 0.01551363617181778
reasons O 0 0.012089269235730171
for O 0 0.0078400494530797
these O 0 0.005489162169396877
changes O 0 0.006227032281458378
in O 0 0.00606351625174284
results O 0 0.007722106296569109
and O 0 0.0057121277786791325
impact O 0 0.008019561879336834
of O 0 0.006779996212571859
these O 0 0.006192244589328766
risk O 0 0.010930510237812996
reversals O 0 0.06693888455629349
on O 0 0.008724992163479328
both O 0 0.007922339253127575
patients O 1 0.5004259943962097
and O 0 0.0064302776008844376
the O 0 0.008525325916707516
counseling O 1 0.9904769659042358
team O 0 0.012423726730048656
can O 0 0.0061012012884020805
assist O 0 0.010120498947799206
in O 0 0.006005491130053997
the O 0 0.006346512585878372
development O 0 0.007408086210489273
of O 0 0.007446916773915291
strategies O 0 0.009348339401185513
for O 0 0.005999436601996422
the O 0 0.00911068357527256
prevention O 1 0.9999328851699829
and O 0 0.0077807060442864895
, O 0 0.0064964997582137585
where O 0 0.005805005319416523
necessary O 0 0.006747628562152386
, O 0 0.00758345378562808
management O 0 0.01152478065341711
of O 0 0.008486839011311531
a O 0 0.011994159780442715
risk O 0 0.29683375358581543
reversal O 0 0.022158892825245857
in O 0 0.010093720629811287
any O 0 0.012319369241595268
predictive O 0 0.028755050152540207
testing O 0 0.029031841084361076
program O 0 0.031592532992362976
. O 0 0.029097968712449074
. O 0 0.04403453320264816

A O 0 0.0505220927298069
novel O 0 0.04544226825237274
common O 0 0.025696272030472755
missense O 0 0.04934654012322426
mutation O 0 0.024846671149134636
G301C O 0 0.038831669837236404
in O 0 0.012166308239102364
the O 0 0.013285583816468716
N O 0 0.02561722695827484
- O 0 0.10859575122594833
acetylgalactosamine O 1 0.8816086649894714
- O 1 0.8883925080299377
6 O 0 0.07692913711071014
- O 1 0.9981291890144348
sulfate O 1 0.9999556541442871
sulfatase O 1 0.9999743700027466
gene O 0 0.04015370085835457
in O 0 0.03457087278366089
mucopolysaccharidosis B-Disease 1 0.9999006986618042
IVA I-Disease 1 0.999996542930603
. O 0 0.07965771853923798

Mucopolysaccharidosis B-Disease 1 0.9997578263282776
IVA I-Disease 1 0.9999986886978149
( O 0 0.0849185362458229
MPS B-Disease 1 0.9988697171211243
IVA I-Disease 1 0.9999998807907104
) O 0 0.019008101895451546
is O 0 0.014282872900366783
an O 0 0.016805829480290413
autosomal B-Disease 1 0.9999948740005493
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 1 0.9997542500495911
by O 0 0.011201889254152775
a O 0 0.39533182978630066
genetic B-Disease 1 0.9979985356330872
defect I-Disease 1 0.9999772310256958
in O 0 0.014360187575221062
N O 0 0.04556263983249664
- O 1 0.6619246006011963
acetylgalactosamine O 1 0.9667401313781738
- O 1 0.9013519883155823
6 O 0 0.1458689272403717
- O 1 0.9994920492172241
sulfate O 1 0.9999916553497314
sulfatase O 1 0.9999960660934448
( O 0 0.3888680934906006
GALNS O 1 0.9998340606689453
) O 0 0.04892618581652641
. O 0 0.05889323353767395

In O 0 0.022568048909306526
previous O 0 0.01649637334048748
studies O 0 0.012372439727187157
, O 0 0.008157121017575264
we O 0 0.005705542396754026
have O 0 0.00441579706966877
found O 0 0.00487676402553916
two O 0 0.004840546753257513
common O 0 0.0070978193543851376
mutations O 0 0.00916521716862917
in O 0 0.008842785842716694
Caucasians O 1 0.9175463914871216
and O 0 0.013760918751358986
Japanese O 0 0.37618422508239746
, O 0 0.02281917817890644
respectively O 0 0.03515089303255081
. O 0 0.04301188141107559

To O 0 0.035210270434617996
characterize O 0 0.04556619003415108
the O 0 0.026723559945821762
mutational O 1 0.931755542755127
spectrum O 0 0.027697494253516197
in O 0 0.01301562413573265
various O 0 0.010184808634221554
ethnic O 0 0.010407277382910252
groups O 0 0.008410352282226086
, O 0 0.009535567834973335
mutations O 0 0.010046562179923058
in O 0 0.007334902882575989
the O 0 0.010766187682747841
GALNS O 1 0.9927799105644226
gene O 0 0.010407430119812489
in O 0 0.009510166011750698
Colombian O 0 0.31402939558029175
MPS B-Disease 1 0.9993777275085449
IVA I-Disease 1 1.0
patients O 1 0.976355791091919
were O 0 0.009379174560308456
investigated O 0 0.017164332792162895
, O 0 0.008521324954926968
and O 0 0.008124489337205887
genetic O 0 0.009742689318954945
backgrounds O 0 0.009573301300406456
were O 0 0.007009963039308786
extensively O 0 0.011444414034485817
analyzed O 0 0.010436823591589928
to O 0 0.00792656373232603
identify O 0 0.012097911909222603
racial O 0 0.01153292041271925
origin O 0 0.008516624569892883
, O 0 0.00790006760507822
based O 0 0.009435220621526241
on O 0 0.011077195405960083
mitochondrial O 0 0.01928703300654888
DNA O 0 0.018858294934034348
( O 0 0.01881721243262291
mtDNA O 0 0.03352361172437668
) O 0 0.028675610199570656
lineages O 0 0.05091696232557297
. O 0 0.045009300112724304

Three O 0 0.03797866404056549
novel O 0 0.04283081367611885
missense O 0 0.09879699349403381
mutations O 0 0.023344499990344048
never O 0 0.015085680410265923
identified O 0 0.012003403156995773
previously O 0 0.010915015824139118
in O 0 0.0067339264787733555
other O 0 0.005707709118723869
populations O 0 0.006194463465362787
and O 0 0.006486754398792982
found O 0 0.0056605227291584015
in O 0 0.006372884381562471
16 O 0 0.009425973519682884
out O 0 0.00852995365858078
of O 0 0.009928423911333084
19 O 0 0.020656153559684753
Colombian O 0 0.05041160807013512
MPS B-Disease 1 0.9497708678245544
IVA I-Disease 1 0.9999992847442627
unrelated O 0 0.04837803915143013
alleles O 0 0.03323564678430557
account O 0 0.02199331857264042
for O 0 0.023564618080854416
84 O 0 0.08280491083860397
. O 0 0.050533369183540344

2 O 0 0.0474860742688179
% O 0 0.02462402731180191
of O 0 0.01834060065448284
the O 0 0.019103974103927612
alleles O 0 0.02272971346974373
in O 0 0.01388794556260109
this O 0 0.015884798020124435
study O 0 0.02806028537452221
. O 0 0.036613382399082184

The O 0 0.056317899376153946
G301C O 1 0.5513947010040283
and O 0 0.03282686322927475
S162F O 1 0.9309685230255127
mutations O 0 0.029827356338500977
account O 0 0.020682744681835175
for O 0 0.020952263846993446
68 O 0 0.06252933293581009
. O 0 0.04463299736380577

4 O 0 0.06405528634786606
% O 0 0.03761562705039978
and O 0 0.03259541094303131
10 O 0 0.04496811702847481
. O 0 0.05328541249036789

5 O 0 0.035513490438461304
% O 0 0.020866720005869865
of O 0 0.014918923377990723
mutations O 0 0.01663104258477688
, O 0 0.01171359233558178
respectively O 0 0.01251827273517847
, O 0 0.009373314678668976
whereas O 0 0.010783599689602852
the O 0 0.008880524896085262
remaining O 0 0.01662537455558777
F69V O 1 0.997962236404419
is O 0 0.010940014384686947
limited O 0 0.012491045519709587
to O 0 0.012257365509867668
a O 0 0.019204752519726753
single O 0 0.030211497098207474
allele O 0 0.05292365327477455
. O 0 0.04358135163784027

The O 0 0.04398674517869949
skewed O 0 0.04798366501927376
prevalence O 1 0.543807327747345
of O 0 0.018797315657138824
G301C O 1 0.7556414008140564
in O 0 0.012179981917142868
only O 0 0.011224787682294846
Colombian O 0 0.26895013451576233
patients O 1 0.8455204367637634
and O 0 0.010301359929144382
haplotype O 0 0.02538490481674671
analysis O 0 0.010249529965221882
by O 0 0.009046744555234909
restriction O 0 0.016975829377770424
fragment O 0 0.02198365516960621
length O 0 0.015014578588306904
polymorphisms O 0 0.021324219182133675
in O 0 0.012340829707682133
the O 0 0.016353024169802666
GALNS O 1 0.9987732768058777
gene O 0 0.017603904008865356
suggest O 0 0.013995779678225517
that O 0 0.010357769206166267
G301C O 0 0.041147928684949875
originated O 0 0.019427185878157616
from O 0 0.014036954380571842
a O 0 0.01879911683499813
common O 0 0.0265843253582716
ancestor O 0 0.06115129962563515
. O 0 0.04159845784306526

Investigation O 0 0.0392451174557209
of O 0 0.019176693633198738
the O 0 0.016924185678362846
genetic O 0 0.014130562543869019
background O 0 0.01331587228924036
by O 0 0.008591840043663979
means O 0 0.008849244564771652
of O 0 0.00976005382835865
mtDNA O 0 0.014590118080377579
lineages O 0 0.013325579464435577
indicate O 0 0.008657136000692844
that O 0 0.005484068300575018
all O 0 0.006214774679392576
our O 0 0.010503750294446945
patients O 0 0.2071881741285324
are O 0 0.006885211449116468
probably O 0 0.01435147039592266
of O 0 0.014964885078370571
native O 0 0.028476862236857414
American O 0 0.04803743213415146
descent O 0 0.08419685065746307

Low O 0 0.04544348269701004
frequency O 0 0.03158821165561676
of O 0 0.02560167759656906
BRCA1 O 1 0.9588669538497925
germline O 0 0.05774306505918503
mutations O 0 0.018947552889585495
in O 0 0.012172852642834187
45 O 0 0.02989092469215393
German O 1 0.9999831914901733
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.8909410238265991
. O 0 0.05748268589377403

In O 0 0.023781241849064827
this O 0 0.011496936902403831
study O 0 0.011696690693497658
we O 0 0.00910243485122919
investigated O 0 0.01583709567785263
45 O 0 0.020065665245056152
German O 1 0.9994939565658569
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.026187334209680557
for O 0 0.018396535888314247
germline O 1 0.9398520588874817
mutations O 0 0.02423758991062641
in O 0 0.016813842579722404
the O 0 0.029304159805178642
BRCA1 O 1 0.9999275207519531
gene O 0 0.04477814584970474
. O 0 0.04675818234682083

We O 0 0.0238404031842947
identified O 0 0.02051701582968235
four O 0 0.015352144837379456
germline O 0 0.03145325556397438
mutations O 0 0.01376964058727026
in O 0 0.009526112116873264
three O 0 0.013813411816954613
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999991655349731
families O 0 0.008635996840894222
and O 0 0.005854832474142313
in O 0 0.006932205054908991
one O 0 0.24588051438331604
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.7962251901626587
. O 0 0.008430558256804943
among O 0 0.007467234972864389
these O 0 0.0051066335290670395
were O 0 0.006338425911962986
one O 0 0.010414469987154007
frameshift O 0 0.2505705952644348
mutation O 0 0.015527954325079918
, O 0 0.009342160075902939
one O 0 0.009709659963846207
nonsense O 0 0.04768276959657669
mutation O 0 0.013643038459122181
, O 0 0.010419951751828194
one O 0 0.010991238057613373
novel O 0 0.018734697252511978
splice O 0 0.03377300128340721
site O 0 0.017746279016137123
mutation O 0 0.016244525089859962
, O 0 0.010261896066367626
and O 0 0.011385488323867321
one O 0 0.017469177022576332
missense O 0 0.06728485971689224
mutation O 0 0.04207667335867882
. O 0 0.0420430526137352

The O 0 0.045968782156705856
missense O 0 0.08625899255275726
mutation O 0 0.03479785844683647
was O 0 0.02334996499121189
also O 0 0.015336603857576847
found O 0 0.015481379814445972
in O 0 0.018055615946650505
2 O 0 0.03734634071588516
. O 0 0.04264315217733383

8 O 0 0.03465275838971138
% O 0 0.01691771298646927
of O 0 0.011875297874212265
the O 0 0.010679696686565876
general O 0 0.012939460575580597
population O 0 0.007702987641096115
, O 0 0.008175813592970371
suggesting O 0 0.008190830238163471
that O 0 0.005311358720064163
it O 0 0.007245298940688372
is O 0 0.010637796483933926
not O 0 0.013265364803373814
disease O 1 0.9999940395355225
associated O 0 0.050160232931375504
. O 0 0.03894928842782974

The O 0 0.02340017631649971
average O 0 0.022074107080698013
age O 0 0.02018367126584053
of O 0 0.40180495381355286
disease O 1 1.0
onset O 1 0.9999997615814209
in O 0 0.015493295155465603
those O 0 0.012160989455878735
families O 0 0.02342858910560608
harbouring O 1 0.9999791383743286
causative O 1 0.9998461008071899
mutations O 0 0.038633521646261215
was O 0 0.029918646439909935
between O 0 0.01956074684858322
32 O 0 0.04206288605928421
. O 0 0.042021743953228

3 O 0 0.07559339702129364
and O 0 0.0507776215672493
37 O 0 0.09723801165819168
. O 0 0.07574399560689926

4 O 0 0.04840103164315224
years O 0 0.02796412818133831
, O 0 0.01740751788020134
whereas O 0 0.017884189262986183
the O 0 0.014527863822877407
family O 0 0.021328527480363846
harbouring O 1 0.9305820465087891
the O 0 0.018930288031697273
missense O 0 0.21121928095817566
mutation O 0 0.01631379872560501
had O 0 0.010994769632816315
an O 0 0.010973183438181877
average O 0 0.015107019804418087
age O 0 0.016992708668112755
of O 0 0.01795998401939869
onset O 1 0.9995288848876953
of O 0 0.03237540274858475
51 O 0 0.27542200684547424
. O 0 0.047244902700185776

2 O 0 0.09022020548582077
years O 0 0.06864924728870392
. O 0 0.07587090879678726

These O 0 0.022711247205734253
findings O 0 0.021721897646784782
show O 0 0.0182599239051342
that O 0 0.012318352237343788
BRCA1 O 1 0.9780559539794922
is O 0 0.010743976570665836
implicated O 0 0.01709975302219391
in O 0 0.007268308196216822
a O 0 0.008597723208367825
small O 0 0.008043731562793255
fraction O 0 0.012368030846118927
of O 0 0.3922698199748993
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.021938849240541458
suggesting O 0 0.015335611067712307
the O 0 0.01322920061647892
involvement O 0 0.017079127952456474
of O 0 0.01347241923213005
another O 0 0.06186931952834129
susceptibility O 1 0.9999088048934937
gene O 0 0.19250768423080444
( O 0 0.032787371426820755
s O 1 0.5624333024024963
) O 0 0.05546656623482704

Paternal O 1 0.9973625540733337
transmission O 1 0.9996469020843506
of O 1 0.9999724626541138
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.9998329877853394

We O 0 0.024771766737103462
report O 0 0.016349151730537415
a O 0 0.014213543385267258
rare O 0 0.015078391879796982
case O 0 0.013322967104613781
of O 0 0.0355493389070034
paternally O 1 0.9999997615814209
transmitted O 1 1.0
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
DM B-Disease 1 1.0
) O 1 0.8278235197067261
. O 0 0.07359999418258667

The O 0 0.037819866091012955
proband O 0 0.22323724627494812
is O 0 0.014573167078197002
a O 0 0.01373054925352335
23 O 0 0.01590522564947605
year O 0 0.014190958812832832
old O 0 0.026196081191301346
, O 0 0.018263816833496094
mentally B-Disease 1 0.999954104423523
retarded I-Disease 1 0.9999693632125854
male O 1 0.9995566010475159
who O 1 0.9999972581863403
suffers O 1 1.0
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 1 0.9974330067634583

He O 0 0.0371076725423336
presented O 0 0.04240996018052101
with O 1 0.8073642253875732
respiratory O 1 1.0
and O 1 0.9816708564758301
feeding O 1 0.9989809393882751
difficulties O 1 0.9999632835388184
at O 1 0.9480283260345459
birth O 1 0.9043976068496704
. O 0 0.04521890729665756

His O 0 0.049072325229644775
two O 0 0.036564771085977554
sibs O 1 0.9999819993972778
suffer O 1 0.9999135732650757
from O 1 0.901538074016571
childhood O 1 0.9999998807907104
onset O 1 1.0
DM B-Disease 1 1.0
. O 1 0.826770007610321

Their O 0 0.026011640205979347
late O 0 0.02544810064136982
father O 0 0.021553879603743553
had O 0 0.011828834190964699
the O 0 0.010046946816146374
adult O 0 0.013511300086975098
type O 0 0.0188791174441576
of O 0 0.023024166002869606
DM B-Disease 1 1.0
, O 0 0.019178278744220734
with O 0 0.01618080399930477
onset O 1 0.9998226761817932
around O 0 0.022164950147271156
30 O 0 0.031107695773243904
years O 0 0.03459124267101288
. O 0 0.04417188838124275

Only O 0 0.021692831069231033
six O 0 0.014300755225121975
other O 0 0.008777817711234093
cases O 0 0.008285491727292538
of O 0 0.009874561801552773
paternal O 1 0.9579510688781738
transmission O 1 0.9980931878089905
of O 1 0.9999547004699707
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 0.10092485696077347
been O 0 0.019851211458444595
reported O 0 0.033823881298303604
recently O 0 0.044840455055236816
. O 0 0.03970440849661827

We O 0 0.025412801653146744
review O 0 0.024048466235399246
the O 0 0.016161860898137093
sex O 0 0.01690942794084549
related O 0 0.012838679365813732
effects O 0 0.0150635140016675
on O 0 0.01553039625287056
transmission O 1 0.9850446581840515
of O 1 0.9993700385093689
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.989642322063446

Decreased O 0 0.07739271968603134
fertility O 0 0.05889125540852547
of O 0 0.017422571778297424
males O 0 0.01731918938457966
with O 0 0.01317385770380497
adult O 1 0.9764788746833801
onset O 1 1.0
DM B-Disease 1 1.0
and O 0 0.07990865409374237
contraction O 0 0.10838146507740021
of O 0 0.010394497774541378
the O 0 0.011778847314417362
repeat O 0 0.018333828076720238
upon O 0 0.012661628425121307
male O 0 0.018862951546907425
transmission O 0 0.019639618694782257
contribute O 0 0.013544629327952862
to O 0 0.00867111049592495
the O 0 0.008883178234100342
almost O 0 0.008739883080124855
absent O 0 0.014604005962610245
occurrence O 0 0.013424301519989967
of O 0 0.012165653519332409
paternal O 1 0.976860523223877
transmission O 1 0.9996175765991211
of O 1 0.9999533891677856
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.988713264465332

Also O 0 0.030273795127868652
the O 0 0.018075549975037575
fathers O 0 0.02262948453426361
of O 0 0.010784409940242767
the O 0 0.011257080361247063
reported O 0 0.12778380513191223
congenitally O 1 0.9999779462814331
affected O 0 0.033276960253715515
children O 0 0.011805057525634766
showed O 0 0.009151613339781761
, O 0 0.007505744695663452
on O 0 0.00762572605162859
average O 0 0.01027234923094511
, O 0 0.010204622521996498
shorter O 0 0.02066628821194172
CTG O 1 0.8001781702041626
repeat O 0 0.024861618876457214
lengths O 0 0.020939674228429794
and O 0 0.009338348172605038
hence O 0 0.01157271396368742
less O 0 0.01320409495383501
severe O 1 0.9999980926513672
clinical O 1 0.9999997615814209
symptoms O 1 0.999998927116394
than O 0 0.008712459355592728
the O 0 0.010988983325660229
mothers O 0 0.1804971992969513
of O 0 0.0160320196300745
children O 1 0.954273521900177
with O 1 0.9998261332511902
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9952229857444763

We O 0 0.02449144423007965
conclude O 0 0.026576807722449303
that O 0 0.012440131045877934
paternal O 0 0.062377508729696274
transmission O 1 0.8523308634757996
of O 1 0.9997743964195251
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 1 0.995080828666687
rare O 1 0.8900609612464905
and O 0 0.01325234491378069
preferentially O 0 0.025533858686685562
occurs O 0 0.010698622092604637
with O 0 0.009814681485295296
onset O 1 0.9996448755264282
of O 0 0.033093828707933426
DM B-Disease 1 1.0
past O 0 0.01736627146601677
30 O 0 0.01487837452441454
years O 0 0.010689672082662582
in O 0 0.010456724092364311
the O 0 0.015176585875451565
father O 0 0.05370402708649635
. O 0 0.021630452945828438
. O 0 0.03550954535603523

The O 0 0.05811556056141853
RB1 O 1 0.9995620846748352
gene O 0 0.03253083676099777
mutation O 0 0.02400072291493416
in O 0 0.01359756663441658
a O 0 0.018747132271528244
child O 1 0.9454342126846313
with O 1 0.9283120036125183
ectopic B-Disease 1 1.0
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 1.0
. O 0 0.23434549570083618

The O 0 0.05847030133008957
RB1 O 1 0.9998781681060791
gene O 0 0.03013519197702408
mutation O 0 0.02045982889831066
was O 0 0.01574639417231083
investigated O 0 0.014433391392230988
in O 0 0.009184355847537518
a O 0 0.011183408088982105
child O 1 0.5386415123939514
with O 0 0.1601640284061432
ectopic B-Disease 1 0.9999998807907104
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 0.9999769926071167
using O 0 0.014234042726457119
DNA O 0 0.01394674926996231
obtained O 0 0.00999657716602087
from O 0 0.007529421243816614
both O 0 0.00800085999071598
the O 0 0.013127539306879044
pineal B-Disease 1 0.9999703168869019
and I-Disease 1 0.7115381956100464
retinal I-Disease 1 0.9999998807907104
tumours I-Disease 1 0.9999998807907104
of O 1 0.5881837010383606
the O 1 0.9400355219841003
patient O 1 0.9999887943267822
. O 0 0.0608813539147377

A O 0 0.058921929448843
nonsense O 0 0.06704673916101456
mutation O 0 0.03514733910560608
in O 0 0.019526226446032524
exon O 0 0.04305541142821312
17 O 0 0.022642796859145164
( O 0 0.015857405960559845
codon O 0 0.027371734380722046
556 O 0 0.03471001237630844
) O 0 0.012099609710276127
of O 0 0.009857882745563984
the O 0 0.012871379032731056
RB1 O 1 0.9999561309814453
gene O 0 0.014886140823364258
was O 0 0.012256147339940071
found O 0 0.008830823935568333
to O 0 0.007701030932366848
be O 0 0.006818628404289484
present O 0 0.010203398764133453
homozygously O 0 0.028734240680933
in O 0 0.008773215115070343
both O 0 0.008715561591088772
the O 0 0.016371028497815132
retinal B-Disease 1 0.9999815225601196
and I-Disease 0 0.031323790550231934
the I-Disease 1 0.8580701351165771
pineal I-Disease 1 0.9999994039535522
tumours I-Disease 1 0.9999998807907104
. O 0 0.0751144140958786

The O 0 0.02791242115199566
same O 0 0.019916214048862457
mutation O 0 0.02518262341618538
was O 0 0.017986448481678963
present O 0 0.014130509458482265
heterozygously O 0 0.1797875165939331
in O 0 0.00918805692344904
the O 0 0.00847178976982832
DNA O 0 0.009174628183245659
from O 0 0.0054819597862660885
the O 0 0.006008643191307783
constitutional O 0 0.010866409167647362
cells O 0 0.00893971137702465
of O 0 0.006461046170443296
the O 0 0.011346920393407345
patient O 1 0.999147891998291
, O 0 0.010647009126842022
proving O 0 0.037544019520282745
it O 0 0.006619078107178211
to O 0 0.007764359470456839
be O 0 0.008989671245217323
of O 0 0.014791312627494335
germline O 0 0.06084231287240982
origin O 0 0.03295423090457916
. O 0 0.03849099576473236

The O 0 0.030097978189587593
initial O 0 0.030136629939079285
mutation O 0 0.021965190768241882
was O 0 0.014860933646559715
shown O 0 0.01001555472612381
to O 0 0.008303833194077015
have O 0 0.006791990250349045
occurred O 0 0.011248663999140263
in O 0 0.010244742035865784
the O 0 0.021122317761182785
paternally O 1 0.9403905272483826
derived O 0 0.0465785376727581
RB1 O 1 0.9997968077659607
allele O 0 0.09358076006174088
. O 0 0.06011835113167763

The O 0 0.03378213569521904
mutation O 0 0.0272207111120224
is O 0 0.011339342221617699
in O 0 0.007500628009438515
an O 0 0.007185462862253189
area O 0 0.007707144133746624
of O 0 0.006434498354792595
the O 0 0.008170838467776775
gene O 0 0.007510189898312092
that O 0 0.006035044323652983
encodes O 0 0.01162203960120678
the O 0 0.009019470773637295
protein O 0 0.011933112516999245
- O 0 0.017386820167303085
binding O 0 0.011475696228444576
region O 0 0.009880686178803444
known O 0 0.008286146447062492
as O 0 0.007258770056068897
the O 0 0.0085778022184968
pocket O 1 0.9954923391342163
region O 0 0.012075068429112434
and O 0 0.007296624593436718
has O 0 0.007384283933788538
been O 0 0.006480288226157427
detected O 0 0.009669709950685501
in O 0 0.006944410037249327
other O 0 0.00786147266626358
cases O 0 0.010883539915084839
of O 0 0.019858870655298233
retinoblastoma B-Disease 1 0.9999904632568359
. O 0 0.026728380471467972
. O 0 0.03749631717801094

Low O 0 0.04347679018974304
levels O 0 0.021645335480570793
of O 0 0.016661977395415306
beta O 0 0.03289980813860893
hexosaminidase O 0 0.1840668022632599
A O 0 0.015774689614772797
in O 0 0.010638680309057236
healthy O 0 0.01602945663034916
individuals O 0 0.00899770762771368
with O 0 0.013744807802140713
apparent O 1 0.9999892711639404
deficiency O 1 1.0
of O 1 0.9805108904838562
this O 0 0.16258174180984497
enzyme O 0 0.17651011049747467
. O 0 0.04753711074590683

Appreciable O 0 0.26287969946861267
beta O 0 0.07563183456659317
hexosaminidase O 1 0.8374256491661072
A O 0 0.03021402657032013
( O 0 0.01810828596353531
hex O 0 0.03840300813317299
A O 0 0.018413163721561432
) O 0 0.011029964312911034
activity O 0 0.008607903495430946
has O 0 0.006218710448592901
been O 0 0.005962328985333443
detected O 0 0.01023994293063879
in O 0 0.00888886395841837
cultured O 1 0.9983710646629333
skin O 1 0.9999998807907104
fibroblasts O 1 0.999998927116394
and O 1 0.9999469518661499
melanoma B-Disease 1 1.0
tissue O 1 0.9999958276748657
from O 0 0.013490837067365646
healthy O 0 0.4634263515472412
individuals O 0 0.007568626198917627
previously O 0 0.010226776823401451
reported O 0 0.010590486228466034
as O 0 0.009861838072538376
having O 0 0.4869648218154907
deficiency B-Disease 1 0.9999998807907104
of I-Disease 0 0.07300849258899689
hex I-Disease 1 0.7817744016647339
A I-Disease 0 0.018170559778809547
activity O 0 0.011135445907711983
indistinguishable O 0 0.01391555741429329
from O 0 0.006443552672863007
that O 0 0.005318840965628624
of O 0 0.007242301944643259
patients O 0 0.49195951223373413
with O 1 0.5039454698562622
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9969778060913086
TSD B-Disease 1 0.9999998807907104
) O 0 0.04896354302763939
. O 0 0.06052791699767113

Identification O 0 0.05002705380320549
and O 0 0.030810799449682236
quantitation O 0 0.35350531339645386
of O 0 0.026188356801867485
hex O 0 0.1882772296667099
A O 0 0.030808407813310623
, O 0 0.021206345409154892
amounting O 0 0.03823080286383629
to O 0 0.021960703656077385
3 O 0 0.0423855260014534
. O 0 0.04652691259980202

5 O 0 0.06913577765226364
% O 0 0.04806450009346008
- O 0 0.2313246876001358
6 O 0 0.06882813572883606
. O 0 0.06434229761362076

9 O 0 0.045090410858392715
% O 0 0.01965128257870674
of O 0 0.016222959384322166
total O 0 0.01844288595020771
beta O 0 0.03603358566761017
hexosaminidase O 1 0.6585164666175842
activity O 0 0.015694646164774895
, O 0 0.01212280709296465
has O 0 0.010057656094431877
been O 0 0.008979749865829945
obtained O 0 0.011923377402126789
by O 0 0.013965701684355736
cellulose O 1 0.9994654059410095
acetate O 1 0.9999240636825562
gel O 1 0.9991477727890015
electrophoresis O 0 0.42553582787513733
, O 0 0.028983555734157562
DEAE O 1 0.9998173117637634
- O 1 0.9834566712379456
cellulose O 1 0.995786726474762
ion O 0 0.478031724691391
- O 0 0.30541253089904785
exchange O 0 0.027889758348464966
chromatography O 0 0.2226315140724182
, O 0 0.027513474225997925
radial O 1 0.9079069495201111
immunodiffusion O 1 0.9959563612937927
, O 0 0.03406564146280289
and O 0 0.03704165667295456
radioimmunoassay O 1 0.8952643275260925
. O 0 0.06346973031759262

Previous O 0 0.03708375245332718
family O 0 0.02547331340610981
studies O 0 0.013832268305122852
suggested O 0 0.010953427292406559
that O 0 0.005788756068795919
these O 0 0.005236057098954916
individuals O 0 0.0052771843038499355
may O 0 0.00671372702345252
be O 0 0.007018581498414278
compound O 0 0.018588494509458542
heterozygotes O 0 0.033301737159490585
for O 0 0.009813401848077774
the O 0 0.012658326886594296
common O 0 0.015123716555535793
mutant O 1 0.8114211559295654
TSD B-Disease 1 0.9999889135360718
gene O 0 0.019180523231625557
and O 0 0.012120546773076057
a O 0 0.014790701679885387
rare O 0 0.26044726371765137
( O 0 0.02228938229382038
allelic O 1 0.9972496628761292
) O 0 0.02778557315468788
mutant O 0 0.0765301063656807
gene O 0 0.04224441573023796
. O 0 0.04521462321281433

Thus O 0 0.03494824096560478
, O 0 0.018304072320461273
the O 0 0.016962459310889244
postulated O 0 0.031843144446611404
rate O 0 0.014822238124907017
mutant O 0 0.030132442712783813
gene O 0 0.012604417279362679
appears O 0 0.010957427322864532
to O 0 0.006922963075339794
code O 0 0.007759721018373966
for O 0 0.006033227778971195
the O 0 0.007672523148357868
expression O 0 0.0091177336871624
of O 0 0.008719895966351032
low O 0 0.014736310578882694
amounts O 0 0.015545769594609737
of O 0 0.018426474183797836
hex O 0 0.06968843936920166
A O 0 0.0490960031747818
. O 0 0.049512118101119995

Heterozygotes O 0 0.13516749441623688
for O 0 0.018997738137841225
the O 0 0.01819986291229725
rare O 1 0.6865017414093018
mutant O 1 0.914419949054718
may O 0 0.011670339852571487
be O 0 0.008791474625468254
indistinguishable O 0 0.01746245287358761
from O 0 0.010311574675142765
heterozygotes O 0 0.04250679910182953
for O 0 0.012036500498652458
the O 0 0.019371716305613518
common O 0 0.13956229388713837
TSD B-Disease 1 0.9999986886978149
mutant O 1 0.9304826259613037
. O 0 0.06594032049179077

However O 0 0.03142265975475311
, O 0 0.01993187516927719
direct O 0 0.019652457907795906
visualization O 0 0.03634548932313919
and O 0 0.01438658032566309
quantitation O 1 0.6704699397087097
of O 0 0.014130907133221626
hex O 0 0.03879911080002785
A O 0 0.014034049585461617
by O 0 0.007227999158203602
the O 0 0.0075126527808606625
methods O 0 0.00838126614689827
described O 0 0.009497193619608879
may O 0 0.0089058643206954
prevent O 0 0.010703952983021736
false O 0 0.016475258395075798
- O 1 0.9482872486114502
positive O 0 0.017990320920944214
prenatal O 1 0.9999727010726929
diagnosis O 1 0.9999788999557495
of O 0 0.4232925772666931
TSD B-Disease 1 0.9999998807907104
in O 0 0.015428717248141766
fetuses O 0 0.49138107895851135
having O 0 0.012752246111631393
the O 0 0.010218019597232342
incomplete O 0 0.01746363937854767
hex B-Disease 0 0.33107563853263855
A I-Disease 1 0.8645123243331909
deficiency I-Disease 1 0.9999997615814209
of O 0 0.015029629692435265
the O 0 0.022019024938344955
type O 1 0.5296837687492371
described O 0 0.013697875663638115
in O 0 0.011268826201558113
the O 0 0.015695316717028618
four O 0 0.023976637050509453
healthy O 0 0.05637168884277344
individuals O 0 0.044634733349084854

The O 0 0.058030497282743454
tumor B-Disease 1 0.9999470710754395
suppressor O 1 0.9994062185287476
gene O 0 0.10939563065767288
Smad4 O 1 0.9999802112579346
/ O 1 0.9996902942657471
Dpc4 O 1 0.9925234913825989
is O 0 0.013777625747025013
required O 0 0.011997421272099018
for O 0 0.011855561286211014
gastrulation O 1 0.9621756076812744
and O 0 0.01299159787595272
later O 0 0.013946671038866043
for O 0 0.011978376656770706
anterior O 1 0.8989996314048767
development O 0 0.01801307126879692
of O 0 0.017231930047273636
the O 0 0.030269943177700043
mouse O 1 0.8906159400939941
embryo O 0 0.07724371552467346
. O 0 0.05379394069314003

Mutations O 0 0.042518503963947296
in O 0 0.02070526033639908
the O 0 0.023280851542949677
SMAD4 O 1 0.9999920129776001
/ O 1 0.9999933242797852
DPC4 O 1 0.9999998807907104
tumor B-Disease 1 0.9999998807907104
suppressor O 1 0.9997149109840393
gene O 0 0.01704447902739048
, O 0 0.010961582884192467
a O 0 0.010857385583221912
key O 0 0.012768091633915901
signal O 0 0.016107099130749702
transducer O 0 0.02387891709804535
in O 0 0.00947317574173212
most O 0 0.01053236611187458
TGFbeta O 1 0.9989367127418518
- O 1 0.9512119889259338
related O 0 0.016644055023789406
pathways O 0 0.01948777586221695
, O 0 0.008514964953064919
are O 0 0.005340483970940113
involved O 0 0.007459725718945265
in O 0 0.007636100985109806
50 O 0 0.014975981786847115
% O 0 0.017999108880758286
of O 0 0.1593334823846817
pancreatic B-Disease 1 1.0
cancers I-Disease 1 0.9999943971633911
. O 0 0.05774904787540436

Homozygous O 0 0.2819022238254547
Smad4 O 1 0.9992678761482239
mutant O 1 0.9897185564041138
mice O 1 0.8843705058097839
die O 0 0.19209857285022736
before O 0 0.025106390938162804
day O 0 0.034367140382528305
7 O 0 0.05108501389622688
. O 0 0.05300626531243324

5 O 0 0.07534177601337433
of O 0 0.06638654321432114
embryogenesis O 1 0.7898736000061035
. O 0 0.08303919434547424

Mutant O 0 0.07323114573955536
embryos O 0 0.029151301831007004
have O 0 0.012232146225869656
reduced O 0 0.017153283581137657
size O 0 0.015984753146767616
, O 0 0.01254867110401392
fail O 0 0.016245102509856224
to O 0 0.013232355937361717
gastrulate O 0 0.05353657156229019
or O 0 0.011792213656008244
express O 0 0.020532360300421715
a O 0 0.016037002205848694
mesodermal O 1 0.9981923699378967
marker O 1 0.8831885457038879
, O 0 0.016765372827649117
and O 0 0.017496438696980476
show O 0 0.030666664242744446
abnormal O 1 0.9461118578910828
visceral O 1 0.999944806098938
endoderm O 1 0.9999719858169556
development O 0 0.2032897174358368
. O 0 0.059212639927864075

Growth B-Disease 1 0.5457755923271179
retardation I-Disease 1 0.9997439980506897
of O 0 0.021081749349832535
the O 0 0.05517909675836563
Smad4 O 1 0.9999990463256836
- O 1 0.9999290704727173
deficient O 1 0.9632934331893921
embryos O 0 0.013800554908812046
results O 0 0.009652359411120415
from O 0 0.009208178147673607
reduced O 0 0.01679767668247223
cell O 0 0.029740700498223305
proliferation O 0 0.03074660338461399
rather O 0 0.013632872141897678
than O 0 0.015327757224440575
increased O 0 0.031154466792941093
apoptosis O 0 0.4554009437561035
. O 0 0.05261477082967758

Aggregation O 0 0.07113564759492874
of O 0 0.038890305906534195
mutant O 1 0.7550435662269592
Smad4 O 1 0.9999467134475708
ES O 1 0.9997794032096863
cells O 0 0.025518309324979782
with O 0 0.01651790365576744
wild O 0 0.028720708563923836
- O 1 0.9155252575874329
type O 0 0.174569234251976
tetraploid O 1 0.8050935864448547
morulae O 1 0.9962490200996399
rescues O 1 0.9901559352874756
the O 0 0.07828603684902191
gastrulation B-Disease 1 0.9999849796295166
defect I-Disease 1 0.9999545812606812
. O 0 0.07300456613302231

These O 0 0.019983528181910515
results O 0 0.016454201191663742
indicate O 0 0.013454824686050415
that O 0 0.008912373334169388
Smad4 O 1 0.7543016076087952
is O 0 0.009021046571433544
initially O 0 0.010050158016383648
required O 0 0.006389252841472626
for O 0 0.006055337842553854
the O 0 0.007950857281684875
differentiation O 0 0.013025018386542797
of O 0 0.009746458381414413
the O 0 0.013300207443535328
visceral O 1 0.9999580383300781
endoderm O 1 0.9999104738235474
and O 0 0.010632362216711044
that O 0 0.007714532781392336
the O 0 0.012537762522697449
gastrulation B-Disease 1 0.9999761581420898
defect I-Disease 1 0.991758406162262
in O 0 0.012979106977581978
the O 0 0.01709066703915596
epiblast O 1 0.9999325275421143
is O 0 0.013853221200406551
secondary O 0 0.0177287757396698
and O 0 0.01327007357031107
non O 0 0.3292231261730194
- O 1 0.9991297125816345
cell O 0 0.2691887617111206
autonomous O 0 0.04879407584667206
. O 0 0.04423721134662628

Rescued O 0 0.09645308554172516
embryos O 0 0.044625233858823776
show O 0 0.03916994482278824
severe O 1 0.9999817609786987
anterior O 1 0.9999972581863403
truncations O 1 0.9999949932098389
, O 0 0.02354106493294239
indicating O 0 0.018575681373476982
a O 0 0.012860635295510292
second O 0 0.013364468701183796
important O 0 0.01033302303403616
role O 0 0.012284478172659874
for O 0 0.011623825877904892
Smad4 O 1 0.9950332641601562
in O 0 0.023723021149635315
anterior O 1 0.999947190284729
patterning O 1 0.999967098236084
during O 1 0.9216070175170898
embryogenesis O 1 0.9978563189506531
. O 0 0.062435321509838104

Prevalence O 1 0.6885055899620056
of O 0 0.0380091555416584
p16 O 1 0.9819492697715759
and O 0 0.030096909031271935
CDK4 O 1 0.999538779258728
germline O 0 0.1711270660161972
mutations O 0 0.02306857705116272
in O 0 0.01586337946355343
48 O 1 0.8338257670402527
melanoma B-Disease 1 1.0
- O 1 0.9999992847442627
prone O 1 0.9999926090240479
families O 0 0.02334793098270893
in O 0 0.020880255848169327
France O 0 0.07742460072040558
. O 0 0.043874453753232956

The O 0 0.0650823712348938
French O 1 0.9941727519035339
Familial B-Disease 1 0.9999996423721313
Melanoma I-Disease 1 1.0
Study O 1 0.949276328086853
Group O 0 0.12571175396442413
. O 0 0.062217485159635544

Germline O 0 0.15968668460845947
mutations O 0 0.032927174121141434
in O 0 0.01687646098434925
the O 0 0.018769312649965286
p16 O 1 0.9225205779075623
and O 0 0.019226334989070892
CDK4 O 1 0.9999692440032959
genes O 0 0.011259659193456173
have O 0 0.005583909340202808
been O 0 0.005556168034672737
reported O 0 0.006753146648406982
in O 0 0.005688877776265144
a O 0 0.008644460700452328
subset O 0 0.018142160028219223
of O 0 0.4326845705509186
melanoma B-Disease 1 1.0
pedigrees O 1 0.9975875616073608
, O 0 0.010861068032681942
but O 0 0.007538221310824156
their O 0 0.008301732130348682
prevalence O 1 0.9941070079803467
is O 0 0.010140037164092064
not O 0 0.009433873929083347
well O 0 0.01570141687989235
known O 0 0.026593465358018875
. O 0 0.03753669932484627

We O 0 0.03377462550997734
searched O 0 0.031590864062309265
for O 0 0.013612175360321999
such O 0 0.013032966293394566
germline O 0 0.03350470960140228
mutations O 0 0.013387230224907398
in O 0 0.010277848690748215
48 O 0 0.02376464754343033
French O 1 0.9982576966285706
melanoma B-Disease 1 1.0
- O 1 0.9999923706054688
prone O 1 0.998796820640564
families O 0 0.011141208931803703
selected O 0 0.0117948604747653
according O 0 0.005504196975380182
to O 0 0.005567851942032576
two O 0 0.005600864067673683
major O 0 0.008600344881415367
criteria O 0 0.008833934552967548
families O 0 0.006732274312525988
with O 0 0.005679860711097717
at O 0 0.007553708739578724
least O 0 0.006756678689271212
three O 0 0.007365867029875517
affected O 0 0.009113477542996407
members O 0 0.008407259359955788
( O 0 0.010191250592470169
n O 0 0.01681947335600853
= O 0 0.019134612753987312
20 O 0 0.01201491616666317
) O 0 0.008322875946760178
or O 0 0.006340762600302696
families O 0 0.0069222222082316875
with O 0 0.005841458681970835
two O 0 0.005636205431073904
affected O 0 0.0069371238350868225
members O 0 0.005485826637595892
, O 0 0.005900609772652388
one O 0 0.004986129235476255
of O 0 0.005163177847862244
them O 0 0.005026999395340681
affected O 0 0.006365678738802671
before O 0 0.006655816454440355
the O 0 0.006649211049079895
age O 0 0.007973426021635532
of O 0 0.007250572554767132
50 O 0 0.011438400484621525
( O 0 0.010143980383872986
n O 0 0.015824303030967712
= O 0 0.01957881450653076
28 O 0 0.01644059456884861
) O 0 0.01053136121481657
, O 0 0.01068145502358675
and O 0 0.009960136376321316
one O 0 0.011878526769578457
additional O 0 0.02045322395861149
minor O 0 0.061103515326976776
criterion O 1 0.7447516322135925
. O 0 0.049929067492485046

Sixteen O 0 0.06774117052555084
different O 0 0.025924859568476677
p16 O 1 0.5643010139465332
germline O 0 0.22159741818904877
mutations O 0 0.018508346751332283
were O 0 0.008111780509352684
found O 0 0.00785461813211441
in O 0 0.007472410798072815
21 O 0 0.01158947218209505
families O 0 0.009178959764540195
, O 0 0.00848866906017065
while O 0 0.009480267763137817
one O 0 0.011350760236382484
germline O 0 0.09605620056390762
mutation O 0 0.020169176161289215
, O 0 0.014344902709126472
Arg24His O 1 0.8809043169021606
, O 0 0.012061555869877338
was O 0 0.01597796566784382
detected O 0 0.018450990319252014
in O 0 0.013939131051301956
the O 0 0.02383846789598465
CDK4 O 1 0.9997138381004333
gene O 0 0.04821909964084625
. O 0 0.04818296805024147

The O 0 0.028149785473942757
frequency O 0 0.023907311260700226
of O 0 0.019867369905114174
p16 O 1 0.8679015040397644
gene O 0 0.01744939759373665
mutation O 0 0.012406584806740284
in O 0 0.006798066198825836
our O 0 0.007695057429373264
sample O 0 0.00899001955986023
( O 0 0.008609237149357796
44 O 0 0.01296151801943779
% O 0 0.007686091121286154
) O 0 0.006875785067677498
is O 0 0.006219045724719763
among O 0 0.00613986374810338
the O 0 0.006080264691263437
highest O 0 0.011518123559653759
rates O 0 0.008371368050575256
yet O 0 0.007678682450205088
reported O 0 0.007767354603856802
and O 0 0.00702253682538867
the O 0 0.009900064207613468
CDK4 O 1 0.9995206594467163
mutation O 0 0.014004805125296116
is O 0 0.007233965676277876
the O 0 0.008793601766228676
second O 0 0.014261742122471333
mutation O 0 0.015630541369318962
detected O 0 0.012330164201557636
in O 0 0.008518560789525509
this O 0 0.00973974633961916
gene O 0 0.01976791024208069
worldwide O 0 0.030757946893572807
. O 0 0.040416866540908813

In O 0 0.027842318639159203
summary O 0 0.029724575579166412
, O 0 0.014291603118181229
our O 0 0.013848491944372654
results O 0 0.011496980674564838
show O 0 0.01180342212319374
frequent O 0 0.012675334699451923
involvement O 0 0.013790071941912174
of O 0 0.008977576158940792
the O 0 0.01115222368389368
p16 O 1 0.9159138798713684
gene O 0 0.014059099368751049
in O 0 0.016834894195199013
familial B-Disease 1 0.9999997615814209
melanoma I-Disease 1 1.0
and O 0 0.01690058223903179
confirm O 0 0.011059283278882504
the O 0 0.008224600926041603
role O 0 0.009436222724616528
of O 0 0.009243281558156013
the O 0 0.011959023773670197
CDK4 O 1 0.9980047345161438
gene O 0 0.014618601649999619
as O 0 0.013020587153732777
a O 0 0.10214457660913467
melanoma B-Disease 1 1.0
- O 1 0.9999988079071045
predisposing O 1 0.9999850988388062
gene O 0 0.036530133336782455
. O 0 0.02648264728486538
. O 0 0.040824294090270996

Progression O 0 0.2091762125492096
of O 0 0.041076067835092545
somatic O 1 0.6185594797134399
CTG O 1 0.9976328611373901
repeat O 0 0.043789926916360855
length O 0 0.022864416241645813
heterogeneity O 0 0.030310338363051414
in O 0 0.013112431392073631
the O 0 0.01597295142710209
blood O 1 0.8761715292930603
cells O 1 0.6054633259773254
of O 1 0.9989468455314636
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999998807907104
. O 1 0.6839784979820251

The O 0 0.027810920029878616
genetic O 0 0.019231000915169716
basis O 0 0.014642242342233658
of O 1 0.8861435651779175
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999992847442627
DM B-Disease 1 1.0
) O 0 0.019758913666009903
is O 0 0.010395394638180733
the O 0 0.010274763219058514
expansion O 0 0.01616346277296543
of O 0 0.013360949233174324
an O 0 0.01652548834681511
unstable O 1 0.9949129819869995
CTG O 1 0.9996904134750366
repeat O 0 0.028927719220519066
in O 0 0.013485747389495373
the O 0 0.012993096373975277
34 O 0 0.026750707998871803
UTR O 0 0.06052011623978615
of O 0 0.018758907914161682
the O 0 0.02517654187977314
DM B-Disease 1 1.0
protein O 0 0.04186900705099106
kinase O 0 0.05268453434109688
gene O 0 0.023955466225743294
on O 0 0.021725939586758614
chromosome O 0 0.03838973864912987
19 O 0 0.04612456634640694
. O 0 0.044258370995521545

One O 0 0.024896517395973206
of O 0 0.014875084161758423
the O 0 0.011791959404945374
principal O 0 0.013634755276143551
features O 0 0.010708468966186047
of O 0 0.009196717292070389
the O 1 0.6193292737007141
DM B-Disease 1 1.0
mutation O 0 0.15579067170619965
is O 0 0.00836054515093565
an O 0 0.007644662167876959
extraordinarily O 0 0.02540726773440838
high O 0 0.012204532511532307
level O 0 0.010905789211392403
of O 0 0.011850188486278057
somatic O 1 0.9532400965690613
mosaicism O 1 0.9997417330741882
, O 0 0.012361573055386543
due O 0 0.009940299205482006
to O 0 0.008219227194786072
an O 0 0.007978474721312523
extremely O 0 0.011647174134850502
high O 0 0.01047738827764988
degree O 0 0.012626387178897858
of O 0 0.011899996548891068
somatic O 1 0.6061749458312988
instability O 0 0.3858974874019623
both O 0 0.00981188751757145
within O 0 0.0095595708116889
and O 0 0.010122205130755901
between O 0 0.011920665390789509
different O 0 0.015983350574970245
tissues O 0 0.34198978543281555
. O 0 0.04551902040839195

This O 0 0.03300517052412033
instability O 0 0.2741645872592926
appears O 0 0.022992869839072227
to O 0 0.012793679721653461
be O 0 0.008871321566402912
biased O 0 0.01331304106861353
towards O 0 0.010693066753447056
further O 0 0.009470099583268166
expansion O 0 0.01500464603304863
and O 0 0.009143315255641937
continuous O 0 0.01166419219225645
throughout O 0 0.008340463042259216
the O 0 0.007892290130257607
life O 0 0.008830494247376919
of O 0 0.005934151355177164
an O 0 0.006192473229020834
individual O 0 0.006588728632777929
, O 0 0.00677825603634119
features O 0 0.008434110321104527
that O 0 0.005424338858574629
could O 0 0.005948913749307394
be O 0 0.005736960098147392
associated O 0 0.006951259449124336
with O 0 0.005997520871460438
the O 0 0.008930688723921776
progressive O 0 0.44664624333381653
nature O 0 0.014642477035522461
of O 0 0.03114902414381504
the O 1 0.9641263484954834
disease O 1 0.9999998807907104
. O 0 0.05368845909833908

Although O 0 0.02821226604282856
increasing O 0 0.020328165963292122
measured O 0 0.024057436734437943
allele O 0 0.024177437648177147
size O 0 0.016115570440888405
between O 0 0.012207454070448875
patients O 1 0.6470961570739746
clearly O 0 0.012091883458197117
correlates O 0 0.015465236268937588
with O 0 0.006583761889487505
an O 0 0.006290629040449858
increased O 0 0.012375249527394772
severity O 1 0.9994692206382751
of O 1 0.879370391368866
symptoms O 1 0.9999986886978149
and O 0 0.007345103193074465
an O 0 0.006742421537637711
earlier O 0 0.007891707122325897
age O 0 0.010078591294586658
of O 0 0.01363884937018156
onset O 1 0.9999923706054688
, O 0 0.009005419909954071
this O 0 0.005945824086666107
correlation O 0 0.009258367121219635
is O 0 0.006079443264752626
not O 0 0.0049563245847821236
precise O 0 0.007700899615883827
and O 0 0.007491673808544874
measured O 0 0.011347549967467785
allele O 0 0.014380814507603645
length O 0 0.008785376325249672
cannot O 0 0.007159500382840633
be O 0 0.004868853837251663
used O 0 0.0054130759090185165
as O 0 0.006493508815765381
an O 0 0.007113691419363022
accurate O 0 0.013932526111602783
predictor O 0 0.02888217754662037
of O 0 0.011327415704727173
age O 0 0.02377196028828621
of O 0 0.030049894005060196
onset O 1 0.9999914169311523
. O 0 0.054245371371507645

In O 0 0.025453999638557434
order O 0 0.017804879695177078
to O 0 0.011989053338766098
further O 0 0.012336944229900837
characterize O 0 0.021539371460676193
the O 0 0.01259599719196558
dynamics O 0 0.027516920119524002
of O 0 0.03945661336183548
DM B-Disease 1 1.0
CTG O 1 0.9999996423721313
repeat O 1 0.9981984496116638
somatic O 1 0.9852411150932312
instability O 1 0.8698734641075134
, O 0 0.011690541170537472
we O 0 0.007340088486671448
have O 0 0.00668642483651638
studied O 0 0.011651110835373402
repeat O 0 0.013931531459093094
length O 0 0.008762016892433167
changes O 0 0.006158350966870785
over O 0 0.007137808948755264
time O 0 0.008084623143076897
in O 0 0.012196958996355534
111 O 1 0.9998573064804077
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999252557754517
with O 0 0.013460889458656311
varying O 0 0.020293423905968666
clinical O 1 0.9999878406524658
severity O 1 0.9999840259552002
and O 0 0.2652888298034668
CTG O 1 0.9999774694442749
repeat O 0 0.03264804929494858
size O 0 0.015499252825975418
over O 0 0.010122296400368214
time O 0 0.01018565334379673
intervals O 0 0.012403675355017185
of O 0 0.011729169636964798
1 O 0 0.020268235355615616
- O 0 0.05609627813100815
7 O 0 0.03220963850617409
years O 0 0.032106101512908936
. O 0 0.0487905889749527

We O 0 0.024333834648132324
have O 0 0.011386512778699398
found O 0 0.010339241474866867
a O 0 0.010271504521369934
direct O 0 0.01257686223834753
progression O 0 0.020422784611582756
of O 0 0.008999603800475597
the O 0 0.00932332593947649
size O 0 0.013268017210066319
heterogeneity O 0 0.020308678969740868
over O 0 0.009426115080714226
time O 0 0.00836713332682848
related O 0 0.008884445764124393
to O 0 0.009441603906452656
initial O 0 0.0198899544775486
CTG O 1 0.9960620999336243
repeat O 0 0.025016291067004204
size O 0 0.013786439783871174
and O 0 0.009599890559911728
the O 0 0.00936190690845251
time O 0 0.011609120294451714
interval O 0 0.01783057488501072
and O 0 0.011255094781517982
always O 0 0.014802622608840466
biased O 0 0.018093425780534744
towards O 0 0.021537885069847107
further O 0 0.023148206993937492
expansion O 0 0.04706399142742157
. O 0 0.04972351714968681

Attempts O 0 0.0396108478307724
to O 0 0.018188921734690666
mathematically O 0 0.027699774131178856
model O 0 0.019003666937351227
the O 0 0.012810198590159416
dynamics O 0 0.021689273416996002
have O 0 0.008927923627197742
proved O 0 0.012717431411147118
only O 0 0.007909075357019901
partially O 0 0.015247946605086327
successful O 0 0.012791939079761505
suggesting O 0 0.009801419451832771
that O 0 0.00513637438416481
individual O 0 0.005429635290056467
specific O 0 0.005377898924052715
genetic O 0 0.008543397299945354
and O 0 0.012760593555867672
/ O 1 0.9962116479873657
or O 0 0.008846677839756012
environmental O 0 0.016308069229125977
factors O 0 0.009161434136331081
also O 0 0.007596577983349562
play O 0 0.009942040778696537
a O 0 0.010949702933430672
role O 0 0.015789231285452843
in O 0 0.016699377447366714
somatic O 1 0.8911145329475403
mosaicism O 1 0.9998037219047546
. O 0 0.03437075391411781
. O 0 0.04694907367229462

Aspartylglucosaminuria B-Disease 1 0.9996867179870605
among O 0 0.04590196907520294
Palestinian O 0 0.054808102548122406
Arabs O 0 0.07456310838460922
. O 0 0.06948541104793549

Aspartylglucosaminuria B-Disease 1 0.9999964237213135
( O 1 0.8462598919868469
AGU B-Disease 1 0.9999998807907104
) O 0 0.020544685423374176
is O 0 0.014395608566701412
a O 0 0.01627529226243496
rare O 1 0.8963671326637268
disorder B-Disease 1 0.9999995231628418
of I-Disease 1 0.987475574016571
glycoprotein I-Disease 1 0.9999998807907104
metabolism I-Disease 1 0.9994751811027527
caused O 1 0.5865203738212585
by O 0 0.010753331705927849
the O 0 0.06681197136640549
deficiency B-Disease 1 1.0
of I-Disease 0 0.3905490040779114
the I-Disease 1 0.9927599430084229
lysosomal I-Disease 1 1.0
enzyme I-Disease 1 0.9983129501342773
aspartylglucosaminidase I-Disease 1 0.9999834299087524
( O 1 0.6975053548812866
AGA O 1 0.9999970197677612
) O 0 0.05076960101723671
. O 0 0.06414469331502914

AGU B-Disease 1 0.999998927116394
is O 0 0.032377853989601135
inherited O 1 0.9933772683143616
as O 0 0.014945639297366142
an O 0 0.2674478590488434
autosomal O 1 0.9999998807907104
recessive O 1 1.0
trait O 1 0.9999972581863403
and O 0 0.21749970316886902
occurs O 0 0.009546748362481594
with O 0 0.007212140131741762
a O 0 0.009450888261198997
high O 0 0.012908321805298328
frequency O 0 0.010896842926740646
in O 0 0.009828217327594757
Finland O 0 0.02226671203970909
because O 0 0.011513054370880127
of O 0 0.012433917261660099
a O 0 0.0226117093116045
founder O 1 0.9877836108207703
effect O 0 0.04327309504151344
. O 0 0.04828967899084091

While O 0 0.02713010087609291
very O 0 0.01387752778828144
few O 0 0.013838415965437889
patients O 1 0.8492844700813293
with O 0 0.021396057680249214
AGU B-Disease 1 1.0
have O 0 0.007153960410505533
been O 0 0.00639994814991951
reported O 0 0.006726747378706932
from O 0 0.005693616811186075
non O 0 0.010464532300829887
- O 0 0.14378765225410461
Finnish O 0 0.20077526569366455
origin O 0 0.008716599084436893
, O 0 0.00838156696408987
we O 0 0.009882809594273567
diagnosed O 1 0.9999961853027344
the O 0 0.14835228025913239
disorder O 1 0.9999991655349731
in O 0 0.01298125647008419
8 O 0 0.0611310675740242
patients O 0 0.4660016596317291
originating O 0 0.011654740199446678
from O 0 0.007530294358730316
3 O 0 0.012691374868154526
unrelated O 0 0.013932920061051846
families O 0 0.008973179385066032
, O 0 0.007095245644450188
all O 0 0.006297831889241934
Palestinian O 0 0.00965342577546835
Arabs O 0 0.01179145835340023
from O 0 0.009141962043941021
the O 0 0.012382876127958298
region O 0 0.018722455948591232
of O 0 0.02179579995572567
Jerusalem O 0 0.22780592739582062
. O 0 0.048697441816329956

The O 0 0.040399372577667236
clinical O 1 0.9997619986534119
diagnosis O 1 0.9999991655349731
of O 1 0.9993988275527954
AGU B-Disease 1 1.0
is O 0 0.06138819828629494
often O 0 0.009811540134251118
difficult O 0 0.010641345754265785
, O 0 0.007184469141066074
in O 0 0.005948076955974102
particular O 0 0.006030580494552851
early O 0 0.006434501148760319
in O 0 0.005442355759441853
the O 0 0.005565753672271967
course O 0 0.008233372122049332
of O 0 0.006755075883120298
the O 0 0.11674107611179352
disease O 1 0.9999979734420776
, O 0 0.005835787858814001
and O 0 0.004397266544401646
most O 0 0.0044206841848790646
of O 0 0.006139002740383148
the O 0 0.011281073093414307
patients O 1 0.9933472871780396
are O 0 0.0068082017824053764
diagnosed O 1 0.9999498128890991
after O 0 0.010383771732449532
the O 0 0.01044708676636219
age O 0 0.012910308316349983
of O 0 0.012505147606134415
5 O 0 0.022372284904122353
years O 0 0.026812894269824028
. O 0 0.036748599261045456

However O 0 0.02464212290942669
, O 0 0.015541969798505306
since O 0 0.012438969686627388
these O 0 0.010465728119015694
patients O 1 0.7045713663101196
excrete O 1 0.6444379091262817
early O 0 0.012693267315626144
large O 0 0.009852493181824684
amounts O 0 0.011007765308022499
of O 0 0.010809593833982944
aspartylglucosamine O 1 0.823815107345581
in O 0 0.011447068303823471
urine O 0 0.02160804159939289
, O 0 0.013610626570880413
biochemical O 0 0.029371783137321472
screening O 0 0.020762857049703598
is O 0 0.012040187604725361
easy O 0 0.016575679183006287
by O 0 0.014240426942706108
urine O 0 0.05868595466017723
chromatography O 1 0.6965368390083313
. O 0 0.03125961869955063
. O 0 0.05057429522275925

Detection O 0 0.06997562944889069
of O 0 0.03129521757364273
heterozygous O 0 0.03952183201909065
carriers O 0 0.02819414623081684
of O 0 0.015126698650419712
the O 0 0.15716877579689026
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.3838583528995514
ATM O 1 0.977447509765625
) O 0 0.016228849068284035
gene O 0 0.017033353447914124
by O 0 0.014757517725229263
G2 O 1 0.9998846054077148
phase O 0 0.16581034660339355
chromosomal O 1 0.8999550342559814
radiosensitivity O 1 0.9995300769805908
of O 1 0.9659702181816101
peripheral O 1 0.9999998807907104
blood O 1 0.9999911785125732
lymphocytes O 1 0.9998960494995117
. O 0 0.06524822115898132

In O 0 0.045955557376146317
ataxia B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999836683273315
telangiectasia I-Disease 1 0.9999991655349731
( O 0 0.04918960481882095
A B-Disease 1 0.999858021736145
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
) O 0 0.04521264508366585
patients O 1 0.9308938980102539
, O 0 0.009266284294426441
mutations O 0 0.008811067789793015
in O 0 0.0062231882475316525
a O 0 0.007954059168696404
single O 0 0.009740706533193588
gene O 0 0.009357980452477932
, O 0 0.008225155994296074
ATM O 0 0.02770613133907318
, O 0 0.006868297234177589
result O 0 0.0061166733503341675
in O 0 0.007918836548924446
an O 1 0.5626833438873291
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 0.04162805899977684
embraces O 1 0.9796679019927979
a O 0 0.012116892263293266
variety O 0 0.01116195134818554
of O 0 0.011747445911169052
clinical O 1 0.9996336698532104
features O 0 0.02126993052661419
and O 0 0.014661120250821114
manifests O 1 0.9395844340324402
extreme O 1 0.9173393845558167
radiosensitivity O 1 0.9969860911369324
and O 0 0.012277784757316113
a O 0 0.014543217606842518
strong O 0 0.018743405118584633
pre O 1 0.9875149726867676
- O 1 0.995859682559967
disposition O 1 0.9073083400726318
to O 0 0.037024032324552536
malignancy B-Disease 1 0.9999923706054688
. O 0 0.05236377194523811

Heterozygotes O 0 0.08450168371200562
for O 0 0.020545916631817818
the O 0 0.018319591879844666
ATM O 0 0.2945745885372162
gene O 0 0.012361305765807629
have O 0 0.006020749919116497
no O 0 0.0068387784995138645
clinical O 0 0.01383872702717781
expression O 0 0.008078660815954208
of O 0 0.00818262156099081
A B-Disease 1 0.9999312162399292
- I-Disease 1 0.9999998807907104
T I-Disease 1 0.9999995231628418
but O 0 0.007451147306710482
may O 0 0.008861101232469082
be O 0 0.008958675898611546
cancer B-Disease 1 0.9999953508377075
prone O 1 0.948387861251831
with O 0 0.008956331759691238
a O 0 0.013222024776041508
moderate O 0 0.0679137334227562
increase O 0 0.014065953902900219
in O 0 0.013912213034927845
in O 0 0.022666193544864655
vitro O 0 0.14826014637947083
radiosensitivity O 1 0.9045642018318176
. O 0 0.05949075520038605

We O 0 0.03045996092259884
performed O 0 0.035184431821107864
a O 0 0.024767689406871796
blind O 0 0.04199996218085289
chromosomal O 0 0.032606225460767746
analysis O 0 0.017801156267523766
on O 0 0.017408454790711403
G2 O 1 0.9999983310699463
- O 1 0.9828243255615234
phase O 0 0.048777468502521515
lymphocytes O 0 0.038017939776182175
from O 0 0.011979551054537296
7 O 0 0.017720678821206093
unrelated O 0 0.018439799547195435
A B-Disease 1 0.8977452516555786
- I-Disease 1 0.9999974966049194
T I-Disease 1 0.9999996423721313
patients O 1 0.8034056425094604
, O 0 0.009003305807709694
13 O 0 0.013738461770117283
obligate O 0 0.023490609601140022
A B-Disease 1 0.9773371815681458
- I-Disease 1 0.9999986886978149
T I-Disease 1 0.9999998807907104
heterozygotes O 1 0.9874950051307678
( O 0 0.009920421987771988
parents O 0 0.008985920809209347
of O 0 0.0075829485431313515
the O 0 0.014255267567932606
patients O 1 0.9964146614074707
) O 0 0.007398558314889669
, O 0 0.0067978594452142715
and O 0 0.00557453278452158
14 O 0 0.007533695083111525
normal O 0 0.007849937304854393
controls O 0 0.01212785579264164
following O 0 0.010725210420787334
X O 0 0.12749715149402618
- O 0 0.13734686374664307
irradiation O 0 0.028553778305649757
with O 0 0.011368770152330399
1 O 0 0.019087597727775574
Gy O 1 0.9618317484855652
in O 0 0.0114951366558671
order O 0 0.011346299201250076
to O 0 0.012503063306212425
evaluate O 0 0.021087288856506348
this O 0 0.011354168877005577
cytogenetic O 0 0.03647270426154137
method O 0 0.014774332754313946
as O 0 0.011539054103195667
a O 0 0.013240030035376549
tool O 0 0.021812481805682182
for O 0 0.012011491693556309
detection O 0 0.03177940845489502
of O 0 0.02449367381632328
ATM O 1 0.9909351468086243
carriers O 0 0.19858630001544952
. O 0 0.0497654527425766

Both O 0 0.0347917303442955
A B-Disease 1 0.9361252188682556
- I-Disease 1 0.9999884366989136
T I-Disease 1 0.9999985694885254
homozygotes O 1 0.9988970756530762
and O 0 0.02389378845691681
heterozygotes O 1 0.6437711119651794
showed O 0 0.019349999725818634
significantly O 0 0.01474588830024004
increased O 0 0.011522848159074783
levels O 0 0.011151382699608803
of O 0 0.012640895321965218
radiation O 1 0.9995552897453308
- O 1 0.9999706745147705
induced O 1 0.9999932050704956
chromatid O 1 0.999997615814209
damage O 1 0.9763302206993103
relative O 0 0.016539575532078743
to O 0 0.011124903336167336
that O 0 0.009655946865677834
of O 0 0.014321343973279
normal O 0 0.025783933699131012
controls O 0 0.043585509061813354
. O 0 0.047376904636621475

These O 0 0.019266074523329735
results O 0 0.016592897474765778
show O 0 0.013659758493304253
that O 0 0.009125856682658195
the O 0 0.013719446957111359
G2 O 1 0.9999953508377075
- O 1 0.9890023469924927
phase O 1 0.5473797917366028
chromosomal O 1 0.9682220220565796
radiosensitivity O 1 0.9986340403556824
assay O 0 0.038052238523960114
can O 0 0.009119214490056038
be O 0 0.0070174019783735275
used O 0 0.006915729027241468
for O 0 0.006138641387224197
the O 0 0.00855204463005066
detection O 0 0.017295217141509056
of O 0 0.014002618379890919
A B-Disease 1 0.9997969269752502
- I-Disease 1 0.9999985694885254
T I-Disease 1 0.9999978542327881
heterozygotes O 1 0.9947951436042786
. O 0 0.06577493250370026

In O 0 0.02728714607656002
combination O 0 0.023413222283124924
with O 0 0.013587133958935738
molecular O 0 0.020103774964809418
genetic O 0 0.011762578971683979
analyses O 0 0.011506271548569202
, O 0 0.007214332465082407
this O 0 0.0057351007126271725
test O 0 0.009064716286957264
may O 0 0.005972319282591343
be O 0 0.004437031224370003
of O 0 0.005498275626450777
value O 0 0.006652818061411381
in O 0 0.005767324008047581
studies O 0 0.007583762984722853
of O 0 0.008913476951420307
familial B-Disease 1 0.9981732368469238
and I-Disease 0 0.017802147194743156
sporadic I-Disease 1 0.9868011474609375
cancers I-Disease 1 0.9999951124191284
aimed O 0 0.04154147952795029
at O 0 0.01100643165409565
determination O 0 0.013608617708086967
of O 0 0.008663256652653217
the O 0 0.00883580930531025
potential O 0 0.012087725102901459
involvement O 0 0.013379027135670185
of O 0 0.01159157045185566
ATM O 1 0.7656577229499817
mutations O 0 0.018636412918567657
in O 0 0.022656552493572235
tumor B-Disease 1 0.9999997615814209
risk O 1 0.9973382353782654
or O 0 0.017781905829906464
development O 0 0.0410703644156456
. O 0 0.026663826778531075
. O 0 0.04360455647110939

Ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999933242797852
telangiectasia I-Disease 1 0.9999983310699463
: O 0 0.01979968696832657
identification O 0 0.015793675556778908
and O 0 0.01059533841907978
detection O 0 0.018803991377353668
of O 0 0.013291510753333569
founder O 1 0.9999620914459229
- O 1 0.9851218461990356
effect O 0 0.012061026878654957
mutations O 0 0.011567555367946625
in O 0 0.008018909022212029
the O 0 0.011054725386202335
ATM O 1 0.5500072240829468
gene O 0 0.014388973824679852
in O 0 0.013190618716180325
ethnic O 0 0.01835649646818638
populations O 0 0.02254248782992363
. O 0 0.034333933144807816

To O 0 0.028630448505282402
facilitate O 0 0.027128389105200768
the O 0 0.0166289322078228
evaluation O 0 0.025106502696871758
of O 0 0.01879800111055374
ATM O 1 0.8998971581459045
heterozygotes O 1 0.6520658731460571
for O 0 0.013311092741787434
susceptibility O 0 0.16922123730182648
to O 0 0.010303208604454994
other O 0 0.009423844516277313
diseases O 1 0.9999245405197144
, O 0 0.007812628522515297
such O 0 0.00687805563211441
as O 1 0.9678252339363098
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.014858964830636978
we O 0 0.005317839328199625
have O 0 0.0049414802342653275
attempted O 0 0.010059037245810032
to O 0 0.006003669463098049
define O 0 0.008674993179738522
the O 0 0.007496139034628868
most O 0 0.007270886097103357
common O 0 0.008141410537064075
mutations O 0 0.007599951699376106
and O 0 0.005283047445118427
their O 0 0.005260248202830553
frequencies O 0 0.009608744643628597
in O 0 0.010990642011165619
ataxia B-Disease 1 0.9999986886978149
- I-Disease 1 0.9999631643295288
telangiectasia I-Disease 1 0.9999991655349731
( O 0 0.029703956097364426
A B-Disease 1 0.9997918009757996
- I-Disease 1 0.9999994039535522
T I-Disease 1 0.999998927116394
) O 0 0.02052287943661213
homozygotes O 0 0.0856664851307869
from O 0 0.0164144616574049
10 O 0 0.023208508267998695
ethnic O 0 0.024602334946393967
populations O 0 0.029986359179019928
. O 0 0.041444480419158936

Both O 0 0.03095979243516922
genomic O 0 0.04752083495259285
mutations O 0 0.02326459251344204
and O 0 0.011916295625269413
their O 0 0.011692695319652557
effects O 0 0.02028728649020195
on O 0 0.015860609710216522
cDNA O 0 0.04617977514863014
were O 0 0.02211134135723114
characterized O 0 0.0461430624127388
. O 0 0.042109984904527664

Protein O 0 0.0668523833155632
- O 0 0.05637521669268608
truncation O 0 0.0652996301651001
testing O 0 0.028457362204790115
of O 0 0.01983550749719143
the O 0 0.018356187269091606
entire O 0 0.02567923814058304
ATM O 0 0.043748144060373306
cDNA O 0 0.040109116584062576
detected O 0 0.025279872119426727
92 O 0 0.03533374145627022
( O 0 0.018279604613780975
66 O 0 0.03229965269565582
% O 0 0.016441388055682182
) O 0 0.01699148677289486
truncating O 0 0.05485709011554718
mutations O 0 0.02528466284275055
in O 0 0.0181248988956213
140 O 0 0.04240727424621582
mutant O 0 0.07481663674116135
alleles O 0 0.05983048677444458
screened O 0 0.07550094276666641
. O 0 0.05106319487094879

The O 0 0.03984885290265083
haplotyping O 1 0.5254243016242981
of O 0 0.024649860337376595
patients O 1 0.8560895919799805
with O 0 0.012836722657084465
identical O 0 0.02502022124826908
mutations O 0 0.014901526272296906
indicates O 0 0.011041450314223766
that O 0 0.0057748910039663315
almost O 0 0.0057576741091907024
all O 0 0.004776460118591785
of O 0 0.005599364172667265
these O 0 0.0045195454731583595
represent O 0 0.006798880640417337
common O 0 0.006674217060208321
ancestry O 0 0.00926291849464178
and O 0 0.006716140080243349
that O 0 0.005501530598849058
very O 0 0.00853587593883276
few O 0 0.012133410200476646
spontaneously O 0 0.057084959000349045
recurring O 1 0.9957627654075623
ATM O 1 0.9948042035102844
mutations O 0 0.04178431257605553
exist O 0 0.0297850389033556
. O 0 0.0413379892706871

Assays O 0 0.07643619179725647
requiring O 0 0.03763420134782791
minimal O 0 0.03198635205626488
amounts O 0 0.018334247171878815
of O 0 0.013905653730034828
genomic O 0 0.023293519392609596
DNA O 0 0.014262184500694275
were O 0 0.008085125125944614
designed O 0 0.01195947453379631
to O 0 0.008038664236664772
allow O 0 0.0110826026648283
rapid O 0 0.020846383646130562
screening O 0 0.020471116527915
for O 0 0.012824129313230515
common O 0 0.016371389850974083
ethnic O 0 0.02306189574301243
mutations O 0 0.04128802940249443
. O 0 0.04175696149468422

These O 0 0.034158509224653244
rapid O 0 0.04903808981180191
assays O 0 0.04123665392398834
detected O 0 0.028492996469140053
mutations O 0 0.019415879622101784
in O 0 0.011646224185824394
76 O 0 0.02403927408158779
% O 0 0.011689984239637852
of O 0 0.012101741507649422
Costa O 0 0.0421266183257103
Rican O 1 0.7609760165214539
patients O 1 0.9269562363624573
( O 0 0.012044113129377365
3 O 0 0.014371071942150593
) O 0 0.009161524474620819
, O 0 0.008173439651727676
50 O 0 0.010185057297348976
% O 0 0.00738539919257164
of O 0 0.0072349137626588345
Norwegian O 0 0.021663488820195198
patients O 1 0.6837300062179565
( O 0 0.008442815393209457
1 O 0 0.010696986690163612
) O 0 0.006916465703397989
, O 0 0.006611081305891275
25 O 0 0.008795352652668953
% O 0 0.006813420914113522
of O 0 0.008738500066101551
Polish O 1 0.9990591406822205
patients O 1 0.9983348250389099
( O 0 0.01008841022849083
4 O 0 0.014138988219201565
) O 0 0.008483381941914558
, O 0 0.007583281956613064
and O 0 0.006517486646771431
14 O 0 0.009627025574445724
% O 0 0.007845229469239712
of O 0 0.00926761981099844
Italian O 1 0.9768257141113281
patients O 1 0.9883877635002136
( O 0 0.010505029931664467
1 O 0 0.013885490596294403
) O 0 0.00832323357462883
, O 0 0.0069892192259430885
as O 0 0.005955313332378864
well O 0 0.006532168481498957
as O 0 0.006800181232392788
in O 0 0.008034201338887215
patients O 0 0.019159410148859024
of O 0 0.014414362609386444
Amish O 1 0.9807177186012268
/ O 1 0.9961079955101013
Mennonite O 1 0.7667768597602844
and O 0 0.02063455805182457
Irish O 0 0.034655362367630005
English O 0 0.028613245114684105
backgrounds O 0 0.043059270828962326
. O 0 0.04035566747188568

Additional O 0 0.04069112613797188
mutations O 0 0.02527157962322235
were O 0 0.010422076098620892
observed O 0 0.012018986977636814
in O 0 0.010022622533142567
Japanese O 0 0.020513951778411865
, O 0 0.014257841743528843
Utah O 0 0.027681035920977592
Mormon O 0 0.030103133991360664
, O 0 0.013938724994659424
and O 0 0.014912337996065617
African O 0 0.037349801510572433
American O 1 0.5447671413421631
patients O 1 0.9953786134719849
. O 0 0.04200694337487221

These O 0 0.02884978987276554
assays O 0 0.03413994610309601
should O 0 0.012530162930488586
facilitate O 0 0.017926683649420738
screening O 0 0.019688379019498825
for O 0 0.01263095997273922
A B-Disease 1 0.983902633190155
- I-Disease 1 0.9999904632568359
T I-Disease 1 0.9999963045120239
heterozygotes O 1 0.6961583495140076
in O 0 0.014072124846279621
the O 0 0.015422133728861809
populations O 0 0.01598578691482544
studied O 0 0.027924980968236923
. O 0 0.02674223855137825
. O 0 0.03800501301884651

The O 0 0.0531122088432312
von B-Disease 1 0.9849224090576172
Hippel I-Disease 1 0.9999926090240479
- I-Disease 1 0.9999954700469971
Lindau I-Disease 1 0.9999998807907104
tumor I-Disease 1 0.9999998807907104
suppressor O 1 0.9999372959136963
gene O 0 0.017308032140135765
is O 0 0.009255158714950085
required O 0 0.009271998889744282
for O 0 0.010551703162491322
cell O 0 0.01978958770632744
cycle O 0 0.023144889622926712
exit O 0 0.03405934199690819
upon O 0 0.035286035388708115
serum O 1 0.9879976511001587
withdrawal O 0 0.2403169572353363
. O 0 0.05583781749010086

The O 0 0.05000379681587219
inactivation O 0 0.13366489112377167
of O 0 0.026342369616031647
the O 0 0.02853843942284584
von B-Disease 1 0.983985960483551
Hippel I-Disease 1 0.9999890327453613
- I-Disease 1 0.9999535083770752
Lindau I-Disease 1 0.9999966621398926
( I-Disease 0 0.2363739311695099
VHL I-Disease 1 0.9999986886978149
) I-Disease 0 0.07715671509504318
tumor I-Disease 1 0.9999939203262329
suppressor O 1 0.9998088479042053
gene O 0 0.03229900822043419
predisposes O 1 0.9791812896728516
affected O 0 0.011553661897778511
individuals O 0 0.00646052323281765
to O 0 0.006928059738129377
the O 0 0.010873339138925076
human O 1 0.9988511800765991
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 1 0.7627034187316895
is O 0 0.010910660028457642
associated O 0 0.009669686667621136
with O 0 0.010781729593873024
sporadic B-Disease 1 0.9994589686393738
renal I-Disease 1 1.0
cell I-Disease 1 0.9999998807907104
carcinomas I-Disease 1 1.0
( O 1 0.9999847412109375
RCC B-Disease 1 1.0
) O 0 0.2883049249649048
and O 0 0.2594965100288391
brain B-Disease 1 0.9990819692611694
hemangioblastomas I-Disease 1 0.9991852641105652
. O 0 0.05838104709982872

VHL O 1 0.9993382096290588
- O 0 0.1724502444267273
negative O 0 0.037373900413513184
786 O 1 0.9993211030960083
- O 1 0.9994658827781677
0 O 0 0.40167689323425293
RCC B-Disease 1 0.9999985694885254
cells O 0 0.027346596121788025
are O 0 0.01209106296300888
tumorigenic O 0 0.08852425962686539
in O 0 0.01880425028502941
nude O 1 0.9913596510887146
mice O 0 0.08050601929426193
which O 0 0.010428008623421192
is O 0 0.011159610003232956
suppressed O 0 0.02082814648747444
by O 0 0.010902220383286476
the O 0 0.01628687046468258
reintroduction O 0 0.44292882084846497
of O 0 0.06909874081611633
VHL B-Disease 1 0.9999972581863403
. O 0 0.06001773849129677

Remarkably O 0 0.0776609554886818
, O 0 0.01981472782790661
this O 0 0.010383154265582561
occurs O 0 0.010305780917406082
without O 0 0.007344296667724848
affecting O 0 0.01029906515032053
the O 0 0.008014040999114513
growth O 0 0.010469510219991207
rate O 0 0.00793534331023693
and O 0 0.007835504598915577
cell O 0 0.013057436794042587
cycle O 0 0.013888689689338207
profile O 0 0.016871167346835136
of O 0 0.011915421113371849
these O 0 0.010648923926055431
cells O 0 0.016880106180906296
in O 0 0.017114296555519104
culture O 0 0.03809472173452377
. O 0 0.047952983528375626

The O 0 0.0387214832007885
786 O 1 0.953062117099762
- O 1 0.8066943287849426
0 O 0 0.02700492925941944
cell O 0 0.020263291895389557
line O 0 0.013119046576321125
, O 0 0.008696104399859905
like O 0 0.008183198980987072
many O 0 0.009661128744482994
cancer B-Disease 1 0.9999998807907104
cells O 0 0.03932984918355942
, O 0 0.009662305936217308
fails O 0 0.014804089441895485
to O 0 0.009212564677000046
exit O 0 0.018826821818947792
the O 0 0.015002390369772911
cell O 0 0.030663758516311646
cycle O 0 0.026061881333589554
upon O 0 0.027494870126247406
serum O 1 0.9929280877113342
withdrawal O 0 0.21847151219844818
. O 0 0.05351272597908974

Here O 0 0.02777804434299469
, O 0 0.015977060422301292
it O 0 0.010945754125714302
is O 0 0.009520407766103745
shown O 0 0.008750052191317081
that O 0 0.006126557942479849
reintroduction O 0 0.016843201592564583
of O 0 0.008056791499257088
the O 0 0.009050028398633003
wild O 0 0.016363952308893204
- O 1 0.9963288903236389
type O 1 0.7223920822143555
VHL B-Disease 1 0.9999455213546753
gene O 0 0.015720339491963387
restores O 0 0.02638443373143673
the O 0 0.010806758888065815
ability O 0 0.011202437803149223
of O 0 0.01321393996477127
VHL O 1 0.9999996423721313
- O 1 0.9999891519546509
negative O 1 0.997031569480896
RCC B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
cells O 0 0.018065568059682846
to O 0 0.011764192022383213
exit O 0 0.019141368567943573
the O 0 0.012709160335361958
cell O 0 0.01876923441886902
cycle O 0 0.01814158633351326
and O 0 0.01437147706747055
enter O 0 0.028975611552596092
G0 O 1 0.9998887777328491
/ O 1 0.9845762252807617
quiescence O 1 0.9758023619651794
in O 0 0.02900487184524536
low O 0 0.13415297865867615
serum O 1 0.9949605464935303
. O 0 0.05308667570352554

Both O 0 0.04117158427834511
VHL O 1 0.9999500513076782
- O 1 0.7588202953338623
positive O 0 0.02229897864162922
and O 0 0.02290552668273449
VHL O 1 0.9999980926513672
- O 1 0.9994631409645081
negative O 0 0.2059098184108734
RCC B-Disease 1 0.9999995231628418
cells O 0 0.027779506519436836
exit O 0 0.029543815180659294
the O 0 0.019991783425211906
cell O 0 0.03165202960371971
cycle O 0 0.027244901284575462
by O 0 0.020054444670677185
contact O 0 0.04255066439509392
inhibition O 0 0.1405879706144333
. O 0 0.04681655019521713

The O 0 0.06599373370409012
cyclin O 1 0.9937219023704529
- O 1 0.7607713937759399
dependent O 0 0.046946898102760315
kinase O 1 0.8779699802398682
inhibitor O 1 0.970061182975769
, O 0 0.025175921618938446
p27 O 1 0.973095178604126
, O 0 0.019109508022665977
accumulates O 0 0.03835277259349823
upon O 0 0.018617087975144386
serum O 1 0.9865717887878418
withdrawal O 0 0.05031568184494972
, O 0 0.00852429773658514
only O 0 0.005695096217095852
in O 0 0.005844818893820047
the O 0 0.007035047747194767
presence O 0 0.009100297465920448
of O 0 0.011319098062813282
VHL B-Disease 1 0.9999911785125732
, O 0 0.009326541796326637
as O 0 0.0074088857509195805
a O 0 0.008379794657230377
result O 0 0.006650723051279783
of O 0 0.006640363950282335
the O 0 0.009699219837784767
stabilization O 1 0.5684901475906372
of O 0 0.016100961714982986
the O 0 0.023343224078416824
protein O 0 0.03799555078148842
. O 0 0.04026027023792267

We O 0 0.024788755923509598
propose O 0 0.024933643639087677
that O 0 0.009942791424691677
the O 0 0.010427363216876984
loss O 0 0.013966817408800125
of O 0 0.009357335977256298
wild O 0 0.07292860001325607
- O 1 0.9998929500579834
type O 1 0.9887261986732483
VHL B-Disease 1 0.9999891519546509
gene O 0 0.014120766893029213
results O 0 0.009602248668670654
in O 0 0.00712118623778224
a O 0 0.008836557157337666
specific O 0 0.011009971611201763
cellular O 0 0.3495680093765259
defect O 1 0.9666446447372437
in O 0 0.01372525654733181
serum O 1 0.9997455477714539
- O 1 0.9331023693084717
dependent O 0 0.01457177009433508
growth O 0 0.012826168909668922
control O 0 0.013197534717619419
, O 0 0.01145450584590435
which O 0 0.010304142720997334
may O 0 0.017811326310038567
initiate O 1 0.8948186635971069
tumor B-Disease 1 0.999969482421875
formation O 0 0.14472799003124237
. O 0 0.05386592075228691

This O 0 0.025621579959988594
is O 0 0.017768271267414093
corrected O 0 0.026214653626084328
by O 0 0.009498192928731441
the O 0 0.009630950167775154
reintroduction O 0 0.02102673426270485
of O 0 0.011029538698494434
wild O 0 0.02197427488863468
- O 1 0.997435986995697
type O 1 0.8893906474113464
VHL B-Disease 1 0.9999792575836182
, O 0 0.02347860112786293
implicating O 1 0.9985595345497131
VHL B-Disease 1 0.9999743700027466
as O 0 0.012606339529156685
the O 0 0.012110158801078796
first O 0 0.2036411464214325
tumor B-Disease 1 0.9999960660934448
suppressor O 1 0.9910542368888855
involved O 0 0.009787322022020817
in O 0 0.006521398667246103
the O 0 0.007543305866420269
regulation O 0 0.008424617350101471
of O 0 0.007788741961121559
cell O 0 0.014585510827600956
cycle O 0 0.012048601172864437
exit O 0 0.015456208027899265
, O 0 0.008045146241784096
which O 0 0.005615622736513615
is O 0 0.00583588145673275
consistent O 0 0.007691995706409216
with O 0 0.0058272648602724075
its O 0 0.008527631871402264
gatekeeper O 1 0.9991757273674011
function O 0 0.010393591597676277
in O 0 0.010771872475743294
the O 0 0.40866491198539734
kidney O 1 0.9999998807907104
. O 0 0.02933032251894474
. O 0 0.04063420742750168

Piebaldism B-Disease 1 0.9999387264251709
with O 0 0.3707655668258667
deafness B-Disease 1 1.0
: O 0 0.025827286764979362
molecular O 0 0.021129371598362923
evidence O 0 0.012043029069900513
for O 0 0.01143796369433403
an O 0 0.02361058071255684
expanded O 1 0.9968198537826538
syndrome O 1 1.0
. O 0 0.07478407770395279

In O 0 0.02941240929067135
a O 0 0.021981798112392426
South O 0 0.021339599043130875
African O 0 0.020720098167657852
girl O 0 0.0251113623380661
of O 0 0.013574670068919659
Xhosa O 1 0.999948263168335
stock O 0 0.11206607520580292
with O 0 0.012211859226226807
severe O 1 0.9999970197677612
piebaldism B-Disease 1 0.9999984502792358
and O 1 0.9983994364738464
profound O 1 1.0
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 1 0.575796365737915
identified O 0 0.021086707711219788
a O 0 0.01610656827688217
novel O 0 0.02500101365149021
missense O 0 0.030810968950390816
substitution O 0 0.02009149268269539
at O 0 0.014273243956267834
a O 0 0.014103922992944717
highly O 0 0.015243452042341232
conserved O 0 0.020510083064436913
residue O 0 0.02118871547281742
in O 0 0.012143095955252647
the O 0 0.01656392402946949
intracellular O 0 0.0393010750412941
kinase O 0 0.03173783794045448
domain O 0 0.021048368886113167
of O 0 0.01576995849609375
the O 0 0.02362990379333496
KIT O 1 0.9999984502792358
proto O 1 0.9999858140945435
- O 1 0.9998801946640015
oncogene O 1 0.9999488592147827
, O 0 0.06183771789073944
R796G O 1 0.6209584474563599
. O 0 0.08027920126914978

Though O 0 0.041359204798936844
auditory B-Disease 1 0.9873244762420654
anomalies I-Disease 1 0.5811219215393066
have O 0 0.011182470247149467
been O 0 0.008822188712656498
observed O 0 0.009021524339914322
in O 0 0.007989521138370037
mice O 0 0.012907514348626137
with O 0 0.008665058761835098
dominant O 0 0.0339505709707737
white O 0 0.4707939028739929
spotting O 1 0.9999309778213501
( O 0 0.30044278502464294
W O 1 0.9998987913131714
) O 0 0.010581055656075478
due O 0 0.012409687973558903
to O 0 0.014606676064431667
KIT O 1 0.9999898672103882
mutations O 0 0.1655641794204712
, O 0 0.21044714748859406
deafness B-Disease 1 0.9999998807907104
is O 0 0.013819478452205658
not O 0 0.01189170777797699
typical O 0 0.01963617652654648
in O 0 0.017431292682886124
human O 0 0.029213717207312584
piebaldism B-Disease 1 0.9981202483177185
. O 0 0.04982974752783775

Thus O 0 0.030127335339784622
, O 0 0.016320060938596725
the O 0 0.013869436457753181
occurrence O 0 0.023056011646986008
of O 0 0.20173364877700806
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 0 0.15451399981975555
this O 0 0.011677964590489864
patient O 1 0.9817214012145996
extends O 0 0.02575545944273472
considerably O 0 0.016717271879315376
the O 0 0.011916065588593483
phenotypic O 0 0.02016102336347103
range O 0 0.0135390255600214
of O 0 0.01030064094811678
piebaldism B-Disease 0 0.2518883943557739
due O 0 0.011634168215095997
to O 0 0.013675718568265438
KIT O 1 0.999962568283081
gene O 0 0.017511116340756416
mutation O 0 0.013929442502558231
in O 0 0.00888804905116558
humans O 0 0.009159642271697521
and O 0 0.009563594125211239
tightens O 1 0.6097095012664795
the O 0 0.012131844647228718
clinical O 1 0.8251919746398926
similarity O 0 0.01600085012614727
between O 0 0.011247148737311363
piebaldism B-Disease 1 0.797200620174408
and O 0 0.008267799392342567
the O 0 0.008204181678593159
various O 0 0.008496463298797607
forms O 0 0.01430952176451683
of O 1 0.992620587348938
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9186669588088989
. O 0 0.05333731696009636

Cycloheximide O 1 0.9371069073677063
facilitates O 0 0.04875025153160095
the O 0 0.02064760960638523
identification O 0 0.02165260910987854
of O 0 0.017598649486899376
aberrant O 0 0.09621623903512955
transcripts O 0 0.02345091477036476
resulting O 0 0.013920792378485203
from O 0 0.008983055129647255
a O 0 0.012741085141897202
novel O 0 0.022442393004894257
splice O 0 0.1057300791144371
- O 0 0.06314674019813538
site O 0 0.018062124028801918
mutation O 0 0.015781976282596588
in O 0 0.012328688986599445
COL17A1 O 1 0.8492842316627502
in O 0 0.013034959323704243
a O 0 0.02018568105995655
patient O 1 0.9960803389549255
with O 0 0.09217896312475204
generalized O 1 0.9999940395355225
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999998807907104
. O 1 0.6744266748428345

Patients O 1 0.9839298129081726
with O 0 0.05072365701198578
generalized O 1 0.9999947547912598
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
often O 0 0.03285268321633339
show O 0 0.02321290411055088
decreased O 0 0.02472168765962124
expression O 0 0.017680345103144646
of O 0 0.022012772038578987
type O 1 0.9998552799224854
XVII O 1 1.0
collagen O 1 0.9999990463256836
, O 0 0.027894938364624977
a O 0 0.034923255443573
transmembrane O 1 0.9911330342292786
hemidesmosomal O 1 0.9872517585754395
protein O 0 0.03579895198345184
encoded O 0 0.03699319809675217
by O 0 0.030931491404771805
COL17A1 O 1 0.9877257943153381
. O 0 0.06717349588871002

This O 0 0.023385440930724144
report O 0 0.0210335161536932
documents O 0 0.01843707263469696
a O 0 0.01622941344976425
novel O 0 0.025354325771331787
splice O 0 0.3020963668823242
- O 0 0.18065772950649261
site O 0 0.02124904841184616
mutation O 0 0.016743015497922897
in O 0 0.010636149905622005
COL17A1 O 1 0.846824586391449
in O 0 0.010804842226207256
a O 0 0.01479122880846262
patient O 1 0.9948055148124695
with O 0 0.03488045558333397
generalized O 1 0.9999977350234985
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 0.2304026037454605
and O 0 0.014797595329582691
applies O 0 0.01624147593975067
a O 0 0.012027556076645851
new O 0 0.013435629196465015
methodology O 0 0.018333207815885544
to O 0 0.010942285880446434
define O 0 0.01922444999217987
and O 0 0.013979983516037464
characterize O 0 0.024971047416329384
the O 0 0.01741909608244896
resulting O 0 0.027893953025341034
mRNA O 0 0.045896295458078384
splice O 0 0.09227345883846283
variants O 0 0.060024045407772064
. O 0 0.0616983138024807

Mutational O 0 0.20037706196308136
analysis O 0 0.036598578095436096
of O 0 0.029023753479123116
COL17A1 O 1 0.8776445984840393
identified O 0 0.02155802771449089
a O 0 0.02303417958319187
maternally O 1 0.9780916571617126
inherited O 1 0.999954342842102
G O 1 0.9996567964553833
- O 1 0.7745543122291565
to O 0 0.015976682305336
- O 1 0.9896406531333923
T O 1 0.9983329176902771
transversion O 0 0.21823135018348694
at O 0 0.016072029247879982
the O 0 0.015321915037930012
- O 0 0.02927076257765293
1 O 0 0.02242857776582241
position O 0 0.02469893917441368
of O 0 0.026504330337047577
exon O 0 0.07894498854875565
32 O 0 0.062225788831710815
. O 0 0.05577721446752548

This O 0 0.03516610339283943
acceptor O 0 0.05828062817454338
splice O 0 0.1199292317032814
- O 0 0.21534880995750427
site O 0 0.024438638240098953
mutation O 0 0.017781997099518776
led O 0 0.015427788719534874
to O 0 0.010004168376326561
the O 0 0.010604973882436752
formation O 0 0.014352240599691868
of O 0 0.012525596655905247
aberrant O 0 0.034506794065237045
transcripts O 0 0.020469553768634796
present O 0 0.01557108387351036
at O 0 0.017964879050850868
extremely O 0 0.0235349889844656
low O 0 0.028879327699542046
levels O 0 0.03245193511247635
. O 0 0.04154950752854347

Based O 0 0.029448289424180984
on O 0 0.017292208969593048
our O 0 0.01747133955359459
recent O 0 0.016340628266334534
finding O 0 0.016402484849095345
that O 0 0.013067574240267277
cycloheximide O 1 0.963552713394165
stabilized O 1 0.9552915692329407
mutant O 0 0.2322431057691574
COL17A1 O 1 0.9979813694953918
transcripts O 0 0.030451402068138123
in O 0 0.016644446179270744
keratinocytes O 0 0.3716801702976227
homozygous O 0 0.022340288385748863
for O 0 0.011633075773715973
a O 0 0.01664036512374878
frameshift O 1 0.9880797266960144
mutation O 0 0.01634388603270054
, O 0 0.008984248153865337
the O 0 0.008328624069690704
effects O 0 0.009552696719765663
of O 0 0.007688695564866066
the O 0 0.011178325861692429
splice O 1 0.6289588809013367
- O 0 0.27742698788642883
site O 0 0.01691167801618576
mutation O 0 0.01401807926595211
on O 0 0.010433057323098183
splicing O 0 0.018950214609503746
of O 0 0.014515143819153309
COL17A1 O 1 0.9164495468139648
transcripts O 0 0.021783659234642982
were O 0 0.010478697717189789
determined O 0 0.014098579995334148
using O 0 0.013136623427271843
reverse O 0 0.029073866084218025
transcriptase O 0 0.3004010021686554
polymerase O 0 0.04665222018957138
chain O 0 0.029395967721939087
reaction O 0 0.017074285075068474
of O 0 0.013813916593790054
total O 0 0.016288015991449356
RNA O 0 0.028626803308725357
from O 0 0.018370693549513817
keratinocytes O 0 0.1260133534669876
incubated O 0 0.055457960814237595
for O 0 0.025479884818196297
2 O 0 0.05037972331047058
. O 0 0.049569521099328995

5 O 0 0.042858805507421494
h O 0 0.04046889394521713
in O 0 0.014196394942700863
the O 0 0.013069910928606987
presence O 0 0.013681959360837936
or O 0 0.01052086241543293
absence O 0 0.016144700348377228
of O 0 0.014070914126932621
10 O 0 0.02393738366663456
microg O 1 0.9931422472000122
cycloheximide O 1 0.9942611455917358
per O 0 0.03968282788991928
ml O 1 0.834114670753479
. O 0 0.05756464600563049

Using O 0 0.028570417314767838
this O 0 0.017045941203832626
approach O 0 0.02160562388598919
, O 0 0.013364896178245544
an O 0 0.013211265206336975
abnormally O 1 0.6803886890411377
spliced O 0 0.03353264182806015
transcript O 0 0.023413997143507004
was O 0 0.014637069776654243
identified O 0 0.011069885455071926
that O 0 0.0068437024019658566
contains O 0 0.008939475752413273
an O 0 0.008656183257699013
extra O 0 0.017164751887321472
264 O 0 0.026907145977020264
bases O 0 0.0191548652946949
upstream O 0 0.019848879426717758
from O 0 0.013592593371868134
exon O 0 0.033131830394268036
32 O 0 0.01862320490181446
, O 0 0.011178074404597282
resulting O 0 0.012442831881344318
in O 0 0.00923559907823801
a O 0 0.013598814606666565
premature O 1 0.7373155355453491
termination O 0 0.44247519969940186
codon O 0 0.03339570388197899
27 O 0 0.03181604668498039
bp O 0 0.04647252708673477
downstream O 0 0.03125052526593208
from O 0 0.017527669668197632
the O 0 0.023528682067990303
cryptic O 0 0.14226575195789337
splice O 0 0.2080860286951065
site O 0 0.06724712997674942
. O 0 0.06127898395061493

Three O 0 0.025005709379911423
other O 0 0.0167600829154253
splice O 0 0.04322773590683937
variants O 0 0.01943291909992695
, O 0 0.011441785842180252
including O 0 0.009674080647528172
one O 0 0.009701487608253956
derived O 0 0.009416884742677212
from O 0 0.007794957607984543
the O 0 0.00999451894313097
skipping O 0 0.019999567419290543
of O 0 0.012049010023474693
exon O 0 0.049880269914865494
32 O 0 0.018946532160043716
, O 0 0.012637817300856113
were O 0 0.011056091636419296
also O 0 0.01755906641483307
identified O 0 0.029867688193917274
. O 0 0.03661248832941055

These O 0 0.019843967631459236
results O 0 0.018423346802592278
indicate O 0 0.012018505483865738
the O 0 0.01169981062412262
usefulness O 0 0.02691209688782692
of O 0 0.017876217141747475
cycloheximide O 1 0.999925971031189
treatment O 1 0.9326751232147217
in O 0 0.012645400129258633
evaluating O 0 0.020011216402053833
the O 0 0.012610020115971565
abnormal O 0 0.017340844497084618
processing O 0 0.01302425842732191
of O 0 0.009378425776958466
mRNA O 0 0.013691886328160763
due O 0 0.009150765836238861
to O 0 0.010623042471706867
splice O 0 0.030185356736183167
- O 0 0.02226395346224308
site O 0 0.01768391579389572
mutations O 0 0.014513302594423294
, O 0 0.010215947404503822
because O 0 0.009559055790305138
( O 0 0.011582394130527973
i O 0 0.015758270397782326
) O 0 0.014508651569485664
aberrant O 0 0.0322636216878891
splicing O 0 0.02533472515642643
often O 0 0.01102736871689558
generates O 0 0.02018585056066513
a O 0 0.014611837454140186
premature O 0 0.11515555530786514
termination O 0 0.20995400846004486
codon O 0 0.028265926986932755
, O 0 0.014768468216061592
( O 0 0.013088266365230083
ii O 1 0.9662689566612244
) O 0 0.010719960555434227
transcripts O 0 0.014948488213121891
with O 0 0.009609769098460674
premature O 1 0.8090736865997314
termination O 1 0.8936544060707092
codons O 0 0.017725370824337006
can O 0 0.006415133364498615
occur O 0 0.005969667341560125
at O 0 0.008303556591272354
low O 0 0.011515028774738312
or O 0 0.009410154074430466
undetectable O 1 0.8349100947380066
levels O 0 0.010100254788994789
due O 0 0.007731451187282801
to O 0 0.008922272361814976
nonsense O 0 0.024029208347201347
- O 0 0.06336334347724915
mediated O 0 0.02393992990255356
mRNA O 0 0.019663115963339806
decay O 0 0.020097708329558372
, O 0 0.010792190209031105
and O 0 0.008731849491596222
( O 0 0.011966508813202381
iii O 1 0.9458483457565308
) O 0 0.0094425855204463
the O 0 0.009005025029182434
levels O 0 0.007706308737397194
of O 0 0.007548902649432421
these O 0 0.006347691640257835
transcripts O 0 0.014024280942976475
can O 0 0.007199747022241354
be O 0 0.008426561020314693
increased O 0 0.015603240579366684
by O 0 0.019909381866455078
cycloheximide O 1 0.9465857744216919
. O 0 0.04947966709733009

A O 0 0.056368038058280945
deletion O 0 0.06428244709968567
mutation O 0 0.02905481867492199
in O 0 0.017387496307492256
COL17A1 O 1 0.9027636647224426
in O 0 0.011868651024997234
five O 0 0.014126523397862911
Austrian O 0 0.2299535572528839
families O 0 0.016295529901981354
with O 0 0.018827801570296288
generalized O 1 0.99998939037323
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
represents O 1 0.8999171257019043
propagation O 0 0.10868625342845917
of O 0 0.024232931435108185
an O 0 0.030416470021009445
ancestral O 1 0.960184633731842
allele O 0 0.15455688536167145
. O 0 0.056508868932724

Patients O 1 0.9946783781051636
with O 0 0.05385487154126167
generalized O 1 0.9999933242797852
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 0.22138145565986633
a O 0 0.022228702902793884
usually O 0 0.015662308782339096
nonlethal O 0 0.043182533234357834
form O 0 0.018405992537736893
of O 0 0.04193757474422455
junctional B-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 0.019839392974972725
have O 0 0.011065802536904812
generalized O 1 0.8008055686950684
blistering B-Disease 1 0.999988317489624
, O 1 0.9948937892913818
nail B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 1 0.999351441860199
patchy B-Disease 1 1.0
alopecia I-Disease 1 1.0
, O 1 0.9998528957366943
and O 1 0.9997876286506653
dental B-Disease 1 1.0
abnormalities I-Disease 1 0.9999994039535522
. O 0 0.2149910032749176

Skin B-Disease 1 0.9999995231628418
fragility I-Disease 1 0.9999675750732422
in O 0 0.018257025629281998
most O 0 0.011557108722627163
cases O 0 0.00995330698788166
is O 0 0.007139225024729967
due O 0 0.007435770705342293
to O 0 0.00798709224909544
mutations O 0 0.008954857476055622
in O 0 0.006673427298665047
the O 0 0.00899343192577362
gene O 0 0.01442515105009079
encoding O 0 0.023663748055696487
type O 1 0.9584672451019287
XVII O 1 1.0
collagen O 1 0.9999998807907104
( O 1 0.7640913724899292
COL17A1 O 1 0.9999513626098633
) O 0 0.055133722722530365
. O 0 0.06353413313627243

Recently O 0 0.04778755083680153
, O 0 0.021431347355246544
we O 0 0.012990167364478111
reported O 0 0.01466994546353817
five O 0 0.013228945434093475
Austrian O 0 0.16986490786075592
families O 0 0.015407971106469631
with O 0 0.01870829425752163
generalized O 1 0.9999841451644897
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
who O 0 0.19146114587783813
share O 0 0.02814248949289322
the O 0 0.023237546905875206
same O 0 0.028570666909217834
COL17A1 O 1 0.9999496936798096
mutation O 0 0.11985640227794647
. O 0 0.05380237475037575

Affected O 0 0.03685222566127777
individuals O 0 0.015563484281301498
in O 0 0.011543776839971542
three O 0 0.009798393584787846
families O 0 0.01074395701289177
are O 0 0.006495321169495583
homozygous O 0 0.01464830432087183
for O 0 0.009995793923735619
4003delTC O 1 0.9925162196159363
, O 0 0.01037058886140585
whereas O 0 0.010074466466903687
those O 0 0.006427600514143705
in O 0 0.007049712352454662
two O 0 0.008832585997879505
others O 0 0.011836550198495388
are O 0 0.010597622022032738
compound O 0 0.057270459830760956
heterozygotes O 1 0.9686093330383301
. O 0 0.05098900943994522

To O 0 0.026606764644384384
determine O 0 0.01839447021484375
if O 0 0.010743419639766216
the O 0 0.010536063462495804
occurrence O 0 0.01608884334564209
of O 0 0.01185760647058487
4003delTC O 1 0.9478945732116699
in O 0 0.010050797834992409
these O 0 0.007698563858866692
unrelated O 0 0.014714323915541172
families O 0 0.011675872839987278
signifies O 0 0.13802264630794525
propagation O 0 0.01765725575387478
of O 0 0.01067282259464264
an O 0 0.011765134520828724
ancestral O 0 0.19993747770786285
allele O 0 0.02165244333446026
or O 0 0.00945167988538742
a O 0 0.014846288599073887
mutational O 1 0.999583899974823
hot O 1 0.814500093460083
spot O 0 0.03716547414660454
, O 0 0.015473537147045135
haplotypes O 0 0.028192773461341858
were O 0 0.010759786702692509
determined O 0 0.014493986032903194
for O 0 0.011494552716612816
polymorphisms O 0 0.022986767813563347
both O 0 0.012581956572830677
within O 0 0.016881531104445457
and O 0 0.028193648904561996
flanking O 1 0.9987006187438965
COL17A1 O 1 0.9999626874923706
. O 0 0.05866288021206856

Five O 0 0.050328921526670456
intragenic O 1 0.8809224963188171
polymorphisms O 0 0.037977997213602066
were O 0 0.014537765644490719
chosen O 0 0.02031131461262703
based O 0 0.016561849042773247
on O 0 0.018856793642044067
their O 0 0.023674406111240387
informativeness O 1 0.7790073156356812
. O 0 0.05145210772752762

One O 0 0.021969329565763474
of O 0 0.012506053782999516
these O 0 0.007902415469288826
, O 0 0.007050345651805401
not O 0 0.005441674496978521
previously O 0 0.008997894823551178
reported O 0 0.009407282806932926
, O 0 0.007791064213961363
was O 0 0.012050281278789043
2988 O 1 0.5573331713676453
A O 0 0.018562445417046547
or O 0 0.012120592407882214
C O 0 0.02862151712179184
that O 0 0.007999905385077
introduces O 0 0.020335424691438675
a O 0 0.012408711947500706
new O 0 0.013727296143770218
restriction O 0 0.021090205758810043
site O 0 0.025385906919836998
for O 0 0.022899094969034195
Eco0109 O 1 0.873903751373291
I O 0 0.06898050010204315
. O 0 0.052857622504234314

All O 0 0.02690383978188038
the O 0 0.027058681473135948
4003delTC O 1 0.8391725420951843
alleles O 0 0.027558917179703712
showed O 0 0.01670650765299797
the O 0 0.012409400194883347
same O 0 0.011223004199564457
haplotype O 0 0.026615729555487633
for O 0 0.010265829972922802
these O 0 0.010747034102678299
five O 0 0.020116036757826805
polymorphic O 0 0.12582659721374512
markers O 0 0.06990985572338104
. O 0 0.05031626299023628

Fourteen O 0 0.10335122793912888
microsatellite O 1 0.8895065188407898
polymorphisms O 0 0.04413820430636406
were O 0 0.014195728115737438
selected O 0 0.017257215455174446
based O 0 0.011004356667399406
on O 0 0.009109077975153923
their O 0 0.009748248383402824
high O 0 0.016465533524751663
heterozygosity O 1 0.7546257972717285
and O 0 0.011335739865899086
their O 0 0.009956374764442444
location O 0 0.01622699201107025
within O 0 0.01741720736026764
10q23 O 1 0.9306456446647644
- O 1 0.9759067893028259
q25 O 1 0.9689474105834961
near O 0 0.07488023489713669
COL17A1 O 1 0.9981281161308289
. O 0 0.0682453140616417

Three O 0 0.029163770377635956
families O 0 0.024154603481292725
shared O 0 0.030176423490047455
microsatellite O 1 0.9684996008872986
polymorphisms O 0 0.02926667407155037
covering O 0 0.022216055542230606
at O 0 0.011615194380283356
most O 0 0.008043989539146423
19 O 0 0.01644003950059414
cM O 0 0.02176804468035698
, O 0 0.009783760644495487
whereas O 0 0.008764791302382946
the O 0 0.007855389267206192
others O 0 0.008536392822861671
shared O 0 0.011300863698124886
smaller O 0 0.009486694820225239
regions O 0 0.007587995380163193
consistent O 0 0.009757651947438717
with O 0 0.007995706982910633
cross O 0 0.014020787551999092
- O 0 0.018847063183784485
over O 0 0.010031207464635372
events O 0 0.011032581329345703
during O 0 0.009935771115124226
passage O 0 0.013766862452030182
of O 0 0.009844216518104076
this O 0 0.009913917630910873
mutation O 0 0.016494842246174812
through O 0 0.012881319038569927
several O 0 0.015148857608437538
generations O 0 0.03709978610277176
. O 0 0.03975561261177063

These O 0 0.024885034188628197
results O 0 0.02172318659722805
indicate O 0 0.018255190923810005
that O 0 0.013104566372931004
4003delTC O 0 0.17123495042324066
occurs O 0 0.015944555401802063
on O 0 0.012607935816049576
a O 0 0.017517851665616035
single O 0 0.025079526007175446
ancestral O 0 0.10226564854383469
allele O 0 0.04852941259741783
. O 0 0.026431236416101456
. O 0 0.03856958448886871

The O 0 0.06705968081951141
haptoglobin O 1 0.9988841414451599
- O 1 0.973124086856842
gene O 0 0.037982065230607986
deletion O 0 0.04402877390384674
responsible O 0 0.030427517369389534
for O 0 0.031036077067255974
anhaptoglobinemia B-Disease 1 0.9897491335868835
. O 0 0.056156497448682785

We O 0 0.02604956552386284
have O 0 0.012213435024023056
found O 0 0.01196641381829977
an O 0 0.012370291166007519
allelic O 0 0.039601072669029236
deletion O 0 0.02436828427016735
of O 0 0.01321922056376934
the O 0 0.017772579565644264
haptoglobin O 1 0.9999676942825317
( O 0 0.02603304386138916
Hp O 1 0.9842677712440491
) O 0 0.012988394126296043
gene O 0 0.012338797561824322
from O 0 0.009209718555212021
an O 0 0.012365427799522877
individual O 0 0.016875121742486954
with O 0 0.023260753601789474
anhaptoglobinemia B-Disease 1 0.9892581105232239
. O 0 0.04777678847312927

The O 0 0.04468119889497757
Hp O 1 0.8216651678085327
gene O 0 0.02622687816619873
cluster O 0 0.02659010887145996
consists O 0 0.01793115958571434
of O 0 0.012495859526097775
coding O 0 0.01718258485198021
regions O 0 0.010229640640318394
of O 0 0.008582478389143944
the O 0 0.011183840222656727
alpha O 0 0.03378528729081154
chain O 0 0.023727571591734886
and O 0 0.010962532833218575
beta O 0 0.019964179024100304
chain O 0 0.016274468973279
of O 0 0.009682992473244667
the O 0 0.011648157611489296
haptoglobin O 1 0.9986869692802429
gene O 0 0.016359422355890274
( O 0 0.012327173724770546
Hp O 0 0.48936009407043457
) O 0 0.00986582599580288
and O 0 0.008180176839232445
of O 0 0.007750914432108402
the O 0 0.010711216367781162
alpha O 0 0.027561403810977936
chain O 0 0.02021781913936138
and O 0 0.010419454425573349
beta O 0 0.017633723095059395
chain O 0 0.01427588053047657
of O 0 0.008039436303079128
the O 0 0.010789918713271618
haptoglobin O 1 0.99456787109375
- O 1 0.8288509249687195
related O 0 0.01488861721009016
gene O 0 0.014299685135483742
( O 0 0.014022903516888618
Hpr O 1 0.9975054860115051
) O 0 0.011356396600604057
, O 0 0.010128007270395756
in O 0 0.009788903407752514
tandem O 0 0.02490389719605446
from O 0 0.011744959279894829
the O 0 0.01584685407578945
5 O 0 0.029637407511472702
side O 0 0.03838004171848297
. O 0 0.04263707622885704

Southern O 0 0.06145164370536804
blot O 1 0.9563055634498596
and O 0 0.024845343083143234
PCR O 0 0.04877156391739845
analyses O 0 0.01961352489888668
have O 0 0.00847534742206335
indicated O 0 0.009046937339007854
that O 0 0.005816795863211155
the O 0 0.0070135085843503475
individual O 0 0.006897629704326391
with O 0 0.008468570187687874
anhaptoglobinemia B-Disease 1 0.9949333071708679
was O 0 0.014640343375504017
homozygous O 0 0.013291848823428154
for O 0 0.0062969159334897995
the O 0 0.008586499840021133
gene O 0 0.009708466939628124
deletion O 0 0.012890173122286797
and O 0 0.005630721803754568
that O 0 0.004379371181130409
the O 0 0.007035267539322376
gene O 0 0.009155145846307278
deletion O 0 0.014565696939826012
was O 0 0.010419399477541447
included O 0 0.00918540172278881
at O 0 0.008611002936959267
least O 0 0.006391505710780621
from O 0 0.007218923885375261
the O 0 0.009891574271023273
promoter O 0 0.03327848017215729
region O 0 0.012679388746619225
of O 0 0.011195912025868893
Hp O 1 0.7827833890914917
to O 0 0.01552130002528429
Hpr O 1 0.9796409606933594
alpha O 0 0.02640545554459095
but O 0 0.009631377644836903
not O 0 0.008648599497973919
to O 0 0.017199093475937843
Hpr O 1 0.9967468976974487
beta O 0 0.25482168793678284
( O 0 0.03997804597020149
Hpdel O 1 0.9509657621383667
) O 0 0.04963713884353638
. O 0 0.059180792421102524

In O 0 0.02339758537709713
addition O 0 0.01735015958547592
, O 0 0.011366251856088638
we O 0 0.006857685744762421
found O 0 0.0062149870209395885
seven O 0 0.006213802844285965
individuals O 0 0.004841295536607504
with O 0 0.006359335966408253
hypohaptoglobinemia B-Disease 1 0.6853309869766235
in O 0 0.006478618830442429
three O 0 0.00636318139731884
families O 0 0.0071295578964054585
, O 0 0.006620100699365139
and O 0 0.007303213234990835
the O 0 0.008115698583424091
genotypes O 0 0.01836245134472847
of O 0 0.00736194895580411
six O 0 0.007651868276298046
of O 0 0.0062695518136024475
the O 0 0.006360654719173908
seven O 0 0.007956378161907196
individuals O 0 0.005382284987717867
were O 0 0.005073103122413158
found O 0 0.005396299064159393
to O 0 0.00802725087851286
be O 0 0.012958730570971966
Hp2 O 1 0.9998000264167786
/ O 1 0.9919182658195496
Hpdel O 1 0.9685482382774353
. O 0 0.05751519650220871

The O 0 0.03865986689925194
phenotypes O 0 0.09165985137224197
and O 0 0.017349231988191605
genotypes O 0 0.07062716037034988
in O 0 0.009158811531960964
one O 0 0.007669390179216862
of O 0 0.0063634770922362804
these O 0 0.003924609161913395
three O 0 0.005319090560078621
families O 0 0.006052371114492416
showed O 0 0.008059483021497726
the O 0 0.006565707735717297
father O 0 0.01031737681478262
to O 0 0.0070050121285021305
be O 0 0.007686777971684933
hypohaptoglobinemic B-Disease 1 0.9163867235183716
( O 0 0.0117171760648489
Hp2 O 1 0.866881251335144
) O 0 0.011463981121778488
and O 0 0.01344167347997427
Hp2 O 1 0.9981545805931091
/ O 1 0.9890230894088745
Hpdel O 1 0.9833606481552124
, O 0 0.011951364576816559
the O 0 0.00931335985660553
mother O 0 0.013060903176665306
to O 0 0.007951588369905949
be O 0 0.007754035759717226
Hp2 O 0 0.20208708941936493
- O 0 0.03612929955124855
1 O 0 0.013782798312604427
and O 0 0.012927639298141003
Hp1 O 1 0.9997220635414124
/ O 1 0.9953973889350891
Hp2 O 1 0.980423092842102
, O 0 0.010227911174297333
one O 0 0.006676399614661932
of O 0 0.006500388495624065
the O 0 0.006467732600867748
two O 0 0.00532553531229496
children O 0 0.006576003972440958
to O 0 0.00698392279446125
be O 0 0.007422177586704493
hypohaptoglobinemic B-Disease 1 0.7685083150863647
( O 0 0.01182590238749981
Hp2 O 1 0.7904478907585144
) O 0 0.011505329050123692
and O 0 0.012531595304608345
Hp2 O 1 0.9995498061180115
/ O 1 0.9969154596328735
Hpdel O 1 0.9968186616897583
, O 0 0.011761903762817383
and O 0 0.008024866692721844
the O 0 0.00797305628657341
other O 0 0.006763114593923092
child O 0 0.010355423204600811
to O 0 0.007754788268357515
be O 0 0.008879240602254868
Hp1 O 0 0.39281490445137024
and O 0 0.015605980530381203
Hp1 O 1 0.9999417066574097
/ O 1 0.9994207620620728
Hpdel O 1 0.9908439517021179
, O 0 0.01765596494078636
showing O 0 0.01917039044201374
an O 0 0.015818675979971886
anomalous O 0 0.042571380734443665
inheritance O 0 0.03257621452212334
of O 0 0.01825539767742157
Hp O 1 0.9988705515861511
phenotypes O 0 0.3933448791503906
in O 0 0.01676681824028492
the O 0 0.021325532346963882
child O 0 0.24798524379730225
with O 0 0.029079023748636246
Hp1 O 1 0.9993593096733093
. O 0 0.05200283229351044

The O 0 0.04847145080566406
Hp2 O 1 0.9999748468399048
/ O 1 0.9989653825759888
Hpdel O 1 0.9823514223098755
individuals O 0 0.012338981963694096
had O 0 0.00992327369749546
an O 0 0.008887272328138351
extremely O 0 0.012347538024187088
low O 0 0.011576238088309765
level O 0 0.009774844162166119
of O 0 0.01043486874550581
Hp O 1 0.6169450879096985
( O 0 0.013900568708777428
mean O 0 0.016121765598654747
+ O 0 0.03019420988857746
/ O 0 0.05340924859046936
- O 0 0.18327561020851135
SD O 1 0.6566938757896423
= O 0 0.03667040541768074
0 O 0 0.028216879814863205
. O 0 0.01997300609946251
049 O 1 0.7025243043899536
+ O 0 0.04911113902926445
/ O 0 0.053789716213941574
- O 0 0.03560933843255043
0 O 0 0.02750975452363491
. O 0 0.019693657755851746
043 O 1 0.7045081853866577
mg O 1 0.9925029277801514
/ O 1 0.7810205817222595
ml O 0 0.4365193247795105
; O 0 0.01950960047543049
n O 0 0.027724742889404297
= O 0 0.025668831542134285
6 O 0 0.018016252666711807
) O 0 0.009921390563249588
, O 0 0.008349933661520481
compared O 0 0.007061738520860672
with O 0 0.0056470842100679874
the O 0 0.006502377800643444
level O 0 0.007628523278981447
( O 0 0.007309027016162872
1 O 0 0.010530347935855389
. O 0 0.007654623128473759
64 O 0 0.019171474501490593
+ O 0 0.025220312178134918
/ O 0 0.030644813552498817
- O 0 0.02497723512351513
1 O 0 0.016838068142533302
. O 0 0.014018915593624115
07 O 1 0.9316434264183044
mg O 1 0.9995619654655457
/ O 1 0.9299979209899902
ml O 0 0.41573983430862427
) O 0 0.013882748782634735
obtained O 0 0.014822578988969326
from O 0 0.012515975162386894
52 O 0 0.024965375661849976
healthy O 0 0.0253639817237854
volunteers O 0 0.027904687449336052
having O 0 0.019329875707626343
phenotype O 1 0.819901168346405
Hp2 O 1 0.9958149790763855
, O 0 0.013454382307827473
whereas O 0 0.014169313944876194
the O 0 0.01401369646191597
serum O 1 0.9946855306625366
Hp O 1 0.7793283462524414
level O 0 0.012391433119773865
of O 0 0.009495211765170097
an O 0 0.00893185380846262
individual O 0 0.010878720320761204
with O 0 0.015323159284889698
Hp1 O 1 0.9999347925186157
/ O 1 0.9993009567260742
Hpdel O 1 0.9987677335739136
was O 0 0.04967664182186127
0 O 0 0.05628080293536186
. O 0 0.04999726265668869

50 O 0 0.06591033935546875
mg O 1 0.999969482421875
/ O 1 0.9997021555900574
ml O 1 0.9942882061004639
, O 0 0.014779303222894669
which O 0 0.008651250042021275
was O 0 0.010227293707430363
approximately O 0 0.008667774498462677
half O 0 0.008037319406867027
the O 0 0.006922435946762562
level O 0 0.008843855932354927
of O 0 0.009925005957484245
Hp O 0 0.05602638050913811
in O 0 0.011161881498992443
control O 0 0.01621469482779503
sera O 0 0.426664799451828
from O 0 0.010609859600663185
the O 0 0.015673311427235603
Hp1 O 1 0.9908725619316101
phenotype O 0 0.07785124331712723
( O 0 0.014627974480390549
1 O 0 0.015768295153975487
. O 0 0.010821842588484287
26 O 0 0.01770596019923687
+ O 0 0.027048740535974503
/ O 0 0.03126076981425285
- O 0 0.024713844060897827
0 O 0 0.016467172652482986
. O 0 0.01070394180715084
33 O 0 0.025720536708831787
mg O 1 0.783150315284729
/ O 0 0.3356969654560089
ml O 0 0.24127204716205597
; O 0 0.01654575765132904
n O 0 0.024158824235200882
= O 0 0.02314966730773449
9 O 0 0.017633121460676193
) O 0 0.010506932623684406
, O 0 0.009623752906918526
showing O 0 0.011414382606744766
a O 0 0.014588876627385616
gene O 0 0.023599106818437576
- O 1 0.9954432249069214
dosage O 1 0.9776935577392578
effect O 0 0.037345416843891144
. O 0 0.04288307949900627

The O 0 0.030889833346009254
other O 0 0.019671622663736343
allele O 0 0.03283291310071945
( O 0 0.01885847933590412
Hp2 O 1 0.8659813404083252
) O 0 0.010803322307765484
of O 0 0.008572570979595184
individuals O 0 0.007320338860154152
with O 0 0.010819580405950546
Hp2 O 1 0.9999902248382568
/ O 1 0.9999456405639648
Hpdel O 1 0.9972262978553772
was O 0 0.01691519096493721
found O 0 0.008190110325813293
to O 0 0.0070091295056045055
have O 0 0.004798672627657652
, O 0 0.005786119028925896
in O 0 0.005962456576526165
all O 0 0.006847676821053028
exons O 0 0.01634221337735653
, O 0 0.010690297931432724
no O 0 0.012135056778788567
mutation O 0 0.01729159988462925
, O 0 0.012530586682260036
by O 0 0.01540026068687439
DNA O 0 0.029835127294063568
sequencing O 0 0.055018652230501175
. O 0 0.04435209557414055

On O 0 0.02076849713921547
the O 0 0.013811592012643814
basis O 0 0.010105682536959648
of O 0 0.009789093397557735
the O 0 0.008509073406457901
present O 0 0.008553334511816502
study O 0 0.009246156550943851
, O 0 0.007788517512381077
the O 0 0.007898076437413692
mechanism O 0 0.012195867486298084
of O 0 0.010952126234769821
anhaptoglobinemia B-Disease 1 0.9949466586112976
and O 0 0.009375014342367649
the O 0 0.009382758289575577
mechanism O 0 0.011944238096475601
of O 0 0.012173070572316647
anomalous O 0 0.3711715638637543
inheritance O 0 0.2353540062904358
of O 0 0.04078290984034538
Hp O 1 0.9999728202819824
phenotypes O 1 0.925694465637207
were O 0 0.01429639384150505
well O 0 0.01883198320865631
explained O 0 0.03414878994226456
. O 0 0.03505515307188034

However O 0 0.03083370439708233
, O 0 0.021339967846870422
the O 0 0.017518222332000732
mechanism O 0 0.028203768655657768
of O 0 0.028942685574293137
hypohaptoglobinemia B-Disease 1 0.9994320273399353
remains O 0 0.3083694279193878
unknown O 0 0.08100061863660812

ATM O 0 0.3017318844795227
mutations O 0 0.03165766969323158
and O 0 0.017451198771595955
phenotypes O 0 0.08538004010915756
in O 0 0.030011245980858803
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
telangiectasia I-Disease 1 0.9999997615814209
families O 0 0.015752095729112625
in O 0 0.009357609786093235
the O 0 0.009197290986776352
British O 0 0.016628844663500786
Isles O 0 0.03710520267486572
: O 0 0.010306437499821186
expression O 0 0.009597678668797016
of O 0 0.010210606269538403
mutant O 0 0.04046756029129028
ATM O 0 0.037166547030210495
and O 0 0.007413442246615887
the O 0 0.007862476631999016
risk O 0 0.014591455459594727
of O 0 0.19107471406459808
leukemia B-Disease 1 1.0
, O 1 0.9999973773956299
lymphoma B-Disease 1 1.0
, O 1 0.9999582767486572
and O 1 0.9999939203262329
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.3164539337158203

We O 0 0.02856587804853916
report O 0 0.019114887341856956
the O 0 0.015129066072404385
spectrum O 0 0.022008713334798813
of O 0 0.016505397856235504
59 O 0 0.03137929365038872
ATM O 0 0.03795897215604782
mutations O 0 0.01494109071791172
observed O 0 0.012438829988241196
in O 0 0.013042495585978031
ataxia B-Disease 1 0.9999994039535522
- I-Disease 1 0.999993085861206
telangiectasia I-Disease 1 0.9999991655349731
( O 0 0.04545607790350914
A B-Disease 1 0.9999734163284302
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
) O 0 0.020626787096261978
patients O 0 0.083725705742836
in O 0 0.013766265474259853
the O 0 0.02066636271774769
British O 0 0.04211319610476494
Isles O 0 0.2593199908733368
. O 0 0.04768585041165352

Of O 0 0.037948038429021835
51 O 0 0.05373348668217659
ATM O 1 0.6750258207321167
mutations O 0 0.01891412027180195
identified O 0 0.012631483376026154
in O 0 0.008640398271381855
families O 0 0.007674116641283035
native O 0 0.008262102492153645
to O 0 0.006635852623730898
the O 0 0.007554191164672375
British O 0 0.011440962553024292
Isles O 0 0.02035382390022278
, O 0 0.007640871684998274
11 O 0 0.009437662549316883
were O 0 0.007764995098114014
founder O 0 0.3258245289325714
mutations O 0 0.009917190298438072
, O 0 0.006990817375481129
and O 0 0.005407956428825855
2 O 0 0.007600839249789715
of O 0 0.005813498981297016
these O 0 0.004864696878939867
11 O 0 0.009494919329881668
conferred O 0 0.022459983825683594
a O 0 0.014820832759141922
milder O 1 0.9616830348968506
clinical O 1 0.9967875480651855
phenotype O 0 0.3599514365196228
with O 0 0.009220375679433346
respect O 0 0.01130395382642746
to O 0 0.012160749174654484
both O 0 0.021372387185692787
cerebellar B-Disease 1 0.9999998807907104
degeneration I-Disease 1 1.0
and O 1 0.9917784333229065
cellular O 1 0.9997530579566956
features O 0 0.07763735949993134
. O 0 0.05526486039161682

We O 0 0.020950922742486
report O 0 0.013440237380564213
, O 0 0.009238139726221561
in O 0 0.007085185032337904
two O 0 0.00700313551351428
A B-Disease 1 0.8106076121330261
- I-Disease 1 0.9999898672103882
T I-Disease 1 0.9999868869781494
families O 0 0.010351661592721939
, O 0 0.00847078487277031
an O 0 0.009956643916666508
ATM O 0 0.03200627863407135
mutation O 0 0.01506112888455391
( O 0 0.012427997775375843
7271T O 0 0.24882982671260834
- O 1 0.9844527840614319
- O 1 0.998725950717926
> O 1 0.9985619187355042
G O 1 0.9317266345024109
) O 0 0.009262769483029842
that O 0 0.006376116536557674
may O 0 0.006078345701098442
be O 0 0.004301086533814669
associated O 0 0.0044549014419317245
with O 0 0.0038521031383424997
an O 0 0.004861184861510992
increased O 0 0.007779159117490053
risk O 0 0.49429449439048767
of O 1 0.9399458765983582
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.009850251488387585
both O 0 0.01112616341561079
homozygotes O 1 0.9970468878746033
and O 0 0.015121848322451115
heterozygotes O 1 0.8136498332023621
( O 0 0.013521866872906685
relative O 0 0.016097653657197952
risk O 0 0.01213981956243515
12 O 0 0.0126108443364501
. O 0 0.008754441514611244
7 O 0 0.014661705121397972
; O 0 0.012246920727193356
P O 0 0.033210888504981995
= O 0 0.022155815735459328
. O 0 0.0140462014824152
0025 O 1 0.9836640357971191
) O 0 0.01188209094107151
, O 0 0.008618716150522232
although O 0 0.0063997781835496426
there O 0 0.005138045642524958
is O 0 0.0054045128636062145
a O 0 0.006818815134465694
less O 0 0.00797045137733221
severe O 1 0.9997782111167908
A B-Disease 1 0.9999988079071045
- I-Disease 1 1.0
T I-Disease 1 0.9999998807907104
phenotype O 0 0.2715502679347992
in O 0 0.008676108904182911
terms O 0 0.00925704836845398
of O 0 0.008869125507771969
the O 0 0.01255593542009592
degree O 0 0.04508840665221214
of O 1 0.9184810519218445
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
. O 0 0.4900732934474945

This O 0 0.032911285758018494
mutation O 0 0.03475799784064293
( O 0 0.02199646458029747
7271T O 1 0.9099168181419373
- O 1 0.998775064945221
- O 1 0.9991536140441895
> O 1 0.995958149433136
G O 1 0.6824121475219727
) O 0 0.011772804893553257
also O 0 0.009658018127083778
allows O 0 0.009477437473833561
expression O 0 0.008097855374217033
of O 0 0.007629317697137594
full O 0 0.012375966645777225
- O 0 0.2248237580060959
length O 0 0.012152406387031078
ATM O 0 0.026096604764461517
protein O 0 0.009653217159211636
at O 0 0.008503032848238945
a O 0 0.009086612612009048
level O 0 0.009729844518005848
comparable O 0 0.013366084545850754
with O 0 0.008105866611003876
that O 0 0.00873374380171299
in O 0 0.014822266064584255
unaffected O 0 0.14495941996574402
individuals O 0 0.022914467379450798
. O 0 0.038335829973220825

In O 0 0.025362499058246613
addition O 0 0.01929617114365101
, O 0 0.011028253473341465
we O 0 0.0069689578376710415
have O 0 0.004729708656668663
studied O 0 0.008254986256361008
18 O 0 0.009585951454937458
A B-Disease 1 0.9465612769126892
- I-Disease 1 0.9999996423721313
T I-Disease 1 1.0
patients O 1 0.9453261494636536
, O 0 0.007027659099549055
in O 0 0.006080541759729385
15 O 0 0.008545522578060627
families O 0 0.00719251437112689
, O 0 0.007215677760541439
who O 0 0.012118480168282986
developed O 1 0.9948298335075378
leukemia B-Disease 1 1.0
, O 1 0.9990729093551636
lymphoma B-Disease 1 1.0
, O 1 0.7667014598846436
preleukemic O 1 0.9999973773956299
T O 1 0.9999971389770508
- O 1 0.9991570711135864
cell O 1 0.667634129524231
proliferation O 1 0.9926980137825012
, O 1 0.6722550392150879
or O 1 0.9998453855514526
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 1 0.9604597091674805
mostly O 0 0.021223219111561775
in O 0 0.025703154504299164
childhood O 1 0.9982250332832336
. O 0 0.050445374101400375

A O 0 0.036476314067840576
wide O 0 0.02313176542520523
variety O 0 0.015433665364980698
of O 0 0.015063080005347729
ATM O 1 0.9602237939834595
mutation O 0 0.01569286361336708
types O 0 0.010710802860558033
, O 0 0.010130186565220356
including O 0 0.009748165495693684
missense O 0 0.022821402177214622
mutations O 0 0.0113961948081851
and O 0 0.007782090455293655
in O 0 0.009755285456776619
- O 1 0.959621250629425
frame O 0 0.05379953235387802
deletions O 0 0.023696105927228928
, O 0 0.01043348666280508
were O 0 0.007734194863587618
seen O 0 0.011119979433715343
in O 0 0.010381242260336876
these O 0 0.015398083254694939
patients O 1 0.8375483751296997
. O 0 0.0407412126660347

We O 0 0.025529270991683006
also O 0 0.01496011484414339
show O 0 0.011868897825479507
that O 0 0.006953979376703501
25 O 0 0.010541323572397232
% O 0 0.006381699349731207
of O 0 0.005726813338696957
all O 0 0.006314280908554792
A B-Disease 1 0.9734758734703064
- I-Disease 1 0.9999972581863403
T I-Disease 1 0.9999980926513672
patients O 0 0.1998169720172882
carried O 0 0.012818424962460995
in O 0 0.0118049131706357
- O 0 0.3323020935058594
frame O 0 0.025941506028175354
deletions O 0 0.02847842499613762
or O 0 0.01322412770241499
missense O 0 0.027830082923173904
mutations O 0 0.011052983812987804
, O 0 0.0069166324101388454
many O 0 0.005049094092100859
of O 0 0.0058594741858541965
which O 0 0.005018654279410839
were O 0 0.005090953782200813
also O 0 0.0072594089433550835
associated O 0 0.008380226790904999
with O 0 0.007847880013287067
expression O 0 0.012232687324285507
of O 0 0.019094863906502724
mutant O 1 0.7655770778656006
ATM O 1 0.9569669961929321
protein O 0 0.04496527835726738
. O 0 0.04549188166856766

The O 0 0.04008147865533829
DMPK O 1 0.9785102605819702
gene O 0 0.022212591022253036
of O 0 0.023720698431134224
severely O 1 0.9999927282333374
affected O 1 0.9999983310699463
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 1.0
is O 1 0.9936226010322571
hypermethylated O 1 0.9999988079071045
proximal O 1 0.9999282360076904
to O 0 0.016732532531023026
the O 0 0.01967538148164749
largely O 0 0.026408875361084938
expanded O 0 0.05466333404183388
CTG O 1 0.9997281432151794
repeat O 0 0.15133313834667206
. O 0 0.06490085273981094

Using O 0 0.03311586007475853
methylation O 0 0.04000096023082733
- O 0 0.11568433791399002
sensitive O 0 0.025319162756204605
restriction O 0 0.0221458338201046
enzymes O 0 0.016311366111040115
, O 0 0.011202153749763966
we O 0 0.00877471175044775
characterized O 0 0.011680523864924908
the O 0 0.008951607160270214
methylation O 0 0.013609742745757103
pattern O 0 0.009813208132982254
on O 0 0.007539654616266489
the O 0 0.008466469123959541
5 O 0 0.012257222086191177
side O 0 0.011503532528877258
of O 0 0.009176323190331459
the O 0 0.012886224314570427
CTG O 1 0.988804280757904
repeat O 0 0.020396703854203224
in O 0 0.01051293220371008
the O 0 0.011249508708715439
DMPK O 1 0.9854839444160461
gene O 0 0.011272735893726349
of O 0 0.007698960602283478
normal O 0 0.006971436552703381
individuals O 0 0.005525309592485428
and O 0 0.006210853345692158
of O 0 0.009493373334407806
patients O 1 0.9998607635498047
affected O 1 0.9095281362533569
with O 1 0.9883008003234863
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 0.4470975697040558
showing O 0 0.05334274843335152
expansions O 0 0.047198306769132614
of O 0 0.02105146273970604
the O 0 0.027372602373361588
repetitive O 0 0.47808486223220825
sequence O 0 0.037998877465724945
. O 0 0.04549015313386917

The O 0 0.041140902787446976
gene O 0 0.03132246062159538
segment O 0 0.03550861403346062
analyzed O 0 0.026182426139712334
corresponds O 0 0.021633325144648552
to O 0 0.012766366824507713
the O 0 0.01749606803059578
genomic O 0 0.046705733984708786
SacI O 1 0.9981045722961426
- O 1 0.6775327324867249
HindIII O 0 0.45602115988731384
fragment O 0 0.04203230142593384
carrying O 0 0.03176553547382355
exons O 0 0.04865025728940964
11 O 0 0.04033882915973663
- O 0 0.06805868446826935
15 O 0 0.05046243965625763
. O 0 0.055888377130031586

There O 0 0.03414250537753105
is O 0 0.024173086509108543
constitutive O 0 0.04839262366294861
methylation O 0 0.030569881200790405
in O 0 0.018699612468481064
intron O 1 0.704439640045166
12 O 0 0.017516465857625008
at O 0 0.015415937639772892
restriction O 0 0.016079245135188103
sites O 0 0.01354124117642641
of O 0 0.013561537489295006
SacII O 1 0.6067886352539062
and O 0 0.015469696372747421
HhaI O 1 0.9163473844528198
, O 0 0.015722766518592834
localized O 0 0.025046363472938538
1 O 0 0.018185589462518692
, O 0 0.01616501621901989
159 O 0 0.031678978353738785
- O 0 0.028863875195384026
1 O 0 0.02185363695025444
, O 0 0.017087087035179138
232 O 0 0.03477402403950691
bp O 0 0.0299578495323658
upstream O 0 0.021476587280631065
of O 0 0.01220859307795763
the O 0 0.016155829653143883
CTG O 1 0.9986704587936401
repeat O 0 0.03200027719140053
, O 0 0.012530463747680187
whereas O 0 0.010475093498826027
most O 0 0.00651572085916996
, O 0 0.0066023352555930614
if O 0 0.004860924556851387
not O 0 0.003855685703456402
all O 0 0.003908751532435417
, O 0 0.005051204934716225
of O 0 0.005379215348511934
the O 0 0.006618282292038202
other O 0 0.005087714176625013
sites O 0 0.00771098118275404
of O 0 0.008815757930278778
SacII O 1 0.9537009000778198
, O 0 0.01384825725108385
HhaI O 1 0.9766269326210022
, O 0 0.011462338268756866
and O 0 0.010910644195973873
HpaII O 0 0.4863584041595459
in O 0 0.008292817510664463
this O 0 0.006093951407819986
region O 0 0.008575627580285072
are O 0 0.005617383401840925
unmethylated O 0 0.1696489304304123
, O 0 0.0077290041372179985
in O 0 0.0059726363979279995
normal O 0 0.007093445863574743
individuals O 0 0.005142496433109045
and O 0 0.006063585635274649
most O 0 0.006200677715241909
of O 0 0.010310382582247257
the O 0 0.05028362199664116
patients O 1 0.9995867609977722
. O 0 0.03644402697682381

In O 0 0.020440999418497086
a O 0 0.01416805014014244
number O 0 0.008593843318521976
of O 0 0.009387555532157421
young O 0 0.016929691657423973
and O 0 0.01744800992310047
severely O 1 0.9999610185623169
affected O 1 0.9982226490974426
patients O 1 0.999987006187439
, O 0 0.01106441579759121
however O 0 0.006871318910270929
, O 0 0.007975330576300621
complete O 0 0.010874426923692226
methylation O 0 0.013251321390271187
of O 0 0.008893945254385471
these O 0 0.006302232388406992
restriction O 0 0.012798710726201534
sites O 0 0.011591493152081966
was O 0 0.013907104730606079
found O 0 0.010289023630321026
in O 0 0.011876852251589298
the O 0 0.02107004076242447
mutated O 0 0.12364573776721954
allele O 0 0.06091361492872238
. O 0 0.04917321726679802

In O 0 0.019843485206365585
most O 0 0.010998161509633064
of O 0 0.010150101967155933
these O 0 0.00711892731487751
patients O 0 0.07421170920133591
, O 0 0.00684024253860116
the O 0 0.008637882769107819
onset O 1 0.9999879598617554
of O 1 0.7363921403884888
the O 1 0.999945878982544
disease O 1 1.0
was O 1 1.0
congenital O 1 1.0
. O 1 0.9816597104072571

Preliminary O 0 0.049659181386232376
in O 0 0.02930181287229061
vivo O 0 0.06292923539876938
footprinting O 1 0.5458822846412659
data O 0 0.016337838023900986
gave O 0 0.01852128840982914
evidence O 0 0.01123612280935049
for O 0 0.009856672026216984
protein O 0 0.01314657274633646
- O 0 0.02260974980890751
DNA O 0 0.012713007628917694
contact O 0 0.010653083212673664
in O 0 0.008315468207001686
normal O 0 0.010277556255459785
genes O 0 0.009772245772182941
at O 0 0.011140850372612476
an O 0 0.01165905874222517
Sp1 O 1 0.9799695611000061
consensus O 0 0.019695959985256195
binding O 0 0.014239664189517498
site O 0 0.016230439767241478
upstream O 0 0.017050111666321754
of O 0 0.011074061505496502
the O 0 0.014311674982309341
CTG O 1 0.9977800250053406
repeat O 0 0.023050038143992424
and O 0 0.009119512513279915
for O 0 0.006426927167922258
a O 0 0.007336107082664967
significant O 0 0.007824513129889965
reduction O 0 0.011046652682125568
of O 0 0.007469200063496828
this O 0 0.005809619557112455
interaction O 0 0.008596361614763737
in O 0 0.007576327305287123
cells O 0 0.00981973297894001
with O 0 0.010093335062265396
a O 0 0.019990038126707077
hypermethylated O 1 0.9999287128448486
DMPK O 1 0.9999725818634033
gene O 0 0.03651108965277672
. O 0 0.030233189463615417
. O 0 0.04303906112909317

The O 0 0.07043639570474625
hemochromatosis B-Disease 1 0.9999979734420776
gene O 0 0.03975553810596466
product O 0 0.031750161200761795
complexes O 0 0.030824551358819008
with O 0 0.013743819668889046
the O 0 0.01922912895679474
transferrin O 1 0.9996647834777832
receptor O 0 0.03240601718425751
and O 0 0.019777216017246246
lowers O 1 0.5379946827888489
its O 0 0.019080838188529015
affinity O 0 0.03239119425415993
for O 0 0.02441578172147274
ligand O 0 0.08279378712177277
binding O 0 0.04809391498565674
. O 0 0.051887769252061844

We O 0 0.03316498175263405
recently O 0 0.030406810343265533
reported O 0 0.023474568501114845
the O 0 0.01616808772087097
positional O 0 0.03363651782274246
cloning O 0 0.022194024175405502
of O 0 0.011239833198487759
a O 0 0.01393597200512886
candidate O 0 0.018982645124197006
gene O 0 0.02016395702958107
for O 0 0.05691792443394661
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 1 0.9999887943267822
HFE O 1 0.9999997615814209
. O 0 0.07533565908670425

The O 0 0.03538412228226662
gene O 0 0.024134887382388115
product O 0 0.017508096992969513
, O 0 0.011738375760614872
a O 0 0.011785686947405338
member O 0 0.010928628966212273
of O 0 0.008416120894253254
the O 0 0.010777345858514309
major O 0 0.09894603490829468
histocompatibility O 1 0.999995231628418
complex O 0 0.02678391896188259
class O 0 0.2516046464443207
I O 1 0.7272225022315979
- O 1 0.712812066078186
like O 0 0.011293274350464344
family O 0 0.01180057879537344
, O 0 0.008281962014734745
was O 0 0.009559407830238342
found O 0 0.005620201583951712
to O 0 0.006454973015934229
have O 0 0.00519998325034976
a O 0 0.009314953349530697
mutation O 0 0.012974035926163197
, O 0 0.011624406091868877
Cys O 1 0.9977849721908569
- O 1 0.5481220483779907
282 O 1 0.9542720913887024
- O 1 0.9986180067062378
- O 1 0.9997279047966003
> O 1 0.9985021352767944
Tyr O 1 0.9999760389328003
( O 0 0.02675594761967659
C282Y O 0 0.2557423412799835
) O 0 0.01674339734017849
, O 0 0.012131798081099987
in O 0 0.011472894810140133
85 O 0 0.026588182896375656
% O 0 0.017369281500577927
of O 0 0.023759230971336365
patient O 1 0.9871541857719421
chromosomes O 0 0.060872796922922134
. O 0 0.05104891583323479

This O 0 0.03443719819188118
mutation O 0 0.040036652237176895
eliminates O 0 0.044251300394535065
the O 0 0.016264988109469414
ability O 0 0.017518607899546623
of O 0 0.015301540493965149
HFE O 1 0.9973568916320801
to O 0 0.012402121908962727
associate O 0 0.018251679837703705
with O 0 0.012120946310460567
beta2 O 1 0.999690055847168
- O 1 0.99937903881073
microglobulin O 1 0.9997695088386536
( O 0 0.019327886402606964
beta2m O 1 0.9327179789543152
) O 0 0.01307106763124466
and O 0 0.013991773128509521
prevents O 0 0.09431753307580948
cell O 1 0.7757885456085205
- O 1 0.9851502776145935
surface O 0 0.03947819769382477
expression O 0 0.03971114754676819
. O 0 0.04946187138557434

A O 0 0.03947753831744194
second O 0 0.032014649361371994
mutation O 0 0.01804189383983612
that O 0 0.007445947267115116
has O 0 0.007873324677348137
no O 0 0.0072250161319971085
effect O 0 0.007488359231501818
on O 0 0.008295610547065735
beta2m O 1 0.9237440228462219
association O 0 0.033026810735464096
, O 0 0.015144852921366692
H63D O 1 0.9994520545005798
, O 0 0.010702644474804401
was O 0 0.012231327593326569
found O 0 0.007614948321133852
in O 0 0.006022308487445116
eight O 0 0.0073549626395106316
out O 0 0.00794319249689579
of O 0 0.009012674912810326
nine O 0 0.015557787381112576
patients O 0 0.43367522954940796
heterozygous O 0 0.022601142525672913
for O 0 0.017383448779582977
the O 0 0.025281520560383797
C282Y O 1 0.9505164623260498
mutant O 0 0.14081281423568726
. O 0 0.05631064623594284

In O 0 0.024906249716877937
this O 0 0.014363927766680717
report O 0 0.014541611075401306
, O 0 0.011842804029583931
we O 0 0.009611439891159534
demonstrate O 0 0.015457630157470703
in O 0 0.01222103089094162
cultured O 0 0.03194942697882652
293 O 1 0.5025536417961121
cells O 0 0.025738634169101715
overexpressing O 1 0.8002058267593384
wild O 0 0.024236485362052917
- O 1 0.9368273615837097
type O 0 0.04015149548649788
or O 0 0.015096962451934814
mutant O 1 0.5424442291259766
HFE O 1 0.9999390840530396
proteins O 0 0.014746920205652714
that O 0 0.008463267236948013
both O 0 0.007881134748458862
the O 0 0.01072067953646183
wild O 0 0.016809113323688507
- O 1 0.7703754901885986
type O 0 0.026317361742258072
and O 0 0.01903264969587326
H63D O 1 0.9999616146087646
HFE O 1 0.999975323677063
proteins O 0 0.022299863398075104
form O 0 0.016310205683112144
stable O 0 0.026736821979284286
complexes O 0 0.025340955704450607
with O 0 0.013730330392718315
the O 0 0.02582773007452488
transferrin O 1 0.9999918937683105
receptor O 1 0.9800501465797424
( O 0 0.04108257591724396
TfR O 1 0.9998062252998352
) O 0 0.03787156939506531
. O 0 0.04968725144863129

The O 0 0.05485057830810547
C282Y O 0 0.26352670788764954
mutation O 0 0.036292966455221176
nearly O 0 0.02233189344406128
completely O 0 0.02267688512802124
prevents O 0 0.023243218660354614
the O 0 0.013028893619775772
association O 0 0.016805283725261688
of O 0 0.01360586378723383
the O 0 0.018730971962213516
mutant O 1 0.9379306435585022
HFE O 1 0.9999790191650391
protein O 0 0.030056852847337723
with O 0 0.01949368789792061
the O 0 0.03427672013640404
TfR O 1 0.9988092184066772
. O 0 0.06257311999797821

Studies O 0 0.038605038076639175
on O 0 0.02313045971095562
cell O 0 0.0386713445186615
- O 0 0.0634855106472969
associated O 0 0.019411897286772728
transferrin O 0 0.1492590457201004
at O 0 0.018763190135359764
37 O 0 0.024745972827076912
degrees O 0 0.02467903308570385
C O 0 0.030783556401729584
suggest O 0 0.014367127791047096
that O 0 0.007102791219949722
the O 0 0.01130716223269701
overexpressed O 0 0.08559489995241165
wild O 0 0.0227873083204031
- O 1 0.9869577884674072
type O 1 0.5112747550010681
HFE O 1 0.9999076128005981
protein O 0 0.025336384773254395
decreases O 0 0.024966154247522354
the O 0 0.01536710187792778
affinity O 0 0.02343422919511795
of O 0 0.01699514500796795
the O 0 0.02382567897439003
TfR O 1 0.9999163150787354
for O 0 0.044452108442783356
transferrin O 1 0.9995607733726501
. O 0 0.0646936371922493

The O 0 0.04106781631708145
overexpressed O 1 0.9984796643257141
H63D O 1 0.9999830722808838
protein O 0 0.023301394656300545
does O 0 0.009622517041862011
not O 0 0.005742819048464298
have O 0 0.004578060936182737
this O 0 0.005683033727109432
effect O 0 0.00753981526941061
, O 0 0.007146766874939203
providing O 0 0.008984379470348358
the O 0 0.007651190739125013
first O 0 0.009026171639561653
direct O 0 0.009151232428848743
evidence O 0 0.008476987481117249
for O 0 0.007706767879426479
a O 0 0.011667347513139248
functional O 0 0.016800157725811005
consequence O 0 0.021230028942227364
of O 0 0.01612168364226818
the O 0 0.031862009316682816
H63D O 1 0.9999885559082031
mutation O 0 0.07941924780607224
. O 0 0.04544662684202194

Addition O 0 0.03960757702589035
of O 0 0.02522663027048111
soluble O 0 0.12730368971824646
wild O 0 0.02966766059398651
- O 1 0.9969525337219238
type O 1 0.975074052810669
HFE O 1 0.9999997615814209
/ O 1 0.9999443292617798
beta2m O 1 0.9999065399169922
heterodimers O 1 0.9997019171714783
to O 0 0.019660597667098045
cultured O 0 0.39951008558273315
cells O 0 0.018073340877890587
also O 0 0.012699848972260952
decreased O 0 0.015774134546518326
the O 0 0.011326146312057972
apparent O 0 0.01945425383746624
affinity O 0 0.015927117317914963
of O 0 0.01044969167560339
the O 0 0.010885397903621197
TfR O 1 0.9684245586395264
for O 0 0.009367679245769978
its O 0 0.010281593538820744
ligand O 0 0.021053221076726913
under O 0 0.012273507192730904
steady O 0 0.03299242630600929
- O 0 0.041208405047655106
state O 0 0.009296235628426075
conditions O 0 0.010524670593440533
, O 0 0.008859536610543728
both O 0 0.008093627169728279
in O 0 0.011851003393530846
293 O 1 0.8254427909851074
cells O 0 0.023344704881310463
and O 0 0.01913788728415966
in O 0 0.02727319858968258
HeLa O 1 0.9999804496765137
cells O 0 0.06135436147451401
. O 0 0.0566345639526844

Furthermore O 0 0.040519896894693375
, O 0 0.018266543745994568
at O 0 0.01639684848487377
4 O 0 0.016809595748782158
degrees O 0 0.02030458115041256
C O 0 0.025930307805538177
, O 0 0.010620996356010437
the O 0 0.010665453970432281
added O 0 0.016509629786014557
soluble O 0 0.030601926147937775
complex O 0 0.01870231330394745
of O 0 0.02254144847393036
HFE O 1 0.9999996423721313
/ O 1 0.9999397993087769
beta2m O 1 0.9991969466209412
inhibited O 0 0.06098206341266632
binding O 0 0.02243933640420437
of O 0 0.020967792719602585
transferrin O 1 0.8517991304397583
to O 0 0.027737006545066833
HeLa O 1 0.9996659755706787
cell O 0 0.07875699549913406
TfR O 1 0.8245769739151001
in O 0 0.018132776021957397
a O 0 0.022480947896838188
concentration O 1 0.9339983463287354
- O 1 0.9532607793807983
dependent O 0 0.04060686379671097
manner O 0 0.03981032222509384
. O 0 0.044094379991292953

Scatchard O 0 0.09956079721450806
plots O 0 0.03445262834429741
of O 0 0.014879444614052773
these O 0 0.007262090221047401
data O 0 0.008384979330003262
indicate O 0 0.008178803138434887
that O 0 0.005582656245678663
the O 0 0.008768094703555107
added O 0 0.016838936135172844
heterodimer O 1 0.9840637445449829
substantially O 0 0.023061653599143028
reduced O 0 0.015217303298413754
the O 0 0.014457211829721928
affinity O 0 0.02453036420047283
of O 0 0.021434888243675232
TfR O 1 0.9998672008514404
for O 0 0.037966176867485046
transferrin O 1 0.9995971322059631
. O 0 0.06853596866130829

These O 0 0.019274339079856873
results O 0 0.014843017794191837
establish O 0 0.016024433076381683
a O 0 0.01300375908613205
molecular O 0 0.0181915033608675
link O 0 0.015680775046348572
between O 0 0.012305143289268017
HFE O 1 0.999922513961792
and O 0 0.010113760828971863
a O 0 0.011287148110568523
key O 0 0.013592112809419632
protein O 0 0.009966081939637661
involved O 0 0.008941495791077614
in O 0 0.008613991551101208
iron O 1 0.980377733707428
transport O 0 0.016735488548874855
, O 0 0.009382780641317368
the O 0 0.012025726027786732
TfR O 1 0.9998261332511902
, O 0 0.010199095122516155
and O 0 0.007668044418096542
raise O 0 0.010793350636959076
the O 0 0.007806738372892141
possibility O 0 0.009475808590650558
that O 0 0.00649086432531476
alterations O 0 0.012429642491042614
in O 0 0.006861616391688585
this O 0 0.006176096852868795
regulatory O 0 0.013895236887037754
mechanism O 0 0.01333090290427208
may O 0 0.007859965786337852
play O 0 0.008192356675863266
a O 0 0.009088408201932907
role O 0 0.010888921096920967
in O 0 0.010287825018167496
the O 0 0.014888686127960682
pathogenesis O 1 0.9999935626983643
of O 1 0.9990828037261963
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.9930334091186523
. O 0 0.06574323028326035

Genomic O 0 0.06929448992013931
organization O 0 0.033071476966142654
of O 0 0.022757718339562416
the O 0 0.029545729979872704
UBE3A O 1 0.9999933242797852
/ O 1 0.9998071789741516
E6 O 1 0.9999561309814453
- O 1 0.9993816614151001
AP O 1 0.9264589548110962
gene O 0 0.02860683761537075
and O 0 0.021346643567085266
related O 0 0.03692779690027237
pseudogenes O 0 0.26815828680992126
. O 0 0.05542030930519104

The O 0 0.06575518846511841
UBE3A O 1 0.923478364944458
gene O 0 0.0400254987180233
encodes O 0 0.039481934159994125
the O 0 0.025185585021972656
E6 O 1 0.9399687051773071
- O 1 0.6374983191490173
AP O 0 0.38568025827407837
ubiquitin O 1 0.7860381007194519
- O 1 0.8903043866157532
protein O 0 0.01938328891992569
ligase O 0 0.029767584055662155
and O 0 0.010002327151596546
has O 0 0.00904242042452097
recently O 0 0.011090041138231754
been O 0 0.006179897114634514
shown O 0 0.006124220788478851
to O 0 0.005431878846138716
be O 0 0.006270888727158308
mutated O 0 0.14551255106925964
in O 1 0.9607862234115601
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999998807907104
who O 1 0.9398825764656067
lack O 1 0.9884627461433411
15q11 O 1 0.9999947547912598
- O 1 0.9999221563339233
q13 O 1 0.9987320303916931
deletions O 0 0.14735400676727295
or O 0 0.02155790850520134
chromosome O 0 0.0406525619328022
15 O 0 0.04641145467758179
paternal O 1 0.9748591184616089
uniparental B-Disease 1 0.9999898672103882
disomy I-Disease 1 0.9985103011131287
. O 0 0.07709484547376633

Previous O 0 0.07311997562646866
UBE3A O 1 0.9768059253692627
cDNA O 0 0.0619097575545311
analysis O 0 0.022168150171637535
has O 0 0.015183542855083942
shown O 0 0.012870380654931068
a O 0 0.01305654551833868
coding O 0 0.02357735112309456
region O 0 0.017324382439255714
of O 0 0.016782406717538834
approximately O 0 0.024709554389119148
2 O 0 0.043441545218229294
. O 0 0.0475359670817852

6 O 0 0.0625668615102768
kb O 0 0.0746266096830368
and O 0 0.018526315689086914
a O 0 0.019167745485901833
3 O 0 0.02217279188334942
- O 0 0.26298871636390686
untranslated O 1 0.5522316098213196
region O 0 0.019097505137324333
( O 0 0.01615135557949543
UTR O 1 0.722996711730957
) O 0 0.013013224117457867
of O 0 0.01257706992328167
< O 0 0.131058007478714
50 O 0 0.019015397876501083
bp O 0 0.028176413848996162
, O 0 0.01299279648810625
whereas O 0 0.012413485907018185
Northern O 0 0.012695364654064178
analysis O 0 0.010461624711751938
has O 0 0.010456043295562267
indicated O 0 0.011763093993067741
mRNA O 0 0.016596218571066856
sizes O 0 0.013777976855635643
of O 0 0.012873117811977863
5 O 0 0.022313889116048813
- O 0 0.10826572775840759
8 O 0 0.04788303002715111
kb O 0 0.3685993254184723
. O 0 0.05634453147649765

We O 0 0.028018154203891754
have O 0 0.012969214469194412
analyzed O 0 0.02069776877760887
additional O 0 0.01891169138252735
cDNA O 0 0.04079782962799072
clones O 0 0.03469059243798256
and O 0 0.011481584049761295
provide O 0 0.010957627557218075
evidence O 0 0.011121319606900215
for O 0 0.010052810423076153
an O 0 0.013138298876583576
additional O 0 0.022782092913985252
0 O 0 0.042476728558540344
. O 0 0.04385964572429657

5 O 0 0.05440362170338631
kb O 0 0.06513071060180664
of O 0 0.02173704095184803
5 O 0 0.029202817007899284
- O 0 0.19340640306472778
UTR O 1 0.6456174850463867
and O 0 0.019847584888339043
> O 0 0.0525345578789711
2 O 0 0.02622256614267826
kb O 0 0.05217777192592621
of O 0 0.02497290074825287
3 O 0 0.04344587028026581
- O 1 0.8158292770385742
UTR O 1 0.9637625813484192
. O 0 0.07265421748161316

We O 0 0.023647576570510864
have O 0 0.012526563368737698
established O 0 0.016916640102863312
the O 0 0.013669089414179325
genomic O 0 0.028755247592926025
organization O 0 0.020646529272198677
of O 0 0.01880863681435585
UBE3A O 1 0.9986687898635864
and O 0 0.01732320711016655
the O 0 0.015225517563521862
sequence O 0 0.017771556973457336
of O 0 0.022814380005002022
intron O 1 0.9998549222946167
- O 1 0.9955701231956482
exon O 1 0.6501028537750244
borders O 0 0.04984648898243904
. O 0 0.05192587897181511

We O 0 0.027957728132605553
have O 0 0.014247911982238293
also O 0 0.015450731851160526
mapped O 0 0.02944405935704708
two O 0 0.012658433988690376
highly O 0 0.018276860937476158
homologous O 0 0.02663012221455574
processed O 0 0.023063652217388153
pseudogenes O 0 0.03818226233124733
, O 0 0.018123378977179527
UBE3AP1 O 1 0.9981234669685364
and O 0 0.014391996897757053
UBE3AP2 O 1 0.9951121211051941
, O 0 0.01003809180110693
to O 0 0.008023958653211594
chromosomes O 0 0.011534268967807293
2 O 0 0.01255712378770113
and O 0 0.00873271469026804
21 O 0 0.014324979856610298
, O 0 0.009842845611274242
respectively O 0 0.013070821762084961
, O 0 0.011260905303061008
and O 0 0.011059512384235859
determined O 0 0.017038455232977867
their O 0 0.015610734932124615
genomic O 0 0.046013712882995605
organization O 0 0.045142557471990585
. O 0 0.0500042624771595

These O 0 0.019599879160523415
results O 0 0.015819016844034195
will O 0 0.010283446870744228
form O 0 0.008294858038425446
the O 0 0.007584156934171915
basis O 0 0.007346048951148987
for O 0 0.007942700758576393
studies O 0 0.010998373851180077
of O 0 0.013484668917953968
mutation O 0 0.01934715546667576
and O 0 0.017908059060573578
imprinting O 1 0.9203206896781921
of O 0 0.04611534625291824
UBE3A O 1 0.9999909400939941
. O 0 0.06278466433286667

Mutation O 0 0.06364602595567703
spectrum O 0 0.049442633986473083
and O 0 0.024739373475313187
genotype O 1 0.875138521194458
- O 1 0.8708623647689819
phenotype O 0 0.14883601665496826
analyses O 0 0.028909580782055855
in O 0 0.0231670793145895
Cowden B-Disease 1 0.9999998807907104
disease I-Disease 1 0.9999991655349731
and O 1 0.7062882781028748
Bannayan B-Disease 1 0.9999998807907104
- I-Disease 1 1.0
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.2706010639667511
two O 0 0.04828748479485512
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
with O 1 0.9982993006706238
germline O 1 0.9999988079071045
PTEN O 1 0.9999997615814209
mutation O 1 0.8498286008834839
. O 0 0.06265293061733246

The O 0 0.252182275056839
tumour B-Disease 1 0.9999998807907104
suppressor O 1 0.99998939037323
gene O 1 0.8652631044387817
PTEN O 1 0.9998667240142822
, O 0 0.024581363424658775
which O 0 0.018075229600071907
maps O 0 0.03295842930674553
to O 0 0.031116843223571777
10q23 O 0 0.23745228350162506
. O 0 0.05372614040970802

3 O 0 0.055506616830825806
and O 0 0.03037738986313343
encodes O 0 0.04728705435991287
a O 0 0.029932238161563873
403 O 0 0.05849389359354973
amino O 0 0.030911672860383987
acid O 0 0.034706003963947296
dual O 0 0.040215443819761276
specificity O 0 0.046787016093730927
phosphatase O 1 0.9390074610710144
( O 0 0.024271681904792786
protein O 0 0.02429153583943844
tyrosine O 0 0.04157179221510887
phosphatase O 1 0.8555461168289185
; O 0 0.019106535241007805
PTPase O 1 0.991663932800293
) O 0 0.013383502140641212
, O 0 0.010766197927296162
was O 0 0.012578189373016357
shown O 0 0.009448996745049953
recently O 0 0.011396544985473156
to O 0 0.008239530958235264
play O 0 0.00952912587672472
a O 0 0.012218769639730453
broad O 0 0.018659256398677826
role O 0 0.017065182328224182
in O 0 0.019883189350366592
human O 0 0.31249114871025085
malignancy B-Disease 1 0.9999973773956299
. O 0 0.05203929543495178

Somatic O 1 0.9924978613853455
PTEN O 1 0.9997785687446594
deletions O 0 0.18561741709709167
and O 0 0.018229780718684196
mutations O 0 0.015237406827509403
were O 0 0.008185013197362423
observed O 0 0.008687891066074371
in O 0 0.008417537435889244
sporadic B-Disease 0 0.136944979429245
breast I-Disease 1 0.9999985694885254
, I-Disease 0 0.22956839203834534
brain I-Disease 1 0.9993329644203186
, I-Disease 1 0.9718698263168335
prostate I-Disease 1 1.0
and I-Disease 1 0.9999983310699463
kidney I-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.9998546838760376
lines O 0 0.012229681015014648
and O 0 0.006560568697750568
in O 0 0.0066282120533287525
several O 0 0.00790716428309679
primary O 0 0.024241439998149872
tumours B-Disease 1 0.9999449253082275
such O 0 0.009651018306612968
as O 1 0.7523578405380249
endometrial B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 1 0.9999998807907104
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 1.0
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 1 0.9727069139480591

In O 0 0.028560658916831017
addition O 0 0.024006403982639313
, O 0 0.02098107896745205
PTEN O 1 0.9995309114456177
was O 0 0.017842410132288933
identified O 0 0.011541556566953659
as O 0 0.009520381689071655
the O 0 0.010382081381976604
susceptibility O 0 0.027938498184084892
gene O 0 0.009472809731960297
for O 0 0.009856577962636948
two O 0 0.016870921477675438
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
Cowden B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.8841800689697266
CD B-Disease 1 0.9987303614616394
; O 0 0.03245706483721733
MIM O 1 0.9999825954437256
158350 O 1 0.9904583692550659
) O 0 0.019086765125393867
and O 0 0.019001835957169533
Bannayan B-Disease 1 0.9994493126869202
- I-Disease 1 0.999319314956665
Zonana I-Disease 1 0.9999862909317017
( I-Disease 0 0.030909379944205284
BZS I-Disease 1 0.9981166124343872
) I-Disease 0 0.021232860162854195
or I-Disease 0 0.019762184470891953
Ruvalcaba I-Disease 1 0.9993360638618469
- I-Disease 1 0.9945072531700134
Riley I-Disease 1 0.9996323585510254
- I-Disease 1 0.9999847412109375
Smith I-Disease 1 0.9999814033508301
syndrome I-Disease 1 1.0
( O 1 0.9912909269332886
MIM O 1 0.9999998807907104
153480 O 1 0.9999899864196777
) O 0 0.055325575172901154
. O 0 0.05855308473110199

Constitutive O 0 0.09664574265480042
DNA O 0 0.03331097215414047
from O 0 0.01745699532330036
37 O 0 0.02979379892349243
CD B-Disease 0 0.03800806403160095
families O 0 0.014793050475418568
and O 0 0.012886691838502884
seven O 0 0.01812230981886387
BZS B-Disease 1 0.9975927472114563
families O 0 0.020502395927906036
was O 0 0.02325405366718769
screened O 0 0.039279285818338394
for O 0 0.02647344022989273
germline O 1 0.9991963505744934
PTEN O 1 0.9999781847000122
mutations O 0 0.07826589792966843
. O 0 0.06420093774795532

PTEN O 1 0.9996750354766846
mutations O 0 0.03609593212604523
were O 0 0.013898908160626888
identified O 0 0.01326664350926876
in O 0 0.00911630317568779
30 O 0 0.0126084228977561
of O 0 0.010473067872226238
37 O 0 0.016969820484519005
( O 0 0.014961435459554195
81 O 0 0.029872745275497437
% O 0 0.01431674137711525
) O 0 0.01479541976004839
CD B-Disease 0 0.033297862857580185
families O 0 0.013620675541460514
, O 0 0.010959876701235771
including O 0 0.010989202186465263
missense O 0 0.02368006482720375
and O 0 0.012612958438694477
nonsense O 0 0.029270919039845467
point O 0 0.01803959161043167
mutations O 0 0.0179748497903347
, O 0 0.014912961050868034
deletions O 0 0.029361886903643608
, O 0 0.016797684133052826
insertions O 0 0.03863813728094101
, O 0 0.014401029795408249
a O 0 0.01840111054480076
deletion O 0 0.2643580436706543
/ O 1 0.9121503233909607
insertion O 0 0.07110361754894257
and O 0 0.025299986824393272
splice O 0 0.357056200504303
site O 0 0.05403436720371246
mutations O 0 0.053116846829652786
. O 0 0.04893109202384949

These O 0 0.023830529302358627
mutations O 0 0.023283323273062706
were O 0 0.010553346946835518
scattered O 0 0.01282540988177061
over O 0 0.008413662202656269
the O 0 0.008470011875033379
entire O 0 0.011862590909004211
length O 0 0.011498595587909222
of O 0 0.012907830066978931
PTEN O 1 0.9999479055404663
, O 0 0.009593754075467587
with O 0 0.006917985621839762
the O 0 0.007949869148433208
exception O 0 0.010184390470385551
of O 0 0.007317078299820423
the O 0 0.007670314982533455
first O 0 0.011215322650969028
, O 0 0.011092416010797024
fourth O 0 0.021650956943631172
and O 0 0.013912559486925602
last O 0 0.023245224729180336
exons O 0 0.060325633734464645
. O 0 0.043735209852457047

A O 0 0.051088955253362656
hot O 0 0.06665705889463425
spot O 0 0.03903310373425484
for O 0 0.022226853296160698
PTEN O 1 0.9992901086807251
mutation O 0 0.024781154468655586
in O 0 0.014179469086229801
CD B-Disease 0 0.036213431507349014
was O 0 0.01716924086213112
identified O 0 0.012500602751970291
in O 0 0.00958515889942646
exon O 0 0.02446918562054634
5 O 0 0.013147217221558094
that O 0 0.007912560366094112
contains O 0 0.009676314890384674
the O 0 0.010897881351411343
PTPase O 1 0.8423641324043274
core O 0 0.03230765461921692
motif O 0 0.023463968187570572
, O 0 0.009331587702035904
with O 0 0.006669388618320227
13 O 0 0.009897222742438316
of O 0 0.007646000944077969
30 O 0 0.01114099845290184
( O 0 0.010311580263078213
43 O 0 0.01888609677553177
% O 0 0.012598654255270958
) O 0 0.014471751637756824
CD B-Disease 0 0.04873370751738548
mutations O 0 0.018032096326351166
identified O 0 0.01322139147669077
in O 0 0.012436386197805405
this O 0 0.018284225836396217
exon O 0 0.08451595902442932
. O 0 0.04723108559846878

Seven O 0 0.030299734324216843
of O 0 0.018552929162979126
30 O 0 0.01895884796977043
( O 0 0.014253854751586914
23 O 0 0.01707930490374565
% O 0 0.011134895496070385
) O 0 0.007668748032301664
were O 0 0.005794832017272711
within O 0 0.006330613512545824
the O 0 0.008729163557291031
core O 0 0.021704889833927155
motif O 0 0.02491627261042595
, O 0 0.008321132510900497
the O 0 0.008238774724304676
majority O 0 0.007763114757835865
( O 0 0.007094942964613438
five O 0 0.006072621326893568
of O 0 0.006801173556596041
seven O 0 0.006906460504978895
) O 0 0.006244922522455454
of O 0 0.0060205222107470036
which O 0 0.006035815924406052
were O 0 0.008112245239317417
missense O 0 0.02415723353624344
mutations O 0 0.011777088046073914
, O 0 0.007946139201521873
possibly O 0 0.010915854014456272
pointing O 0 0.012058872729539871
to O 0 0.008152978494763374
the O 0 0.010751296766102314
functional O 0 0.016383765265345573
significance O 0 0.017784811556339264
of O 0 0.014998494647443295
this O 0 0.016185984015464783
region O 0 0.03269253671169281
. O 0 0.04618627578020096

Germline O 1 0.998407781124115
PTEN O 1 0.9997801184654236
mutations O 0 0.033562276512384415
were O 0 0.01244236808270216
identified O 0 0.011596105061471462
in O 0 0.007810912560671568
four O 0 0.008105199784040451
of O 0 0.007983122020959854
seven O 0 0.010838189162313938
( O 0 0.012799402698874474
57 O 0 0.031100649386644363
% O 0 0.021194342523813248
) O 0 0.026996949687600136
BZS B-Disease 1 0.954537570476532
families O 0 0.04055033251643181
studied O 0 0.053686272352933884
. O 0 0.05121668800711632

Interestingly O 0 0.06669215112924576
, O 0 0.024039844051003456
none O 0 0.017333995550870895
of O 0 0.011022555641829967
these O 0 0.008666041307151318
mutations O 0 0.012388906441628933
was O 0 0.01138036884367466
observed O 0 0.010780802927911282
in O 0 0.011165948584675789
the O 0 0.019627980887889862
PTPase O 1 0.9991194605827332
core O 1 0.7057746052742004
motif O 0 0.4961091876029968
. O 0 0.05432649701833725

It O 0 0.024697378277778625
is O 0 0.016356583684682846
also O 0 0.01518863346427679
worthy O 0 0.022696735337376595
of O 0 0.009377884678542614
note O 0 0.010765030980110168
that O 0 0.0061557660810649395
a O 0 0.008666452020406723
single O 0 0.011718682944774628
nonsense O 0 0.02018251083791256
point O 0 0.013671359978616238
mutation O 0 0.01421735156327486
, O 0 0.011136039160192013
R233X O 0 0.33012130856513977
, O 0 0.011588161811232567
was O 0 0.013493427075445652
observed O 0 0.011159219779074192
in O 0 0.008511761203408241
the O 0 0.011400261893868446
germline O 0 0.02493010275065899
DNA O 0 0.013218392618000507
from O 0 0.009549408219754696
two O 0 0.009985474869608879
unrelated O 0 0.018864113837480545
CD B-Disease 0 0.0392579510807991
families O 0 0.017632359638810158
and O 0 0.01709025166928768
one O 0 0.02819281816482544
BZS B-Disease 1 0.9995946288108826
family O 0 0.05943092703819275
. O 0 0.05102524533867836

Genotype O 1 0.9965104460716248
- O 1 0.997367799282074
phenotype O 1 0.7938991189002991
studies O 0 0.01644192822277546
were O 0 0.009891528636217117
not O 0 0.008285678923130035
performed O 0 0.01113886572420597
on O 0 0.008462151512503624
this O 0 0.00782052706927061
small O 0 0.011477562598884106
group O 0 0.01935199834406376
of O 0 0.022084342315793037
BZS B-Disease 1 0.9997825026512146
families O 0 0.04385657608509064
. O 0 0.04719534516334534

However O 0 0.03404206410050392
, O 0 0.030502773821353912
genotype O 0 0.14878951013088226
- O 0 0.46221721172332764
phenotype O 0 0.04268750175833702
analysis O 0 0.017781788483262062
inthe O 0 0.05586424097418785
group O 0 0.018221234902739525
of O 0 0.013451818376779556
CD B-Disease 0 0.13061779737472534
families O 0 0.013387028127908707
revealed O 0 0.012828602455556393
two O 0 0.00746582169085741
possible O 0 0.010003743693232536
associations O 0 0.010777641087770462
worthy O 0 0.018378127366304398
of O 0 0.009288675151765347
follow O 0 0.013393377885222435
- O 0 0.03736482188105583
up O 0 0.016321750357747078
in O 0 0.01519920863211155
independent O 0 0.021840238943696022
analyses O 0 0.04057843238115311
. O 0 0.04384433105587959

The O 0 0.023625805974006653
first O 0 0.017769109457731247
was O 0 0.015924884006381035
an O 0 0.009772324934601784
association O 0 0.012859486043453217
noted O 0 0.008957761339843273
in O 0 0.006589771248400211
the O 0 0.00760921323671937
group O 0 0.00935129914432764
of O 0 0.00938990619033575
CD B-Disease 1 0.7594816088676453
families O 0 0.031068796291947365
with O 1 0.9861162304878235
breast B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.21599459648132324

A O 0 0.039948832243680954
correlation O 0 0.029092280194163322
was O 0 0.016950998455286026
observed O 0 0.01206208486109972
between O 0 0.008890233002603054
the O 0 0.00988004170358181
presence O 0 0.013863151893019676
/ O 0 0.33803877234458923
absence O 0 0.014360849745571613
of O 0 0.011271019466221333
a O 0 0.02007783018052578
PTEN O 1 0.9999641180038452
mutation O 0 0.016248472034931183
and O 0 0.007950086146593094
the O 0 0.008386248722672462
type O 0 0.013240315951406956
of O 0 0.01674903742969036
breast O 1 0.9999998807907104
involvement O 1 0.9957422614097595
( O 0 0.28482338786125183
unaffected O 1 0.9998571872711182
versus O 1 0.9999792575836182
benign O 1 0.9999998807907104
versus O 1 0.9999979734420776
malignant O 1 1.0
) O 0 0.058975592255592346
. O 0 0.059861697256565094

Specifically O 0 0.03230547532439232
and O 0 0.013064081780612469
more O 0 0.009046616964042187
directly O 0 0.009451108053326607
, O 0 0.008055450394749641
an O 0 0.007641320116817951
association O 0 0.017148982733488083
was O 0 0.015832139179110527
also O 0 0.00858155358582735
observed O 0 0.007933796383440495
between O 0 0.006121040787547827
the O 0 0.005998129025101662
presence O 0 0.00796495657414198
of O 0 0.007966135628521442
a O 0 0.01952941343188286
PTEN O 1 0.9999995231628418
mutation O 1 0.9964271187782288
and O 1 0.9997958540916443
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.9288868308067322

Secondly O 0 0.4731270670890808
, O 0 0.020831800997257233
there O 0 0.010659744963049889
appeared O 0 0.01146030705422163
to O 0 0.0073569538071751595
be O 0 0.006518511567264795
an O 0 0.008845493197441101
interdependent O 1 0.6188867688179016
association O 0 0.015395243652164936
between O 0 0.01038705836981535
mutations O 0 0.012460357509553432
upstream O 0 0.01283205859363079
and O 0 0.007716503459960222
within O 0 0.008122941479086876
the O 0 0.010665514506399632
PTPase O 1 0.9895923137664795
core O 0 0.06590837240219116
motif O 0 0.028755992650985718
, O 0 0.01208540890365839
the O 0 0.011682280339300632
core O 0 0.024527525529265404
motif O 0 0.024464815855026245
containing O 0 0.01305306889116764
the O 0 0.01025371067225933
majority O 0 0.010102072730660439
of O 0 0.011474204249680042
missense O 0 0.06233533099293709
mutations O 0 0.012681029736995697
, O 0 0.008230498991906643
and O 0 0.007336204871535301
the O 0 0.006983088795095682
involvement O 0 0.009109869599342346
of O 0 0.006375700235366821
all O 0 0.006002508569508791
major O 0 0.042706429958343506
organ O 1 0.9895868301391602
systems O 0 0.254459023475647
( O 0 0.00813144352287054
central O 0 0.010498053394258022
nervous O 0 0.22694149613380432
system O 0 0.016656439751386642
, O 0 0.3125317394733429
thyroid O 1 1.0
, O 1 0.9995697140693665
breast O 1 1.0
, O 1 0.9999905824661255
skin O 1 1.0
and O 1 0.9999995231628418
gastrointestinal O 1 1.0
tract O 1 1.0
) O 1 0.9890909790992737
. O 0 0.05854794755578041

However O 0 0.026003330945968628
, O 0 0.013322051614522934
these O 0 0.007195433136075735
observations O 0 0.012136382982134819
would O 0 0.007620996795594692
need O 0 0.00853378139436245
to O 0 0.007516796234995127
be O 0 0.006167030427604914
confirmed O 0 0.008433802984654903
by O 0 0.007061805110424757
studying O 0 0.011120172217488289
a O 0 0.010477575473487377
larger O 0 0.013614987954497337
number O 0 0.012085472233593464
of O 0 0.0188271664083004
CD B-Disease 0 0.09785535931587219
families O 0 0.039354778826236725
. O 0 0.0409676730632782

Molecular O 1 0.7498044371604919
defects O 1 0.9961368441581726
leading O 0 0.02800663560628891
to O 0 0.01495117973536253
human O 0 0.017832336947321892
complement B-Disease 1 0.9964655637741089
component I-Disease 1 0.9999992847442627
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.016431190073490143
an O 0 0.019343556836247444
African O 1 0.8553863763809204
- O 1 0.9987672567367554
American O 0 0.19147147238254547
family O 0 0.04562016576528549
. O 0 0.044178638607263565

Complement B-Disease 1 0.8982012867927551
component I-Disease 1 0.999984860420227
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 1 0.9789313673973083
C6D B-Disease 1 0.9999995231628418
) O 0 0.056460049003362656
was O 1 0.7663629651069641
diagnosed O 1 0.9999070167541504
in O 0 0.008429617621004581
a O 0 0.010718125849962234
16 O 0 0.013852061703801155
- O 0 0.02098444104194641
year O 0 0.012195500545203686
- O 0 0.04875648394227028
old O 0 0.018301747739315033
African O 0 0.020866522565484047
- O 1 0.7850907444953918
American O 0 0.039197392761707306
male O 0 0.35604554414749146
with O 1 0.9296402931213379
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 0.25888288021087646

The O 0 0.04554714262485504
patients O 1 0.9952329993247986
father O 0 0.039603717625141144
and O 0 0.01067221350967884
two O 0 0.007837076671421528
brothers O 0 0.026820847764611244
also O 0 0.008860996924340725
had O 0 0.014351227320730686
C6D B-Disease 1 0.9998449087142944
, O 0 0.008349648676812649
but O 0 0.006163556594401598
gave O 0 0.009076965041458607
no O 0 0.0073029883205890656
history O 0 0.011906799860298634
of O 0 0.05669765919446945
meningitis B-Disease 1 1.0
or O 0 0.15053923428058624
other O 0 0.035216499119997025
neisserial B-Disease 1 0.9999985694885254
infection I-Disease 1 0.9999991655349731
. O 0 0.05022326484322548

By O 0 0.026885157451033592
using O 0 0.025238778442144394
exon O 0 0.049925796687603
- O 0 0.0322173647582531
specific O 0 0.018025726079940796
polymerase O 0 0.04259568825364113
chain O 0 0.030836304649710655
reaction O 0 0.01967739313840866
( O 0 0.015612896531820297
PCR O 0 0.043408747762441635
) O 0 0.017658669501543045
/ O 0 0.034809522330760956
single O 0 0.022753264755010605
- O 0 0.034933801740407944
strand O 0 0.028857767581939697
conformation O 0 0.025113185867667198
polymorphism O 0 0.02279798500239849
as O 0 0.011122355237603188
a O 0 0.012382904067635536
screening O 0 0.019980531185865402
step O 0 0.015867194160819054
and O 0 0.009336521849036217
nucleotide O 0 0.01573479175567627
sequencing O 0 0.014168276451528072
of O 0 0.009781206026673317
target O 0 0.012983474880456924
exons O 0 0.019221894443035126
, O 0 0.009276792407035828
we O 0 0.006927830167114735
determined O 0 0.008660636842250824
that O 0 0.006041872780770063
the O 0 0.008588635362684727
proband O 1 0.6247780323028564
was O 0 0.016138747334480286
a O 0 0.01638048328459263
compound O 0 0.0323464572429657
heterozygote O 0 0.06345795840024948
for O 0 0.019894631579518318
two O 0 0.02518432028591633
C6 O 1 0.9999392032623291
gene O 0 0.056730967015028
mutations O 0 0.06142742186784744
. O 0 0.05473362281918526

The O 0 0.03509805351495743
first O 0 0.029524898156523705
, O 0 0.024258464574813843
1195delC O 0 0.060938481241464615
located O 0 0.02203507348895073
in O 0 0.014658626168966293
exon O 0 0.04055585339665413
7 O 0 0.019423209130764008
, O 0 0.01224604994058609
is O 0 0.009571745060384274
a O 0 0.011160492897033691
novel O 0 0.016547396779060364
mutation O 0 0.01208538468927145
, O 0 0.008137976750731468
while O 0 0.007923198863863945
the O 0 0.008433784358203411
second O 0 0.013012818992137909
, O 0 0.01165615301579237
1936delG O 0 0.027770115062594414
in O 0 0.01142607070505619
exon O 0 0.029217055067420006
12 O 0 0.012478147633373737
, O 0 0.008187956176698208
has O 0 0.0072446404956281185
been O 0 0.006263915449380875
described O 0 0.007221954874694347
before O 0 0.008793107233941555
to O 0 0.01073524821549654
cause O 0 0.08430291712284088
C6D B-Disease 1 0.9957940578460693
in O 0 0.010068072937428951
an O 0 0.01237054169178009
unrelated O 0 0.02270049974322319
African O 0 0.044147249311208725
- O 1 0.8875221014022827
American O 0 0.03351616486907005
individual O 0 0.026595816016197205
. O 0 0.04119037836790085

Both O 0 0.031081439927220345
mutations O 0 0.026485253125429153
result O 0 0.01653262786567211
in O 0 0.016417548060417175
premature O 1 0.9862697720527649
termination O 1 0.9995152950286865
codons O 0 0.2185136377811432
and O 0 0.05052429810166359
C6 O 1 0.9999830722808838
null O 0 0.23217973113059998
alleles O 0 0.08207274973392487
. O 0 0.05860697850584984

Allele O 0 0.09951627999544144
- O 0 0.0731411874294281
specific O 0 0.020591575652360916
PCR O 0 0.03535548597574234
indicated O 0 0.016572151333093643
that O 0 0.008915014564990997
the O 0 0.012007576413452625
probands O 0 0.08929786831140518
two O 0 0.010063080117106438
brothers O 0 0.020602954551577568
also O 0 0.011681541800498962
inherited O 1 0.9270497560501099
the O 0 0.014078536070883274
1195delC O 1 0.9979671835899353
mutation O 0 0.01403088215738535
from O 0 0.009106521494686604
their O 0 0.009034372866153717
heterozygous O 0 0.020860107615590096
mother O 0 0.019090432673692703
and O 0 0.010296130552887917
the O 0 0.012148990295827389
1936delG O 1 0.914454460144043
mutation O 0 0.015694521367549896
from O 0 0.010941066779196262
their O 0 0.013988707214593887
homozygous O 0 0.050397634506225586
father O 0 0.3490464985370636
. O 0 0.02847994677722454
. O 0 0.04711073264479637

PAX6 O 1 0.9997466206550598
mutations O 0 0.11750301718711853
reviewed O 0 0.11192023009061813
. O 0 0.08739190548658371

Mutations O 0 0.048036858439445496
in O 0 0.02443067915737629
PAX6 O 1 0.9987906813621521
are O 0 0.008794276043772697
responsible O 0 0.010296748019754887
for O 0 0.007952133193612099
human O 0 0.01329504419118166
aniridia B-Disease 1 0.9999958276748657
and O 0 0.009035235270857811
have O 0 0.004915905185043812
also O 0 0.005331375170499086
been O 0 0.004771224223077297
found O 0 0.005087797995656729
in O 0 0.006033545825630426
patients O 0 0.06806451827287674
with O 0 0.008091031573712826
Peters B-Disease 1 0.9999619722366333
anomaly I-Disease 1 0.9999899864196777
, O 1 0.5102124214172363
with O 1 0.9990948438644409
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 1 0.9945955872535706
with O 1 0.9775139093399048
autosomal B-Disease 1 0.9999998807907104
dominant I-Disease 1 0.9999994039535522
keratitis I-Disease 1 1.0
, O 1 0.7394303679466248
and O 0 0.040598731487989426
with O 0 0.09222731739282608
isolated B-Disease 1 0.998936116695404
foveal I-Disease 1 0.9999995231628418
hypoplasia I-Disease 1 0.9999998807907104
. O 0 0.1428532898426056

No O 0 0.03875017166137695
locus O 0 0.047137025743722916
other O 0 0.013628845103085041
than O 0 0.01384045835584402
chromosome O 0 0.025728894397616386
11p13 O 0 0.13135778903961182
has O 0 0.011222156696021557
been O 0 0.0092094661667943
implicated O 0 0.0252342838793993
in O 0 0.011043318547308445
aniridia B-Disease 1 0.9999878406524658
, O 0 0.01391944382339716
and O 0 0.01442683208733797
PAX6 O 1 0.9999896287918091
is O 0 0.008904041722416878
clearly O 0 0.008777721785008907
the O 0 0.007669433951377869
major O 0 0.010688199661672115
, O 0 0.007460268214344978
if O 0 0.006371345371007919
not O 0 0.006174258887767792
only O 0 0.008163523860275745
, O 0 0.01287497766315937
gene O 0 0.0192034300416708
responsible O 0 0.024983782321214676
. O 0 0.03536669537425041

Twenty O 0 0.06319354474544525
- O 0 0.04170498251914978
eight O 0 0.020597143098711967
percent O 0 0.017204616218805313
of O 0 0.015029622241854668
identified O 0 0.021363841369748116
PAX6 O 1 0.999108612537384
mutations O 0 0.020055146887898445
are O 0 0.010425557382404804
C O 1 0.8369290232658386
- O 1 0.9265225529670715
T O 1 0.5634260177612305
changes O 0 0.014653680846095085
at O 0 0.02064337208867073
CpG O 0 0.048617154359817505
dinucleotides O 0 0.09517211467027664
, O 0 0.012986390851438046
20 O 0 0.013561587780714035
% O 0 0.01003750879317522
are O 0 0.006355371791869402
splicing O 0 0.01601051352918148
errors O 0 0.013217597268521786
, O 0 0.007914903573691845
and O 0 0.006279244087636471
more O 0 0.005310642998665571
than O 0 0.005912842229008675
30 O 0 0.010842099785804749
% O 0 0.009536806493997574
are O 0 0.00822748988866806
deletion O 0 0.027402669191360474
or O 0 0.018749959766864777
insertion O 0 0.05043667182326317
events O 0 0.03911105915904045
. O 0 0.04996739327907562

There O 0 0.023362603038549423
is O 0 0.017246048897504807
a O 0 0.018240243196487427
noticeably O 0 0.31264880299568176
elevated O 1 0.9651334285736084
level O 0 0.0133204972371459
of O 0 0.010518777184188366
mutation O 0 0.01225046906620264
in O 0 0.008281296119093895
the O 0 0.011370303109288216
paired O 0 0.020629141479730606
domain O 0 0.013589031994342804
compared O 0 0.01108807697892189
with O 0 0.008492045104503632
the O 0 0.010910655371844769
rest O 0 0.01570827327668667
of O 0 0.015118731185793877
the O 0 0.021027514711022377
gene O 0 0.035595718771219254
. O 0 0.04270365834236145

Increased O 0 0.04708921164274216
mutation O 0 0.03202471509575844
in O 0 0.016314184293150902
the O 0 0.019447434693574905
homeodomain O 1 0.9623715877532959
is O 0 0.014508514665067196
accounted O 0 0.019122663885354996
for O 0 0.010192829184234142
by O 0 0.011422489769756794
the O 0 0.022082490846514702
hypermutable O 1 0.9952120780944824
CpG O 1 0.8910353779792786
dinucleotide O 1 0.8861176371574402
in O 0 0.03978549316525459
codon O 0 0.08310595899820328
240 O 0 0.10221786051988602
. O 0 0.07402928173542023

Very O 0 0.02641785331070423
nearly O 0 0.01975235715508461
all O 0 0.011281094513833523
mutations O 0 0.012145602144300938
appear O 0 0.00881769135594368
to O 0 0.00774733629077673
cause O 0 0.04150955379009247
loss O 0 0.05142493173480034
of O 0 0.008655487559735775
function O 0 0.008768661879003048
of O 0 0.008402606472373009
the O 0 0.01046402845531702
mutant O 0 0.4561860263347626
allele O 0 0.021079886704683304
, O 0 0.00925647933036089
and O 0 0.0069539654068648815
more O 0 0.00610645767301321
than O 0 0.00734702916815877
80 O 0 0.013711100444197655
% O 0 0.011526085436344147
of O 0 0.013910867273807526
exonic O 0 0.13445159792900085
substitutions O 0 0.03136124461889267
result O 0 0.018475215882062912
in O 0 0.01956556737422943
nonsense O 0 0.06385358422994614
codons O 0 0.0666775032877922
. O 0 0.04699602723121643

In O 0 0.023967700079083443
a O 0 0.01876736991107464
gene O 0 0.015102160163223743
with O 0 0.009851465001702309
such O 0 0.008545994758605957
extraordinarily O 0 0.05697314813733101
high O 0 0.014499178156256676
sequence O 0 0.00970607902854681
conservation O 0 0.011961538344621658
throughout O 0 0.009157773107290268
evolution O 0 0.011600707657635212
, O 0 0.008729198947548866
there O 0 0.006924950052052736
are O 0 0.006281946320086718
presumed O 0 0.019048182293772697
undiscovered O 1 0.9214017391204834
missense O 0 0.40243127942085266
mutations O 0 0.016600914299488068
, O 0 0.00921118538826704
these O 0 0.006035319063812494
are O 0 0.00512950774282217
hypothesized O 0 0.0124441497027874
to O 0 0.007194935344159603
exist O 0 0.006673724856227636
in O 0 0.007183271925896406
as O 0 0.011169275268912315
- O 0 0.06863950192928314
yet O 0 0.020364223048090935
unidentified O 0 0.04539092630147934
phenotypes O 0 0.06851834803819656
. O 0 0.027537893503904343
. O 0 0.04084468260407448

Genetic O 0 0.054392009973526
heterogeneity O 0 0.06653252989053726
and O 0 0.01986479014158249
penetrance O 0 0.1513614058494568
analysis O 0 0.012637866660952568
of O 0 0.010224300436675549
the O 0 0.014276758767664433
BRCA1 O 1 0.9993636012077332
and O 0 0.020654495805501938
BRCA2 O 1 0.9999454021453857
genes O 0 0.08553662151098251
in O 1 0.943287193775177
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.586605429649353
. O 0 0.04579971358180046

The O 1 0.9990090131759644
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.999870777130127
Consortium O 1 0.9926348328590393
. O 0 0.06663999706506729

The O 0 0.03214830532670021
contribution O 0 0.03187887743115425
of O 0 0.019854310899972916
BRCA1 O 1 0.9948992133140564
and O 0 0.017304733395576477
BRCA2 O 1 0.9999239444732666
to O 1 0.5184655785560608
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 1 0.9920988082885742
assessed O 0 0.036280062049627304
by O 0 0.009394636377692223
linkage O 0 0.029766399413347244
and O 0 0.010560504160821438
mutation O 0 0.01101929135620594
analysis O 0 0.008207030594348907
in O 0 0.008186358027160168
237 O 0 0.022566987201571465
families O 0 0.009285428561270237
, O 0 0.006702932063490152
each O 0 0.005133397411555052
with O 0 0.0048935627564787865
at O 0 0.007009222637861967
least O 0 0.005400802940130234
four O 0 0.006908541079610586
cases O 0 0.007169594522565603
of O 0 0.19141241908073425
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
, O 0 0.00916283205151558
collected O 0 0.010244669392704964
by O 0 0.009652113541960716
the O 1 0.8873229026794434
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.9997201561927795
Consortium O 1 0.909127414226532
. O 0 0.060901742428541183

Families O 0 0.030037609860301018
were O 0 0.014372334815561771
included O 0 0.014370403252542019
without O 0 0.008608667179942131
regard O 0 0.009609351865947247
to O 0 0.0075455657206475735
the O 0 0.00919097475707531
occurrence O 0 0.019410714507102966
of O 1 0.6321141123771667
ovarian B-Disease 1 1.0
or I-Disease 1 0.8553295731544495
other I-Disease 0 0.09920398145914078
cancers I-Disease 1 0.9999938011169434
. O 0 0.04389281943440437

Overall O 1 0.9420615434646606
, O 1 0.553395688533783
disease O 1 0.9999970197677612
was O 1 0.536668062210083
linked O 0 0.09781306236982346
to O 0 0.010629328899085522
BRCA1 O 1 0.9704726934432983
in O 0 0.007338830269873142
an O 0 0.007253342308104038
estimated O 0 0.009605418890714645
52 O 0 0.014490975067019463
% O 0 0.008991910144686699
of O 0 0.008284229785203934
families O 0 0.008926954120397568
, O 0 0.008996832184493542
to O 0 0.009665299206972122
BRCA2 O 0 0.08131683617830276
in O 0 0.007967277429997921
32 O 0 0.014054043218493462
% O 0 0.008338096551597118
of O 0 0.008155442774295807
families O 0 0.008421748876571655
, O 0 0.00695256981998682
and O 0 0.006677562836557627
to O 0 0.007471452467143536
neither O 0 0.010936629958450794
gene O 0 0.009135248139500618
in O 0 0.007434890139847994
16 O 0 0.011566661298274994
% O 0 0.00932717602699995
( O 0 0.009620262309908867
95 O 0 0.017052054405212402
% O 0 0.012164903804659843
confidence O 0 0.019895458593964577
interval O 0 0.02476418949663639
[ O 0 0.027267303317785263
CI O 1 0.9862719774246216
] O 0 0.025064701214432716
6 O 0 0.01932004652917385
% O 0 0.011535813100636005
- O 0 0.02049771137535572
28 O 0 0.01656953990459442
% O 0 0.011946898885071278
) O 0 0.01018566358834505
, O 0 0.011512440629303455
suggesting O 0 0.020168298855423927
other O 0 0.017219021916389465
predisposition O 1 0.9864411950111389
genes O 0 0.03816383332014084
. O 0 0.04488210752606392

The O 0 0.0285671167075634
majority O 0 0.019599217921495438
( O 0 0.014110435731709003
81 O 0 0.024167105555534363
% O 0 0.008903145790100098
) O 0 0.0069948239251971245
of O 0 0.008150340989232063
the O 0 0.08515560626983643
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.014843057841062546
were O 0 0.007152924779802561
due O 0 0.007470868993550539
to O 0 0.009890935383737087
BRCA1 O 1 0.980227530002594
, O 0 0.007499116472899914
with O 0 0.005274972412735224
most O 0 0.006274084094911814
others O 0 0.007401732262223959
( O 0 0.00859102327376604
14 O 0 0.012772589921951294
% O 0 0.010742624290287495
) O 0 0.013144686818122864
due O 0 0.019106334075331688
to O 0 0.029430115595459938
BRCA2 O 1 0.9929494857788086
. O 0 0.049478527158498764

Conversely O 0 0.05855425074696541
, O 0 0.017698515206575394
the O 0 0.011959034949541092
majority O 0 0.009920209646224976
of O 0 0.007590153254568577
families O 0 0.007307961583137512
with O 0 0.006072530057281256
male B-Disease 0 0.04548727348446846
and I-Disease 0 0.1646047979593277
female I-Disease 1 0.9999889135360718
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 0.007969369180500507
due O 0 0.01076454296708107
to O 0 0.014332395046949387
BRCA2 O 1 0.998599112033844
( O 0 0.018189862370491028
76 O 1 0.5721774697303772
% O 0 0.027814002707600594
) O 0 0.03354392200708389
. O 0 0.04468956217169762

The O 0 0.031893905252218246
largest O 0 0.02932731620967388
proportion O 0 0.0186682790517807
( O 0 0.01276139821857214
67 O 0 0.022731773555278778
% O 0 0.01120233815163374
) O 0 0.007835622876882553
of O 0 0.007968612015247345
families O 0 0.007221838925033808
due O 0 0.007150794379413128
to O 0 0.006354419980198145
other O 0 0.005850603803992271
genes O 0 0.00760391540825367
was O 0 0.00851783249527216
found O 0 0.0054059382528066635
in O 0 0.005345881916582584
families O 0 0.005848410073667765
with O 0 0.005004363600164652
four O 0 0.006585053168237209
or O 0 0.005811021663248539
five O 0 0.006555423606187105
cases O 0 0.008562134578824043
of O 0 0.016335003077983856
female O 1 0.9999628067016602
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
only O 0 0.03234271705150604
. O 0 0.04645431041717529

These O 0 0.0199135709553957
estimates O 0 0.018834777176380157
were O 0 0.009438103064894676
not O 0 0.008014559745788574
substantially O 0 0.0148562490940094
affected O 0 0.009981544688344002
either O 0 0.006425900850445032
by O 0 0.005710816942155361
changing O 0 0.009233776479959488
the O 0 0.00869390182197094
assumed O 0 0.01840583048760891
penetrance O 1 0.729286789894104
model O 0 0.016398156061768532
for O 0 0.012700656428933144
BRCA1 O 1 0.9964894652366638
or O 0 0.008288857527077198
by O 0 0.007341453805565834
including O 0 0.009831749834120274
or O 0 0.013549868017435074
excluding O 0 0.07188394665718079
BRCA1 O 1 0.9993119239807129
mutation O 0 0.03752350062131882
data O 0 0.034452106803655624
. O 0 0.04558359831571579

Among O 0 0.024872716516256332
those O 0 0.013031345792114735
families O 0 0.013778935186564922
with O 0 0.017308350652456284
disease O 1 0.9999994039535522
due O 0 0.03561002016067505
to O 0 0.011930194683372974
BRCA1 O 1 0.9997261166572571
that O 0 0.005550069734454155
were O 0 0.00518032256513834
tested O 0 0.00798704195767641
by O 0 0.004525107331573963
one O 0 0.00504683842882514
of O 0 0.005278673954308033
the O 0 0.006495035253465176
standard O 0 0.010625587776303291
screening O 0 0.012949073687195778
methods O 0 0.009292520582675934
, O 0 0.008858170360326767
mutations O 0 0.008547037839889526
were O 0 0.005732670426368713
detected O 0 0.010649506002664566
in O 0 0.0075299921445548534
the O 0 0.010145638138055801
coding O 0 0.016467873007059097
sequence O 0 0.010969174094498158
or O 0 0.009230914525687695
splice O 0 0.02255251817405224
sites O 0 0.009857709519565105
in O 0 0.007468960247933865
an O 0 0.007283155340701342
estimated O 0 0.011961858719587326
63 O 0 0.01953243650496006
% O 0 0.011120869778096676
( O 0 0.010334608145058155
95 O 0 0.02151188999414444
% O 0 0.017921127378940582
CI O 0 0.4941491484642029
51 O 0 0.03156161308288574
% O 0 0.020063349977135658
- O 0 0.11603102087974548
77 O 0 0.05191763862967491
% O 0 0.03150172904133797
) O 0 0.032243747264146805
. O 0 0.04852590337395668

The O 0 0.03498608246445656
estimated O 0 0.025500530377030373
sensitivity O 0 0.031277526170015335
was O 0 0.021478140726685524
identical O 0 0.01706717349588871
for O 0 0.011670888401567936
direct O 0 0.016927868127822876
sequencing O 0 0.02530801296234131
and O 0 0.016732914373278618
other O 0 0.01824422925710678
techniques O 0 0.03575732558965683
. O 0 0.04296162351965904

The O 0 0.049294084310531616
penetrance O 1 0.5242446660995483
of O 0 0.03501340001821518
BRCA2 O 1 0.999871015548706
was O 0 0.02180134691298008
estimated O 0 0.0138378432020545
by O 0 0.009881982579827309
maximizing O 0 0.030857481062412262
the O 0 0.014860311523079872
LOD O 1 0.9888219833374023
score O 0 0.018833773210644722
in O 0 0.01664057746529579
BRCA2 O 1 0.9995914101600647
- O 1 0.956505298614502
mutation O 0 0.01805468648672104
families O 0 0.012833252549171448
, O 0 0.009100852534174919
over O 0 0.009288662113249302
all O 0 0.009638603776693344
possible O 0 0.01902996003627777
penetrance O 1 0.8530553579330444
functions O 0 0.029306260868906975
. O 0 0.03759172186255455

The O 0 0.028580034151673317
estimated O 0 0.024674154818058014
cumulative O 0 0.030225403606891632
risk O 0 0.05373329669237137
of O 1 0.5462182760238647
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
reached O 0 0.09609135240316391
28 O 0 0.017451459541916847
% O 0 0.010363753885030746
( O 0 0.010440799407660961
95 O 0 0.019940394908189774
% O 0 0.013649719767272472
CI O 1 0.8275855183601379
9 O 0 0.01827806606888771
% O 0 0.011917492374777794
- O 0 0.01978103443980217
44 O 0 0.017642753198742867
% O 0 0.009689985774457455
) O 0 0.0073103210888803005
by O 0 0.00624424684792757
age O 0 0.01005241647362709
50 O 0 0.009964806027710438
years O 0 0.007787562906742096
and O 0 0.00921153835952282
84 O 0 0.01890818402171135
% O 0 0.01107314694672823
( O 0 0.011496199294924736
95 O 0 0.021404176950454712
% O 0 0.015804247930645943
CI O 1 0.5455132126808167
43 O 0 0.02401251718401909
% O 0 0.014440968632698059
- O 0 0.023070167750120163
95 O 0 0.022410297766327858
% O 0 0.013099067844450474
) O 0 0.011329660192131996
by O 0 0.010872211307287216
age O 0 0.020107733085751534
70 O 0 0.029685134068131447
years O 0 0.031260088086128235
. O 0 0.04250045493245125

The O 0 0.059512849897146225
corresponding O 1 0.9984644651412964
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 1 0.9999537467956543
were O 0 0.03098118305206299
0 O 0 0.055255815386772156
. O 0 0.04996327683329582

4 O 0 0.04864535853266716
% O 0 0.024828726425766945
( O 0 0.017081817612051964
95 O 0 0.02900533564388752
% O 0 0.018621167168021202
CI O 1 0.5985528230667114
0 O 0 0.02208336442708969
% O 0 0.013772670179605484
- O 0 0.023968825116753578
1 O 0 0.013813527300953865
% O 0 0.009504987858235836
) O 0 0.007472757250070572
by O 0 0.0062917680479586124
age O 0 0.010671715252101421
50 O 0 0.011245031841099262
years O 0 0.009467902593314648
and O 0 0.009268981404602528
27 O 0 0.0169124323874712
% O 0 0.012720073573291302
( O 0 0.01246047392487526
95 O 0 0.02398611232638359
% O 0 0.018345443531870842
CI O 1 0.6617196202278137
0 O 0 0.022796953096985817
% O 0 0.01585511304438114
- O 0 0.025414040312170982
47 O 0 0.024277066811919212
% O 0 0.013543577864766121
) O 0 0.0118615897372365
by O 0 0.01117736753076315
age O 0 0.021264085546135902
70 O 0 0.029969559982419014
years O 0 0.03210924193263054
. O 0 0.042702943086624146

The O 0 0.031029587611556053
lifetime O 0 0.28692519664764404
risk O 1 0.9126071333885193
of O 1 0.9962815642356873
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
appears O 0 0.1096760630607605
similar O 0 0.008056135848164558
to O 0 0.006828099023550749
the O 0 0.007321059703826904
risk O 0 0.022494029253721237
in O 0 0.012739124707877636
BRCA1 O 1 0.9999980926513672
carriers O 1 0.844038724899292
, O 0 0.008727449923753738
but O 0 0.005952281877398491
there O 0 0.006122813560068607
was O 0 0.008824850432574749
some O 0 0.006623989436775446
suggestion O 0 0.01367461308836937
of O 0 0.007977372035384178
a O 0 0.010650118812918663
lower O 0 0.016772139817476273
risk O 0 0.016442814841866493
in O 0 0.014281182549893856
BRCA2 O 1 0.9999501705169678
carriers O 0 0.3828907310962677
< O 0 0.27990350127220154
50 O 0 0.021487070247530937
years O 0 0.019022343680262566
of O 0 0.023795099928975105
age O 0 0.03698069602251053
. O 0 0.04548674821853638

Eye B-Disease 1 0.9998642206192017
movement I-Disease 0 0.23370777070522308
abnormalities I-Disease 1 0.9901565313339233
correlate O 0 0.03761924058198929
with O 0 0.018323829397559166
genotype O 1 0.5347792506217957
in O 0 0.02272549830377102
autosomal O 1 0.9999979734420776
dominant O 1 0.9999997615814209
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 0.9999996423721313
I I-Disease 1 0.9998694658279419
. O 0 0.05788060277700424

We O 0 0.03244215250015259
compared O 0 0.02812221087515354
horizontal O 0 0.04925793781876564
eye O 1 0.9595638513565063
movements O 0 0.022634895518422127
( O 0 0.020413491874933243
visually O 0 0.04284829646348953
guided O 0 0.144756019115448
saccades O 1 0.9998132586479187
, O 0 0.022368602454662323
antisaccades O 1 0.9615544676780701
, O 0 0.012840989045798779
and O 0 0.010032004676759243
smooth O 0 0.019192790612578392
pursuit O 0 0.08130761235952377
) O 0 0.009042345918715
in O 0 0.007690795231610537
control O 0 0.010013343766331673
subjects O 0 0.012461266480386257
( O 0 0.010639662854373455
n O 0 0.016380390152335167
= O 0 0.01666458509862423
14 O 0 0.01377064362168312
) O 0 0.009322555735707283
and O 0 0.009080263786017895
patients O 0 0.01209867000579834
with O 0 0.005438119173049927
three O 0 0.0063744341023266315
forms O 0 0.006765644531697035
of O 0 0.011058853007853031
autosomal O 1 0.9998941421508789
dominant O 1 0.9996055960655212
cerebellar B-Disease 1 0.9999997615814209
ataxias I-Disease 1 0.9999992847442627
type I-Disease 1 0.9980033040046692
I I-Disease 1 0.9874399900436401
spinocerebellar B-Disease 1 0.9999946355819702
ataxias I-Disease 1 0.9872905611991882
1 I-Disease 0 0.020712686702609062
and I-Disease 0 0.013439768925309181
2 I-Disease 0 0.017928943037986755
( O 0 0.016748307272791862
SCA1 B-Disease 0 0.42943722009658813
, O 0 0.015781398862600327
n O 0 0.02253512106835842
= O 0 0.024899715557694435
11 O 0 0.018538087606430054
; O 0 0.017467942088842392
SCA2 B-Disease 0 0.41263577342033386
, O 0 0.01639949344098568
n O 0 0.019843515008687973
= O 0 0.021750114858150482
10 O 0 0.013471088372170925
) O 0 0.010484964586794376
and O 0 0.011737475171685219
SCA3 B-Disease 1 0.999923825263977
/ O 1 0.9879174828529358
Machado B-Disease 1 0.9994218349456787
- I-Disease 1 0.9997401833534241
Joseph I-Disease 1 0.9996625185012817
disease I-Disease 1 0.9999991655349731
( O 0 0.40637773275375366
MJD B-Disease 1 0.9999997615814209
) O 0 0.021551601588726044
( O 0 0.02024221234023571
n O 0 0.03400474786758423
= O 0 0.042747221887111664
16 O 0 0.042333848774433136
) O 0 0.03709660470485687
. O 0 0.051364172250032425

In O 0 0.042899031192064285
SCA1 B-Disease 1 0.9976859092712402
, O 0 0.032191067934036255
saccade O 1 0.9098213315010071
amplitude O 0 0.03886478766798973
was O 0 0.021973153576254845
significantly O 0 0.02163025178015232
increased O 0 0.018338289111852646
, O 0 0.01684456691145897
resulting O 0 0.023566683754324913
in O 0 0.02760165184736252
hypermetria B-Disease 1 0.9822547435760498
. O 0 0.0590796172618866

The O 0 0.04237613081932068
smooth O 0 0.05325201153755188
pursuit O 1 0.5268198847770691
gain O 0 0.05774188041687012
was O 0 0.22083401679992676
decreased O 0 0.40421703457832336
. O 0 0.04890710487961769

In O 0 0.053847115486860275
SCA2 B-Disease 1 0.9988055229187012
, O 0 0.04282674565911293
saccade O 1 0.992900013923645
velocity O 0 0.057508163154125214
was O 0 0.05293119326233864
markedly O 0 0.11670997738838196
decreased O 0 0.10693058371543884
. O 0 0.05784403160214424

The O 0 0.028894860297441483
percentage O 0 0.02350483275949955
of O 0 0.015417465008795261
errors O 0 0.01867765001952648
in O 0 0.012567983008921146
antisaccades O 1 0.993645429611206
was O 0 0.019102098420262337
greatly O 0 0.01585962250828743
increased O 0 0.01241188496351242
and O 0 0.008299891836941242
was O 0 0.012128381989896297
significantly O 0 0.012737654149532318
correlated O 0 0.017129937186837196
with O 0 0.011180359870195389
age O 1 0.5828739404678345
at O 1 0.9983252882957458
disease O 1 1.0
onset O 1 0.9999997615814209
. O 0 0.06932752579450607

In O 0 0.0275974590331316
addition O 0 0.019733242690563202
, O 0 0.012656240724027157
a O 0 0.012034500017762184
correlation O 0 0.013966362923383713
between O 0 0.00901502650231123
smooth O 0 0.0179618950933218
pursuit O 0 0.044957585632801056
gain O 0 0.01504826731979847
and O 0 0.008873049169778824
the O 0 0.009441444650292397
number O 0 0.009256267920136452
of O 0 0.016458328813314438
trinucleotide O 1 0.9994974136352539
repeats O 0 0.051795702427625656
was O 0 0.03397618606686592
found O 0 0.033116843551397324
. O 0 0.04029230773448944

In O 0 0.047879718244075775
SCA3 B-Disease 1 0.9995625615119934
, O 0 0.03651479259133339
gaze B-Disease 1 0.9780250787734985
- I-Disease 1 0.9997197985649109
evoked I-Disease 1 0.9998475313186646
nystagmus I-Disease 1 0.9999892711639404
was O 0 0.05397426709532738
often O 0 0.010412834584712982
present O 0 0.011245100758969784
as O 0 0.01184956356883049
was O 0 0.027345316484570503
saccade O 1 0.9994340538978577
hypometria O 1 0.9961859583854675
and O 0 0.016282616183161736
smooth O 0 0.03240983188152313
pursuit O 0 0.28210917115211487
gain O 0 0.03805137053132057
was O 0 0.22999362647533417
markedly O 1 0.5949652194976807
decreased O 0 0.1779368370771408
. O 0 0.05478474125266075

Three O 0 0.03209557384252548
major O 0 0.027786554768681526
criteria O 0 0.025073889642953873
, O 0 0.020394735038280487
saccade O 1 0.9767430424690247
amplitude O 0 0.03526187688112259
, O 0 0.02024179697036743
saccade O 1 0.8384817242622375
velocity O 0 0.02163112349808216
, O 0 0.011865218169987202
and O 0 0.009475051425397396
presence O 0 0.01097074244171381
of O 0 0.01164162065833807
gaze B-Disease 1 0.989326000213623
- I-Disease 1 0.9998664855957031
evoked I-Disease 1 0.9999345541000366
nystagmus I-Disease 1 0.9999803304672241
, O 0 0.013571196235716343
permitted O 0 0.012219298630952835
the O 0 0.010196726769208908
correct O 0 0.014250846579670906
assignment O 0 0.018792670220136642
of O 0 0.010703730396926403
90 O 0 0.013164205476641655
% O 0 0.008536718785762787
of O 0 0.007926339283585548
the O 0 0.01039890293031931
SCA1 B-Disease 1 0.9561318159103394
, O 0 0.00932144932448864
90 O 0 0.01039670966565609
% O 0 0.006864116061478853
of O 0 0.007353806868195534
the O 0 0.00908537209033966
SCA2 B-Disease 1 0.9947512745857239
, O 0 0.007531146518886089
and O 0 0.006636789068579674
93 O 0 0.01454260852187872
% O 0 0.007206870708614588
of O 0 0.006637077312916517
the O 0 0.009230038151144981
patients O 1 0.8890537619590759
with O 0 0.008938934653997421
SCA3 B-Disease 1 0.9997935891151428
to O 0 0.009002131409943104
their O 0 0.0066599189303815365
genetically O 0 0.00925255287438631
confirmed O 0 0.010218435898423195
patient O 1 0.8658879995346069
group O 0 0.01055438257753849
and O 0 0.007315679453313351
, O 0 0.00751351797953248
therefore O 0 0.006942795589566231
, O 0 0.007965559139847755
may O 0 0.008064540103077888
help O 0 0.015498955734074116
orient O 0 0.046293292194604874
diagnoses O 1 0.8541181683540344
of O 0 0.01835988089442253
SCA1 B-Disease 1 0.9999814033508301
, O 0 0.02389775961637497
SCA2 B-Disease 1 0.9991942048072815
, O 0 0.01442024391144514
and O 0 0.013795740902423859
SCA3 B-Disease 1 0.9996688365936279
at O 0 0.014237187802791595
early O 0 0.014647966250777245
clinical O 0 0.2166461944580078
stages O 0 0.024931542575359344
of O 0 0.020454812794923782
the O 1 0.94638991355896
diseases O 1 0.9999998807907104
. O 0 0.03240913525223732
. O 0 0.044751763343811035

Genetic O 0 0.036789216101169586
basis O 0 0.018714437261223793
and O 0 0.01794118992984295
molecular O 0 0.03338770940899849
mechanism O 0 0.3605034053325653
for O 1 0.9909041523933411
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 1 0.9887232780456543

Ventricular B-Disease 1 0.9999998807907104
fibrillation I-Disease 1 0.9999995231628418
causes O 1 0.7661887407302856
more O 0 0.013302059844136238
than O 0 0.011381984688341618
300 O 0 0.019115334376692772
, O 0 0.014240354299545288
000 O 0 0.030090579763054848
sudden O 0 0.05256311967968941
deaths O 0 0.01578627899289131
each O 0 0.008840344846248627
year O 0 0.012841767631471157
in O 0 0.01246354915201664
the O 0 0.018918855115771294
USA O 0 0.08551129698753357
alone O 0 0.04503443464636803
. O 0 0.04081959277391434

In O 0 0.02579827979207039
approximately O 0 0.021194851025938988
5 O 0 0.019726619124412537
- O 0 0.019904587417840958
12 O 0 0.013025784865021706
% O 0 0.008775366470217705
of O 0 0.007057377137243748
these O 0 0.004877428524196148
cases O 0 0.006075379904359579
, O 0 0.005926114972680807
there O 0 0.004670186899602413
are O 0 0.0041926708072423935
no O 0 0.007594184949994087
demonstrable O 1 0.998563826084137
cardiac O 1 0.9999983310699463
or O 0 0.13028112053871155
non O 1 0.9991361498832703
- O 1 0.9999997615814209
cardiac O 1 1.0
causes O 1 0.7918277382850647
to O 0 0.007578890770673752
account O 0 0.007266013417392969
for O 0 0.005586875136941671
the O 0 0.007654543966054916
episode O 0 0.012657003477215767
, O 0 0.0074751838110387325
which O 0 0.0057592857629060745
is O 0 0.007037825882434845
therefore O 0 0.007631259970366955
classified O 0 0.016297439113259315
as O 0 0.4526965916156769
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 1 0.9999977350234985
IVF B-Disease 1 1.0
) O 0 0.05858727917075157
. O 0 0.051269643008708954

A O 0 0.034865234047174454
distinct O 0 0.02056524157524109
group O 0 0.01863754540681839
of O 0 0.04535900056362152
IVF B-Disease 1 1.0
patients O 1 0.99992835521698
has O 0 0.009892167523503304
been O 0 0.006546406075358391
found O 0 0.00545521080493927
to O 0 0.005922977346926928
present O 0 0.007895931601524353
with O 0 0.008125239051878452
a O 0 0.016506044194102287
characteristic O 1 0.8804052472114563
electrocardiographic O 1 0.9999246597290039
pattern O 0 0.26115280389785767
. O 0 0.04516051709651947

Because O 0 0.025110160931944847
of O 0 0.016916640102863312
the O 0 0.012889652512967587
small O 0 0.010886243544518948
size O 0 0.010898996144533157
of O 0 0.007411849685013294
most O 0 0.006446291226893663
pedigrees O 0 0.013055268675088882
and O 0 0.006526235956698656
the O 0 0.00662745488807559
high O 0 0.02291611209511757
incidence O 1 0.9896190762519836
of O 0 0.016236890107393265
sudden B-Disease 1 0.9998899698257446
death I-Disease 1 0.9266136288642883
, O 0 0.009192738682031631
however O 0 0.007166058756411076
, O 0 0.008562693372368813
molecular O 0 0.012095690704882145
genetic O 0 0.009170250035822392
studies O 0 0.009150177240371704
of O 0 0.010992031544446945
IVF B-Disease 1 0.9998102784156799
have O 0 0.008873132057487965
not O 0 0.009988467209041119
yet O 0 0.015402286313474178
been O 0 0.018381403759121895
done O 0 0.03041594661772251
. O 0 0.04343830794095993

Because O 0 0.07133933156728745
IVF B-Disease 1 0.9999994039535522
causes O 1 0.9999982118606567
cardiac O 1 1.0
rhythm O 1 0.9999936819076538
disturbance O 1 0.9999499320983887
, O 0 0.016843514516949654
we O 0 0.012028355151414871
investigated O 0 0.018540281802415848
whether O 0 0.01257821824401617
malfunction O 1 0.5156753659248352
of O 0 0.012431989423930645
ion O 0 0.037242341786623
channels O 0 0.012582968920469284
could O 0 0.011473658494651318
cause O 0 0.07567676901817322
the O 0 0.01885538175702095
disorder O 1 0.999972939491272
by O 0 0.008462422527372837
studying O 0 0.017941096797585487
mutations O 0 0.014698320999741554
in O 0 0.011773336678743362
the O 0 0.020438583567738533
cardiac O 1 0.9999986886978149
sodium O 1 0.9580873847007751
channel O 0 0.05629882588982582
gene O 0 0.060161344707012177
SCN5A O 1 0.9760977029800415
. O 0 0.06790231168270111

We O 0 0.025561803951859474
have O 0 0.013954372145235538
now O 0 0.0160670205950737
identified O 0 0.013221627101302147
a O 0 0.014566716738045216
missense O 0 0.03153415769338608
mutation O 0 0.01754722371697426
, O 0 0.011699139140546322
a O 0 0.013335991650819778
splice O 0 0.4542013704776764
- O 1 0.8879560828208923
donor O 0 0.14374704658985138
mutation O 0 0.016426991671323776
, O 0 0.009449733421206474
and O 0 0.00882961880415678
a O 0 0.012782086618244648
frameshift O 1 0.9349982738494873
mutation O 0 0.013910546898841858
in O 0 0.008439606986939907
the O 0 0.01019309926778078
coding O 0 0.01909768395125866
region O 0 0.01562357135117054
of O 0 0.015667162835597992
SCN5A O 1 0.9977091550827026
in O 0 0.017978867515921593
three O 0 0.022458959370851517
IVF B-Disease 1 0.9991173148155212
families O 0 0.04265066608786583
. O 0 0.048415444791316986

We O 0 0.02516534924507141
show O 0 0.020169438794255257
that O 0 0.011713635176420212
sodium O 0 0.024166716262698174
channels O 0 0.011365523561835289
with O 0 0.008119788020849228
the O 0 0.01047539059072733
missense O 0 0.0303302351385355
mutation O 0 0.015301985666155815
recover O 0 0.10666314512491226
from O 0 0.008783134631812572
inactivation O 1 0.991628885269165
more O 0 0.008616232313215733
rapidly O 0 0.012668037787079811
than O 0 0.005654425825923681
normal O 0 0.006645254325121641
and O 0 0.0051347860135138035
that O 0 0.005454572848975658
the O 0 0.009161217138171196
frameshift O 1 0.9451321363449097
mutation O 0 0.01638016849756241
causes O 0 0.015822572633624077
the O 0 0.00907992571592331
sodium O 0 0.02397174946963787
channel O 0 0.012247584760189056
to O 0 0.010559606365859509
be O 0 0.011076646856963634
non O 0 0.025777842849493027
- O 1 0.7525434494018555
functional O 0 0.05212632566690445
. O 0 0.04660101234912872

Our O 0 0.03398854285478592
results O 0 0.020587939769029617
indicate O 0 0.014815429225564003
that O 0 0.008976761251688004
mutations O 0 0.014817518182098866
in O 0 0.012600185349583626
cardiac O 1 0.9999971389770508
ion O 1 0.9902368187904358
- O 1 0.8010104298591614
channel O 0 0.02032579854130745
genes O 0 0.011085127480328083
contribute O 0 0.011459097266197205
to O 0 0.008492081426084042
the O 0 0.010781836695969105
risk O 0 0.01707371696829796
of O 0 0.015081875957548618
developing O 1 0.993837296962738
IVF B-Disease 1 0.9999982118606567
. O 0 0.03086669370532036
. O 0 0.04540634900331497

Molecular O 0 0.07994799315929413
heterogeneity O 0 0.07748392224311829
in O 0 0.03554771468043327
mucopolysaccharidosis B-Disease 1 0.9998262524604797
IVA I-Disease 1 0.999994158744812
in O 0 0.020411651581525803
Australia O 0 0.021297605708241463
and O 0 0.013032713904976845
Northern O 0 0.015422148630023003
Ireland O 0 0.016852140426635742
: O 0 0.01198050007224083
nine O 0 0.014166518114507198
novel O 0 0.017825398594141006
mutations O 0 0.011714319698512554
including O 0 0.00933454092592001
T312S O 1 0.9419491291046143
, O 0 0.00954423751682043
a O 0 0.010855624452233315
common O 0 0.011061054654419422
allele O 0 0.020295238122344017
that O 0 0.012755957432091236
confers O 1 0.9995617270469666
a O 1 0.8507841229438782
mild O 1 0.9999940395355225
phenotype O 1 0.999283492565155
. O 0 0.053205229341983795

Mucopolysaccharidosis B-Disease 1 0.9997519850730896
IVA I-Disease 1 0.9999951124191284
( O 0 0.07277092337608337
MPS B-Disease 1 0.9991768002510071
IVA I-Disease 1 0.9999998807907104
) O 0 0.019866997376084328
is O 0 0.015003709122538567
an O 0 0.019237658008933067
autosomal B-Disease 1 0.9999901056289673
recessive I-Disease 1 0.9999997615814209
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 1 0.9997386336326599
by O 0 0.012639544904232025
a O 0 0.25377821922302246
genetic B-Disease 1 0.9852892756462097
defect I-Disease 1 0.9999310970306396
in O 0 0.015238421969115734
N O 0 0.10672875493764877
- O 1 0.6232713460922241
acetylgalactosamine O 1 0.9754094481468201
- O 1 0.9636856317520142
6 O 0 0.11904814839363098
- O 1 0.999640703201294
sulfate O 1 0.9999935626983643
sulfatase O 1 0.9999970197677612
( O 0 0.24283848702907562
GALNS O 1 0.9999240636825562
) O 0 0.0502559058368206
. O 0 0.06306436657905579

Previous O 0 0.03363429009914398
studies O 0 0.020932164043188095
of O 0 0.016251033172011375
patients O 0 0.05532525107264519
from O 0 0.008388489484786987
a O 0 0.01045896578580141
British O 0 0.01874578930437565
- O 0 0.3900771141052246
Irish O 0 0.012399441562592983
population O 0 0.006699340417981148
showed O 0 0.0072313593700528145
that O 0 0.005472131073474884
the O 0 0.009146875701844692
I113F O 1 0.9739907383918762
mutation O 0 0.01158897951245308
is O 0 0.0062816874124109745
the O 0 0.0064471070654690266
most O 0 0.006250090431421995
common O 0 0.007297466974705458
single O 0 0.01015118882060051
mutation O 0 0.012774297036230564
among O 0 0.01214241050183773
MPS B-Disease 1 0.9998272061347961
IVA I-Disease 1 1.0
patients O 1 0.9999901056289673
and O 0 0.08973994106054306
produces O 1 0.8987980484962463
a O 1 0.8911636471748352
severe O 1 0.9999998807907104
clinical O 1 0.9999990463256836
phenotype O 1 0.9999269247055054
. O 0 0.06940381228923798

We O 0 0.034449078142642975
studied O 0 0.030567485839128494
mutations O 0 0.020629102364182472
in O 0 0.011482661589980125
the O 0 0.01509113609790802
GALNS O 1 0.78509521484375
gene O 0 0.013365430757403374
from O 0 0.009033392183482647
23 O 0 0.014390123076736927
additional O 0 0.015560702420771122
MPS B-Disease 1 0.9987666606903076
IVA I-Disease 1 1.0
patients O 1 0.9996668100357056
( O 0 0.010975848883390427
15 O 0 0.010701003484427929
from O 0 0.007265614811331034
Australia O 0 0.010867832228541374
, O 0 0.007821060717105865
8 O 0 0.009274792857468128
from O 0 0.00658416748046875
Northern O 0 0.009683518670499325
Ireland O 0 0.010464275255799294
) O 0 0.006572756450623274
, O 0 0.005843253340572119
with O 0 0.005197727121412754
various O 0 0.0063029187731444836
clinical O 1 0.9997487664222717
phenotypes O 1 0.9991188645362854
( O 0 0.13344411551952362
severe O 1 0.9999414682388306
, O 0 0.012902460992336273
16 O 0 0.015539598651230335
cases O 0 0.010754208080470562
; O 0 0.009405495598912239
intermediate O 0 0.014761907048523426
, O 0 0.00962043646723032
4 O 0 0.013257166370749474
cases O 0 0.009765258058905602
; O 0 0.01150782871991396
mild O 1 0.9439553022384644
, O 0 0.016461290419101715
3 O 0 0.02543170377612114
cases O 0 0.020376622676849365
) O 0 0.02799864113330841
. O 0 0.04059765860438347

We O 0 0.024037539958953857
found O 0 0.016724515706300735
two O 0 0.012244896963238716
common O 0 0.012706414796411991
mutations O 0 0.011751021258533001
that O 0 0.007258323486894369
together O 0 0.010119534097611904
accounted O 0 0.013049186207354069
for O 0 0.008077021688222885
32 O 0 0.013597497716546059
% O 0 0.008457871153950691
of O 0 0.00859815813601017
the O 0 0.010327201336622238
44 O 0 0.020950142294168472
unrelated O 0 0.023017261177301407
alleles O 0 0.019840320572257042
in O 0 0.015474903397262096
these O 0 0.018144061788916588
patients O 1 0.9001631736755371
. O 0 0.042597681283950806

One O 0 0.03371502831578255
is O 0 0.02100067026913166
the O 0 0.021614929661154747
T312S O 1 0.5327649712562561
mutation O 0 0.026981499046087265
, O 0 0.0159288439899683
a O 0 0.016566377133131027
novel O 0 0.02397080324590206
mutation O 0 0.017773279920220375
found O 0 0.009849386289715767
exclusively O 0 0.016887815669178963
in O 0 0.019164465367794037
milder O 1 0.9992114305496216
patients O 1 0.9985488057136536
. O 0 0.05346965417265892

The O 0 0.02895679883658886
other O 0 0.012779530137777328
is O 0 0.01109290774911642
the O 0 0.01110267173498869
previously O 0 0.014087893068790436
described O 0 0.015681656077504158
I113F O 1 0.8271047472953796
that O 0 0.011400681920349598
produces O 0 0.03744135797023773
a O 0 0.18073531985282898
severe O 1 0.9999986886978149
phenotype O 1 0.999942421913147
. O 0 0.057592980563640594

The O 0 0.043946973979473114
I113F O 0 0.4067380726337433
and O 0 0.023041225969791412
T312S O 0 0.3654141128063202
mutations O 0 0.02065887302160263
accounted O 0 0.016289232298731804
for O 0 0.0090310825034976
8 O 0 0.013288035988807678
( O 0 0.009459080174565315
18 O 0 0.011751576326787472
% O 0 0.009153597988188267
) O 0 0.008062324486672878
and O 0 0.008166423067450523
6 O 0 0.012698126956820488
( O 0 0.009831824339926243
14 O 0 0.013953899964690208
% O 0 0.010777411982417107
) O 0 0.010924968868494034
of O 0 0.012800432741641998
44 O 0 0.027670251205563545
unrelated O 0 0.03073364868760109
alleles O 0 0.033992595970630646
, O 0 0.025192035362124443
respectively O 0 0.04161851108074188
. O 0 0.04870537295937538

The O 0 0.03228920325636864
relatively O 0 0.02619333192706108
high O 0 0.03196139261126518
residual O 1 0.9900510907173157
GALNS O 1 0.9999585151672363
activity O 0 0.01822604052722454
seen O 0 0.016936104744672775
when O 0 0.015293257310986519
the O 0 0.01695428602397442
T312S O 0 0.089214026927948
mutant O 0 0.03726515173912048
cDNA O 0 0.04117739573121071
is O 0 0.017367850989103317
overexpressed O 0 0.04936441034078598
in O 0 0.01456125546246767
mutant O 0 0.032415490597486496
cells O 0 0.012499883770942688
provides O 0 0.011379553936421871
an O 0 0.008144276216626167
explanation O 0 0.009801492094993591
for O 0 0.00808616541326046
the O 0 0.014032579958438873
mild O 1 0.9999850988388062
phenotype O 1 0.9990430474281311
in O 0 0.03228773549199104
patients O 1 0.9986088871955872
with O 0 0.014689954929053783
this O 0 0.01900174468755722
mutation O 0 0.03794335946440697
. O 0 0.0413474515080452

The O 0 0.03339540213346481
distribution O 0 0.019566768780350685
and O 0 0.013269534334540367
relative O 0 0.01621456816792488
frequencies O 0 0.011857270263135433
of O 0 0.010584441013634205
the O 0 0.01214049942791462
I113F O 1 0.8913499116897583
and O 0 0.014980857260525227
T312S O 1 0.7680056691169739
mutations O 0 0.014763398095965385
in O 0 0.009954786859452724
Australia O 0 0.013016054406762123
corresponded O 0 0.013532372191548347
to O 0 0.00645400071516633
those O 0 0.005357054993510246
observed O 0 0.0056943404488265514
in O 0 0.005835535936057568
Northern O 0 0.008242129348218441
Ireland O 0 0.008637666702270508
and O 0 0.005995281506329775
are O 0 0.0037248360458761454
unique O 0 0.00585756404325366
to O 0 0.004596860613673925
these O 0 0.00353803182952106
two O 0 0.004080993589013815
populations O 0 0.004968158435076475
, O 0 0.005166457034647465
suggesting O 0 0.0063648521900177
that O 0 0.004251238889992237
both O 0 0.005433922633528709
mutations O 0 0.008604839444160461
were O 0 0.005767444614320993
probably O 0 0.009139393456280231
introduced O 0 0.00919036753475666
to O 0 0.008897151798009872
Australia O 0 0.013514259830117226
by O 0 0.008647536858916283
Irish O 0 0.01728064939379692
migrants O 0 0.01573609933257103
during O 0 0.015491591766476631
the O 0 0.018402330577373505
19th O 0 0.04751092940568924
century O 0 0.054713863879442215
. O 0 0.04633742943406105

Haplotype O 0 0.07399728894233704
analysis O 0 0.02656412124633789
using O 0 0.017618052661418915
6 O 0 0.027935538440942764
RFLPs O 0 0.050629980862140656
provides O 0 0.016058942303061485
additional O 0 0.011826782487332821
data O 0 0.008069774135947227
that O 0 0.00748183811083436
the O 0 0.011706121265888214
I113F O 1 0.5777847766876221
mutation O 0 0.019054455682635307
originated O 0 0.01657198928296566
from O 0 0.011060054413974285
a O 0 0.01632029004395008
common O 0 0.021435938775539398
ancestor O 0 0.06165605038404465
. O 0 0.042522311210632324

The O 0 0.02719992585480213
other O 0 0.01413733884692192
9 O 0 0.021448887884616852
novel O 0 0.018970074132084846
mutations O 0 0.011015061289072037
identified O 0 0.007743432652205229
in O 0 0.005972836632281542
these O 0 0.00526822404935956
23 O 0 0.01428183913230896
patients O 0 0.04510671645402908
were O 0 0.005609956569969654
each O 0 0.005612202454358339
limited O 0 0.009295729920268059
to O 0 0.01072209607809782
a O 0 0.0174602922052145
single O 0 0.02628925070166588
family O 0 0.0420055165886879
. O 0 0.04318809136748314

These O 0 0.01906633749604225
data O 0 0.015372883528470993
provide O 0 0.013757903128862381
further O 0 0.011251910589635372
evidence O 0 0.00967493001371622
for O 0 0.009557854384183884
extensive O 0 0.018156614154577255
allelic O 1 0.5188563466072083
heterogeneity O 0 0.06599143892526627
in O 0 0.01482872199267149
MPS B-Disease 1 0.8204241394996643
IVA I-Disease 1 0.9999984502792358
in O 0 0.013015907257795334
British O 0 0.38922518491744995
- O 1 0.9995468258857727
Irish O 1 0.8856712579727173
patients O 1 0.9577792286872864
and O 0 0.0058708288706839085
provide O 0 0.006620731204748154
evidence O 0 0.005224081687629223
for O 0 0.004977941047400236
their O 0 0.005318846087902784
transmission O 0 0.011421832256019115
to O 0 0.007703767158091068
Australia O 0 0.012122401036322117
by O 0 0.010209000669419765
British O 0 0.02267364226281643
- O 0 0.34965744614601135
Irish O 0 0.028210656717419624
migrants O 0 0.027844073250889778
. O 0 0.026073843240737915
. O 0 0.041289858520030975

Identification O 0 0.04292094707489014
of O 0 0.02532028593122959
constitutional O 0 0.04930510371923447
WT1 O 1 0.9999943971633911
mutations O 0 0.028718486428260803
, O 0 0.014173731207847595
in O 0 0.011264410801231861
patients O 0 0.43154576420783997
with O 0 0.013769413344562054
isolated O 1 0.9960322976112366
diffuse B-Disease 1 0.9999998807907104
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 0.04704509302973747
and O 0 0.010779445059597492
analysis O 0 0.011508994735777378
of O 0 0.015789471566677094
genotype O 1 0.9997448325157166
/ O 1 0.9989564418792725
phenotype O 0 0.26488786935806274
correlations O 0 0.02048528753221035
by O 0 0.00855551939457655
use O 0 0.009265596978366375
of O 0 0.011403610929846764
a O 0 0.018290219828486443
computerized O 1 0.9185929298400879
mutation O 0 0.03934134915471077
database O 0 0.037487179040908813
. O 0 0.04221179336309433

Constitutional O 0 0.052557431161403656
mutations O 0 0.033328473567962646
of O 0 0.019212251529097557
the O 0 0.021143024787306786
WT1 O 1 0.9997913241386414
gene O 0 0.015486053191125393
, O 0 0.012026275508105755
encoding O 0 0.015080401673913002
a O 0 0.015952130779623985
zinc O 1 0.9999500513076782
- O 1 0.991124153137207
finger O 1 0.5492760539054871
transcription O 0 0.019740156829357147
factor O 0 0.015588540583848953
involved O 0 0.01106945052742958
in O 0 0.01568898931145668
renal O 1 1.0
and O 1 0.936102569103241
gonadal O 1 0.9999998807907104
development O 0 0.09682969748973846
, O 0 0.00900302454829216
are O 0 0.004754997324198484
found O 0 0.005630236119031906
in O 0 0.005530366208404303
most O 0 0.006610797252506018
patients O 0 0.02292713150382042
with O 0 0.011624394915997982
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9984194040298462
DDS B-Disease 1 1.0
) O 0 0.015026113018393517
, O 0 0.013149667531251907
or O 0 0.018641863018274307
diffuse B-Disease 1 0.9999995231628418
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 1 0.9999041557312012
DMS B-Disease 1 1.0
) O 0 0.012627259828150272
associated O 0 0.010170632041990757
with O 0 0.008725070394575596
pseudohermaphroditism B-Disease 1 0.9999926090240479
and O 0 0.39649420976638794
/ O 1 0.999996542930603
or O 1 0.9982311129570007
Wilms B-Disease 1 1.0
tumor I-Disease 1 1.0
( O 1 0.9944109320640564
WT B-Disease 1 0.9999996423721313
) O 0 0.05240177363157272
. O 0 0.061037350445985794

Most O 0 0.04537121579051018
mutations O 0 0.0431692898273468
in O 0 0.032851215451955795
DDS B-Disease 1 1.0
patients O 1 0.9983652234077454
lie O 0 0.03638092055916786
in O 0 0.019299663603305817
exon O 0 0.04998920485377312
8 O 0 0.02163979969918728
or O 0 0.013399542309343815
exon O 0 0.03128723427653313
9 O 0 0.01815997064113617
, O 0 0.01396513544023037
encoding O 0 0.021283729001879692
zinc O 1 0.9700045585632324
finger O 0 0.06076289340853691
2 O 0 0.02033037133514881
or O 0 0.015209125354886055
zinc O 1 0.9984734654426575
finger O 0 0.42855536937713623
3 O 0 0.01582958921790123
, O 0 0.010945991612970829
respectively O 0 0.0121963731944561
, O 0 0.008181538432836533
with O 0 0.0079353591427207
a O 0 0.011131913401186466
hot O 1 0.5097085237503052
spot O 0 0.13260382413864136
( O 0 0.01849343255162239
R394W O 0 0.40534350275993347
) O 0 0.02068398892879486
in O 0 0.026171866804361343
exon O 0 0.07982970774173737
9 O 0 0.06295553594827652
. O 0 0.05491425469517708

We O 0 0.02652265504002571
analyzed O 0 0.024073129519820213
a O 0 0.014159847050905228
series O 0 0.014485870487987995
of O 0 0.011296506971120834
24 O 0 0.01761685498058796
patients O 0 0.04962272197008133
, O 0 0.008374851197004318
10 O 0 0.00976466666907072
with O 0 0.01039053127169609
isolated B-Disease 0 0.4214227497577667
DMS I-Disease 1 0.9999998807907104
( O 0 0.4016965627670288
IDMS B-Disease 1 0.9999994039535522
) O 0 0.013762537389993668
, O 0 0.010649374686181545
10 O 0 0.012345713563263416
with O 0 0.011102210730314255
DDS B-Disease 1 0.9999959468841553
, O 0 0.012702221982181072
and O 0 0.010790582746267319
4 O 0 0.017746934667229652
with O 0 0.01706366427242756
urogenital B-Disease 1 0.9999998807907104
abnormalities I-Disease 1 0.9999969005584717
and O 1 0.9804491400718689
/ O 1 0.9999949932098389
or O 1 0.7043817043304443
WT B-Disease 1 0.9999971389770508
. O 0 0.06689020246267319

We O 0 0.03739979490637779
report O 0 0.037030261009931564
WT1 O 1 0.9449012875556946
heterozygous O 0 0.03919321298599243
mutations O 0 0.017741691321134567
in O 0 0.010927284136414528
16 O 0 0.019685856997966766
patients O 0 0.49112623929977417
, O 0 0.01070183701813221
4 O 0 0.013961694203317165
of O 0 0.011775879189372063
whom O 0 0.0199284590780735
presented O 0 0.03393925353884697
with O 0 0.04440732300281525
IDMS B-Disease 1 0.9999992847442627
. O 0 0.06273939460515976

One O 0 0.029487241059541702
male O 0 0.026968341320753098
and O 0 0.014863264746963978
two O 0 0.013349920511245728
female O 1 0.957882821559906
IDMS B-Disease 1 1.0
patients O 1 0.9999675750732422
with O 1 0.7083940505981445
WT1 O 1 0.9999998807907104
mutations O 1 0.9966451525688171
underwent O 1 0.9999980926513672
normal O 0 0.4142841398715973
puberty O 1 0.9894689321517944
. O 0 0.059970419853925705

Two O 0 0.028075307607650757
mutations O 0 0.02632822096347809
associated O 0 0.01709175854921341
with O 0 0.016884665936231613
IDMS B-Disease 1 0.9999929666519165
are O 0 0.007344744633883238
different O 0 0.006087568122893572
from O 0 0.007161741144955158
those O 0 0.008693289011716843
described O 0 0.017668532207608223
in O 0 0.09346818178892136
DDS B-Disease 1 1.0
patients O 1 0.9999818801879883
. O 0 0.05939484387636185

No O 0 0.05029802769422531
WT1 O 1 0.9995520710945129
mutations O 0 0.027862340211868286
were O 0 0.011985637247562408
detected O 0 0.012901796959340572
in O 0 0.006951904855668545
the O 0 0.007406760938465595
six O 0 0.010244200937449932
other O 0 0.011027057655155659
IDMS B-Disease 1 1.0
patients O 1 0.9997809529304504
, O 0 0.011513977311551571
suggesting O 0 0.014949955977499485
genetic O 0 0.01623188704252243
heterogeneity O 0 0.4893282651901245
of O 0 0.0938357263803482
this O 0 0.17984363436698914
disease O 1 0.9999983310699463
. O 0 0.04731510207056999

We O 0 0.03514290228486061
analyzed O 0 0.04747458174824715
genotype O 1 0.9212854504585266
/ O 1 0.9981885552406311
phenotype O 1 0.8341551423072815
correlations O 0 0.02351655811071396
, O 0 0.01079331524670124
on O 0 0.009202089160680771
the O 0 0.008209079504013062
basis O 0 0.0069010304287076
of O 0 0.007499711588025093
the O 0 0.00887564942240715
constitution O 0 0.012829340063035488
of O 0 0.011082147248089314
a O 0 0.01701933890581131
WT1 O 1 0.9958252906799316
mutation O 0 0.015362427569925785
database O 0 0.013594658114016056
of O 0 0.011187436990439892
84 O 0 0.3892943263053894
germ O 1 0.9999886751174927
- O 1 0.9943796992301941
line O 0 0.021172573789954185
mutations O 0 0.01196746714413166
, O 0 0.006678386125713587
to O 0 0.006450940854847431
compare O 0 0.010182173922657967
the O 0 0.007026565261185169
distribution O 0 0.007930719293653965
and O 0 0.007269257679581642
type O 0 0.010829400271177292
of O 0 0.008557169698178768
mutations O 0 0.010279806330800056
, O 0 0.007729760836809874
according O 0 0.007293857634067535
to O 0 0.009850284084677696
the O 0 0.014134880155324936
different O 0 0.01634185202419758
symptoms O 1 0.9980389475822449
. O 0 0.040482521057128906

This O 0 0.025297289714217186
demonstrated O 0 0.030054667964577675
( O 0 0.018285604193806648
1 O 0 0.01787685416638851
) O 0 0.011593187227845192
the O 0 0.011495879851281643
association O 0 0.015088081359863281
between O 0 0.01015545055270195
mutations O 0 0.01044868491590023
in O 0 0.008547093719244003
exons O 0 0.017213689163327217
8 O 0 0.013267050497233868
and O 0 0.009288882836699486
9 O 0 0.01570247672498226
and O 0 0.012478072196245193
DMS B-Disease 1 0.9999779462814331
; O 0 0.011465109884738922
( O 0 0.010434947907924652
2 O 0 0.013472977094352245
) O 0 0.010691219940781593
among O 0 0.012311710976064205
patients O 0 0.31064411997795105
with O 0 0.014197337441146374
DMS B-Disease 1 0.9999982118606567
, O 0 0.010935553349554539
a O 0 0.0106736421585083
higher O 0 0.011302878148853779
frequency O 0 0.010868765413761139
of O 0 0.010295100510120392
exon O 0 0.03210078179836273
8 O 0 0.017066843807697296
mutations O 0 0.013985985890030861
among O 0 0.010850971564650536
46 O 0 0.02179870754480362
, O 0 0.017948634922504425
XY O 1 0.999915361404419
patients O 1 0.8057335615158081
with O 0 0.010870366357266903
female O 0 0.018440986052155495
phenotype O 0 0.026322945952415466
than O 0 0.006864580791443586
among O 0 0.009168500080704689
46 O 0 0.021360548213124275
, O 0 0.02067193016409874
XY O 1 0.9999836683273315
patients O 1 0.5625833868980408
with O 0 0.00930468924343586
sexual O 0 0.013280116021633148
ambiguity O 0 0.020969446748495102
or O 0 0.011856678873300552
male O 0 0.4217912256717682
phenotype O 1 0.9945313930511475
; O 0 0.009216703474521637
and O 0 0.008398892357945442
( O 0 0.009770958684384823
3 O 0 0.011751675978302956
) O 0 0.009505347348749638
statistically O 0 0.01172818522900343
significant O 0 0.007924262434244156
evidence O 0 0.006952839903533459
that O 0 0.005296988412737846
mutations O 0 0.007723882328718901
in O 0 0.006569842342287302
exons O 0 0.01616067998111248
8 O 0 0.012373151257634163
and O 0 0.009214609861373901
9 O 0 0.015542153269052505
preferentially O 0 0.02264578454196453
affect O 0 0.014179603196680546
amino O 0 0.014313342981040478
acids O 0 0.012730089016258717
with O 0 0.009644853882491589
different O 0 0.01018057856708765
functions O 0 0.017551448196172714
. O 0 0.02321099489927292
. O 0 0.035786040127277374

The O 0 0.05789113789796829
185delAG O 1 0.9993065595626831
BRCA1 O 1 0.9993855953216553
mutation O 0 0.030490199103951454
originated O 0 0.02291439101099968
before O 0 0.01279942225664854
the O 0 0.011810870841145515
dispersion O 0 0.01704130880534649
of O 0 0.009793240576982498
Jews O 0 0.01056099683046341
in O 0 0.007241444196552038
the O 0 0.009095903486013412
diaspora O 0 0.018818480893969536
and O 0 0.009608432650566101
is O 0 0.009092457592487335
not O 0 0.009747338481247425
limited O 0 0.016520436853170395
to O 0 0.02638760581612587
Ashkenazim O 0 0.29943016171455383
. O 0 0.04792073369026184

The O 0 0.05445374175906181
185delAG O 1 0.5292271971702576
mutation O 0 0.04049196466803551
in O 0 0.02167407236993313
BRCA1 O 1 0.9942759871482849
is O 0 0.013161515817046165
detected O 0 0.013517694547772408
in O 0 0.009794678539037704
Ashkenazi O 0 0.028078647330403328
Jews O 0 0.010458382777869701
both O 0 0.007306294050067663
in O 0 0.010143550112843513
familial B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.7158867716789246
in O 0 0.013065632432699203
the O 0 0.016582708805799484
general O 0 0.028317943215370178
population O 0 0.022259704768657684
. O 0 0.04392830282449722

All O 0 0.03365495428442955
tested O 0 0.05169123411178589
Ashkenazi O 1 0.6519534587860107
mutation O 0 0.0305817611515522
carriers O 0 0.025980621576309204
share O 0 0.015831170603632927
the O 0 0.012867683544754982
same O 0 0.013164762407541275
allelic O 0 0.3128967881202698
pattern O 0 0.024524414911866188
at O 0 0.024877943098545074
the O 0 0.03202570602297783
BRCA1 O 1 0.9993589520454407
locus O 1 0.9216426610946655
. O 0 0.06552639603614807

Our O 0 0.02927052043378353
previous O 0 0.016834745183587074
study O 0 0.01342927198857069
showed O 0 0.011465882882475853
that O 0 0.005691827274858952
this O 0 0.006940432358533144
Ashkenazi O 1 0.8673506379127502
mutation O 0 0.014034380204975605
also O 0 0.008966328576207161
occurs O 0 0.008152889087796211
in O 0 0.007485630922019482
Iraqi O 0 0.012172858230769634
Jews O 0 0.01177037414163351
with O 0 0.010426591150462627
a O 0 0.01771945133805275
similar O 0 0.021817229688167572
allelic O 1 0.984743595123291
pattern O 0 0.056306105107069016
. O 0 0.046262502670288086

We O 0 0.027694661170244217
extended O 0 0.02504551038146019
our O 0 0.016026483848690987
analysis O 0 0.011917767114937305
to O 0 0.010362537577748299
other O 0 0.009813387878239155
non O 0 0.019147854298353195
- O 0 0.45139577984809875
Ashkenazi O 0 0.058040373027324677
subsets O 0 0.03456060588359833
354 O 0 0.04247865825891495
of O 0 0.017031827941536903
Moroccan O 0 0.03293350338935852
origin O 0 0.01571997068822384
, O 0 0.015789689496159554
200 O 0 0.0312165729701519
Yemenites O 0 0.37529322504997253
and O 0 0.022498873993754387
150 O 0 0.03855593875050545
Iranian O 0 0.05250226706266403
Jews O 0 0.05107640102505684
. O 0 0.05816603824496269

Heteroduplex O 0 0.4754260778427124
analysis O 0 0.04086686670780182
complemented O 0 0.04688065126538277
by O 0 0.016680127009749413
direct O 0 0.018232600763440132
DNA O 0 0.020878033712506294
sequencing O 0 0.023974023759365082
of O 0 0.021103115752339363
abnormally O 0 0.43621525168418884
migrating O 0 0.03620041161775589
bands O 0 0.03517746552824974
were O 0 0.024632388725876808
employed O 0 0.042905572801828384
. O 0 0.045587923377752304

Four O 0 0.027703652158379555
of O 0 0.02069922350347042
Moroccan O 0 0.030456343665719032
origin O 0 0.01218332163989544
( O 0 0.011449879966676235
1 O 0 0.01245865598320961
. O 0 0.008200853131711483
1 O 0 0.011576095595955849
% O 0 0.00864641647785902
) O 0 0.007272713351994753
and O 0 0.00754996994510293
none O 0 0.009452384896576405
of O 0 0.008930869400501251
the O 0 0.01312964502722025
Yemenites O 1 0.9967733025550842
or O 0 0.010722444392740726
Iranians O 0 0.018253915011882782
was O 0 0.015971843153238297
a O 0 0.015485979616641998
carrier O 0 0.04418666660785675
of O 0 0.01906818524003029
the O 0 0.026631472632288933
185delAG O 1 0.9976046085357666
mutation O 0 0.0596340075135231
. O 0 0.05499995872378349

BRCA1 O 1 0.9994107484817505
allelic O 1 0.5499292612075806
patterns O 0 0.020835723727941513
were O 0 0.010199450887739658
determined O 0 0.009588816203176975
for O 0 0.006913627032190561
four O 0 0.006798452232033014
of O 0 0.006315507926046848
these O 0 0.00409136526286602
individuals O 0 0.004414713010191917
and O 0 0.004633937031030655
for O 0 0.005220091436058283
12 O 0 0.009151124395430088
additional O 0 0.009741631336510181
non O 0 0.016101082786917686
- O 1 0.6021251678466797
Ashkenazi O 0 0.3215372562408447
185delAG O 1 0.7780367136001587
mutation O 0 0.020255455747246742
carriers O 0 0.024038972333073616
who O 0 0.02958567813038826
had O 1 0.9993440508842468
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.751924991607666

Six O 0 0.04218025133013725
non O 0 0.04142533615231514
- O 1 0.7091124653816223
Ashkenazi O 0 0.08302362263202667
individuals O 0 0.010240629315376282
shared O 0 0.013107743114233017
the O 0 0.010111726820468903
common O 0 0.01287604495882988
Ashkenazi O 1 0.9883484840393066
haplotype O 0 0.4954647719860077
, O 0 0.008171288296580315
four O 0 0.007174786180257797
had O 0 0.007174951955676079
a O 0 0.007070570718497038
closely O 0 0.007999474182724953
related O 0 0.007534261327236891
pattern O 0 0.008157456293702126
, O 0 0.0057249488309025764
and O 0 0.0053724003955721855
the O 0 0.00657077319920063
rest O 0 0.010779887437820435
( O 0 0.011586620472371578
n O 0 0.0179610438644886
= O 0 0.02252553217113018
6 O 0 0.01892710290849209
) O 0 0.013310673646628857
displayed O 0 0.02178684063255787
a O 0 0.02017299272119999
distinct O 0 0.029896743595600128
BRCA1 O 1 0.9994020462036133
allelic O 1 0.9883261322975159
pattern O 0 0.07633774727582932
. O 0 0.05295355245471001

We O 0 0.024314187467098236
conclude O 0 0.025793345645070076
that O 0 0.01064294669777155
the O 0 0.016291838139295578
185delAG O 1 0.9999629259109497
BRCA1 O 1 0.9999926090240479
mutation O 0 0.024063963443040848
occurs O 0 0.011860830709338188
in O 0 0.007798484060913324
some O 0 0.008244854398071766
non O 0 0.016362430527806282
- O 1 0.6845971941947937
Ashkenazi O 0 0.05333387479186058
populations O 0 0.010492615401744843
at O 0 0.012047726660966873
rates O 0 0.011088191531598568
comparable O 0 0.014196082018315792
with O 0 0.00918358750641346
that O 0 0.010489067062735558
of O 0 0.02117729000747204
Ashkenazim O 1 0.9678407907485962
. O 0 0.04573371633887291

The O 0 0.0313514843583107
majority O 0 0.02068036049604416
of O 0 0.01702149398624897
Jewish O 0 0.02947869896888733
185delAG O 1 0.9992747902870178
mutation O 0 0.04885932058095932
carriers O 0 0.022016970440745354
have O 0 0.0070328619331121445
a O 0 0.010612753219902515
common O 0 0.010870595462620258
allelic O 1 0.7762415409088135
pattern O 0 0.015061774291098118
, O 0 0.009949468076229095
supporting O 0 0.012213533744215965
the O 0 0.011348037049174309
founder O 1 0.9642485976219177
effect O 0 0.011253810487687588
notion O 0 0.013552634045481682
, O 0 0.008821850642561913
but O 0 0.007169615011662245
dating O 0 0.011734852567315102
the O 0 0.009475083090364933
mutations O 0 0.009340011514723301
origin O 0 0.006864996161311865
to O 0 0.006994711235165596
an O 0 0.00786540936678648
earlier O 0 0.01178285013884306
date O 0 0.01443981472402811
than O 0 0.011987041682004929
currently O 0 0.022663284093141556
estimated O 0 0.030783168971538544
. O 0 0.03983289748430252

However O 0 0.026326008141040802
, O 0 0.0158529169857502
the O 0 0.01191423088312149
different O 0 0.008905557915568352
allelic O 0 0.03141967952251434
pattern O 0 0.015890097245573997
at O 0 0.013272382318973541
the O 0 0.014487053267657757
BRCA1 O 1 0.9992161989212036
locus O 0 0.06489982455968857
even O 0 0.00801978912204504
in O 0 0.005986339412629604
some O 0 0.006068280432373285
Jewish O 0 0.012075978331267834
mutation O 0 0.01852186769247055
carriers O 0 0.07473384588956833
, O 0 0.008717695251107216
might O 0 0.00915441196411848
suggest O 0 0.007806325331330299
that O 0 0.006459580268710852
the O 0 0.011235732585191727
mutation O 0 0.016933802515268326
arose O 0 0.02032335102558136
independently O 0 0.020318694412708282
. O 0 0.02092125080525875
. O 0 0.0403473787009716

Crystal O 0 0.07246937602758408
structure O 0 0.02872137539088726
of O 0 0.019572481513023376
the O 0 0.26353397965431213
hemochromatosis B-Disease 1 1.0
protein O 1 0.9337484240531921
HFE O 1 0.9999864101409912
and O 0 0.018372371792793274
characterization O 0 0.026117095723748207
of O 0 0.014192546717822552
its O 0 0.014490771107375622
interaction O 0 0.020823946222662926
with O 0 0.02209705486893654
transferrin O 1 0.9999023675918579
receptor O 0 0.15891145169734955
. O 0 0.053466808050870895

HFE O 1 0.9922531247138977
is O 0 0.028408490121364594
an O 0 0.027861449867486954
MHC O 1 0.9999922513961792
- O 1 0.9775233864784241
related O 0 0.02106529474258423
protein O 0 0.013537847436964512
that O 0 0.00749219162389636
is O 0 0.007717343047261238
mutated O 0 0.013821123167872429
in O 0 0.008574027568101883
the O 0 0.020969703793525696
iron B-Disease 1 1.0
- I-Disease 1 1.0
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.9993622899055481

HFE O 1 0.9967945218086243
binds O 0 0.07571614533662796
to O 0 0.03441643342375755
transferrin O 1 0.9904879927635193
receptor O 0 0.11596035212278366
( O 0 0.027934227138757706
TfR O 1 0.9995095729827881
) O 0 0.01638471893966198
and O 0 0.013254603371024132
reduces O 0 0.018512466922402382
its O 0 0.012269426137208939
affinity O 0 0.019237125292420387
for O 0 0.015907159075140953
iron O 1 0.9990177154541016
- O 1 0.9319858551025391
loaded O 0 0.06679202616214752
transferrin O 1 0.9844686388969421
, O 0 0.03303680196404457
implicating O 1 0.9988780617713928
HFE O 1 0.9999970197677612
in O 0 0.17692247033119202
iron O 1 0.9999932050704956
metabolism O 1 0.9931129813194275
. O 0 0.058163102716207504

The O 0 0.0756487175822258
2 O 0 0.09278887510299683
. O 0 0.07635613530874252

6 O 0 0.05367917940020561
A O 0 0.03606923297047615
crystal O 0 0.05231155827641487
structure O 0 0.025011098012328148
of O 0 0.020454682409763336
HFE O 1 0.9994617104530334
reveals O 0 0.03164055570960045
the O 0 0.012561381794512272
locations O 0 0.014796656556427479
of O 0 0.015426680445671082
hemochromatosis B-Disease 1 1.0
mutations O 0 0.01938105933368206
and O 0 0.00879946444183588
a O 0 0.014663559384644032
patch O 1 0.9999773502349854
of O 0 0.03563273325562477
histidines O 1 0.9997441172599792
that O 0 0.006456722505390644
could O 0 0.006451005581766367
be O 0 0.006055865436792374
involved O 0 0.008399655111134052
in O 0 0.011352740228176117
pH O 1 0.9970535039901733
- O 1 0.9339035153388977
dependent O 0 0.035786792635917664
interactions O 0 0.03572127968072891
. O 0 0.0424005351960659

We O 0 0.022898277267813683
also O 0 0.015183992683887482
demonstrate O 0 0.018590813502669334
that O 0 0.012725883163511753
soluble O 1 0.9975245594978333
TfR O 1 0.9999786615371704
and O 0 0.042840439826250076
HFE O 1 0.9999942779541016
bind O 0 0.035511817783117294
tightly O 0 0.02443305402994156
at O 0 0.013423530384898186
the O 0 0.010878571309149265
basic O 0 0.015304177068173885
pH O 0 0.02552291378378868
of O 0 0.00995277613401413
the O 0 0.011466369964182377
cell O 0 0.059374403208494186
surface O 0 0.012994459830224514
, O 0 0.00824068859219551
but O 0 0.00608800956979394
not O 0 0.006248763762414455
at O 0 0.011234529316425323
the O 0 0.014863175339996815
acidic O 1 0.9481378793716431
pH O 1 0.9556204080581665
of O 0 0.03792070224881172
intracellular O 1 0.9837149977684021
vesicles O 1 0.8737699389457703
. O 0 0.06914812326431274

TfR O 1 0.9998501539230347
HFE O 1 0.9998819828033447
stoichiometry O 0 0.38386720418930054
( O 0 0.03062145784497261
2 O 0 0.028837036341428757
1 O 0 0.02293526940047741
) O 0 0.015124412253499031
differs O 0 0.021775370463728905
from O 0 0.017134465277194977
TfR O 1 0.9914224743843079
transferrin O 1 0.991201639175415
stoichiometry O 0 0.09398356825113297
( O 0 0.018168967217206955
2 O 0 0.01959923654794693
2 O 0 0.018382521346211433
) O 0 0.011862238869071007
, O 0 0.012208724394440651
implying O 0 0.01547876838594675
a O 0 0.00898295734077692
different O 0 0.005985025782138109
mode O 0 0.013233651407063007
of O 0 0.009023911319673061
binding O 0 0.012467811815440655
for O 0 0.012310517020523548
HFE O 1 0.9999032020568848
and O 0 0.017715392634272575
transferrin O 1 0.9929799437522888
to O 0 0.018218033015727997
TfR O 1 0.9952749013900757
, O 0 0.014198685064911842
consistent O 0 0.013219598680734634
with O 0 0.008683797903358936
our O 0 0.012060868553817272
demonstration O 0 0.02078160271048546
that O 0 0.012274668551981449
HFE O 1 0.9999758005142212
, O 0 0.0240810364484787
transferrin O 1 0.9992408752441406
, O 0 0.01902851089835167
and O 0 0.01845329813659191
TfR O 1 0.9972062706947327
form O 0 0.021068083122372627
a O 0 0.02959166094660759
ternary O 1 0.6959857940673828
complex O 0 0.06382707506418228
. O 0 0.05625424534082413

Identification O 0 0.035334356129169464
of O 0 0.019350584596395493
three O 0 0.013573107309639454
novel O 0 0.019895968958735466
mutations O 0 0.011866102926433086
and O 0 0.006763473153114319
a O 0 0.0075704059563577175
high O 0 0.009398923255503178
frequency O 0 0.008196420967578888
of O 0 0.008157706819474697
the O 0 0.010711802169680595
Arg778Leu O 1 0.9776694178581238
mutation O 0 0.015002680011093616
in O 0 0.01120936032384634
Korean O 1 0.998106837272644
patients O 1 0.9999176263809204
with O 1 0.7294195890426636
Wilson B-Disease 1 0.9999927282333374
disease I-Disease 1 0.9999997615814209
. O 0 0.05329637974500656

Four O 0 0.04338257759809494
mutations O 0 0.04446540027856827
- O 1 0.7712525129318237
- O 1 0.9171323776245117
R778L O 1 0.9199085831642151
, O 0 0.02022172138094902
A874V O 0 0.09208235889673233
, O 0 0.016935907304286957
L1083F O 0 0.040990956127643585
, O 0 0.013424325734376907
and O 0 0.012568037025630474
2304delC O 1 0.9674457311630249
- O 1 0.6293045282363892
- O 0 0.02443338744342327
in O 0 0.009228629991412163
the O 0 0.012009681202471256
copper O 1 0.9251418113708496
- O 0 0.17846764624118805
transporting O 0 0.02462816797196865
enzyme O 0 0.01769191026687622
, O 0 0.013928832486271858
P O 0 0.18521416187286377
- O 1 0.7088447213172913
type O 0 0.19342727959156036
ATPase O 1 0.9978376030921936
( O 0 0.019755644723773003
ATP7B O 1 0.9965806603431702
) O 0 0.012598520144820213
, O 0 0.010200008749961853
were O 0 0.0072197988629341125
identified O 0 0.008650700561702251
in O 0 0.010057575069367886
Korean O 1 0.9868735671043396
Patients O 1 0.999822199344635
with O 0 0.4228774607181549
Wilson B-Disease 1 0.9999899864196777
disease I-Disease 1 0.9999997615814209
. O 0 0.05921195074915886

Arg778Leu O 1 0.9558737874031067
, O 0 0.02382059022784233
the O 0 0.014265201985836029
most O 0 0.01125927735120058
frequently O 0 0.011683623306453228
reported O 0 0.010518956929445267
mutation O 0 0.010081188753247261
of O 0 0.006486351601779461
this O 0 0.006045897491276264
enzyme O 0 0.011311844922602177
, O 0 0.00753144221380353
was O 0 0.007884103804826736
found O 0 0.005808377638459206
in O 0 0.005155847407877445
six O 0 0.005404546391218901
of O 0 0.0062555777840316296
eight O 0 0.010358629748225212
unrelated O 0 0.04278034716844559
patients O 1 0.7675832509994507
studied O 0 0.014047397300601006
, O 0 0.009776441380381584
an O 0 0.010908668860793114
allele O 0 0.02315853349864483
frequency O 0 0.019176337867975235
of O 0 0.022722488269209862
37 O 0 0.04945109039545059
. O 0 0.046680107712745667

5 O 0 0.04045344889163971
% O 0 0.022548167034983635
, O 0 0.015152636915445328
which O 0 0.009242836385965347
is O 0 0.008927435614168644
considerably O 0 0.013410805724561214
higher O 0 0.010279598645865917
than O 0 0.008243388496339321
those O 0 0.007688702549785376
in O 0 0.010927527211606503
other O 0 0.013439527712762356
Asian O 0 0.03249945491552353
populations O 0 0.02932569943368435
. O 0 0.04241682216525078

The O 0 0.04424479976296425
novel O 0 0.04289986938238144
single O 0 0.027795137837529182
nucleotide O 0 0.03380296751856804
deletion O 0 0.03603965416550636
, O 0 0.01909928023815155
2304delC O 1 0.89463210105896
, O 0 0.015055888332426548
was O 0 0.015206733718514442
found O 0 0.010868960991501808
in O 0 0.01122995838522911
one O 0 0.019627101719379425
patient O 1 0.9527094960212708
. O 0 0.040084440261125565

Since O 0 0.03500373661518097
a O 0 0.027569087222218513
mutation O 0 0.026111682876944542
at O 0 0.019343040883541107
cDNA O 0 0.04121018201112747
nucleotide O 0 0.03205481544137001
2302 O 1 0.9955236911773682
( O 0 0.020838623866438866
2302insC O 0 0.4030844569206238
) O 0 0.011382654309272766
had O 0 0.010442759841680527
been O 0 0.007367576006799936
previously O 0 0.009350817650556564
described O 0 0.008544282987713814
, O 0 0.005706878378987312
this O 0 0.004805086646229029
region O 0 0.007090336177498102
of O 0 0.00678001856431365
the O 0 0.01053447276353836
ATP7B O 1 0.9999911785125732
gene O 0 0.012315064668655396
may O 0 0.008625352755188942
be O 0 0.008291912265121937
susceptible O 0 0.01884545013308525
to O 0 0.011200832203030586
gene O 0 0.02369246445596218
rearrangements O 1 0.9918866753578186
causing O 1 0.9998083710670471
Wilson B-Disease 1 0.9999889135360718
disease I-Disease 1 0.9999994039535522
. O 0 0.06023793667554855

Disruption O 0 0.0800178050994873
of O 0 0.03029301017522812
splicing O 0 0.03444094955921173
regulated O 0 0.020512405782938004
by O 0 0.011937344446778297
a O 0 0.02084183506667614
CUG O 1 0.9997808337211609
- O 1 0.8098598718643188
binding O 0 0.0248396173119545
protein O 0 0.030552657321095467
in O 0 0.048579901456832886
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.4057585299015045

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999980926513672
DM B-Disease 1 1.0
) O 0 0.11795607954263687
is O 0 0.016158632934093475
caused O 0 0.02235240861773491
by O 0 0.01038123294711113
a O 0 0.016660531982779503
CTG O 1 0.9996942281723022
expansion O 0 0.021993214264512062
in O 0 0.01217297837138176
the O 0 0.012082709930837154
3 O 0 0.018587401136755943
untranslated O 0 0.044193290174007416
region O 0 0.01859913021326065
of O 0 0.017839444801211357
the O 0 0.38705864548683167
DM B-Disease 1 1.0
gene O 0 0.24936413764953613
. O 0 0.05361166223883629

One O 0 0.03624033182859421
model O 0 0.03739846870303154
of O 0 0.23444543778896332
DM B-Disease 1 1.0
pathogenesis O 1 0.9999998807907104
suggests O 0 0.054532356560230255
that O 0 0.012979687191545963
RNAs O 0 0.03222505748271942
from O 0 0.010453211143612862
the O 0 0.01039817277342081
expanded O 0 0.017993217334151268
allele O 0 0.018557976931333542
create O 0 0.010848652571439743
a O 0 0.010103384032845497
gain O 0 0.013316962867975235
- O 0 0.02894836664199829
of O 0 0.011820532381534576
- O 1 0.6779168248176575
function O 0 0.009741120971739292
mutation O 0 0.010151635855436325
by O 0 0.006068708840757608
the O 0 0.008315648883581161
inappropriate O 0 0.014516672119498253
binding O 0 0.012282834388315678
of O 0 0.010510988533496857
proteins O 0 0.011998132802546024
to O 0 0.01404501497745514
the O 0 0.024219250306487083
CUG O 1 0.9983672499656677
repeats O 0 0.07948535680770874
. O 0 0.06452207267284393

Data O 0 0.032092925161123276
presented O 0 0.028904937207698822
here O 0 0.01689102128148079
indicate O 0 0.014240479096770287
that O 0 0.009175260551273823
the O 0 0.01383837591856718
conserved O 0 0.022696154192090034
heterogeneous O 0 0.032465286552906036
nuclear O 0 0.028905071318149567
ribonucleoprotein O 1 0.9988945126533508
, O 0 0.02231593243777752
CUG O 1 0.9983863830566406
- O 0 0.05055878311395645
binding O 0 0.018410546705126762
protein O 0 0.015001938678324223
( O 0 0.016575757414102554
CUG O 1 0.998508870601654
- O 1 0.9340874552726746
BP O 0 0.39672380685806274
) O 0 0.014074936509132385
, O 0 0.01078981813043356
may O 0 0.009198143146932125
mediate O 0 0.019821498543024063
the O 0 0.013228435069322586
trans O 1 0.6370880007743835
- O 1 0.8514161109924316
dominant O 0 0.025435935705900192
effect O 0 0.015226919203996658
of O 0 0.01496731024235487
the O 0 0.02340342104434967
RNA O 0 0.05179725959897041
. O 0 0.044679898768663406

CUG O 1 0.9997327923774719
- O 1 0.993948221206665
BP O 1 0.6835049390792847
was O 0 0.01953480765223503
found O 0 0.010363294743001461
to O 0 0.008018090389668941
bind O 0 0.011493458412587643
to O 0 0.007974655367434025
the O 0 0.009500240907073021
human O 0 0.05443582683801651
cardiac O 1 1.0
troponin O 1 1.0
T O 1 0.9999982118606567
( O 0 0.026956943795084953
cTNT O 1 0.8250746130943298
) O 0 0.02002020739018917
pre O 0 0.05510268360376358
- O 0 0.444501131772995
messenger O 0 0.05806061998009682
RNA O 0 0.028621232137084007
and O 0 0.016937794163823128
regulate O 0 0.026436524465680122
its O 0 0.02274421602487564
alternative O 0 0.04421451315283775
splicing O 0 0.06734728068113327
. O 0 0.05578988790512085

Splicing O 0 0.05994395911693573
of O 0 0.027159081771969795
cTNT O 0 0.4748521149158478
was O 0 0.03013080358505249
disrupted O 0 0.42991042137145996
in O 0 0.43081656098365784
DM B-Disease 1 1.0
striated O 1 1.0
muscle O 1 0.9999730587005615
and O 0 0.016299566254019737
in O 0 0.012640739791095257
normal O 0 0.01658017188310623
cells O 0 0.01623193360865116
expressing O 0 0.02155776135623455
transcripts O 0 0.027796167880296707
that O 0 0.017213616520166397
contain O 0 0.035809531807899475
CUG O 1 0.9973256587982178
repeats O 0 0.08603660762310028
. O 0 0.0589740164577961

Altered O 0 0.05572648346424103
expression O 0 0.030940555036067963
of O 0 0.01928948052227497
genes O 0 0.017560867592692375
regulated O 0 0.021698586642742157
posttranscriptionally O 0 0.3590344190597534
by O 0 0.016316263005137444
CUG O 1 0.9999951124191284
- O 1 0.999241828918457
BP O 1 0.8454791307449341
therefore O 0 0.018582826480269432
may O 0 0.01507712434977293
contribute O 0 0.02696620114147663
to O 0 0.03384512662887573
DM B-Disease 1 1.0
pathogenesis O 1 0.9999995231628418
. O 0 0.045851439237594604
. O 0 0.05744116008281708

Identification O 0 0.04230919107794762
of O 0 0.022370869293808937
a O 0 0.020893441513180733
novel O 0 0.03888960927724838
nonsense O 0 0.17960305511951447
mutation O 0 0.023165076971054077
and O 0 0.012239430099725723
a O 0 0.014698481187224388
missense O 0 0.0277668759226799
substitution O 0 0.01825978048145771
in O 0 0.011848592199385166
the O 0 0.014948301017284393
vasopressin O 1 0.7391061782836914
- O 1 0.9986931681632996
neurophysin O 1 0.9997647404670715
II O 1 0.9998793601989746
gene O 0 0.014421016909182072
in O 0 0.010377652943134308
two O 0 0.009748497977852821
Spanish O 0 0.02224452793598175
kindreds O 0 0.36154255270957947
with O 0 0.03686653450131416
familial B-Disease 1 0.9999998807907104
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
. O 1 0.5023386478424072

Familial B-Disease 1 0.9999982118606567
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 1 0.9985163807868958
FNDI B-Disease 1 0.9999998807907104
) O 0 0.016777968034148216
is O 0 0.011398070491850376
an O 0 0.01624256558716297
autosomal B-Disease 1 0.9999984502792358
dominant I-Disease 1 0.9999995231628418
disease I-Disease 1 1.0
caused O 1 0.9999995231628418
by O 1 0.99649977684021
deficiency O 1 1.0
in O 0 0.1971382349729538
the O 1 0.7189027070999146
antidiuretic O 1 0.9999958276748657
hormone O 1 0.9989295601844788
arginine O 1 0.7926950454711914
vasopressin O 1 0.9894341826438904
( O 0 0.030442913994193077
AVP O 1 0.9965369701385498
) O 0 0.015475659631192684
encoded O 0 0.013813580386340618
by O 0 0.010088077746331692
the O 0 0.016103273257613182
AVP O 1 0.9998325109481812
- O 1 0.9906366467475891
neurophysin O 1 0.999697208404541
II O 1 0.9999934434890747
( O 0 0.07894863188266754
AVP O 1 0.9999979734420776
- O 1 0.9998205304145813
NPII O 1 0.999854326248169
) O 0 0.02496444061398506
gene O 0 0.027432506904006004
on O 0 0.029944121837615967
chromosome O 0 0.05871677026152611
20p13 O 1 0.5220170021057129
. O 0 0.057809602469205856

In O 0 0.02304041013121605
this O 0 0.011967838741838932
study O 0 0.012456104159355164
, O 0 0.008435370400547981
we O 0 0.006785118952393532
analyzed O 0 0.009487529285252094
two O 0 0.005960362032055855
families O 0 0.007901428267359734
with O 0 0.009162991307675838
FNDI B-Disease 1 0.9941436648368835
using O 0 0.01082098949700594
direct O 0 0.013880281709134579
automated O 0 0.026638556271791458
fluorescent O 0 0.03971334546804428
, O 0 0.012015906162559986
solid O 0 0.01975662261247635
phase O 0 0.022250456735491753
, O 0 0.015123218297958374
single O 0 0.018275978043675423
- O 0 0.028752289712429047
stranded O 0 0.028196360915899277
DNA O 0 0.02093328721821308
sequencing O 0 0.02382684126496315
of O 0 0.019586358219385147
PCR O 0 0.06009146198630333
- O 0 0.31132814288139343
amplified O 0 0.26628977060317993
AVP O 1 0.9999504089355469
- O 1 0.9945000410079956
NPII O 1 0.9989198446273804
DNA O 0 0.0735035315155983
. O 0 0.057115502655506134

In O 0 0.021926626563072205
one O 0 0.01276388019323349
of O 0 0.010892624966800213
the O 0 0.010721751488745213
families O 0 0.012313161045312881
, O 0 0.011504937894642353
affected O 0 0.011910710483789444
individuals O 0 0.008215161971747875
presented O 0 0.015228914096951485
a O 0 0.014754869975149632
novel O 0 0.023901712149381638
nonsense O 0 0.028718501329421997
mutation O 0 0.014765278436243534
in O 0 0.008819996379315853
exon O 0 0.02423771284520626
3 O 0 0.012257395312190056
of O 0 0.009034483693540096
the O 0 0.010779663920402527
gene O 0 0.009805979207158089
, O 0 0.008553910069167614
consisting O 0 0.010280117392539978
in O 0 0.0073110791854560375
a O 0 0.012330849654972553
G O 0 0.04694078490138054
to O 0 0.013964058831334114
T O 0 0.1301949918270111
transition O 0 0.020504148676991463
at O 0 0.01770106889307499
nucleotide O 0 0.026905696839094162
2101 O 1 0.9580979943275452
, O 0 0.012930377386510372
which O 0 0.009162100031971931
produces O 0 0.013523711822926998
a O 0 0.011259117163717747
stop O 0 0.014377261511981487
signal O 0 0.015390373766422272
in O 0 0.012265445664525032
codon O 0 0.02982468530535698
82 O 0 0.04740224406123161
( O 0 0.029552049934864044
Glu O 1 0.9998674392700195
) O 0 0.03244907036423683
of O 0 0.04470144957304001
NPII O 1 0.9951111674308777
. O 0 0.0591469332575798

The O 0 0.04876955971121788
premature O 1 0.8839237689971924
termination O 1 0.7058374881744385
eliminates O 0 0.062367890030145645
part O 0 0.016096459701657295
of O 0 0.01187172718346119
the O 0 0.014122527092695236
C O 1 0.9856336712837219
- O 1 0.9052550792694092
terminal O 0 0.06861787289381027
domain O 0 0.017299089580774307
of O 0 0.01392138097435236
NPII O 1 0.994823694229126
, O 0 0.012021875008940697
including O 0 0.008411741815507412
a O 0 0.010608277283608913
cysteine O 0 0.01702415943145752
residue O 0 0.015123994089663029
in O 0 0.0075894491747021675
position O 0 0.012018516659736633
85 O 0 0.01679372414946556
, O 0 0.008679940365254879
which O 0 0.005912330001592636
could O 0 0.005955917295068502
be O 0 0.005016492214053869
involved O 0 0.006841466762125492
in O 0 0.006287381052970886
the O 0 0.009209292009472847
correct O 0 0.019314536824822426
folding O 1 0.8615846037864685
of O 0 0.018967801705002785
the O 0 0.036304645240306854
prohormone O 1 0.9998899698257446
. O 0 0.055739786475896835

In O 0 0.025600967928767204
the O 0 0.02066575363278389
second O 0 0.02357225865125656
family O 0 0.01795029081404209
, O 0 0.012225314974784851
a O 0 0.013887254521250725
G279A O 0 0.03746407479047775
substitution O 0 0.019135043025016785
at O 0 0.01237381063401699
position O 0 0.014433818869292736
- O 0 0.018884046003222466
1 O 0 0.011413425207138062
of O 0 0.009076597169041634
the O 0 0.008778776042163372
signal O 0 0.015532013960182667
peptide O 0 0.018447553738951683
was O 0 0.012678236700594425
observed O 0 0.011075085029006004
in O 0 0.010012105107307434
all O 0 0.0118253780528903
affected O 0 0.024303629994392395
individuals O 0 0.022176505997776985
. O 0 0.04008658230304718

This O 0 0.031164931133389473
missense O 0 0.05515825003385544
mutation O 0 0.023769591003656387
, O 0 0.014492760412395
which O 0 0.011086558923125267
replaces O 1 0.9996987581253052
Ala O 1 0.999998927116394
with O 0 0.023190217092633247
Thr O 1 0.9999957084655762
, O 0 0.012241148389875889
is O 0 0.009015259332954884
frequent O 0 0.015262103639543056
among O 0 0.246981680393219
FNDI B-Disease 1 1.0
patients O 1 0.9999600648880005
and O 0 0.01011405698955059
is O 0 0.007707023527473211
thought O 0 0.008263759315013885
to O 0 0.007023658137768507
reduce O 0 0.010898732580244541
the O 0 0.009191240184009075
efficiency O 0 0.017780780792236328
of O 0 0.014307263307273388
cleavage O 1 0.5060662627220154
by O 0 0.01651383563876152
signal O 0 0.037525441497564316
peptidases O 0 0.3779084384441376
. O 0 0.03668270260095596
. O 0 0.04515497758984566

Genetic O 0 0.04859768971800804
heterogeneity O 0 0.055854812264442444
of O 0 0.03167306259274483
Saethre B-Disease 1 0.9999996423721313
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.13748548924922943
due O 0 0.02134370617568493
to O 0 0.020756088197231293
TWIST O 1 0.9904568791389465
and O 0 0.09903133660554886
FGFR O 1 0.9999874830245972
mutations O 0 0.05948258563876152
. O 0 0.05053798109292984

Thirty O 0 0.07054886966943741
- O 0 0.050385016947984695
two O 0 0.01656319387257099
unrelated O 0 0.02605055458843708
patients O 0 0.023515930399298668
with O 0 0.009665020741522312
features O 0 0.013235794380307198
of O 0 0.017252307385206223
Saethre B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999998807907104
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.015053130686283112
a O 0 0.013814969919621944
common O 0 0.025396792218089104
autosomal B-Disease 1 0.9953184723854065
dominant I-Disease 1 0.9869270920753479
condition I-Disease 1 0.9985907673835754
of O 1 0.9989330172538757
craniosynostosis B-Disease 1 1.0
and O 1 0.9999728202819824
limb B-Disease 1 1.0
anomalies I-Disease 1 0.9999924898147583
, O 0 0.013898842968046665
were O 0 0.008381646126508713
screened O 0 0.01637459173798561
for O 0 0.009718365035951138
mutations O 0 0.013797453604638577
in O 0 0.010422764346003532
TWIST O 1 0.8913277387619019
, O 0 0.024213913828134537
FGFR2 O 1 0.9998189806938171
, O 0 0.02612983249127865
and O 0 0.030835863202810287
FGFR3 O 1 0.999064028263092
. O 0 0.05411810055375099

Nine O 0 0.049969933927059174
novel O 0 0.03876565024256706
and O 0 0.019336221739649773
three O 0 0.018452486023306847
recurrent O 1 0.9998835325241089
TWIST O 1 0.9959036707878113
mutations O 0 0.0213442612439394
were O 0 0.01127563789486885
found O 0 0.0111276526004076
in O 0 0.012685997411608696
12 O 0 0.023296214640140533
families O 0 0.027346251532435417
. O 0 0.0375201478600502

Seven O 0 0.03029116615653038
families O 0 0.016350647434592247
were O 0 0.008426648564636707
found O 0 0.006407657638192177
to O 0 0.005966389086097479
have O 0 0.005344958510249853
the O 0 0.00979883223772049
FGFR3 O 1 0.9999094009399414
P250R O 1 0.9978218078613281
mutation O 0 0.01641380600631237
, O 0 0.007820342667400837
and O 0 0.006644516717642546
one O 0 0.0061091529205441475
individual O 0 0.0063630579970777035
was O 0 0.008312311954796314
found O 0 0.005643047858029604
to O 0 0.006317123770713806
have O 0 0.006855299696326256
an O 0 0.013474078848958015
FGFR2 O 1 0.999795138835907
VV269 O 1 0.9985617995262146
- O 1 0.9207985997200012
270 O 0 0.10167519003152847
deletion O 0 0.10290427505970001
. O 0 0.05279427021741867

To O 0 0.028748348355293274
date O 0 0.02178090624511242
, O 0 0.014356841333210468
our O 0 0.013272306881844997
detection O 0 0.017956722527742386
rate O 0 0.010059839114546776
for O 0 0.008501836098730564
TWIST O 0 0.21408429741859436
or O 0 0.01236459519714117
FGFR O 1 0.9992625117301941
mutations O 0 0.012491676025092602
is O 0 0.008553190156817436
68 O 0 0.016588244587183
% O 0 0.00899952370673418
in O 0 0.008231460116803646
our O 0 0.014628374017775059
Saethre B-Disease 1 0.9999450445175171
- I-Disease 1 0.999998927116394
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.999911904335022
, O 0 0.01078854501247406
including O 0 0.008847322314977646
our O 0 0.01243626419454813
five O 0 0.013897458091378212
patients O 1 0.9319792985916138
elsewhere O 0 0.01803836040198803
reported O 0 0.018400341272354126
with O 0 0.01868096925318241
TWIST O 1 0.9904664754867554
mutations O 0 0.05017387121915817
. O 0 0.04411907121539116

More O 0 0.02171778306365013
than O 0 0.0138527387753129
35 O 0 0.01765897497534752
different O 0 0.01013073232024908
TWIST O 0 0.03680215775966644
mutations O 0 0.0140431122854352
are O 0 0.006310333032160997
now O 0 0.010408963076770306
known O 0 0.010933072306215763
in O 0 0.011448019184172153
the O 0 0.018947521224617958
literature O 0 0.034636422991752625
. O 0 0.03641326725482941

The O 0 0.027010222896933556
most O 0 0.014657674357295036
common O 0 0.013903534971177578
phenotypic O 0 0.023759277537465096
features O 0 0.013605519197881222
, O 0 0.008310212753713131
present O 0 0.0074210078455507755
in O 0 0.00616344902664423
more O 0 0.005279575474560261
than O 0 0.004875545389950275
a O 0 0.007244749926030636
third O 0 0.010073957964777946
of O 0 0.007156802341341972
our O 0 0.010471082292497158
patients O 0 0.16344383358955383
with O 0 0.008952138014137745
TWIST O 1 0.9464974403381348
mutations O 0 0.013604034669697285
, O 0 0.008960292674601078
are O 0 0.0070493584498763084
coronal B-Disease 0 0.4462035298347473
synostosis I-Disease 1 0.8348706364631653
, O 0 0.012834160588681698
brachycephaly B-Disease 1 0.9763922095298767
, O 0 0.01608971878886223
low B-Disease 1 0.6974987387657166
frontal I-Disease 1 0.9999984502792358
hairline I-Disease 1 1.0
, O 1 0.9658932685852051
facial B-Disease 1 0.9999988079071045
asymmetry I-Disease 1 0.9999918937683105
, O 1 0.992099404335022
ptosis B-Disease 1 1.0
, O 1 0.6761779189109802
hypertelorism B-Disease 1 0.9999943971633911
, O 0 0.024697890505194664
broad B-Disease 1 0.7401572465896606
great I-Disease 1 0.980352520942688
toes I-Disease 1 0.9997870326042175
, O 0 0.03228749707341194
and O 0 0.03077550046145916
clinodactyly B-Disease 1 0.9989432692527771
. O 0 0.05304921790957451

Significant O 0 0.0505710132420063
intra O 1 0.9506449699401855
- O 1 0.9158049821853638
and O 0 0.0216753538697958
interfamilial O 1 0.8791508674621582
phenotypic O 0 0.035145219415426254
variability O 0 0.026386264711618423
is O 0 0.00980099756270647
present O 0 0.009040795266628265
for O 0 0.008679021149873734
either O 0 0.012734176591038704
TWIST O 1 0.9019628167152405
mutations O 0 0.027310287579894066
or O 0 0.023156452924013138
FGFR O 1 0.9999536275863647
mutations O 0 0.05198198929429054
. O 0 0.0448460653424263

The O 0 0.025830430909991264
overlap O 0 0.02154001221060753
in O 0 0.012468433007597923
clinical O 1 0.9237725138664246
features O 0 0.013025185093283653
and O 0 0.007300259079784155
the O 0 0.007688440382480621
presence O 0 0.009416289627552032
, O 0 0.0062415399588644505
in O 0 0.005469178780913353
the O 0 0.006011693272739649
same O 0 0.005873738322407007
genes O 0 0.006497435737401247
, O 0 0.005958249792456627
of O 0 0.0062070246785879135
mutations O 0 0.006714874878525734
for O 0 0.004829369019716978
more O 0 0.005030554719269276
than O 0 0.005801495164632797
one O 0 0.008672229945659637
craniosynostotic B-Disease 1 0.9394506216049194
condition I-Disease 0 0.0787610411643982
- O 0 0.021215829998254776
such O 0 0.00685212854295969
as O 0 0.010717801749706268
Saethre B-Disease 1 0.9984866380691528
- I-Disease 1 0.9899086952209473
Chotzen I-Disease 1 0.9911660552024841
, I-Disease 0 0.014617502689361572
Crouzon I-Disease 1 0.9834722280502319
, I-Disease 0 0.015812506899237633
and I-Disease 0 0.036149054765701294
Pfeiffer I-Disease 1 0.9999998807907104
syndromes I-Disease 1 1.0
- O 1 0.9964959025382996
support O 0 0.015560803934931755
the O 0 0.012993487529456615
hypothesis O 0 0.01833728700876236
that O 0 0.010143226012587547
TWIST O 0 0.04103470966219902
and O 0 0.012839161790907383
FGFRs O 0 0.3089645504951477
are O 0 0.006673446856439114
components O 0 0.01049803290516138
of O 0 0.007838478311896324
the O 0 0.00885031558573246
same O 0 0.00802698452025652
molecular O 0 0.013430604711174965
pathway O 0 0.012092533521354198
involved O 0 0.007895132526755333
in O 0 0.007385119795799255
the O 0 0.010467455722391605
modulation O 0 0.025092294439673424
of O 0 0.11126156151294708
craniofacial O 1 1.0
and O 1 0.9944047927856445
limb O 1 0.9999998807907104
development O 1 0.8927918672561646
in O 0 0.02225494384765625
humans O 0 0.024828245863318443
. O 0 0.024780409410595894
. O 0 0.0366772785782814

Mutation O 0 0.05018557608127594
analysis O 0 0.02938125841319561
of O 0 0.032871853560209274
UBE3A O 1 0.9999997615814209
in O 1 0.9999889135360718
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 1.0
. O 1 0.9733177423477173

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9946541786193848
AS B-Disease 1 0.9993465542793274
) O 0 0.016319723799824715
is O 0 0.013100150972604752
caused O 0 0.018004629760980606
by O 0 0.011791571043431759
chromosome O 0 0.03577271103858948
15q11 O 1 0.9916447997093201
- O 1 0.9151860475540161
q13 O 1 0.7357659935951233
deletions O 0 0.03688601404428482
of O 0 0.018122179433703423
maternal O 0 0.23530647158622742
origin O 0 0.012811374850571156
, O 0 0.011334509588778019
by O 0 0.011507492512464523
paternal O 1 0.9977188110351562
uniparental B-Disease 1 0.9999998807907104
disomy I-Disease 1 0.999994158744812
( O 1 0.5045181512832642
UPD B-Disease 1 0.9999995231628418
) O 0 0.015419483184814453
15 O 0 0.015394448302686214
, O 0 0.012436392717063427
by O 0 0.010789552703499794
imprinting O 1 0.9997193217277527
defects O 1 0.9999711513519287
, O 0 0.012402062304317951
and O 0 0.009627225808799267
by O 0 0.00863417237997055
mutations O 0 0.01384673360735178
in O 0 0.012394893914461136
the O 0 0.024531101807951927
UBE3A O 1 0.9999736547470093
gene O 0 0.04958908632397652
. O 0 0.048182163387537

UBE3A O 1 0.985575795173645
encodes O 0 0.07717552036046982
a O 0 0.039487097412347794
ubiquitin O 1 0.650124192237854
- O 1 0.5066341161727905
protein O 0 0.028454342857003212
ligase O 0 0.04421501234173775
and O 0 0.020864838734269142
shows O 0 0.026211731135845184
brain O 1 0.9591872692108154
- O 1 0.5571706891059875
specific O 0 0.03789322450757027
imprinting O 1 0.836679220199585
. O 0 0.06218613311648369

Here O 0 0.035727109760046005
we O 0 0.023121271282434464
describe O 0 0.03212381899356842
UBE3A O 1 0.988612711429596
coding O 0 0.19943255186080933
- O 0 0.48943549394607544
region O 0 0.024798933416604996
mutations O 0 0.017023824155330658
detected O 0 0.015137508511543274
by O 0 0.009801224805414677
SSCP O 0 0.41822201013565063
analysis O 0 0.010693328455090523
in O 0 0.009728530421853065
13 O 0 0.015584385022521019
AS B-Disease 0 0.020793747156858444
individuals O 0 0.012883041985332966
or O 0 0.015068821609020233
families O 0 0.022129833698272705
. O 0 0.03502688929438591

Two O 0 0.03786798194050789
identical O 0 0.04547502100467682
de O 0 0.05475954711437225
novo O 0 0.06602463126182556
5 O 0 0.036776334047317505
- O 0 0.04862455278635025
bp O 0 0.06238193437457085
duplications O 0 0.05725639685988426
in O 0 0.023678837344050407
exon O 0 0.05390654876828194
16 O 0 0.02792743593454361
were O 0 0.02037203498184681
found O 0 0.027569295838475227
. O 0 0.04460255429148674

Among O 0 0.024989452213048935
the O 0 0.01644299179315567
other O 0 0.008914289996027946
11 O 0 0.013887567445635796
unique O 0 0.012015641666948795
mutations O 0 0.012211116962134838
, O 0 0.009075126610696316
8 O 0 0.012717186473309994
were O 0 0.00867241807281971
small O 0 0.011275723576545715
deletions O 0 0.01963585428893566
or O 0 0.011322476901113987
insertions O 0 0.030168931931257248
predicted O 0 0.017175983637571335
to O 0 0.013188124634325504
cause O 0 0.054450925439596176
frameshifts O 1 0.9732786417007446
, O 0 0.011683205142617226
1 O 0 0.013301069848239422
was O 0 0.011783936992287636
a O 0 0.010658669285476208
mutation O 0 0.011107447557151318
to O 0 0.007619705516844988
a O 0 0.010531147010624409
stop O 0 0.014105495065450668
codon O 0 0.019405605271458626
, O 0 0.010171022266149521
1 O 0 0.013493552803993225
was O 0 0.012272726744413376
a O 0 0.011530878022313118
missense O 0 0.02250939980149269
mutation O 0 0.012736755423247814
, O 0 0.008288932032883167
and O 0 0.006939577870070934
1 O 0 0.01136945653706789
was O 0 0.011361783370375633
predicted O 0 0.012781357392668724
to O 0 0.01005238201469183
cause O 0 0.012926677241921425
insertion O 0 0.016133878380060196
of O 0 0.00903570931404829
an O 0 0.01012259628623724
isoleucine O 1 0.9966630339622498
in O 0 0.009525786153972149
the O 0 0.010681133717298508
hect O 0 0.2070145457983017
domain O 0 0.015730131417512894
of O 0 0.012292510829865932
the O 0 0.016534309834241867
UBE3A O 1 0.999975323677063
protein O 0 0.017727237194776535
, O 0 0.012628463096916676
which O 0 0.00981332827359438
functions O 0 0.01249681692570448
in O 0 0.01617531105875969
E2 O 1 0.9782882928848267
binding O 0 0.02938564494252205
and O 0 0.02663099765777588
ubiquitin O 0 0.08342589437961578
transfer O 0 0.05228796601295471
. O 0 0.05480988323688507

Eight O 0 0.029198136180639267
of O 0 0.015770092606544495
the O 0 0.013551793992519379
cases O 0 0.010591880418360233
were O 0 0.010895495302975178
familial O 1 0.9990228414535522
, O 0 0.012454038485884666
and O 0 0.01039253082126379
five O 0 0.014233267866075039
were O 0 0.014946692623198032
sporadic O 0 0.03624024987220764
. O 0 0.038251250982284546

In O 0 0.026894964277744293
two O 0 0.019812578335404396
familial O 1 0.9675475358963013
cases O 0 0.013539507985115051
and O 0 0.010461910627782345
one O 0 0.010113894939422607
sporadic O 0 0.013442007824778557
case O 0 0.012414626777172089
, O 0 0.012653738260269165
mosaicism O 1 0.997500479221344
for O 0 0.015286458656191826
UBE3A O 1 0.9999922513961792
mutations O 0 0.01944882422685623
was O 0 0.014901728369295597
detected O 0 0.013398257084190845
in O 0 0.008742007426917553
the O 0 0.009150316938757896
mother O 0 0.013582846149802208
of O 0 0.008851337246596813
three O 0 0.008717270568013191
AS B-Disease 0 0.07350224256515503
sons O 0 0.3203621506690979
, O 0 0.008417458273470402
in O 0 0.007311843801289797
the O 0 0.011387651786208153
maternal O 1 0.9430903196334839
grandfather O 0 0.3083854019641876
of O 0 0.00852755457162857
two O 0 0.007021852768957615
AS B-Disease 0 0.016030576080083847
first O 0 0.013153355568647385
cousins O 0 0.03628726676106453
, O 0 0.008979028090834618
and O 0 0.00734814302995801
in O 0 0.007806849200278521
the O 0 0.009560244157910347
mother O 0 0.015149811282753944
of O 0 0.010699525475502014
an O 0 0.016415484249591827
AS B-Disease 1 0.9804580807685852
daughter O 1 0.9961065649986267
. O 0 0.04306286945939064

The O 0 0.0236942321062088
frequencies O 0 0.017325373366475105
with O 0 0.009082079865038395
which O 0 0.007078408729285002
we O 0 0.007904216647148132
detected O 0 0.012586335651576519
mutations O 0 0.008995982818305492
were O 0 0.0064389873296022415
5 O 0 0.010121115483343601
( O 0 0.009044179692864418
14 O 0 0.011085137724876404
% O 0 0.010097223334014416
) O 0 0.007724712137132883
of O 0 0.008309779688715935
35 O 0 0.01249359268695116
in O 0 0.008299773558974266
sporadic O 0 0.012146391905844212
cases O 0 0.007642470300197601
and O 0 0.007384096272289753
8 O 0 0.010800154879689217
( O 0 0.009094559587538242
80 O 0 0.014900349080562592
% O 0 0.009221307002007961
) O 0 0.00934167392551899
of O 0 0.009737741202116013
10 O 0 0.013617932796478271
in O 0 0.015412426553666592
familial O 1 0.9963867664337158
cases O 0 0.025363607332110405
. O 0 0.02769922837615013
. O 0 0.03935815766453743

The O 0 0.07080386579036713
hemochromatosis B-Disease 1 0.9999984502792358
845 O 1 0.999990701675415
G O 1 0.9999403953552246
- O 1 0.9990941286087036
- O 1 0.968505859375
> O 0 0.04650615155696869
A O 0 0.020024864003062248
and O 0 0.014539554715156555
187 O 0 0.03416573628783226
C O 0 0.17635199427604675
- O 1 0.6861758232116699
- O 1 0.9180833101272583
> O 1 0.9638808965682983
G O 1 0.8707916736602783
mutations O 0 0.022548360750079155
: O 0 0.01730426214635372
prevalence O 0 0.1974412351846695
in O 0 0.01603027619421482
non O 0 0.10619750618934631
- O 1 0.9988353848457336
Caucasian O 1 0.9914920926094055
populations O 0 0.040674395859241486
. O 0 0.04911857843399048

Hemochromatosis B-Disease 1 0.9999779462814331
, O 0 0.028539763763546944
the O 0 0.14872421324253082
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 0.999995231628418
iron I-Disease 1 1.0
metabolism I-Disease 1 0.9999992847442627
, O 0 0.18624700605869293
leads O 1 0.8988134264945984
, O 0 0.01001992542296648
if O 0 0.008767925202846527
untreated O 1 0.9948638081550598
, O 0 0.009469347074627876
to O 0 0.012683788314461708
progressive O 1 0.9999887943267822
iron B-Disease 1 1.0
overload I-Disease 1 1.0
and O 1 0.9859218001365662
premature B-Disease 1 0.999967098236084
death I-Disease 1 0.9125314950942993
. O 0 0.056219592690467834

The O 0 0.054147422313690186
hemochromatosis B-Disease 1 0.9999997615814209
gene O 0 0.056302156299352646
, O 0 0.030789021402597427
HFE O 1 0.9999921321868896
, O 0 0.013044077903032303
recently O 0 0.01241373736411333
has O 0 0.007642516866326332
been O 0 0.006342833396047354
identified O 0 0.006419575307518244
, O 0 0.005511771887540817
and O 0 0.005530285649001598
characterization O 0 0.009578398428857327
of O 0 0.005845951847732067
this O 0 0.005503461696207523
gene O 0 0.007675188593566418
has O 0 0.006769353989511728
shown O 0 0.006150566507130861
that O 0 0.004726284649223089
it O 0 0.005407335702329874
contains O 0 0.007152371574193239
two O 0 0.006674694828689098
mutations O 0 0.009410584345459938
that O 0 0.005956459324806929
result O 0 0.008678865619003773
in O 0 0.011206934228539467
amino O 0 0.01608777977526188
acid O 0 0.02143418975174427
substitutions O 0 0.026896942406892776
- O 0 0.028971735388040543
cDNA O 0 0.036961305886507034
nucleotides O 0 0.031359296292066574
845 O 0 0.2998291254043579
G O 1 0.7975104451179504
- O 1 0.8251021504402161
- O 1 0.5180028080940247
> O 0 0.07004110515117645
A O 0 0.02021985873579979
( O 0 0.01615791954100132
C282Y O 0 0.03507677838206291
) O 0 0.009997040033340454
and O 0 0.009785193018615246
187 O 0 0.02358677051961422
C O 0 0.1375223994255066
- O 1 0.8956503868103027
- O 1 0.9934263229370117
> O 1 0.9968910813331604
G O 1 0.9949710369110107
( O 0 0.033994708210229874
H63D O 1 0.9989179372787476
) O 0 0.04261867329478264
. O 0 0.05621374770998955

Although O 0 0.0922587513923645
hemochromatosis B-Disease 1 0.999998927116394
is O 0 0.019667409360408783
common O 0 0.016480010002851486
in O 0 0.0131726935505867
Caucasians O 1 0.7826144695281982
, O 0 0.015210432931780815
affecting O 0 0.025634462013840675
> O 1 0.9698802828788757
= O 0 0.03262164816260338
1 O 0 0.02136271633207798
/ O 0 0.02524474821984768
300 O 0 0.01670699752867222
individuals O 0 0.0072685424238443375
of O 0 0.007988352328538895
northern O 0 0.009694495238363743
European O 0 0.009186625480651855
origin O 0 0.007176956627517939
, O 0 0.006396537646651268
it O 0 0.0054521718993783
has O 0 0.006192707922309637
not O 0 0.00547794159501791
been O 0 0.007299574092030525
recognized O 0 0.01126055046916008
in O 0 0.011846973560750484
other O 0 0.013631949201226234
populations O 0 0.02516360767185688
. O 0 0.040049392729997635

The O 0 0.028446756303310394
present O 0 0.019187135621905327
study O 0 0.01565328799188137
used O 0 0.011438384652137756
PCR O 0 0.029628310352563858
and O 0 0.01339198648929596
restriction O 0 0.025418542325496674
- O 1 0.9789157509803772
enzyme O 0 0.02443552203476429
digestion O 0 0.02922995388507843
to O 0 0.010944132693111897
analyze O 0 0.01537452731281519
the O 0 0.009489603340625763
frequency O 0 0.009771355427801609
of O 0 0.009130251593887806
the O 0 0.011640770360827446
845 O 1 0.9989631175994873
G O 1 0.9975883960723877
- O 1 0.9756784439086914
- O 0 0.4293452799320221
> O 0 0.03310875967144966
A O 0 0.015912797302007675
and O 0 0.012975441291928291
187 O 0 0.02998002991080284
C O 0 0.10667161643505096
- O 1 0.5229244232177734
- O 0 0.4009893536567688
> O 0 0.2762550413608551
G O 0 0.10664010792970657
mutations O 0 0.023184478282928467
in O 0 0.019483033567667007
HLA O 1 0.9999459981918335
- O 0 0.04618680849671364
typed O 0 0.028096532449126244
samples O 0 0.013711286708712578
from O 0 0.010503824800252914
non O 0 0.02000729739665985
- O 1 0.7747019529342651
Caucasian O 1 0.5387797951698303
populations O 0 0.012276194989681244
, O 0 0.011465770192444324
comprising O 0 0.01576690375804901
Australian O 0 0.0199914388358593
Aboriginal O 0 0.028448082506656647
, O 0 0.015087819658219814
Chinese O 0 0.020047932863235474
, O 0 0.01673009991645813
and O 0 0.020012693479657173
Pacific O 0 0.060796741396188736
Islanders O 0 0.0829690545797348
. O 0 0.053921811282634735

Results O 0 0.02998530864715576
showed O 0 0.01883847638964653
that O 0 0.00878087617456913
the O 0 0.012146025896072388
845 O 1 0.9978078007698059
G O 1 0.9997656941413879
- O 1 0.9982267022132874
- O 1 0.9786651730537415
> O 0 0.11886730045080185
A O 0 0.01591179519891739
mutation O 0 0.013941282406449318
was O 0 0.011274191550910473
present O 0 0.00806171353906393
in O 0 0.007054867688566446
these O 0 0.0057300697080791
populations O 0 0.007474681828171015
( O 0 0.010171549394726753
allele O 0 0.015219277702271938
frequency O 0 0.011661013588309288
0 O 0 0.012438395991921425
. O 0 0.008226039819419384
32 O 0 0.013177379965782166
% O 0 0.009405536577105522
) O 0 0.007589392364025116
, O 0 0.00750436307862401
and O 0 0.0068586464039981365
, O 0 0.007644083350896835
furthermore O 0 0.010608638636767864
, O 0 0.006810156162828207
it O 0 0.00693932780995965
was O 0 0.011362806893885136
always O 0 0.009820104576647282
seen O 0 0.009022638201713562
in O 0 0.008038653060793877
conjunction O 0 0.016333378851413727
with O 0 0.017201542854309082
HLA O 1 0.9999998807907104
haplotypes O 1 0.9488860368728638
common O 0 0.014471077360212803
in O 0 0.01339807827025652
Caucasians O 0 0.17824393510818481
, O 0 0.012095187790691853
suggesting O 0 0.013944892212748528
that O 0 0.010452521033585072
845 O 1 0.9190672636032104
G O 1 0.9893324375152588
- O 1 0.9970313310623169
- O 1 0.9954383969306946
> O 1 0.7159263491630554
A O 0 0.018378350883722305
may O 0 0.008693055249750614
have O 0 0.006425110157579184
been O 0 0.007589363493025303
introduced O 0 0.010621617548167706
into O 0 0.008992674760520458
these O 0 0.008571562357246876
populations O 0 0.013475499115884304
by O 0 0.020043067634105682
Caucasian O 1 0.9074869751930237
admixture O 1 0.8977037668228149
. O 0 0.05681466683745384

187 O 0 0.07682880014181137
C O 1 0.6091887354850769
- O 1 0.9708831310272217
- O 1 0.9938045740127563
> O 1 0.9872497916221619
G O 1 0.552401065826416
was O 0 0.01577696204185486
present O 0 0.013240153901278973
at O 0 0.011912320740520954
an O 0 0.012298393994569778
allele O 0 0.023103056475520134
frequency O 0 0.018789898604154587
of O 0 0.01912703365087509
2 O 0 0.035925719887018204
. O 0 0.04038306325674057

68 O 0 0.059443630278110504
% O 0 0.023142565041780472
in O 0 0.012414040975272655
the O 0 0.011002876795828342
two O 0 0.007997522130608559
populations O 0 0.009003165178000927
analyzed O 0 0.015132006257772446
( O 0 0.012490293942391872
Australian O 0 0.0223405584692955
Aboriginal O 0 0.03149966895580292
and O 0 0.016952918842434883
Chinese O 0 0.03271341696381569
) O 0 0.029796980321407318
. O 0 0.04329663887619972

In O 0 0.028567854315042496
the O 0 0.021612249314785004
Australian O 0 0.028224967420101166
Aboriginal O 0 0.026151137426495552
samples O 0 0.015988878905773163
, O 0 0.012200768105685711
187 O 0 0.026359323412179947
C O 0 0.11481451243162155
- O 1 0.9506383538246155
- O 1 0.9828769564628601
> O 1 0.9247766137123108
G O 0 0.29044994711875916
was O 0 0.011702066287398338
found O 0 0.007062018848955631
to O 0 0.0062553854659199715
be O 0 0.005861450452357531
associated O 0 0.008517392911016941
with O 0 0.010981928557157516
HLA O 1 0.9999997615814209
haplotypes O 1 0.7024446725845337
common O 0 0.01142918411642313
in O 0 0.011406348086893559
Caucasians O 1 0.9833832383155823
, O 0 0.01067336555570364
suggesting O 0 0.011490154080092907
that O 0 0.006650528404861689
it O 0 0.00783481914550066
was O 0 0.012839114293456078
introduced O 0 0.015639588236808777
by O 0 0.012867962941527367
recent O 0 0.02597292698919773
admixture O 0 0.1112690269947052
. O 0 0.04471355676651001

In O 0 0.028280511498451233
the O 0 0.019287647679448128
Chinese O 0 0.021855272352695465
samples O 0 0.02030283398926258
analyzed O 0 0.01882602833211422
, O 0 0.013567009940743446
187 O 0 0.028129488229751587
C O 0 0.14936594665050507
- O 1 0.8797870874404907
- O 1 0.9487770199775696
> O 1 0.7543429136276245
G O 0 0.28945064544677734
was O 0 0.01480281725525856
present O 0 0.011137888766825199
in O 0 0.009146991185843945
association O 0 0.010791314765810966
with O 0 0.006796339992433786
a O 0 0.008444983512163162
wide O 0 0.010519611649215221
variety O 0 0.01086810976266861
of O 0 0.017949514091014862
HLA O 1 0.9999998807907104
haplotypes O 1 0.9026912450790405
, O 0 0.013207612559199333
showing O 0 0.01358752977102995
this O 0 0.008424641564488411
mutation O 0 0.010653737001121044
to O 0 0.006137332879006863
be O 0 0.006108304485678673
widespread O 0 0.010051376186311245
and O 0 0.007870061323046684
likely O 0 0.009098375216126442
to O 0 0.009726758114993572
predate O 0 0.020527232438325882
the O 0 0.011199739761650562
more O 0 0.009161398746073246
genetically O 0 0.01623392663896084
restricted O 0 0.018628956750035286
845 O 1 0.9968171715736389
G O 1 0.9992969036102295
- O 1 0.9989088773727417
- O 1 0.9944868683815002
> O 1 0.7627620100975037
A O 0 0.0568404458463192
mutation O 0 0.06018218398094177
. O 0 0.04992670938372612

Genotype O 1 0.9457087516784668
- O 1 0.9663602709770203
phenotype O 1 0.643119752407074
correlations O 0 0.07513231784105301
in O 0 0.056674957275390625
attenuated B-Disease 1 0.9999978542327881
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999997615814209
. O 0 0.43125903606414795

Germ O 1 0.9997546076774597
- O 1 0.6171179413795471
line O 0 0.03252929821610451
mutations O 0 0.020983008667826653
of O 0 0.01591264083981514
the O 0 0.02907119318842888
tumor B-Disease 1 0.9999977350234985
suppressor O 1 0.9998929500579834
APC O 1 0.9950889945030212
are O 0 0.01348906010389328
implicated O 0 0.03880911320447922
in O 0 0.025213206186890602
attenuated B-Disease 1 0.9999994039535522
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 1 0.9999631643295288
AAPC B-Disease 1 1.0
) O 0 0.0160068329423666
, O 0 0.011992678977549076
a O 0 0.0138246463611722
variant O 0 0.15578530728816986
of O 1 0.5950259566307068
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999991655349731
FAP B-Disease 1 1.0
) O 0 0.2795511484146118
. O 0 0.06669893115758896

AAPC B-Disease 1 0.9999914169311523
is O 0 0.026092110201716423
recognized O 0 0.020816517993807793
by O 0 0.010581400245428085
the O 0 0.012977024540305138
occurrence O 0 0.019420582801103592
of O 0 0.015395576134324074
< O 1 0.9214105010032654
100 O 0 0.039169423282146454
colonic B-Disease 1 0.99997878074646
adenomas I-Disease 1 0.9995115995407104
and O 0 0.012276489287614822
a O 0 0.01132410578429699
later O 0 0.016323933377861977
onset O 1 0.9999916553497314
of O 1 0.9998737573623657
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.8055620789527893
age O 1 0.6557909846305847
> O 1 0.9553877115249634
40 O 0 0.026761623099446297
years O 0 0.02232641912996769
) O 0 0.029683444648981094
. O 0 0.043885067105293274

The O 0 0.03348436579108238
aim O 0 0.03254304081201553
of O 0 0.01428236998617649
this O 0 0.010827360674738884
study O 0 0.013546759262681007
was O 0 0.015518918633460999
to O 0 0.01348438486456871
assess O 0 0.03211832419037819
genotype O 1 0.7123870253562927
- O 1 0.9917234778404236
phenotype O 1 0.9301151633262634
correlations O 0 0.05154590308666229
in O 0 0.0365598164498806
AAPC B-Disease 1 0.9999932050704956
families O 0 0.06062515079975128
. O 0 0.06325936317443848

By O 0 0.029234400019049644
protein O 0 0.028236016631126404
- O 0 0.05994930490851402
truncation O 0 0.10871563851833344
test O 0 0.02640400268137455
( O 0 0.021173810586333275
PTT O 1 0.7838172316551208
) O 0 0.015151013620197773
assay O 0 0.021980710327625275
, O 0 0.009587774984538555
the O 0 0.008192035369575024
entire O 0 0.012570026330649853
coding O 0 0.014299229718744755
region O 0 0.010974648408591747
of O 0 0.009457171894609928
the O 0 0.012932050973176956
APC B-Disease 1 0.9999761581420898
gene O 0 0.015393068082630634
was O 0 0.016810264438390732
screened O 0 0.02121858485043049
in O 0 0.01041373796761036
affected O 0 0.012441437691450119
individuals O 0 0.00817869883030653
from O 0 0.01084580272436142
11 O 0 0.03953419625759125
AAPC B-Disease 1 0.9999997615814209
kindreds O 1 0.994195282459259
, O 0 0.016839150339365005
and O 0 0.011908438988029957
their O 0 0.01146765612065792
phenotypic O 0 0.026855256408452988
differences O 0 0.017946548759937286
were O 0 0.0174880214035511
examined O 0 0.05217073857784271
. O 0 0.04559679701924324

Five O 0 0.03948083892464638
novel O 0 0.05478067696094513
germ O 1 0.9998400211334229
- O 1 0.9982301592826843
line O 0 0.24892669916152954
APC B-Disease 1 0.9996492862701416
mutations O 0 0.024535054340958595
were O 0 0.013490568846464157
identified O 0 0.017394544556736946
in O 0 0.018798736855387688
seven O 0 0.030892621725797653
kindreds O 1 0.7737837433815002
. O 0 0.05424831807613373

Mutations O 0 0.03927086293697357
were O 0 0.0148455910384655
located O 0 0.015793051570653915
in O 0 0.007983620278537273
three O 0 0.0067251864820718765
different O 0 0.004717957228422165
regions O 0 0.006472804583609104
of O 0 0.007213218603283167
the O 0 0.010993006639182568
APC B-Disease 1 0.9998642206192017
gene O 0 0.013133909553289413
( O 0 0.010146346874535084
1 O 0 0.01232846174389124
) O 0 0.008355287835001945
at O 0 0.00946715660393238
the O 0 0.007799746934324503
5 O 0 0.010278449393808842
end O 0 0.010537007823586464
spanning O 0 0.017592865973711014
exons O 0 0.020213456824421883
4 O 0 0.01512095332145691
and O 0 0.009156067855656147
5 O 0 0.012383785098791122
, O 0 0.009729926474392414
( O 0 0.008390580303966999
2 O 0 0.010572928003966808
) O 0 0.008232243359088898
within O 0 0.008304986171424389
exon O 0 0.02042733132839203
9 O 0 0.013291248120367527
, O 0 0.00805668905377388
and O 0 0.007722076494246721
( O 0 0.007825711742043495
3 O 0 0.01076480746269226
) O 0 0.008011671714484692
at O 0 0.0101007129997015
the O 0 0.01083145197480917
3 O 0 0.019542353227734566
distal O 0 0.06052757799625397
end O 0 0.017537962645292282
of O 0 0.016592368483543396
the O 0 0.024126973003149033
gene O 0 0.03374463692307472
. O 0 0.0396498441696167

Variability O 0 0.05286458879709244
in O 0 0.018528614193201065
the O 0 0.015239788219332695
number O 0 0.01386106014251709
of O 1 0.9198564887046814
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 1 0.9043497443199158
most O 0 0.010637877508997917
apparent O 0 0.017460979521274567
in O 0 0.0070952256210148335
individuals O 0 0.005840921308845282
with O 0 0.0059178476221859455
mutations O 0 0.007678097113966942
in O 0 0.005714139901101589
region O 0 0.00810919888317585
1 O 0 0.01027030311524868
, O 0 0.007459425367414951
and O 0 0.00952344760298729
upper O 1 0.9988111257553101
- O 1 0.9999988079071045
gastrointestinal O 1 1.0
manifestations O 1 0.9999688863754272
were O 0 0.013599121943116188
more O 0 0.013246983289718628
severe O 1 0.9998863935470581
in O 0 0.01782766729593277
them O 0 0.023171523585915565
. O 0 0.03799597918987274

In O 0 0.0223639365285635
individuals O 0 0.013089769519865513
with O 0 0.011466974392533302
mutations O 0 0.011598668992519379
in O 0 0.007268122397363186
either O 0 0.007660197094082832
region O 0 0.009341176599264145
2 O 0 0.011222505941987038
or O 0 0.006807044614106417
region O 0 0.008840331807732582
3 O 0 0.009705800563097
, O 0 0.006443454883992672
the O 0 0.006557458080351353
average O 0 0.008300798013806343
number O 0 0.0066484143026173115
of O 0 0.009867986664175987
adenomas B-Disease 1 0.999819815158844
tended O 0 0.012665205635130405
to O 0 0.006445420905947685
be O 0 0.005087270401418209
lower O 0 0.008024764247238636
than O 0 0.004452175460755825
those O 0 0.003538919845595956
in O 0 0.004387387074530125
individuals O 0 0.003859084565192461
with O 0 0.004814819898456335
mutations O 0 0.006034532096236944
in O 0 0.0055313752964138985
region O 0 0.007361879572272301
1 O 0 0.008908436633646488
, O 0 0.006789742037653923
although O 0 0.0064246198162436485
age O 0 0.012389576993882656
at O 0 0.02814485877752304
diagnosis O 1 0.9997504353523254
was O 0 0.03626658767461777
similar O 0 0.02770126797258854
. O 0 0.043745044618844986

In O 0 0.03987821936607361
all O 0 0.039159469306468964
AAPC B-Disease 1 0.9999957084655762
kindreds O 1 0.7898989915847778
, O 0 0.019899263978004456
a O 0 0.016458401456475258
predominance O 0 0.04557156562805176
of O 0 0.016461333259940147
right O 1 0.8809642195701599
- O 1 0.9999996423721313
sided O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 1 0.9999945163726807
rectal B-Disease 1 1.0
polyp I-Disease 1 1.0
sparing O 1 0.9999982118606567
was O 1 0.9887378215789795
observed O 0 0.04677308350801468
. O 0 0.045566849410533905

No O 0 0.0610070526599884
desmoid B-Disease 1 0.9999326467514038
tumors I-Disease 1 0.9999678134918213
were O 0 0.016990676522254944
found O 0 0.016564201563596725
in O 0 0.015922626480460167
these O 0 0.018515348434448242
kindreds O 1 0.5871036052703857
. O 0 0.04845995083451271

Our O 0 0.031246062368154526
data O 0 0.017043422907590866
suggest O 0 0.015066011808812618
that O 0 0.008831867948174477
, O 0 0.010846705175936222
in O 0 0.012029193341732025
AAPC B-Disease 1 0.999995231628418
families O 0 0.013248131610453129
, O 0 0.008561236783862114
the O 0 0.007586145773530006
location O 0 0.009583125822246075
of O 0 0.00842310395091772
the O 0 0.017185162752866745
APC B-Disease 1 0.9999969005584717
mutation O 0 0.08770398050546646
may O 0 0.014573371969163418
partially O 0 0.029498757794499397
predict O 0 0.02393384650349617
specific O 0 0.02084394358098507
phenotypic O 0 0.046747393906116486
expression O 0 0.04209420457482338
. O 0 0.04739559441804886

This O 0 0.021227562800049782
should O 0 0.014908659271895885
help O 0 0.016134129837155342
in O 0 0.009659791365265846
the O 0 0.009735211730003357
design O 0 0.014264731667935848
of O 0 0.01260505709797144
tailored O 1 0.8943257927894592
clinical O 1 0.9998679161071777
- O 1 0.9987248778343201
management O 1 0.5007367730140686
protocols O 0 0.021610060706734657
in O 0 0.009385041892528534
this O 0 0.008472580462694168
subset O 0 0.022513870149850845
of O 0 0.47105157375335693
FAP B-Disease 1 1.0
patients O 1 0.9999927282333374
. O 0 0.031215447932481766
. O 0 0.04607323184609413

Wilms B-Disease 1 0.9999988079071045
' I-Disease 1 0.7190753817558289
tumor I-Disease 1 0.9990106821060181
1 O 0 0.03457155451178551
and O 0 0.02612942084670067
Dax O 1 0.9999806880950928
- O 0 0.37093621492385864
1 O 0 0.024838019162416458
modulate O 0 0.03738977015018463
the O 0 0.018234319984912872
orphan O 1 0.8193693161010742
nuclear O 0 0.034314822405576706
receptor O 0 0.2968883812427521
SF O 1 0.9999940395355225
- O 0 0.38039687275886536
1 O 0 0.021294405683875084
in O 0 0.012656253762543201
sex O 0 0.019884228706359863
- O 0 0.04105669632554054
specific O 0 0.019588427618145943
gene O 0 0.0258120559155941
expression O 0 0.035156622529029846
. O 0 0.03972093015909195

Products O 0 0.043538134545087814
of O 0 0.028960013762116432
steroidogenic O 1 0.9989169836044312
factor O 0 0.03034147247672081
1 O 0 0.021939881145954132
( O 0 0.018432237207889557
SF O 1 0.9999867677688599
- O 1 0.9400936365127563
1 O 0 0.018579401075839996
) O 0 0.014340170659124851
and O 0 0.018577536568045616
Wilms B-Disease 1 0.9999998807907104
tumor I-Disease 1 0.9999927282333374
1 O 0 0.10960293561220169
( O 0 0.02560603618621826
WT1 O 1 0.9998319149017334
) O 0 0.017261818051338196
genes O 0 0.012922479771077633
are O 0 0.006714759860187769
essential O 0 0.013577774167060852
for O 0 0.011519153602421284
mammalian O 0 0.03296181187033653
gonadogenesis O 1 0.8999488949775696
prior O 0 0.022575024515390396
to O 0 0.02235410362482071
sexual O 0 0.035933684557676315
differentiation O 0 0.2168431133031845
. O 0 0.04911686107516289

In O 0 0.028934821486473083
males O 0 0.026551302522420883
, O 0 0.024614157155156136
SF O 1 0.9999977350234985
- O 1 0.9789947867393494
1 O 0 0.02293846756219864
participates O 0 0.02196863293647766
in O 0 0.01063938345760107
sexual O 0 0.011662647128105164
development O 0 0.010012908838689327
by O 0 0.008517654612660408
regulating O 0 0.014530142769217491
expression O 0 0.012863673269748688
of O 0 0.012695557437837124
the O 0 0.022134127095341682
polypeptide O 1 0.9989558458328247
hormone O 1 0.9996730089187622
Mullerian O 1 0.9999992847442627
inhibiting O 1 0.9997135996818542
substance O 1 0.9990923404693604
( O 0 0.47132283449172974
MIS O 1 0.9999804496765137
) O 0 0.046959128230810165
. O 0 0.058694854378700256

Here O 0 0.037376102060079575
, O 0 0.01971893385052681
we O 0 0.014983143657445908
show O 0 0.017150092869997025
that O 0 0.015382867306470871
WT1 O 1 0.9997208714485168
- O 1 0.991472065448761
KTS O 1 0.9997120499610901
isoforms O 0 0.03521149232983589
associate O 0 0.03624684736132622
and O 0 0.019819552078843117
synergize O 1 0.8320072293281555
with O 0 0.02478800341486931
SF O 1 0.9999991655349731
- O 1 0.967100203037262
1 O 0 0.030784863978624344
to O 0 0.026306942105293274
promote O 0 0.05145798251032829
MIS O 1 0.9992958307266235
expression O 0 0.057795144617557526
. O 0 0.0638076439499855

In O 0 0.03522816672921181
contrast O 0 0.03669833764433861
, O 0 0.028656691312789917
WT1 O 1 0.9995554089546204
missense O 0 0.17684875428676605
mutations O 0 0.024381417781114578
, O 0 0.013469118624925613
associated O 0 0.009834177792072296
with O 0 0.008788641542196274
male B-Disease 0 0.01801467500627041
pseudohermaphroditism I-Disease 1 0.9994972944259644
in O 0 0.04996786266565323
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.021823706105351448
fail O 0 0.02633616328239441
to O 0 0.01762828789651394
synergize O 1 0.9919449687004089
with O 0 0.03451826050877571
SF O 1 0.9999997615814209
- O 1 0.9994938373565674
1 O 0 0.057391274720430374
. O 0 0.05827208608388901

Additionally O 0 0.045599572360515594
, O 0 0.02083626762032509
the O 0 0.016301071271300316
X O 1 0.617213785648346
- O 1 0.5657268762588501
linked O 0 0.019054997712373734
, O 0 0.01297227293252945
candidate O 0 0.02260400354862213
dosage O 1 0.9740360379219055
- O 0 0.398164302110672
sensitive O 0 0.020408019423484802
sex O 0 0.01752631552517414
- O 0 0.07762943208217621
reversal O 0 0.026472631841897964
gene O 0 0.016389736905694008
, O 0 0.019150853157043457
Dax O 1 0.9999319314956665
- O 0 0.12651501595973969
1 O 0 0.023433929309248924
, O 0 0.01921689510345459
antagonizes O 0 0.0669216513633728
synergy O 0 0.050932057201862335
between O 0 0.020461060106754303
SF O 1 0.9999988079071045
- O 1 0.9826050996780396
1 O 0 0.028250113129615784
and O 0 0.018649667501449585
WT1 O 1 0.9996161460876465
, O 0 0.014648009091615677
most O 0 0.011305499821901321
likely O 0 0.011395367793738842
through O 0 0.009074586443603039
a O 0 0.01055358536541462
direct O 0 0.012075785547494888
interaction O 0 0.014743720181286335
with O 0 0.018467554822564125
SF O 1 0.9999998807907104
- O 1 0.9993769526481628
1 O 0 0.050861068069934845
. O 0 0.04985492676496506

We O 0 0.031538330018520355
propose O 0 0.038769155740737915
that O 0 0.019443459808826447
WT1 O 1 0.9961534142494202
and O 0 0.028806453570723534
Dax O 1 0.9999972581863403
- O 1 0.9816837310791016
1 O 0 0.02469278685748577
functionally O 0 0.02984103560447693
oppose O 0 0.01750359497964382
each O 0 0.008828016929328442
other O 0 0.00806527491658926
in O 0 0.011955092661082745
testis O 0 0.21837207674980164
development O 0 0.015426536090672016
by O 0 0.014247669838368893
modulating O 1 0.999029278755188
SF O 1 0.9999996423721313
- O 1 0.9976935982704163
1 O 0 0.04924760013818741
- O 1 0.8409605026245117
mediated O 0 0.39251604676246643
transactivation O 1 0.9910246133804321
. O 0 0.03823229297995567
. O 0 0.05216645076870918

A O 0 0.04982268065214157
mouse O 0 0.050673432648181915
model O 0 0.03068290464580059
for O 0 0.02884538099169731
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 1.0
- O 1 0.9999996423721313
centre O 1 0.9997910857200623
mutations O 0 0.2791171669960022
. O 0 0.05318990349769592

Imprinting O 0 0.09244145452976227
in O 0 0.024418123066425323
the O 0 0.02330348640680313
15q11 O 1 0.9894137382507324
- O 1 0.8746617436408997
q13 O 0 0.11747454106807709
region O 0 0.019321253523230553
involves O 0 0.0156855508685112
an O 0 0.01283350121229887
imprinting O 1 0.9918402433395386
centre O 1 0.981024980545044
( O 0 0.23341508209705353
IC O 1 0.9999933242797852
) O 0 0.011893820017576218
, O 0 0.009183158166706562
mapping O 0 0.011108720675110817
in O 0 0.006667749490588903
part O 0 0.008673058822751045
to O 0 0.007533470168709755
the O 0 0.010527788661420345
promoter O 0 0.2888193726539612
and O 0 0.013918665237724781
first O 0 0.023210693150758743
exon O 0 0.06914149224758148
of O 0 0.03387279063463211
SNRPN O 1 0.9992303848266602
. O 0 0.059084076434373856

Deletion O 0 0.07505018264055252
of O 0 0.02967184968292713
this O 0 0.02226373367011547
IC O 1 0.9996968507766724
abolishes O 1 0.9529005289077759
local O 0 0.020813437178730965
paternally O 0 0.2209448218345642
derived O 0 0.014152194373309612
gene O 0 0.011673870496451855
expression O 0 0.010045593604445457
and O 0 0.009232698939740658
results O 0 0.012033303268253803
in O 0 0.02343689277768135
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999982118606567
PWS B-Disease 1 1.0
) O 0 0.31348901987075806
. O 0 0.06591344624757767

We O 0 0.02428491972386837
have O 0 0.013202131725847721
created O 0 0.018605297431349754
two O 0 0.012162239290773869
deletion O 0 0.029080644249916077
mutations O 0 0.013945621438324451
in O 0 0.00976648461073637
mice O 0 0.016437571495771408
to O 0 0.011328378692269325
understand O 0 0.02734186500310898
PWS B-Disease 1 0.9999997615814209
and O 0 0.01368162501603365
the O 0 0.013435021974146366
mechanism O 0 0.0209472868591547
of O 0 0.01649031788110733
this O 0 0.020886478945612907
IC O 1 0.9999386072158813
. O 0 0.05246797576546669

Mice O 0 0.154786616563797
harbouring O 1 0.8254028558731079
an O 0 0.029083121567964554
intragenic O 1 0.9968553781509399
deletion O 0 0.23684518039226532
in O 0 0.020587420091032982
Snrpn O 1 0.9945669174194336
are O 0 0.011693394742906094
phenotypically O 0 0.470885306596756
normal O 0 0.013755368068814278
, O 0 0.011070854030549526
suggesting O 0 0.012602665461599827
that O 0 0.007570836693048477
mutations O 0 0.012341178953647614
of O 0 0.011010647751390934
SNRPN O 1 0.9990697503089905
are O 0 0.00807956699281931
not O 0 0.009243176318705082
sufficient O 0 0.019819950684905052
to O 0 0.0280446819961071
induce O 1 0.8910674452781677
PWS B-Disease 1 0.9999982118606567
. O 0 0.06877592951059341

Mice O 0 0.0653170645236969
with O 0 0.02252553217113018
a O 0 0.020636897534132004
larger O 0 0.021705633029341698
deletion O 0 0.030507486313581467
involving O 0 0.018268359825015068
both O 0 0.014264932833611965
Snrpn O 1 0.6039806008338928
and O 0 0.014175564050674438
the O 0 0.019685594365000725
putative O 1 0.9995790123939514
PWS O 1 1.0
- O 1 0.9999734163284302
IC O 1 0.9999417066574097
lack O 0 0.022405549883842468
expression O 0 0.016939258202910423
of O 0 0.014234042726457119
the O 0 0.018059011548757553
imprinted O 1 0.9977570176124573
genes O 0 0.02423267439007759
Zfp127 O 1 0.9519842267036438
( O 0 0.020161697641015053
mouse O 0 0.03855530172586441
homologue O 0 0.052648816257715225
of O 0 0.020122572779655457
ZNF127 O 1 0.9997631907463074
) O 0 0.017528114840388298
, O 0 0.018358614295721054
Ndn O 1 0.9994710087776184
and O 0 0.016917116940021515
Ipw O 1 0.9688090085983276
, O 0 0.014183016493916512
and O 0 0.011940563097596169
manifest O 0 0.025973515585064888
several O 0 0.01305692084133625
phenotypes O 0 0.4984821081161499
common O 0 0.03258996456861496
to O 1 0.5980454683303833
PWS B-Disease 1 1.0
infants O 1 0.9999935626983643
. O 0 0.07135111838579178

These O 0 0.019002865999937057
data O 0 0.015407899394631386
demonstrate O 0 0.015506742522120476
that O 0 0.00741219986230135
both O 0 0.006122566759586334
the O 0 0.006597623694688082
position O 0 0.008359173312783241
of O 0 0.007505975663661957
the O 0 0.011195422150194645
IC O 1 0.9999693632125854
and O 0 0.008078967221081257
its O 0 0.007066246587783098
role O 0 0.008366057649254799
in O 0 0.006103465799242258
the O 0 0.007199225481599569
coordinate O 0 0.012545552104711533
expression O 0 0.008938622660934925
of O 0 0.009054728783667088
genes O 0 0.009747401811182499
is O 0 0.008398018777370453
conserved O 0 0.01227076817303896
between O 0 0.008473360911011696
mouse O 0 0.019507018849253654
and O 0 0.00745409308001399
human O 0 0.00580932991579175
, O 0 0.006575191393494606
and O 0 0.005771229509264231
indicate O 0 0.006630413234233856
that O 0 0.005018096882849932
the O 0 0.007487675175070763
mouse O 0 0.016478674486279488
is O 0 0.006020085420459509
a O 0 0.007139293011277914
suitable O 0 0.010806228965520859
model O 0 0.009336099028587341
system O 0 0.007353340741246939
in O 0 0.0056941513903439045
which O 0 0.005053312052041292
to O 0 0.0065050735138356686
investigate O 0 0.012111990712583065
the O 0 0.009053424932062626
molecular O 0 0.0133721474558115
mechanisms O 0 0.012094162404537201
of O 0 0.010054750367999077
imprinting O 0 0.260329008102417
in O 0 0.008466408587992191
this O 0 0.006801254115998745
region O 0 0.010025939904153347
of O 0 0.009836249053478241
the O 0 0.015193420462310314
genome O 0 0.043591201305389404
. O 0 0.02302194945514202
. O 0 0.03796942159533501

Mutations O 0 0.03639641031622887
of O 0 0.01717687025666237
the O 0 0.015327130444347858
ATM O 0 0.4627409875392914
gene O 0 0.012787382118403912
detected O 0 0.013255045749247074
in O 0 0.010408148169517517
Japanese O 1 0.9956763386726379
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.9998811483383179
: O 0 0.015638912096619606
possible O 0 0.013626152649521828
preponderance O 0 0.04896700009703636
of O 0 0.012853335589170456
the O 0 0.013758687302470207
two O 0 0.01493436936289072
founder O 1 0.9873934984207153
mutations O 0 0.042124174535274506
4612del165 O 1 0.9441402554512024
and O 0 0.036251895129680634
7883del5 O 1 0.8812219500541687
. O 0 0.05861090123653412

The O 0 0.03663169965147972
ATM O 0 0.09170112758874893
( O 0 0.022016964852809906
A O 1 0.8353966474533081
- O 1 0.9999828338623047
T O 1 0.999995231628418
, O 0 0.018882280215620995
mutated O 0 0.03129979968070984
) O 0 0.014148436486721039
gene O 0 0.014856802299618721
on O 0 0.014745029620826244
human O 0 0.023659266531467438
chromosome O 0 0.06397853046655655
11q22 O 1 0.9264553785324097
. O 0 0.05093204975128174

3 O 0 0.03811272606253624
has O 0 0.01813799887895584
recently O 0 0.01730199158191681
been O 0 0.00897583644837141
identified O 0 0.009921634569764137
as O 0 0.006338723003864288
the O 0 0.00734157208353281
gene O 0 0.0077507384121418
responsible O 0 0.007158801890909672
for O 0 0.005980687215924263
the O 0 0.008249783888459206
human O 0 0.23374876379966736
recessive B-Disease 1 0.9999996423721313
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9727056622505188
A B-Disease 1 0.9999982118606567
- I-Disease 1 0.9999998807907104
T I-Disease 1 0.9999998807907104
) O 0 0.03961047902703285
. O 0 0.05344487354159355

In O 0 0.02268022485077381
order O 0 0.014133830554783344
to O 0 0.009678402915596962
define O 0 0.011595349758863449
the O 0 0.00786585919559002
types O 0 0.009746868163347244
of O 0 0.03796015679836273
disease O 1 1.0
- O 1 0.9999946355819702
causing O 1 0.9780158400535583
ATM O 1 0.801929771900177
mutations O 0 0.010393639095127583
in O 0 0.007020505145192146
Japanese O 0 0.02178962156176567
A B-Disease 1 0.9998658895492554
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
patients O 1 0.9966513514518738
as O 0 0.00795537605881691
well O 0 0.007911356166005135
as O 0 0.006880238186568022
to O 0 0.007188242394477129
look O 0 0.011301619932055473
for O 0 0.008901875466108322
possible O 0 0.013912488706409931
mutational O 1 0.7709667086601257
hotspots O 1 0.5933675765991211
, O 0 0.014283571392297745
reverse O 0 0.02226765640079975
- O 0 0.11067160218954086
transcribed O 0 0.02193341590464115
RNA O 0 0.01610397733747959
derived O 0 0.009182802401483059
from O 0 0.008585729636251926
ten O 0 0.013334240764379501
patients O 0 0.016475358977913857
belonging O 0 0.012017367407679558
to O 0 0.007490252610296011
eight O 0 0.00881185382604599
unrelated O 0 0.013394619338214397
Japanese O 0 0.0302499458193779
A B-Disease 1 0.9940910935401917
- I-Disease 1 0.9999922513961792
T I-Disease 1 0.9999860525131226
families O 0 0.012643103487789631
was O 0 0.012691874988377094
analyzed O 0 0.013578999787569046
for O 0 0.010355217382311821
mutations O 0 0.012875293381512165
by O 0 0.008997045457363129
the O 0 0.015956906601786613
restriction O 0 0.03378739580512047
endonuclease O 0 0.3091246783733368
fingerprinting O 0 0.06891856342554092
method O 0 0.047901153564453125
. O 0 0.05105148255825043

As O 0 0.02125973254442215
has O 0 0.014428758062422276
been O 0 0.009153361432254314
reported O 0 0.010403202846646309
by O 0 0.006342845503240824
others O 0 0.00815272331237793
, O 0 0.008554345928132534
mutations O 0 0.009080659598112106
that O 0 0.006114647723734379
lead O 0 0.010312173515558243
to O 0 0.011502953246235847
exon O 0 0.04234013333916664
skipping O 0 0.032302211970090866
or O 0 0.015364374965429306
premature O 0 0.10915245860815048
protein O 0 0.01882096566259861
truncation O 0 0.03497539088129997
were O 0 0.012161994352936745
also O 0 0.015490195713937283
predominant O 0 0.026141388341784477
in O 0 0.018019719049334526
our O 0 0.030745118856430054
mutants O 0 0.14496035873889923
. O 0 0.04635663330554962

Six O 0 0.030117448419332504
different O 0 0.01482064463198185
mutations O 0 0.01676522195339203
were O 0 0.00955002661794424
identified O 0 0.01022105012089014
on O 0 0.007892872206866741
12 O 0 0.012250406667590141
of O 0 0.01060452964156866
the O 0 0.014409568160772324
16 O 0 0.026359714567661285
alleles O 0 0.041532088071107864
examined O 0 0.05244024470448494
. O 0 0.044344473630189896

Four O 0 0.03343359753489494
were O 0 0.020197661593556404
deletions O 0 0.030909277498722076
involving O 0 0.017438340932130814
a O 0 0.015498975291848183
loss O 0 0.02738046459853649
of O 0 0.01224020216614008
a O 0 0.01660149171948433
single O 0 0.022663036361336708
exon O 0 0.07045920938253403
exon O 0 0.05057670921087265
7 O 0 0.028727198019623756
, O 0 0.022126005962491035
exon O 0 0.044417232275009155
16 O 0 0.026234183460474014
, O 0 0.022131986916065216
exon O 0 0.05516583472490311
33 O 0 0.04069345444440842
or O 0 0.02885480225086212
exon O 0 0.08875084668397903
35 O 0 0.0625109151005745
. O 0 0.054533977061510086

The O 0 0.03708815202116966
others O 0 0.024630652740597725
were O 0 0.01507758442312479
minute O 0 0.02841009758412838
deletions O 0 0.0358123704791069
, O 0 0.020364975556731224
4649delA O 0 0.04720919951796532
in O 0 0.019783329218626022
exon O 0 0.050141237676143646
33 O 0 0.03235272690653801
and O 0 0.0233423113822937
7883del5 O 0 0.06586474925279617
in O 0 0.02944101206958294
exon O 0 0.0938451811671257
55 O 0 0.07016275823116302
. O 0 0.05353419855237007

The O 0 0.046485453844070435
mutations O 0 0.038146961480379105
4612del165 O 0 0.1420104205608368
and O 0 0.019626008346676826
7883del5 O 0 0.4894786775112152
were O 0 0.009740481153130531
found O 0 0.007485265843570232
in O 0 0.005944049917161465
more O 0 0.005137076135724783
than O 0 0.005158169660717249
two O 0 0.005938320886343718
unrelated O 0 0.01011493057012558
families O 0 0.007298298645764589
; O 0 0.007158547639846802
44 O 0 0.012394736520946026
% O 0 0.0076630632393062115
( O 0 0.007548052351921797
7 O 0 0.01118889357894659
of O 0 0.008189556188881397
16 O 0 0.011079096235334873
) O 0 0.00769800366833806
of O 0 0.008134117349982262
the O 0 0.00922588724642992
mutant O 0 0.020148057490587234
alleles O 0 0.014023087918758392
had O 0 0.009673257358372211
one O 0 0.0075581916607916355
of O 0 0.008386137895286083
the O 0 0.011950260028243065
two O 0 0.01496168877929449
mutations O 0 0.03086039237678051
. O 0 0.0372149795293808

The O 0 0.04066401720046997
4612del165 O 1 0.8133676052093506
mutations O 0 0.022433971986174583
in O 0 0.010206703096628189
three O 0 0.007532963994890451
different O 0 0.005095760338008404
families O 0 0.0071203699335455894
were O 0 0.005642239935696125
all O 0 0.005671975668519735
ascribed O 0 0.01060017291456461
to O 0 0.006021811626851559
the O 0 0.007881216704845428
same O 0 0.009920443408191204
T O 1 0.9999470710754395
- O 1 0.9915920495986938
- O 1 0.90692538022995
> O 0 0.03416512534022331
A O 0 0.016514059156179428
substitution O 0 0.021175524219870567
at O 0 0.015792163088917732
the O 0 0.017126917839050293
splice O 0 0.04580680653452873
donor O 0 0.026587381958961487
site O 0 0.03055000491440296
in O 0 0.027182165533304214
intron O 1 0.9706146717071533
33 O 0 0.06546633690595627
. O 0 0.05989586189389229

Microsatellite O 1 0.7748726010322571
genotyping O 0 0.10951761901378632
around O 0 0.026036888360977173
the O 0 0.022537890821695328
ATM O 1 0.773578941822052
locus O 0 0.34914055466651917
also O 0 0.012668248265981674
indicated O 0 0.012167517095804214
that O 0 0.006288680247962475
a O 0 0.010417641140520573
common O 0 0.009675761684775352
haplotype O 0 0.07057464122772217
was O 0 0.014529119245707989
shared O 0 0.013813378289341927
by O 0 0.007958286441862583
the O 0 0.011360553093254566
mutant O 0 0.035248346626758575
alleles O 0 0.021793771535158157
in O 0 0.014864123426377773
both O 0 0.01903947815299034
mutations O 0 0.033817123621702194
. O 0 0.03326927870512009

This O 0 0.020757300779223442
suggests O 0 0.018110089004039764
that O 0 0.007967066019773483
these O 0 0.006506223231554031
two O 0 0.009204342029988766
founder O 1 0.9894686341285706
mutations O 0 0.016851698979735374
may O 0 0.00890540610998869
be O 0 0.009596763178706169
predominant O 0 0.023501385003328323
among O 0 0.019045794382691383
Japanese O 0 0.21598611772060394
ATM O 1 0.9629104137420654
mutant O 0 0.1049351692199707
alleles O 0 0.06847571581602097
. O 0 0.05701417848467827

W474C O 1 0.9079142212867737
amino O 0 0.056068748235702515
acid O 0 0.05166710168123245
substitution O 0 0.035675451159477234
affects O 0 0.025875044986605644
early O 0 0.013868212699890137
processing O 0 0.014962784014642239
of O 0 0.010431359522044659
the O 0 0.01114688254892826
alpha O 0 0.02463851496577263
- O 0 0.02235664427280426
subunit O 0 0.019650427624583244
of O 0 0.011255534365773201
beta O 0 0.023863229900598526
- O 0 0.15497632324695587
hexosaminidase O 0 0.40322545170783997
A O 0 0.014236143790185452
and O 0 0.00860412698239088
is O 0 0.007799034472554922
associated O 0 0.010487250052392483
with O 0 0.017023958265781403
subacute O 1 1.0
G B-Disease 1 0.9999996423721313
( I-Disease 1 0.9384476542472839
M2 I-Disease 1 0.9999527931213379
) I-Disease 0 0.04764518514275551
gangliosidosis I-Disease 1 0.7619363069534302
. O 0 0.05806314945220947

Mutations O 0 0.04704516753554344
in O 0 0.02216857299208641
the O 0 0.024488218128681183
HEXA O 1 0.9998332262039185
gene O 0 0.022448167204856873
, O 0 0.013762286864221096
encoding O 0 0.01625789701938629
the O 0 0.012858867645263672
alpha O 0 0.028236933052539825
- O 0 0.02500830590724945
subunit O 0 0.02399766817688942
of O 0 0.014711338095366955
beta O 0 0.026332180947065353
- O 0 0.18107016384601593
hexosaminidase O 0 0.25060370564460754
A O 0 0.02065437100827694
( O 0 0.015421049669384956
Hex O 0 0.040214426815509796
A O 0 0.018818384036421776
) O 0 0.012124190106987953
, O 0 0.010686369612812996
that O 0 0.00848205853253603
abolish O 0 0.024355795234441757
Hex O 0 0.03637051582336426
A O 0 0.019023215398192406
enzyme O 0 0.018572602421045303
activity O 0 0.015342740342020988
cause O 1 0.9960846900939941
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9642055034637451
TSD B-Disease 1 0.9999997615814209
) O 0 0.01505883689969778
, O 0 0.012932884506881237
the O 0 0.013849742710590363
fatal O 1 0.999711811542511
infantile B-Disease 1 0.999994158744812
form I-Disease 0 0.022599879652261734
of I-Disease 1 0.7428644895553589
G I-Disease 1 0.9999954700469971
( I-Disease 0 0.45538049936294556
M2 I-Disease 1 0.9999738931655884
) I-Disease 0 0.022004704922437668
gangliosidosis I-Disease 1 0.8729417324066162
, I-Disease 0 0.026383059099316597
Type I-Disease 0 0.04493848606944084
1 I-Disease 0 0.0520278625190258
. O 0 0.05430835857987404

Less O 0 0.041241396218538284
severe O 1 0.9997405409812927
, O 0 0.11375010013580322
subacute O 1 1.0
( O 1 0.7156776189804077
juvenile O 1 0.9999967813491821
- O 1 0.9999995231628418
onset O 1 1.0
) O 0 0.050117023289203644
and O 0 0.10910484194755554
chronic O 1 1.0
( O 0 0.48412612080574036
adult O 1 0.9900965690612793
- O 1 0.9999995231628418
onset O 1 1.0
) O 0 0.01312576700001955
variants O 0 0.012590649537742138
are O 0 0.005950056482106447
characterized O 0 0.009224200621247292
by O 0 0.006282825022935867
a O 0 0.008229467086493969
broad O 0 0.012533335946500301
spectrum O 0 0.017561376094818115
of O 0 0.01807512901723385
clinical O 1 0.9999938011169434
manifestations O 1 0.999909520149231
and O 0 0.011574208736419678
are O 0 0.0065194689668715
associated O 0 0.010085919871926308
with O 0 0.010348090901970863
residual O 0 0.21047969162464142
levels O 0 0.015443312004208565
of O 0 0.01689259149134159
Hex O 0 0.28953659534454346
A O 0 0.05252660810947418
enzyme O 0 0.04077688604593277
activity O 0 0.0357435867190361
. O 0 0.04918454587459564

We O 0 0.029991451650857925
identified O 0 0.022804846987128258
a O 0 0.02330801635980606
1422 O 1 0.999887228012085
G O 1 0.9987785220146179
- O 1 0.998536229133606
- O 1 0.999299168586731
> O 1 0.994763195514679
C O 1 0.6323113441467285
( O 0 0.02113720402121544
amino O 0 0.024767573922872543
acid O 0 0.032821059226989746
W474C O 0 0.24124442040920258
) O 0 0.015952443704009056
substitution O 0 0.01971982792019844
in O 0 0.00995179358869791
the O 0 0.009117534384131432
first O 0 0.011512971483170986
position O 0 0.014611185528337955
of O 0 0.012532604858279228
exon O 0 0.029445284977555275
13 O 0 0.017778923735022545
of O 0 0.015003037638962269
HEXA O 1 0.98638516664505
of O 0 0.013644019141793251
a O 0 0.014754620380699635
non O 0 0.021420693024992943
- O 1 0.73304682970047
Jewish O 0 0.0208218265324831
proband O 1 0.8341641426086426
who O 0 0.021431470289826393
manifested O 0 0.22685377299785614
a O 0 0.024154378101229668
subacute O 1 0.9999997615814209
variant O 1 0.9864902496337891
of O 1 0.9213285446166992
G B-Disease 1 0.9999966621398926
( I-Disease 1 0.7321180105209351
M2 I-Disease 1 0.9999006986618042
) I-Disease 0 0.0437651053071022
gangliosidosis I-Disease 1 0.5955802202224731
. O 0 0.059797562658786774

On O 0 0.02890356071293354
the O 0 0.023256519809365273
second O 0 0.04133868217468262
maternally O 1 0.9996923208236694
inherited O 1 0.9999628067016602
allele O 0 0.036503005772829056
, O 0 0.010025366209447384
we O 0 0.006615990307182074
identified O 0 0.00828215479850769
the O 0 0.009406526573002338
common O 1 0.6834284067153931
infantile O 1 1.0
disease O 1 1.0
- O 1 0.9999986886978149
causing O 1 0.999170184135437
4 O 0 0.07193145900964737
- O 0 0.20256537199020386
bp O 0 0.042189665138721466
insertion O 0 0.049009956419467926
, O 0 0.023828405886888504
+ O 0 0.12277163565158844
TATC O 1 0.9993717074394226
1278 O 1 0.9996405839920044
, O 0 0.02746051363646984
in O 0 0.028289027512073517
exon O 0 0.08314850926399231
11 O 0 0.05081486701965332
. O 0 0.05733015760779381

Pulse O 1 0.7283182740211487
- O 0 0.1057841032743454
chase O 0 0.04519188031554222
analysis O 0 0.020497895777225494
using O 0 0.019301433116197586
proband O 1 0.9214584231376648
fibroblasts O 0 0.09903228282928467
revealed O 0 0.017336856573820114
that O 0 0.008890687488019466
the O 0 0.01268778182566166
W474C O 0 0.28833168745040894
- O 0 0.0317312553524971
containing O 0 0.01671941950917244
alpha O 0 0.030236084014177322
- O 0 0.07725902646780014
subunit O 0 0.026816483587026596
precursor O 0 0.02318347990512848
was O 0 0.01530016865581274
normally O 0 0.014467203058302402
synthesized O 0 0.018346084281802177
, O 0 0.00859692133963108
but O 0 0.006541269365698099
not O 0 0.007001660298556089
phosphorylated O 0 0.02061380073428154
or O 0 0.009315591305494308
secreted O 0 0.019738372415304184
, O 0 0.009918462485074997
and O 0 0.009298281744122505
the O 0 0.012568817473948002
mature O 0 0.03547130525112152
lysosomal O 1 0.9999111890792847
alpha O 1 0.6817203760147095
- O 1 0.7665612697601318
subunit O 0 0.040405962616205215
was O 0 0.026455456390976906
not O 0 0.019528672099113464
detected O 0 0.041069500148296356
. O 0 0.043325480073690414

When O 0 0.04332296922802925
the O 0 0.0315801277756691
W474C O 0 0.12597307562828064
- O 0 0.04287753999233246
containing O 0 0.02591799758374691
alpha O 0 0.038400012999773026
- O 0 0.037073712795972824
subunit O 0 0.034224845468997955
was O 0 0.02585993893444538
transiently O 1 0.6090248823165894
co O 0 0.22005045413970947
- O 0 0.027490198612213135
expressed O 0 0.013436109758913517
with O 0 0.00983638409525156
the O 0 0.01385045237839222
beta O 0 0.028083493933081627
- O 0 0.026297206059098244
subunit O 0 0.02148447558283806
to O 0 0.011278722435235977
produce O 0 0.01413209643214941
Hex O 0 0.03197035193443298
A O 0 0.018752429634332657
( O 0 0.017649102956056595
alphabeta O 0 0.06517423689365387
) O 0 0.015065920539200306
in O 0 0.017192590981721878
COS O 1 0.9999433755874634
- O 1 0.5784794688224792
7 O 0 0.023257480934262276
cells O 0 0.014406886883080006
, O 0 0.010527675971388817
the O 0 0.011667567305266857
mature O 0 0.018434185534715652
alpha O 0 0.029228994622826576
- O 0 0.04815318435430527
subunit O 0 0.024888113141059875
was O 0 0.014966798014938831
present O 0 0.010331266559660435
, O 0 0.008572418242692947
but O 0 0.006150837522000074
its O 0 0.0070285312831401825
level O 0 0.008487874642014503
was O 0 0.010399585589766502
much O 0 0.00844505149871111
lower O 0 0.009071228094398975
than O 0 0.0049585639499127865
that O 0 0.0041639418341219425
from O 0 0.005864075850695372
normal O 0 0.009461460635066032
alpha O 0 0.023155048489570618
- O 0 0.07642964273691177
subunit O 0 0.027658477425575256
transfections O 0 0.047329969704151154
, O 0 0.01018780842423439
although O 0 0.008475427515804768
higher O 0 0.007303548976778984
than O 0 0.00575172109529376
in O 0 0.006431297864764929
those O 0 0.007252203766256571
cells O 0 0.013551467098295689
transfected O 0 0.03616887331008911
with O 0 0.009246098808944225
an O 0 0.011701553128659725
alpha O 0 0.05654184892773628
- O 0 0.2464396059513092
subunit O 0 0.03910650312900543
associated O 0 0.02531362697482109
with O 0 0.035272642970085144
infantile O 1 0.9999967813491821
TSD B-Disease 1 0.9999972581863403
. O 0 0.08037810027599335

Furthermore O 0 0.043804243206977844
, O 0 0.0176174845546484
the O 0 0.014860248193144798
precursor O 0 0.021892055869102478
level O 0 0.010661494918167591
of O 0 0.009191184304654598
the O 0 0.01097234059125185
W474C O 1 0.8789526224136353
alpha O 0 0.03707325458526611
- O 0 0.048738326877355576
subunit O 0 0.02316109463572502
was O 0 0.011942964978516102
found O 0 0.008171855472028255
to O 0 0.00852343998849392
accumulate O 0 0.017090467736124992
in O 0 0.008249441161751747
comparison O 0 0.01076598558574915
to O 0 0.007866227068006992
the O 0 0.009621911682188511
normal O 0 0.017023518681526184
alpha O 0 0.043177079409360886
- O 0 0.312192440032959
subunit O 0 0.06078245863318443
precursor O 0 0.07189395278692245
levels O 0 0.045131243765354156
. O 0 0.05472560599446297

We O 0 0.030741741880774498
conclude O 0 0.030242150649428368
that O 0 0.01226610504090786
the O 0 0.017710696905851364
1422 O 1 0.9996366500854492
G O 1 0.9961982369422913
- O 1 0.9975177049636841
- O 1 0.9984652996063232
> O 1 0.9906941056251526
C O 1 0.6975482106208801
mutation O 0 0.016918513923883438
is O 0 0.008843576535582542
the O 0 0.009558730758726597
cause O 0 0.012998957186937332
of O 0 0.012799290008842945
Hex B-Disease 1 0.9970715045928955
A I-Disease 1 0.9999297857284546
enzyme I-Disease 1 0.9999879598617554
deficiency I-Disease 1 1.0
in O 0 0.02571754716336727
the O 0 0.09050066024065018
proband O 1 0.9998039603233337
. O 0 0.056024111807346344

The O 0 0.04190657660365105
resulting O 0 0.039921339601278305
W474C O 1 0.7703810334205627
substitution O 0 0.032477766275405884
clearly O 0 0.02262711711227894
interferes O 0 0.03181718662381172
with O 0 0.013410060666501522
alpha O 0 0.036713894456624985
- O 0 0.2404865324497223
subunit O 0 0.025552472099661827
processing O 0 0.016295934095978737
, O 0 0.009991622529923916
but O 0 0.007568164262920618
because O 0 0.006277845706790686
the O 0 0.009062891826033592
base O 0 0.015761641785502434
substitution O 0 0.01695413701236248
falls O 0 0.02390708401799202
at O 0 0.011601232923567295
the O 0 0.009832530282437801
first O 0 0.011474096216261387
position O 0 0.014492269605398178
of O 0 0.012185837142169476
exon O 0 0.03415490314364433
13 O 0 0.016982922330498695
, O 0 0.0134310657158494
aberrant O 0 0.0295496117323637
splicing O 0 0.021853584796190262
may O 0 0.01197101455181837
also O 0 0.010169517248868942
contribute O 0 0.013487079180777073
to O 0 0.011720400303602219
Hex B-Disease 0 0.49776408076286316
A I-Disease 1 0.9558952450752258
deficiency I-Disease 1 0.9999998807907104
in O 0 0.015273207798600197
this O 0 0.016803346574306488
proband O 1 0.9995736479759216
. O 0 0.028497230261564255
. O 0 0.04577521234750748

Two O 0 0.03867621719837189
frequent O 0 0.04956044256687164
missense O 0 0.08381953835487366
mutations O 0 0.04889816790819168
in O 0 0.10041166096925735
Pendred B-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
. O 1 0.6734932661056519

Pendred B-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
is O 0 0.2670295834541321
an O 1 0.9997846484184265
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 0.9999997615814209
by O 1 0.9977796673774719
early O 1 0.9999997615814209
childhood O 1 1.0
deafness B-Disease 1 1.0
and O 1 0.9999991655349731
goiter B-Disease 1 1.0
. O 1 0.9955911636352539

A O 0 0.03739684075117111
century O 0 0.025627270340919495
after O 0 0.013905149884521961
its O 0 0.01036806870251894
recognition O 0 0.013161019422113895
as O 0 0.010206818580627441
a O 0 0.02925683744251728
syndrome O 1 0.9999997615814209
by O 0 0.010710634291172028
Vaughan O 1 0.9993054866790771
Pendred O 1 0.9997324347496033
, O 0 0.013448338955640793
the O 0 0.1513478308916092
disease O 1 0.9999998807907104
gene O 1 0.5428418517112732
( O 0 0.13753202557563782
PDS O 1 0.9999936819076538
) O 0 0.01641254313290119
was O 0 0.019840653985738754
mapped O 0 0.03092077374458313
to O 0 0.022642049938440323
chromosome O 0 0.04612800478935242
7q22 O 1 0.9822599291801453
- O 1 0.9930483102798462
q31 O 1 0.9446194767951965
. O 0 0.06442858278751373

1 O 0 0.04199405387043953
and O 0 0.02081654779613018
, O 0 0.01791168749332428
recently O 0 0.02069048397243023
, O 0 0.013016960583627224
found O 0 0.010528395883738995
to O 0 0.012943084351718426
encode O 0 0.028121810406446457
a O 0 0.03179604560136795
putative O 1 0.9919955730438232
sulfate O 1 0.9999887943267822
transporter O 1 0.9988160133361816
. O 0 0.06713932752609253

We O 0 0.02656850405037403
performed O 0 0.025572950020432472
mutation O 0 0.017383122816681862
analysis O 0 0.010098453611135483
of O 0 0.010392319411039352
the O 0 0.013216023333370686
PDS B-Disease 1 0.9999983310699463
gene O 0 0.015517876483500004
in O 0 0.010963537730276585
patients O 0 0.19610312581062317
from O 0 0.009334263391792774
14 O 0 0.016321413218975067
Pendred B-Disease 1 0.6821798086166382
families O 0 0.012373887002468109
originating O 0 0.012662462890148163
from O 0 0.008235888555645943
seven O 0 0.009773511439561844
countries O 0 0.0078897038474679
and O 0 0.01066870428621769
identified O 0 0.015188178047537804
all O 0 0.016613030806183815
mutations O 0 0.0335349515080452
. O 0 0.03678802773356438

The O 0 0.040072061121463776
mutations O 0 0.027908578515052795
include O 0 0.016369737684726715
three O 0 0.012392336502671242
single O 0 0.016830749809741974
base O 0 0.02504872903227806
deletions O 0 0.02853522077202797
, O 0 0.0124423922970891
one O 0 0.012829695828258991
splice O 0 0.03787929192185402
site O 0 0.02405865676701069
mutation O 0 0.020539678633213043
and O 0 0.015975194051861763
10 O 0 0.028521882370114326
missense O 0 0.0747566819190979
mutations O 0 0.048367973417043686
. O 0 0.04487865790724754

One O 0 0.042153410613536835
missense O 0 0.07618597149848938
mutation O 0 0.038493555039167404
( O 0 0.022523336112499237
L236P O 1 0.9021815657615662
) O 0 0.015480644069612026
was O 0 0.015173749066889286
found O 0 0.009291155263781548
in O 0 0.006950193550437689
a O 0 0.009259103797376156
homozygous O 0 0.013503286987543106
state O 0 0.00649799220263958
in O 0 0.007450642995536327
two O 0 0.009562166407704353
consanguineous O 0 0.35079994797706604
families O 0 0.009924380108714104
and O 0 0.007722150068730116
in O 0 0.008035034872591496
a O 0 0.01054426934570074
heterozygous O 0 0.013674398884177208
state O 0 0.007400330621749163
in O 0 0.00796059425920248
five O 0 0.009859799407422543
additional O 0 0.015573913231492043
non O 0 0.03216489776968956
- O 1 0.9720075726509094
consanguineous O 1 0.9625569581985474
families O 0 0.04260474815964699
. O 0 0.04605935141444206

Another O 0 0.05508877709507942
missense O 0 0.12277401238679886
mutation O 0 0.0411381758749485
( O 0 0.022825373336672783
T416P O 1 0.9707486629486084
) O 0 0.013937349431216717
was O 0 0.013423227705061436
found O 0 0.008174468763172626
in O 0 0.007452886085957289
a O 0 0.008815191686153412
homozygous O 0 0.013939879834651947
state O 0 0.006501875817775726
in O 0 0.007589589338749647
one O 0 0.008260547183454037
family O 0 0.009334749542176723
and O 0 0.006425310857594013
in O 0 0.007450460456311703
a O 0 0.00975270476192236
heterozygous O 0 0.015765992924571037
state O 0 0.008239662274718285
in O 0 0.011642328463494778
four O 0 0.017782414332032204
families O 0 0.026441486552357674
. O 0 0.03720724955201149

Pendred B-Disease 1 0.9979554414749146
patients O 0 0.08358018100261688
in O 0 0.016558930277824402
three O 0 0.014396158047020435
non O 0 0.026666581630706787
- O 1 0.9857643246650696
consanguineous O 1 0.7438059449195862
families O 0 0.015284011140465736
were O 0 0.009570691734552383
shown O 0 0.009938492439687252
to O 0 0.010142573155462742
be O 0 0.009782656095921993
compound O 0 0.02793847769498825
heterozygotes O 0 0.39638879895210266
for O 0 0.023540033027529716
L236P O 1 0.9914094805717468
and O 0 0.03972398489713669
T416P O 1 0.8953416347503662
. O 0 0.06417954713106155

In O 0 0.022403892129659653
total O 0 0.01621181145310402
, O 0 0.01173943281173706
one O 0 0.007673644460737705
or O 0 0.0057734353467822075
both O 0 0.005255965981632471
of O 0 0.00590767664834857
these O 0 0.005103148054331541
mutations O 0 0.006860482972115278
were O 0 0.004665994551032782
found O 0 0.0051190718077123165
in O 0 0.005170166026800871
nine O 0 0.00807077158242464
of O 0 0.008451762609183788
the O 0 0.010662625543773174
14 O 0 0.020805897191166878
families O 0 0.021616026759147644
analyzed O 0 0.03887857124209404
. O 0 0.038164637982845306

The O 0 0.02679045870900154
identification O 0 0.023839037865400314
of O 0 0.014839348383247852
two O 0 0.012349655851721764
frequent O 0 0.24316240847110748
PDS B-Disease 1 0.9999988079071045
mutations O 0 0.018823182210326195
will O 0 0.009876884520053864
facilitate O 0 0.013917663134634495
the O 0 0.013526727445423603
molecular O 0 0.15917818248271942
diagnosis O 1 0.9999922513961792
of O 1 0.9988676309585571
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.7903515696525574

Insertional O 1 0.8697128891944885
mutation O 0 0.05002780258655548
by O 0 0.023183582350611687
transposable O 1 0.8266729712486267
element O 0 0.04112715646624565
, O 0 0.023534482344985008
L1 O 1 0.997520387172699
, O 0 0.014091131277382374
in O 0 0.01174203772097826
the O 0 0.01696723885834217
DMD B-Disease 1 0.9999946355819702
gene O 0 0.014630566351115704
results O 0 0.013003649190068245
in O 0 0.014758119359612465
X B-Disease 1 0.9994341731071472
- I-Disease 1 0.9999902248382568
linked I-Disease 1 0.9999415874481201
dilated I-Disease 1 0.9999997615814209
cardiomyopathy I-Disease 1 1.0
. O 1 0.778815507888794

X B-Disease 1 0.990342378616333
- I-Disease 1 0.9999041557312012
linked I-Disease 1 0.9999510049819946
dilated I-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
( O 1 0.9999593496322632
XLDCM B-Disease 1 0.9999998807907104
) O 0 0.013348614796996117
is O 0 0.010188770480453968
a O 0 0.013609499670565128
clinical O 1 0.9920146465301514
phenotype O 1 0.7120814323425293
of O 0 0.031560637056827545
dystrophinopathy B-Disease 1 0.9999500513076782
which O 0 0.009662630036473274
is O 0 0.009222601540386677
characterized O 0 0.015440694987773895
by O 0 0.010995069518685341
preferential O 1 0.9991647005081177
myocardial B-Disease 1 1.0
involvement I-Disease 1 0.6525089144706726
without O 0 0.013222267851233482
any O 0 0.012300490401685238
overt O 1 0.8245001435279846
clinical O 1 0.9998823404312134
signs O 1 0.996512234210968
of O 1 0.9971883893013
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 1 0.8609828948974609

To O 0 0.027451220899820328
date O 0 0.020644620060920715
, O 0 0.013596925884485245
several O 0 0.009146884083747864
mutations O 0 0.010151826776564121
in O 0 0.009183256886899471
the O 0 0.4912353754043579
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 1 0.9999713897705078
, O 1 0.9995935559272766
DMD O 1 1.0
, O 0 0.01228827890008688
have O 0 0.0055350493639707565
been O 0 0.005742988549172878
identified O 0 0.007401787675917149
in O 0 0.007673975080251694
patients O 1 0.9149749875068665
with O 0 0.012277248315513134
XLDCM B-Disease 1 0.9999970197677612
, O 0 0.00994768738746643
but O 0 0.0066760266199707985
a O 0 0.008836034685373306
pathogenic O 0 0.014957170002162457
correlation O 0 0.011875312775373459
of O 0 0.0081073809415102
these O 0 0.0075583928264677525
cardiospecific O 1 0.7246137857437134
mutations O 0 0.015592178329825401
in O 0 0.012467700056731701
DMD O 1 0.9999991655349731
with O 0 0.01348771434277296
the O 0 0.033029813319444656
XLDCM B-Disease 1 0.9999957084655762
phenotype O 1 0.9690414667129517
has O 0 0.017177481204271317
remained O 0 0.026423076167702675
to O 0 0.017268238589167595
be O 0 0.02218194119632244
elucidated O 0 0.2901999056339264
. O 0 0.05775908753275871

We O 0 0.02696397714316845
report O 0 0.017907531931996346
here O 0 0.01371573843061924
the O 0 0.010341593995690346
identification O 0 0.012545913457870483
of O 0 0.009128734469413757
a O 0 0.012720491737127304
unique O 0 0.018082959577441216
de O 0 0.05445006489753723
novo O 1 0.522678017616272
L1 O 1 0.9857109189033508
insertion O 0 0.03244517743587494
in O 0 0.01332609448581934
the O 0 0.016364067792892456
muscle O 0 0.26382994651794434
exon O 0 0.06956145167350769
1 O 0 0.019085370004177094
in O 0 0.015503553673624992
DMD O 1 0.9999933242797852
in O 0 0.015149910002946854
three O 0 0.016130980104207993
XLDCM B-Disease 1 0.9999748468399048
patients O 0 0.42075785994529724
from O 0 0.013697566464543343
two O 0 0.015450011938810349
unrelated O 0 0.03480920195579529
Japanese O 0 0.09716146439313889
families O 0 0.037521082907915115
. O 0 0.048178497701883316

The O 0 0.03634068742394447
insertion O 0 0.04222422093153
was O 0 0.023057758808135986
a O 0 0.017850587144494057
5 O 0 0.0213498342782259
- O 0 0.033834926784038544
truncated O 0 0.03123318962752819
form O 0 0.012577247805893421
of O 0 0.013110462576150894
human O 0 0.015729453414678574
L1 O 1 0.9935116171836853
inversely O 0 0.035159602761268616
integrated O 0 0.025258010253310204
in O 0 0.01081294845789671
the O 0 0.012034283019602299
5 O 0 0.018824752420186996
- O 0 0.09293010830879211
untranslated O 0 0.11517320573329926
region O 0 0.016124697402119637
in O 0 0.011137773282825947
the O 0 0.015285898931324482
muscle O 1 0.9317995309829712
exon O 1 0.610741138458252
1 O 0 0.018116381019353867
, O 0 0.01015195157378912
which O 0 0.007402985356748104
affected O 0 0.009343616664409637
the O 0 0.008507139049470425
transcription O 0 0.012585731223225594
or O 0 0.0071142613887786865
the O 0 0.008677799254655838
stability O 0 0.01342946756631136
of O 0 0.01027098298072815
the O 0 0.014554312452673912
muscle O 1 0.9684727787971497
form O 0 0.009756220504641533
of O 0 0.013477427884936333
dystrophin O 1 0.9978765249252319
transcripts O 0 0.01657288894057274
but O 0 0.0063038114458322525
not O 0 0.004564393311738968
that O 0 0.0045908596366643906
of O 0 0.006549104582518339
the O 0 0.010072550736367702
brain O 1 0.997680127620697
or O 0 0.13196240365505219
Purkinje O 1 0.9999996423721313
cell O 1 0.861416220664978
form O 0 0.01071564294397831
, O 0 0.008689259178936481
probably O 0 0.010360781103372574
due O 0 0.007703385315835476
to O 0 0.008070179261267185
its O 0 0.010222655721008778
unique O 0 0.014443743973970413
site O 0 0.019468149170279503
of O 0 0.01720244809985161
integration O 0 0.046429626643657684
. O 0 0.04651976749300957

We O 0 0.027174299582839012
speculate O 0 0.029522845521569252
that O 0 0.009592168964445591
this O 0 0.008309323340654373
insertion O 0 0.01892867684364319
of O 0 0.010012351907789707
an O 0 0.011371305212378502
L1 O 1 0.999613344669342
sequence O 0 0.013060257770121098
in O 0 0.014011877588927746
DMD O 1 0.9999996423721313
is O 0 0.01046398002654314
responsible O 0 0.010026597417891026
for O 0 0.006128561217337847
some O 0 0.004743972793221474
of O 0 0.005249328911304474
the O 0 0.005569111090153456
population O 0 0.00557315070182085
of O 0 0.008981379680335522
Japanese O 1 0.9786392450332642
patients O 1 0.9966849684715271
with O 0 0.030977001413702965
XLDCM B-Disease 1 0.9999916553497314
. O 0 0.033836301416158676
. O 0 0.046074941754341125

Severe O 1 0.9945968389511108
early O 1 0.6652968525886536
- O 1 0.9999994039535522
onset O 1 1.0
obesity B-Disease 1 1.0
, O 1 0.9999905824661255
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9999816417694092
red O 1 1.0
hair O 1 1.0
pigmentation O 1 1.0
caused O 1 0.9999454021453857
by O 1 0.5970500111579895
POMC O 1 1.0
mutations O 1 0.5328640937805176
in O 0 0.026787538081407547
humans O 0 0.03814629465341568
. O 0 0.04526061192154884

Sequential O 0 0.07512485980987549
cleavage O 0 0.05809766426682472
of O 0 0.017442770302295685
the O 0 0.01644148863852024
precursor O 0 0.027952171862125397
protein O 0 0.021152304485440254
pre O 0 0.0437479168176651
- O 1 0.654412031173706
pro O 0 0.19556355476379395
- O 1 0.9979870319366455
opiomelanocortin O 1 0.9995595812797546
( O 0 0.032403815537691116
POMC O 1 0.9988915324211121
) O 0 0.02695195935666561
generates O 0 0.0385807640850544
the O 0 0.026550790295004845
melanocortin O 1 0.9941102862358093
peptides O 0 0.06645303964614868
adrenocorticotrophin O 1 0.9924321174621582
( O 0 0.03483417257666588
ACTH O 1 0.9986029267311096
) O 0 0.02488032355904579
, O 0 0.02548193372786045
melanocyte O 1 0.9999904632568359
- O 1 0.9998661279678345
stimulating O 1 0.9996469020843506
hormones O 1 0.9645087122917175
( O 0 0.026462821289896965
MSH O 1 0.9999904632568359
) O 0 0.017622672021389008
alpha O 0 0.02887282893061638
, O 0 0.015183044597506523
beta O 0 0.023951973766088486
and O 0 0.012178490869700909
gamma O 0 0.021412596106529236
as O 0 0.00977239292114973
well O 0 0.007871766574680805
as O 0 0.008153418079018593
the O 0 0.013256623409688473
opioid O 1 0.9813892245292664
- O 1 0.987379789352417
receptor O 0 0.06280230730772018
ligand O 0 0.2847348749637604
beta O 0 0.28292614221572876
- O 1 0.9631474614143372
endorphin O 1 0.98802649974823
. O 0 0.07640918344259262

While O 0 0.02600303292274475
a O 0 0.014234952628612518
few O 0 0.010710894130170345
cases O 0 0.009720481000840664
of O 0 0.019521614536643028
isolated O 1 0.9999895095825195
ACTH B-Disease 1 1.0
deficiency I-Disease 1 1.0
have O 0 0.009162260219454765
been O 0 0.009999380446970463
reported O 0 0.01609848625957966
( O 0 0.017534347251057625
OMIM O 1 0.999984860420227
201400 O 1 0.9883335828781128
) O 0 0.012869658879935741
, O 0 0.011644292622804642
an O 0 0.015918666496872902
inherited O 1 0.9999998807907104
POMC O 1 1.0
defect O 1 0.9999997615814209
has O 0 0.02077496238052845
not O 0 0.008464046753942966
been O 0 0.009514816105365753
described O 0 0.013983059674501419
so O 0 0.013113913126289845
far O 0 0.02201426774263382
. O 0 0.03262796625494957

Recent O 0 0.03737897798418999
studies O 0 0.026612840592861176
in O 0 0.016059696674346924
animal O 0 0.021194126456975937
models O 0 0.021253162994980812
elucidated O 0 0.034835632890462875
a O 0 0.013492809608578682
central O 0 0.011733736842870712
role O 0 0.012789388187229633
of O 0 0.013269553892314434
alpha O 0 0.18837422132492065
- O 1 0.9738277792930603
MSH O 1 0.9992097616195679
in O 0 0.011687681078910828
the O 0 0.01054737251251936
regulation O 0 0.01178138330578804
of O 0 0.009631159715354443
food O 0 0.013882494531571865
intake O 0 0.018342150375247
by O 0 0.008465304039418697
activation O 0 0.015324044041335583
of O 0 0.009867045097053051
the O 0 0.0124233178794384
brain O 1 0.9361962676048279
melanocortin O 1 0.999941349029541
- O 1 0.8662314414978027
4 O 0 0.025018097832798958
- O 0 0.14016829431056976
receptor O 0 0.02914135716855526
( O 0 0.02287081629037857
MC4 O 1 0.9997069239616394
- O 0 0.38766589760780334
R O 0 0.05345635861158371
; O 0 0.013955689035356045
refs O 0 0.03151768073439598
3 O 0 0.019088542088866234
- O 0 0.029843242838978767
5 O 0 0.013449206948280334
) O 0 0.009525050409138203
and O 0 0.008060820400714874
the O 0 0.008576472289860249
linkage O 0 0.01661657728254795
of O 0 0.010780848562717438
human O 0 0.031078027561306953
obesity B-Disease 1 0.9999996423721313
to O 0 0.011856081895530224
chromosome O 0 0.014724974520504475
2 O 0 0.010627754032611847
in O 0 0.007308937143534422
close O 0 0.010715299285948277
proximity O 0 0.01162275206297636
to O 0 0.00975398626178503
the O 0 0.0152378985658288
POMC O 1 0.9999932050704956
locus O 1 0.8285878300666809
, O 0 0.01110067404806614
led O 0 0.01156381145119667
to O 0 0.007328663021326065
the O 0 0.007147686555981636
proposal O 0 0.010336607694625854
of O 0 0.007091565523296595
an O 0 0.008227930404245853
association O 0 0.017846381291747093
of O 0 0.021557334810495377
POMC O 1 0.9999990463256836
with O 0 0.10660701245069504
human O 1 0.9914231896400452
obesity B-Disease 1 1.0
. O 0 0.06115598604083061

The O 0 0.04003679379820824
dual O 0 0.039964091032743454
role O 0 0.025482159107923508
of O 0 0.021555814892053604
alpha O 1 0.6469879746437073
- O 1 0.9981820583343506
MSH O 1 0.9999568462371826
in O 0 0.015132823958992958
regulating O 0 0.018161237239837646
food O 0 0.01784399151802063
intake O 0 0.027142347767949104
and O 0 0.012115431018173695
influencing O 0 0.057507436722517014
hair O 1 0.9894128441810608
pigmentation O 1 0.9999825954437256
predicts O 0 0.3835282325744629
that O 0 0.0077015734277665615
the O 0 0.0107627147808671
phenotype O 0 0.15081317722797394
associated O 0 0.009510395117104053
with O 0 0.008853135630488396
a O 0 0.018499085679650307
defect O 1 0.9999271631240845
in O 0 0.019055744633078575
POMC O 1 0.9999938011169434
function O 0 0.011829881928861141
would O 0 0.011597711592912674
include O 0 0.017564337700605392
obesity B-Disease 1 0.9999984502792358
, O 0 0.015398859977722168
alteration O 1 0.9355037808418274
in O 0 0.25817859172821045
pigmentation O 1 1.0
and O 1 0.9999861717224121
ACTH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 1 0.6991550922393799

The O 0 0.028103921562433243
observation O 0 0.033070776611566544
of O 0 0.01695380173623562
these O 0 0.01177325937896967
symptoms O 1 0.9993202686309814
in O 0 0.010726258158683777
two O 0 0.010151606053113937
probands O 1 0.9024770259857178
prompted O 0 0.018015703186392784
us O 0 0.012223979458212852
to O 0 0.00900479406118393
search O 0 0.014537245966494083
for O 0 0.010374735109508038
mutations O 0 0.014213450253009796
within O 0 0.013327455148100853
their O 0 0.019373096525669098
POMC O 1 0.9999403953552246
genes O 0 0.04882606491446495
. O 0 0.05322955921292305

Patient O 1 0.9763085246086121
1 O 0 0.025782745331525803
was O 0 0.01837478019297123
found O 0 0.009550418704748154
to O 0 0.008771112188696861
be O 0 0.007237757556140423
a O 0 0.011446166783571243
compound O 0 0.01999410055577755
heterozygote O 0 0.035911925137043
for O 0 0.009282630868256092
two O 0 0.00911800004541874
mutations O 0 0.012438302859663963
in O 0 0.010417895391583443
exon O 0 0.032302290201187134
3 O 0 0.015919988974928856
( O 0 0.01411665789783001
G7013T O 0 0.3576280176639557
, O 0 0.016577592119574547
C7133delta O 1 0.9736527800559998
) O 0 0.014328387565910816
which O 0 0.010416539385914803
interfere O 0 0.01628815568983555
with O 0 0.010606696829199791
appropriate O 0 0.014059839770197868
synthesis O 0 0.02312997169792652
of O 0 0.02136269025504589
ACTH O 1 0.9996423721313477
and O 0 0.029500821605324745
alpha O 1 0.8835588097572327
- O 1 0.9992092251777649
MSH O 1 0.9999344348907471
. O 0 0.06804808229207993

Patient O 1 0.9657763838768005
2 O 0 0.03566138446331024
was O 0 0.02569624036550522
homozygous O 0 0.02633867785334587
for O 0 0.01368772704154253
a O 0 0.014986235648393631
mutation O 0 0.017192300409078598
in O 0 0.01352305430918932
exon O 0 0.05865103378891945
2 O 0 0.02360834740102291
( O 0 0.020887233316898346
C3804A O 0 0.2844674289226532
) O 0 0.023341519758105278
which O 0 0.029120104387402534
abolishes O 1 0.9853134751319885
POMC O 1 0.9999314546585083
translation O 0 0.07272560149431229
. O 0 0.06377799808979034

These O 0 0.023248961195349693
findings O 0 0.02070389688014984
represent O 0 0.013461921364068985
the O 0 0.009761449880897999
first O 0 0.010635376907885075
examples O 0 0.010657678358256817
of O 0 0.008777071721851826
a O 0 0.014527098275721073
genetic B-Disease 1 0.678113579750061
defect I-Disease 1 0.999029278755188
within O 0 0.011722770519554615
the O 0 0.018889205530285835
POMC O 1 0.9999959468841553
gene O 0 0.013412193395197392
and O 0 0.007981573231518269
define O 0 0.011299138888716698
a O 0 0.01161477155983448
new O 0 0.06078137829899788
monogenic B-Disease 1 1.0
endocrine I-Disease 1 1.0
disorder I-Disease 1 0.9999996423721313
resulting O 0 0.18323203921318054
in O 0 0.012781713157892227
early O 1 0.9189764261245728
- O 1 0.9999998807907104
onset O 1 1.0
obesity B-Disease 1 1.0
, O 1 0.9999852180480957
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9999556541442871
red O 1 0.9999996423721313
hair O 1 0.9999970197677612
pigmentation O 1 0.9999982118606567
. O 0 0.04330052435398102
. O 0 0.054449353367090225

A O 0 0.04818829149007797
European O 0 0.03754140064120293
multicenter O 0 0.37887272238731384
study O 0 0.02660459652543068
of O 0 0.0720498189330101
phenylalanine B-Disease 1 0.9999995231628418
hydroxylase I-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
: O 0 0.02165958099067211
classification O 0 0.02255118079483509
of O 0 0.013601704500615597
105 O 0 0.15553078055381775
mutations O 0 0.012445795349776745
and O 0 0.0072848000563681126
a O 0 0.00804869830608368
general O 0 0.00925038568675518
system O 0 0.00848566833883524
for O 0 0.009235790930688381
genotype O 0 0.036939386278390884
- O 0 0.048756618052721024
based O 0 0.014306960627436638
prediction O 0 0.09037530422210693
of O 0 0.03106309287250042
metabolic O 1 0.999907374382019
phenotype O 1 0.982330322265625
. O 0 0.048301130533218384

Phenylketonuria B-Disease 1 0.9999960660934448
( O 1 0.8373977541923523
PKU B-Disease 1 0.9999998807907104
) O 0 0.023800350725650787
and O 0 0.08502029627561569
mild B-Disease 1 0.9999996423721313
hyperphenylalaninemia I-Disease 1 1.0
( O 1 0.9996281862258911
MHP B-Disease 1 1.0
) O 0 0.021792421117424965
are O 0 0.012371833436191082
allelic B-Disease 1 0.9999967813491821
disorders I-Disease 1 1.0
caused O 1 0.9989827275276184
by O 0 0.011039815843105316
mutations O 0 0.013451787643134594
in O 0 0.009236425161361694
the O 0 0.012182783335447311
gene O 0 0.017559921368956566
encoding O 0 0.026427725329995155
phenylalanine O 1 0.9404688477516174
hydroxylase O 1 0.9996902942657471
( O 1 0.8896360397338867
PAH O 1 0.9999998807907104
) O 0 0.05866235867142677
. O 0 0.06237823888659477

Previous O 0 0.029393896460533142
studies O 0 0.017418377101421356
have O 0 0.008991391398012638
suggested O 0 0.010498112067580223
that O 0 0.006321318913251162
the O 0 0.008420969359576702
highly O 0 0.01442783698439598
variable O 0 0.020308639854192734
metabolic O 1 0.9915790557861328
phenotypes O 1 0.9786039590835571
of O 1 0.9995891451835632
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
correlate O 1 0.9999744892120361
with O 1 0.9987165927886963
PAH O 1 1.0
genotypes O 1 0.9999624490737915
. O 0 0.08196787536144257

We O 0 0.027738070115447044
identified O 0 0.0216397512704134
both O 0 0.016171615570783615
causative O 0 0.23255549371242523
mutations O 0 0.01815430074930191
in O 0 0.013326150365173817
686 O 1 0.9999843835830688
patients O 1 0.9874082803726196
from O 0 0.012947295792400837
seven O 0 0.017053892835974693
European O 0 0.022973816841840744
centers O 0 0.03820903226733208
. O 0 0.04044225439429283

On O 0 0.02445944957435131
the O 0 0.01540397759526968
basis O 0 0.010919488035142422
of O 0 0.009502610191702843
the O 0 0.011011175811290741
phenotypic O 0 0.01907772198319435
characteristics O 0 0.013249022886157036
of O 0 0.012392919510602951
297 O 1 0.9973986148834229
functionally O 1 0.9996668100357056
hemizygous O 1 0.9999831914901733
patients O 1 0.8566086888313293
, O 0 0.01141339261084795
105 O 0 0.020914385095238686
of O 0 0.010519670322537422
the O 0 0.011647679843008518
mutations O 0 0.011609633453190327
were O 0 0.0071445032954216
assigned O 0 0.012768080458045006
to O 0 0.008122972212731838
one O 0 0.007962604984641075
of O 0 0.008860861882567406
four O 0 0.011868730187416077
arbitrary O 0 0.021047955378890038
phenotype O 1 0.5807395577430725
categories O 0 0.047658760100603104
. O 0 0.050902459770441055

We O 0 0.025628425180912018
proposed O 0 0.02183195762336254
and O 0 0.0120115727186203
tested O 0 0.01769476756453514
a O 0 0.01218736357986927
simple O 0 0.012271731160581112
model O 0 0.01414517592638731
for O 0 0.010935435071587563
correlation O 0 0.01707497425377369
between O 0 0.01398937962949276
genotype O 0 0.040394287556409836
and O 0 0.018647965043783188
phenotypic O 0 0.04431131109595299
outcome O 0 0.04024982452392578
. O 0 0.04776586964726448

The O 0 0.036030713468790054
observed O 0 0.030633334070444107
phenotype O 0 0.041321251541376114
matched O 0 0.024014845490455627
the O 0 0.014038767665624619
predicted O 0 0.018921727314591408
phenotype O 0 0.018645942211151123
in O 0 0.009943392127752304
79 O 0 0.02025662176311016
% O 0 0.008442815393209457
of O 0 0.007254153024405241
the O 0 0.007631953340023756
cases O 0 0.0073281084187328815
, O 0 0.006382488179951906
and O 0 0.005049252416938543
in O 0 0.0048371716402471066
only O 0 0.0046316212974488735
5 O 0 0.00854223407804966
of O 0 0.007781349588185549
184 O 0 0.2291155755519867
patients O 0 0.4155067503452301
was O 0 0.011819301173090935
the O 0 0.008880320005118847
observed O 0 0.011121021583676338
phenotype O 0 0.01438161265105009
more O 0 0.005748997908085585
than O 0 0.006349490024149418
one O 0 0.007886442355811596
category O 0 0.012552471831440926
away O 0 0.01068428810685873
from O 0 0.00973209273070097
that O 0 0.011887500993907452
expected O 0 0.024281002581119537
. O 0 0.034531302750110626

Among O 0 0.02758990414440632
the O 0 0.017183059826493263
seven O 0 0.016492405906319618
contributing O 0 0.01865563355386257
centers O 0 0.012906097806990147
, O 0 0.008426632732152939
the O 0 0.007531346287578344
proportion O 0 0.010791140608489513
of O 0 0.010294751264154911
patients O 1 0.9489124417304993
for O 0 0.0075237685814499855
whom O 0 0.010804828256368637
the O 0 0.010090910829603672
observed O 0 0.011765600182116032
phenotype O 0 0.024016138166189194
did O 0 0.008696433156728745
not O 0 0.00596113596111536
match O 0 0.01034476701170206
the O 0 0.00888768769800663
predicted O 0 0.016213135793805122
phenotype O 0 0.019297262653708458
was O 0 0.012183994054794312
4 O 0 0.013869061134755611
% O 0 0.010859317146241665
- O 0 0.018824495375156403
23 O 0 0.01721307449042797
% O 0 0.011987753212451935
( O 0 0.014849759638309479
P O 0 0.1806064397096634
< O 0 0.0688060000538826
. O 0 0.01441046129912138
0001 O 0 0.11330041289329529
) O 0 0.012622537091374397
, O 0 0.01048207562416792
suggesting O 0 0.010552280582487583
that O 0 0.005298933945596218
differences O 0 0.007324425503611565
in O 0 0.005822774488478899
methods O 0 0.006180480122566223
used O 0 0.006753172259777784
for O 0 0.007779197301715612
mutation O 0 0.014065121300518513
detection O 0 0.27910956740379333
or O 0 0.011874083429574966
phenotype O 1 0.8503699898719788
classification O 0 0.10515390336513519
may O 0 0.009647054597735405
account O 0 0.009937300346791744
for O 0 0.0077726999297738075
a O 0 0.011787476018071175
considerable O 0 0.01792965643107891
proportion O 0 0.01702212169766426
of O 0 0.018440674990415573
genotype O 1 0.9958729147911072
- O 1 0.9995057582855225
phenotype O 1 0.9631733298301697
inconsistencies O 0 0.08699231594800949
. O 0 0.05306118726730347

Our O 0 0.03181643784046173
data O 0 0.019155554473400116
indicate O 0 0.016069592908024788
that O 0 0.011202437803149223
the O 0 0.02092963084578514
PAH O 1 1.0
- O 1 0.9996378421783447
mutation O 0 0.03033503331243992
genotype O 0 0.031135354191064835
is O 0 0.011189168319106102
the O 0 0.011398177593946457
main O 0 0.014535687863826752
determinant O 0 0.10773921757936478
of O 0 0.017048906534910202
metabolic O 1 0.999471127986908
phenotype O 0 0.4268132150173187
in O 0 0.01153167150914669
most O 0 0.02163108065724373
patients O 1 0.9999973773956299
with O 1 0.9999648332595825
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 1 0.8496493697166443

In O 0 0.025966711342334747
the O 0 0.017510797828435898
present O 0 0.0153005700558424
study O 0 0.012736611068248749
, O 0 0.009620359167456627
the O 0 0.00888275820761919
classification O 0 0.014987916685640812
of O 0 0.013472527265548706
105 O 1 0.9994179010391235
PAH O 1 1.0
mutations O 0 0.02273073047399521
may O 0 0.008337733335793018
allow O 0 0.007132441736757755
the O 0 0.008090618066489697
prediction O 0 0.01484723575413227
of O 0 0.00803451333194971
the O 0 0.00972465518862009
biochemical O 0 0.0543753057718277
phenotype O 0 0.03087496943771839
in O 0 0.011291127651929855
> O 0 0.06596995890140533
10 O 0 0.01294411439448595
, O 0 0.011985658667981625
000 O 0 0.02327769063413143
genotypes O 0 0.09915278851985931
, O 0 0.010891704820096493
which O 0 0.007233876734972
may O 0 0.007397808600217104
be O 0 0.0053235250525176525
useful O 0 0.007869007997214794
for O 0 0.0067323315888643265
the O 0 0.00897197425365448
management O 0 0.022847188636660576
of O 0 0.020222676917910576
hyperphenylalaninemia B-Disease 1 0.9999890327453613
in O 0 0.04601068049669266
newborns O 1 0.9962827563285828
. O 0 0.05214053392410278

Somatic O 0 0.16320179402828217
instability O 0 0.05556100606918335
of O 0 0.025066308677196503
the O 0 0.027063768357038498
CTG O 1 0.9999468326568604
repeat O 0 0.05027556046843529
in O 0 0.0171518512070179
mice O 0 0.02302401326596737
transgenic O 0 0.026216119527816772
for O 0 0.013784379698336124
the O 1 0.5687194466590881
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 1 0.9887976050376892
is O 0 0.022325128316879272
age O 0 0.061303313821554184
dependent O 0 0.01206501480191946
but O 0 0.00826328992843628
not O 0 0.006497352849692106
correlated O 0 0.011362298391759396
to O 0 0.009476747363805771
the O 0 0.0115725789219141
relative O 0 0.02347259595990181
intertissue O 1 0.9452294707298279
transcription O 0 0.04233946278691292
levels O 0 0.029120441526174545
and O 0 0.035111360251903534
proliferative O 1 0.9999964237213135
capacities O 1 0.9447542428970337
. O 0 0.0676455944776535

A O 0 0.06056945398449898
( O 0 0.038549114018678665
CTG O 1 0.9988596439361572
) O 0 0.02003736048936844
nexpansion O 0 0.033598002046346664
in O 0 0.009735680185258389
the O 0 0.011447208933532238
3 O 0 0.017812838777899742
- O 0 0.2352381944656372
untranslated O 1 0.7414031624794006
region O 0 0.016307754442095757
( O 0 0.014229385182261467
UTR O 0 0.3707138001918793
) O 0 0.010388167575001717
of O 0 0.009528730064630508
the O 0 0.015681052580475807
DM O 1 1.0
protein O 0 0.03633497655391693
kinase O 1 0.6531144380569458
gene O 0 0.016060644760727882
( O 0 0.014024551957845688
DMPK O 1 0.9977186918258667
) O 0 0.009616575203835964
is O 0 0.007594823371618986
responsible O 0 0.011333559639751911
for O 0 0.024843450635671616
causing O 1 0.9999997615814209
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999996423721313
DM B-Disease 1 1.0
) O 0 0.29273074865341187
. O 0 0.06963139027357101

Major O 0 0.10199929028749466
instability O 1 0.8036212921142578
, O 0 0.01589944399893284
with O 0 0.009529287926852703
very O 0 0.008979239501059055
large O 0 0.009262332692742348
expansions O 0 0.017263241112232208
between O 0 0.00916940625756979
generations O 0 0.01352209597826004
and O 0 0.009383149445056915
high O 0 0.01155267097055912
levels O 0 0.010985719040036201
of O 0 0.013690551742911339
somatic O 1 0.9577584862709045
mosaicism O 1 0.9999430179595947
, O 0 0.01753283478319645
is O 0 0.013848435133695602
observed O 0 0.018236367031931877
in O 0 0.022174298763275146
patients O 1 0.7588263154029846
. O 0 0.04074100777506828

There O 0 0.02099248394370079
is O 0 0.013515202328562737
a O 0 0.012209656648337841
good O 0 0.012861344963312149
correlation O 0 0.011909982189536095
between O 0 0.008297423832118511
repeat O 0 0.015869954600930214
size O 0 0.01188636850565672
( O 0 0.008124110288918018
at O 0 0.00765234837308526
least O 0 0.005480729974806309
in O 0 0.007128977682441473
leucocytes O 1 0.887275218963623
) O 0 0.008741999045014381
, O 0 0.01100752130150795
clinical O 1 0.9927661418914795
severity O 1 0.9949384927749634
and O 0 0.013262132182717323
age O 0 0.10018928349018097
of O 0 0.19269347190856934
onset O 1 0.9999992847442627
. O 0 0.05546645075082779

The O 0 0.05355345830321312
trinucleotide O 1 0.9978567957878113
repeat O 0 0.08612053096294403
instability O 0 0.2715567350387573
mechanisms O 0 0.018948733806610107
involved O 0 0.014890589751303196
in O 0 0.05702855437994003
DM B-Disease 1 1.0
and O 0 0.018046099692583084
other O 0 0.011747290380299091
human O 1 0.8427610397338867
genetic B-Disease 1 0.9999942779541016
diseases I-Disease 1 1.0
are O 0 0.018278097733855247
unknown O 0 0.0389789454638958
. O 0 0.04092329740524292

We O 0 0.03555541858077049
studied O 0 0.03669662028551102
somatic O 0 0.049209482967853546
instability O 0 0.029024356976151466
by O 0 0.012556963600218296
measuring O 0 0.02432243525981903
the O 0 0.016312889754772186
CTG O 1 0.9998648166656494
repeat O 0 0.023519307374954224
length O 0 0.014266482554376125
at O 0 0.010126175358891487
several O 0 0.007967732846736908
ages O 0 0.012591646052896976
in O 0 0.00855342485010624
various O 0 0.010110309347510338
tissues O 0 0.021663587540388107
of O 0 0.015641674399375916
transgenic O 0 0.11670007556676865
mice O 0 0.02443111315369606
carrying O 0 0.021448686718940735
a O 0 0.01966244727373123
( O 0 0.023861968889832497
CTG O 1 0.9988136291503906
) O 0 0.020855577662587166
55expansion O 0 0.04968637600541115
surrounded O 0 0.02436506561934948
by O 0 0.009496014565229416
45 O 0 0.017062118276953697
kb O 0 0.03482013940811157
of O 0 0.011260178871452808
the O 0 0.013524715788662434
human O 0 0.07936696708202362
DM B-Disease 1 1.0
region O 0 0.02380259335041046
, O 0 0.014558122493326664
using O 0 0.014342987909913063
small O 0 0.021025191992521286
- O 1 0.6752204298973083
pool O 0 0.12906156480312347
PCR O 0 0.09066348522901535
. O 0 0.05757352337241173

These O 0 0.02597363106906414
mice O 0 0.025394761934876442
have O 0 0.01074352115392685
been O 0 0.009479187428951263
shown O 0 0.008991910144686699
to O 0 0.009842729195952415
reproduce O 0 0.017021238803863525
the O 0 0.011413780972361565
intergenerational O 1 0.8131201267242432
and O 0 0.013405505567789078
somatic O 0 0.031981732696294785
instability O 0 0.02260398678481579
of O 0 0.011352045461535454
the O 0 0.013968052342534065
55 O 0 0.0453495979309082
CTG O 1 0.9996222257614136
repeat O 0 0.025183556601405144
suggesting O 0 0.015430237166583538
that O 0 0.008642763830721378
surrounding O 0 0.012698748148977757
sequences O 0 0.011025714688003063
and O 0 0.008639944717288017
the O 0 0.010511980392038822
chromatin O 0 0.021092521026730537
environment O 0 0.013757592998445034
are O 0 0.007865721359848976
involved O 0 0.013761178590357304
in O 0 0.015473480336368084
instability O 1 0.9861706495285034
mechanisms O 0 0.17113126814365387
. O 0 0.04473766312003136

As O 0 0.022841801866889
observed O 0 0.014451351016759872
in O 0 0.007511964067816734
some O 0 0.0054833428002893925
of O 0 0.006598080508410931
the O 0 0.008343652822077274
tissues O 1 0.989897608757019
of O 1 0.9981247782707214
DM B-Disease 1 1.0
patients O 1 0.9999982118606567
, O 0 0.01086520403623581
there O 0 0.007704780902713537
is O 0 0.00679960148409009
a O 0 0.00819761585444212
tendency O 0 0.011006338521838188
for O 0 0.007266649976372719
repeat O 0 0.01595628447830677
length O 0 0.012273973785340786
and O 0 0.01051239762455225
somatic O 0 0.22561420500278473
mosaicism O 1 0.9509075880050659
to O 0 0.01001590583473444
increase O 0 0.008739801123738289
with O 0 0.0069101108238101006
the O 0 0.009819845668971539
age O 0 0.01378630381077528
of O 0 0.014702921733260155
the O 0 0.023846331983804703
mouse O 1 0.5935980081558228
. O 0 0.0438959114253521

Furthermore O 0 0.04640018939971924
, O 0 0.01919955015182495
we O 0 0.011924996972084045
observed O 0 0.011439505964517593
no O 0 0.009632077999413013
correlation O 0 0.009979071095585823
between O 0 0.007604782935231924
the O 0 0.010301515460014343
somatic O 0 0.12061145156621933
mutation O 0 0.021203942596912384
rate O 0 0.01631872169673443
and O 0 0.02367573231458664
tissue O 1 0.9997302889823914
proliferation O 1 0.9908303022384644
capacity O 0 0.07838085293769836
. O 0 0.05822227895259857

The O 0 0.0389522947371006
somatic O 0 0.11567027866840363
mutation O 0 0.02722354047000408
rates O 0 0.014866302721202374
in O 0 0.009017663076519966
different O 0 0.0069182636216282845
tissues O 0 0.01769830845296383
were O 0 0.006548167206346989
also O 0 0.0070249419659376144
not O 0 0.005904736928641796
correlated O 0 0.008900209330022335
to O 0 0.005967773962765932
the O 0 0.007269168272614479
relative O 0 0.012923289090394974
inter O 1 0.8633059859275818
- O 1 0.990400493144989
tissue O 0 0.36680829524993896
difference O 0 0.011496991850435734
in O 0 0.007387315854430199
transcriptional O 0 0.013300136663019657
levels O 0 0.006602679379284382
of O 0 0.006047175265848637
the O 0 0.006837861612439156
three O 0 0.007345283403992653
genes O 0 0.008867960423231125
( O 0 0.010087486356496811
DMAHP O 1 0.9913235902786255
, O 0 0.01382504217326641
DMPK O 1 0.9799832701683044
and O 0 0.012644448317587376
59 O 0 0.02491373009979725
) O 0 0.011922535486519337
surrounding O 0 0.017186524346470833
the O 0 0.017627354711294174
repeat O 0 0.048106689006090164
. O 0 0.028503641486167908
. O 0 0.04330892488360405

A O 0 0.05091811716556549
novel O 0 0.04566219449043274
missense O 0 0.05109351873397827
mutation O 0 0.02127276360988617
in O 0 0.01159850973635912
patients O 0 0.2349763959646225
from O 0 0.008245076984167099
a O 0 0.02929333783686161
retinoblastoma B-Disease 1 0.9999983310699463
pedigree O 1 0.9890100359916687
showing O 0 0.018072128295898438
only O 0 0.011040303856134415
mild O 1 0.7992563843727112
expression O 0 0.014816377311944962
of O 0 0.01887899823486805
the O 1 0.8432528972625732
tumor B-Disease 1 0.9999994039535522
phenotype O 1 0.9991775155067444
. O 0 0.05341236665844917

We O 0 0.02479216270148754
have O 0 0.013447466306388378
used O 0 0.013807572424411774
single O 0 0.016913659870624542
strand O 0 0.025282680988311768
conformation O 0 0.023895693942904472
polymorphism O 0 0.02436417154967785
analysis O 0 0.011457088403403759
to O 0 0.008449877612292767
study O 0 0.009926797822117805
the O 0 0.008995319716632366
27 O 0 0.015332947485148907
exons O 0 0.01685628853738308
of O 0 0.010988227091729641
the O 0 0.014712526462972164
RB1 O 1 0.9999728202819824
gene O 0 0.012470729649066925
in O 0 0.008583017624914646
individuals O 0 0.0067074173130095005
from O 0 0.008048225194215775
a O 0 0.011075162328779697
family O 0 0.015936005860567093
showing O 0 0.020315689966082573
mild O 1 0.9631876349449158
expression O 0 0.01706571877002716
of O 0 0.01879636012017727
the O 0 0.47708067297935486
retinoblastoma B-Disease 1 0.9999995231628418
phenotype O 1 0.999104917049408
. O 0 0.05658065527677536

In O 0 0.025342043489217758
this O 0 0.014846880920231342
family O 0 0.01702878810465336
affected O 0 0.012025363743305206
individuals O 0 0.0082887914031744
developed O 1 0.783740758895874
unilateral B-Disease 1 0.9995959401130676
tumors I-Disease 1 1.0
and O 0 0.0407930351793766
, O 0 0.008730383589863777
as O 0 0.007266436703503132
a O 0 0.008660686202347279
result O 0 0.007314550690352917
of O 0 0.007982642389833927
linkage O 0 0.02058371715247631
analysis O 0 0.011330192908644676
, O 0 0.013134948909282684
unaffected O 0 0.43538549542427063
mutation O 0 0.019892875105142593
carriers O 0 0.019979912787675858
were O 0 0.009555797092616558
also O 0 0.010913028381764889
identified O 0 0.014278315007686615
within O 0 0.015477688051760197
the O 0 0.026156151667237282
pedigree O 0 0.4135611057281494
. O 0 0.04802345857024193

A O 0 0.040943194180727005
single O 0 0.02846776694059372
band O 0 0.033076606690883636
shift O 0 0.0283970907330513
using O 0 0.016884244978427887
SSCP O 1 0.884552538394928
was O 0 0.019497854635119438
identified O 0 0.01480930671095848
in O 0 0.01239782478660345
exon O 0 0.036189302802085876
21 O 0 0.019010229036211967
which O 0 0.011091547086834908
resulted O 0 0.015641475096344948
in O 0 0.011047099716961384
a O 0 0.01602206565439701
missense O 0 0.03776468709111214
mutation O 0 0.020705899223685265
converting O 0 0.023489758372306824
a O 0 0.021410388872027397
cys O 1 0.9999572038650513
- O 1 0.9994926452636719
- O 1 0.9973301887512207
> O 1 0.9300758242607117
arg O 1 0.7341318726539612
at O 0 0.02618195116519928
nucleotide O 0 0.03103639744222164
position O 0 0.024494871497154236
28 O 0 0.02568918652832508
in O 0 0.02156783826649189
the O 0 0.03371798247098923
exon O 0 0.1263398677110672
. O 0 0.056357793509960175

The O 0 0.040596287697553635
mutation O 0 0.04193703830242157
destroyed O 0 0.03662300109863281
an O 0 0.02500256523489952
NdeI O 1 0.9998348951339722
restriction O 0 0.10004385560750961
enzyme O 0 0.052281688898801804
site O 0 0.055153150111436844
. O 0 0.05149461328983307

Analysis O 0 0.02814924344420433
of O 0 0.01726742461323738
all O 0 0.012362517416477203
family O 0 0.0141494395211339
members O 0 0.009696993976831436
demonstrated O 0 0.01379033736884594
that O 0 0.007314122281968594
the O 0 0.009900391101837158
missense O 0 0.03036775067448616
mutation O 0 0.018166257068514824
co O 0 0.32391589879989624
- O 0 0.4605849087238312
segregated O 0 0.02780235931277275
with O 0 0.010882728733122349
patients O 1 0.9991126656532288
with O 1 0.6560819745063782
tumors B-Disease 1 1.0
or O 0 0.010502065531909466
who O 0 0.010597842745482922
, O 0 0.007165250834077597
as O 0 0.006211158819496632
a O 0 0.007310044020414352
result O 0 0.006380939856171608
of O 0 0.007017654366791248
linkage O 0 0.014680295251309872
analysis O 0 0.008272782899439335
had O 0 0.009111423045396805
been O 0 0.0074657294899225235
predicted O 0 0.012405423447489738
to O 0 0.011045416817069054
carry O 0 0.01709543541073799
the O 0 0.026465393602848053
predisposing O 1 0.8524352312088013
mutation O 0 0.05808867886662483
. O 0 0.05527647212147713

These O 0 0.020428964868187904
observations O 0 0.02436300925910473
point O 0 0.014086497016251087
to O 0 0.009184989146888256
another O 0 0.010433929041028023
region O 0 0.008884089067578316
of O 0 0.008253097534179688
the O 0 0.013967158272862434
RB1 O 1 0.9999971389770508
gene O 0 0.01376860961318016
where O 0 0.010930958203971386
mutations O 0 0.009838632307946682
only O 0 0.006191459018737078
modify O 0 0.012475045397877693
the O 0 0.007432741113007069
function O 0 0.007667311001569033
of O 0 0.007241143845021725
the O 0 0.008666516281664371
gene O 0 0.008979935199022293
and O 0 0.007370798382908106
raise O 0 0.010813103057444096
important O 0 0.007660631090402603
questions O 0 0.008724567480385303
for O 0 0.007742725312709808
genetic O 0 0.011994516476988792
counseling O 0 0.17688140273094177
in O 0 0.008881825953722
families O 0 0.010006539523601532
with O 0 0.009373457171022892
these O 0 0.01086034718900919
distinctive O 0 0.2991979420185089
phenotypes O 1 0.8677857518196106
. O 0 0.02658773958683014
. O 0 0.043571121990680695

Maternal B-Disease 1 0.9916182160377502
disomy I-Disease 1 0.9989904761314392
and O 1 0.9133502840995789
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 1 0.9555299282073975
with O 0 0.15211813151836395
gamete O 1 0.999957799911499
complementation O 1 0.9999468326568604
in O 0 0.015398373827338219
a O 0 0.014207566156983376
case O 0 0.012859181500971317
of O 0 0.01438558753579855
familial O 1 0.9993610978126526
translocation O 1 0.9567345976829529
( O 0 0.012232492677867413
3 O 0 0.014213422313332558
; O 0 0.010642715729773045
15 O 0 0.014815674163401127
) O 0 0.013388615101575851
( O 0 0.01878529228270054
p25 O 1 0.5197989344596863
; O 0 0.024428725242614746
q11 O 0 0.17113801836967468
. O 0 0.020135238766670227
2 O 0 0.03360559046268463
) O 0 0.037836141884326935
. O 0 0.050330597907304764

Maternal B-Disease 1 0.9999340772628784
uniparental I-Disease 1 0.9999997615814209
disomy I-Disease 1 0.9999982118606567
( I-Disease 1 0.9821641445159912
UPD I-Disease 1 0.9999998807907104
) I-Disease 0 0.018475878983736038
for I-Disease 0 0.013655305840075016
chromosome I-Disease 0 0.020955171436071396
15 I-Disease 0 0.012722971849143505
is O 0 0.007879848591983318
responsible O 0 0.007994882762432098
for O 0 0.005595547147095203
an O 0 0.006736458744853735
estimated O 0 0.008210842497646809
30 O 0 0.008972886018455029
% O 0 0.0066354526206851006
of O 0 0.006842046044766903
cases O 0 0.009105316363275051
of O 0 0.09981440752744675
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999972581863403
PWS B-Disease 1 1.0
) O 0 0.21333470940589905
. O 0 0.06753281503915787

We O 0 0.027214784175157547
report O 0 0.015875311568379402
on O 0 0.011312516406178474
an O 0 0.01140872947871685
unusual O 0 0.012602031230926514
case O 0 0.01032770425081253
of O 0 0.010723880492150784
maternal B-Disease 1 0.9616459608078003
disomy I-Disease 1 0.9982006549835205
15 I-Disease 0 0.01783440075814724
in O 0 0.01766645349562168
PWS B-Disease 1 0.9999998807907104
that O 0 0.007960240356624126
is O 0 0.007088278885930777
most O 0 0.006690587382763624
consistent O 0 0.008852156810462475
with O 0 0.007747570518404245
adjacent O 0 0.01430504396557808
- O 0 0.04532546177506447
1 O 0 0.012930377386510372
segregation O 0 0.016278430819511414
of O 0 0.009357909671962261
a O 0 0.014807289466261864
paternal O 1 0.9799410700798035
t O 1 0.89366215467453
( O 0 0.009702958166599274
3 O 0 0.01351518277078867
; O 0 0.010561017319560051
15 O 0 0.014223801903426647
) O 0 0.012021240778267384
( O 0 0.01535233948379755
p25 O 0 0.1423671990633011
; O 0 0.019013963639736176
q11 O 0 0.04922008514404297
. O 0 0.012605270370841026
2 O 0 0.017634185031056404
) O 0 0.012317673303186893
with O 0 0.011730373837053776
simultaneous O 0 0.02669023536145687
maternal O 1 0.9583114385604858
meiotic O 1 0.9999145269393921
nondisjunction O 1 0.9858118295669556
for O 0 0.027333125472068787
chromosome O 0 0.04956468939781189
15 O 0 0.050017546862363815
. O 0 0.048608824610710144

The O 0 0.04286205396056175
patient O 1 0.9963445067405701
( O 0 0.04753093048930168
J O 1 0.999951958656311
. O 0 0.017392786219716072
B O 1 0.6652156114578247
. O 0 0.010555313900113106
) O 0 0.008507614023983479
, O 0 0.007566910237073898
a O 0 0.00788191705942154
17 O 0 0.012131798081099987
- O 0 0.017684219405055046
year O 0 0.010856126435101032
- O 0 0.05677604675292969
old O 0 0.016325119882822037
white O 0 0.016931580379605293
male O 0 0.016024727374315262
with O 0 0.01906200684607029
PWS B-Disease 1 1.0
, O 0 0.013069763779640198
was O 0 0.011595884338021278
found O 0 0.006514349952340126
to O 0 0.005637832917273045
have O 0 0.005512511357665062
47 O 0 0.014127986505627632
chromosomes O 0 0.010958491824567318
with O 0 0.006933514028787613
a O 0 0.010849425569176674
supernumerary O 1 0.9983009696006775
, O 0 0.018304428085684776
paternal O 1 0.9806824922561646
der O 1 0.9722157716751099
( O 0 0.012040805071592331
15 O 0 0.012264370918273926
) O 0 0.008045420981943607
consisting O 0 0.008239439688622952
of O 0 0.006778432056307793
the O 0 0.007698917295783758
short O 0 0.012022463604807854
arm O 1 0.6315562725067139
and O 0 0.008780191652476788
the O 0 0.012016364373266697
proximal O 1 0.9976660013198853
long O 0 0.017131902277469635
arm O 1 0.6593824625015259
of O 0 0.012939570471644402
chromosome O 0 0.024435896426439285
15 O 0 0.014108591713011265
, O 0 0.014894905500113964
and O 0 0.020049525424838066
distal O 1 0.9996057152748108
chromosome O 1 0.9132075905799866
arm O 1 0.9996591806411743
3p O 1 0.9999109506607056
. O 0 0.0654885396361351

The O 0 0.04033908620476723
t O 1 0.5554751753807068
( O 0 0.01849721185863018
3 O 0 0.01692376285791397
; O 0 0.011313817463815212
15 O 0 0.012171706184744835
) O 0 0.008755078539252281
was O 0 0.010488664731383324
present O 0 0.006750502623617649
in O 0 0.006377908401191235
the O 0 0.0063518644310534
balanced O 0 0.009411451406776905
state O 0 0.006287178490310907
in O 0 0.007863563485443592
the O 0 0.014278068207204342
patients O 1 0.991396963596344
father O 0 0.15592992305755615
and O 0 0.017151329666376114
a O 0 0.03212307393550873
sister O 0 0.32226160168647766
. O 0 0.04603685438632965

Fluorescent O 0 0.10952940583229065
in O 0 0.03055841103196144
situ O 0 0.0642966628074646
hybridization O 0 0.03372004255652428
analysis O 0 0.018627939745783806
demonstrated O 0 0.01845988817512989
that O 0 0.009098968468606472
the O 0 0.015359470620751381
PWS B-Disease 1 1.0
critical O 0 0.06838784366846085
region O 0 0.015623131766915321
resided O 0 0.020020538941025734
on O 0 0.008678381331264973
the O 0 0.009845723398029804
derivative O 0 0.019323769956827164
chromosome O 0 0.013909165747463703
3 O 0 0.010568015277385712
and O 0 0.0065842741169035435
that O 0 0.004652967676520348
there O 0 0.005425727926194668
was O 0 0.009128957986831665
no O 0 0.007239086553454399
deletion O 0 0.01484047994017601
of O 0 0.009345236234366894
the O 0 0.022219594568014145
PWS B-Disease 1 0.9999998807907104
region O 0 0.01393407303839922
on O 0 0.009334025904536247
the O 0 0.009900727309286594
normal O 0 0.012463074177503586
pair O 0 0.01962626725435257
of O 0 0.016428429633378983
15s O 1 0.9911754131317139
present O 0 0.03088998980820179
in O 0 0.03358687460422516
J O 1 0.9993680119514465
. O 0 0.06050184741616249

B O 1 0.9325794577598572
. O 0 0.12025047838687897

Methylation O 0 0.0638568177819252
analysis O 0 0.029953956604003906
at O 0 0.027602093294262886
exon O 0 0.045169319957494736
alpha O 0 0.027605153620243073
of O 0 0.013601597398519516
the O 0 0.012509194202721119
small O 0 0.013438782654702663
nuclear O 0 0.025586433708667755
ribonucleoprotein O 1 0.9931222796440125
- O 1 0.5398880839347839
associated O 0 0.023612944409251213
polypeptide O 1 0.7569476366043091
N O 0 0.045455437153577805
( O 0 0.02301831915974617
SNRPN O 1 0.9917379021644592
) O 0 0.01720156893134117
gene O 0 0.015604207292199135
showed O 0 0.0140253696590662
a O 0 0.01352363359183073
pattern O 0 0.01531413197517395
characteristic O 0 0.013173263520002365
of O 0 0.008610181510448456
only O 0 0.009168651886284351
the O 0 0.01372817438095808
maternal O 1 0.9665504097938538
chromosome O 0 0.0308426171541214
15 O 0 0.024669978767633438
in O 0 0.025643985718488693
J O 1 0.9961298704147339
. O 0 0.052835043519735336

B O 1 0.9267884492874146
. O 0 0.10589946806430817

Maternal B-Disease 1 0.9995278120040894
disomy I-Disease 1 0.9965810179710388
was O 0 0.030073126778006554
confirmed O 0 0.019176730886101723
by O 0 0.01463090255856514
polymerase O 0 0.04379243403673172
chain O 0 0.02600351721048355
reaction O 0 0.014359566383063793
analysis O 0 0.012901159934699535
of O 0 0.013568785041570663
microsatellite O 0 0.09583534300327301
repeats O 0 0.022735431790351868
at O 0 0.015177546069025993
the O 0 0.0144338458776474
gamma O 0 0.11301033943891525
- O 1 0.9158093929290771
aminobutyric O 1 0.9891095161437988
acid O 0 0.07849179953336716
receptor O 0 0.04415090009570122
beta3 O 1 0.6416013836860657
subunit O 0 0.06586874276399612
( O 0 0.03874729201197624
GABRB3 O 1 0.9997550845146179
) O 0 0.0472085066139698
locus O 0 0.13379450142383575
. O 0 0.057724479585886

A O 0 0.06376092880964279
niece O 1 0.9991254210472107
( O 0 0.028643300756812096
B O 1 0.9632304310798645
. O 0 0.01463889330625534
B O 0 0.3943779766559601
. O 0 0.00815028790384531
) O 0 0.007347669918090105
with O 0 0.006638841237872839
45 O 0 0.012544476427137852
chromosomes O 0 0.011175627820193768
and O 0 0.006631562951952219
the O 0 0.007936522364616394
derivative O 0 0.012079926207661629
3 O 0 0.008866418153047562
but O 0 0.005619852803647518
without O 0 0.006095871329307556
the O 0 0.008359469473361969
der O 1 0.8505619168281555
( O 0 0.008494775742292404
15 O 0 0.01031652931123972
) O 0 0.007739664521068335
demonstrated O 0 0.01119302399456501
a O 0 0.010207329876720905
phenotype O 0 0.04393496736884117
consistent O 0 0.009649770334362984
with O 0 0.006439404562115669
that O 0 0.005727522075176239
reported O 0 0.008584544062614441
for O 0 0.01068278681486845
haploinsufficiency O 1 0.8665717840194702
of O 0 0.021849850192666054
distal O 1 0.999060332775116
3 O 0 0.04778661951422691
p O 0 0.07449036091566086
. O 0 0.049981340765953064

Uniparental B-Disease 1 0.9999978542327881
disomy I-Disease 1 0.9996486902236938
associated O 0 0.03397176414728165
with O 0 0.019884398207068443
unbalanced O 0 0.1352374106645584
segregation O 0 0.044238414615392685
of O 0 0.017031285911798477
non O 1 0.5403302311897278
- O 1 0.9997298121452332
Robertsonian O 1 0.9996658563613892
translocations O 0 0.2866835594177246
has O 0 0.009643170051276684
been O 0 0.007083061616867781
reported O 0 0.008875195868313313
previously O 0 0.00871910061687231
but O 0 0.005645285360515118
has O 0 0.006107088644057512
not O 0 0.004701939411461353
, O 0 0.005463286302983761
to O 0 0.0059654442593455315
our O 0 0.008164828643202782
knowledge O 0 0.010146289132535458
, O 0 0.00825805589556694
been O 0 0.0070957220159471035
observed O 0 0.008995471522212029
in O 0 0.009634612128138542
a O 0 0.01521076075732708
case O 0 0.022493982687592506
of O 0 0.038952648639678955
PWS B-Disease 1 0.9999998807907104
. O 0 0.06364746391773224

Furthermore O 0 0.049964796751737595
, O 0 0.020456358790397644
our O 0 0.01657753624022007
findings O 0 0.014425807632505894
are O 0 0.006840822286903858
best O 0 0.013050630688667297
interpreted O 0 0.012942797504365444
as O 0 0.012675853446125984
true O 0 0.02448616735637188
gamete O 1 0.9699828028678894
complementation O 1 0.9997349381446838
resulting O 0 0.03934617340564728
in O 0 0.03404175117611885
maternal B-Disease 1 0.9999507665634155
UPD I-Disease 1 0.9999998807907104
15 I-Disease 0 0.18276365101337433
and O 0 0.08154524862766266
PWS B-Disease 1 0.9999903440475464

Schwartz B-Disease 1 0.9973787069320679
- I-Disease 1 0.9999414682388306
Jampel I-Disease 1 0.9999994039535522
syndrome I-Disease 1 1.0
type I-Disease 1 0.9525293707847595
2 I-Disease 0 0.02723000757396221
and O 0 0.028250975534319878
Stuve B-Disease 1 0.9999988079071045
- I-Disease 1 0.9999998807907104
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
: O 0 0.025958247482776642
a O 0 0.018743177875876427
case O 0 0.019879769533872604
for O 0 0.015851622447371483
" O 0 0.025478754192590714
lumping O 1 0.5974528789520264
" O 0 0.039723001420497894
. O 0 0.050593771040439606

Recent O 0 0.029325006529688835
studies O 0 0.01891111209988594
demonstrated O 0 0.017585620284080505
the O 0 0.011757026426494122
existence O 0 0.01186036691069603
of O 0 0.008811704814434052
a O 0 0.010996231809258461
genetically O 0 0.016347525641322136
distinct O 0 0.010986155830323696
, O 0 0.009022155776619911
usually O 0 0.008865905925631523
lethal O 0 0.011436616070568562
form O 0 0.007299736142158508
of O 0 0.008166495710611343
the O 0 0.011092949658632278
Schwartz B-Disease 1 0.9992629885673523
- I-Disease 1 0.9999871253967285
Jampel I-Disease 1 0.9999997615814209
syndrome I-Disease 1 1.0
( O 1 0.9810891151428223
SJS B-Disease 1 0.9999998807907104
) O 0 0.01792587712407112
of O 0 0.026840107515454292
myotonia B-Disease 1 1.0
and O 1 0.9978867173194885
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 0.2812492251396179
which O 0 0.010941417887806892
we O 0 0.012781725265085697
called O 0 0.11080123484134674
SJS B-Disease 1 0.9999992847442627
type I-Disease 1 0.519981861114502
2 I-Disease 0 0.052132390439510345
. O 0 0.04955226927995682

This O 0 0.03683681786060333
disorder O 1 0.9998551607131958
is O 0 0.015558459796011448
reminiscent O 0 0.16746504604816437
of O 0 0.01202590111643076
another O 0 0.023440804332494736
rare O 0 0.25164568424224854
condition O 0 0.4444955289363861
, O 0 0.008730437606573105
the O 0 0.014927362091839314
Stuve B-Disease 1 0.9999992847442627
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9983747005462646
SWS B-Disease 1 0.9999998807907104
) O 0 0.015102814882993698
, O 0 0.01104661077260971
which O 0 0.00899456162005663
comprises O 0 0.016989314928650856
campomelia B-Disease 1 0.6234145164489746
at O 0 0.014793571084737778
birth O 0 0.13453993201255798
with O 0 0.08505704253911972
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 1 0.9994192123413086
contractures B-Disease 1 1.0
, O 0 0.03934125974774361
and O 0 0.017178237438201904
early B-Disease 0 0.027672532945871353
death I-Disease 0 0.08571133762598038
. O 0 0.04164974018931389

To O 0 0.02441546320915222
test O 0 0.020902570337057114
for O 0 0.012145900167524815
possible O 0 0.013499901629984379
nosologic O 0 0.24032214283943176
identity O 0 0.013088049367070198
between O 0 0.008700656704604626
these O 0 0.009760485962033272
disorders O 1 0.9999997615814209
, O 0 0.008654971607029438
we O 0 0.006096923723816872
reviewed O 0 0.010436036624014378
the O 0 0.006841168738901615
literature O 0 0.007818803191184998
and O 0 0.005702467169612646
obtained O 0 0.006378303747624159
a O 0 0.007253954187035561
follow O 0 0.008040227927267551
- O 0 0.011497119441628456
up O 0 0.007112822961062193
of O 0 0.005507218185812235
the O 0 0.005335613153874874
only O 0 0.004774375353008509
two O 0 0.006495755165815353
surviving O 0 0.048452191054821014
patients O 0 0.031093956902623177
, O 0 0.007152663078159094
one O 0 0.007072991691529751
with O 0 0.008746347390115261
SJS B-Disease 1 0.9999946355819702
type I-Disease 0 0.016209881752729416
2 I-Disease 0 0.011600838042795658
at O 0 0.008556279353797436
age O 0 0.008949273265898228
10 O 0 0.009369923733174801
years O 0 0.008525264449417591
and O 0 0.007609155494719744
another O 0 0.011660592630505562
with O 0 0.012470347806811333
SWS B-Disease 1 0.9997473359107971
at O 0 0.02183053083717823
age O 0 0.024069134145975113
7 O 0 0.033116959035396576
years O 0 0.03586495295166969
. O 0 0.04290934279561043

Patients O 1 0.7210289239883423
reported O 0 0.02440018393099308
as O 0 0.016451217234134674
having O 0 0.01874729059636593
either O 0 0.04875320568680763
neonatal O 1 1.0
SJS B-Disease 1 1.0
or O 0 0.16677848994731903
SWS B-Disease 1 0.9999350309371948
presented O 0 0.023587865754961967
a O 0 0.014333552680909634
combination O 0 0.014058496803045273
of O 0 0.008051740005612373
a O 0 0.011782621964812279
severe O 1 0.9999449253082275
, O 1 0.8106277585029602
prenatal O 1 1.0
- O 1 1.0
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 0.9991480112075806
with O 1 0.9998373985290527
congenital B-Disease 1 1.0
joint I-Disease 1 1.0
contractures I-Disease 1 1.0
, O 1 0.9999998807907104
respiratory O 1 1.0
and O 1 0.9995598196983337
feeding O 1 0.9999055862426758
difficulties O 1 0.99996018409729
, O 0 0.05787241831421852
tendency O 0 0.2759780287742615
to O 0 0.015199842862784863
hyperthermia B-Disease 1 0.9999996423721313
, O 0 0.010969738475978374
and O 0 0.008962944149971008
frequent O 0 0.013777568005025387
death O 0 0.034679993987083435
in O 0 0.010698743164539337
infancy O 1 0.9656141996383667
) O 0 0.008203848265111446
with O 0 0.007246996741741896
a O 0 0.011678272858262062
distinct O 0 0.020446166396141052
campomelic B-Disease 1 0.9999978542327881
- I-Disease 1 0.999998927116394
metaphyseal I-Disease 1 0.9999995231628418
skeletal I-Disease 1 0.9999998807907104
dysplasia I-Disease 1 0.9999998807907104
. O 0 0.11230802536010742

The O 0 0.032701946794986725
similarity O 0 0.029709376394748688
of O 0 0.015555967576801777
the O 0 0.015567204914987087
clinical O 1 0.9971670508384705
and O 0 0.019812246784567833
radiographic O 1 0.9997522234916687
findings O 0 0.016560561954975128
is O 0 0.008435234427452087
so O 0 0.00722037348896265
extensive O 0 0.011027779430150986
that O 0 0.007108291145414114
these O 0 0.009054477326571941
disorders O 1 0.9999879598617554
appear O 0 0.009248440153896809
to O 0 0.00879377219825983
be O 0 0.008365520276129246
a O 0 0.01658291183412075
single O 0 0.02398352324962616
entity O 0 0.045423299074172974
. O 0 0.040237609297037125

The O 0 0.029857104644179344
follow O 0 0.02246147207915783
- O 0 0.028069976717233658
up O 0 0.014442461542785168
observation O 0 0.01810579001903534
of O 0 0.008299773558974266
an O 0 0.007800355087965727
identical O 0 0.010422862134873867
and O 0 0.006867877673357725
unique O 0 0.008997567929327488
pattern O 0 0.011537889949977398
of O 0 0.43054330348968506
progressive O 1 1.0
bone B-Disease 1 1.0
dysplasia I-Disease 1 1.0
in O 0 0.01042960211634636
the O 0 0.010175789706408978
two O 0 0.00902552716434002
patients O 1 0.6635702252388
( O 0 0.007869971916079521
one O 0 0.009256058372557163
with O 0 0.011913169175386429
SJS B-Disease 1 0.9999990463256836
type I-Disease 0 0.02576284483075142
2 I-Disease 0 0.013402278535068035
, O 0 0.008607552386820316
one O 0 0.009128371253609657
with O 0 0.010662203654646873
SWS B-Disease 1 0.9998496770858765
) O 0 0.014976474456489086
surviving O 0 0.034253619611263275
beyond O 0 0.018911946564912796
infancy O 1 0.9201916456222534
adds O 0 0.017663227394223213
to O 0 0.010583733208477497
the O 0 0.010696320794522762
evidence O 0 0.012005257420241833
in O 0 0.011107683181762695
favor O 0 0.018603473901748657
of O 0 0.01887993887066841
identity O 0 0.03285691887140274
. O 0 0.04198279604315758

The O 0 0.038438890129327774
hypothesis O 0 0.0417366586625576
that O 0 0.019065294414758682
SWS B-Disease 1 0.9997153878211975
and O 0 0.06719211488962173
SJS B-Disease 1 0.9999996423721313
type I-Disease 0 0.13054171204566956
2 I-Disease 0 0.016166169196367264
are O 0 0.006733948830515146
the O 0 0.010422990657389164
same O 0 0.013233078643679619
disorder O 1 0.9999243021011353
should O 0 0.010420517064630985
be O 0 0.009553107433021069
testable O 0 0.025702282786369324
by O 0 0.01096936035901308
molecular O 0 0.021024679765105247
methods O 0 0.019039183855056763
. O 0 0.021651342511177063
. O 0 0.03682265058159828

A O 0 0.042185939848423004
mouse O 0 0.041876863688230515
model O 0 0.02642965316772461
of O 0 0.034734368324279785
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 1 0.9999498128890991
defects O 1 0.9999998807907104
in O 1 0.9978445768356323
hemostasis O 1 1.0
and O 1 0.9998787641525269
thrombosis B-Disease 1 1.0
. O 1 0.5459739565849304

von B-Disease 1 0.9991880059242249
Willebrand I-Disease 1 0.999998927116394
factor I-Disease 1 0.865786612033844
( I-Disease 0 0.28289517760276794
vWf I-Disease 1 0.9999949932098389
) I-Disease 1 0.9920205473899841
deficiency I-Disease 1 1.0
causes O 1 1.0
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 1 0.997617781162262
humans O 0 0.44913992285728455
. O 0 0.0560389943420887

We O 0 0.026166513562202454
generated O 0 0.024437306448817253
a O 0 0.01735328882932663
mouse O 0 0.026985790580511093
model O 0 0.0177241750061512
for O 0 0.01190400030463934
this O 0 0.013172674924135208
disease O 1 0.9984662532806396
by O 0 0.011475025676190853
using O 0 0.01761002279818058
gene O 0 0.02856314741075039
targeting O 0 0.04451937973499298
. O 0 0.04467109590768814

vWf B-Disease 1 0.9997441172599792
- I-Disease 1 0.999612033367157
deficient I-Disease 1 0.9984360337257385
mice O 0 0.040629249066114426
appeared O 0 0.016014037653803825
normal O 0 0.01309218443930149
at O 0 0.012813900597393513
birth O 0 0.01673937402665615
; O 0 0.0092115243896842
they O 0 0.007386513985693455
were O 0 0.008819901384413242
viable O 0 0.023770293220877647
and O 0 0.020669572055339813
fertile O 0 0.08907967060804367
. O 0 0.0485716387629509

Neither O 0 0.09206853061914444
vWf O 1 0.679720401763916
nor O 0 0.06764114648103714
vWf O 1 0.9894347786903381
propolypeptide O 1 0.9970892071723938
( O 0 0.04920622333884239
von B-Disease 1 0.9999438524246216
Willebrand I-Disease 1 1.0
antigen O 1 0.999997615814209
II O 1 0.9999896287918091
) O 0 0.01841311901807785
were O 0 0.013207678683102131
detectable O 0 0.02503611147403717
in O 0 0.012516351416707039
plasma O 0 0.05691663175821304
, O 0 0.02032722346484661
platelets O 1 0.9974521994590759
, O 0 0.014741767197847366
or O 0 0.01393374614417553
endothelial O 1 0.997361958026886
cells O 0 0.017169594764709473
of O 0 0.014547121711075306
the O 0 0.021961553022265434
homozygous O 0 0.2690677046775818
mutant O 1 0.8814650177955627
mice O 0 0.24501967430114746
. O 0 0.053869523108005524

The O 0 0.04641040414571762
mutant O 1 0.8706071376800537
mice O 1 0.5842689871788025
exhibited O 1 0.9242607355117798
defects O 1 0.9997358918190002
in O 0 0.018264830112457275
hemostasis O 1 0.9999908208847046
with O 0 0.010783788748085499
a O 0 0.02117655612528324
highly O 1 0.9583137631416321
prolonged O 1 0.9999996423721313
bleeding O 1 0.9999998807907104
time O 0 0.01659943349659443
and O 0 0.042033322155475616
spontaneous O 1 0.8908022046089172
bleeding O 1 0.999990701675415
events O 0 0.01350189559161663
in O 0 0.010119992308318615
approximately O 0 0.015560571104288101
10 O 0 0.016916656866669655
% O 0 0.020438900217413902
of O 0 0.027344699949026108
neonates O 1 0.9023221135139465
. O 0 0.05948592349886894

As O 0 0.023117033764719963
in O 0 0.014438423328101635
the O 0 0.014569463208317757
human O 0 0.05968134477734566
disease O 1 0.999993085861206
, O 0 0.009857184253633022
the O 0 0.012854373082518578
factor O 1 0.5841332674026489
VIII O 1 0.9999656677246094
level O 0 0.01254369132220745
in O 0 0.009029866196215153
these O 0 0.007190675474703312
mice O 0 0.013626371510326862
was O 0 0.011115328408777714
reduced O 0 0.00969768688082695
strongly O 0 0.008316203951835632
as O 0 0.006108559668064117
a O 0 0.007200854364782572
result O 0 0.006390506401658058
of O 0 0.006822248455137014
the O 0 0.008198383264243603
lack O 0 0.011293821968138218
of O 0 0.013357987627387047
protection O 1 0.955351710319519
provided O 0 0.03449729457497597
by O 0 0.027364810928702354
vWf O 1 0.9846972227096558
. O 0 0.05826421082019806

Defective O 1 0.9999889135360718
thrombosis B-Disease 1 0.9999996423721313
in O 0 0.03186028078198433
mutant O 1 0.9923621416091919
mice O 1 0.6568456888198853
was O 0 0.03601986914873123
also O 0 0.010617781430482864
evident O 0 0.013210167177021503
in O 0 0.006928148213773966
an O 0 0.007283593527972698
in O 0 0.009585954248905182
vivo O 0 0.04048475995659828
model O 0 0.030547576025128365
of O 1 0.8821753263473511
vascular B-Disease 1 1.0
injury I-Disease 1 0.9999997615814209
. O 0 0.1283513456583023

In O 0 0.0259399451315403
this O 0 0.016048457473516464
model O 0 0.02162635698914528
, O 0 0.015636343508958817
the O 0 0.017504751682281494
exteriorized O 1 0.9188093543052673
mesentery O 1 0.9957228899002075
was O 0 0.07194787263870239
superfused O 1 0.9936544895172119
with O 0 0.02781958505511284
ferric O 1 0.9999997615814209
chloride O 1 0.9992445707321167
and O 0 0.014652261510491371
the O 0 0.016163939610123634
accumulation O 0 0.1429813802242279
of O 0 0.02755221165716648
fluorescently O 1 0.9999898672103882
labeled O 1 0.9998549222946167
platelets O 1 0.999771773815155
was O 0 0.027608748525381088
observed O 0 0.026289077475667
by O 0 0.02446063794195652
intravital O 1 0.9043734073638916
microscopy O 0 0.09149472415447235
. O 0 0.06693469732999802

We O 0 0.024161923676729202
conclude O 0 0.026610007509589195
that O 0 0.010906579904258251
these O 0 0.008571154437959194
mice O 0 0.014543210156261921
very O 0 0.008992514573037624
closely O 0 0.0121773025020957
mimic O 0 0.38566336035728455
severe O 1 0.9999881982803345
human O 1 0.9998732805252075
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 1 0.9446297883987427
will O 0 0.01027233898639679
be O 0 0.007641833275556564
very O 0 0.007249453570693731
useful O 0 0.007868200540542603
for O 0 0.006323729641735554
investigating O 0 0.009383561089634895
the O 0 0.007833828218281269
role O 0 0.010088266804814339
of O 0 0.009589903987944126
vWf O 1 0.7277624011039734
in O 0 0.009640642441809177
normal O 0 0.0131564075127244
physiology O 1 0.7955147624015808
and O 0 0.014327396638691425
in O 0 0.10004766285419464
disease O 1 0.9999988079071045
models O 0 0.20964020490646362
. O 0 0.024514956399798393
. O 0 0.0374661460518837

Oral O 1 0.9610327482223511
contraceptives O 1 0.9950709342956543
and O 0 0.017633482813835144
the O 0 0.017729928717017174
risk O 1 0.9502376914024353
of O 1 0.9997819066047668
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9962526559829712

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 1 0.9999997615814209
Study O 1 0.9638671278953552
Group O 0 0.2659660577774048
. O 0 0.05088808387517929

BACKGROUND O 0 0.05527326464653015
Women O 0 0.02688836306333542
with O 0 0.014466481283307076
mutations O 0 0.013466604053974152
in O 0 0.00789310410618782
either O 0 0.008323107846081257
the O 0 0.01119060255587101
BRCA1 O 1 0.9952379465103149
or O 0 0.008209619671106339
the O 0 0.012601099908351898
BRCA2 O 1 0.9997557997703552
gene O 0 0.00831974670290947
have O 0 0.004401118028908968
a O 0 0.008006908930838108
high O 0 0.013508603908121586
lifetime O 1 0.988614559173584
risk O 1 0.9996199607849121
of O 1 0.999962329864502
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.3567114770412445

Oral O 1 0.9403462409973145
contraceptives O 1 0.9998049139976501
protect O 1 0.9961702227592468
against O 1 0.9999567270278931
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.14511074125766754
general O 1 0.5314523577690125
, O 0 0.010309675708413124
but O 0 0.006232334300875664
it O 0 0.005463861394673586
is O 0 0.005473218392580748
not O 0 0.00394448870792985
known O 0 0.005586316343396902
whether O 0 0.005594974383711815
they O 0 0.004180361516773701
also O 0 0.006332197226583958
protect O 0 0.009972510859370232
against O 0 0.011048774234950542
hereditary B-Disease 1 0.9999828338623047
forms I-Disease 1 0.9757063388824463
of I-Disease 1 0.9999991655349731
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9628472328186035

METHODS O 0 0.03816752880811691
We O 0 0.01925092563033104
enrolled O 0 0.03419886529445648
207 O 0 0.0695929303765297
women O 0 0.02052086777985096
with O 0 0.23565025627613068
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.3208257555961609
161 O 1 0.5449371933937073
of O 0 0.011708039790391922
their O 0 0.0100177600979805
sisters O 0 0.024425188079476357
as O 0 0.010577408596873283
controls O 0 0.01375666819512844
in O 0 0.010336986742913723
a O 0 0.012938826344907284
case O 0 0.019529158249497414
- O 1 0.8599631786346436
control O 0 0.030960777774453163
study O 0 0.03378833085298538
. O 0 0.039429984986782074

All O 0 0.025037042796611786
the O 0 0.023568464443087578
patients O 0 0.044987887144088745
carried O 0 0.015895025804638863
a O 0 0.014113672077655792
pathogenic O 0 0.030314572155475616
mutation O 0 0.013791056349873543
in O 0 0.008626437745988369
either O 0 0.011847028508782387
BRCA1 O 1 0.9541270732879639
( O 0 0.012262159027159214
179 O 0 0.043829839676618576
women O 0 0.01701410859823227
) O 0 0.01321367733180523
or O 0 0.016451694071292877
BRCA2 O 1 0.9988980293273926
( O 0 0.019817005842924118
28 O 0 0.03715293109416962
women O 0 0.03727934882044792
) O 0 0.03776051476597786
. O 0 0.05008239671587944

The O 0 0.026618164032697678
control O 0 0.021935611963272095
women O 0 0.014104287140071392
were O 0 0.009137873537838459
enrolled O 0 0.019898289814591408
regardless O 0 0.010479504242539406
of O 0 0.007403966970741749
whether O 0 0.008552608080208302
or O 0 0.007702509872615337
not O 0 0.0065016234293580055
they O 0 0.006748264655470848
had O 0 0.014491936191916466
either O 0 0.01800568401813507
mutation O 0 0.03215602785348892
. O 0 0.03665034472942352

Lifetime O 0 0.06470417231321335
histories O 0 0.03340422362089157
of O 0 0.021312061697244644
oral O 1 0.9982295632362366
- O 1 0.9999512434005737
contraceptive O 1 0.9999839067459106
use O 0 0.010487586259841919
were O 0 0.007386049721390009
obtained O 0 0.007827101275324821
by O 0 0.007062105927616358
interview O 0 0.011584649793803692
or O 0 0.006005231756716967
by O 0 0.0055501325987279415
written O 0 0.007775351870805025
questionnaire O 0 0.012513675726950169
and O 0 0.005501697771251202
were O 0 0.004759737756103277
compared O 0 0.006986322812736034
between O 0 0.006535904016345739
patients O 0 0.2415359765291214
and O 0 0.007052670232951641
control O 0 0.01603998802602291
women O 0 0.011983063071966171
, O 0 0.007104795426130295
after O 0 0.009210954420268536
adjustment O 0 0.028592893853783607
for O 0 0.007659659720957279
year O 0 0.010744786821305752
of O 0 0.014379301108419895
birth O 0 0.03603309392929077
and O 0 0.02402159385383129
parity O 0 0.07285107672214508
. O 0 0.05004509165883064

RESULTS O 0 0.029104551300406456
The O 0 0.01968434453010559
adjusted O 0 0.024558119475841522
odds O 0 0.026754453778266907
ratio O 0 0.027333607897162437
for O 1 0.9197053909301758
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 0.0334525890648365
with O 0 0.008730875328183174
any O 0 0.007624077145010233
past O 0 0.01033752504736185
use O 0 0.010639096610248089
of O 0 0.0163271501660347
oral O 1 0.9944266080856323
contraceptives O 1 0.9999827146530151
was O 1 0.6006770730018616
0 O 0 0.05079365149140358
. O 0 0.052586160600185394

5 O 0 0.03957171365618706
( O 0 0.02100948430597782
95 O 0 0.027135640382766724
percent O 0 0.021173374727368355
confidence O 0 0.02359025552868843
interval O 0 0.0212820153683424
, O 0 0.012243326753377914
0 O 0 0.014383694157004356
. O 0 0.00872424989938736
3 O 0 0.01258799433708191
to O 0 0.01076545100659132
0 O 0 0.01999574527144432
. O 0 0.014696670696139336
8 O 0 0.02779466286301613
) O 0 0.030024003237485886
. O 0 0.03815656900405884

The O 0 0.039772000163793564
risk O 0 0.06268356740474701
decreased O 0 0.021810706704854965
with O 0 0.009862597100436687
increasing O 0 0.011929580941796303
duration O 0 0.016522139310836792
of O 0 0.010398387908935547
use O 0 0.009360738098621368
( O 0 0.012193306349217892
P O 0 0.02392531931400299
for O 0 0.009394760243594646
trend O 0 0.01690172404050827
, O 0 0.012581956572830677
< O 0 0.02955295518040657
0 O 0 0.020677240565419197
. O 0 0.010934422723948956
001 O 0 0.16944429278373718
) O 0 0.01055709645152092
; O 0 0.007706312462687492
use O 0 0.0060454364866018295
for O 0 0.005552062764763832
six O 0 0.0066634779796004295
or O 0 0.004965584725141525
more O 0 0.0046178982593119144
years O 0 0.006509359460324049
was O 0 0.009235131554305553
associated O 0 0.006655995734035969
with O 0 0.005635567009449005
a O 0 0.008874056860804558
60 O 0 0.01588270254433155
percent O 0 0.014613623730838299
reduction O 0 0.022877268493175507
in O 0 0.02007700316607952
risk O 0 0.0481656938791275
. O 0 0.037453606724739075

Oral O 1 0.7920616865158081
- O 1 0.7931090593338013
contraceptive O 1 0.9921731948852539
use O 0 0.016285480931401253
protected O 1 0.6418934464454651
against O 1 0.9992097616195679
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 0.009148634970188141
for O 0 0.008593467995524406
carriers O 0 0.016030674800276756
of O 0 0.009057129733264446
the O 0 0.0146668441593647
BRCA1 O 1 0.9999817609786987
mutation O 0 0.017159797251224518
( O 0 0.010191569104790688
odds O 0 0.019215621054172516
ratio O 0 0.014397694729268551
, O 0 0.00942651554942131
0 O 0 0.012773046270012856
. O 0 0.007449701894074678
5 O 0 0.011647239327430725
; O 0 0.008561033755540848
95 O 0 0.0172401275485754
percent O 0 0.013631307519972324
confidence O 0 0.017320998013019562
interval O 0 0.017551762983202934
, O 0 0.010284456424415112
0 O 0 0.011718517169356346
. O 0 0.0067551652900874615
3 O 0 0.009575520642101765
to O 0 0.007370679639279842
0 O 0 0.011921266093850136
. O 0 0.007956404238939285
9 O 0 0.011246755719184875
) O 0 0.007486151996999979
and O 0 0.006239576730877161
for O 0 0.006700863130390644
carriers O 0 0.013731067068874836
of O 0 0.00921953096985817
the O 0 0.014015113934874535
BRCA2 O 1 0.9993215799331665
mutation O 0 0.017315374687314034
( O 0 0.011437629349529743
odds O 0 0.021620627492666245
ratio O 0 0.015264890156686306
, O 0 0.01024025771766901
0 O 0 0.01248313207179308
. O 0 0.008041045628488064
4 O 0 0.01215402688831091
; O 0 0.009476675651967525
95 O 0 0.016700029373168945
percent O 0 0.012824714183807373
confidence O 0 0.01604243367910385
interval O 0 0.017139950767159462
, O 0 0.01056812983006239
0 O 0 0.012899265624582767
. O 0 0.008071603253483772
2 O 0 0.01228814572095871
to O 0 0.010078195482492447
1 O 0 0.018382368609309196
. O 0 0.014967297203838825
1 O 0 0.02778843231499195
) O 0 0.026760784909129143
. O 0 0.04393891617655754

CONCLUSIONS O 0 0.05445133149623871
Oral O 1 0.9934844374656677
- O 1 0.9995805621147156
contraceptive O 1 0.999890923500061
use O 0 0.010884243063628674
may O 0 0.008167884312570095
reduce O 0 0.010557031258940697
the O 0 0.008660468272864819
risk O 1 0.7112289667129517
of O 1 0.9996223449707031
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.10858901590108871
women O 0 0.04010778293013573
with O 0 0.012283875606954098
pathogenic O 0 0.08021289110183716
mutations O 0 0.015375589020550251
in O 0 0.012748602777719498
the O 0 0.025832602754235268
BRCA1 O 1 0.9999645948410034
or O 0 0.1529880166053772
BRCA2 O 1 0.9999233484268188
gene O 0 0.07981246709823608

A O 0 0.045757681131362915
Japanese O 0 0.07396533340215683
family O 0 0.031348321586847305
with O 0 0.021328110247850418
adrenoleukodystrophy B-Disease 1 0.9999992847442627
with O 0 0.015684496611356735
a O 0 0.017985906451940536
codon O 0 0.0304731372743845
291 O 0 0.041596073657274246
deletion O 0 0.02695266716182232
: O 0 0.012984861619770527
a O 0 0.01265770010650158
clinical O 1 0.9971285462379456
, O 0 0.017561951652169228
biochemical O 1 0.8945522904396057
, O 0 0.01605880632996559
pathological O 1 0.9539548754692078
, O 0 0.016764160245656967
and O 0 0.016803929582238197
genetic O 0 0.026596009731292725
report O 0 0.030171385034918785
. O 0 0.03651503100991249

We O 0 0.023934559896588326
report O 0 0.016732677817344666
a O 0 0.01587747037410736
Japanese O 0 0.026308076456189156
family O 0 0.02410602942109108
with O 0 0.3889962136745453
adrenoleukodystrophy B-Disease 1 1.0
( O 1 0.99989914894104
ALD B-Disease 1 1.0
) O 0 0.015369064174592495
with O 0 0.010008741170167923
a O 0 0.011592596769332886
three O 0 0.009704195894300938
base O 0 0.02000553160905838
pair O 0 0.022274041548371315
deletion O 0 0.05210389941930771
( O 0 0.016231680288910866
delGAG O 1 0.9018829464912415
291 O 0 0.05181103199720383
) O 0 0.016313232481479645
in O 0 0.015284148044884205
the O 0 0.03275364637374878
ALD B-Disease 1 1.0
gene O 0 0.06345491111278534
. O 0 0.052774250507354736

A O 0 0.036470670253038406
variety O 0 0.022710388526320457
of O 0 0.017394227907061577
phenotypes O 0 0.05687452852725983
were O 0 0.011484405025839806
observed O 0 0.012109075672924519
within O 0 0.012912611477077007
this O 0 0.017144130542874336
family O 0 0.03734892979264259
. O 0 0.04098397493362427

While O 0 0.03359953686594963
the O 0 0.026088988408446312
proband O 1 0.951836109161377
( O 0 0.02202572673559189
patient O 1 0.92816162109375
1 O 0 0.018645618110895157
) O 0 0.010319518856704235
was O 0 0.012691570445895195
classified O 0 0.011157789267599583
as O 0 0.007172004319727421
having O 0 0.007689059246331453
a O 0 0.007945883087813854
rare O 0 0.01413337979465723
intermediate O 0 0.03776536509394646
type O 0 0.011901129968464375
of O 0 0.009853443130850792
adult O 0 0.019554179161787033
cerebral O 1 0.9998292922973633
and O 0 0.11157996952533722
cerebello O 1 0.9999995231628418
- O 1 0.9999986886978149
brain O 1 0.9984362721443176
stem O 0 0.016653932631015778
forms O 0 0.009453590959310532
, O 0 0.008654206991195679
his O 0 0.013807338662445545
younger O 0 0.4394458532333374
brother O 1 0.7884196043014526
( O 0 0.012151067145168781
patient O 1 0.8253923654556274
2 O 0 0.012778976932168007
) O 0 0.009523824788630009
and O 0 0.009961518459022045
nephew O 1 0.9959486722946167
( O 0 0.011991533450782299
patient O 1 0.9095513224601746
3 O 0 0.014136847108602524
) O 0 0.010721967555582523
had O 0 0.014007359743118286
a O 0 0.12920276820659637
childhood O 1 0.9999997615814209
ALD B-Disease 1 1.0
type O 1 0.999933123588562
. O 0 0.07118592411279678

Another O 0 0.054355818778276443
nephew O 1 0.9981826543807983
( O 0 0.021731099113821983
patient O 1 0.6146534085273743
4 O 0 0.016195690259337425
) O 0 0.010198344476521015
of O 0 0.010283184237778187
patient O 1 0.8893440365791321
1 O 0 0.016478821635246277
was O 0 0.016434572637081146
classified O 0 0.015983304008841515
as O 0 0.010550618171691895
having O 0 0.014400212094187737
an O 0 0.019384048879146576
adolescent O 1 0.9998290538787842
form O 0 0.03374353423714638
. O 0 0.041761528700590134

The O 0 0.03582588955760002
tau O 0 0.05402010679244995
level O 0 0.01823236420750618
in O 0 0.011958044953644276
the O 0 0.01669047214090824
cerebrospinal O 1 0.9999918937683105
fluid O 1 0.9958319067955017
( O 0 0.14453595876693726
CSF O 1 0.9999960660934448
) O 0 0.01133010908961296
in O 0 0.010587329044938087
patient O 1 0.5789047479629517
1 O 0 0.013237020000815392
was O 0 0.010290073230862617
as O 0 0.007880697958171368
high O 0 0.008529732935130596
as O 0 0.005870540160685778
that O 0 0.005091975908726454
of O 0 0.008386347442865372
patients O 1 0.9996570348739624
with O 1 0.9998177886009216
Alzheimers B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9990178346633911
AD B-Disease 1 0.9997064471244812
) O 0 0.040564946830272675
. O 0 0.05613308027386665

His O 0 0.06268768012523651
brain O 0 0.36700743436813354
magnetic O 0 0.035791728645563126
resonance O 0 0.03649108111858368
image O 0 0.2784617841243744
( O 0 0.020522361621260643
MRI O 1 0.9968763589859009
) O 0 0.014177297241985798
showed O 0 0.016169771552085876
abnormalities B-Disease 0 0.08577143400907516
in I-Disease 0 0.007920180447399616
the I-Disease 0 0.011020932346582413
bilateral I-Disease 1 0.9728108048439026
cerebellar I-Disease 1 0.9999997615814209
hemispheres I-Disease 1 0.9988405108451843
and O 1 0.9754864573478699
brain O 1 0.9999535083770752
stem O 0 0.35973066091537476
, O 0 0.007763493340462446
but O 0 0.005273676943033934
not O 0 0.00427513662725687
in O 0 0.00609074579551816
the O 0 0.012763068079948425
cerebral O 1 0.9999971389770508
white O 1 0.5285596251487732
matter O 0 0.009044834412634373
, O 0 0.007694627158343792
where O 0 0.007033182308077812
marked O 0 0.009986389428377151
reductions O 0 0.012705770321190357
of O 0 0.009142182767391205
the O 0 0.03999349847435951
cerebral O 1 0.9999988079071045
blood O 1 0.9414387345314026
flow O 0 0.015380455181002617
and O 0 0.014017095789313316
oxygen O 0 0.3867938816547394
metabolism O 0 0.032781120389699936
were O 0 0.010357662104070187
clearly O 0 0.016954150050878525
demonstrated O 0 0.017181597650051117
by O 0 0.013158116489648819
positron O 0 0.06613956391811371
emission O 0 0.03993122652173042
tomography O 0 0.17743755877017975
( O 0 0.036751605570316315
PET O 1 0.985975444316864
) O 0 0.03780083358287811
. O 0 0.04998945817351341

In O 0 0.02840888686478138
patients O 1 0.7352187037467957
2 O 0 0.017975758761167526
and O 0 0.01070569921284914
3 O 0 0.013187242671847343
, O 0 0.010357281193137169
the O 0 0.011080157943069935
autopsy O 0 0.020116010680794716
findings O 0 0.013590667396783829
showed O 0 0.01535533182322979
massive O 0 0.3871307969093323
demyelination B-Disease 1 0.9999994039535522
of I-Disease 0 0.1348949521780014
the I-Disease 1 0.8095399737358093
cerebral I-Disease 1 0.9999983310699463
white I-Disease 0 0.14413106441497803
matter I-Disease 0 0.011576064862310886
with O 0 0.008223620243370533
sparing O 0 0.02045677788555622
of O 0 0.010156115517020226
the O 0 0.018690340220928192
U O 1 0.999990701675415
- O 1 0.999862790107727
fibers O 1 0.9771366715431213
, O 0 0.01137975137680769
compatible O 0 0.016972273588180542
with O 0 0.0089177330955863
the O 0 0.011379022151231766
findings O 0 0.018230535089969635
of O 0 0.06539416313171387
childhood O 1 0.9999974966049194
ALD B-Disease 1 1.0
. O 0 0.40670257806777954

Oleic O 1 0.9175124168395996
and O 0 0.048266615718603134
erucic O 1 0.9995989203453064
acids O 0 0.03829120472073555
( O 0 0.02569100260734558
Lorenzos O 1 0.9105464816093445
Oil O 0 0.021078728139400482
) O 0 0.011015595868229866
were O 0 0.008470072411000729
administered O 0 0.011787219904363155
to O 0 0.008751594461500645
patients O 0 0.07480644434690475
1 O 0 0.012013710103929043
and O 0 0.007752690464258194
4 O 0 0.010988150723278522
, O 0 0.0085227582603693
but O 0 0.0075735594145953655
sufficient O 0 0.013122246600687504
effectiveness O 0 0.032482486218214035
was O 0 0.020926164463162422
not O 0 0.014899847097694874
obtained O 0 0.02646493911743164
. O 0 0.03530522435903549

The O 0 0.030105097219347954
findings O 0 0.021086599677801132
in O 0 0.013172246515750885
this O 0 0.009264765307307243
family O 0 0.013424288481473923
suggest O 0 0.011705778539180756
that O 0 0.008196773938834667
delGAG291 O 0 0.09738002717494965
is O 0 0.008875498548150063
part O 0 0.009481726214289665
of O 0 0.007523253094404936
the O 0 0.009486174210906029
cause O 0 0.3452678322792053
of O 0 0.04982805252075195
Japanese O 1 0.999907374382019
ALD B-Disease 1 1.0
with O 0 0.03644001483917236
phenotypic O 0 0.38267987966537476
variations O 0 0.04306169971823692
. O 0 0.043193936347961426

Moreover O 0 0.03895656764507294
, O 0 0.015619127079844475
although O 0 0.00945953093469143
the O 0 0.009754621423780918
scale O 0 0.011458335444331169
of O 0 0.007353047840297222
the O 0 0.007771596312522888
study O 0 0.0075236898846924305
is O 0 0.006293622776865959
limited O 0 0.007661490701138973
, O 0 0.006177249830216169
there O 0 0.004949701484292746
is O 0 0.004771457519382238
a O 0 0.005977196153253317
possibility O 0 0.00882582925260067
that O 0 0.006528166122734547
PET O 0 0.17374064028263092
can O 0 0.007614245638251305
detect O 0 0.017471708357334137
an O 0 0.014840973541140556
insidious B-Disease 1 0.999997615814209
lesion I-Disease 1 0.9999985694885254
which O 0 0.010124226100742817
is O 0 0.010695836506783962
undetectable O 0 0.08564265817403793
by O 0 0.00819668173789978
computed O 0 0.01971634104847908
tomogram O 1 0.9455520510673523
( O 0 0.01780702732503414
CT O 1 0.9998942613601685
) O 0 0.013051927089691162
or O 0 0.009458779357373714
MRI O 0 0.20921003818511963
analysis O 0 0.010290762409567833
, O 0 0.007774784695357084
and O 0 0.006148345302790403
that O 0 0.004742664750665426
the O 0 0.00548846460878849
higher O 0 0.007459895219653845
level O 0 0.008451858535408974
of O 0 0.00969349592924118
tau O 0 0.035879358649253845
reflects O 0 0.01610654592514038
the O 0 0.010477056726813316
process O 0 0.01271333172917366
of O 0 0.021588321775197983
neuronal B-Disease 1 0.9992623925209045
degeneration I-Disease 1 1.0
in O 1 0.9578659534454346
ALD B-Disease 1 1.0
. O 0 0.10693467408418655

Lorenzos O 1 0.894164502620697
Oil O 0 0.03394143283367157
should O 0 0.014057704247534275
be O 0 0.00928492471575737
given O 0 0.007915787398815155
in O 0 0.007811711635440588
the O 0 0.010566998273134232
early O 0 0.017997179180383682
stage O 0 0.0383307971060276
. O 0 0.02482139877974987
. O 0 0.03749343007802963

Nonsense O 0 0.09271616488695145
mutation O 0 0.04198280721902847
in O 0 0.019549453631043434
exon O 0 0.04025139659643173
4 O 0 0.018833931535482407
of O 0 0.013011166825890541
human O 0 0.014413075521588326
complement O 0 0.49538320302963257
C9 O 1 0.9999936819076538
gene O 0 0.01572793908417225
is O 0 0.00964055210351944
the O 0 0.01042213011533022
major O 0 0.015139782801270485
cause O 0 0.0754246711730957
of O 0 0.019296180456876755
Japanese O 1 0.9997588992118835
complement B-Disease 1 0.9999754428863525
C9 I-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.08461957424879074

Deficiency B-Disease 1 0.9999945163726807
of I-Disease 0 0.025050843134522438
the I-Disease 0 0.021178970113396645
ninth I-Disease 1 0.9915587902069092
component I-Disease 0 0.06820536404848099
of I-Disease 0 0.012424252927303314
human I-Disease 0 0.014140063896775246
complement I-Disease 1 0.9548001885414124
( O 0 0.26497402787208557
C9 O 1 0.9999969005584717
) O 0 0.010394541546702385
is O 0 0.007604699581861496
the O 0 0.008148486725986004
most O 0 0.007603418547660112
common O 0 0.22394530475139618
complement B-Disease 1 0.9999914169311523
deficiency I-Disease 1 1.0
in O 0 0.03767812252044678
Japan O 1 0.8478406071662903
but O 0 0.010572404600679874
is O 0 0.010804465971887112
rare O 0 0.015027645044028759
in O 0 0.012304783798754215
other O 0 0.012264370918273926
countries O 0 0.020342327654361725
. O 0 0.0383450873196125

We O 0 0.025537503883242607
studied O 0 0.026103045791387558
the O 0 0.01542644202709198
molecular O 0 0.01788773201406002
basis O 0 0.01208448689430952
of O 0 0.02414444461464882
C9 B-Disease 1 1.0
deficiency I-Disease 1 0.9999997615814209
in O 0 0.013470321893692017
four O 0 0.014446467161178589
Japanese O 1 0.9780220985412598
C9 B-Disease 1 1.0
- I-Disease 1 0.9999933242797852
deficient I-Disease 1 0.9999830722808838
patients O 1 0.9974383115768433
who O 0 0.24006378650665283
had O 1 0.9759684801101685
suffered O 1 1.0
from O 1 0.9999130964279175
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 1 0.9719171524047852

Direct O 0 0.04998825490474701
sequencing O 0 0.05800624564290047
of O 0 0.03437671437859535
amplified O 0 0.07502224296331406
C9 O 1 0.9988906979560852
cDNA O 0 0.0667232796549797
and O 0 0.022398890927433968
DNA O 0 0.021383000537753105
revealed O 0 0.021912727504968643
a O 0 0.015348115935921669
nonsense O 0 0.025167791172862053
substitution O 0 0.02324570342898369
( O 0 0.01751311868429184
CGA O 1 0.5473757386207581
- O 1 0.9984424710273743
- O 1 0.9975314140319824
> O 1 0.9812920093536377
TGA O 1 0.9984612464904785
) O 0 0.01961885392665863
at O 0 0.020063893869519234
codon O 0 0.030596841126680374
95 O 0 0.026597760617733
in O 0 0.016485385596752167
exon O 0 0.03594614937901497
4 O 0 0.017591586336493492
in O 0 0.012138116173446178
the O 0 0.01585596799850464
four O 0 0.027171747758984566
C9 B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999254941940308
deficient I-Disease 1 0.9995062351226807
individuals O 0 0.030930163338780403
. O 0 0.04363072291016579

An O 0 0.034126512706279755
allele O 0 0.04845152422785759
- O 0 0.055310849100351334
specific O 0 0.018190620467066765
polymerase O 0 0.14376719295978546
chain O 0 0.031225383281707764
reaction O 0 0.015097997151315212
system O 0 0.012220789678394794
designed O 0 0.016134286299347878
to O 0 0.010350186377763748
detect O 0 0.014353407546877861
exclusively O 0 0.010312898084521294
only O 0 0.006281925830990076
one O 0 0.006797617767006159
of O 0 0.006283809896558523
the O 0 0.007426793687045574
normal O 0 0.009191270917654037
and O 0 0.009598799049854279
mutant O 0 0.022856973111629486
alleles O 0 0.013735870830714703
indicated O 0 0.009736214764416218
that O 0 0.005012220237404108
all O 0 0.005166740622371435
the O 0 0.0075883036479353905
four O 0 0.009575472213327885
patients O 0 0.10902131348848343
were O 0 0.0071131461299955845
homozygous O 0 0.013257834129035473
for O 0 0.008071308955550194
the O 0 0.00944450218230486
mutation O 0 0.011838647536933422
in O 0 0.009450383484363556
exon O 0 0.03226161003112793
4 O 0 0.014043370261788368
and O 0 0.008622580207884312
that O 0 0.006533273961395025
the O 0 0.008971241302788258
parents O 0 0.011820248328149319
of O 0 0.013025471940636635
patient O 1 0.9309513568878174
2 O 0 0.027088936418294907
were O 0 0.023396998643875122
heterozygous O 0 0.05255782604217529
. O 0 0.0454733744263649

The O 0 0.04070281982421875
common O 0 0.02627929113805294
mutation O 0 0.029441533610224724
at O 0 0.020282229408621788
codon O 0 0.029934760183095932
95 O 0 0.027640605345368385
in O 0 0.016055703163146973
exon O 0 0.03836498036980629
4 O 0 0.01937658153474331
might O 0 0.012231160886585712
be O 0 0.008406980894505978
responsible O 0 0.011731673032045364
for O 0 0.010743865743279457
most O 0 0.01598065160214901
Japanese O 1 0.9997538924217224
C9 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.05029284954071045
. O 0 0.055063389241695404

BRCA1 O 0 0.3779354691505432
required O 0 0.021018490195274353
for O 0 0.018099229782819748
transcription O 0 0.03667154535651207
- O 1 0.9841340184211731
coupled O 1 0.9296345114707947
repair O 1 0.9997908473014832
of O 0 0.18809659779071808
oxidative O 1 0.9996097683906555
DNA O 0 0.2671370208263397
damage O 1 0.8982384204864502
. O 0 0.055563561618328094

The O 0 0.13132447004318237
breast B-Disease 1 0.9999998807907104
and I-Disease 1 0.9998635053634644
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 1 0.9999992847442627
gene O 1 0.8809754848480225
BRCA1 O 1 0.9998387098312378
encodes O 0 0.04872771352529526
a O 0 0.15404480695724487
zinc O 1 0.9999986886978149
finger O 1 0.9910051822662354
protein O 0 0.01782461442053318
of O 0 0.016069304198026657
unknown O 0 0.02290266752243042
function O 0 0.02428792417049408
. O 0 0.03625327721238136

Association O 0 0.03966095671057701
of O 0 0.02009979821741581
the O 0 0.02014544978737831
BRCA1 O 1 0.9957619309425354
protein O 0 0.01469254307448864
with O 0 0.00869084894657135
the O 0 0.011567098088562489
DNA O 0 0.019743662327528
repair O 1 0.9985302686691284
protein O 0 0.02292395569384098
Rad51 O 1 0.969990611076355
and O 0 0.011974433436989784
changes O 0 0.00912121869623661
in O 0 0.007790998090058565
the O 0 0.009477830491960049
phosphorylation O 0 0.014804938808083534
and O 0 0.01027231477200985
cellular O 0 0.01794975996017456
localization O 0 0.01905943639576435
of O 0 0.009571678005158901
the O 0 0.009541790001094341
protein O 0 0.010962771251797676
after O 0 0.01111316867172718
exposure O 0 0.01634063571691513
to O 0 0.009208339266479015
DNA O 0 0.014851588755846024
- O 0 0.2990458309650421
damaging O 0 0.034191954880952835
agents O 0 0.010603334754705429
are O 0 0.0050704083405435085
consistent O 0 0.00876081082969904
with O 0 0.0069726575165987015
a O 0 0.009523232467472553
role O 0 0.01251301635056734
for O 0 0.01332911103963852
BRCA1 O 1 0.9958933591842651
in O 0 0.015971580520272255
DNA O 0 0.037802696228027344
repair O 1 0.9907926917076111
. O 0 0.04485118016600609

Here O 0 0.029761457815766335
, O 0 0.015068613924086094
it O 0 0.009147174656391144
is O 0 0.008088559843599796
shown O 0 0.008280469104647636
that O 0 0.007466959301382303
mouse O 0 0.025211969390511513
embryonic O 0 0.06652678549289703
stem O 0 0.28730687499046326
cells O 0 0.029513847082853317
deficient B-Disease 1 0.9596552848815918
in I-Disease 0 0.013998282141983509
BRCA1 I-Disease 1 0.9995661377906799
are O 0 0.007595845032483339
defective O 0 0.32892072200775146
in O 0 0.006623522844165564
the O 0 0.007192862220108509
ability O 0 0.007550109643489122
to O 0 0.006347940769046545
carry O 0 0.008882020600140095
out O 0 0.010471940040588379
transcription O 0 0.016056425869464874
- O 0 0.1543554961681366
coupled O 0 0.039852894842624664
repair O 1 0.8527835011482239
of O 0 0.014772911556065083
oxidative O 1 0.9929776787757874
DNA O 0 0.029782894998788834
damage O 1 0.7211583852767944
, O 0 0.010949183255434036
and O 0 0.009145828895270824
are O 0 0.008060953579843044
hypersensitive O 1 0.9518142342567444
to O 0 0.021544944494962692
ionizing O 1 0.999599277973175
radiation O 1 0.998608410358429
and O 0 0.03451724350452423
hydrogen O 0 0.183590829372406
peroxide O 1 0.9409959316253662
. O 0 0.07050316780805588

These O 0 0.019786998629570007
results O 0 0.016665581613779068
suggest O 0 0.016323136165738106
that O 0 0.011468407697975636
BRCA1 O 1 0.9939901828765869
participates O 0 0.022751597687602043
, O 0 0.01066460832953453
directly O 0 0.009864818304777145
or O 0 0.00874248705804348
indirectly O 0 0.012647918425500393
, O 0 0.007218396756798029
in O 0 0.00881023146212101
transcription O 0 0.023856427520513535
- O 1 0.8603087067604065
coupled O 1 0.6526568531990051
repair O 1 0.998534083366394
of O 0 0.04106602817773819
oxidative O 1 0.9996077418327332
DNA O 0 0.40273183584213257
damage O 1 0.9546751976013184
. O 0 0.033341385424137115
. O 0 0.0462784543633461

Truncation O 0 0.29160529375076294
mutations O 0 0.033930785953998566
in O 0 0.016368456184864044
the O 0 0.016656851395964622
transactivation O 1 0.8249633312225342
region O 0 0.02008974365890026
of O 0 0.0185538399964571
PAX6 O 1 0.9999510049819946
result O 0 0.017121870070695877
in O 0 0.017015846446156502
dominant O 1 0.8347125053405762
- O 1 0.9929090738296509
negative O 0 0.03902289643883705
mutants O 0 0.2714713215827942
. O 0 0.04621108993887901

PAX6 O 1 0.9989577531814575
is O 0 0.023258643224835396
a O 0 0.02047429047524929
transcription O 0 0.02470492757856846
factor O 0 0.018222948536276817
with O 0 0.008903696201741695
two O 0 0.009291019290685654
DNA O 0 0.01405555009841919
- O 0 0.02689746767282486
binding O 0 0.015274498611688614
domains O 0 0.01862144283950329
( O 0 0.012727033346891403
paired O 0 0.027802396565675735
box O 0 0.04510590434074402
and O 0 0.01631060242652893
homeobox O 1 0.9867253303527832
) O 0 0.014173485338687897
and O 0 0.012140745297074318
a O 0 0.016440631821751595
proline O 1 0.5046937465667725
- O 1 0.9161947965621948
serine O 0 0.36801180243492126
- O 1 0.8319763541221619
threonine O 1 0.5515701770782471
( O 0 0.028951622545719147
PST O 1 0.9994574189186096
) O 0 0.032107435166835785
- O 0 0.13307568430900574
rich O 0 0.055774230509996414
transactivation O 1 0.8348666429519653
domain O 0 0.06445825099945068
. O 0 0.05662785843014717

PAX6 O 1 0.9999915361404419
regulates O 1 0.9318526983261108
eye O 1 0.9972972273826599
development O 0 0.025374777615070343
in O 0 0.01490618847310543
animals O 0 0.014722968451678753
ranging O 0 0.018627164885401726
from O 0 0.014557753689587116
jellyfish O 0 0.03386491909623146
to O 0 0.01917182467877865
Drosophila O 0 0.04302765056490898
to O 0 0.0280049629509449
humans O 0 0.036270227283239365
. O 0 0.04852050915360451

Heterozygous O 0 0.07093235850334167
mutations O 0 0.02751251868903637
in O 0 0.012435948476195335
the O 0 0.011723654344677925
human O 0 0.017890121787786484
PAX6 O 1 0.9999995231628418
gene O 0 0.015364672057330608
result O 0 0.008084433153271675
in O 0 0.007212010677903891
various O 0 0.00890160258859396
phenotypes O 0 0.01918252743780613
, O 0 0.0094496700912714
including O 0 0.010731775313615799
aniridia B-Disease 1 0.9999644756317139
, O 0 0.02640565298497677
Peters B-Disease 1 0.999758780002594
anomaly I-Disease 1 0.999854326248169
, O 0 0.05560615658760071
autosomal B-Disease 1 0.9999523162841797
dominant I-Disease 1 0.9999362230300903
keratitis I-Disease 1 1.0
, O 1 0.9203967452049255
and O 1 0.9815142750740051
familial B-Disease 1 1.0
foveal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 0 0.4458014667034149

It O 0 0.027923384681344032
is O 0 0.018526960164308548
believed O 0 0.016615459695458412
that O 0 0.009788363240659237
the O 0 0.013255849480628967
mutated O 0 0.02750488929450512
allele O 0 0.023190954700112343
of O 0 0.015828898176550865
PAX6 O 1 0.9999442100524902
produces O 0 0.020691659301519394
an O 0 0.0133569510653615
inactive O 0 0.040654782205820084
protein O 0 0.015777502208948135
and O 0 0.0130307637155056
aniridia B-Disease 1 0.9999716281890869
is O 0 0.014756858348846436
caused O 0 0.4700741767883301
due O 0 0.014719988219439983
to O 0 0.01742096245288849
genetic O 0 0.11354727298021317
haploinsufficiency O 1 0.9984563589096069
. O 0 0.047501906752586365

However O 0 0.0246399138122797
, O 0 0.0157800130546093
several O 0 0.012137504294514656
truncation O 0 0.2946948707103729
mutations O 0 0.014217507094144821
have O 0 0.006258747540414333
been O 0 0.006751880515366793
found O 0 0.006407186854630709
to O 0 0.006102560553699732
occur O 0 0.005453530233353376
in O 0 0.006601934786885977
the O 0 0.009691785089671612
C O 1 0.920413613319397
- O 0 0.15039122104644775
terminal O 0 0.021831996738910675
half O 0 0.013110321946442127
of O 0 0.014218221418559551
PAX6 O 1 0.999751627445221
in O 0 0.014691888354718685
patients O 0 0.44083061814308167
with O 0 0.014001255854964256
Aniridia B-Disease 1 0.9999657869338989
resulting O 0 0.019350815564393997
in O 0 0.012622537091374397
mutant O 0 0.025666257366538048
proteins O 0 0.012911949306726456
that O 0 0.007184527348726988
retain O 0 0.015756677836179733
the O 0 0.010784094221889973
DNA O 0 0.014123993925750256
- O 0 0.048757873475551605
binding O 0 0.011490755714476109
domains O 0 0.011897698976099491
but O 0 0.006689963862299919
have O 0 0.006541324779391289
lost O 0 0.012288840487599373
most O 0 0.008873552083969116
of O 0 0.01206615287810564
the O 0 0.02345692366361618
transactivation O 1 0.9845863580703735
domain O 0 0.056503161787986755
. O 0 0.050664134323596954

It O 0 0.024688730016350746
is O 0 0.014797587879002094
not O 0 0.008639263920485973
clear O 0 0.011377916671335697
whether O 0 0.009592771530151367
such O 0 0.009519167244434357
mutants O 0 0.03105509653687477
really O 0 0.012345992960035801
behave O 0 0.011329430155456066
as O 0 0.0071272775530815125
loss O 0 0.06839292496442795
- O 1 0.8881979584693909
of O 0 0.014585607685148716
- O 1 0.9963967204093933
function O 0 0.01386028341948986
mutants O 0 0.02910914644598961
as O 0 0.0135591896250844
predicted O 0 0.029362887144088745
by O 0 0.025770636275410652
haploinsufficiency O 1 0.8442433476448059
. O 0 0.054401930421590805

Contrary O 0 0.03240732103586197
to O 0 0.015326700173318386
this O 0 0.009300341829657555
theory O 0 0.011481687426567078
, O 0 0.008153876289725304
our O 0 0.008843650110065937
data O 0 0.007585647515952587
showed O 0 0.009039625525474548
that O 0 0.0046411980874836445
these O 0 0.0048066540621221066
mutants O 0 0.01349069643765688
are O 0 0.005296672228723764
dominant O 0 0.017141444608569145
- O 0 0.16926762461662292
negative O 0 0.011435839347541332
in O 0 0.01154559850692749
transient O 1 0.8576210737228394
transfection O 1 0.9971734285354614
assays O 0 0.021482976153492928
when O 0 0.011028029955923557
they O 0 0.007484125439077616
are O 0 0.006962031126022339
coexpressed O 0 0.029812581837177277
with O 0 0.013344482518732548
wild O 0 0.03657008707523346
- O 1 0.9988155364990234
type O 1 0.9027937650680542
PAX6 O 1 0.9998082518577576
. O 0 0.0761120542883873

We O 0 0.022384697571396828
found O 0 0.011552855372428894
that O 0 0.007050966843962669
the O 0 0.009272094815969467
dominant O 0 0.31754618883132935
- O 1 0.9486743211746216
negative O 0 0.01353175938129425
effects O 0 0.012306262739002705
result O 0 0.007243279833346605
from O 0 0.0069158305414021015
the O 0 0.008832585997879505
enhanced O 0 0.022607853636145592
DNA O 0 0.016210732981562614
binding O 0 0.015990223735570908
ability O 0 0.014256004244089127
of O 0 0.014923940412700176
these O 0 0.0159144327044487
mutants O 0 0.06463810801506042
. O 0 0.05151195079088211

Kinetic O 0 0.06518486887216568
studies O 0 0.023762384429574013
of O 0 0.017122415825724602
binding O 0 0.017686955630779266
and O 0 0.013481593690812588
dissociation O 0 0.25519081950187683
revealed O 0 0.014189003966748714
that O 0 0.00702403299510479
various O 0 0.007909083738923073
truncation O 0 0.03023429401218891
mutants O 0 0.021956123411655426
have O 0 0.008041935041546822
3 O 0 0.014360080473124981
- O 0 0.025465264916419983
5 O 0 0.018863806501030922
- O 0 0.02654094435274601
fold O 0 0.025008831173181534
higher O 0 0.014726911671459675
affinity O 0 0.015901003032922745
to O 0 0.009346220642328262
various O 0 0.008758625946938992
DNA O 0 0.013465222902595997
- O 0 0.016819166019558907
binding O 0 0.011142962612211704
sites O 0 0.008879344910383224
when O 0 0.00895616039633751
compared O 0 0.009649615734815598
with O 0 0.007984047755599022
the O 0 0.011975363828241825
wild O 0 0.03259432315826416
- O 1 0.9994958639144897
type O 1 0.9478159546852112
PAX6 O 1 0.9998369216918945
. O 0 0.07067970931529999

These O 0 0.018407560884952545
results O 0 0.013579715974628925
provide O 0 0.012958132661879063
a O 0 0.01004465576261282
new O 0 0.011703881435096264
insight O 0 0.01980316825211048
into O 0 0.01088104397058487
the O 0 0.00965132936835289
role O 0 0.013116918504238129
of O 0 0.015223653055727482
mutant O 1 0.8968803286552429
PAX6 O 1 0.9999891519546509
in O 0 0.030833778902888298
causing O 1 0.995855987071991
aniridia B-Disease 1 0.9999834299087524
. O 0 0.035987913608551025
. O 0 0.05475949868559837

Reversal O 0 0.2126254439353943
of O 1 0.9351329207420349
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 1 0.9994555115699768
excellent O 1 0.997191846370697
neuropsychologic O 1 0.997154951095581
outcome O 0 0.017860570922493935
in O 0 0.011053192429244518
very B-Disease 0 0.01264942530542612
- I-Disease 0 0.08959880471229553
long I-Disease 0 0.02185722440481186
- I-Disease 1 0.8595758676528931
chain I-Disease 0 0.40751007199287415
acyl I-Disease 1 0.9975252747535706
- I-Disease 1 0.998814582824707
coenzyme I-Disease 1 0.9993081092834473
A I-Disease 1 0.9997846484184265
dehydrogenase I-Disease 1 0.9999945163726807
deficiency I-Disease 1 1.0
. O 0 0.06554006040096283

Very B-Disease 0 0.04237265884876251
- I-Disease 0 0.18247205018997192
long I-Disease 0 0.03176017105579376
- I-Disease 1 0.8878726363182068
chain I-Disease 0 0.34940800070762634
acyl I-Disease 1 0.953403890132904
- I-Disease 1 0.8762452006340027
coenzyme I-Disease 0 0.4939191937446594
A I-Disease 0 0.3076377809047699
dehydrogenase I-Disease 1 0.9723634719848633
( I-Disease 0 0.04935379698872566
VLCAD I-Disease 1 0.999998927116394
) I-Disease 0 0.36958107352256775
deficiency I-Disease 1 0.9999997615814209
is O 0 0.013953136280179024
a O 1 0.540306806564331
disorder O 1 1.0
of O 1 0.9990087747573853
fatty O 1 0.9999953508377075
acid O 1 0.9961038827896118
beta O 0 0.2371641844511032
oxidation O 0 0.01966422237455845
that O 0 0.008968621492385864
reportedly O 0 0.01676934026181698
has O 0 0.010357778519392014
high O 0 0.013813047669827938
rates O 0 0.015281499363481998
of O 0 0.020698538050055504
morbidity O 1 0.9999966621398926
and O 0 0.391666442155838
mortality O 1 0.9994351267814636
. O 0 0.058447785675525665

We O 0 0.025924839079380035
describe O 0 0.022480454295873642
the O 0 0.012903954833745956
outcome O 0 0.013910074718296528
of O 0 0.009162585251033306
a O 0 0.010274259373545647
5 O 0 0.014746920205652714
- O 0 0.02337350696325302
year O 0 0.013032505288720131
- O 0 0.08292093873023987
old O 0 0.020289532840251923
girl O 0 0.049216777086257935
with O 0 0.05507922172546387
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 1 0.5898615717887878
was O 0 0.050512153655290604
first O 0 0.008962389081716537
seen O 0 0.008275792002677917
at O 0 0.0076055265963077545
5 O 0 0.008247334510087967
months O 0 0.007515534292906523
of O 0 0.006881811656057835
age O 0 0.01188721414655447
with O 0 0.04190610349178314
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 1 1.0
hepatomegaly B-Disease 1 1.0
, O 1 0.9999998807907104
encephalopathy B-Disease 1 1.0
, O 1 0.9991158843040466
and O 1 0.9891698956489563
hypotonia B-Disease 1 0.9999984502792358
. O 0 0.07341247797012329

Biochemical O 0 0.1181793287396431
studies O 0 0.04554117098450661
indicated O 1 0.9969390630722046
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 1 0.9992862343788147
by O 0 0.019977157935500145
a O 0 0.1468723565340042
stable O 1 0.9757319688796997
yet O 0 0.04293690249323845
inactive O 1 0.9088864326477051
enzyme O 0 0.07310650497674942
. O 0 0.057529937475919724

Molecular O 0 0.05698554962873459
genetic O 0 0.030075235292315483
analysis O 0 0.020023657009005547
of O 0 0.018592726439237595
her O 0 0.030774209648370743
VLCAD O 1 0.9998076558113098
gene O 0 0.01920713298022747
revealed O 0 0.019338831305503845
a O 0 0.017535202205181122
T1372C O 1 0.9231943488121033
( O 0 0.020242122933268547
F458L O 1 0.7566829323768616
) O 0 0.019462529569864273
missense O 0 0.03927566856145859
mutation O 0 0.02165871113538742
and O 0 0.01544459629803896
a O 0 0.02594788186252117
1668 O 1 0.9999740123748779
ACAG O 1 0.9999707937240601
1669 O 1 0.9999005794525146
splice O 1 0.9179129004478455
site O 0 0.0720309168100357
mutation O 0 0.07288600504398346
. O 0 0.0533602237701416

After O 0 0.0362565703690052
initial O 0 0.03173654153943062
treatment O 1 0.836068332195282
with O 0 0.022084534168243408
intravenous O 1 0.9999990463256836
glucose O 1 0.9985546469688416
and O 0 0.030969198793172836
carnitine O 1 0.9999852180480957
, O 0 0.014941932633519173
the O 0 0.013256598263978958
patient O 1 0.8159074187278748
has O 0 0.011965392157435417
thrived O 0 0.025935575366020203
on O 0 0.008909042924642563
a O 0 0.011635768227279186
low O 0 0.02137511968612671
- O 1 0.7755641937255859
fat O 0 0.027469895780086517
diet O 0 0.026220468804240227
supplemented O 0 0.020973099395632744
with O 0 0.012115620076656342
medium O 0 0.02809496410191059
- O 1 0.6917197704315186
chain O 0 0.04372359812259674
triglyceride O 0 0.03960005193948746
oil O 0 0.020033380016684532
and O 0 0.016102036461234093
carnitine O 1 0.9997277855873108
and O 0 0.02202528342604637
avoidance O 1 0.9998350143432617
of O 0 0.12729164958000183
fasting O 1 0.8677747845649719
. O 0 0.05451149865984917

Her O 1 0.999476969242096
ventricular O 1 0.9999998807907104
hypertrophy O 1 0.9999992847442627
resolved O 0 0.04117944836616516
significantly O 0 0.01767696626484394
over O 0 0.012340161949396133
1 O 0 0.014139358885586262
year O 0 0.010865166783332825
, O 0 0.009941204451024532
and O 0 0.011561168357729912
cognitively O 1 0.9888455271720886
, O 0 0.012234720401465893
she O 0 0.011875542812049389
is O 0 0.00782452430576086
in O 0 0.007146371062844992
the O 0 0.009936694987118244
superior O 0 0.020072059705853462
range O 0 0.017477519810199738
for O 0 0.018454058095812798
age O 0 0.03712163865566254
. O 0 0.04379969462752342

Clinical O 1 0.5224083662033081
recognition O 0 0.10129167139530182
of O 1 0.9988667964935303
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 0.15304425358772278
important O 0 0.012475773692131042
because O 0 0.00709978211671114
it O 0 0.0053358860313892365
is O 0 0.00484486436471343
one O 0 0.004726603627204895
of O 0 0.004497880581766367
the O 0 0.005247723311185837
few O 0 0.007119243964552879
directly O 0 0.014436489902436733
treatable O 1 0.9999998807907104
causes O 1 0.9999208450317383
of O 1 0.9996304512023926
cardiomyopathy B-Disease 1 1.0
in O 1 0.9359089136123657
children O 1 0.9447459578514099
. O 0 0.02832813188433647
. O 0 0.045061882585287094

Cloning O 0 0.05468292906880379
of O 0 0.022098196670413017
a O 0 0.01824689656496048
novel O 0 0.020239772275090218
member O 0 0.011754289269447327
of O 0 0.00938798114657402
the O 0 0.012331627309322357
low O 1 0.5328598618507385
- O 1 0.999509334564209
density O 0 0.3826797902584076
lipoprotein O 1 0.999913215637207
receptor O 0 0.06552733480930328
family O 0 0.04919526353478432
. O 0 0.04809553921222687

A O 0 0.043909139931201935
gene O 0 0.027830015867948532
encoding O 0 0.022886790335178375
a O 0 0.017154350876808167
novel O 0 0.026432806625962257
transmembrane O 0 0.36251434683799744
protein O 0 0.015775488689541817
was O 0 0.013247008435428143
identified O 0 0.009003211744129658
by O 0 0.006437940988689661
DNA O 0 0.00870530866086483
sequence O 0 0.006576832849532366
analysis O 0 0.0062756831757724285
within O 0 0.0071225278079509735
the O 0 0.01090950332581997
insulin B-Disease 1 0.9999176263809204
- I-Disease 1 0.9999918937683105
dependent I-Disease 1 0.9999716281890869
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 1 0.9708677530288696
IDDM B-Disease 1 0.9999942779541016
) O 0 0.040139831602573395
locus O 1 0.964482843875885
IDDM4 O 1 0.9996322393417358
on O 0 0.04115499183535576
chromosome O 0 0.09223564714193344
11q13 O 1 0.6138432621955872
. O 0 0.0676627829670906

Based O 0 0.0266125425696373
on O 0 0.01627611741423607
its O 0 0.015187801793217659
chromosomal O 0 0.07043042778968811
position O 0 0.013697371818125248
, O 0 0.010003299452364445
this O 0 0.0070137279108166695
gene O 0 0.009350468404591084
is O 0 0.00716183939948678
a O 0 0.008981697261333466
candidate O 0 0.01348944753408432
for O 0 0.01301029697060585
conferring O 1 0.9848905205726624
susceptibility O 1 0.9998407363891602
to O 0 0.4426892101764679
diabetes B-Disease 1 0.9999998807907104
. O 0 0.052336376160383224

The O 0 0.04295121878385544
gene O 0 0.02824636735022068
, O 0 0.018855281174182892
termed O 0 0.03090524487197399
low O 0 0.02553519979119301
- O 0 0.3815172612667084
density O 0 0.024228671565651894
lipoprotein O 1 0.9679731130599976
receptor O 0 0.02526749111711979
related O 0 0.01595095358788967
protein O 0 0.01568826101720333
5 O 0 0.018706699833273888
( O 0 0.017777692526578903
LRP5 O 1 0.9511058330535889
) O 0 0.015404289588332176
, O 0 0.013149457983672619
encodes O 0 0.018143465742468834
a O 0 0.012600161135196686
protein O 0 0.014315658248960972
of O 0 0.013597010634839535
1615 O 0 0.38465416431427
amino O 0 0.018324900418519974
acids O 0 0.011506175622344017
that O 0 0.007731912191957235
contains O 0 0.012230532243847847
conserved O 0 0.0151237016543746
modules O 0 0.0180058516561985
which O 0 0.007895419374108315
are O 0 0.004897368140518665
characteristic O 0 0.009745762683451176
of O 0 0.007236742880195379
the O 0 0.009592145681381226
low O 0 0.03336455672979355
- O 1 0.9955992698669434
density O 0 0.23012158274650574
lipoprotein O 1 0.9999899864196777
( O 0 0.4808211922645569
LDL O 1 0.9999948740005493
) O 0 0.029614485800266266
receptor O 0 0.05162811279296875
family O 0 0.04810027778148651
. O 0 0.04830663278698921

These O 0 0.031173178926110268
modules O 0 0.046249449253082275
include O 0 0.021030258387327194
a O 0 0.019451934844255447
putative O 0 0.12618999183177948
signal O 0 0.02427896298468113
peptide O 0 0.02084990218281746
for O 0 0.010785889811813831
protein O 0 0.012241839431226254
export O 0 0.012369843199849129
, O 0 0.01069797482341528
four O 0 0.012597030028700829
epidermal O 1 0.9483388662338257
growth O 0 0.024173678830266
factor O 0 0.05170152336359024
( O 0 0.019114451482892036
EGF O 1 0.9996850490570068
) O 0 0.014910089783370495
repeats O 0 0.019477376714348793
with O 0 0.010645231232047081
associated O 0 0.013555362820625305
spacer O 0 0.035360340029001236
domains O 0 0.017011523246765137
, O 0 0.010677918791770935
three O 0 0.013468439690768719
LDL O 1 0.9999849796295166
- O 1 0.9991896748542786
receptor O 0 0.07317958027124405
( O 0 0.016669979318976402
LDLR O 1 0.9981416463851929
) O 0 0.013292411342263222
repeats O 0 0.0209850762039423
, O 0 0.010511921718716621
a O 0 0.010931618511676788
single O 0 0.015424197539687157
transmembrane O 0 0.03984902799129486
spanning O 0 0.022686908021569252
domain O 0 0.01895749568939209
, O 0 0.014177163131535053
and O 0 0.01424836739897728
a O 0 0.02673332765698433
cytoplasmic O 0 0.06720985472202301
domain O 0 0.05559931695461273
. O 0 0.053063858300447464

The O 0 0.03567292541265488
encoded O 0 0.026646705344319344
protein O 0 0.017811253666877747
has O 0 0.01213435921818018
a O 0 0.01108460407704115
unique O 0 0.012394788675010204
organization O 0 0.013763418421149254
of O 0 0.013970993459224701
EGF O 1 0.9999799728393555
and O 0 0.03270254656672478
LDLR O 1 0.999993085861206
repeats O 0 0.06866523623466492
; O 0 0.013503274880349636
therefore O 0 0.012538300827145576
, O 0 0.013431400991976261
LRP5 O 1 0.974585235118866
likely O 0 0.012901294976472855
represents O 0 0.013287058100104332
a O 0 0.010260221548378468
new O 0 0.012500284239649773
category O 0 0.01679181680083275
of O 0 0.01390049047768116
the O 0 0.02307623066008091
LDLR O 1 0.9999576807022095
family O 0 0.05553904548287392
. O 0 0.043612539768218994

Both O 0 0.027785494923591614
human O 0 0.021407462656497955
and O 0 0.0208723284304142
mouse O 1 0.8651547431945801
LRP5 O 1 0.999976396560669
cDNAs O 1 0.9835627675056458
have O 0 0.00970714632421732
been O 0 0.010220103897154331
isolated O 0 0.012146873399615288
and O 0 0.008034749887883663
the O 0 0.009286587126553059
encoded O 0 0.011271748691797256
mature O 0 0.014413509517908096
proteins O 0 0.008951413445174694
are O 0 0.00531346770003438
95 O 0 0.013782376423478127
% O 0 0.010226299054920673
identical O 0 0.010210050269961357
, O 0 0.008099601604044437
indicating O 0 0.01041644997894764
a O 0 0.008740796707570553
high O 0 0.01200244203209877
degree O 0 0.012883284129202366
of O 0 0.014267925173044205
evolutionary O 0 0.02924969606101513
conservation O 0 0.03469095751643181
. O 0 0.026414241641759872
. O 0 0.04063963517546654

The O 0 0.052415668964385986
APC B-Disease 1 0.9784849286079407
variants O 0 0.039975181221961975
I1307K O 0 0.2773393392562866
and O 0 0.014473662711679935
E1317Q O 0 0.05384683609008789
are O 0 0.007473011966794729
associated O 0 0.04617824777960777
with O 1 0.9999222755432129
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 1 0.8053733706474304
but O 0 0.008492925204336643
not O 0 0.007484880276024342
always O 0 0.011053192429244518
with O 0 0.009937337599694729
a O 0 0.017907237634062767
family O 0 0.025329578667879105
history O 0 0.03419295325875282
. O 0 0.03952741622924805

Classical O 0 0.43412941694259644
familial B-Disease 1 0.9999998807907104
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999176263809204
FAP B-Disease 1 1.0
) O 0 0.0208952184766531
is O 0 0.012363813817501068
a O 0 0.013594516552984715
high O 0 0.10306915640830994
- O 1 0.9997163414955139
penetrance O 1 0.9999949932098389
autosomal B-Disease 1 0.9999994039535522
dominant I-Disease 1 0.9999914169311523
disease I-Disease 1 0.9999997615814209
that O 0 0.011896375566720963
predisposes O 1 0.9992423057556152
to O 0 0.00926335621625185
hundreds O 0 0.008632335811853409
or O 0 0.00679874187335372
thousands O 0 0.012128278613090515
of O 1 0.993043839931488
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999990463256836
carcinoma I-Disease 1 1.0
and O 0 0.06959501653909683
that O 0 0.009014390408992767
results O 0 0.01019473560154438
from O 0 0.012059304863214493
truncating O 0 0.3139433264732361
mutations O 0 0.018771743401885033
in O 0 0.01440072525292635
the O 0 0.02732612006366253
APC B-Disease 1 0.9999178647994995
gene O 0 0.044427525252103806
. O 0 0.04619421064853668

A O 0 0.05125734210014343
variant O 0 0.05499400943517685
of O 0 0.0334823913872242
FAP B-Disease 1 0.9999997615814209
is O 1 0.691551923751831
attenuated B-Disease 1 0.9999996423721313
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
, O 0 0.021600786596536636
which O 0 0.008418655954301357
results O 0 0.009368591010570526
from O 0 0.011682246811687946
germ O 1 0.9999707937240601
- O 1 0.9546800255775452
line O 0 0.01626448519527912
mutations O 0 0.01029183529317379
in O 0 0.007059392053633928
the O 0 0.008742623962461948
5 O 0 0.012031035497784615
and O 0 0.009232921525835991
3 O 0 0.013612048700451851
regions O 0 0.012749748304486275
of O 0 0.014148169197142124
the O 0 0.02490040473639965
APC B-Disease 1 0.9999431371688843
gene O 0 0.04916992411017418
. O 0 0.049761172384023666

Attenuated B-Disease 1 0.9999972581863403
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 1 0.9999868869781494
have O 0 0.011046355590224266
" O 0 0.014678724110126495
multiple O 1 0.5117425918579102
" O 1 0.9995900988578796
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 0.023223107680678368
typically O 0 0.013265932910144329
fewer O 0 0.011607707478106022
than O 0 0.007868907414376736
100 O 0 0.013025657273828983
) O 0 0.00948633998632431
without O 0 0.009550879709422588
the O 0 0.014847605489194393
florid O 1 0.9929486513137817
phenotype O 1 0.5068375468254089
of O 0 0.02599964663386345
classical O 1 0.7144882678985596
FAP B-Disease 1 0.9999994039535522
. O 0 0.06574753671884537

Another O 0 0.035691455006599426
group O 0 0.02446136251091957
of O 0 0.015540226362645626
patients O 1 0.9267122149467468
with O 0 0.012828746810555458
multiple O 1 0.6137101054191589
adenomas B-Disease 1 0.9999978542327881
has O 0 0.011333794333040714
no O 0 0.009676575660705566
mutations O 0 0.00987612921744585
in O 0 0.007277545053511858
the O 0 0.011442897841334343
APC B-Disease 1 0.9999597072601318
gene O 0 0.011027405969798565
, O 0 0.00817321240901947
and O 0 0.0073197041638195515
their O 0 0.007304537575691938
phenotype O 0 0.029851291328668594
probably O 0 0.009909271262586117
results O 0 0.007312882225960493
from O 0 0.005666645709425211
variation O 0 0.009277913719415665
at O 0 0.009108793921768665
a O 0 0.010748493485152721
locus O 0 0.4548746943473816
, O 0 0.011087019927799702
or O 0 0.01040054764598608
loci O 0 0.019319720566272736
, O 0 0.012363750487565994
elsewhere O 0 0.014645202085375786
in O 0 0.016248198226094246
the O 0 0.02414000779390335
genome O 0 0.05496581271290779
. O 0 0.04716995730996132

Recently O 0 0.05111047625541687
, O 0 0.0221495870500803
however O 0 0.013236913830041885
, O 0 0.011426388286054134
a O 0 0.01238516066223383
missense O 0 0.027014702558517456
variant O 0 0.02136681228876114
of O 0 0.01622682437300682
APC B-Disease 1 0.9999942779541016
( O 0 0.0348629504442215
I1307K O 1 0.9932117462158203
) O 0 0.012753987684845924
was O 0 0.013377131894230843
described O 0 0.010782785713672638
that O 0 0.006196377333253622
confers O 0 0.019943954423069954
an O 0 0.007878231815993786
increased O 0 0.013551932759582996
risk O 1 0.9881258010864258
of O 1 0.9999735355377197
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 0.031561512500047684
including O 0 0.017003271728754044
multiple O 1 0.7854968309402466
adenomas B-Disease 1 0.9999990463256836
, O 0 0.03169287368655205
in O 0 0.03101000376045704
Ashkenazim O 1 0.9751063585281372
. O 0 0.06008325517177582

We O 0 0.02540212869644165
have O 0 0.012442134320735931
studied O 0 0.016498183831572533
a O 0 0.01013774424791336
set O 0 0.009510223753750324
of O 0 0.009099781513214111
164 O 0 0.02915625274181366
patients O 0 0.2908008396625519
with O 0 0.011247031390666962
multiple O 1 0.9980993866920471
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999808073043823
/ I-Disease 1 0.9999998807907104
or I-Disease 1 0.9881332516670227
carcinoma I-Disease 1 1.0
and O 0 0.021450454369187355
analyzed O 0 0.03099410980939865
codons O 0 0.044064052402973175
1263 O 1 0.9993300437927246
- O 1 0.9733754396438599
1377 O 1 0.9966896772384644
( O 0 0.03475525602698326
exon O 0 0.1183551773428917
15G O 0 0.14519397914409637
) O 0 0.016653917729854584
of O 0 0.014635590836405754
the O 0 0.01905176229774952
APC B-Disease 1 0.9923672080039978
gene O 0 0.020761625841259956
for O 0 0.0191058237105608
germ O 1 0.9999881982803345
- O 1 0.9980337023735046
line O 0 0.05772699788212776
variants O 0 0.05830373987555504
. O 0 0.05652478337287903

Three O 0 0.0313720740377903
patients O 0 0.056276898831129074
with O 0 0.012845364399254322
the O 0 0.017206817865371704
I1307K O 1 0.9920265078544617
allele O 0 0.024916989728808403
were O 0 0.01079174131155014
detected O 0 0.01731758937239647
, O 0 0.011142395436763763
each O 0 0.010989979840815067
of O 0 0.019617395475506783
Ashkenazi O 1 0.5232858061790466
descent O 0 0.05529089644551277
. O 0 0.04578300192952156

Four O 0 0.042364753782749176
patients O 0 0.17715437710285187
had O 0 0.01907956972718239
a O 0 0.022987360134720802
germ O 1 0.9999622106552124
- O 1 0.9614428281784058
line O 0 0.030737217515707016
E1317Q O 1 0.6976246237754822
missense O 0 0.038356054574251175
variant O 0 0.026239991188049316
of O 0 0.01764446310698986
APC O 1 0.9996215105056763
that O 0 0.009271823801100254
was O 0 0.009781557135283947
not O 0 0.005950301419943571
present O 0 0.006336435209959745
in O 0 0.006033639889210463
controls O 0 0.010122247040271759
; O 0 0.006200083997100592
one O 0 0.005287524312734604
of O 0 0.00464427238330245
these O 0 0.004085833672434092
individuals O 0 0.0043642278760671616
had O 0 0.006295471917837858
an O 0 0.006564137060195208
unusually O 0 0.013540578074753284
large O 0 0.009576435200870037
number O 0 0.008689090609550476
of O 0 0.013157800771296024
metaplastic B-Disease 1 0.9991447925567627
polyps I-Disease 1 0.9957935810089111
of I-Disease 0 0.02335360273718834
the I-Disease 0 0.031395476311445236
colorectum I-Disease 1 0.9981507658958435
. O 0 0.054682232439517975

There O 0 0.024179544299840927
is O 0 0.014364548027515411
increasing O 0 0.011649508029222488
evidence O 0 0.007639721967279911
that O 0 0.00586280319839716
there O 0 0.006438483949750662
exist O 0 0.008007689379155636
germ O 1 0.9971477389335632
- O 1 0.5802109837532043
line O 0 0.012264116667211056
variants O 0 0.010865326970815659
of O 0 0.00899951159954071
the O 0 0.011542356573045254
APC B-Disease 1 0.9998468160629272
gene O 0 0.011304594576358795
that O 0 0.006561108864843845
predispose O 0 0.017087198793888092
to O 0 0.0062552341260015965
the O 0 0.006323134060949087
development O 0 0.00857551395893097
of O 0 0.01246400736272335
multiple O 1 0.9999039173126221
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.999997615814209
carcinoma I-Disease 1 1.0
, O 0 0.02860899269580841
but O 0 0.00839656125754118
without O 0 0.008260410279035568
the O 0 0.011657631024718285
florid O 1 0.9849672913551331
phenotype O 0 0.08897490799427032
of O 0 0.012741600163280964
classical O 0 0.18781454861164093
FAP B-Disease 1 0.9999998807907104
, O 0 0.012692137621343136
and O 0 0.00902988389134407
possibly O 0 0.00842359010130167
with O 0 0.006073485594242811
importance O 0 0.018526412546634674
for O 1 0.9987710118293762
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 1 0.999790608882904
in O 0 0.012596791610121727
the O 0 0.012840118259191513
general O 0 0.02466101385653019
population O 0 0.01684434339404106
. O 0 0.0233700480312109
. O 0 0.0394706055521965

Genomic O 0 0.05381253361701965
structure O 0 0.024865176528692245
of O 0 0.01541422214359045
the O 0 0.023549005389213562
human O 1 0.9999816417694092
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 1.0
CLD B-Disease 1 1.0
) O 1 0.8142950534820557
gene O 0 0.05367011949419975
. O 0 0.05169149115681648

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 0.9999971389770508
CLD B-Disease 1 1.0
) O 0 0.12275376170873642
is O 0 0.015274218283593655
caused O 0 0.047401104122400284
by O 0 0.010069227777421474
mutations O 0 0.011816299520432949
in O 0 0.008728365413844585
a O 0 0.011825544759631157
gene O 0 0.014611213468015194
which O 0 0.012044493108987808
encodes O 0 0.0340324230492115
an O 0 0.05442037060856819
intestinal O 1 1.0
anion O 1 0.9999761581420898
transporter O 1 0.9990847110748291
. O 0 0.08429203182458878

We O 0 0.02796681970357895
report O 0 0.017688503488898277
here O 0 0.014140077866613865
the O 0 0.011186404153704643
complete O 0 0.014382991008460522
genomic O 0 0.018928393721580505
organization O 0 0.01344353798776865
of O 0 0.011576718650758266
the O 0 0.01181591022759676
human O 0 0.022238312289118767
CLD B-Disease 1 0.9999991655349731
gene O 0 0.020665068179368973
which O 0 0.013210048899054527
spans O 0 0.027897043153643608
approximately O 0 0.023524541407823563
39kb O 0 0.3137313425540924
, O 0 0.020920109003782272
and O 0 0.020042311400175095
comprises O 0 0.04536633938550949
21 O 0 0.04773256555199623
exons O 0 0.09241347759962082
. O 0 0.06389258056879044

All O 0 0.05287948623299599
exon O 0 0.21152803301811218
/ O 0 0.30011147260665894
intron O 0 0.09582372009754181
boundaries O 0 0.022660480812191963
conform O 0 0.024047648534178734
to O 0 0.016714606434106827
the O 0 0.02521696500480175
GT O 1 0.9999833106994629
/ O 1 0.9999700784683228
AG O 1 0.9999939203262329
rule O 0 0.05855727940797806
. O 0 0.05679117888212204

An O 0 0.027929382398724556
analysis O 0 0.02177468128502369
of O 0 0.016249433159828186
the O 0 0.018989963456988335
putative O 1 0.6030917763710022
promoter O 1 0.5197392702102661
region O 0 0.019532978534698486
sequence O 0 0.014650329016149044
shows O 0 0.015543635003268719
a O 0 0.020969584584236145
putative O 1 0.9229139685630798
TATA O 1 0.999997615814209
box O 0 0.38970518112182617
and O 0 0.018075723201036453
predicts O 0 0.043101198971271515
multiple O 0 0.02189553901553154
transcription O 0 0.03493770211935043
factor O 0 0.03181985393166542
binding O 0 0.029850726947188377
sites O 0 0.03441958501935005
. O 0 0.042130246758461

The O 0 0.03861929476261139
genomic O 0 0.04640018939971924
structure O 0 0.024713603779673576
was O 0 0.01710786484181881
determined O 0 0.014321944676339626
using O 0 0.009562668390572071
DNA O 0 0.010450084693729877
from O 0 0.006435425020754337
several O 0 0.005131489131599665
sources O 0 0.006456368137151003
including O 0 0.006610781420022249
multiple O 0 0.00968764815479517
large O 0 0.01212482899427414
- O 1 0.8210291266441345
insert O 1 0.8267038464546204
libaries O 0 0.1530439704656601
and O 0 0.01467902585864067
genomic O 0 0.026671774685382843
DNA O 0 0.019012965261936188
from O 0 0.018003398552536964
Finnish O 1 0.9998059868812561
CLD B-Disease 1 0.9999998807907104
patients O 1 0.9996734857559204
and O 0 0.03193923458456993
controls O 0 0.05946439877152443
. O 0 0.04692674055695534

Exon O 1 0.8774912357330322
- O 0 0.3615320324897766
specific O 0 0.02167605049908161
primers O 0 0.06765604764223099
developed O 0 0.015083547681570053
in O 0 0.008804220706224442
this O 0 0.0069996677339077
study O 0 0.008473047986626625
will O 0 0.0085081085562706
facilitate O 0 0.013859924860298634
mutation O 0 0.012890246696770191
screening O 0 0.014323161914944649
studies O 0 0.010315332561731339
of O 0 0.012178984470665455
patients O 1 0.9666769504547119
with O 0 0.019998136907815933
the O 1 0.9695945382118225
disease O 1 0.9999998807907104
. O 0 0.06780432164669037

Genomic O 0 0.08284134417772293
sequencing O 0 0.043793439865112305
of O 0 0.02500944584608078
a O 0 0.0311792753636837
BAC O 1 0.9999730587005615
clone O 1 0.9998948574066162
H O 1 0.9999923706054688
_ O 0 0.027666503563523293
RG364P16 O 0 0.30833104252815247
revealed O 0 0.017056241631507874
the O 0 0.009876889176666737
presence O 0 0.009986069053411484
of O 0 0.009685507975518703
another O 0 0.01133185438811779
, O 0 0.009738614782691002
highly O 0 0.0123980101197958
homologous O 0 0.012883470393717289
gene O 0 0.008585769683122635
3 O 0 0.008876615203917027
of O 0 0.008157112635672092
the O 0 0.011656037531793118
CLD B-Disease 1 0.9999995231628418
gene O 0 0.011028092354536057
, O 0 0.006600386928766966
with O 0 0.0055284625850617886
a O 0 0.00695318216457963
similar O 0 0.007398480549454689
genomic O 0 0.015609578229486942
structure O 0 0.01012198906391859
, O 0 0.007797200232744217
recently O 0 0.010286075994372368
identified O 0 0.008980173617601395
as O 0 0.0077636875212192535
the O 0 0.031268585473299026
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 1 0.9986656904220581
( O 1 0.9725067615509033
PDS B-Disease 1 1.0
) O 0 0.03273126110434532
. O 0 0.029205989092588425
. O 0 0.043782979249954224

The O 0 0.04433098062872887
APCI1307K O 1 0.9999359846115112
allele O 1 0.6500464677810669
and O 0 0.3558122217655182
cancer B-Disease 1 0.9999995231628418
risk O 0 0.4843204617500305
in O 0 0.009045436978340149
a O 0 0.01120026782155037
community O 0 0.01234500389546156
- O 0 0.18139369785785675
based O 0 0.012019077315926552
study O 0 0.015186565928161144
of O 0 0.018493199720978737
Ashkenazi O 1 0.6930281519889832
Jews O 0 0.04182863608002663
. O 0 0.04727613553404808

Mutations O 0 0.0645332932472229
in O 0 0.029400773346424103
APC O 1 0.9427592754364014
are O 0 0.015415502712130547
classically O 0 0.3559098243713379
associated O 0 0.019230032339692116
with O 0 0.032173383980989456
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999991655349731
FAP B-Disease 1 1.0
) O 0 0.01935500279068947
, O 0 0.012297478504478931
a O 0 0.01279420405626297
highly O 0 0.09304194152355194
penetrant O 1 0.9999996423721313
autosomal B-Disease 1 0.9999998807907104
dominant I-Disease 1 0.9999979734420776
disorder I-Disease 1 1.0
characterized O 1 0.9998774528503418
by O 1 0.8153407573699951
multiple O 1 0.9999982118606567
intestinal O 1 1.0
polyps B-Disease 1 1.0
and O 1 0.6200836896896362
, O 0 0.014501807279884815
without O 0 0.011540811508893967
surgical O 1 0.9999977350234985
intervention O 0 0.4505847990512848
, O 0 0.009114907123148441
the O 0 0.00900399498641491
development O 0 0.2735515832901001
of O 1 0.9999823570251465
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9999743700027466
CRC B-Disease 1 0.9999995231628418
) O 0 0.05465802922844887
. O 0 0.059188712388277054

APC B-Disease 1 0.9451926946640015
is O 0 0.025741353631019592
a O 0 0.03458819165825844
tumour O 1 1.0
- O 1 0.999994158744812
suppressor O 1 0.9999278783798218
gene O 0 0.017435409128665924
, O 0 0.012088773772120476
and O 0 0.014747141860425472
somatic O 1 0.9642900824546814
loss O 1 0.9988386034965515
occurs O 0 0.10905028134584427
in O 0 0.04098322242498398
tumours B-Disease 1 0.9999969005584717
. O 0 0.06666228175163269

The O 0 0.045345187187194824
germline O 1 0.987939715385437
T O 1 0.9995013475418091
- O 0 0.17364880442619324
to O 0 0.017753461375832558
- O 0 0.11327103525400162
A O 0 0.021665330976247787
transversion O 0 0.2964932918548584
responsible O 0 0.014250677078962326
for O 0 0.012179914861917496
the O 0 0.016680696979165077
APC O 1 0.9998182654380798
I1307K O 1 0.8031181693077087
allele O 0 0.03069022111594677
converts O 0 0.022741371765732765
the O 0 0.013676876202225685
wild O 0 0.017109382897615433
- O 0 0.02960917353630066
type O 0 0.012270529754459858
sequence O 0 0.009140370413661003
to O 0 0.008209824562072754
a O 0 0.014283552765846252
homopolymer O 1 0.9999619722366333
tract O 1 0.9999997615814209
( O 1 0.9875116348266602
A8 O 1 0.9999997615814209
) O 0 0.013001433573663235
that O 0 0.009535690769553185
is O 0 0.012182994745671749
genetically O 0 0.022375328466296196
unstable O 1 0.9503729939460754
and O 0 0.024360062554478645
prone O 1 0.9995306730270386
to O 0 0.029140347614884377
somatic O 1 0.978996753692627
mutation O 0 0.06066858768463135
. O 0 0.0478832870721817

The O 0 0.054773811250925064
I1307K O 1 0.8807957768440247
allele O 0 0.04635166749358177
was O 0 0.024598313495516777
found O 0 0.017811544239521027
in O 0 0.019091136753559113
6 O 0 0.042498629540205
. O 0 0.045266978442668915

1 O 0 0.043992411345243454
% O 0 0.025108398869633675
of O 0 0.022962501272559166
unselected O 1 0.9949414134025574
Ashkenazi O 1 0.9202991724014282
Jews O 0 0.019720595329999924
and O 0 0.012301666662096977
higher O 0 0.014275745488703251
proportions O 0 0.018855422735214233
of O 0 0.011615445837378502
Ashkenazim O 1 0.9912632703781128
with O 0 0.009903897531330585
family O 0 0.013743148185312748
or O 0 0.008472014218568802
personal O 0 0.015825118869543076
histories O 0 0.01808120496571064
of O 0 0.023971183225512505
CRC B-Disease 1 0.9999991655349731
( O 0 0.07830003648996353
ref O 1 0.9993367791175842
. O 0 0.021369166672229767
2 O 0 0.03489980101585388
) O 0 0.03111230954527855
. O 0 0.04293132573366165

To O 0 0.0288174357265234
evaluate O 0 0.030224550515413284
the O 0 0.01457076333463192
role O 0 0.016587024554610252
of O 0 0.013892673887312412
I1307K O 1 0.9845678806304932
in O 0 0.019474610686302185
cancer B-Disease 1 0.9999949932098389
, O 0 0.012560540810227394
we O 0 0.01050685252994299
genotyped O 0 0.3971749246120453
5 O 0 0.022342747077345848
, O 0 0.022154550999403
081 O 1 0.9993261098861694
Ashkenazi O 1 0.7094042897224426
volunteers O 0 0.031093111261725426
in O 0 0.0159481018781662
a O 0 0.022716311737895012
community O 0 0.03061400167644024
survey O 0 0.04862900450825691
. O 0 0.04852720722556114

Risk O 0 0.03417356312274933
of O 0 0.021100105717778206
developing O 1 0.9996834993362427
colorectal B-Disease 1 1.0
, I-Disease 1 0.9998098015785217
breast I-Disease 1 1.0
and I-Disease 1 0.5922829508781433
other I-Disease 0 0.012387668713927269
cancers I-Disease 1 0.9998332262039185
were O 0 0.007723377551883459
compared O 0 0.010781942866742611
between O 0 0.011118168942630291
genotyped O 1 0.7168809175491333
I1307K O 1 0.7898297309875488
carriers O 0 0.025149498134851456
and O 0 0.012119782157242298
non O 0 0.018854685127735138
- O 1 0.5653074383735657
carriers O 0 0.02012225054204464
and O 0 0.008851390331983566
their O 0 0.008274097926914692
first O 0 0.015711944550275803
- O 1 0.8583385348320007
degree O 0 0.03241310641169548
relatives O 0 0.041607003659009933
. O 0 0.04049045592546463

Sperm O 0 0.051708467304706573
DNA O 0 0.027783069759607315
analysis O 0 0.020411012694239616
in O 0 0.01727382466197014
a O 0 0.03182804584503174
Friedreich B-Disease 1 0.9999984502792358
ataxia I-Disease 1 0.9999997615814209
premutation O 1 0.9999895095825195
carrier O 1 0.999508261680603
suggests O 0 0.03243179991841316
both O 0 0.019505731761455536
meiotic O 1 0.9972137808799744
and O 0 0.020664861425757408
mitotic O 1 0.7041898369789124
expansion O 0 0.028232548385858536
in O 0 0.020224059000611305
the O 0 0.02791420929133892
FRDA B-Disease 1 0.9998437166213989
gene O 0 0.04822240397334099
. O 0 0.05106968805193901

Friedreich B-Disease 1 0.9999997615814209
ataxia I-Disease 1 0.9999998807907104
is O 0 0.09742065519094467
usually O 0 0.01645098440349102
caused O 0 0.01581442728638649
by O 0 0.007865732535719872
an O 0 0.009149070829153061
expansion O 0 0.016296956688165665
of O 0 0.01352661196142435
a O 0 0.01988813281059265
GAA O 1 0.8326842188835144
trinucleotide O 1 0.9140539169311523
repeat O 0 0.03328811004757881
in O 0 0.0200883187353611
intron O 0 0.44928255677223206
1 O 0 0.023611031472682953
of O 0 0.018697161227464676
the O 0 0.027113167569041252
FRDA B-Disease 1 0.9998036026954651
gene O 0 0.0497853085398674
. O 0 0.05267079919576645

Occasionally O 0 0.04401947557926178
, O 0 0.01918168179690838
a O 0 0.01577010750770569
fully O 0 0.017325209453701973
expanded O 0 0.018809203058481216
allele O 0 0.01978704147040844
has O 0 0.009375719353556633
been O 0 0.008042019791901112
found O 0 0.007184898480772972
to O 0 0.0077292053028941154
arise O 0 0.010402324609458447
from O 0 0.0073576439172029495
a O 0 0.011782493442296982
premutation O 0 0.14812937378883362
of O 0 0.010854028165340424
100 O 0 0.017338788136839867
or O 0 0.014659962616860867
less O 0 0.021530531346797943
triplet O 1 0.8788018822669983
repeats O 0 0.0632912740111351
. O 0 0.04824082925915718

We O 0 0.024118700996041298
have O 0 0.01356473844498396
examined O 0 0.023532483726739883
the O 0 0.013886723667383194
sperm O 0 0.020994484424591064
DNA O 0 0.018540246412158012
of O 0 0.01653490588068962
a O 0 0.02712477743625641
premutation O 1 0.9993357062339783
carrier O 1 0.9836871027946472
. O 0 0.059646446257829666

This O 0 0.04084086790680885
mans O 0 0.10473528504371643
leucocyte O 0 0.1437796950340271
DNA O 0 0.026502421125769615
showed O 0 0.019402511417865753
one O 0 0.013478053733706474
normal O 0 0.014562400057911873
allele O 0 0.01870962604880333
and O 0 0.009566851891577244
one O 0 0.012063436210155487
allele O 0 0.022075138986110687
of O 0 0.012475480325520039
approximately O 0 0.021572807803750038
100 O 0 0.03736281767487526
repeats O 0 0.06399782001972198
. O 0 0.05512236803770065

His O 0 0.04662664979696274
sperm O 0 0.03158285468816757
showed O 0 0.02117869071662426
an O 0 0.013621321879327297
expanded O 0 0.020523445680737495
allele O 0 0.022986574098467827
in O 0 0.01121019572019577
a O 0 0.013071910478174686
tight O 0 0.02003382332623005
range O 0 0.017994223162531853
centering O 0 0.027456630021333694
on O 0 0.01125398464500904
a O 0 0.013317124918103218
size O 0 0.01593889854848385
of O 0 0.015293882228434086
approximately O 0 0.02733595296740532
320 O 0 0.08000089228153229
trinucleotide O 1 0.9823600053787231
repeats O 0 0.09179793298244476
. O 0 0.07033776491880417

His O 0 0.0631578266620636
affected O 0 0.046716757118701935
son O 1 0.9322832226753235
has O 0 0.01801072619855404
repeat O 0 0.03018925152719021
sizes O 0 0.025412268936634064
of O 0 0.021297287195920944
1040 O 1 0.9848151206970215
and O 0 0.032502662390470505
540 O 0 0.4756104350090027
. O 0 0.05636441335082054

These O 0 0.01811971887946129
data O 0 0.01516728661954403
suggest O 0 0.01135248877108097
that O 0 0.006552971433848143
expansion O 0 0.013540667481720448
occurs O 0 0.008340958505868912
in O 0 0.007296151015907526
two O 0 0.006820781622081995
stages O 0 0.013250674121081829
, O 0 0.008578109554946423
the O 0 0.008749200962483883
first O 0 0.012496164999902248
during O 0 0.016166463494300842
meiosis O 0 0.052888598293066025
followed O 0 0.015319928526878357
by O 0 0.010453177616000175
a O 0 0.016157593578100204
second O 0 0.03247795253992081
mitotic O 1 0.8014078736305237
expansion O 0 0.0635305643081665
. O 0 0.05484194681048393

We O 0 0.024771830067038536
also O 0 0.013799704611301422
show O 0 0.01349661871790886
that O 0 0.007307166233658791
in O 0 0.008363605476915836
all O 0 0.008071916177868843
informative O 0 0.02343001216650009
carrier O 0 0.264316201210022
father O 0 0.014463340863585472
to O 0 0.009206059388816357
affected O 0 0.011958444491028786
child O 0 0.028018515557050705
transmissions O 0 0.0162349920719862
, O 0 0.008465664461255074
with O 0 0.006518499460071325
the O 0 0.008487959392368793
notable O 0 0.010889541357755661
exception O 0 0.01052124984562397
of O 0 0.008621846325695515
the O 0 0.01188863255083561
premutation O 1 0.9967747330665588
carrier O 1 0.7315934300422668
, O 0 0.01171449851244688
the O 0 0.013713894411921501
expansion O 0 0.025610078126192093
size O 0 0.028150875121355057
decreases O 0 0.03799988329410553
. O 0 0.027703458443284035
. O 0 0.04085307568311691

The O 0 0.045677315443754196
R496H O 0 0.23724094033241272
mutation O 0 0.03006654791533947
of O 0 0.019055336713790894
arylsulfatase O 1 0.9937188625335693
A O 0 0.07483789324760437
does O 0 0.01655607298016548
not O 0 0.017461691051721573
cause O 1 0.9996613264083862
metachromatic B-Disease 1 0.9999996423721313
leukodystrophy I-Disease 1 1.0
. O 0 0.0844775140285492

Deficiency B-Disease 1 0.9999920129776001
of I-Disease 0 0.03880198299884796
arylsulfatase I-Disease 1 0.9997363686561584
A I-Disease 1 0.9676589369773865
( O 1 0.5275470018386841
ARSA O 1 0.9999988079071045
) O 0 0.020318973809480667
enzyme O 0 0.02334676682949066
activity O 0 0.01984637975692749
causes O 1 0.9982748031616211
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 1 0.9999616146087646
MLD B-Disease 1 1.0
) O 0 0.06901470571756363
. O 0 0.059837035834789276

A O 0 0.03440163657069206
number O 0 0.01851547136902809
of O 0 0.020408743992447853
ARSA O 1 0.9999721050262451
gene O 0 0.02256792224943638
mutations O 0 0.015745576471090317
responsible O 0 0.014895066618919373
for O 0 0.016051914542913437
MLD B-Disease 1 1.0
have O 0 0.014524539932608604
been O 0 0.01832224242389202
identified O 0 0.028382837772369385
. O 0 0.035014558583498

Recently O 0 0.047995347529649734
, O 0 0.024889860302209854
the O 0 0.0212116539478302
R496H O 1 0.5298649072647095
mutation O 0 0.025509916245937347
of O 0 0.01831793040037155
ARSA O 1 0.9999874830245972
was O 0 0.01815410703420639
proposed O 0 0.01394694671034813
to O 0 0.007952623069286346
be O 0 0.006419949233531952
a O 0 0.009671298786997795
cause O 0 0.016130594536662102
of O 0 0.017912352457642555
MLD B-Disease 1 1.0
( O 0 0.13560797274112701
Draghia O 1 0.9996421337127686
et O 0 0.04151582345366478
al O 0 0.03296029195189476
. O 0 0.015788502991199493
, O 0 0.01911361888051033
1997 O 0 0.03666205331683159
) O 0 0.032655760645866394
. O 0 0.045371245592832565

We O 0 0.025821948423981667
have O 0 0.012984250672161579
investigated O 0 0.019348133355379105
the O 0 0.014798145741224289
R496H O 1 0.9469314217567444
mutation O 0 0.017319651320576668
and O 0 0.008020133711397648
found O 0 0.006552803795784712
this O 0 0.005858258344233036
mutation O 0 0.008644389919936657
at O 0 0.007939431816339493
a O 0 0.008123448118567467
relatively O 0 0.007864288985729218
high O 0 0.008809676393866539
frequency O 0 0.007509258575737476
in O 0 0.005982379429042339
an O 0 0.006834996398538351
African O 0 0.009954847395420074
American O 0 0.009730607271194458
population O 0 0.008410236798226833
( O 0 0.012359977699816227
f O 0 0.028537528589367867
= O 0 0.026861418038606644
0 O 0 0.021598991006612778
. O 0 0.014861559495329857
09 O 0 0.045912887901067734
, O 0 0.020009025931358337
n O 0 0.03050938807427883
= O 0 0.03911503031849861
61 O 0 0.045320142060518265
subjects O 0 0.04328247159719467
) O 0 0.035904768854379654
. O 0 0.05126965418457985

The O 0 0.05177843198180199
ARSA O 1 0.999984622001648
enzyme O 0 0.030232923105359077
activity O 0 0.011930549517273903
in O 0 0.00895164255052805
subjects O 0 0.01145599689334631
with O 0 0.006644334178417921
and O 0 0.0055600316263735294
without O 0 0.006156500894576311
the O 0 0.008422457613050938
R496H O 1 0.9975388050079346
mutation O 0 0.015941258519887924
was O 0 0.011903658509254456
determined O 0 0.010025215335190296
and O 0 0.007840198464691639
found O 0 0.00784439779818058
to O 0 0.010723269544541836
be O 0 0.013503585010766983
normal O 0 0.02833353355526924
. O 0 0.03647328168153763

It O 0 0.026939496397972107
is O 0 0.015668706968426704
therefore O 0 0.01235600933432579
concluded O 0 0.014031886123120785
that O 0 0.007669038139283657
the O 0 0.010706942528486252
R496H O 1 0.7941597700119019
mutation O 0 0.01901101879775524
of O 0 0.015514670871198177
ARSA O 1 0.9999942779541016
does O 0 0.010311496444046497
not O 0 0.007196997292339802
negatively O 0 0.011417611502110958
influence O 0 0.009336963295936584
the O 0 0.0077457609586417675
activity O 0 0.009601982310414314
of O 0 0.011861618608236313
ARSA O 1 0.999998927116394
and O 0 0.011168068274855614
is O 0 0.010068852454423904
not O 0 0.008384623564779758
a O 0 0.01655035838484764
cause O 0 0.3986610472202301
of O 0 0.13734811544418335
MLD B-Disease 1 0.9999996423721313

Down O 0 0.0573551170527935
- O 0 0.04655023664236069
regulation O 0 0.030100446194410324
of O 0 0.02374308370053768
transmembrane O 1 0.6391011476516724
carbonic O 1 0.9801124334335327
anhydrases O 1 0.9994111061096191
in O 1 0.7488526701927185
renal B-Disease 1 1.0
cell I-Disease 1 0.9999996423721313
carcinoma I-Disease 1 1.0
cell O 1 0.9668147563934326
lines O 0 0.01624297723174095
by O 0 0.01128497626632452
wild O 0 0.0223703496158123
- O 1 0.9889774918556213
type O 1 0.8729205131530762
von B-Disease 1 0.9997817873954773
Hippel I-Disease 1 0.9999961853027344
- I-Disease 1 0.9997716546058655
Lindau I-Disease 1 0.9998294115066528
transgenes O 1 0.9138587117195129
. O 0 0.08279649913311005

To O 0 0.038098108023405075
discover O 0 0.04830694571137428
genes O 0 0.02076193131506443
involved O 0 0.014687622897326946
in O 0 0.015764735639095306
von B-Disease 1 0.9838637113571167
Hippel I-Disease 1 0.9999973773956299
- I-Disease 1 0.9999825954437256
Lindau I-Disease 1 0.9999921321868896
( O 0 0.04013426601886749
VHL B-Disease 1 0.9999781847000122
) O 0 0.022921482101082802
- O 1 0.7519925832748413
mediated O 0 0.2681160271167755
carcinogenesis O 1 0.9993250370025635
, O 0 0.013554317876696587
we O 0 0.012157462537288666
used O 0 0.02158495970070362
renal B-Disease 1 1.0
cell I-Disease 1 0.9999980926513672
carcinoma I-Disease 1 1.0
cell O 1 0.9962462782859802
lines O 0 0.031343359500169754
stably O 1 0.7592246532440186
transfected O 0 0.49763017892837524
with O 0 0.015859093517065048
wild O 0 0.03403342142701149
- O 1 0.9997184872627258
type O 1 0.9950007796287537
VHL O 1 0.9999983310699463
- O 1 0.9967116117477417
expressing O 0 0.3040105402469635
transgenes O 1 0.960077166557312
. O 0 0.07823693752288818

Large O 0 0.0420476458966732
- O 0 0.04373719543218613
scale O 0 0.029128558933734894
RNA O 0 0.026840299367904663
differential O 0 0.0238137599080801
display O 0 0.019425367936491966
technology O 0 0.01741424947977066
applied O 0 0.012373232282698154
to O 0 0.00864008441567421
these O 0 0.007395084947347641
cell O 0 0.015617698431015015
lines O 0 0.012540739960968494
identified O 0 0.012938029132783413
several O 0 0.01085626520216465
differentially O 0 0.02667093090713024
expressed O 0 0.015552595257759094
genes O 0 0.012331563048064709
, O 0 0.010078467428684235
including O 0 0.00915340706706047
an O 0 0.014260655269026756
alpha O 0 0.10971483588218689
carbonic O 1 0.9969817996025085
anhydrase O 1 0.9996845722198486
gene O 0 0.030856851488351822
, O 0 0.0279635451734066
termed O 0 0.2990470826625824
CA12 O 1 0.9993409514427185
. O 0 0.06263726204633713

The O 0 0.03829476609826088
deduced O 0 0.049631308764219284
protein O 0 0.02243301086127758
sequence O 0 0.01396466325968504
was O 0 0.013260366395115852
classified O 0 0.012411791831254959
as O 0 0.008378302678465843
a O 0 0.01007618848234415
one O 0 0.010597008280456066
- O 1 0.5961748957633972
pass O 0 0.020030563697218895
transmembrane O 1 0.895207941532135
CA O 0 0.03145598620176315
possessing O 0 0.018629834055900574
an O 0 0.01209472119808197
apparently O 0 0.019281823188066483
intact O 0 0.029679488390684128
catalytic O 0 0.024753527715802193
domain O 0 0.019797341898083687
in O 0 0.014720982871949673
the O 0 0.021753882989287376
extracellular O 1 0.583366334438324
CA O 1 0.720320999622345
module O 1 0.9007591605186462
. O 0 0.06656607985496521

Reintroduced O 0 0.07979150861501694
wild O 0 0.049816738814115524
- O 1 0.9798858761787415
type O 1 0.738316535949707
VHL B-Disease 1 0.9998859167098999
strongly O 0 0.027170151472091675
inhibited O 0 0.03839123621582985
the O 0 0.017691122367978096
overexpression O 0 0.08587473630905151
of O 0 0.012467294000089169
the O 0 0.015223237685859203
CA12 O 1 0.9992592930793762
gene O 0 0.014974884688854218
in O 0 0.01137993298470974
the O 0 0.01802404597401619
parental O 1 0.9998077750205994
renal B-Disease 1 1.0
cell I-Disease 1 0.9999998807907104
carcinoma I-Disease 1 1.0
cell O 1 0.9999059438705444
lines O 0 0.178501158952713
. O 0 0.04808689281344414

Similar O 0 0.03091542050242424
results O 0 0.01889139786362648
were O 0 0.012973060831427574
obtained O 0 0.016269812360405922
with O 0 0.015658767893910408
CA9 O 1 0.9966830611228943
, O 0 0.016444744542241096
encoding O 0 0.02163471281528473
another O 0 0.022787366062402725
transmembrane O 1 0.5910527110099792
CA O 0 0.03050476871430874
with O 0 0.01674339361488819
an O 0 0.022484583780169487
intact O 0 0.11046003550291061
catalytic O 0 0.06591923534870148
domain O 0 0.06411342322826385
. O 0 0.05688684806227684

Although O 0 0.026734065264463425
both O 0 0.014436592347919941
domains O 0 0.018806062638759613
of O 0 0.013766025193035603
the O 0 0.018674926832318306
VHL B-Disease 1 0.9999914169311523
protein O 0 0.016499629244208336
contribute O 0 0.013789461925625801
to O 0 0.00926008727401495
regulation O 0 0.01341317780315876
of O 0 0.013015649281442165
CA12 O 1 0.998700737953186
expression O 0 0.015168349258601665
, O 0 0.012789279222488403
the O 0 0.014477594755589962
elongin O 0 0.3851900100708008
binding O 0 0.021911660209298134
domain O 0 0.02535942941904068
alone O 0 0.022200079634785652
could O 0 0.01741539128124714
effectively O 0 0.0308072529733181
regulate O 0 0.048065245151519775
CA9 O 1 0.9996182918548584
expression O 0 0.06391439586877823
. O 0 0.06701850146055222

We O 0 0.04763863980770111
mapped O 0 0.07949113845825195
CA12 O 1 0.998702883720398
and O 0 0.03518959879875183
CA9 O 1 0.9996966123580933
loci O 0 0.04759541526436806
to O 0 0.025681840255856514
chromosome O 0 0.041020333766937256
bands O 0 0.03878116235136986
15q22 O 1 0.9712960720062256
and O 0 0.04069202020764351
17q21 O 1 0.8831776976585388
. O 0 0.06747341901063919

2 O 0 0.0487121120095253
respectively O 0 0.03151137754321098
, O 0 0.02037039026618004
regions O 0 0.01711121015250683
prone O 0 0.2235420197248459
to O 0 0.011074051260948181
amplification O 0 0.028847182169556618
in O 0 0.010176052339375019
some O 0 0.013571523129940033
human O 0 0.051172953099012375
cancers B-Disease 1 0.9999517202377319
. O 0 0.04209849238395691

Additional O 0 0.04346325621008873
experiments O 0 0.03194791078567505
are O 0 0.010522197932004929
needed O 0 0.014966236427426338
to O 0 0.009660735726356506
define O 0 0.013783452101051807
the O 0 0.009974507614970207
role O 0 0.013127476908266544
of O 0 0.012407970614731312
CA O 1 0.9730556607246399
IX O 1 0.999997615814209
and O 0 0.03442544862627983
CA O 1 0.9776977896690369
XII O 1 0.9999933242797852
enzymes O 0 0.01611853577196598
in O 0 0.00873530376702547
the O 0 0.009264783002436161
regulation O 0 0.011835145764052868
of O 0 0.010189346969127655
pH O 0 0.10456188768148422
in O 0 0.009538410231471062
the O 0 0.012405701912939548
extracellular O 0 0.03979811817407608
microenvironment O 0 0.3591312766075134
and O 0 0.009907517582178116
its O 0 0.00994774978607893
potential O 0 0.013322665356099606
impact O 0 0.018759118393063545
on O 0 0.06902206689119339
cancer B-Disease 1 0.9999998807907104
cell O 1 0.9823694825172424
growth O 0 0.04964432492852211
. O 0 0.04683367535471916

A O 0 0.041425514966249466
gene O 0 0.02636013552546501
encoding O 0 0.022174187004566193
a O 0 0.0177293810993433
transmembrane O 0 0.10879667848348618
protein O 0 0.015964558348059654
is O 0 0.011067776009440422
mutated O 0 0.017499003559350967
in O 0 0.010699798353016376
patients O 1 0.9975618124008179
with O 1 0.9855664968490601
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 1 0.9999998807907104
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 1 0.811988890171051
. O 0 0.058681003749370575

Wolfram B-Disease 1 0.9999997615814209
syndrome I-Disease 1 1.0
( O 1 0.9975748658180237
WFS B-Disease 1 1.0
; O 1 0.9406508803367615
OMIM O 1 0.9999997615814209
222300 O 1 0.9997552037239075
) O 0 0.015718000009655952
is O 0 0.012866884469985962
an O 0 0.05041809007525444
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 1.0
defined O 1 0.6984777450561523
by O 0 0.016514377668499947
young O 1 0.9870581030845642
- O 1 0.9999449253082275
onset O 1 0.9999982118606567
non O 1 0.9965577721595764
- O 1 0.9999978542327881
immune O 1 1.0
insulin B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999997615814209
dependent I-Disease 1 0.9999897480010986
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.9999786615371704
progressive O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
. O 1 0.9194758534431458

Linkage O 0 0.07346617430448532
to O 0 0.02990136481821537
markers O 0 0.0367312990128994
on O 0 0.02172013744711876
chromosome O 0 0.07890161871910095
4p O 1 0.9999641180038452
was O 0 0.028482481837272644
confirmed O 0 0.02216646447777748
in O 0 0.016619287431240082
five O 0 0.022496456280350685
families O 0 0.029336770996451378
. O 0 0.041516076773405075

On O 0 0.02302486076951027
the O 0 0.014295628294348717
basis O 0 0.013124964199960232
of O 0 0.016098031774163246
meiotic O 1 0.9999884366989136
recombinants O 1 0.9999966621398926
and O 1 0.9951775074005127
disease O 1 1.0
- O 1 0.9999001026153564
associated O 0 0.027680668979883194
haplotypes O 0 0.07011692225933075
, O 0 0.015060563571751118
the O 0 0.019588537514209747
WFS B-Disease 1 0.9999874830245972
gene O 0 0.023159828037023544
was O 0 0.019089842215180397
localized O 0 0.02287561073899269
to O 0 0.014975003898143768
a O 0 0.025664884597063065
BAC O 1 0.9999933242797852
/ O 1 0.993575394153595
P1 O 1 0.993084192276001
contig O 0 0.09957606345415115
of O 0 0.020743682980537415
less O 0 0.019047558307647705
than O 0 0.02204887568950653
250 O 0 0.050301969051361084
kb O 0 0.15649820864200592
. O 0 0.064643494784832

Mutations O 0 0.04478957876563072
in O 0 0.018726257607340813
a O 0 0.019368110224604607
novel O 0 0.028770605102181435
gene O 0 0.019081449136137962
( O 0 0.017578184604644775
WFS1 O 1 0.9489216804504395
) O 0 0.012646461836993694
encoding O 0 0.015473713167011738
a O 0 0.016224542632699013
putative O 0 0.13646936416625977
transmembrane O 0 0.4335019886493683
protein O 0 0.01403304748237133
were O 0 0.006611470598727465
found O 0 0.006140844896435738
in O 0 0.005678982473909855
all O 0 0.005162396933883429
affected O 0 0.007180667947977781
individuals O 0 0.00462857773527503
in O 0 0.006676709279417992
six O 0 0.012620740570127964
WFS B-Disease 1 0.9999994039535522
families O 0 0.010559159331023693
, O 0 0.007484472822397947
and O 0 0.006536075379699469
these O 0 0.005072530824691057
mutations O 0 0.0071298289112746716
were O 0 0.005921546369791031
associated O 0 0.00866149552166462
with O 0 0.010425467975437641
the O 1 0.9549757242202759
disease O 1 1.0
phenotype O 1 0.9999315738677979
. O 0 0.05683876946568489

WFS1 O 1 0.9979398846626282
appears O 0 0.03182118386030197
to O 0 0.01548190787434578
function O 0 0.013210042379796505
in O 0 0.010083287954330444
survival O 0 0.026205243542790413
of O 0 0.013759483583271503
islet O 1 0.9998989105224609
beta O 1 0.9998192191123962
- O 1 0.9999438524246216
cells O 0 0.279847115278244
and O 0 0.01815805397927761
neurons O 0 0.034853510558605194
. O 0 0.024380464106798172
. O 0 0.04090630263090134

Stable O 0 0.05854121968150139
interaction O 0 0.02602328732609749
between O 0 0.013102625496685505
the O 0 0.011345967650413513
products O 0 0.012836722657084465
of O 0 0.010448912158608437
the O 0 0.01581845059990883
BRCA1 O 1 0.999969482421875
and O 1 0.755927562713623
BRCA2 O 1 0.9999992847442627
tumor B-Disease 1 0.9999997615814209
suppressor O 1 0.9998929500579834
genes O 0 0.021304262802004814
in O 0 0.02157828025519848
mitotic O 1 0.9963465332984924
and O 0 0.07295182347297668
meiotic O 1 0.9999723434448242
cells O 0 0.09261655062437057
. O 0 0.05854395031929016

BRCA1 O 1 0.9997701048851013
and O 0 0.033003855496644974
BRCA2 O 1 0.9514357447624207
account O 0 0.013563667424023151
for O 0 0.007556286174803972
most O 0 0.006462883669883013
cases O 0 0.006474985741078854
of O 0 0.007670221384614706
familial O 1 0.9871013164520264
, O 0 0.009153645485639572
early O 0 0.10912598669528961
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 1 0.9990707635879517
/ I-Disease 1 0.9999998807907104
or I-Disease 1 0.9999792575836182
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.056714557111263275
encode O 0 0.023414665833115578
products O 0 0.015032953582704067
that O 0 0.009925438091158867
each O 0 0.011433587409555912
interact O 0 0.01990269497036934
with O 0 0.020236795768141747
hRAD51 O 1 0.9207943677902222
. O 0 0.04831023886799812

Results O 0 0.03070501983165741
presented O 0 0.025257470086216927
here O 0 0.015252531506121159
show O 0 0.014473301358520985
that O 0 0.011214043945074081
BRCA1 O 1 0.998128354549408
and O 0 0.016456956043839455
BRCA2 O 1 0.999545156955719
coexist O 0 0.020187709480524063
in O 0 0.00953618437051773
a O 0 0.011849947273731232
biochemical O 0 0.028586454689502716
complex O 0 0.014931351877748966
and O 0 0.011854611337184906
colocalize O 1 0.8481146693229675
in O 0 0.01516904029995203
subnuclear O 1 0.9981393814086914
foci O 1 0.9592740535736084
in O 0 0.01604963093996048
somatic O 1 0.6618104577064514
cells O 0 0.01577867940068245
and O 0 0.00916802417486906
on O 0 0.010790928266942501
the O 0 0.013879667036235332
axial O 0 0.027325253933668137
elements O 0 0.019402774050831795
of O 0 0.020818278193473816
developing O 0 0.18393567204475403
synaptonemal O 1 0.999458372592926
complexes O 1 0.7259925007820129
. O 0 0.06347417086362839

Like O 0 0.06926923245191574
BRCA1 O 1 0.9965232610702515
and O 0 0.04255938529968262
RAD51 O 1 0.9999904632568359
, O 0 0.04805472865700722
BRCA2 O 1 0.9991105198860168
relocates O 1 0.5721740126609802
to O 0 0.026541277766227722
PCNA O 1 0.9996376037597656
+ O 0 0.03634551912546158
replication O 0 0.02326848916709423
sites O 0 0.012497635558247566
following O 0 0.011147665791213512
exposure O 0 0.01744304597377777
of O 0 0.012451277114450932
S O 1 0.9972829818725586
phase O 0 0.48635542392730713
cells O 0 0.019858533516526222
to O 0 0.021644990891218185
hydroxyurea O 1 0.9999516010284424
or O 0 0.07344180345535278
UV O 1 0.9999963045120239
irradiation O 1 0.9794390797615051
. O 0 0.07071178406476974

Thus O 0 0.04447639733552933
, O 0 0.02886349894106388
BRCA1 O 1 0.9952706694602966
and O 0 0.020414387807250023
BRCA2 O 1 0.9904270172119141
participate O 0 0.015813106670975685
, O 0 0.009757615625858307
together O 0 0.008893262594938278
, O 0 0.006755878683179617
in O 0 0.006050085183233023
a O 0 0.00914313830435276
pathway O 0 0.07810607552528381
( O 0 0.01239741500467062
s O 0 0.22367875277996063
) O 0 0.008895933628082275
associated O 0 0.007823842577636242
with O 0 0.006073749624192715
the O 0 0.008208349347114563
activation O 0 0.01417002733796835
of O 0 0.00970364548265934
double O 0 0.023061567917466164
- O 1 0.8839790225028992
strand O 0 0.02427373267710209
break O 0 0.024666281417012215
repair O 1 0.9989149570465088
and O 0 0.023488160222768784
/ O 1 0.8635047078132629
or O 0 0.023505687713623047
homologous O 0 0.054701559245586395
recombination O 0 0.06530044227838516
. O 0 0.04754313454031944

Dysfunction O 1 0.9999890327453613
of O 0 0.021994037553668022
this O 0 0.013280076906085014
pathway O 0 0.1566670835018158
may O 0 0.009301621466875076
be O 0 0.006793981418013573
a O 0 0.009751301258802414
general O 0 0.012737174518406391
phenomenon O 0 0.013710081577301025
in O 0 0.006741038989275694
the O 0 0.00759946508333087
majority O 0 0.006823321804404259
of O 0 0.006175265647470951
cases O 0 0.006258664187043905
of O 0 0.016500573605298996
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 0.9999910593032837
/ I-Disease 1 1.0
or I-Disease 1 0.9999986886978149
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.09981240332126617
. O 0 0.050271328538656235

A O 0 0.060274332761764526
novel O 0 0.05708873271942139
Arg362Ser O 1 0.8115099668502808
mutation O 0 0.025240018963813782
in O 0 0.01289318222552538
the O 0 0.014759480021893978
sterol O 0 0.1334179788827896
27 O 0 0.03500639274716377
- O 1 0.9459744095802307
hydroxylase O 1 0.9420456886291504
gene O 0 0.020448721945285797
( O 0 0.019863469526171684
CYP27 O 1 0.9915552735328674
) O 0 0.015721458941698074
: O 0 0.014307882636785507
its O 0 0.012962148524820805
effects O 0 0.014757392928004265
on O 0 0.014206516556441784
pre O 0 0.039869554340839386
- O 0 0.05480153486132622
mRNA O 0 0.03762553259730339
splicing O 0 0.03883808106184006
and O 0 0.026994792744517326
enzyme O 0 0.04148221015930176
activity O 0 0.040190163999795914
. O 0 0.0503382682800293

A O 0 0.05049675330519676
novel O 0 0.04523332044482231
C O 0 0.04504391551017761
to O 0 0.017654433846473694
A O 0 0.019211020320653915
mutation O 0 0.016140123829245567
in O 0 0.009968932718038559
the O 0 0.012670137919485569
sterol O 0 0.07179856300354004
27 O 0 0.030695557594299316
- O 1 0.9218328595161438
hydroxylase O 1 0.8911776542663574
gene O 0 0.021005423739552498
( O 0 0.01815510354936123
CYP27 O 1 0.9965898990631104
) O 0 0.01290178019553423
was O 0 0.014140371233224869
identified O 0 0.011485866270959377
by O 0 0.008438235148787498
sequencing O 0 0.020503459498286247
amplified O 0 0.03222671523690224
CYP27 O 1 0.9937250018119812
gene O 0 0.013490239158272743
products O 0 0.01160502154380083
from O 0 0.007985909469425678
a O 0 0.011596125550568104
patient O 1 0.7629787921905518
with O 0 0.022819699719548225
cerebrotendinous B-Disease 1 0.9999992847442627
xanthomatosis I-Disease 1 0.9999998807907104
( O 1 0.9894695281982422
CTX B-Disease 1 0.9999997615814209
) O 0 0.05150675028562546
. O 0 0.060948558151721954

The O 0 0.04163052886724472
mutation O 0 0.03825711831450462
changed O 0 0.027300894260406494
the O 0 0.022719018161296844
adrenodoxin O 1 0.9448121190071106
cofactor O 1 0.8290799856185913
binding O 0 0.03401632606983185
residue O 0 0.04387310519814491
362Arg O 0 0.20014309883117676
to O 0 0.021151840686798096
362Ser O 1 0.8925999402999878
( O 0 0.023625371977686882
CGT O 1 0.9794222712516785
362Arg O 1 0.8290691375732422
to O 0 0.02890772372484207
AGT O 1 1.0
362Ser O 1 0.9995328187942505
) O 0 0.01832468807697296
, O 0 0.01214260421693325
and O 0 0.010093316435813904
was O 0 0.014788158237934113
responsible O 0 0.013190867379307747
for O 0 0.014374442398548126
deficiency O 1 0.9999979734420776
in O 0 0.011095256544649601
the O 0 0.013246335089206696
sterol O 1 0.976538896560669
27 O 0 0.31726884841918945
- O 1 0.9985973238945007
hydroxylase O 1 0.8461846113204956
activity O 0 0.012538328766822815
, O 0 0.009027204476296902
as O 0 0.008125070482492447
confirmed O 0 0.00918703805655241
by O 0 0.0071403272449970245
expression O 0 0.010286271572113037
of O 0 0.012212630361318588
mutant O 0 0.028512751683592796
cDNA O 0 0.039797209203243256
into O 0 0.02643582783639431
COS O 1 0.9999896287918091
- O 1 0.992066502571106
1 O 0 0.04638106748461723
cells O 0 0.04383525997400284
. O 0 0.043048009276390076

Quantitative O 0 0.04378137364983559
analysis O 0 0.023732267320156097
showed O 0 0.01831844449043274
that O 0 0.009196260944008827
the O 0 0.011163881979882717
expression O 0 0.012187172658741474
of O 0 0.014859810471534729
CYP27 O 1 0.9993313550949097
gene O 0 0.017847927287220955
mRNA O 0 0.02028169482946396
in O 0 0.01422159094363451
the O 0 0.01817319542169571
patient O 0 0.04802722856402397
represented O 0 0.030510734766721725
52 O 0 0.06037325784564018
. O 0 0.05243133753538132

5 O 0 0.04313724488019943
% O 0 0.024611331522464752
of O 0 0.017902079969644547
the O 0 0.019871382042765617
normal O 0 0.02429226040840149
level O 0 0.036554280668497086
. O 0 0.04197467863559723

As O 0 0.0299647506326437
the O 0 0.021263452246785164
mutation O 0 0.022976459935307503
occurred O 0 0.015684859827160835
at O 0 0.013393530622124672
the O 0 0.013492187485098839
penultimate O 0 0.05380437523126602
nucleotide O 0 0.02022121101617813
of O 0 0.014820044860243797
exon O 0 0.04040369391441345
6 O 0 0.021295806393027306
( O 0 0.01590975746512413
- O 0 0.023407863453030586
2 O 0 0.01807178556919098
position O 0 0.015073866583406925
of O 0 0.01364448107779026
exon O 0 0.035637255758047104
6 O 0 0.025538993999361992
- O 0 0.0508994534611702
intron O 1 0.7898187637329102
6 O 0 0.024001391604542732
splice O 0 0.03287036716938019
site O 0 0.01620817929506302
) O 0 0.010147861205041409
of O 0 0.00882068369537592
the O 0 0.00907297432422638
gene O 0 0.010135691612958908
, O 0 0.007947703823447227
we O 0 0.006792267318814993
hypothesized O 0 0.01174536906182766
that O 0 0.005034493748098612
the O 0 0.00841742567718029
mutation O 0 0.011391747742891312
may O 0 0.007032096851617098
partially O 0 0.011635197326540947
affect O 0 0.008280646987259388
the O 0 0.007559448014944792
normal O 0 0.009387573227286339
splicing O 0 0.015749946236610413
efficiency O 0 0.015636680647730827
in O 0 0.012384735979139805
exon O 0 0.032957836985588074
6 O 0 0.01882336102426052
and O 0 0.011032305657863617
cause O 0 0.013565223664045334
alternative O 0 0.012533980421721935
splicing O 0 0.018746711313724518
elsewhere O 0 0.013124260120093822
, O 0 0.008928093127906322
which O 0 0.008095341734588146
resulted O 0 0.011388917453587055
in O 0 0.009082294069230556
decreased O 0 0.019578155130147934
transcript O 0 0.022140536457300186
in O 0 0.014662937261164188
the O 0 0.02577611431479454
patient O 1 0.963044285774231
. O 0 0.04697294533252716

Transfection O 0 0.46549198031425476
of O 0 0.03047107718884945
constructed O 0 0.04573081433773041
minigenes O 1 0.9240877628326416
, O 0 0.012723103165626526
with O 0 0.008796773850917816
or O 0 0.007451976649463177
without O 0 0.006774083711206913
the O 0 0.008023066446185112
mutation O 0 0.010722124949097633
, O 0 0.008421286940574646
into O 0 0.011390447616577148
COS O 1 0.9999961853027344
- O 1 0.9734171032905579
1 O 0 0.01880735158920288
cells O 0 0.012502885423600674
confirmed O 0 0.011447333730757236
that O 0 0.00779741769656539
the O 0 0.012398365885019302
mutant O 0 0.03591606393456459
minigene O 1 0.8248940110206604
was O 0 0.018565069884061813
responsible O 0 0.014964436180889606
for O 0 0.01113109476864338
a O 0 0.014458870515227318
mRNA O 0 0.01940501667559147
species O 0 0.011079900898039341
alternatively O 0 0.020419158041477203
spliced O 0 0.026414718478918076
at O 0 0.01699286699295044
an O 0 0.016879182308912277
activated O 0 0.11653568595647812
cryptic O 0 0.05260321870446205
5 O 0 0.02970069833099842
splice O 0 0.052900414913892746
site O 0 0.035155877470970154
88 O 0 0.04559643194079399
bp O 0 0.050574738532304764
upstream O 0 0.032003261148929596
from O 0 0.014611247926950455
the O 0 0.014877304434776306
3 O 0 0.020561199635267258
end O 0 0.02155441604554653
of O 0 0.024430880323052406
exon O 0 0.083695188164711
6 O 0 0.06068708002567291
. O 0 0.05432572960853577

Our O 0 0.030213216319680214
data O 0 0.0167110413312912
suggest O 0 0.013181162066757679
that O 0 0.006622779183089733
the O 0 0.009704469703137875
C O 0 0.02111966535449028
to O 0 0.009258766658604145
A O 0 0.015263422392308712
mutation O 0 0.014827705919742584
at O 0 0.01282555516809225
the O 0 0.012529288418591022
penultimate O 0 0.04514811933040619
nucleotide O 0 0.019897766411304474
of O 0 0.013254552148282528
exon O 0 0.026308786123991013
6 O 0 0.015558868646621704
of O 0 0.010481076315045357
the O 0 0.011631441302597523
CYP27 O 1 0.9982637763023376
gene O 0 0.01098625361919403
not O 0 0.00599601399153471
only O 0 0.008046722039580345
causes O 0 0.07921073585748672
the O 0 0.015116323716938496
deficiency B-Disease 1 0.9999991655349731
in I-Disease 0 0.0102461539208889
the I-Disease 0 0.012552057392895222
sterol I-Disease 1 0.9519208073616028
27 I-Disease 0 0.0745692327618599
- I-Disease 1 0.9675770998001099
hydroxylase I-Disease 0 0.3752451241016388
activity I-Disease 0 0.012566990219056606
, O 0 0.010446534492075443
but O 0 0.009723414666950703
also O 0 0.010167944245040417
partially O 0 0.01804712787270546
leads O 0 0.0136340893805027
to O 0 0.009037644602358341
alternative O 0 0.014920976012945175
pre O 0 0.03783039748668671
- O 0 0.02806253544986248
mRNA O 0 0.0241229385137558
splicing O 0 0.025774089619517326
of O 0 0.016509702429175377
the O 0 0.02471413090825081
gene O 0 0.03481888025999069
. O 0 0.04090677201747894

To O 0 0.025538569316267967
our O 0 0.017494577914476395
knowledge O 0 0.014976615086197853
, O 0 0.00939817726612091
this O 0 0.005956608802080154
is O 0 0.005776386708021164
the O 0 0.006364236585795879
first O 0 0.008219366893172264
report O 0 0.008964819833636284
regarding O 0 0.010341525077819824
effects O 0 0.011191194877028465
on O 0 0.010459517128765583
pre O 0 0.027783581987023354
- O 0 0.023525362834334373
mRNA O 0 0.017931755632162094
splicing O 0 0.017331235110759735
of O 0 0.010596472769975662
a O 0 0.011763205751776695
mutation O 0 0.012708699330687523
at O 0 0.010360262356698513
the O 0 0.010691992938518524
- O 0 0.021060043945908546
2 O 0 0.015469993464648724
position O 0 0.016642970964312553
of O 0 0.012851182371377945
a O 0 0.01785174012184143
5 O 0 0.03376011177897453
splice O 0 0.07449229061603546
site O 0 0.053117409348487854
. O 0 0.04869777336716652

ATM O 0 0.19504034519195557
germline O 0 0.10056954622268677
mutations O 0 0.03295326977968216
in O 0 0.019791390746831894
classical O 0 0.3585846424102783
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.9998688697814941
in O 0 0.016572359949350357
the O 0 0.021031489595770836
Dutch O 0 0.3158562481403351
population O 0 0.027425263077020645
. O 0 0.04125889763236046

Germline O 1 0.6147142648696899
mutations O 0 0.026297394186258316
in O 0 0.013051416724920273
the O 0 0.012848968617618084
ATM O 0 0.43473824858665466
gene O 0 0.009163403883576393
are O 0 0.004510452039539814
responsible O 0 0.00718918489292264
for O 0 0.007036816328763962
the O 0 0.05497678741812706
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9991078972816467
A B-Disease 1 0.9999990463256836
- I-Disease 1 1.0
T I-Disease 1 0.9999998807907104
) O 0 0.036158282309770584
. O 0 0.046727344393730164

In O 0 0.023386415094137192
our O 0 0.018250808119773865
study O 0 0.01566598005592823
, O 0 0.010342258028686047
we O 0 0.007715743966400623
have O 0 0.006015338934957981
determined O 0 0.009257279336452484
the O 0 0.009566102176904678
ATM O 0 0.044124189764261246
mutation O 0 0.01331621129065752
spectrum O 0 0.013186722062528133
in O 0 0.0074375225231051445
19 O 0 0.011728616431355476
classical O 0 0.014205860905349255
A B-Disease 1 0.9956983327865601
- I-Disease 1 0.9999996423721313
T I-Disease 1 1.0
patients O 1 0.9748564958572388
, O 0 0.009231464006006718
including O 0 0.007814056240022182
some O 0 0.007314273621886969
immigrant O 0 0.011541904881596565
populations O 0 0.007813053205609322
, O 0 0.007863902486860752
as O 0 0.008005080744624138
well O 0 0.008203794248402119
as O 0 0.008951243944466114
12 O 0 0.015656767413020134
of O 0 0.01581178605556488
Dutch O 0 0.037414535880088806
ethnic O 0 0.023764902725815773
origin O 0 0.031037239357829094
. O 0 0.04315304011106491

Both O 0 0.02538325823843479
the O 0 0.021632835268974304
protein O 0 0.023728203028440475
truncation O 0 0.05493124946951866
test O 0 0.025614574551582336
( O 0 0.019858960062265396
PTT O 1 0.662510871887207
) O 0 0.011769520118832588
and O 0 0.01037317793816328
the O 0 0.011111839674413204
restriction O 0 0.01972285658121109
endonuclease O 1 0.5050991177558899
fingerprinting O 0 0.09410838037729263
( O 0 0.019955964758992195
REF O 1 0.9911631345748901
) O 0 0.012692186050117016
method O 0 0.010045727714896202
were O 0 0.006466102320700884
used O 0 0.006777184549719095
and O 0 0.006376286037266254
compared O 0 0.007807352114468813
for O 0 0.0063175964169204235
their O 0 0.006737467832863331
detection O 0 0.014282847754657269
efficiency O 0 0.014694304205477238
, O 0 0.009555463679134846
identifying O 0 0.013988951221108437
76 O 0 0.021765876561403275
% O 0 0.008607316762208939
and O 0 0.007817219942808151
60 O 0 0.011476859450340271
% O 0 0.008921387605369091
of O 0 0.009896579198539257
the O 0 0.012833730317652225
mutations O 0 0.018903125077486038
, O 0 0.018031002953648567
respectively O 0 0.02982303313910961
. O 0 0.03430081903934479

Most O 0 0.04074748232960701
patients O 0 0.3415586054325104
were O 0 0.014416511170566082
found O 0 0.01290154829621315
to O 0 0.0158853642642498
be O 0 0.0203486867249012
compound O 0 0.07561134546995163
heterozygote O 1 0.8567260503768921
. O 0 0.06584862619638443

Seventeen O 0 0.07604970037937164
mutations O 0 0.028611082583665848
were O 0 0.011663312092423439
distinct O 0 0.010971088893711567
, O 0 0.0076103913597762585
of O 0 0.007747782859951258
which O 0 0.00715113990008831
10 O 0 0.009723395109176636
were O 0 0.007691253442317247
not O 0 0.00875223707407713
reported O 0 0.016153251752257347
previously O 0 0.027159035205841064
. O 0 0.03378024324774742

Mutations O 0 0.042024411261081696
are O 0 0.014316661283373833
small O 0 0.018958760425448418
deletions O 0 0.032314807176589966
or O 0 0.014543861150741577
point O 0 0.020182419568300247
mutations O 0 0.023711426183581352
frequently O 0 0.021163493394851685
affecting O 0 0.03128459304571152
splice O 0 0.0790126621723175
sites O 0 0.03990672156214714
. O 0 0.04404107853770256

Moreover O 0 0.06966108828783035
, O 0 0.0364515520632267
a O 0 0.035242024809122086
16 O 0 0.05368349328637123
. O 0 0.054512377828359604

7 O 0 0.06788332760334015
- O 0 0.08002720773220062
kb O 0 0.08207179605960846
genomic O 0 0.04171082377433777
deletion O 0 0.02725452184677124
of O 0 0.01227026991546154
the O 0 0.0097756152972579
3 O 0 0.011943927966058254
end O 0 0.009096777066588402
of O 0 0.007111141923815012
the O 0 0.00808024313300848
gene O 0 0.009051628410816193
, O 0 0.006724103353917599
most O 0 0.00565336924046278
likely O 0 0.006396679673343897
a O 0 0.006673790980130434
result O 0 0.0062768785282969475
of O 0 0.006793502252548933
recombination O 0 0.01211310364305973
between O 0 0.005613428540527821
two O 0 0.00770547054708004
LINE O 0 0.017626769840717316
elements O 0 0.015316348522901535
, O 0 0.014230377040803432
was O 0 0.021791836246848106
identified O 0 0.02673007920384407
. O 0 0.032515812665224075

The O 0 0.02790033631026745
most O 0 0.01674671284854412
frequently O 0 0.01525114942342043
found O 0 0.01157183013856411
mutation O 0 0.012614598497748375
, O 0 0.007813341915607452
identified O 0 0.007399364374577999
in O 0 0.006032359320670366
three O 0 0.00524583924561739
unrelated O 0 0.009911095723509789
Turkish O 0 0.014399398118257523
A B-Disease 1 0.9775710105895996
- I-Disease 1 0.9999943971633911
T I-Disease 1 0.9999915361404419
individuals O 0 0.007561194244772196
, O 0 0.007808959111571312
was O 0 0.010854574851691723
previously O 0 0.009249712340533733
described O 0 0.00833067949861288
to O 0 0.006028709001839161
be O 0 0.005910682026296854
a O 0 0.008984850719571114
Turkish O 0 0.017853904515504837
A B-Disease 1 0.9778913259506226
- I-Disease 1 0.999995231628418
T I-Disease 1 0.9999991655349731
founder O 1 0.9995967745780945
mutation O 0 0.06471750140190125
. O 0 0.04581265524029732

The O 0 0.03199174627661705
presence O 0 0.022612659260630608
of O 0 0.016391243785619736
a O 0 0.01950717344880104
founder O 1 0.9961995482444763
mutation O 0 0.01972690410912037
among O 0 0.01077287271618843
relatively O 0 0.00936159212142229
small O 0 0.007922575809061527
ethnic O 0 0.006595780607312918
population O 0 0.00548601383343339
groups O 0 0.004814098123461008
in O 0 0.005952869076281786
Western O 0 0.009058179333806038
Europe O 0 0.009763975627720356
could O 0 0.007161472458392382
indicate O 0 0.009251031093299389
a O 0 0.010689763352274895
high O 0 0.018778536468744278
carrier O 0 0.24183470010757446
frequency O 0 0.016728373244404793
in O 0 0.015094537287950516
such O 0 0.018859168514609337
communities O 0 0.0276243407279253
. O 0 0.042258135974407196

In O 0 0.03234000504016876
patients O 0 0.034874480217695236
of O 0 0.015377175994217396
Dutch O 0 0.03153003379702568
ethnic O 0 0.010167589411139488
origin O 0 0.008440596051514149
, O 0 0.007934225723147392
however O 0 0.007149426732212305
, O 0 0.007419307716190815
no O 0 0.007916363887488842
significant O 0 0.010936765000224113
founder O 1 0.9542255401611328
effect O 0 0.01346921268850565
could O 0 0.011499863117933273
be O 0 0.013583670370280743
identified O 0 0.028549904003739357
. O 0 0.03857128322124481

The O 0 0.0381191186606884
observed O 0 0.02617504633963108
genetic O 0 0.02414732798933983
heterogeneity O 0 0.029700931161642075
including O 0 0.010624153539538383
the O 0 0.010787670500576496
relative O 0 0.011265143752098083
high O 0 0.011684608645737171
percentage O 0 0.010481185279786587
of O 0 0.010297047905623913
splice O 0 0.06852323561906815
- O 0 0.2579163610935211
site O 0 0.017730101943016052
mutations O 0 0.01248374953866005
had O 0 0.010294245555996895
no O 0 0.009308482520282269
reflection O 0 0.020443368703126907
on O 0 0.016916340216994286
the O 0 0.028400786221027374
phenotype O 1 0.7005620002746582
. O 0 0.04896434769034386

All O 0 0.036795973777770996
patients O 0 0.09292936325073242
manifested O 0 0.05021824687719345
classical O 0 0.027496065944433212
A B-Disease 1 0.9992790818214417
- I-Disease 1 0.9999979734420776
T I-Disease 1 0.9999938011169434
and O 0 0.017705215141177177
increased O 0 0.024214109405875206
cellular O 1 0.6082556247711182
radioresistant O 1 0.9849624633789062
DNA O 0 0.04575446620583534
synthesis O 0 0.05761519819498062
. O 0 0.05177095904946327

Determination O 0 0.05129685997962952
of O 0 0.021047748625278473
the O 0 0.01616290956735611
genomic O 0 0.024432003498077393
structure O 0 0.01409134455025196
of O 0 0.011120812967419624
the O 0 0.014293693006038666
COL4A4 O 1 0.9999518394470215
gene O 0 0.015000896528363228
and O 0 0.010457533411681652
of O 0 0.011626782827079296
novel O 0 0.05772628262639046
mutations O 1 0.6801385879516602
causing O 1 0.9999302625656128
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9996212720870972

Autosomal B-Disease 1 0.9999998807907104
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 1 0.961700975894928
a O 1 0.9944962859153748
progressive O 1 0.9999995231628418
hematuric B-Disease 1 1.0
glomerulonephritis I-Disease 1 1.0
characterized O 1 0.9997418522834778
by O 0 0.049075618386268616
glomerular B-Disease 1 1.0
basement I-Disease 1 0.9999997615814209
membrane I-Disease 1 0.9998419284820557
abnormalities I-Disease 1 0.9998264908790588
and O 0 0.010486171580851078
associated O 0 0.008802276104688644
with O 0 0.007062153425067663
mutations O 0 0.009737865999341011
in O 0 0.006757315713912249
either O 0 0.006734582595527172
the O 0 0.008987093344330788
COL4A3 O 1 0.9930022358894348
or O 0 0.01003632415086031
the O 0 0.01222735270857811
COL4A4 O 1 0.9995138645172119
gene O 0 0.012725092470645905
, O 0 0.009158694185316563
which O 0 0.007222943473607302
encode O 0 0.01412525400519371
the O 0 0.010837656445801258
alpha3 O 0 0.30512547492980957
and O 0 0.016987739130854607
alpha4 O 1 0.9998891353607178
type O 1 0.9996650218963623
IV O 1 1.0
collagen O 1 0.9999996423721313
chains O 1 0.9550273418426514
, O 0 0.03591061383485794
respectively O 0 0.04427613317966461
. O 0 0.05279919505119324

To O 0 0.02736305631697178
date O 0 0.024884646758437157
, O 0 0.016416477039456367
mutation O 0 0.017208809033036232
screening O 0 0.017145216464996338
in O 0 0.008549947291612625
the O 0 0.00799446552991867
two O 0 0.0082700839266181
genes O 0 0.00865496788173914
has O 0 0.007517607882618904
been O 0 0.008159906603395939
hampered O 0 0.02823592536151409
by O 0 0.007609725464135408
the O 0 0.011228619143366814
lack O 0 0.01369745098054409
of O 0 0.015918338671326637
genomic O 0 0.08392742276191711
structure O 0 0.031683549284935
information O 0 0.030014201998710632
. O 0 0.04317571967840195

We O 0 0.027485236525535583
report O 0 0.01780208945274353
here O 0 0.013163919560611248
the O 0 0.011757352389395237
complete O 0 0.01607520878314972
characterization O 0 0.019005950540304184
of O 0 0.009791908785700798
the O 0 0.010614966973662376
48 O 0 0.018815426155924797
exons O 0 0.02058970369398594
of O 0 0.012087229639291763
the O 0 0.01348716951906681
COL4A4 O 1 0.9995960593223572
gene O 0 0.011124751530587673
, O 0 0.008286118507385254
a O 0 0.008502969518303871
comprehensive O 0 0.015034286305308342
gene O 0 0.011318592354655266
screen O 0 0.014032223261892796
, O 0 0.0075226398184895515
and O 0 0.006208199542015791
the O 0 0.006997685879468918
subsequent O 0 0.011544070206582546
detection O 0 0.01503487303853035
of O 0 0.007729578763246536
10 O 0 0.010805393569171429
novel O 0 0.013521243818104267
mutations O 0 0.008784580044448376
in O 0 0.0069557540118694305
eight O 0 0.016947945579886436
patients O 1 0.9999940395355225
diagnosed O 1 1.0
with O 1 0.9998633861541748
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9996323585510254

Furthermore O 0 0.050791822373867035
, O 0 0.02002481184899807
we O 0 0.013852335512638092
identified O 0 0.016152115538716316
a O 0 0.014826222322881222
glycine O 0 0.0318005234003067
to O 0 0.015610595233738422
alanine O 0 0.029936600476503372
substitution O 0 0.019066480919718742
in O 0 0.01148021500557661
the O 0 0.014138522557914257
collagenous O 1 0.9994739890098572
domain O 0 0.018082432448863983
that O 0 0.008630817756056786
is O 0 0.00965509470552206
apparently O 0 0.014218393713235855
silent O 0 0.018460329622030258
in O 0 0.009980450384318829
the O 0 0.013968728482723236
heterozygous O 0 0.0267180148512125
carriers O 0 0.030314741656184196
, O 0 0.014930925332009792
in O 0 0.017114248126745224
11 O 0 0.035569798201322556
. O 0 0.040244683623313904

5 O 0 0.03298702836036682
% O 0 0.017827719449996948
of O 0 0.011645845137536526
all O 0 0.008816591463983059
control O 0 0.011064800433814526
individuals O 0 0.006922235246747732
, O 0 0.006999004166573286
and O 0 0.006718870252370834
in O 0 0.007095860317349434
one O 0 0.008828558027744293
control O 0 0.012178938835859299
individual O 0 0.011524888686835766
homozygous O 0 0.020976919680833817
for O 0 0.015205798670649529
this O 0 0.019215071573853493
glycine O 0 0.06052817404270172
substitution O 0 0.060375336557626724
. O 0 0.04906731843948364

There O 0 0.02297477424144745
has O 0 0.015477518551051617
been O 0 0.011604414321482182
no O 0 0.00917382538318634
previous O 0 0.010835101827979088
finding O 0 0.010938581079244614
of O 0 0.008022607304155827
a O 0 0.012136703357100487
glycine O 0 0.02312278561294079
substitution O 0 0.013431350700557232
that O 0 0.006830220576375723
is O 0 0.006503253243863583
not O 0 0.005291253328323364
associated O 0 0.006407808978110552
with O 0 0.0062700421549379826
any O 0 0.008727342821657658
obvious O 0 0.09899374842643738
phenotype O 1 0.678598165512085
in O 0 0.01926109381020069
homozygous O 0 0.04547913745045662
individuals O 0 0.026471350342035294
. O 0 0.04574457183480263

Founder O 1 0.9995706677436829
BRCA1 O 1 0.9998714923858643
and O 0 0.033745087683200836
BRCA2 O 1 0.9965567588806152
mutations O 0 0.017858555540442467
in O 0 0.012642626650631428
French O 1 0.7485973238945007
Canadian O 1 0.9998210072517395
breast B-Disease 1 1.0
and I-Disease 1 0.9999991655349731
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.9234039783477783
. O 0 0.052061907947063446

We O 0 0.02063649520277977
have O 0 0.010313083417713642
identified O 0 0.012027958407998085
four O 0 0.008959281258285046
mutations O 0 0.007958379574120045
in O 0 0.0053792609833180904
each O 0 0.00473248865455389
of O 0 0.006549532525241375
the O 0 0.08691349625587463
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
- O 1 0.999996542930603
susceptibility O 1 0.9999399185180664
genes O 0 0.018819116055965424
, O 0 0.016442900523543358
BRCA1 O 1 0.9981995820999146
and O 0 0.015173913910984993
BRCA2 O 1 0.985805094242096
, O 0 0.009981298819184303
in O 0 0.0075903404504060745
French O 0 0.017460497096180916
Canadian O 1 0.9581486582756042
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9999887943267822
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.5738320350646973
from O 0 0.038354143500328064
Quebec O 1 0.8571207523345947
. O 0 0.0608937032520771

To O 0 0.029657527804374695
identify O 0 0.029321184381842613
founder O 1 0.9751828908920288
effects O 0 0.030308440327644348
, O 0 0.013133680447936058
we O 0 0.010381365194916725
examined O 0 0.0166003480553627
independently O 0 0.012315191328525543
ascertained O 0 0.025335825979709625
French O 0 0.03872618451714516
Canadian O 1 0.8234544396400452
cancer B-Disease 1 0.9999786615371704
families O 0 0.008702544495463371
for O 0 0.006948323920369148
the O 0 0.007668816950172186
distribution O 0 0.008477800525724888
of O 0 0.009202498942613602
these O 0 0.008241759613156319
eight O 0 0.01965992897748947
mutations O 0 0.03163236379623413
. O 0 0.03442395105957985

Mutations O 0 0.04600348323583603
were O 0 0.015490247868001461
found O 0 0.012097074650228024
in O 0 0.011836528778076172
41 O 0 0.023879343643784523
of O 0 0.01833195984363556
97 O 0 0.2265455722808838
families O 0 0.03401541709899902
. O 0 0.046742893755435944

Six O 0 0.0348563976585865
of O 0 0.022628936916589737
eight O 0 0.022037062793970108
mutations O 0 0.0164837297052145
were O 0 0.010464946739375591
observed O 0 0.015118254348635674
at O 0 0.01808616891503334
least O 0 0.019099203869700432
twice O 0 0.03608699515461922
. O 0 0.0434960201382637

The O 0 0.04971254616975784
BRCA1 O 1 0.9996578693389893
C4446T O 1 0.989285409450531
mutation O 0 0.023481177166104317
was O 0 0.014447145164012909
the O 0 0.008683609776198864
most O 0 0.007535742130130529
common O 0 0.008637732826173306
mutation O 0 0.011163313873112202
found O 0 0.006713551469147205
, O 0 0.007250919006764889
followed O 0 0.01003828551620245
by O 0 0.010292924009263515
the O 0 0.025492088869214058
BRCA2 O 1 0.9999638795852661
8765delAG O 1 0.9997957348823547
mutation O 0 0.06944280862808228
. O 0 0.04990868642926216

Together O 0 0.03392825648188591
, O 0 0.018117839470505714
these O 0 0.01043762732297182
mutations O 0 0.011535987257957458
were O 0 0.006918584927916527
found O 0 0.006720760837197304
in O 0 0.006406694650650024
28 O 0 0.010992715135216713
of O 0 0.008493470028042793
41 O 0 0.01664060726761818
families O 0 0.010797934606671333
identified O 0 0.010503462515771389
to O 0 0.009634552523493767
have O 0 0.009986450895667076
a O 0 0.02268427424132824
mutation O 0 0.03963923826813698
. O 0 0.03843850642442703

The O 0 0.0373988151550293
odds O 0 0.04149725288152695
of O 0 0.01942369155585766
detection O 0 0.023167993873357773
of O 0 0.010972915217280388
any O 0 0.00882931798696518
of O 0 0.009516969323158264
the O 0 0.011171908117830753
four O 0 0.018251899629831314
BRCA1 O 1 0.9997888207435608
mutations O 0 0.02538290247321129
was O 0 0.02818477153778076
18 O 0 0.038001175969839096
. O 0 0.045963991433382034

7x O 1 0.9968096613883972
greater O 0 0.03032955899834633
if O 0 0.012261747382581234
one O 0 0.00936281867325306
or O 0 0.005830287002027035
more O 0 0.005049333907663822
cases O 0 0.007776370272040367
of O 1 0.9961989521980286
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 0.015453139320015907
also O 0 0.009821542538702488
present O 0 0.010521546937525272
in O 0 0.011563009582459927
the O 0 0.0184676144272089
family O 0 0.0339663028717041
. O 0 0.03464455530047417

The O 0 0.03611820563673973
odds O 0 0.03913864120841026
of O 0 0.01658175140619278
detection O 0 0.020222391933202744
of O 0 0.01040906086564064
any O 0 0.007275846321135759
of O 0 0.008701244369149208
the O 0 0.011440951377153397
four O 0 0.017598610371351242
BRCA2 O 1 0.9999064207077026
mutations O 0 0.026056980714201927
was O 0 0.034402284771203995
5 O 0 0.04168831929564476
. O 0 0.04402144253253937

3x O 1 0.8257290720939636
greater O 0 0.026960333809256554
if O 0 0.012606850825250149
there O 0 0.007545622065663338
were O 0 0.006806067656725645
at O 0 0.007567930966615677
least O 0 0.005579679273068905
five O 0 0.007193052209913731
cases O 0 0.008097777143120766
of O 1 0.5427332520484924
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.022649697959423065
the O 0 0.030907345935702324
family O 0 0.046911321580410004
. O 0 0.03998873010277748

Interestingly O 0 0.058041300624608994
, O 0 0.018448002636432648
the O 0 0.013321743346750736
presence O 0 0.013389534316956997
of O 0 0.010764328762888908
a O 1 0.9190099835395813
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
case O 0 0.2346392124891281
< O 1 0.8485039472579956
36 O 0 0.015672849491238594
years O 0 0.009842729195952415
of O 0 0.009082491509616375
age O 0 0.012159192003309727
was O 0 0.012353879399597645
strongly O 0 0.011255857534706593
predictive O 0 0.015618637204170227
of O 0 0.008786588907241821
the O 0 0.008477140218019485
presence O 0 0.009625030681490898
of O 0 0.008238783106207848
any O 0 0.00738349836319685
of O 0 0.009564344771206379
the O 0 0.013666389510035515
eight O 0 0.024403724819421768
mutations O 0 0.032635219395160675
screened O 0 0.061334095895290375
. O 0 0.05009197071194649

Carriers O 0 0.046029724180698395
of O 0 0.017710233107209206
the O 0 0.013850875198841095
same O 0 0.011079906485974789
mutation O 0 0.01305741909891367
, O 0 0.007305332459509373
from O 0 0.005905472673475742
different O 0 0.004388805478811264
families O 0 0.006257071625441313
, O 0 0.007270152680575848
shared O 0 0.009690728038549423
similar O 0 0.009177923202514648
haplotypes O 0 0.030758146196603775
, O 0 0.008672287687659264
indicating O 0 0.011005097068846226
that O 0 0.006968917790800333
the O 0 0.009766853414475918
mutant O 0 0.02091374062001705
alleles O 0 0.01251463033258915
were O 0 0.006422702223062515
likely O 0 0.00771655747666955
to O 0 0.006682628765702248
be O 0 0.005342800170183182
identical O 0 0.00865175575017929
by O 0 0.00607339246198535
descent O 0 0.010514679364860058
for O 0 0.007209791801869869
a O 0 0.010034628212451935
mutation O 0 0.013640221208333969
in O 0 0.010915817692875862
the O 0 0.017055418342351913
founder O 1 0.8031677007675171
population O 0 0.024102482944726944
. O 0 0.039127543568611145

The O 0 0.029625222086906433
identification O 0 0.026595985516905785
of O 0 0.018384108319878578
common O 0 0.04594821482896805
BRCA1 O 1 0.9999833106994629
and O 0 0.22017306089401245
BRCA2 O 1 0.9999525547027588
mutations O 0 0.015913350507616997
will O 0 0.011432180181145668
facilitate O 0 0.015656188130378723
carrier O 0 0.04147680103778839
detection O 0 0.015639061108231544
in O 0 0.008037102408707142
French O 0 0.01878826878964901
Canadian O 1 0.9420269727706909
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9999951124191284
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.9802846908569336
. O 0 0.05542607605457306

Are O 0 0.028590748086571693
Dp71 O 1 0.902584433555603
and O 0 0.03433563932776451
Dp140 O 1 0.9999179840087891
brain O 1 0.9984958171844482
dystrophin O 1 0.9985867738723755
isoforms O 0 0.029924774542450905
related O 0 0.01933163031935692
to O 0 0.020205676555633545
cognitive B-Disease 1 0.9989557266235352
impairment I-Disease 1 0.9999998807907104
in O 1 0.9999436140060425
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 1 0.9999771118164062

Molecular O 0 0.06078197434544563
study O 0 0.027291467413306236
and O 0 0.018052976578474045
neuropsychological O 0 0.04277072101831436
analysis O 0 0.01415584608912468
were O 0 0.009318042546510696
performed O 0 0.012516074813902378
concurrently O 0 0.015748266130685806
on O 0 0.009748091921210289
49 O 0 0.022025253623723984
patients O 1 0.9432023763656616
with O 1 0.9044607877731323
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999997615814209
DMD B-Disease 1 1.0
) O 0 0.014622917398810387
in O 0 0.009227540343999863
order O 0 0.008504263125360012
to O 0 0.007954676635563374
find O 0 0.00896640494465828
a O 0 0.008250326849520206
molecular O 0 0.010140868835151196
explanation O 0 0.009394582360982895
for O 0 0.007302124984562397
the O 0 0.011279158294200897
cognitive B-Disease 1 0.9777177572250366
impairment I-Disease 1 0.9999780654907227
observed O 0 0.015153873711824417
in O 0 0.015393798239529133
most O 0 0.2754128873348236
DMD B-Disease 1 1.0
patients O 1 0.9999750852584839
. O 0 0.055770959705114365

Complete O 0 0.035884663462638855
analysis O 0 0.021560413762927055
of O 0 0.017941482365131378
the O 0 0.017690517008304596
dystrophin O 1 0.9998898506164551
gene O 0 0.0178393367677927
was O 0 0.01627698726952076
performed O 0 0.01296195201575756
to O 0 0.009965846315026283
define O 0 0.01458369567990303
the O 0 0.0114132110029459
localization O 0 0.024117428809404373
of O 0 0.014558881521224976
deletions O 0 0.029664820060133934
and O 0 0.014146353118121624
duplications O 0 0.03967282921075821
in O 0 0.009742127731442451
relation O 0 0.01267523318529129
to O 0 0.011837571859359741
the O 0 0.018408825621008873
different O 0 0.02236492931842804
DMD B-Disease 1 0.9999986886978149
promoters O 1 0.9660864472389221
. O 0 0.0612049400806427

Qualitative O 0 0.042322538793087006
analysis O 0 0.01890547201037407
of O 0 0.014717837795615196
the O 0 0.01670519821345806
Dp71 O 1 0.9724442958831787
transcript O 0 0.021968690678477287
and O 0 0.011775844730436802
testing O 0 0.011551755480468273
for O 0 0.007644863799214363
the O 0 0.007918918505311012
specific O 0 0.008343406021595001
first O 0 0.01326827984303236
exon O 0 0.029339337721467018
of O 0 0.013994569890201092
Dp140 O 0 0.3082486093044281
were O 0 0.012331406585872173
also O 0 0.014863146468997002
carried O 0 0.02582141011953354
out O 0 0.030012108385562897
. O 0 0.045447248965501785

Neuropsychological O 0 0.11812546849250793
analysis O 0 0.033097878098487854
assessed O 0 0.031704459339380264
verbal O 0 0.03213423490524292
and O 0 0.018823182210326195
visuospatial O 1 0.9965968728065491
intelligence O 0 0.023788953199982643
, O 0 0.017219683155417442
verbal O 1 0.9152277708053589
memory O 1 0.9996222257614136
, O 0 0.020604735240340233
and O 0 0.020030124112963676
reading O 0 0.04013461619615555
skills O 0 0.11440058797597885
. O 0 0.04237041994929314

Comparison O 0 0.04514447972178459
of O 0 0.026335524395108223
molecular O 0 0.032545167952775955
and O 0 0.018418943509459496
psychometric O 0 0.175059512257576
findings O 0 0.02145703136920929
demonstrated O 0 0.0199265256524086
that O 0 0.010086962953209877
deletions O 0 0.025439994409680367
and O 0 0.013133885338902473
duplications O 0 0.028933947905898094
that O 0 0.007842120714485645
were O 0 0.007609141059219837
localized O 0 0.015281930565834045
in O 0 0.00754661625251174
the O 0 0.010102848522365093
distal O 0 0.21817547082901
part O 0 0.008868178352713585
of O 0 0.007597059942781925
the O 0 0.0087133115157485
gene O 0 0.008847690187394619
seemed O 0 0.008850575424730778
to O 0 0.006829236634075642
be O 0 0.007322778459638357
preferentially O 0 0.01896742172539234
associated O 0 0.01317845843732357
with O 0 0.017018325626850128
cognitive B-Disease 1 0.99481600522995
impairment I-Disease 1 0.9999892711639404
. O 0 0.056149665266275406

Two O 0 0.033501751720905304
altered O 0 0.03998548164963722
Dp71 O 0 0.08205561339855194
transcripts O 0 0.03162756189703941
and O 0 0.015201450325548649
two O 0 0.011245637200772762
deleted O 0 0.02487778291106224
Dp140 O 0 0.03663865476846695
DNA O 0 0.014254958368837833
sequences O 0 0.01000974141061306
were O 0 0.005643042270094156
found O 0 0.005529534537345171
in O 0 0.00651482492685318
four O 0 0.010976433753967285
patients O 1 0.99922776222229
with O 1 0.9948215484619141
severe O 1 1.0
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 1.0
. O 1 0.9905057549476624

These O 0 0.02440888248383999
findings O 0 0.02362748794257641
suggest O 0 0.0141493184491992
that O 0 0.006767497397959232
some O 0 0.006652389653027058
sequences O 0 0.0085830669850111
located O 0 0.010461421683430672
in O 0 0.007423112168908119
the O 0 0.009556014090776443
distal O 0 0.02770848758518696
part O 0 0.009396721608936787
of O 0 0.007571033202111721
the O 0 0.008143379352986813
gene O 0 0.00822782889008522
and O 0 0.005765495356172323
, O 0 0.005732187069952488
in O 0 0.005783938802778721
particular O 0 0.006813375744968653
, O 0 0.00782928615808487
some O 0 0.007981464266777039
DMD B-Disease 1 0.9999949932098389
isoforms O 0 0.01444478239864111
expressed O 0 0.009730718098580837
in O 0 0.008566146716475487
the O 0 0.019694965332746506
brain O 1 0.9676421880722046
may O 0 0.007406224962323904
be O 0 0.006173931993544102
related O 0 0.007132090628147125
to O 0 0.007283045444637537
the O 0 0.011163594201207161
cognitive B-Disease 1 0.9969306588172913
impairment I-Disease 1 0.9999995231628418
associated O 1 0.9463565945625305
with O 1 0.9526111483573914
DMD B-Disease 1 1.0
. O 0 0.04356652870774269
. O 0 0.05447293445467949

I1307K O 1 0.9952012300491333
APC O 1 0.9985687732696533
and O 0 0.03563836216926575
hMLH1 O 1 0.9113703370094299
mutations O 0 0.019950037822127342
in O 0 0.010886558331549168
a O 0 0.013261239975690842
non O 0 0.01616809517145157
- O 0 0.027912061661481857
Jewish O 0 0.013861821964383125
family O 0 0.01337018609046936
with O 0 0.011533905752003193
hereditary B-Disease 1 0.9999996423721313
non I-Disease 1 0.9999984502792358
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9778628349304199

We O 0 0.028241831809282303
describe O 0 0.02651352807879448
a O 0 0.01751355268061161
French O 0 0.022809524089097977
Canadian O 0 0.029946142807602882
hereditary B-Disease 1 0.9999879598617554
non I-Disease 1 0.9999842643737793
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9999957084655762
HNPCC B-Disease 1 1.0
) O 0 0.049448348581790924
kindred O 1 0.9980314373970032
which O 0 0.017434731125831604
carries O 0 0.025116441771388054
a O 0 0.022373178973793983
novel O 0 0.040364254266023636
truncating O 1 0.9801703691482544
mutation O 0 0.041336942464113235
in O 0 0.02862716093659401
hMLH1 O 1 0.9839339852333069
. O 0 0.05197804048657417

Interestingly O 0 0.07155337929725647
, O 0 0.025796599686145782
the O 0 0.022590085864067078
I1307K O 1 0.9965391159057617
APC O 1 0.9995467066764832
polymorphism O 0 0.03787747770547867
, O 0 0.012350671924650669
associated O 0 0.008603150956332684
with O 0 0.005568892229348421
an O 0 0.0058710407465696335
increased O 0 0.009186399169266224
risk O 1 0.9745137095451355
of O 1 0.9999691247940063
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 1 0.9749975800514221
is O 0 0.009737521409988403
also O 0 0.008186052553355694
present O 0 0.00917343981564045
in O 0 0.010930433869361877
this O 0 0.012639204040169716
family O 0 0.028797032311558723
. O 0 0.033247243613004684

The O 0 0.049578502774238586
I1307K O 1 0.8336405158042908
polymorphism O 0 0.03548429161310196
has O 0 0.01544857770204544
previously O 0 0.01477229967713356
only O 0 0.007861335761845112
been O 0 0.0073648979887366295
identified O 0 0.008072641678154469
in O 0 0.005892101675271988
individuals O 0 0.006689091678708792
of O 0 0.008947602473199368
self O 1 0.9315656423568726
- O 1 0.9996446371078491
reported O 0 0.1719864159822464
Ashkenazi O 1 0.9239857792854309
Jewish O 0 0.04040176048874855
origins O 0 0.05261765420436859
. O 0 0.049595437943935394

In O 0 0.024214643985033035
addition O 0 0.017212584614753723
, O 0 0.010737734846770763
in O 0 0.007909775711596012
this O 0 0.006976373493671417
family O 0 0.009891270659863949
, O 0 0.006758164614439011
there O 0 0.005820000544190407
appears O 0 0.008703975938260555
to O 0 0.006112952250987291
be O 0 0.005311422049999237
no O 0 0.005631007254123688
relationship O 0 0.0066481055691838264
between O 0 0.005717460066080093
the O 0 0.008702075108885765
I1307K O 1 0.6335062980651855
polymorphism O 0 0.017018191516399384
and O 0 0.007325388956815004
the O 0 0.007425883784890175
presence O 0 0.00995201338082552
or O 0 0.007892416790127754
absence O 0 0.36992326378822327
of O 1 0.8610501289367676
cancer B-Disease 1 1.0
. O 0 0.029746560379862785
. O 0 0.04303140565752983

Identification O 0 0.047737639397382736
of O 0 0.023849008604884148
a O 0 0.019037963822484016
novel O 0 0.02551235817372799
mutation O 0 0.01781058870255947
of O 0 0.012167063541710377
the O 0 0.015266568399965763
CPO O 1 0.9649673700332642
gene O 0 0.01616479642689228
in O 0 0.012267982587218285
a O 0 0.017513446509838104
Japanese O 1 0.8262380957603455
hereditary B-Disease 1 0.9999915361404419
coproporphyria I-Disease 1 0.9999346733093262
family O 0 0.15713649988174438
. O 0 0.05092746391892433

Hereditary B-Disease 1 0.9999955892562866
coproporphyria I-Disease 1 0.9999958276748657
( O 1 0.8380974531173706
HCP B-Disease 1 0.9999982118606567
) O 0 0.01575101539492607
is O 0 0.011619310826063156
an O 0 0.014903536066412926
autosomal B-Disease 1 0.9999939203262329
dominant I-Disease 1 0.9999973773956299
disease I-Disease 1 1.0
characterized O 1 0.9988470077514648
by O 0 0.015545063652098179
a O 1 0.9961662292480469
deficiency B-Disease 1 1.0
of I-Disease 1 0.9996566772460938
coproporphyrinogen I-Disease 1 1.0
oxidase I-Disease 1 0.9999961853027344
( O 1 0.640820324420929
CPO O 1 0.9998216032981873
) O 0 0.014247095212340355
caused O 0 0.01639702543616295
by O 0 0.009189638309180737
a O 0 0.013950958847999573
mutation O 0 0.01643267832696438
in O 0 0.01319102756679058
the O 0 0.0237139780074358
CPO O 1 0.9949764013290405
gene O 0 0.044863540679216385
. O 0 0.04761095717549324

Only O 0 0.02385769970715046
11 O 0 0.027292460203170776
mutations O 0 0.01689758710563183
of O 0 0.010813111439347267
the O 0 0.009677854366600513
gene O 0 0.00945490226149559
have O 0 0.006260040681809187
been O 0 0.009378128685057163
reported O 0 0.015999257564544678
in O 0 0.02318875677883625
HCP B-Disease 1 0.9999991655349731
patients O 1 0.9993857145309448
. O 0 0.05314860865473747

We O 0 0.028690118342638016
report O 0 0.024205883964896202
another O 0 0.02264336124062538
mutation O 0 0.02003777027130127
in O 0 0.01453848835080862
a O 0 0.021042881533503532
Japanese O 0 0.24695518612861633
family O 0 0.04957467317581177
. O 0 0.046823032200336456

Polymerase O 0 0.1756039708852768
chain O 0 0.06683178246021271
reaction O 0 0.03970254585146904
- O 0 0.05563189834356308
single O 0 0.025525454431772232
strand O 0 0.034866813570261
conformational O 0 0.03492705151438713
polymorphism O 0 0.028317464515566826
and O 0 0.01266796700656414
direct O 0 0.013598340563476086
sequence O 0 0.013214013539254665
analyses O 0 0.015371106564998627
demonstrated O 0 0.014149127528071404
a O 0 0.013992280699312687
C O 0 0.03500942140817642
to O 0 0.01593187265098095
T O 0 0.3152199983596802
substitution O 0 0.02082877978682518
in O 0 0.013044385239481926
exon O 0 0.0339386984705925
1 O 0 0.01646498776972294
of O 0 0.012159398756921291
the O 0 0.013277466408908367
CPO O 0 0.05848003923892975
gene O 0 0.014629912562668324
at O 0 0.013154148124158382
nucleotide O 0 0.01584545709192753
position O 0 0.01426150742918253
85 O 0 0.020359715446829796
, O 0 0.011673386208713055
which O 0 0.009360483847558498
lies O 0 0.015214547514915466
in O 0 0.00978520605713129
the O 0 0.014089793898165226
putative O 0 0.4766414761543274
presequence O 1 0.9284746646881104
for O 0 0.01711600460112095
targeting O 0 0.027061128988862038
to O 0 0.02446034923195839
mitochondria O 0 0.060176387429237366
. O 0 0.045597758144140244

This O 0 0.03260834515094757
mutation O 0 0.03143706172704697
changes O 0 0.016128074377775192
the O 0 0.016895847395062447
codon O 0 0.029979433864355087
for O 0 0.014882310293614864
glutamine O 0 0.03224554285407066
to O 0 0.012629556469619274
a O 0 0.015726057812571526
termination O 0 0.039544444531202316
codon O 0 0.03533878177404404
at O 0 0.0265029426664114
amino O 0 0.027905717492103577
acid O 0 0.03429974243044853
position O 0 0.04108984395861626
29 O 0 0.06017199903726578
. O 0 0.054010987281799316

MaeI O 0 0.3436959385871887
restriction O 0 0.03730763494968414
analysis O 0 0.02160997875034809
showed O 0 0.019755689427256584
two O 0 0.010961324907839298
other O 0 0.011234979145228863
carriers O 0 0.022565973922610283
in O 0 0.014042491093277931
the O 0 0.020468037575483322
family O 0 0.03478727862238884
. O 0 0.03846985846757889

The O 0 0.04779844358563423
C O 1 0.9996752738952637
- O 1 0.9999643564224243
T O 1 0.9999066591262817
mutation O 0 0.02198535017669201
is O 0 0.010835637338459492
located O 0 0.014264638535678387
within O 0 0.00936591811478138
a O 0 0.012137320823967457
recently O 0 0.018141843378543854
proposed O 0 0.017548302188515663
putative O 0 0.03285577893257141
alternative O 0 0.01837436482310295
translation O 0 0.019473010674118996
initiation O 0 0.028825130313634872
codon O 0 0.03232598304748535
( O 0 0.019475610926747322
TIC O 1 0.9988860487937927
- O 1 0.6229287981987
1 O 0 0.016223521903157234
) O 0 0.010153201408684254
, O 0 0.008518936112523079
supporting O 0 0.009986813180148602
that O 0 0.009184260852634907
TIC O 1 0.9999663829803467
- O 0 0.45299071073532104
1 O 0 0.01525066327303648
is O 0 0.009815419092774391
the O 0 0.011180192232131958
real O 0 0.01798221655189991
TIC O 1 0.9963247179985046
rather O 0 0.013637040741741657
than O 0 0.014118184335529804
TIC O 1 0.9999630451202393
- O 1 0.9132526516914368
2 O 0 0.034622181206941605
. O 0 0.029396532103419304
. O 0 0.04013044387102127

Human B-Disease 0 0.04247988760471344
complement I-Disease 0 0.2768023610115051
factor I-Disease 1 0.9995484948158264
H I-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 1 0.9999854564666748
with O 1 0.9999997615814209
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9999654293060303

This O 0 0.01889551617205143
study O 0 0.014467441476881504
reports O 0 0.009685274213552475
on O 0 0.007558052893728018
six O 0 0.009314319118857384
cases O 0 0.00899975374341011
of O 0 0.05649331957101822
deficiency B-Disease 1 1.0
in I-Disease 0 0.008065911941230297
the I-Disease 0 0.008404982276260853
human I-Disease 0 0.008363952860236168
complement I-Disease 0 0.016176417469978333
regulatory I-Disease 0 0.019663747400045395
protein I-Disease 0 0.018790505826473236
Factor I-Disease 1 0.6463161110877991
H I-Disease 1 0.9999887943267822
( O 0 0.021695666015148163
FH O 1 0.9998494386672974
) O 0 0.011410661041736603
in O 0 0.00821265671402216
the O 0 0.008183558471500874
context O 0 0.011815513484179974
of O 0 0.018057990819215775
an O 1 0.9999332427978516
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.999745786190033

Five O 0 0.02460901252925396
of O 0 0.015140949748456478
the O 0 0.011533502489328384
cases O 0 0.008428394794464111
were O 0 0.005887673702090979
observed O 0 0.007167157717049122
in O 0 0.0071420688182115555
children O 0 0.010009411722421646
presenting O 0 0.24386459589004517
with O 1 0.9997735619544983
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 1.0
HUS B-Disease 1 1.0
) O 1 0.9972723126411438
. O 0 0.07259848713874817

Two O 0 0.019445737823843956
of O 0 0.01421985775232315
the O 0 0.013767095282673836
children O 0 0.0160142183303833
exhibited O 1 0.7824622392654419
a O 1 0.9520981311798096
homozygous O 1 0.999994158744812
deficiency O 1 1.0
characterized O 1 0.9976077079772949
by O 0 0.008158794604241848
the O 0 0.010236743837594986
absence O 0 0.012357788160443306
of O 0 0.008173787966370583
the O 0 0.009272409602999687
150 O 0 0.016864335164427757
- O 0 0.43389803171157837
kD O 0 0.2647041082382202
form O 0 0.010537803173065186
of O 0 0.011270508170127869
Factor O 0 0.20496311783790588
H O 1 0.9988678693771362
and O 0 0.00993622187525034
the O 0 0.009991363622248173
presence O 0 0.011108285747468472
, O 0 0.010112768039107323
upon O 0 0.010726915672421455
immunoblotting O 0 0.03666245937347412
, O 0 0.00959688425064087
of O 0 0.008471397683024406
the O 0 0.010112867690622807
42 O 0 0.025381390005350113
- O 1 0.751699686050415
kD O 1 0.9990893602371216
Factor O 0 0.40475162863731384
H O 1 0.9989591836929321
- O 0 0.02635231986641884
like O 0 0.013532256707549095
protein O 0 0.014172950759530067
1 O 0 0.018361179158091545
( O 0 0.015254076570272446
FHL O 1 0.9995504021644592
- O 0 0.3939981460571289
1 O 0 0.016972623765468597
) O 0 0.009449544362723827
and O 0 0.00970518495887518
other O 0 0.010829655453562737
FH O 1 0.9999184608459473
- O 1 0.9871244430541992
related O 0 0.03720187023282051
protein O 0 0.027423493564128876
( O 0 0.028351984918117523
FHR O 1 0.9995301961898804
) O 0 0.03505069017410278
bands O 0 0.06803246587514877
. O 0 0.06049526110291481

Southern O 0 0.05628355219960213
blot O 1 0.6658141016960144
and O 0 0.020650047808885574
PCR O 0 0.03408234566450119
analysis O 0 0.011642399244010448
of O 0 0.008527232334017754
DNA O 0 0.011030270718038082
of O 0 0.008996346965432167
one O 0 0.00968022271990776
patient O 1 0.7371661067008972
with O 0 0.014380990527570248
homozygous O 1 0.998275876045227
deficiency O 1 1.0
ruled O 0 0.05606379359960556
out O 0 0.00916669424623251
the O 0 0.00752775464206934
presence O 0 0.008486221544444561
of O 0 0.006535783410072327
a O 0 0.007459309417754412
large O 0 0.006920717656612396
deletion O 0 0.01157502830028534
of O 0 0.00802481360733509
the O 0 0.012271547690033913
FH O 1 0.9999948740005493
gene O 0 0.01310337707400322
as O 0 0.010236058384180069
the O 0 0.01167712826281786
underlying O 1 0.8942393660545349
defect O 1 0.9998218417167664
for O 0 0.041973356157541275
the O 1 0.9962564706802368
deficiency O 1 1.0
. O 0 0.35049015283584595

The O 0 0.02410411648452282
other O 0 0.012224773876369
four O 0 0.012868234887719154
children O 0 0.012872735038399696
presented O 0 0.015221115201711655
with O 0 0.017467491328716278
heterozygous O 1 0.9988420605659485
deficiency O 1 1.0
and O 0 0.19393132627010345
exhibited O 1 0.8889429569244385
a O 0 0.017777809873223305
normal O 0 0.018161341547966003
immunoblotting O 1 0.6830828189849854
pattern O 0 0.02053612470626831
of O 0 0.01397821493446827
proteins O 0 0.015979668125510216
of O 0 0.01534808799624443
the O 0 0.032244469970464706
FH O 1 0.9999924898147583
family O 0 0.17581568658351898
. O 0 0.05691773071885109

Factor B-Disease 1 0.999812662601471
H I-Disease 1 0.9999997615814209
deficiency I-Disease 1 0.9999995231628418
is O 0 0.016983501613140106
the O 0 0.014736946672201157
only O 0 0.021687693893909454
complement B-Disease 1 0.999996542930603
deficiency I-Disease 1 1.0
associated O 1 0.9915379285812378
with O 1 0.974433183670044
HUS B-Disease 1 1.0
. O 0 0.253734827041626

These O 0 0.023554114624857903
observations O 0 0.02619064599275589
suggest O 0 0.015607168897986412
a O 0 0.0103409793227911
role O 0 0.012399318628013134
for O 0 0.012072294019162655
FH O 1 0.9999972581863403
and O 0 0.08193895220756531
/ O 1 0.9985477328300476
or O 0 0.018697241321206093
FH O 1 0.999963641166687
receptors O 0 0.02667718194425106
in O 0 0.014758744277060032
the O 0 0.020274020731449127
pathogenesis O 1 0.9999992847442627
of O 1 0.999748170375824
idiopathic O 1 1.0
HUS B-Disease 1 1.0
. O 1 0.7791100144386292
. O 0 0.05859622359275818

Further O 0 0.029434897005558014
evidence O 0 0.015676401555538177
for O 0 0.011777854524552822
a O 0 0.011879404075443745
major O 0 0.016829513013362885
ancient O 0 0.025218132883310318
mutation O 1 0.8350017666816711
underlying O 1 0.9999891519546509
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 1 0.978995144367218
linkage O 1 0.9999120235443115
disequilibrium O 1 0.9999862909317017
studies O 0 0.0206814706325531
in O 0 0.013628767803311348
the O 0 0.018625330179929733
Japanese O 0 0.05905158445239067
population O 0 0.025751780718564987
. O 0 0.042387351393699646

The O 1 0.989757776260376
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999938011169434
DM B-Disease 1 1.0
) O 0 0.05100559443235397
mutation O 0 0.024314790964126587
is O 0 0.010877341032028198
an O 0 0.012071008794009686
unstable O 1 0.9967554211616516
( O 0 0.03937504440546036
CTG O 1 0.9999879598617554
) O 0 0.01492741797119379
n O 0 0.020261013880372047
repeat O 0 0.01811833120882511
, O 0 0.010243737138807774
present O 0 0.008731362409889698
at O 0 0.010235974565148354
a O 0 0.009691441431641579
copy O 0 0.01419934630393982
number O 0 0.006789089646190405
of O 0 0.008240820840001106
5 O 0 0.014928539283573627
- O 0 0.021892011165618896
37 O 0 0.020116884261369705
repeats O 0 0.020273933187127113
on O 0 0.011835485696792603
normal O 0 0.015220770612359047
chromosomes O 0 0.01782137341797352
but O 0 0.010891114361584187
amplified O 0 0.022781914100050926
to O 0 0.013184240087866783
50 O 0 0.02269461564719677
- O 0 0.03501349687576294
3000 O 0 0.051440317183732986
copies O 0 0.03406880795955658
on O 0 0.03901618346571922
DM B-Disease 1 0.9999979734420776
chromosomes O 0 0.09228722006082535
. O 0 0.06391993165016174

Previous O 0 0.042164672166109085
findings O 0 0.029487553983926773
in O 0 0.018058158457279205
Caucasian O 0 0.035192254930734634
populations O 0 0.013917244970798492
of O 0 0.013420271687209606
a O 1 0.5733315944671631
DM B-Disease 1 1.0
founder O 1 0.9999758005142212
chromosome O 0 0.04353095591068268
raise O 0 0.01700807735323906
a O 0 0.011060928925871849
question O 0 0.011492656543850899
about O 0 0.007732724770903587
the O 0 0.009293156675994396
molecular O 0 0.01460365578532219
events O 0 0.010949749499559402
involved O 0 0.010440814308822155
in O 0 0.00965692289173603
the O 0 0.015364203602075577
expansion O 0 0.040913909673690796
mutation O 0 0.044164836406707764
. O 0 0.0400935523211956

To O 0 0.02736491709947586
investigate O 0 0.02591744251549244
whether O 0 0.013926605693995953
a O 0 0.016337286680936813
founder O 0 0.12016114592552185
chromosome O 0 0.01939132809638977
for O 0 0.010758298449218273
the O 0 0.04135524481534958
DM B-Disease 1 1.0
mutation O 0 0.029685208573937416
exists O 0 0.01235655602067709
in O 0 0.008806129917502403
the O 0 0.009270448237657547
Japanese O 0 0.01908470131456852
population O 0 0.010019377805292606
, O 0 0.010702447965741158
we O 0 0.013192736543715
genotyped O 0 0.03518148511648178
families O 0 0.013346334919333458
using O 0 0.012804591096937656
polymorphic O 0 0.03052513115108013
markers O 0 0.02519860677421093
near O 0 0.01882864348590374
the O 0 0.01539715938270092
( O 0 0.02007565274834633
CTG O 1 0.998364269733429
) O 0 0.02048417180776596
n O 0 0.02926386147737503
repeat O 0 0.03023722395300865
region O 0 0.023705964908003807
and O 0 0.021571090444922447
constructed O 0 0.07125838845968246
haplotypes O 0 0.2620052397251129
. O 0 0.05729259178042412

Six O 0 0.03494882211089134
different O 0 0.01588449813425541
haplotypes O 0 0.03557397797703743
were O 0 0.011737319640815258
found O 0 0.01294033695012331
and O 0 0.018986579030752182
DM B-Disease 1 1.0
alleles O 0 0.047629933804273605
were O 0 0.01585736684501171
always O 0 0.025931542739272118
haplotype O 0 0.10635362565517426
A O 0 0.05446088686585426
. O 0 0.04802341386675835

To O 0 0.023641787469387054
find O 0 0.018238995224237442
an O 0 0.010289834812283516
origin O 0 0.008263450115919113
of O 0 0.008332334458827972
the O 0 0.0102870874106884
( O 0 0.0165523923933506
CTG O 1 0.9999606609344482
) O 0 0.015127956867218018
n O 0 0.02042968012392521
repeat O 0 0.022131670266389847
mutation O 0 0.013470170088112354
and O 0 0.0067988066002726555
to O 0 0.007253105752170086
investigate O 0 0.0121409110724926
the O 0 0.008133172057569027
mechanism O 0 0.008934690617024899
of O 0 0.006359875202178955
the O 0 0.007482312154024839
expansion O 0 0.014392680488526821
mutation O 0 0.010436386801302433
in O 0 0.0072806840762495995
the O 0 0.008662790060043335
Japanese O 0 0.01536555029451847
population O 0 0.0070407455787062645
we O 0 0.006193758919835091
have O 0 0.006140206940472126
studied O 0 0.01367915514856577
90 O 0 0.018037082627415657
Japanese O 0 0.05235704034566879
DM B-Disease 1 0.9999961853027344
families O 0 0.022730465978384018
comprising O 0 0.0290299691259861
190 O 0 0.037220872938632965
affected O 0 0.020349247381091118
and O 0 0.017864419147372246
130 O 0 0.03930872306227684
unaffected O 0 0.06350365281105042
members O 0 0.03308375924825668
. O 0 0.048582255840301514

The O 0 0.026620276272296906
results O 0 0.01611507311463356
suggest O 0 0.011084718629717827
that O 0 0.0059106540866196156
a O 0 0.008646898902952671
few O 0 0.00799406599253416
common O 0 0.008502214215695858
ancestral O 0 0.036503057926893234
mutations O 0 0.01011308841407299
in O 0 0.0072018736973404884
both O 0 0.008638315834105015
Caucasian O 1 0.9522110223770142
and O 0 0.01045615691691637
Japanese O 0 0.028086695820093155
populations O 0 0.009251371957361698
have O 0 0.006347324699163437
originated O 0 0.010154061019420624
by O 0 0.006333952769637108
expansion O 0 0.012107660993933678
of O 0 0.009816017001867294
an O 0 0.01197853684425354
ancestral O 0 0.03090496174991131
n O 0 0.023923221975564957
= O 0 0.026678310707211494
5 O 0 0.017747526988387108
repeat O 0 0.020552270114421844
to O 0 0.01466626487672329
n O 0 0.025191111490130424
= O 0 0.031261101365089417
19 O 0 0.0338364876806736
- O 0 0.04571598023176193
37 O 0 0.050968535244464874
copies O 0 0.051613807678222656
. O 0 0.0499299131333828

These O 0 0.022968487814068794
data O 0 0.01941186748445034
support O 0 0.019159292802214622
multistep O 0 0.04154345020651817
models O 0 0.0237107016146183
of O 0 0.01841191202402115
triplet O 1 0.6540195941925049
repeat O 0 0.02672773227095604
expansion O 0 0.018278053030371666
that O 0 0.007267392240464687
have O 0 0.005698442924767733
been O 0 0.005285115446895361
proposed O 0 0.008319306187331676
for O 0 0.008713389746844769
both O 0 0.014290904626250267
DM B-Disease 1 1.0
and O 1 0.9805769324302673
Friedreichs B-Disease 1 0.9999997615814209
ataxia I-Disease 1 0.9999998807907104
. O 0 0.03559257090091705
. O 0 0.04829055815935135

The O 0 0.033103570342063904
molecular O 0 0.031150637194514275
basis O 0 0.019145771861076355
of O 1 0.5245302319526672
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.01784621551632881
the O 0 0.018399979919195175
western O 0 0.02433214709162712
Cape O 1 0.9602783918380737
, O 0 0.0232860017567873
South O 0 0.03729412704706192
Africa O 0 0.05436844378709793
. O 0 0.05217295140028

Deficiency B-Disease 1 0.9999821186065674
of I-Disease 0 0.024790145456790924
the I-Disease 0 0.018638478592038155
sixth I-Disease 1 0.7401148080825806
component I-Disease 0 0.03236923739314079
of I-Disease 0 0.011771184392273426
human I-Disease 0 0.011886132881045341
complement I-Disease 1 0.9634053111076355
( O 1 0.5105417966842651
C6 O 1 0.9999990463256836
) O 0 0.011445018462836742
has O 0 0.009500904008746147
been O 0 0.007505165878683329
reported O 0 0.008883186616003513
in O 0 0.00616122130304575
a O 0 0.006953831296414137
number O 0 0.006103196647018194
of O 0 0.006417771335691214
families O 0 0.007755231577903032
from O 0 0.007992023602128029
the O 0 0.011333506554365158
western O 0 0.01774917170405388
Cape O 0 0.4583795666694641
, O 0 0.020601637661457062
South O 0 0.03579704090952873
Africa O 0 0.04679746553301811
. O 0 0.048623956739902496

Meningococcal B-Disease 1 1.0
disease I-Disease 1 1.0
is O 0 0.038114968687295914
endemic O 1 0.9721994996070862
in O 0 0.010632784105837345
the O 0 0.012041519396007061
Cape O 1 0.7287953495979309
and O 0 0.008070201613008976
almost O 0 0.007236524019390345
all O 0 0.0058530536480247974
pedigrees O 0 0.01590586081147194
of O 0 0.011300534009933472
total O 1 0.9759821891784668
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 1 0.9898896217346191
C6Q0 O 1 0.9999977350234985
) O 0 0.014188630506396294
have O 0 0.009123844094574451
been O 0 0.011465278454124928
ascertained O 0 0.028445277363061905
because O 0 0.016315413638949394
of O 1 0.6437467932701111
recurrent O 1 1.0
disease O 1 1.0
. O 1 0.715503990650177

We O 0 0.028361059725284576
have O 0 0.014180775731801987
sequenced O 0 0.0234543289989233
the O 0 0.011653006076812744
expressed O 0 0.012146694585680962
exons O 0 0.018762847408652306
of O 0 0.010539299808442593
the O 0 0.01458584051579237
C6 O 1 0.9999899864196777
gene O 0 0.01283403392881155
from O 0 0.008253776468336582
selected O 0 0.011522104032337666
cases O 0 0.007512582466006279
and O 0 0.005621539894491434
have O 0 0.004212158266454935
found O 0 0.004765693563967943
three O 0 0.0056174518540501595
molecular O 0 0.015783103182911873
defects O 1 0.9885357022285461
leading O 0 0.014466195367276669
to O 0 0.0087356548756361
total O 1 0.7497332096099854
deficiency O 1 1.0
879delG O 1 0.9999778270721436
, O 0 0.010969702154397964
which O 0 0.006481728982180357
is O 0 0.006522304844111204
the O 0 0.0084729278460145
common O 0 0.0105512710288167
defect O 1 0.9799919724464417
in O 0 0.009500665590167046
the O 0 0.011052859015762806
Cape O 0 0.43793877959251404
and O 0 0.011849249713122845
hitherto O 0 0.024917716160416603
unreported O 0 0.020798787474632263
, O 0 0.010299718007445335
and O 0 0.009068476967513561
1195delC O 1 0.9413305521011353
and O 0 0.01239596214145422
1936delG O 1 0.9952418804168701
, O 0 0.010513677261769772
which O 0 0.006788208615034819
have O 0 0.005146495997905731
been O 0 0.0064923521131277084
previously O 0 0.010377065278589725
reported O 0 0.011809657327830791
in O 0 0.011583360843360424
African O 0 0.07677920162677765
- O 1 0.9586067795753479
Americans O 0 0.03551328182220459
. O 0 0.0440470315515995

We O 0 0.023541241884231567
also O 0 0.01533004641532898
show O 0 0.012555250898003578
that O 0 0.007389591541141272
the O 0 0.010001882910728455
879delG O 1 0.9876483678817749
and O 0 0.01714039221405983
1195delC O 1 0.9999685287475586
defects O 1 0.9994590878486633
are O 0 0.006133262533694506
associated O 0 0.009507638402283192
with O 0 0.011996143497526646
characteristic O 1 0.9985790252685547
C6 O 1 1.0
/ O 1 0.9999955892562866
C7 O 1 0.9999938011169434
region O 0 0.02973482385277748
DNA O 0 0.0273439921438694
marker O 0 0.40067487955093384
haplotypes O 0 0.04483221843838692
, O 0 0.015549558214843273
although O 0 0.01416393369436264
small O 0 0.014634567312896252
variations O 0 0.017791593447327614
were O 0 0.017385313287377357
observed O 0 0.02994254231452942
. O 0 0.0411512590944767

The O 0 0.044818416237831116
1936delG O 1 0.9996849298477173
defect O 1 0.9992247819900513
was O 0 0.021022304892539978
observed O 0 0.011836109682917595
only O 0 0.007605124730616808
once O 0 0.009752687066793442
in O 0 0.0067485300824046135
the O 0 0.00853648129850626
Cape O 0 0.047107331454753876
, O 0 0.00866714771836996
but O 0 0.006877833977341652
its O 0 0.009078784845769405
associated O 0 0.012747155502438545
haplotype O 0 0.03895365819334984
could O 0 0.01558712124824524
be O 0 0.01723634824156761
deduced O 0 0.05068545415997505
. O 0 0.04418183118104935

The O 0 0.02749701961874962
data O 0 0.01656903512775898
from O 0 0.011402972042560577
the O 0 0.012953146360814571
haplotypes O 0 0.025440681725740433
indicate O 0 0.009940696880221367
that O 0 0.005908760242164135
these O 0 0.005609685089439154
three O 0 0.008095480501651764
molecular O 0 0.018015161156654358
defects O 0 0.2087327092885971
account O 0 0.009480522014200687
for O 0 0.008090022020041943
the O 0 0.010716204531490803
defects O 1 0.9964938759803772
in O 0 0.0067421793937683105
all O 0 0.006643396336585283
the O 0 0.01009704265743494
38 O 0 0.022632529959082603
unrelated O 0 0.03752746433019638
C6Q0 O 1 0.9984764456748962
individuals O 0 0.010340822860598564
we O 0 0.009865117259323597
have O 0 0.008951514959335327
studied O 0 0.017096228897571564
from O 0 0.014156466349959373
the O 0 0.024940120056271553
Cape O 0 0.196444571018219
. O 0 0.04537288844585419

We O 0 0.025319423526525497
have O 0 0.012465673498809338
also O 0 0.01143310684710741
observed O 0 0.012281931936740875
the O 0 0.012963526882231236
879delG O 1 0.902072548866272
defect O 0 0.3225480020046234
in O 0 0.01167941652238369
two O 0 0.012168038636446
Dutch O 1 0.9976679682731628
C6 B-Disease 1 1.0
- I-Disease 1 0.9999966621398926
deficient I-Disease 1 0.999995231628418
kindreds O 1 0.9838091135025024
, O 0 0.01274384930729866
but O 0 0.009095702320337296
the O 0 0.012986390851438046
879delG O 1 0.9988105297088623
defect O 1 0.9922658801078796
in O 0 0.01020986307412386
the O 0 0.012497718445956707
Cape O 1 0.9870865345001221
probably O 0 0.013043009676039219
did O 0 0.008345283567905426
not O 0 0.006405532360076904
come O 0 0.009310474619269371
from O 0 0.00955800898373127
The O 0 0.015459488146007061
Netherlands O 0 0.03520817309617996
. O 0 0.021477699279785156
. O 0 0.035183463245630264

Complement B-Disease 1 0.9999561309814453
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 0.02878943830728531
seven O 0 0.020925186574459076
further O 0 0.01992853172123432
molecular O 0 0.31435444951057434
defects O 1 0.9985241293907166
and O 0 0.015425196848809719
their O 0 0.016323797404766083
associated O 0 0.036498166620731354
marker O 1 0.9856999516487122
haplotypes O 0 0.4598631262779236
. O 0 0.06500018388032913

Seven O 0 0.03602733090519905
further O 0 0.025671586394309998
molecular O 0 0.03224371373653412
bases O 0 0.04277461767196655
of O 1 0.9895560145378113
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 0.030206086114048958
described O 0 0.06529587507247925
. O 0 0.05513964593410492

All O 0 0.024530841037631035
these O 0 0.015632476657629013
new O 0 0.020211236551404
molecular O 0 0.030954664573073387
defects O 1 0.9700521230697632
involve O 0 0.01838974468410015
single O 0 0.018642710521817207
- O 0 0.13809439539909363
nucleotide O 0 0.02201749011874199
events O 0 0.017150726169347763
, O 0 0.013883988372981548
deletions O 0 0.02391534298658371
and O 0 0.010539179667830467
substitutions O 0 0.019704384729266167
, O 0 0.009626693092286587
some O 0 0.007458207197487354
of O 0 0.009896521456539631
which O 0 0.011062568053603172
alter O 0 0.021282818168401718
splice O 0 0.03690572828054428
sites O 0 0.019006982445716858
, O 0 0.017380379140377045
and O 0 0.018554121255874634
others O 0 0.024391818791627884
codons O 0 0.059210628271102905
. O 0 0.04310845956206322

They O 0 0.017792319878935814
are O 0 0.009027916006743908
distributed O 0 0.013211476616561413
along O 0 0.012418379075825214
the O 0 0.015100543387234211
C7 O 1 0.9999994039535522
gene O 0 0.017096685245633125
, O 0 0.011959655210375786
but O 0 0.009132486768066883
predominantly O 0 0.01170265767723322
towards O 0 0.015995189547538757
the O 0 0.0181801225990057
3 O 0 0.03036872297525406
end O 0 0.03547468036413193
. O 0 0.04452836513519287

All O 0 0.02698671445250511
were O 0 0.016627121716737747
found O 0 0.01558267418295145
in O 0 0.018326858058571815
compound O 0 0.04071802273392677
heterozygous O 0 0.044945064932107925
individuals O 0 0.027602655813097954
. O 0 0.04074665158987045

The O 0 0.07758451998233795
C6 O 1 0.9999982118606567
/ O 1 0.9999382495880127
C7 O 1 0.9999978542327881
marker O 1 0.9220702648162842
haplotypes O 0 0.08451244980096817
associated O 0 0.02154882624745369
with O 0 0.018596427515149117
most O 0 0.09635048359632492
C7 B-Disease 1 1.0
defects I-Disease 1 0.9999773502349854
are O 0 0.01745581068098545
tabulated O 0 0.03852259740233421
. O 0 0.029523171484470367
. O 0 0.04136211797595024

A O 0 0.047857824712991714
genome O 0 0.04196798801422119
- O 0 0.029540250077843666
wide O 0 0.018555210903286934
search O 0 0.016388485208153725
for O 0 0.013022389262914658
chromosomal O 0 0.03429865092039108
loci O 0 0.022354787215590477
linked O 0 0.018818184733390808
to O 0 0.012613482773303986
mental O 1 0.999998927116394
health O 1 0.9999953508377075
wellness O 1 0.9999980926513672
in O 0 0.010492461733520031
relatives O 0 0.016109222546219826
at O 0 0.01231202483177185
high O 0 0.036107443273067474
risk O 1 0.9568418860435486
for O 1 0.9876978993415833
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
among O 1 0.870398998260498
the O 1 0.5536211133003235
Old O 1 0.9429489970207214
Order O 0 0.044671107083559036
Amish O 0 0.25329914689064026
. O 0 0.052486851811409

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 0.99962317943573
BPAD B-Disease 1 1.0
; O 1 0.999980092048645
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 1 0.5681726932525635
is O 0 0.012671753764152527
characterized O 0 0.016179393976926804
by O 0 0.007936538197100163
episodes O 0 0.015026154927909374
of O 0 0.017902014777064323
mania B-Disease 1 0.9999998807907104
and O 1 0.7089073061943054
/ O 1 0.9998849630355835
or O 0 0.06953113526105881
hypomania B-Disease 1 0.9999994039535522
interspersed O 0 0.05016916245222092
with O 0 0.014181495644152164
periods O 0 0.04088404029607773
of O 0 0.288545161485672
depression B-Disease 1 0.9999996423721313
. O 0 0.07435453683137894

Compelling O 0 0.05173372104763985
evidence O 0 0.024254554882645607
supports O 0 0.019617771729826927
a O 0 0.013357071205973625
significant O 0 0.013302747160196304
genetic O 0 0.01666460931301117
component O 0 0.022877367213368416
in O 0 0.011091756634414196
the O 0 0.0158474650233984
susceptibility O 1 0.9881722331047058
to O 0 0.023973539471626282
develop O 1 0.9019788503646851
BPAD B-Disease 1 0.9999881982803345
. O 0 0.058421868830919266

To O 0 0.024103863164782524
date O 0 0.021115245297551155
, O 0 0.013174125924706459
however O 0 0.009958509355783463
, O 0 0.010942584834992886
linkage O 0 0.018708810210227966
studies O 0 0.009687218815088272
have O 0 0.006262541748583317
attempted O 0 0.012366277165710926
only O 0 0.005948688369244337
to O 0 0.007900785654783249
identify O 0 0.012845758348703384
chromosomal O 0 0.026729300618171692
loci O 0 0.014077664352953434
that O 0 0.006964827422052622
cause O 0 0.03805827721953392
or O 0 0.0064528947696089745
increase O 0 0.008144884370267391
the O 0 0.012172137387096882
risk O 0 0.25070860981941223
of O 0 0.023699970915913582
developing O 1 0.9709737300872803
BPAD B-Disease 1 0.9999972581863403
. O 0 0.06295263022184372

To O 0 0.023634979501366615
determine O 0 0.016192946583032608
whether O 0 0.011171202175319195
there O 0 0.00894838571548462
could O 0 0.008301971480250359
be O 0 0.008014881983399391
protective O 1 0.7767153978347778
alleles O 0 0.014690396375954151
that O 0 0.006793097127228975
prevent O 0 0.010021270252764225
or O 0 0.007067705970257521
reduce O 0 0.010420000180602074
the O 0 0.007576985750347376
risk O 0 0.013859658502042294
of O 0 0.009920182637870312
developing O 1 0.9608628153800964
BPAD B-Disease 1 0.9999996423721313
, O 0 0.010407818481326103
similar O 0 0.007460918743163347
to O 0 0.006127811968326569
what O 0 0.005407712887972593
is O 0 0.00496521033346653
observed O 0 0.005512171890586615
in O 0 0.0049142492935061455
other O 0 0.006088716443628073
genetic B-Disease 1 0.9961345195770264
disorders I-Disease 1 1.0
, O 0 0.008569168858230114
we O 0 0.006273126695305109
used O 0 0.009238422848284245
mental O 1 0.9999994039535522
health O 1 0.9999995231628418
wellness O 1 0.9999998807907104
( O 0 0.015051533468067646
absence O 0 0.034454815089702606
of O 0 0.016933368518948555
any O 1 0.5508025884628296
psychiatric B-Disease 1 1.0
disorder I-Disease 1 1.0
) O 0 0.02863655425608158
as O 0 0.009585036896169186
the O 0 0.011161983013153076
phenotype O 0 0.031107449904084206
in O 0 0.008395517244935036
our O 0 0.011257557198405266
genome O 0 0.01949252374470234
- O 0 0.03302117437124252
wide O 0 0.01614518277347088
linkage O 0 0.02623085118830204
scan O 0 0.024405023083090782
of O 0 0.010892022401094437
several O 0 0.00948856770992279
large O 0 0.013476203195750713
multigeneration O 0 0.39763033390045166
Old O 0 0.024876892566680908
Order O 0 0.020121516659855843
Amish O 0 0.04132195562124252
pedigrees O 0 0.03627706691622734
exhibiting O 0 0.027494383975863457
an O 0 0.014374489895999432
extremely O 0 0.029398193582892418
high O 1 0.5411553382873535
incidence O 1 0.9990678429603577
of O 1 0.5296618938446045
BPAD B-Disease 1 0.9999992847442627
. O 0 0.059660978615283966

We O 0 0.02611054666340351
have O 0 0.012285975739359856
found O 0 0.011352745816111565
strong O 0 0.01188656035810709
evidence O 0 0.00959243904799223
for O 0 0.008979128673672676
a O 0 0.01448807679116726
locus O 0 0.033333875238895416
on O 0 0.01552677247673273
chromosome O 0 0.032687511295080185
4p O 1 0.9990655779838562
at O 0 0.026970162987709045
D4S2949 O 0 0.09442844986915588
( O 0 0.021726001054048538
maximum O 0 0.03148737922310829
GENEHUNTER O 1 0.9858278036117554
- O 0 0.05392396077513695
PLUS O 0 0.04171726480126381
nonparametric O 0 0.05441288277506828
linkage O 0 0.03377199545502663
score O 0 0.023435410112142563
= O 0 0.025165023282170296
4 O 0 0.018250269815325737
. O 0 0.012050656601786613
05 O 0 0.067012257874012
, O 0 0.015949036926031113
P O 0 0.03055969811975956
= O 0 0.019891414791345596
5 O 0 0.013260597363114357
. O 0 0.007674969732761383
22 O 0 0.011600293219089508
x O 0 0.015168235637247562
10 O 0 0.011307279579341412
( O 0 0.010368102230131626
- O 0 0.025373026728630066
4 O 0 0.01578177511692047
) O 0 0.011882180348038673
; O 0 0.013503078371286392
SIBPAL O 1 0.6828470826148987
Pempirical O 0 0.04753132537007332
value O 0 0.015223531983792782
< O 0 0.028296183794736862
3 O 0 0.016643790528178215
x O 0 0.019938485696911812
10 O 0 0.01412997767329216
( O 0 0.013447264209389687
- O 0 0.025111796334385872
5 O 0 0.016074741259217262
) O 0 0.01160950306802988
) O 0 0.01093936525285244
and O 0 0.010956310667097569
suggestive O 0 0.017566831782460213
evidence O 0 0.0078183114528656
for O 0 0.00793186854571104
a O 0 0.01276681199669838
locus O 0 0.03460598364472389
on O 0 0.01652449369430542
chromosome O 0 0.030992327257990837
4q O 1 0.9957165122032166
at O 0 0.023794466629624367
D4S397 O 0 0.07589679956436157
( O 0 0.018000727519392967
maximum O 0 0.02691337838768959
GENEHUNTER O 1 0.9942271709442139
- O 0 0.07379147410392761
PLUS O 0 0.03200801834464073
nonparametric O 0 0.04395410418510437
linkage O 0 0.029198624193668365
score O 0 0.019512396305799484
= O 0 0.023221300914883614
3 O 0 0.013193362392485142
. O 0 0.008191755972802639
29 O 0 0.013896046206355095
, O 0 0.01151076890528202
P O 0 0.026572445407509804
= O 0 0.018879473209381104
2 O 0 0.014319103211164474
. O 0 0.009078141301870346
57 O 0 0.019092969596385956
x O 0 0.02006573975086212
10 O 0 0.015556459315121174
( O 0 0.013801184482872486
- O 0 0.02779616415500641
3 O 0 0.020120248198509216
) O 0 0.016324445605278015
; O 0 0.018547311425209045
SIBPAL O 0 0.0854354128241539
Pempirical O 0 0.047868870198726654
value O 0 0.01655295304954052
< O 0 0.03139779716730118
1 O 0 0.01575450599193573
x O 0 0.017971469089388847
10 O 0 0.013209208846092224
( O 0 0.01158581767231226
- O 0 0.08001438528299332
3 O 0 0.013200826942920685
) O 0 0.008791432715952396
) O 0 0.007251289673149586
that O 0 0.005262696649879217
are O 0 0.005512346979230642
linked O 0 0.012471293099224567
to O 0 0.01621255837380886
mental O 1 0.9999997615814209
health O 1 0.9999997615814209
wellness O 1 0.9999998807907104
. O 0 0.13788791000843048

These O 0 0.022356901317834854
findings O 0 0.018945258110761642
are O 0 0.007514043245464563
consistent O 0 0.01094263605773449
with O 0 0.0070490045472979546
the O 0 0.008402841165661812
hypothesis O 0 0.012170949950814247
that O 0 0.006127991713583469
certain O 0 0.007150963414460421
alleles O 0 0.010744402185082436
could O 0 0.006925642024725676
prevent O 0 0.00866453442722559
or O 0 0.00730754341930151
modify O 0 0.012967498041689396
the O 0 0.010244984179735184
clinical O 1 0.990153968334198
manifestations O 1 0.9856142401695251
of O 1 0.5706911683082581
BPAD B-Disease 1 0.9999998807907104
and O 0 0.02204165793955326
perhaps O 0 0.0420311763882637
other O 0 0.01653345674276352
related O 1 0.9973214268684387
affective B-Disease 1 1.0
disorders I-Disease 1 1.0
. O 1 0.5856128931045532

Segregation O 1 0.9742854237556458
distortion O 1 0.9985272884368896
in O 1 0.9704058170318604
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.823150634765625

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999814033508301
DM B-Disease 1 1.0
) O 0 0.020129887387156487
is O 0 0.012019677087664604
an O 0 0.020145969465374947
autosomal B-Disease 1 0.9999994039535522
dominant I-Disease 1 0.9999997615814209
disease I-Disease 1 1.0
which O 0 0.017487095668911934
, O 0 0.008586208336055279
in O 0 0.008390424773097038
the O 0 0.011479711160063744
typical O 0 0.021356547251343727
pedigree O 0 0.05294845625758171
, O 0 0.011430127546191216
shows O 0 0.0124189592897892
a O 0 0.015102466568350792
three O 0 0.016771763563156128
generation O 0 0.06910789757966995
anticipation O 0 0.13689082860946655
cascade O 1 0.6714552640914917
. O 0 0.06500851362943649

This O 0 0.021403176710009575
results O 0 0.019050756469368935
in O 0 0.019095826894044876
infertility B-Disease 1 0.9999998807907104
and O 1 0.9999966621398926
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999992847442627
CDM B-Disease 1 0.9999998807907104
) O 0 0.017777416855096817
with O 0 0.0124900471419096
the O 0 0.01353761088103056
disappearance O 0 0.02854849398136139
of O 0 0.05093438923358917
DM B-Disease 1 1.0
in O 0 0.02738226391375065
that O 0 0.025015784427523613
pedigree O 0 0.3165845572948456
. O 0 0.046498656272888184

The O 0 0.029820790514349937
concept O 0 0.02809135615825653
of O 0 0.01890305057168007
segregation O 1 0.9134716987609863
distortion O 1 0.9934839606285095
, O 0 0.012515113689005375
where O 0 0.009610850363969803
there O 0 0.007258872501552105
is O 0 0.008456699550151825
preferential O 0 0.015426211059093475
transmission O 0 0.013045649975538254
of O 0 0.007869116961956024
the O 0 0.008764506317675114
larger O 0 0.010719500482082367
allele O 0 0.01574629917740822
at O 0 0.012432065792381763
the O 0 0.016118066385388374
DM B-Disease 1 1.0
locus O 1 0.9765008687973022
, O 0 0.012547922320663929
has O 0 0.009356358088552952
been O 0 0.00750993425026536
put O 0 0.010922003537416458
forward O 0 0.010470646433532238
to O 0 0.0077787223272025585
explain O 0 0.013048535212874413
partially O 0 0.014204560779035091
the O 0 0.011005217209458351
maintenance O 1 0.7493016719818115
of O 0 0.0873536542057991
DM B-Disease 1 1.0
in O 0 0.01896240934729576
the O 0 0.02140631712973118
population O 0 0.022159116342663765
. O 0 0.03846890851855278

In O 0 0.02726932428777218
a O 0 0.021870559081435204
survey O 0 0.024337857961654663
of O 0 0.023308733478188515
DM B-Disease 1 1.0
in O 0 0.017611902207136154
Northern O 0 0.023428665474057198
Ireland O 0 0.024248085916042328
, O 0 0.02066841907799244
59 O 0 0.03997056931257248
pedigrees O 0 0.04810214787721634
were O 0 0.02748599275946617
ascertained O 0 0.07367222011089325
. O 0 0.05208117887377739

Sibships O 0 0.41588354110717773
where O 0 0.02208665944635868
the O 0 0.014307626523077488
status O 0 0.012284940108656883
of O 0 0.008611956611275673
all O 0 0.00564664276316762
the O 0 0.0066359336487948895
members O 0 0.0062547712586820126
had O 0 0.006737728603184223
been O 0 0.005817846395075321
identified O 0 0.006083827931433916
were O 0 0.004895114805549383
examined O 0 0.008632081560790539
to O 0 0.005862269550561905
determine O 0 0.006942753214389086
the O 0 0.006975939963012934
transmission O 0 0.011921334080398083
of O 0 0.008745657280087471
the O 0 0.020757272839546204
DM B-Disease 1 1.0
expansion O 0 0.21320627629756927
from O 0 0.013843205757439137
affected O 0 0.017028944566845894
parents O 0 0.016379782930016518
to O 0 0.014895969070494175
their O 0 0.020123107358813286
offspring O 0 0.046834345906972885
. O 0 0.04922676458954811

Where O 0 0.03313976898789406
the O 0 0.02542305551469326
transmitting O 1 0.676200270652771
parent O 1 0.5162057876586914
was O 0 0.03182724863290787
male O 0 0.030219467356801033
, O 0 0.024896737188100815
58 O 0 0.053486768156290054
. O 0 0.04102695360779762

3 O 0 0.03368772938847542
% O 0 0.016141124069690704
of O 0 0.011341843754053116
the O 0 0.010716735385358334
offspring O 0 0.014955905266106129
were O 0 0.007227814290672541
affected O 0 0.00974579993635416
, O 0 0.0073462435975670815
and O 0 0.006381139159202576
in O 0 0.005585166625678539
the O 0 0.007463631685823202
case O 0 0.00940248928964138
of O 0 0.008063692599534988
a O 0 0.012123938649892807
female O 0 0.04969395324587822
transmitting O 1 0.9056227803230286
parent O 0 0.3234690725803375
, O 0 0.0250584464520216
68 O 0 0.059233102947473526
. O 0 0.05198962613940239

7 O 0 0.06909569352865219
% O 0 0.04209813103079796
were O 0 0.03258820250630379
affected O 0 0.04821651428937912
. O 0 0.0534239262342453

Studies O 0 0.035295289009809494
on O 0 0.02828846499323845
meiotic O 1 0.9759975075721741
drive O 0 0.035239558666944504
in O 0 0.02131113037467003
DM B-Disease 1 1.0
have O 0 0.01154050137847662
shown O 0 0.011623375117778778
increased O 0 0.012788429856300354
transmission O 0 0.014902723953127861
of O 0 0.008383615873754025
the O 0 0.009853130206465721
larger O 0 0.012034584768116474
allele O 0 0.019385917112231255
at O 0 0.014046857133507729
the O 0 0.017689291387796402
DM B-Disease 1 1.0
locus O 0 0.4519767463207245
in O 0 0.018393496051430702
non O 1 0.7329262495040894
- O 1 0.9999897480010986
DM O 1 1.0
heterozygotes O 1 0.9994606375694275
for O 0 0.048166971653699875
CTGn O 1 0.9851465821266174
. O 0 0.07375014573335648

This O 0 0.022970475256443024
study O 0 0.020555734634399414
provides O 0 0.015751400962471962
further O 0 0.010369262658059597
evidence O 0 0.008763759396970272
that O 0 0.007439251523464918
the O 0 0.017703207209706306
DM B-Disease 1 1.0
expansion O 1 0.9027437567710876
tends O 0 0.03575999662280083
to O 0 0.021554961800575256
be O 0 0.02635372430086136
transmitted O 0 0.055623650550842285
preferentially O 0 0.08621793240308762
. O 0 0.06429000943899155

Diagnosis O 1 0.9999662637710571
of O 1 0.9032129049301147
hemochromatosis B-Disease 1 0.9999998807907104
. O 0 0.3281354606151581

If O 0 0.0374312549829483
untreated O 1 0.9999710321426392
, O 1 0.9229074120521545
hemochromatosis B-Disease 1 1.0
can O 0 0.4335954785346985
cause O 1 0.9999977350234985
serious O 1 0.9999998807907104
illness O 1 1.0
and O 1 0.7448744773864746
early B-Disease 0 0.28544706106185913
death I-Disease 1 0.9141982197761536
, O 0 0.007452455814927816
but O 0 0.006581893656402826
the O 0 0.052518706768751144
disease O 1 0.9999935626983643
is O 0 0.008208094164729118
still O 0 0.011269950307905674
substantially O 0 0.03159581124782562
under O 1 0.9673857092857361
- O 1 0.9999970197677612
diagnosed O 1 0.9999998807907104
. O 0 0.05401526391506195

The O 0 0.03807057440280914
cornerstone O 1 0.9578086733818054
of O 0 0.023613927885890007
screening O 0 0.06392060965299606
and O 0 0.014081290923058987
case O 0 0.015219700522720814
detection O 0 0.020149460062384605
is O 0 0.008957160636782646
the O 0 0.011086830869317055
measurement O 0 0.019816478714346886
of O 0 0.01682714745402336
serum O 1 0.9986758828163147
transferrin O 1 0.9992522597312927
saturation O 1 0.5388264656066895
and O 0 0.02488013543188572
the O 0 0.03423546999692917
serum O 1 0.9998444318771362
ferritin O 1 0.9995737671852112
level O 0 0.055489227175712585
. O 0 0.06089809909462929

Once O 0 0.0376482792198658
the O 0 0.025866873562335968
diagnosis O 1 0.9995637536048889
is O 0 0.013659711927175522
suspected O 0 0.02261991985142231
, O 0 0.012080804444849491
physicians O 0 0.15644024312496185
must O 0 0.00995180755853653
use O 0 0.012142342515289783
serum O 1 0.9995504021644592
ferritin O 1 0.9996234178543091
levels O 0 0.017069533467292786
and O 0 0.020804645493626595
hepatic O 1 0.9999992847442627
iron O 1 0.9999840259552002
stores O 0 0.07121717184782028
on O 0 0.020913641899824142
liver O 1 0.999998927116394
biopsy O 1 0.9986544847488403
specimens O 0 0.016599541530013084
to O 0 0.010979539714753628
assess O 0 0.019386600703001022
patients O 0 0.026951827108860016
for O 0 0.008994570933282375
the O 0 0.01187594048678875
presence O 0 0.020564261823892593
of O 0 0.11388516426086426
iron B-Disease 1 0.999998927116394
overload I-Disease 1 0.9999978542327881
. O 0 0.06300131231546402

Liver O 1 0.9999998807907104
biopsy O 1 0.9999507665634155
is O 0 0.016337769106030464
also O 0 0.01115570031106472
used O 0 0.006849850062280893
to O 0 0.006939284969121218
establish O 0 0.009801464155316353
the O 0 0.007467676419764757
presence O 0 0.008778486400842667
or O 0 0.007414347026497126
absence O 0 0.014248501509428024
of O 0 0.11581705510616302
cirrhosis B-Disease 1 1.0
, O 0 0.02366063743829727
which O 0 0.00820781011134386
can O 0 0.009873206727206707
affect O 0 0.022191520780324936
prognosis O 1 0.9999970197677612
and O 0 0.031512949615716934
management O 1 0.8631595373153687
. O 0 0.044045716524124146

A O 0 0.038827937096357346
DNA O 0 0.030669428408145905
- O 0 0.026707151904702187
based O 0 0.01153171993792057
test O 0 0.012515786103904247
for O 0 0.009000054560601711
the O 0 0.01374763436615467
HFE O 1 0.9999923706054688
gene O 0 0.01401515118777752
is O 0 0.009464401751756668
commercially O 0 0.01387797761708498
available O 0 0.009694535285234451
, O 0 0.006793122738599777
but O 0 0.005111727863550186
its O 0 0.005679507739841938
place O 0 0.006865558680146933
in O 0 0.006710448767989874
the O 0 0.009679147973656654
diagnosis O 1 0.9999676942825317
of O 1 0.931893527507782
hemochromatosis B-Disease 1 1.0
is O 0 0.19241741299629211
still O 0 0.02356824092566967
being O 0 0.023775406181812286
evaluated O 0 0.04879724234342575
. O 0 0.04469610005617142

Currently O 0 0.03323615342378616
, O 0 0.01747799478471279
the O 0 0.011880407109856606
most O 0 0.009656872600317001
useful O 0 0.010128605179488659
role O 0 0.009271117858588696
for O 0 0.006258056033402681
this O 0 0.00600785156711936
test O 0 0.009473784826695919
is O 0 0.006267543416470289
in O 0 0.005973791237920523
the O 0 0.008267762139439583
detection O 0 0.018718047067523003
of O 0 0.014167656190693378
hemochromatosis B-Disease 1 0.9999997615814209
in O 0 0.009735588915646076
the O 0 0.010072675533592701
family O 0 0.010911263525485992
members O 0 0.007627223618328571
of O 0 0.00967127550393343
patients O 1 0.6289221048355103
with O 0 0.00701754167675972
a O 0 0.011390013620257378
proven O 0 0.03669450432062149
case O 0 0.014029063284397125
of O 0 0.015826372429728508
the O 1 0.5901767611503601
disease O 1 0.999998927116394
. O 0 0.04658982902765274

It O 0 0.02425190433859825
is O 0 0.0158658679574728
crucial O 0 0.020759377628564835
to O 0 0.01878029853105545
diagnose O 1 1.0
hemochromatosis B-Disease 1 1.0
before O 1 0.9999829530715942
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 1 0.9999998807907104
because O 1 0.9865198135375977
phlebotomy O 1 1.0
therapy O 1 0.9999985694885254
can O 0 0.03284786269068718
avert O 1 0.9999998807907104
serious O 1 1.0
chronic O 1 1.0
disease O 1 1.0
and O 1 0.9985144734382629
can O 0 0.008616739884018898
even O 0 0.008046502247452736
lead O 0 0.009504077024757862
to O 0 0.009611611254513264
normal O 0 0.014533312059938908
life O 0 0.023084593936800957
expectancy O 1 0.7707437872886658
. O 0 0.022179383784532547
. O 0 0.03501301631331444

Prevalence O 0 0.3923228681087494
of O 0 0.027521297335624695
the O 0 0.027176175266504288
I1307K O 1 0.9998021721839905
APC B-Disease 1 0.9999598264694214
gene O 0 0.025653420016169548
variant O 0 0.024893565103411674
in O 0 0.011646597646176815
Israeli O 0 0.015467249788343906
Jews O 0 0.014118012972176075
of O 0 0.008947578258812428
differing O 0 0.00924749206751585
ethnic O 0 0.008440572768449783
origin O 0 0.0091122817248106
and O 0 0.013330597430467606
risk O 1 0.9992431402206421
for O 1 0.9999758005142212
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.8907991051673889

BACKGROUND O 0 0.06910326331853867
& O 0 0.2369830310344696
AIMS O 0 0.041286222636699677
Israeli O 0 0.018881501629948616
Jews O 0 0.013149228878319263
of O 0 0.009187953546643257
European O 0 0.01223736722022295
birth O 0 0.17303457856178284
, O 0 0.009112698957324028
i O 0 0.010772284120321274
. O 0 0.0076833488419651985
e O 0 0.013055747374892235
. O 0 0.007023993879556656
, O 0 0.008766595274209976
Ashkenazim O 0 0.02044066973030567
, O 0 0.006253310013562441
have O 0 0.005540887359529734
the O 0 0.011629808694124222
highest O 1 0.9999978542327881
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 1 0.9999964237213135
of O 0 0.0153164342045784
any O 0 0.011460274457931519
Israeli O 0 0.02103130705654621
ethnic O 0 0.0207535233348608
group O 0 0.03337618336081505
. O 0 0.038354527205228806

The O 0 0.0541648343205452
I1307K O 1 0.9957848191261292
APC B-Disease 1 0.9997572302818298
gene O 0 0.03573618084192276
variant O 0 0.0596717931330204
was O 0 0.023363811895251274
found O 0 0.01631103828549385
in O 0 0.017810743302106857
6 O 0 0.040818605571985245
. O 0 0.04621356353163719

1 O 0 0.03433747962117195
% O 0 0.018064728006720543
of O 0 0.01102463435381651
American O 0 0.014763112179934978
Jews O 0 0.013422899879515171
, O 0 0.008072447031736374
28 O 0 0.011224971152842045
% O 0 0.0071834418922662735
of O 0 0.008299507200717926
their O 0 0.012903248891234398
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 1 0.9992978572845459
, O 0 0.029196722432971
but O 0 0.006041491404175758
not O 0 0.005536461714655161
in O 0 0.009815395809710026
non O 0 0.024787332862615585
- O 1 0.928549587726593
Jews O 0 0.0353100560605526
. O 0 0.04091543331742287

We O 0 0.026462949812412262
assessed O 0 0.026079600676894188
the O 0 0.020043522119522095
I1307K O 1 0.9792885184288025
prevalence O 1 0.5200194120407104
in O 0 0.010730644688010216
Israeli O 0 0.01284168940037489
Jews O 0 0.01007351465523243
of O 0 0.008012394420802593
differing O 0 0.008485768921673298
ethnic O 0 0.007483255118131638
origin O 0 0.008224891498684883
and O 0 0.012157702818512917
risk O 1 0.999232292175293
for O 1 0.999950647354126
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.8938735127449036

METHODS O 0 0.04436453804373741
DNA O 0 0.027626343071460724
samples O 0 0.01802898570895195
from O 0 0.0130286430940032
500 O 0 0.021524691954255104
unrelated O 0 0.016383428126573563
Jews O 0 0.011290916241705418
of O 0 0.008243611082434654
European O 0 0.009998379275202751
or O 0 0.00796051137149334
non O 0 0.013066288083791733
- O 0 0.08568495512008667
European O 0 0.009468269534409046
origin O 0 0.007415337022393942
, O 0 0.0062730140052735806
with O 0 0.005739088170230389
or O 0 0.004866807721555233
without O 0 0.005300948861986399
a O 0 0.007182755507528782
personal O 0 0.05998295173048973
and O 0 0.00970726553350687
/ O 1 0.7627301216125488
or O 0 0.007824351079761982
family O 0 0.009280105121433735
history O 0 0.01001383550465107
of O 0 0.017385566607117653
neoplasia B-Disease 1 0.9999992847442627
, O 0 0.009856550954282284
were O 0 0.007299899123609066
examined O 0 0.01085937861353159
for O 0 0.007777238264679909
the O 0 0.010455721989274025
I1307K O 1 0.5863351821899414
variant O 0 0.018547501415014267
by O 0 0.008978203870356083
the O 0 0.012937979772686958
allele O 0 0.024111097678542137
- O 0 0.04636824131011963
specific O 0 0.016555724665522575
oligonucleotide O 1 0.9528424739837646
( O 0 0.03656493127346039
ASO O 1 0.9999650716781616
) O 0 0.03586352616548538
method O 0 0.04109484329819679
. O 0 0.046104587614536285

RESULTS O 0 0.030474821105599403
In O 0 0.01423701923340559
persons O 0 0.010998763144016266
at O 0 0.012099940329790115
average O 0 0.013960856013000011
risk O 0 0.06795848160982132
for O 1 0.979112982749939
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 1 0.975716769695282
I1307K O 1 0.9998416900634766
was O 0 0.023046335205435753
found O 0 0.012834419496357441
in O 0 0.017485883086919785
5 O 0 0.034590933471918106
. O 0 0.036187876015901566

0 O 0 0.05371655523777008
% O 0 0.02661774307489395
of O 0 0.018533270806074142
120 O 0 0.03019585646688938
European O 0 0.027402102947235107
and O 0 0.025204285979270935
1 O 0 0.04425128921866417
. O 0 0.04879520833492279

6 O 0 0.05149073898792267
% O 0 0.022554194554686546
of O 0 0.017746346071362495
188 O 0 0.0342036709189415
non O 0 0.022905830293893814
- O 0 0.031745992600917816
European O 0 0.01819632761180401
Jews O 0 0.019510557875037193
( O 0 0.02047392539680004
P O 0 0.20557084679603577
= O 0 0.037097398191690445
0 O 0 0.03379423916339874
. O 0 0.027677025645971298
08 O 0 0.0925857350230217
) O 0 0.041543420404195786
. O 0 0.057663220912218094

It O 0 0.03812975063920021
occurred O 0 0.040350113064050674
in O 0 0.02930116094648838
15 O 0 0.04832729697227478
. O 0 0.05254310369491577

4 O 0 0.04193094000220299
% O 0 0.02007223851978779
of O 0 0.015218627639114857
52 O 0 0.02536044269800186
Ashkenazi O 0 0.03251824527978897
Israelis O 0 0.01650814525783062
with O 0 0.015494181774556637
familial O 1 0.9999986886978149
cancer B-Disease 1 1.0
( O 1 0.8914090991020203
P O 1 0.9984197616577148
= O 0 0.03490768373012543
0 O 0 0.01918712630867958
. O 0 0.01276788767427206
02 O 1 0.9935599565505981
) O 0 0.010696906596422195
and O 0 0.008628272451460361
was O 0 0.00981700886040926
not O 0 0.0062331752851605415
detected O 0 0.009621712379157543
in O 0 0.00732832308858633
51 O 0 0.015882300212979317
non O 0 0.013297302648425102
- O 0 0.017243407666683197
European O 0 0.012740293517708778
Jews O 0 0.015078759752213955
at O 0 0.02087700180709362
increased O 1 0.7044360637664795
cancer B-Disease 1 0.9999997615814209
risk O 1 0.9956595301628113
. O 0 0.04637928307056427

Colorectal B-Disease 1 1.0
neoplasia I-Disease 1 0.9999980926513672
occurred O 0 0.1881289929151535
personally O 1 0.5960355401039124
or O 0 0.010826749727129936
in O 0 0.009116493165493011
the O 0 0.008718956261873245
families O 0 0.00880744494497776
of O 0 0.0075105237774550915
13 O 0 0.011849953792989254
of O 0 0.009349029511213303
20 O 0 0.015289250761270523
Ashkenazi O 1 0.8143730759620667
I1307K O 1 0.9404840469360352
carriers O 0 0.02187155932188034
, O 0 0.009136863052845001
8 O 0 0.012288127094507217
of O 0 0.00791153497993946
whom O 0 0.009949393570423126
also O 0 0.0075462511740624905
had O 0 0.007940859533846378
a O 0 0.009407233446836472
personal O 0 0.048713259398937225
or O 0 0.0097900265827775
family O 0 0.015442730858922005
history O 0 0.021339479833841324
of O 0 0.04262784495949745
noncolonic O 1 0.9999926090240479
neoplasia B-Disease 1 0.9999983310699463
. O 0 0.06483608484268188

CONCLUSIONS O 0 0.05441097170114517
The O 0 0.03830644115805626
I1307K O 1 0.999295711517334
APC O 1 0.9999817609786987
variant O 0 0.3517945110797882
may O 0 0.014076645486056805
represent O 0 0.012243581004440784
a O 0 0.013334580697119236
susceptibility O 1 0.7490715980529785
gene O 0 0.012580065988004208
for O 0 0.012734176591038704
colorectal B-Disease 1 1.0
, I-Disease 0 0.011406282894313335
or I-Disease 0 0.005988919176161289
other I-Disease 0 0.005380444228649139
, I-Disease 0 0.017792977392673492
cancers I-Disease 1 0.9996451139450073
in O 0 0.008251559920608997
Ashkenazi O 1 0.9804278016090393
Jews O 0 0.012474404647946358
, O 0 0.008893334306776524
and O 0 0.009127398021519184
partially O 0 0.015360933728516102
explains O 0 0.013037732802331448
the O 0 0.00951375998556614
higher O 0 0.014154096134006977
incidence O 1 0.9998862743377686
of O 1 0.9999347925186157
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.07864347845315933
European O 0 0.03364637494087219
Israelis O 0 0.03762243688106537
. O 0 0.04312661662697792

Systematic O 0 0.04776189848780632
analysis O 0 0.023968415334820747
of O 0 0.023216651752591133
coproporphyrinogen O 1 0.9997797608375549
oxidase O 1 0.9915732741355896
gene O 0 0.039276253432035446
defects O 1 0.9972187280654907
in O 0 0.02124125324189663
hereditary B-Disease 1 0.9999997615814209
coproporphyria I-Disease 1 0.9999997615814209
and O 1 0.8491658568382263
mutation O 1 0.7872424721717834
update O 1 0.7031770944595337
. O 0 0.05335526168346405

Hereditary B-Disease 1 0.9999971389770508
coproporphyria I-Disease 1 0.9999823570251465
( O 1 0.8153802156448364
HC B-Disease 1 1.0
) O 0 0.0170754324644804
is O 0 0.012872930616140366
an O 0 0.45171940326690674
acute O 1 1.0
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 1 0.9998044371604919
autosomal O 1 0.9999998807907104
dominant O 1 0.9999986886978149
inheritance O 1 0.9999983310699463
caused O 1 0.999953031539917
by O 0 0.018053019419312477
deficient B-Disease 1 0.9996188879013062
activity I-Disease 0 0.014020214788615704
of I-Disease 0 0.03815415874123573
coproporphyrinogen I-Disease 1 0.9999992847442627
III I-Disease 1 1.0
oxidase I-Disease 1 0.9999665021896362
( O 0 0.051632121205329895
CPO O 1 0.9903647303581238
) O 0 0.04727157950401306
. O 0 0.05856221914291382

Clinical O 1 0.9939913153648376
manifestations O 1 0.7461546659469604
of O 0 0.03707103431224823
the O 1 0.9427304863929749
disease O 1 0.9999997615814209
are O 0 0.00664553651586175
characterized O 0 0.44629740715026855
by O 0 0.009653343819081783
acute O 1 1.0
attacks O 1 0.9994131326675415
of O 1 0.9999986886978149
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 1 0.992745578289032
precipitated O 1 0.9999995231628418
by O 0 0.018660426139831543
drugs O 1 0.9923043847084045
, O 0 0.016505412757396698
fasting O 0 0.09029951691627502
, O 0 0.018044982105493546
cyclical O 1 0.9998250603675842
hormonal O 1 0.9997016787528992
changes O 0 0.02130340039730072
, O 0 0.4583131968975067
or O 1 0.9938306212425232
infectious B-Disease 1 1.0
diseases I-Disease 1 1.0
. O 1 0.6947427988052368

Skin O 1 1.0
photosensitivity O 1 0.9999998807907104
may O 0 0.33037975430488586
also O 0 0.020806821063160896
be O 0 0.02075987309217453
present O 0 0.03339032456278801
. O 0 0.04283532872796059

The O 0 0.03688662871718407
seven O 0 0.027498722076416016
exons O 0 0.03581465780735016
, O 0 0.018996085971593857
the O 0 0.020272668451070786
exon O 1 0.5175894498825073
/ O 1 0.8441945314407349
intron O 1 0.68012535572052
boundaries O 0 0.017444143071770668
and O 0 0.011194957420229912
part O 0 0.012943955138325691
of O 0 0.010766076855361462
3 O 0 0.016963087022304535
noncoding O 0 0.029629098251461983
sequence O 0 0.013748216442763805
of O 0 0.012912769801914692
the O 0 0.015507245436310768
CPO O 1 0.7305670976638794
gene O 0 0.016870465129613876
were O 0 0.012002797797322273
systematically O 0 0.022716926410794258
analyzed O 0 0.01654355227947235
by O 0 0.009819182567298412
an O 0 0.01407492347061634
exon O 0 0.044973134994506836
- O 0 0.028584998100996017
by O 0 0.014680696651339531
- O 0 0.1477869600057602
exon O 0 0.1221458837389946
denaturing O 1 0.984968900680542
gradient O 0 0.4163069427013397
gel O 1 0.9982950091362
electrophoresis O 1 0.9850454926490784
( O 0 0.030896879732608795
DGGE O 1 0.9996696710586548
) O 0 0.017702952027320862
strategy O 0 0.02044939063489437
followed O 0 0.014817003160715103
by O 0 0.008447336032986641
direct O 0 0.009866224601864815
sequencing O 0 0.014933877624571323
in O 0 0.009931587614119053
seven O 0 0.014070882461965084
unrelated O 0 0.023962965235114098
heterozygous O 0 0.039386969059705734
HC B-Disease 1 0.9999996423721313
patients O 1 0.9849640727043152
from O 0 0.014312468469142914
France O 0 0.144265815615654
, O 0 0.018161483108997345
Holland O 0 0.3408108353614807
, O 0 0.017245208844542503
and O 0 0.020612135529518127
Czech O 0 0.41348081827163696
Republic O 0 0.05896766111254692
. O 0 0.04955162853002548

Seven O 0 0.046259067952632904
novel O 0 0.04247857257723808
mutations O 0 0.02566254325211048
and O 0 0.014446290209889412
two O 0 0.011926406063139439
new O 0 0.018909772858023643
polymorphisms O 0 0.038577668368816376
were O 0 0.021278947591781616
detected O 0 0.04505477845668793
. O 0 0.04401170834898949

Among O 0 0.027793895453214645
these O 0 0.012589356862008572
mutations O 0 0.016502253711223602
two O 0 0.009861819446086884
are O 0 0.007893209345638752
missense O 0 0.025724751874804497
( O 0 0.015223551541566849
G197W O 1 0.7074318528175354
, O 0 0.016706284135580063
W427R O 1 0.8891957998275757
) O 0 0.009795339778065681
, O 0 0.009254314005374908
two O 0 0.006845368538051844
are O 0 0.005917679518461227
nonsense O 0 0.01894504204392433
( O 0 0.013321361504495144
Q306X O 1 0.7674254775047302
, O 0 0.015606535598635674
Q385X O 1 0.7558708786964417
) O 0 0.01030384935438633
, O 0 0.008425231091678143
two O 0 0.006099267862737179
are O 0 0.005132662132382393
small O 0 0.010304326191544533
deletions O 0 0.02170642837882042
( O 0 0.015316742472350597
662de14bp O 0 0.16033342480659485
; O 0 0.015568803995847702
1168del3bp O 0 0.04743088409304619
removing O 0 0.02121962420642376
a O 0 0.014556151814758778
glycine O 0 0.025636719539761543
at O 0 0.012630369514226913
position O 0 0.014781899750232697
390 O 0 0.042863860726356506
) O 0 0.012392114847898483
, O 0 0.009681332856416702
and O 0 0.007986268028616905
one O 0 0.008135267533361912
is O 0 0.007398751098662615
a O 0 0.009709898382425308
splicing O 0 0.02100689522922039
mutation O 0 0.015843531116843224
( O 0 0.015122613869607449
IVS1 O 1 0.9880661964416504
- O 1 0.7924513816833496
15c O 1 0.999057948589325
- O 1 0.9983075857162476
- O 1 0.9926597476005554
> O 1 0.9563626646995544
g O 0 0.047937531024217606
) O 0 0.016440032050013542
which O 0 0.013240901753306389
creates O 0 0.024220295250415802
a O 0 0.0190611332654953
new O 0 0.02643400989472866
acceptor O 0 0.059478044509887695
splice O 0 0.09242337197065353
site O 0 0.05753154307603836
. O 0 0.05689232051372528

The O 0 0.03681204840540886
pathological O 0 0.04173939302563667
significance O 0 0.023253662511706352
of O 0 0.013407278805971146
the O 0 0.013183184899389744
point O 0 0.014338957145810127
mutations O 0 0.017771931365132332
G197W O 1 0.6128729581832886
, O 0 0.012948622927069664
W427R O 0 0.09232284873723984
, O 0 0.011124420911073685
and O 0 0.00800876971334219
the O 0 0.008272767066955566
in O 0 0.010356508195400238
- O 1 0.8456708788871765
frame O 0 0.05552748590707779
deletion O 0 0.04601208493113518
390delGly O 0 0.11610367149114609
were O 0 0.010896323248744011
assessed O 0 0.0154511583968997
by O 0 0.007579493336379528
their O 0 0.007597458548843861
respective O 0 0.011866940185427666
expression O 0 0.010745629668235779
in O 0 0.009215463884174824
a O 0 0.010967239737510681
prokaryotic O 0 0.02273119054734707
system O 0 0.013098159804940224
using O 0 0.01361116487532854
site O 0 0.02919374778866768
- O 0 0.11325769871473312
directed O 0 0.042740412056446075
mutagenesis O 0 0.10124591737985611
. O 0 0.047378864139318466

These O 0 0.024491921067237854
mutations O 0 0.019700029864907265
resulted O 0 0.014316141605377197
in O 0 0.009696059860289097
the O 0 0.010956766083836555
absence O 0 0.020144907757639885
or O 0 0.009601314552128315
a O 0 0.012523874640464783
dramatic O 0 0.056074872612953186
decrease O 0 0.027173630893230438
of O 0 0.023968543857336044
CPO O 1 0.9966270923614502
activity O 0 0.046217627823352814
. O 0 0.05371059477329254

The O 0 0.03617701679468155
two O 0 0.021239062771201134
polymorphisms O 0 0.030107581987977028
were O 0 0.014408023096621037
localized O 0 0.024876995012164116
in O 0 0.01350777130573988
noncoding O 0 0.029121235013008118
part O 0 0.012517559342086315
of O 0 0.008888095617294312
the O 0 0.00911654345691204
gene O 0 0.009923920035362244
1 O 0 0.01165201235562563
) O 0 0.009192286990582943
a O 0 0.013338920660316944
C O 1 0.6861144304275513
/ O 1 0.7937222719192505
G O 0 0.04890146106481552
polymorphism O 0 0.025530299171805382
in O 0 0.014248955994844437
the O 0 0.019463306292891502
promotor O 1 0.9877219796180725
region O 0 0.02238241210579872
, O 0 0.017942415550351143
142 O 0 0.03364844620227814
bp O 0 0.03671179339289665
upstream O 0 0.01903720386326313
from O 0 0.010162734426558018
the O 0 0.011403733864426613
transcriptional O 0 0.021111903712153435
initiation O 0 0.019674774259328842
site O 0 0.02018778771162033
( O 0 0.014809578657150269
- O 0 0.2038637399673462
142C O 1 0.9744330644607544
/ O 1 0.9906027317047119
G O 1 0.7866567373275757
) O 0 0.011356963776051998
, O 0 0.009839411824941635
and O 0 0.008819892071187496
2 O 0 0.012226488441228867
) O 0 0.009429397992789745
a O 0 0.011413339525461197
6 O 0 0.018822744488716125
bp O 0 0.03206901624798775
deletion O 0 0.024167083203792572
polymorphism O 0 0.02132643759250641
in O 0 0.009419269859790802
the O 0 0.010983544401824474
3 O 0 0.017198480665683746
noncoding O 0 0.028978388756513596
part O 0 0.013410873711109161
of O 0 0.011112037114799023
the O 0 0.015209839679300785
CPO O 1 0.958649218082428
gene O 0 0.016353661194443703
, O 0 0.013501204550266266
574 O 0 0.046506911516189575
bp O 0 0.02777908183634281
downstream O 0 0.017654309049248695
of O 0 0.008564009331166744
the O 0 0.008302210830152035
last O 0 0.009395319037139416
base O 0 0.014502618461847305
of O 0 0.009549633599817753
the O 0 0.010421897284686565
normal O 0 0.01453402265906334
termination O 0 0.12418187409639359
codon O 0 0.03639925271272659
( O 0 0.02883475087583065
+ O 0 0.07929239422082901
574 O 1 0.9124723076820374
delATTCTT O 1 0.9883037805557251
) O 0 0.051424723118543625
. O 0 0.059565525501966476

Five O 0 0.04649808630347252
intragenic O 1 0.9944631457328796
dimorphisms O 1 0.9646162986755371
are O 0 0.011666412465274334
now O 0 0.0135539211332798
well O 0 0.009847229346632957
characterized O 0 0.012902108952403069
and O 0 0.007953242398798466
the O 0 0.008421724662184715
high O 0 0.012178164906799793
degree O 0 0.013135850429534912
of O 0 0.0131561029702425
allelic O 1 0.8261855244636536
heterogeneity O 0 0.470707505941391
in O 0 0.01939060352742672
HC B-Disease 1 0.9999985694885254
is O 0 0.013246273621916771
demonstrated O 0 0.013776038773357868
with O 0 0.007151010446250439
seven O 0 0.008557120338082314
new O 0 0.007429477758705616
different O 0 0.005061981733888388
mutations O 0 0.008204225450754166
making O 0 0.0073352986946702
a O 0 0.008432016707956791
total O 0 0.010382648557424545
of O 0 0.012775858864188194
nineteen O 0 0.16128484904766083
CPO O 1 0.9997652173042297
gene B-Disease 0 0.15136802196502686
defects I-Disease 1 0.9991245865821838
reported O 0 0.0204914640635252
so O 0 0.014292571693658829
far O 0 0.019318345934152603
. O 0 0.022173527628183365
. O 0 0.03718363493680954

Coincidence O 0 0.05956937000155449
of O 0 0.022243499755859375
two O 0 0.01666439138352871
novel O 0 0.02886865846812725
arylsulfatase O 1 0.6742750406265259
A O 0 0.02539406530559063
alleles O 0 0.025947749614715576
and O 0 0.017308805137872696
mutation O 0 0.030335308983922005
459 O 1 0.9995740056037903
+ O 1 0.9228029251098633
1G O 1 0.999428927898407
> O 0 0.049435507506132126
A O 0 0.018617993220686913
within O 0 0.012909403070807457
a O 0 0.014318604953587055
family O 0 0.01779796928167343
with O 0 0.019067827612161636
metachromatic B-Disease 1 0.9999990463256836
leukodystrophy I-Disease 1 0.9999998807907104
: O 0 0.026374349370598793
molecular O 0 0.02758236601948738
basis O 0 0.01911391317844391
of O 0 0.024554984644055367
phenotypic O 0 0.07173274457454681
heterogeneity O 0 0.4833720028400421
. O 0 0.0624033659696579

In O 0 0.026778995990753174
a O 0 0.01779996231198311
family O 0 0.016772298142313957
with O 0 0.008556727319955826
three O 0 0.01052076369524002
siblings O 0 0.0229164008051157
, O 0 0.00883503258228302
one O 0 0.008655871264636517
developed O 0 0.012382600456476212
classical O 0 0.017491493374109268
late O 0 0.04970802739262581
infantile O 1 0.9999996423721313
metachromatic B-Disease 1 0.9999998807907104
leukodystrophy I-Disease 1 1.0
( O 1 0.9471762776374817
MLD B-Disease 1 1.0
) O 0 0.018702618777751923
, O 0 0.015123752877116203
fatal O 1 0.6044399738311768
at O 0 0.010996968485414982
age O 0 0.011070760898292065
5 O 0 0.01117145549505949
years O 0 0.009182468056678772
, O 0 0.009023400023579597
with O 0 0.009553130716085434
deficient O 1 0.9877505898475647
arylsulfatase O 1 0.9976354837417603
A O 0 0.49685221910476685
( O 0 0.041476864367723465
ARSA O 1 0.9999891519546509
) O 0 0.011790462769567966
activity O 0 0.011257355101406574
and O 0 0.011171050369739532
increased O 0 0.017605088651180267
galactosylsulfatide O 1 0.9997671246528625
( O 1 0.6300804615020752
GS O 1 0.9999998807907104
) O 0 0.051087383180856705
excretion O 0 0.324632853269577
. O 0 0.05802193656563759

The O 0 0.02513054758310318
two O 0 0.014390089549124241
other O 0 0.0119481161236763
siblings O 0 0.02159336395561695
, O 0 0.009947025217115879
apparently O 0 0.012274274602532387
healthy O 0 0.011433102190494537
at O 0 0.009410891681909561
12 O 0 0.010703982785344124
( O 0 0.009904861450195312
1 O 0 0.013733959756791592
/ O 0 0.023384205996990204
2 O 0 0.014198151417076588
) O 0 0.007617034949362278
and O 0 0.007420465815812349
15 O 0 0.01018136739730835
years O 0 0.008811216801404953
, O 0 0.0076594785787165165
respectively O 0 0.00820191204547882
, O 0 0.006197464652359486
and O 0 0.005490740295499563
their O 0 0.005496615078300238
father O 0 0.03235098719596863
, O 0 0.008261593990027905
apparently O 0 0.011321651749312878
healthy O 0 0.018082840368151665
as O 0 0.007079025264829397
well O 0 0.007842397317290306
, O 0 0.009954443201422691
presented O 0 0.02175634540617466
ARSA O 1 0.9999880790710449
and O 0 0.019019553437829018
GS O 1 0.9999938011169434
values O 0 0.01393839716911316
within O 0 0.010349859483540058
the O 0 0.011837542988359928
range O 0 0.020850319415330887
of O 0 0.044357091188430786
MLD B-Disease 1 1.0
patients O 1 0.9999526739120483
. O 0 0.058112967759370804

Mutation O 0 0.06222051382064819
screening O 0 0.038788482546806335
and O 0 0.01724242977797985
sequence O 0 0.015644501894712448
analysis O 0 0.01244512852281332
disclosed O 0 0.016531556844711304
the O 0 0.009078849107027054
involvement O 0 0.013882030732929707
of O 0 0.009365401230752468
three O 0 0.009594333358108997
different O 0 0.011097836308181286
ARSA O 1 0.9998680353164673
mutations O 0 0.018496496602892876
being O 0 0.01124341506510973
the O 0 0.01317597832530737
molecular O 0 0.018784713000059128
basis O 0 0.014471227303147316
of O 0 0.021825643256306648
intrafamilial O 1 0.9620711207389832
phenotypic O 0 0.1454809010028839
heterogeneity O 0 0.3314758539199829
. O 0 0.06569068133831024

The O 0 0.03735565021634102
late O 0 0.26715242862701416
infantile O 1 0.9999996423721313
patient O 1 0.9999970197677612
inherited O 1 0.9999884366989136
from O 0 0.014047952368855476
his O 0 0.08630929887294769
mother O 0 0.25710493326187134
the O 0 0.011753194034099579
frequent O 0 0.01839514635503292
0 O 0 0.02182311937212944
- O 0 0.0430908128619194
type O 0 0.024123242124915123
mutation O 0 0.027820998802781105
459 O 1 0.9921628832817078
+ O 1 0.7640734910964966
1G O 1 0.9997219443321228
> O 0 0.31303393840789795
A O 0 0.021335262805223465
, O 0 0.013418737798929214
and O 0 0.010345200076699257
from O 0 0.010390079580247402
his O 0 0.016156990081071854
father O 0 0.028010856360197067
a O 0 0.015441739931702614
novel O 0 0.020849883556365967
, O 0 0.01348134595900774
single O 0 0.018287992104887962
basepair O 1 0.5255780220031738
microdeletion O 0 0.1345905214548111
of O 0 0.018803969025611877
guanine O 0 0.0406721830368042
at O 0 0.018600482493638992
nucleotide O 0 0.022583553567528725
7 O 0 0.020856136456131935
in O 0 0.01785309426486492
exon O 0 0.05059171840548515
1 O 0 0.029942721128463745
( O 0 0.030156830325722694
7delG O 1 0.7125588059425354
) O 0 0.04453057795763016
. O 0 0.05556994304060936

The O 0 0.039176203310489655
two O 0 0.02766352705657482
clinically O 1 0.9773708581924438
unaffected O 0 0.3154667615890503
siblings O 0 0.036043230444192886
carried O 0 0.01837902143597603
the O 0 0.016262570396065712
maternal O 1 0.9627841114997864
mutation O 0 0.11708657443523407
459 O 1 0.9999516010284424
+ O 1 0.9958001971244812
1G O 1 0.9999717473983765
> O 0 0.22690825164318085
A O 0 0.02123006246984005
and O 0 0.011582176201045513
, O 0 0.009599228389561176
on O 0 0.010193959809839725
their O 0 0.012131193652749062
paternal O 0 0.05681685358285904
allele O 0 0.024623719975352287
, O 0 0.014847397804260254
a O 0 0.016538163647055626
novel O 0 0.023269183933734894
cytosine O 0 0.032558340579271317
to O 0 0.017415618523955345
thymidine O 0 0.04593738168478012
transition O 0 0.026265934109687805
at O 0 0.024881945922970772
nucleotide O 0 0.03213803842663765
2435 O 1 0.6200747489929199
in O 0 0.01946271024644375
exon O 0 0.045914772897958755
8 O 0 0.023541897535324097
, O 0 0.015157340094447136
resulting O 0 0.015682511031627655
in O 0 0.012496541254222393
substitution O 0 0.021591173484921455
of O 0 0.017764724791049957
alanine O 0 0.05955621972680092
464 O 1 0.9102649092674255
by O 0 0.025127695873379707
valine O 1 0.9988627433776855
( O 0 0.04523812234401703
A464V O 1 0.9895607233047485
) O 0 0.048854805529117584
. O 0 0.0585484579205513

The O 0 0.05631188675761223
fathers O 0 0.07077900320291519
genotype O 0 0.07698170095682144
thus O 0 0.031665969640016556
was O 0 0.1875569224357605
7delG O 1 0.9998371601104736
/ O 1 0.9990682005882263
A464V O 1 0.9923365712165833
. O 0 0.0742705836892128

Mutation O 0 0.07802494615316391
A464V O 0 0.2794345021247864
was O 0 0.023173479363322258
not O 0 0.010934000834822655
found O 0 0.01006783451884985
in O 0 0.011826091445982456
18 O 0 0.01863471046090126
unrelated O 1 0.8965307474136353
MLD B-Disease 1 1.0
patients O 1 0.9994204044342041
and O 0 0.02153840847313404
50 O 0 0.03321549668908119
controls O 0 0.04766697436571121
. O 0 0.04840518534183502

A464V O 0 0.4930911958217621
, O 0 0.028895583003759384
although O 0 0.01800166256725788
clearly O 0 0.022733991965651512
modifying O 0 0.0446903370320797
ARSA O 1 0.9999932050704956
and O 0 0.303895503282547
GS O 1 1.0
levels O 0 0.024375827983021736
, O 0 0.01432722993195057
apparently O 0 0.01540056336671114
bears O 0 0.015433600172400475
little O 0 0.012769468128681183
significance O 0 0.014979217201471329
for O 0 0.011796154081821442
clinical O 1 0.9930486679077148
manifestation O 1 0.9990610480308533
of O 1 0.7833195328712463
MLD B-Disease 1 1.0
, O 0 0.06332472711801529
mimicking O 1 0.7346020936965942
the O 0 0.0341951809823513
frequent O 1 0.5352377891540527
ARSA O 1 0.9999942779541016
pseudodeficiency O 1 0.9997796416282654
allele O 0 0.14181919395923615
. O 0 0.07165435701608658

Our O 0 0.03224978968501091
results O 0 0.021233459934592247
demonstrate O 0 0.01946837641298771
that O 0 0.008113959804177284
in O 0 0.009000811725854874
certain O 0 0.00901707448065281
genetic O 0 0.014487708918750286
conditions O 0 0.49567940831184387
MLD B-Disease 1 1.0
- O 1 0.9998692274093628
like O 0 0.2318132072687149
ARSA O 1 0.9999988079071045
and O 0 0.056679874658584595
GS O 1 0.9999994039535522
values O 0 0.014684579335153103
need O 0 0.011024842970073223
not O 0 0.00599444005638361
be O 0 0.00609131995588541
paralleled O 0 0.016542911529541016
by O 0 0.010290894657373428
clinical O 1 0.9999994039535522
disease O 1 0.9999995231628418
, O 0 0.008856621570885181
a O 0 0.008341834880411625
finding O 0 0.010541179217398167
with O 0 0.00929050613194704
serious O 1 0.998664379119873
diagnostic O 1 0.9999939203262329
and O 1 0.651205837726593
prognostic O 1 0.9999988079071045
implications O 1 0.9909254312515259
. O 0 0.05249786749482155

Moreover O 0 0.06363124400377274
, O 0 0.03281114622950554
further O 0 0.03395814076066017
ARSA O 1 0.9995841383934021
alleles O 0 0.03757249563932419
functionally O 0 0.03324943408370018
similar O 0 0.013337227515876293
to O 0 0.013146616518497467
A464V O 1 0.6217594146728516
might O 0 0.012035689316689968
exist O 0 0.007694329135119915
which O 0 0.005900702439248562
, O 0 0.00666844192892313
together O 0 0.006364861968904734
with O 0 0.0072129699401557446
0 O 0 0.015825066715478897
- O 0 0.39490917325019836
type O 0 0.027085954323410988
mutations O 0 0.011436869390308857
, O 0 0.009025298058986664
may O 0 0.009761873632669449
cause O 1 0.6114305853843689
pathological O 1 0.9998557567596436
ARSA O 1 1.0
and O 1 0.9768140912055969
GS O 1 1.0
levels O 0 0.022932998836040497
, O 0 0.008199620991945267
but O 0 0.005926386918872595
not O 0 0.006622161250561476
clinical O 1 0.9170643091201782
outbreak O 1 0.9958840012550354
of O 0 0.06727118045091629
the O 1 0.9901152849197388
disease O 1 1.0
. O 0 0.03193841502070427
. O 0 0.04187183454632759

Human O 1 0.9415397644042969
MLH1 O 1 0.9999998807907104
deficiency O 1 1.0
predisposes O 1 0.9999963045120239
to O 1 0.7730686664581299
hematological B-Disease 1 0.9999998807907104
malignancy I-Disease 1 1.0
and O 1 0.9997976422309875
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9999091625213623
1 I-Disease 0 0.16263726353645325
. O 0 0.058349210768938065

Heterozygous O 0 0.22442668676376343
germ O 1 0.9998648166656494
- O 1 0.90024733543396
line O 0 0.03116677515208721
mutations O 0 0.018254335969686508
in O 0 0.01245042122900486
the O 0 0.012184590101242065
DNA O 0 0.019769351929426193
mismatch O 1 0.9979962110519409
repair O 1 0.9843563437461853
genes O 0 0.01630307361483574
lead O 0 0.016532564535737038
to O 0 0.02378043718636036
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.8098917603492737

The O 1 0.9265285730361938
disease O 1 0.9999997615814209
susceptibility O 1 0.9984264373779297
of O 0 0.017525428906083107
individuals O 0 0.0097753144800663
who O 0 0.016400309279561043
constitutionally O 0 0.055889926850795746
lack O 0 0.013056558556854725
both O 0 0.008955102413892746
wild O 0 0.04937348887324333
- O 1 0.9998036026954651
type O 1 0.9594315886497498
alleles O 0 0.03023678995668888
is O 0 0.019140474498271942
unknown O 0 0.03158168867230415
. O 0 0.03883541002869606

We O 0 0.02466958574950695
have O 0 0.011748895049095154
identified O 0 0.013362827710807323
three O 0 0.00808973889797926
offspring O 0 0.013585004955530167
in O 0 0.008192085660994053
a O 0 0.01632378064095974
hereditary B-Disease 1 0.9999998807907104
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.9956516623497009
who O 1 0.8137750625610352
developed O 1 0.9949771761894226
hematological B-Disease 1 0.9999998807907104
malignancy I-Disease 1 1.0
at O 0 0.02036151848733425
a O 0 0.009567872621119022
very O 0 0.006667491514235735
early O 0 0.007887333631515503
age O 0 0.009476443752646446
, O 0 0.006043462082743645
and O 0 0.005861764308065176
at O 0 0.005836720112711191
least O 0 0.004674988333135843
two O 0 0.003860494354739785
of O 0 0.004626287147402763
them O 0 0.005084377247840166
displayed O 0 0.011360080912709236
signs O 0 0.0149542186409235
of O 0 0.027853550389409065
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9984361529350281
1 I-Disease 1 0.6717199683189392
( O 0 0.04512570798397064
NF1 B-Disease 1 0.9997740387916565
) O 0 0.043807338923215866
. O 0 0.056664761155843735

DNA O 0 0.03928615152835846
sequence O 0 0.02058064378798008
analysis O 0 0.016482718288898468
and O 0 0.014386438764631748
allele O 0 0.025619395077228546
- O 0 0.028629451990127563
specific O 0 0.01074251253157854
amplification O 0 0.020282728597521782
in O 0 0.009786149486899376
two O 0 0.011474895291030407
siblings O 0 0.024025797843933105
revealed O 0 0.01739928312599659
a O 0 0.01629459671676159
homozygous O 0 0.045147597789764404
MLH1 O 1 0.9999536275863647
mutation O 0 0.029897186905145645
( O 0 0.023552143946290016
C676T O 1 0.9970711469650269
- O 1 0.9998781681060791
- O 1 0.9998160004615784
> O 1 0.9986497759819031
Arg226Stop O 1 0.9994912147521973
) O 0 0.040379442274570465
. O 0 0.05354427546262741

Thus O 0 0.03742627426981926
, O 0 0.02175055630505085
a O 0 0.02310970239341259
homozygous O 0 0.05228615552186966
germ O 1 0.9999134540557861
- O 1 0.9784139394760132
line O 0 0.06348413974046707
MLH1 O 1 0.9999558925628662
mutation O 0 0.03064202517271042
and O 0 0.021154703572392464
consequent O 1 0.9999979734420776
mismatch O 1 1.0
repair O 1 1.0
deficiency O 1 1.0
results O 0 0.022426435723900795
in O 0 0.012402028776705265
a O 0 0.02564663253724575
mutator O 1 0.9999938011169434
phenotype O 1 0.9802659153938293
characterized O 0 0.3497850000858307
by O 0 0.018833650276064873
leukemia B-Disease 1 1.0
and O 1 0.9960306286811829
/ O 1 0.9999997615814209
or O 1 0.9990063309669495
lymphoma B-Disease 1 1.0
associated O 1 0.9673417806625366
with O 1 0.9901956915855408
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9999197721481323
1 I-Disease 0 0.15588760375976562
. O 0 0.03179093822836876
. O 0 0.047565873712301254

Missense O 0 0.11235823482275009
mutations O 0 0.030048565939068794
in O 0 0.013250201009213924
the O 0 0.011498523876070976
most O 0 0.011059306561946869
ancient O 0 0.01615961827337742
residues O 0 0.016958635300397873
of O 0 0.012230070307850838
the O 0 0.017294883728027344
PAX6 O 1 0.9998887777328491
paired O 0 0.03673423081636429
domain O 0 0.020718179643154144
underlie O 0 0.02902447246015072
a O 0 0.014034999534487724
spectrum O 0 0.16066989302635193
of O 1 0.7415499687194824
human O 1 0.9999958276748657
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 1.0
. O 1 0.986127495765686

Mutations O 0 0.043250102549791336
of O 0 0.019267018884420395
the O 0 0.019024895504117012
human O 0 0.021919336169958115
PAX6 O 1 0.9999954700469971
gene O 0 0.4992591142654419
underlie O 1 0.9999605417251587
aniridia B-Disease 1 0.9999998807907104
( O 1 0.9841173887252808
congenital B-Disease 1 0.9999998807907104
absence I-Disease 1 0.6185577511787415
of I-Disease 0 0.07961668074131012
the I-Disease 1 0.7534268498420715
iris I-Disease 1 0.9999703168869019
) O 0 0.011744428426027298
, O 0 0.011279025115072727
a O 0 0.01372264139354229
rare O 0 0.04842071607708931
dominant O 1 0.9558708667755127
malformation B-Disease 1 0.9999934434890747
of I-Disease 0 0.08099880069494247
the I-Disease 0 0.35913142561912537
eye I-Disease 1 0.9999548196792603
. O 0 0.0603862963616848

The O 0 0.038474537432193756
spectrum O 0 0.04538612812757492
of O 0 0.029601704329252243
PAX6 O 1 0.9999938011169434
mutations O 0 0.08761914819478989
in O 0 0.06438986212015152
aniridia B-Disease 1 0.9999998807907104
patients O 1 0.9998205304145813
is O 0 0.011735400184988976
highly O 0 0.012667234055697918
biased O 0 0.012596430256962776
, O 0 0.007678711321204901
with O 0 0.006612986326217651
92 O 0 0.01909179799258709
% O 0 0.007419194560497999
of O 0 0.0068884179927408695
all O 0 0.005456993822008371
reported O 0 0.008415751159191132
mutations O 0 0.008230888284742832
leading O 0 0.009781335480511189
to O 0 0.007239456754177809
premature O 0 0.10142873227596283
truncation O 0 0.028901008889079094
of O 0 0.009319213218986988
the O 0 0.010732235386967659
protein O 0 0.011871661059558392
( O 0 0.010180034674704075
nonsense O 0 0.020763855427503586
, O 0 0.011380696669220924
splicing O 0 0.01908395253121853
, O 0 0.012877341359853745
insertions O 0 0.02833651751279831
and O 0 0.012619112618267536
deletions O 0 0.02300877869129181
) O 0 0.010225179605185986
and O 0 0.008573002181947231
just O 0 0.011094675399363041
2 O 0 0.012713534757494926
% O 0 0.010125945322215557
leading O 0 0.012454044073820114
to O 0 0.008778564631938934
substitution O 0 0.01408147718757391
of O 0 0.009173942729830742
one O 0 0.010646246373653412
amino O 0 0.01295590028166771
acid O 0 0.015203400515019894
by O 0 0.00944374967366457
another O 0 0.0195634625852108
( O 0 0.024734895676374435
missense O 0 0.05733177065849304
) O 0 0.033082637935876846
. O 0 0.04326688125729561

The O 0 0.03284117206931114
extraordinary O 0 0.03589486703276634
conservation O 0 0.026921682059764862
of O 0 0.015325685031712055
the O 0 0.019135072827339172
PAX6 O 1 0.9999402761459351
protein O 0 0.016396572813391685
at O 0 0.012929243966937065
the O 0 0.012071087025105953
amino O 0 0.01593887060880661
acid O 0 0.01894559897482395
level O 0 0.013861339539289474
amongst O 0 0.020161952823400497
vertebrates O 0 0.030073674395680428
predicts O 0 0.03013625368475914
that O 0 0.010533363558351994
pathological O 1 0.5120077133178711
missense O 0 0.27509304881095886
mutations O 0 0.012572559528052807
should O 0 0.00743865268304944
in O 0 0.00665789982303977
fact O 0 0.006759947631508112
be O 0 0.005142796318978071
common O 0 0.006145255174487829
even O 0 0.005881921853870153
though O 0 0.005932115018367767
they O 0 0.005005480255931616
are O 0 0.005309943109750748
hardly O 0 0.014379030093550682
ever O 0 0.01383526623249054
seen O 0 0.016760317608714104
in O 0 0.02121310867369175
aniridia B-Disease 1 0.9999938011169434
patients O 1 0.9978525638580322
. O 0 0.04805613309144974

This O 0 0.025839464738965034
indicates O 0 0.025945601984858513
that O 0 0.0105147585272789
there O 0 0.009481888264417648
is O 0 0.010101418010890484
a O 0 0.011913646012544632
heavy O 0 0.41625872254371643
ascertainment O 1 0.9998202919960022
bias O 0 0.017441488802433014
in O 0 0.008390571922063828
the O 0 0.008711281232535839
selection O 0 0.011632840149104595
of O 0 0.010943766683340073
patients O 1 0.8049363493919373
for O 0 0.013554317876696587
PAX6 O 1 0.9999963045120239
mutation O 0 0.01831195317208767
analysis O 0 0.009774266742169857
and O 0 0.007428192533552647
that O 0 0.006958609912544489
the O 0 0.011472132056951523
missing O 0 0.03536092862486839
PAX6 O 1 0.9999808073043823
missense O 1 0.7168527841567993
mutations O 0 0.023828793317079544
frequently O 0 0.015618285164237022
may O 0 0.016759689897298813
underlie O 1 0.8157009482383728
phenotypes O 0 0.44131460785865784
distinct O 0 0.024140918627381325
from O 0 0.03135490417480469
textbook O 1 0.9998898506164551
aniridia B-Disease 1 0.9999924898147583
. O 0 0.06926652044057846

Here O 0 0.030459990724921227
we O 0 0.01624312251806259
present O 0 0.017210057005286217
four O 0 0.015426144935190678
novel O 0 0.034430112689733505
PAX6 O 1 0.999932050704956
missense O 0 0.2914159893989563
mutations O 0 0.01844414509832859
, O 0 0.012107518501579762
two O 0 0.008016595616936684
in O 0 0.009042475372552872
association O 0 0.014823777601122856
with O 0 0.012544412165880203
atypical O 1 0.9999061822891235
phenotypes O 1 0.9993428587913513
ectopia B-Disease 1 0.9999939203262329
pupillae I-Disease 1 0.9999761581420898
( O 0 0.018366379663348198
displaced B-Disease 0 0.06697076559066772
pupils I-Disease 0 0.436245858669281
) O 0 0.02242693491280079
and O 1 0.9072131514549255
congenital B-Disease 1 1.0
nystagmus I-Disease 1 0.9999998807907104
( O 0 0.1057194173336029
searching B-Disease 0 0.0468667671084404
gaze I-Disease 1 0.9024344086647034
) O 0 0.013227973133325577
, O 0 0.009776514954864979
and O 0 0.007738675456494093
two O 0 0.007442784029990435
in O 0 0.008124995976686478
association O 0 0.01346729975193739
with O 0 0.011899923905730247
more O 0 0.015703827142715454
recognizable O 1 0.9957589507102966
aniridia B-Disease 1 0.9999833106994629
phenotypes O 1 0.9229416847229004
. O 0 0.06192634254693985

Strikingly O 0 0.06657245010137558
, O 0 0.019090116024017334
all O 0 0.01160573773086071
four O 0 0.01321977935731411
mutations O 0 0.012151766568422318
are O 0 0.006175277289003134
located O 0 0.011619058437645435
within O 0 0.009416733868420124
the O 0 0.014132848009467125
PAX6 O 1 0.9999054670333862
paired O 0 0.0810878723859787
domain O 0 0.01867886632680893
and O 0 0.01162383146584034
affect O 0 0.01296517439186573
amino O 0 0.014147689566016197
acids O 0 0.01194964163005352
which O 0 0.008195022121071815
are O 0 0.00618534442037344
highly O 0 0.012299210764467716
conserved O 0 0.013511407189071178
in O 0 0.009735832922160625
all O 0 0.012250364758074284
known O 0 0.02220367267727852
paired O 0 0.043151792138814926
domain O 0 0.04237864539027214
proteins O 0 0.038559991866350174
. O 0 0.04304136708378792

Our O 0 0.034092217683792114
results O 0 0.02161542885005474
support O 0 0.015340364538133144
the O 0 0.013514973223209381
hypothesis O 0 0.014856914058327675
that O 0 0.0062083168886601925
the O 0 0.008030042052268982
under O 0 0.009616720490157604
- O 0 0.018011128529906273
representation O 0 0.012114724144339561
of O 0 0.012856041081249714
missense O 0 0.2279967963695526
mutations O 0 0.014781477861106396
is O 0 0.008750076405704021
caused O 0 0.015721969306468964
by O 0 0.010849498212337494
ascertainment O 1 0.9999693632125854
bias O 0 0.035069458186626434
and O 0 0.009938561357557774
suggest O 0 0.010422980412840843
that O 0 0.0061031305231153965
a O 0 0.009030215442180634
substantial O 0 0.013673076406121254
burden O 0 0.41721847653388977
of O 0 0.1350572407245636
PAX6 B-Disease 1 1.0
- I-Disease 1 0.9999995231628418
related I-Disease 1 0.9994813799858093
disease I-Disease 1 0.9999997615814209
remains O 0 0.2468637079000473
to O 0 0.012043595314025879
be O 0 0.01274976134300232
uncovered O 0 0.03912190720438957
. O 0 0.026025330647826195
. O 0 0.03867551311850548

The O 0 0.04140131175518036
chromosomal O 0 0.04395207762718201
order O 0 0.018332237377762794
of O 0 0.011880983598530293
genes O 0 0.013114122673869133
controlling O 0 0.01719982549548149
the O 0 0.011943545192480087
major O 0 0.4706117808818817
histocompatibility O 1 0.9999980926513672
complex O 0 0.02779160439968109
, O 0 0.017909960821270943
properdin O 1 0.9952842593193054
factor O 0 0.18505388498306274
B O 1 0.9929611086845398
, O 0 0.015030495822429657
and O 0 0.01604616828262806
deficiency B-Disease 1 0.9999973773956299
of I-Disease 0 0.01316684391349554
the I-Disease 0 0.015215575695037842
second I-Disease 0 0.22617332637310028
component I-Disease 0 0.46650198101997375
of I-Disease 0 0.02613835223019123
complement I-Disease 0 0.0596044547855854
. O 0 0.04872974753379822

The O 0 0.031492240726947784
relationship O 0 0.020314009860157967
of O 0 0.012405439279973507
the O 0 0.011474295519292355
genes O 0 0.012427540495991707
coding O 0 0.018929386511445045
for O 0 0.012788436375558376
HLA O 1 0.9989412426948547
to O 0 0.011373648419976234
those O 0 0.009378673508763313
coding O 0 0.016852132976055145
for O 0 0.012725594453513622
properdin O 1 0.9621480703353882
Factor O 0 0.11496032029390335
B O 1 0.9355899691581726
allotypes O 1 0.6572707891464233
and O 0 0.011589262634515762
for O 0 0.013363619334995747
deficiency B-Disease 1 0.9999988079071045
of I-Disease 0 0.00936275627464056
the I-Disease 0 0.008938279934227467
second I-Disease 0 0.013160772621631622
component I-Disease 0 0.020315533503890038
of I-Disease 0 0.010854851454496384
complement I-Disease 1 0.6754676103591919
( O 0 0.11541467905044556
C2 O 1 0.9999991655349731
) O 0 0.011007475666701794
was O 0 0.010899505577981472
studied O 0 0.010618152096867561
in O 0 0.007975524291396141
families O 0 0.008860552683472633
of O 0 0.011122459545731544
patients O 1 0.9999237060546875
with O 1 0.9986526966094971
connective O 1 1.0
tissue O 1 1.0
disorders O 1 1.0
. O 1 0.9893497228622437

Patients O 1 0.7703924179077148
were O 0 0.015093199908733368
selected O 0 0.01693846471607685
because O 0 0.009818918071687222
they O 0 0.00814259983599186
were O 0 0.009842514991760254
heterozygous O 0 0.020778045058250427
or O 0 0.013827473856508732
homozygous O 0 0.1018735021352768
for O 1 0.9836633205413818
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 1 0.7716428637504578

12 O 0 0.042126234620809555
families O 0 0.026050856336951256
with O 0 0.017987480387091637
15 O 0 0.02550855651497841
matings O 0 0.053272753953933716
informative O 0 0.09033086150884628
for O 1 0.9463204145431519
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 0.06591398268938065
found O 0 0.038113899528980255
. O 0 0.044849615544080734

Of O 0 0.040059443563222885
57 O 0 0.05458943173289299
informative O 0 0.05217777192592621
meioses O 0 0.21560131013393402
, O 0 0.014923246577382088
two O 0 0.011047173291444778
crossovers O 0 0.019982757046818733
were O 0 0.007741865236312151
noted O 0 0.009548159316182137
between O 0 0.009596817195415497
the O 0 0.08485693484544754
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 0.017572132870554924
and O 0 0.01101467665284872
the O 0 0.4379670321941376
HLA O 1 1.0
- O 1 0.9999927282333374
B O 1 0.9990746974945068
gene O 0 0.01425709668546915
, O 0 0.010146107524633408
with O 0 0.009942349046468735
a O 0 0.014999677427113056
recombinant O 0 0.032887790352106094
fraction O 0 0.02782164327800274
of O 0 0.0232759490609169
0 O 0 0.046974290162324905
. O 0 0.04667771980166435

035 O 1 0.9747087955474854
. O 0 0.14204564690589905

A O 0 0.05826088413596153
lod O 0 0.28179866075515747
score O 0 0.026922909542918205
of O 0 0.016820520162582397
13 O 0 0.01671256124973297
was O 0 0.013104635290801525
calculated O 0 0.011982249096035957
for O 0 0.008831600658595562
linkage O 0 0.0322449654340744
between O 0 0.10932138562202454
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 1 0.9999511241912842
HLA O 1 1.0
- O 1 0.9999985694885254
B O 1 0.9961509704589844
at O 0 0.011726285330951214
a O 0 0.01109624095261097
maximum O 0 0.013286834582686424
likelihood O 0 0.014954233542084694
value O 0 0.010757877491414547
of O 0 0.010560917668044567
the O 0 0.01416830811649561
recombinant O 0 0.03954722732305527
fraction O 0 0.029570484533905983
of O 0 0.025292299687862396
0 O 0 0.04971689358353615
. O 0 0.047879986464977264

04 O 1 0.9945734143257141
. O 0 0.12352917343378067

18 O 0 0.04585379362106323
families O 0 0.027201471850275993
with O 0 0.017894821241497993
21 O 0 0.029209932312369347
informative O 0 0.03682105988264084
matings O 0 0.03528057411313057
for O 0 0.014048104174435139
both O 0 0.015060571022331715
properdin O 1 0.6586325764656067
Factor O 0 0.04396682232618332
B O 1 0.8440003991127014
allotype O 1 0.9904080033302307
and O 0 0.03624424710869789
HLA O 1 0.9999998807907104
- O 1 0.9999536275863647
B O 1 0.9560273289680481
were O 0 0.02073383517563343
found O 0 0.027558064088225365
. O 0 0.03971582278609276

Of O 0 0.04108069837093353
72 O 0 0.05909449979662895
informative O 0 0.0501682385802269
meioses O 0 0.4054301679134369
, O 0 0.01784156821668148
three O 0 0.014335143379867077
recombinants O 0 0.45731377601623535
were O 0 0.012038558721542358
found O 0 0.0113011933863163
, O 0 0.01152486726641655
giving O 0 0.016767235472798347
a O 0 0.01803034357726574
recombinant O 0 0.042372897267341614
fraction O 0 0.036836590617895126
of O 0 0.027663642540574074
0 O 0 0.049801573157310486
. O 0 0.04837275668978691

042 O 1 0.8570405840873718
. O 0 0.13534775376319885

A O 0 0.0521952360868454
lod O 0 0.08056018501520157
score O 0 0.019134100526571274
of O 0 0.012708797119557858
16 O 0 0.018065445125102997
between O 0 0.01615726761519909
HLA O 1 0.9999996423721313
- O 1 0.9998965263366699
B O 1 0.994683563709259
and O 0 0.01781405135989189
Factor O 0 0.13386885821819305
B O 1 0.9170255661010742
allotypes O 0 0.3848225772380829
was O 0 0.019908592104911804
calculated O 0 0.01675540767610073
at O 0 0.012486930005252361
a O 0 0.01219432894140482
maximum O 0 0.01513148844242096
likelihood O 0 0.016300475224852562
value O 0 0.012089445255696774
of O 0 0.011778302490711212
the O 0 0.015999453142285347
recombinant O 0 0.03674108907580376
fraction O 0 0.033183030784130096
of O 0 0.02648838981986046
0 O 0 0.046023305505514145
. O 0 0.04835285246372223

04 O 1 0.9915434122085571
. O 0 0.1263204962015152

A O 0 0.04203300550580025
crossover O 0 0.04482858255505562
was O 0 0.02027437835931778
shown O 0 0.010619153268635273
to O 0 0.008863786235451698
have O 0 0.005833787377923727
occurred O 0 0.007781876251101494
between O 0 0.006293390411883593
genes O 0 0.006801031529903412
for O 0 0.007344161160290241
Factor O 0 0.018252570182085037
B O 0 0.3780971169471741
and O 0 0.016362447291612625
HLA O 1 0.9999997615814209
- O 1 0.9996781349182129
D O 1 0.9735156297683716
, O 0 0.010633139871060848
in O 0 0.009488903917372227
which O 0 0.011544113978743553
HLA O 1 0.99998939037323
- O 1 0.9961200952529907
D O 1 0.998091995716095
segregared O 1 0.9676555395126343
with O 0 0.026913614943623543
HLA O 1 0.9999998807907104
- O 1 0.9987375140190125
A O 0 0.46161073446273804
and O 0 0.03662625327706337
B O 1 0.8969390392303467
. O 0 0.04863840714097023

These O 0 0.021090561524033546
studies O 0 0.01691538840532303
suggest O 0 0.012875021435320377
that O 0 0.00641384394839406
the O 0 0.007206088397651911
genes O 0 0.008147419430315495
for O 0 0.009419050998985767
Factor O 0 0.1375478059053421
B O 1 0.9996789693832397
and O 1 0.9235362410545349
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 0.007873867638409138
located O 0 0.011927254498004913
outside O 0 0.008968023583292961
those O 0 0.0059402016922831535
for O 0 0.009742219932377338
HLA O 1 0.9999960660934448
, O 0 0.009671028703451157
that O 0 0.005946642253547907
the O 0 0.007258701138198376
order O 0 0.009485148824751377
of O 0 0.010386623442173004
genese O 1 0.8768834471702576
is O 0 0.014491984620690346
HLA O 1 0.9999974966049194
- O 0 0.13262967765331268
A O 0 0.01536223292350769
, O 0 0.01274797786027193
- O 1 0.6497790813446045
B O 0 0.22319364547729492
, O 0 0.014271734282374382
- O 1 0.5003498792648315
D O 0 0.32227930426597595
, O 0 0.013587318360805511
Factor O 0 0.025069618597626686
B O 1 0.8292713761329651
allotype O 1 0.9998220801353455
, O 1 0.9988456964492798
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 0.013491572812199593
that O 0 0.0076941256411373615
the O 0 0.009529031813144684
genes O 0 0.01182453241199255
coding O 0 0.03293452039361
for O 1 0.5975913405418396
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 0.4931591749191284
Factor O 1 0.8863753080368042
B O 1 0.9498246312141418
allotypes O 0 0.029697155579924583
are O 0 0.0060209897346794605
approximately O 0 0.009895605966448784
3 O 0 0.012660370208323002
- O 0 0.026702934876084328
- O 0 0.021309148520231247
5 O 0 0.015271853655576706
centimorgans O 0 0.02581200748682022
from O 0 0.01018182747066021
the O 0 0.01320019830018282
HLA O 1 0.999981164932251
- O 0 0.18282145261764526
A O 0 0.019193580374121666
and O 0 0.04201950877904892
HLA O 1 1.0
- O 1 0.9999864101409912
B O 1 0.9984656572341919
loci O 0 0.01992049627006054
, O 0 0.009020399302244186
and O 0 0.0067204968072474
that O 0 0.005519744474440813
the O 0 0.007527949754148722
apparent O 0 0.013619177043437958
lack O 0 0.009877951815724373
of O 0 0.00969631690531969
recombinants O 1 0.8231056332588196
between O 0 0.00729867909103632
the O 0 0.010362375527620316
Factor O 0 0.022623136639595032
B O 1 0.9626662135124207
gene O 0 0.022221246734261513
and O 1 0.9231489896774292
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 0.12544748187065125
suggests O 0 0.011948978528380394
that O 0 0.006018239539116621
these O 0 0.005037000402808189
two O 0 0.006643767934292555
genes O 0 0.009660886600613594
lie O 0 0.013434263877570629
in O 0 0.00827714242041111
close O 0 0.01267162337899208
proximity O 0 0.01721327006816864
to O 0 0.012430011294782162
one O 0 0.017021795734763145
another O 0 0.028504222631454468
. O 0 0.03732968121767044

Distribution O 0 0.03966357186436653
of O 0 0.02669578418135643
emerin O 1 0.9284313917160034
and O 0 0.020596681162714958
lamins O 1 0.9432059526443481
in O 0 0.01587485708296299
the O 0 0.014779767952859402
heart O 1 0.9792898893356323
and O 0 0.012292099185287952
implications O 0 0.021177254617214203
for O 0 0.02359432354569435
Emery B-Disease 1 0.9999986886978149
- I-Disease 1 0.9999998807907104
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.8734535574913025

Emerin O 1 0.896772563457489
is O 0 0.020507168024778366
a O 0 0.018582619726657867
nuclear O 0 0.028841212391853333
membrane O 0 0.0322050005197525
protein O 0 0.01384098082780838
which O 0 0.007997226901352406
is O 0 0.009409032762050629
missing O 0 0.015301632694900036
or O 0 0.01025384571403265
defective O 0 0.38091301918029785
in O 0 0.01719566062092781
Emery B-Disease 1 0.9999706745147705
- I-Disease 1 0.9999996423721313
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999836683273315
EDMD B-Disease 1 1.0
) O 0 0.061792101711034775
. O 0 0.06290637701749802

It O 0 0.024884548038244247
is O 0 0.015387649647891521
one O 0 0.009737024083733559
member O 0 0.01085373479872942
of O 0 0.008419511839747429
a O 0 0.010259867645800114
family O 0 0.012980867177248001
of O 0 0.02661949209868908
lamina O 1 1.0
- O 1 0.999927282333374
associated O 0 0.015205524861812592
proteins O 0 0.010680735111236572
which O 0 0.009446077980101109
includes O 0 0.016055161133408546
LAP1 O 1 0.9901806116104126
, O 0 0.021480556577444077
LAP2 O 1 0.9942864775657654
and O 0 0.031046362593770027
lamin O 1 0.9999326467514038
B O 1 0.999893307685852
receptor O 1 0.552473783493042
( O 0 0.047675009816884995
LBR O 1 0.9999278783798218
) O 0 0.055019814521074295
. O 0 0.05780477821826935

A O 0 0.039588406682014465
panel O 0 0.035611823201179504
of O 0 0.0217863991856575
16 O 0 0.031555112451314926
monoclonal O 1 0.9865149855613708
antibodies O 1 0.9594400525093079
( O 0 0.026529042050242424
mAbs O 1 0.9952558875083923
) O 0 0.012465299107134342
has O 0 0.00999697856605053
been O 0 0.008934779092669487
mapped O 0 0.01460039708763361
to O 0 0.008167682215571404
six O 0 0.008018052205443382
specific O 0 0.008248512633144855
sites O 0 0.00990136805921793
throughout O 0 0.009312991052865982
the O 0 0.010684051550924778
emerin O 0 0.053374841809272766
molecule O 0 0.019069287925958633
using O 0 0.014793897047638893
phage O 1 0.9771925806999207
- O 0 0.3737083077430725
displayed O 0 0.02757342904806137
peptide O 0 0.0247110053896904
libraries O 0 0.014614981599152088
and O 0 0.008832089602947235
has O 0 0.007828537374734879
been O 0 0.006842075847089291
used O 0 0.007210456766188145
to O 0 0.009927988052368164
localize O 0 0.12565366923809052
emerin O 0 0.34979087114334106
in O 0 0.01374251488596201
human O 0 0.016439422965049744
and O 0 0.15403227508068085
rabbit O 1 0.9999918937683105
heart O 1 0.9999951124191284
. O 0 0.05691005662083626

Several O 0 0.038866572082042694
mAbs O 0 0.12360943853855133
against O 0 0.02685796283185482
different O 0 0.01842556707561016
emerin O 1 0.9504070281982422
epitopes O 1 0.5925338864326477
did O 0 0.01605851948261261
not O 0 0.009327889420092106
recognize O 0 0.016453547403216362
intercalated O 1 0.9876197576522827
discs O 0 0.029480740427970886
in O 0 0.012065993621945381
the O 0 0.014432786032557487
heart O 1 0.9992803931236267
, O 0 0.009341113269329071
though O 0 0.008419153280556202
they O 0 0.007207122631371021
recognized O 0 0.013718641363084316
cardiomyocyte O 1 0.9084089398384094
nuclei O 0 0.0184827521443367
strongly O 0 0.0135514996945858
, O 0 0.008429464884102345
both O 0 0.006870197132229805
at O 0 0.009330220520496368
the O 0 0.010812821798026562
rim O 0 0.3436967730522156
and O 0 0.011384924873709679
in O 0 0.013765391893684864
intranuclear O 1 0.9693613648414612
spots O 0 0.03916730359196663
or O 0 0.022054309025406837
channels O 0 0.035236380994319916
. O 0 0.04635493829846382

A O 0 0.09428735822439194
polyclonal O 1 0.9976156949996948
rabbit O 1 0.9864094853401184
antiserum O 1 0.9950041174888611
against O 0 0.032648321241140366
emerin O 1 0.9730541110038757
did O 0 0.014942886307835579
recognize O 0 0.014683053828775883
both O 0 0.010571375489234924
nuclear O 0 0.018569832667708397
membrane O 0 0.02661244198679924
and O 0 0.01220632717013359
intercalated O 1 0.9998704195022583
discs O 0 0.33620113134384155
but O 0 0.009768938645720482
, O 0 0.009663551114499569
after O 0 0.010518133640289307
affinity O 0 0.015466305427253246
purification O 0 0.04102572798728943
against O 0 0.011598591692745686
a O 0 0.013172526843845844
pure O 0 0.025569017976522446
- O 1 0.7722964286804199
emerin O 1 0.5806582570075989
band O 0 0.017376471310853958
on O 0 0.008966934867203236
a O 0 0.011331204324960709
western O 0 0.01321025937795639
blot O 1 0.9214535355567932
, O 0 0.010943183675408363
it O 0 0.01027835626155138
stained O 1 0.9974384307861328
only O 0 0.011167800985276699
the O 0 0.01757648028433323
nuclear O 0 0.04218079149723053
membrane O 0 0.09011884778738022
. O 0 0.0472174808382988

These O 0 0.0186631940305233
results O 0 0.015490938909351826
would O 0 0.008574910461902618
not O 0 0.005903211887925863
be O 0 0.005435809027403593
expected O 0 0.007244054228067398
if O 0 0.007239978294819593
immunostaining O 0 0.11558445543050766
at O 0 0.015578561462461948
intercalated O 1 0.9914986491203308
discs O 0 0.024816766381263733
were O 0 0.007389199919998646
due O 0 0.007904618047177792
to O 0 0.007545423228293657
a O 0 0.007714192848652601
product O 0 0.00866144709289074
of O 0 0.006440030410885811
the O 0 0.0086637232452631
emerin O 1 0.9923183917999268
gene O 0 0.010913815349340439
and O 0 0.008200380019843578
, O 0 0.008761723525822163
therefore O 0 0.007402985356748104
, O 0 0.007023883983492851
cast O 0 0.008876493200659752
some O 0 0.005739610642194748
doubt O 0 0.011105363257229328
upon O 0 0.007946177385747433
the O 0 0.008040384389460087
hypothesis O 0 0.013580143451690674
that O 0 0.009905590675771236
cardiac B-Disease 1 1.0
defects I-Disease 1 0.9999985694885254
in O 0 0.43064606189727783
EDMD B-Disease 1 1.0
are O 0 0.00852785725146532
caused O 0 0.0179522056132555
by O 0 0.009240671060979366
absence O 0 0.0246251430362463
of O 0 0.021396681666374207
emerin O 1 0.9973312616348267
from O 0 0.03781268000602722
intercalated O 1 0.9995112419128418
discs O 1 0.5923916101455688
. O 0 0.07222680747509003

Although O 0 0.03739985451102257
emerin O 1 0.5442324876785278
was O 0 0.021994831040501595
abundant O 0 0.016704538837075233
in O 0 0.010004771873354912
the O 0 0.011178379878401756
membranes O 0 0.029650775715708733
of O 0 0.013933115638792515
cardiomyocyte O 1 0.9999741315841675
nuclei O 0 0.04604397341609001
, O 0 0.009311266243457794
it O 0 0.006859965622425079
was O 0 0.0097782788798213
absent O 0 0.01167712826281786
from O 0 0.006949594710022211
many O 0 0.006621687673032284
non O 0 0.019942525774240494
- O 1 0.9986914992332458
myocyte O 1 0.9999746084213257
cells O 0 0.020824944600462914
in O 0 0.016235822811722755
the O 0 0.02585408464074135
heart O 1 0.9988481998443604
. O 0 0.04217924177646637

This O 0 0.02396649494767189
distribution O 0 0.020423106849193573
of O 0 0.01744156889617443
emerin O 1 0.9271903038024902
was O 0 0.016190920025110245
similar O 0 0.008823956362903118
to O 0 0.008054832927882671
that O 0 0.006066880188882351
of O 0 0.010056189261376858
lamin O 1 0.9935357570648193
A O 0 0.01968316361308098
, O 0 0.008969774469733238
a O 0 0.008857429027557373
candidate O 0 0.011948932893574238
gene O 0 0.009099768474698067
for O 0 0.00791192427277565
an O 0 0.012476667761802673
autosomal O 1 0.8595490455627441
form O 0 0.0202159620821476
of O 0 0.31153327226638794
EDMD B-Disease 1 0.9999995231628418
. O 0 0.060187928378582

In O 0 0.04012196511030197
contrast O 0 0.04503535479307175
, O 0 0.04132942110300064
lamin O 1 0.9999630451202393
B1 O 1 0.9999984502792358
was O 0 0.03336845710873604
absent O 0 0.03388788551092148
from O 0 0.018699534237384796
cardiomyocyte O 1 0.9197867512702942
nuclei O 0 0.03208738937973976
, O 0 0.017088795080780983
showing O 0 0.021098921075463295
that O 0 0.017347022891044617
lamin O 1 0.9999946355819702
B1 O 1 0.9999988079071045
is O 0 0.012990863993763924
not O 0 0.009058481082320213
essential O 0 0.01368570514023304
for O 0 0.011320983059704304
localization O 0 0.028216585516929626
of O 0 0.015653321519494057
emerin O 1 0.7015925645828247
to O 0 0.017300540581345558
the O 0 0.025092467665672302
nuclear O 0 0.06884445250034332
lamina O 1 0.9998230338096619
. O 0 0.06268107146024704

Lamin O 1 0.9999958276748657
B1 O 1 0.9999946355819702
is O 0 0.023200541734695435
also O 0 0.01705920696258545
almost O 0 0.016088375821709633
completely O 0 0.02432781271636486
absent O 0 0.07191365212202072
from O 0 0.03401748836040497
skeletal O 1 0.9999980926513672
muscle O 1 0.9999946355819702
nuclei O 1 0.921155571937561
. O 0 0.06215406954288483

In O 0 0.04342496022582054
EDMD B-Disease 1 0.9996384382247925
, O 0 0.01834847964346409
the O 0 0.013293037191033363
additional O 0 0.01269961055368185
absence O 0 0.017556678503751755
of O 0 0.017405519261956215
lamin O 1 0.9999980926513672
B1 O 1 0.9999995231628418
from O 0 0.021060263738036156
heart O 1 0.9999862909317017
and O 1 0.7162551283836365
skeletal O 1 0.9999995231628418
muscle O 1 0.9999880790710449
nuclei O 0 0.10059380531311035
which O 0 0.00905427522957325
already O 0 0.014175990596413612
lack O 0 0.0723361074924469
emerin O 1 0.9991951584815979
may O 0 0.008667733520269394
offer O 0 0.009378346614539623
an O 0 0.00657395226880908
alternative O 0 0.010479030199348927
explanation O 0 0.010408829897642136
of O 0 0.00816929992288351
why O 0 0.010126424953341484
these O 0 0.00832984410226345
tissues O 0 0.14622506499290466
are O 0 0.00818054098635912
particularly O 0 0.01622915267944336
affected O 0 0.021520940586924553
. O 0 0.020482735708355904
. O 0 0.03887385502457619

Genetic O 0 0.04704209789633751
mapping O 0 0.03910328820347786
of O 0 0.022437818348407745
the O 0 0.0252130925655365
copper B-Disease 1 0.9995064735412598
toxicosis I-Disease 1 0.9999825954437256
locus O 1 0.7089153528213501
in O 0 0.023104509338736534
Bedlington O 1 0.9982191920280457
terriers O 0 0.07006815820932388
to O 0 0.013705556280910969
dog O 0 0.02497565560042858
chromosome O 0 0.016841137781739235
10 O 0 0.010859962552785873
, O 0 0.008081500418484211
in O 0 0.007531638257205486
a O 0 0.00976288877427578
region O 0 0.012585054151713848
syntenic O 0 0.10056828707456589
to O 0 0.01064419187605381
human O 0 0.013899469748139381
chromosome O 0 0.030399424955248833
region O 0 0.038113925606012344
2p13 O 1 0.9998364448547363
- O 1 0.9995662569999695
p16 O 1 0.9945746064186096
. O 0 0.05920427665114403

Abnormal O 1 0.9996976852416992
hepatic B-Disease 1 0.9999995231628418
copper I-Disease 1 0.9999169111251831
accumulation I-Disease 1 0.9528623819351196
is O 0 0.013298967853188515
recognized O 0 0.01316137332469225
as O 0 0.009432435035705566
an O 1 0.6827092170715332
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 1 0.7392613887786865
man O 1 0.9993818998336792
, O 0 0.3506908118724823
mouse O 1 0.9796993136405945
, O 0 0.029966697096824646
rat O 1 0.9990804195404053
and O 0 0.027021897956728935
dog O 0 0.21742533147335052
. O 0 0.0457586869597435

The O 0 0.0334741435945034
major O 0 0.03210919350385666
cause O 1 0.6073036789894104
of O 1 0.8291319608688354
hepatic B-Disease 1 1.0
copper I-Disease 1 0.9999990463256836
accumulation I-Disease 1 0.9995291233062744
in O 0 0.014148715883493423
man O 0 0.019659478217363358
is O 0 0.009651110507547855
a O 0 0.013519137166440487
dysfunctional O 1 0.8987672328948975
ATP7B O 1 0.9998831748962402
gene O 0 0.018269186839461327
, O 0 0.017878662794828415
causing O 1 0.9988112449645996
Wilson B-Disease 1 0.9999991655349731
disease I-Disease 1 1.0
( O 1 0.9997199177742004
WD B-Disease 1 1.0
) O 0 0.04476384446024895
. O 0 0.050685491412878036

Mutations O 0 0.04030715674161911
in O 0 0.018441226333379745
the O 0 0.020423850044608116
ATP7B O 1 0.9999734163284302
genes O 0 0.013638168573379517
have O 0 0.007851370610296726
also O 0 0.00916915014386177
been O 0 0.010038474574685097
demonstrated O 0 0.018630238249897957
in O 0 0.018363360315561295
mouse O 0 0.43827080726623535
and O 0 0.03306038677692413
rat O 1 0.9579402208328247
. O 0 0.05800413712859154

The O 0 0.04509503394365311
ATP7B O 1 0.9997180104255676
gene O 0 0.022288596257567406
has O 0 0.013205460272729397
been O 0 0.009622666984796524
excluded O 0 0.012405767105519772
in O 0 0.0077169048599898815
the O 0 0.008620237000286579
much O 0 0.0121583491563797
rarer O 1 0.9127787351608276
human O 0 0.12397993355989456
copper B-Disease 1 0.9999988079071045
overload I-Disease 1 1.0
disease O 1 0.9999998807907104
non B-Disease 1 0.972350537776947
- I-Disease 1 0.9998372793197632
Indian I-Disease 1 0.9491126537322998
childhood I-Disease 1 0.9999992847442627
cirrhosis I-Disease 1 1.0
, O 0 0.1567678302526474
indicating O 0 0.17361178994178772
genetic O 0 0.16902396082878113
heterogeneity O 1 0.9042232036590576
. O 0 0.054924119263887405

By O 0 0.023329388350248337
investigating O 0 0.026591837406158447
the O 0 0.017470013350248337
common O 0 0.025869999080896378
autosomal O 1 0.9999904632568359
recessive O 1 0.9999996423721313
copper B-Disease 1 1.0
toxicosis I-Disease 1 1.0
( O 1 0.9939796924591064
CT B-Disease 1 0.9999890327453613
) O 0 0.016208406537771225
in O 0 0.01771765947341919
Bedlington O 1 0.9998158812522888
terriers O 1 0.9398075938224792
, O 0 0.010615216568112373
we O 0 0.006586629431694746
have O 0 0.005438517313450575
identified O 0 0.007489674258977175
a O 0 0.008001585491001606
new O 0 0.010770638473331928
locus O 0 0.1456311196088791
involved O 0 0.014630765654146671
in O 1 0.6371316909790039
progressive O 1 1.0
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.7687143683433533

We O 0 0.02809007279574871
examined O 0 0.027864694595336914
whether O 0 0.017074542120099068
the O 0 0.01815791055560112
WD B-Disease 1 0.9999884366989136
gene O 0 0.045223016291856766
ATP7B O 1 0.999884843826294
was O 0 0.028894132003188133
also O 0 0.015163477510213852
causative O 0 0.20567075908184052
for O 0 0.013686155900359154
CT B-Disease 1 0.9621174931526184
by O 0 0.010479869320988655
investigating O 0 0.016802780330181122
the O 0 0.014063824899494648
chromosomal O 1 0.5591963529586792
co O 1 0.7662323713302612
- O 0 0.47328969836235046
localization O 0 0.038042981177568436
of O 0 0.02028840407729149
ATP7B O 1 0.9999244213104248
and O 0 0.01740654744207859
C04107 O 0 0.1490776389837265
, O 0 0.015746789053082466
using O 0 0.012969544157385826
fluorescence O 0 0.026987535879015923
in O 0 0.016036314889788628
situ O 0 0.2640237808227539
hybridization O 0 0.03822508454322815
( O 0 0.026491427794098854
FISH O 0 0.0356769897043705
) O 0 0.03493891656398773
. O 0 0.04437842220067978

C04107 O 0 0.13421322405338287
is O 0 0.029828226193785667
an O 0 0.025343626737594604
anonymous O 0 0.0365319550037384
microsatellite O 1 0.9708729386329651
marker O 0 0.26698625087738037
closely O 0 0.030730372294783592
linked O 0 0.037146877497434616
to O 0 0.032250698655843735
CT B-Disease 1 0.9989482760429382
. O 0 0.0678076222538948

However O 0 0.045939236879348755
, O 0 0.04371649771928787
BAC O 1 0.9972826242446899
clones O 1 0.5229241251945496
containing O 0 0.034340277314186096
ATP7B O 1 0.9932911396026611
and O 0 0.019534708932042122
C04107 O 0 0.06577547639608383
mapped O 0 0.025083351880311966
to O 0 0.012487471103668213
the O 0 0.014316525310277939
canine O 1 0.9473685026168823
chromosome O 0 0.02075098268687725
regions O 0 0.013828306458890438
CFA22q11 O 1 0.9937731623649597
and O 0 0.015054957009851933
CFA10q26 O 1 0.9992039799690247
, O 0 0.011596312746405602
respectively O 0 0.012538413517177105
, O 0 0.009712428785860538
demonstrating O 0 0.016587693244218826
that O 0 0.01316295936703682
WD B-Disease 1 0.999961256980896
cannot O 0 0.0182765182107687
be O 0 0.014948146417737007
homologous O 0 0.03599974885582924
to O 0 0.03161965683102608
CT B-Disease 1 0.9985137581825256
. O 0 0.055795200169086456

The O 0 0.0400378443300724
copper O 1 0.7260100245475769
transport O 0 0.03717214614152908
genes O 0 0.025570157915353775
CTR1 O 1 0.9988168478012085
and O 0 0.020138908177614212
CTR2 O 1 0.9995009899139404
were O 0 0.010327977128326893
also O 0 0.011793581768870354
excluded O 0 0.013666382990777493
as O 0 0.008012334816157818
candidate O 0 0.01314590498805046
genes O 0 0.01117656473070383
for O 0 0.009786305949091911
CT B-Disease 1 0.9949097037315369
since O 0 0.009699632413685322
they O 0 0.006798909045755863
both O 0 0.00899905152618885
mapped O 0 0.022792905569076538
to O 0 0.018688224256038666
canine O 1 0.9953778982162476
chromosome O 0 0.06081516295671463
region O 0 0.04277105629444122
CFA11q22 O 1 0.9985652565956116
. O 0 0.05646168068051338

2 O 0 0.08698155730962753
- O 0 0.16968213021755219
22 O 0 0.07501620054244995
. O 0 0.07060130685567856

5 O 0 0.12821431457996368
. O 0 0.09869983792304993

A O 0 0.0472700335085392
transcribed O 0 0.03760936111211777
sequence O 0 0.018095403909683228
identified O 0 0.01322172675281763
from O 0 0.01083005778491497
the O 0 0.012753362767398357
C04107 O 1 0.7438100576400757
- O 1 0.9237850904464722
containing O 0 0.03446345031261444
BAC O 1 0.9994227886199951
was O 0 0.01306698378175497
found O 0 0.0072668008506298065
to O 0 0.007106360048055649
be O 0 0.006402595434337854
homologous O 0 0.01105878222733736
to O 0 0.007702933624386787
a O 0 0.009074855595827103
gene O 0 0.009226562455296516
expressed O 0 0.00911495927721262
from O 0 0.007803123444318771
human O 0 0.010981648229062557
chromosome O 0 0.029943495988845825
2p13 O 1 0.9984194040298462
- O 1 0.9952676296234131
p16 O 1 0.9763700366020203
, O 0 0.013050059787929058
a O 0 0.014773138798773289
region O 0 0.016448799520730972
devoid O 0 0.02867070958018303
of O 0 0.01447432953864336
any O 0 0.017219409346580505
positional O 0 0.10530740022659302
candidate O 0 0.04913914203643799
genes O 0 0.04534050077199936
. O 0 0.0481068380177021

Molecular O 0 0.05142213776707649
analysis O 0 0.02332346886396408
of O 0 0.018164316192269325
the O 0 0.021730739623308182
APC B-Disease 1 0.9950466156005859
gene O 0 0.01808995194733143
in O 0 0.014742217026650906
205 O 0 0.030022218823432922
families O 0 0.014036701992154121
: O 0 0.013272956945002079
extended O 0 0.020429236814379692
genotype O 0 0.18138279020786285
- O 1 0.7566220164299011
phenotype O 0 0.34798577427864075
correlations O 0 0.030563946813344955
in O 0 0.01742543652653694
FAP B-Disease 1 0.999995231628418
and O 0 0.012476345524191856
evidence O 0 0.00912392046302557
for O 0 0.0078812837600708
the O 0 0.008495351299643517
role O 0 0.013345111161470413
of O 0 0.01303959172219038
APC B-Disease 1 0.9991884827613831
amino O 0 0.01771376095712185
acid O 0 0.021193429827690125
changes O 0 0.017430344596505165
in O 1 0.9909564852714539
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 1 0.9999998807907104
. O 0 0.4026900827884674

BACKGROUND O 0 0.0654364824295044
/ O 0 0.0716211199760437
AIMS O 0 0.03852932155132294
The O 0 0.016098394989967346
development O 0 0.03038177452981472
of O 1 0.9995107650756836
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.025046145543456078
a O 0 0.012466191314160824
variable O 0 0.013129095546901226
range O 0 0.011921281926333904
of O 0 0.011713371612131596
extracolonic O 1 0.8607749938964844
manifestations O 1 0.6818110942840576
in O 0 0.2506619989871979
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999994039535522
FAP B-Disease 1 1.0
) O 0 0.019256405532360077
is O 0 0.00983957014977932
the O 0 0.008619450964033604
result O 0 0.00710965134203434
of O 0 0.006864230148494244
the O 0 0.009913141839206219
dominant O 0 0.02263982780277729
inheritance O 1 0.7848139405250549
of O 1 0.9985387325286865
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 1 0.99988853931427
APC B-Disease 1 0.9999996423721313
) O 0 0.04476730898022652
gene O 0 0.048936162143945694
mutations O 0 0.05101087689399719
. O 0 0.049279991537332535

In O 0 0.023739635944366455
this O 0 0.01225520670413971
study O 0 0.01310710795223713
, O 0 0.009662365540862083
direct O 0 0.010299385525286198
mutation O 0 0.009829949587583542
analysis O 0 0.007062273565679789
of O 0 0.006992158479988575
the O 0 0.011192666366696358
APC B-Disease 1 0.9999386072158813
gene O 0 0.012948622927069664
was O 0 0.011363165453076363
performed O 0 0.010956620797514915
to O 0 0.009196131490170956
determine O 0 0.013806124217808247
genotype O 0 0.04106912761926651
- O 0 0.22538232803344727
phenotype O 0 0.030810853466391563
correlations O 0 0.019957050681114197
for O 0 0.011156773194670677
nine O 0 0.021480876952409744
extracolonic O 1 0.9936264753341675
manifestations O 1 0.6756924390792847
and O 0 0.01069309189915657
to O 0 0.010563579387962818
investigate O 0 0.0158595759421587
the O 0 0.012539180926978588
incidence O 1 0.6551114916801453
of O 0 0.01554593164473772
APC B-Disease 1 0.9998772144317627
mutations O 0 0.020682010799646378
in O 0 0.018378185108304024
non O 1 0.9971206784248352
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.6204748749732971

METHODS O 0 0.05156632885336876
The O 0 0.03614030405879021
APC B-Disease 1 0.9989424347877502
gene O 0 0.024763260036706924
was O 0 0.022938812151551247
analysed O 0 0.0296395942568779
in O 0 0.015528223477303982
190 O 0 0.03485620766878128
unrelated O 0 0.026711050420999527
FAP B-Disease 1 0.9988178610801697
and O 0 0.014802121557295322
15 O 0 0.02184898965060711
non O 1 0.9673117995262146
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.999992847442627
using O 0 0.02656225673854351
denaturing O 1 0.9998948574066162
gradient O 1 0.9769485592842102
gel O 1 0.999248206615448
electrophoresis O 0 0.4457685053348541
, O 0 0.01575351692736149
the O 0 0.015235151164233685
protein O 0 0.016529301181435585
truncation O 0 0.044842008501291275
test O 0 0.020590506494045258
, O 0 0.016892019659280777
and O 0 0.016044963151216507
direct O 0 0.025204263627529144
sequencing O 0 0.053761355578899384
. O 0 0.048659831285476685

RESULTS O 0 0.0547429658472538
Chain O 0 0.05042601004242897
terminating O 0 0.032152023166418076
signals O 0 0.0192201416939497
were O 0 0.008990148082375526
only O 0 0.007410712074488401
identified O 0 0.008962851017713547
in O 0 0.009121649898588657
patients O 0 0.03488043695688248
belonging O 0 0.012739214114844799
to O 0 0.01027726661413908
the O 0 0.016849273815751076
FAP B-Disease 1 0.9999995231628418
group O 0 0.10949097573757172
( O 0 0.025967303663492203
105 O 1 0.8728058934211731
patients O 1 0.9975016713142395
) O 0 0.03631851449608803
. O 0 0.05253438651561737

Amino O 0 0.045703429728746414
acid O 0 0.027736922726035118
changes O 0 0.012397648766636848
were O 0 0.007077202200889587
identified O 0 0.007327862083911896
in O 0 0.006195711437612772
four O 0 0.007726659998297691
patients O 1 0.7811705470085144
, O 0 0.005713074933737516
three O 0 0.004989181645214558
of O 0 0.006243681535124779
whom O 0 0.009941748343408108
belonged O 0 0.011849027127027512
to O 0 0.007868806831538677
the O 0 0.009519652463495731
non O 0 0.019621560350060463
- O 1 0.9981178045272827
FAP O 1 0.9999994039535522
group O 1 0.8104705214500427
of O 1 0.999961256980896
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 1.0
. O 0 0.45428764820098877

Genotype O 1 0.9896341562271118
- O 1 0.9961386322975159
phenotype O 1 0.6882814764976501
correlations O 0 0.03668561577796936
identified O 0 0.01657491736114025
significant O 0 0.013041832484304905
differences O 0 0.010750120505690575
in O 0 0.008285319432616234
the O 0 0.00785939022898674
nature O 0 0.009691968560218811
of O 0 0.008002464659512043
certain O 0 0.010938921011984348
extracolonic O 1 0.9997614026069641
manifestations O 1 0.9996179342269897
in O 1 0.899993896484375
FAP B-Disease 1 1.0
patients O 1 0.9998579025268555
belonging O 0 0.027119196951389313
to O 0 0.01782064698636532
three O 0 0.021452268585562706
mutation O 0 0.04255083575844765
subgroups O 0 0.06457596272230148
. O 0 0.046490125358104706

CONCLUSIONS O 0 0.05672711879014969
Extended O 0 0.04386116564273834
genotype O 1 0.8871098160743713
- O 1 0.9930292963981628
phenotype O 1 0.6066964268684387
correlations O 0 0.020223645493388176
made O 0 0.010061720386147499
in O 0 0.007700739428400993
this O 0 0.006234040949493647
study O 0 0.008414080366492271
may O 0 0.006583101116120815
have O 0 0.004878048785030842
the O 0 0.0061011058278381824
potential O 0 0.008055992424488068
to O 0 0.006368611007928848
determine O 0 0.007298354525119066
the O 0 0.006362768355756998
most O 0 0.006538843736052513
appropriate O 0 0.009667161852121353
surveillance O 0 0.01646687090396881
and O 0 0.01365139614790678
prophylactic O 1 0.999994158744812
treatment O 1 0.9998641014099121
regimens O 1 0.9996335506439209
for O 0 0.011308811604976654
those O 0 0.009810502640902996
patients O 1 0.7112897038459778
with O 0 0.009729872457683086
mutations O 0 0.01613365113735199
associated O 0 0.01156726572662592
with O 0 0.010727375745773315
life O 1 0.6015663743019104
threatening O 1 0.9976772665977478
conditions O 1 0.8907034993171692
. O 0 0.045698314905166626

This O 0 0.020491741597652435
study O 0 0.0178535059094429
also O 0 0.011278013698756695
provided O 0 0.011058713309466839
evidence O 0 0.008339500054717064
for O 0 0.0073974584229290485
the O 0 0.01011741440743208
pathological O 0 0.08177807927131653
nature O 0 0.013271825388073921
of O 0 0.012235354632139206
amino O 0 0.014570166356861591
acid O 0 0.01400356087833643
changes O 0 0.009995339438319206
in O 0 0.010960632935166359
APC O 1 0.9472712874412537
associated O 0 0.010529125109314919
with O 0 0.008064725436270237
both O 0 0.010448182001709938
FAP B-Disease 1 0.9999926090240479
and O 0 0.02261459268629551
non O 1 0.9994615912437439
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 1.0
. O 0 0.21911083161830902
. O 0 0.04737893491983414

Inherited B-Disease 1 1.0
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 1 0.9999830722808838
cancer B-Disease 1 1.0
risk O 1 0.9992237091064453
of O 1 0.5454591512680054
the O 1 0.9827556014060974
APC O 1 0.9999997615814209
I1307K O 1 0.9999364614486694
polymorphism O 1 0.5968610644340515
. O 0 0.06165144592523575

Germ O 1 0.9998546838760376
- O 1 0.913094162940979
line O 0 0.034277305006980896
and O 0 0.020365869626402855
somatic O 0 0.04339231550693512
truncating O 0 0.118224136531353
mutations O 0 0.018877873197197914
of O 0 0.012709513306617737
the O 0 0.017078904435038567
APC B-Disease 1 0.9997034668922424
gene O 0 0.01361768413335085
are O 0 0.006777494680136442
thought O 0 0.011181114241480827
to O 0 0.011024311184883118
initiate O 1 0.7978363037109375
colorectal B-Disease 1 1.0
tumor I-Disease 1 0.9999909400939941
formation O 1 0.7341989278793335
in O 1 0.8727651834487915
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 1 0.9999995231628418
sporadic O 1 1.0
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 1 0.9889724850654602
respectively O 0 0.10949013382196426
. O 0 0.05888056382536888

Recently O 0 0.047258708626031876
, O 0 0.023632632568478584
an O 0 0.022617435082793236
isoleucine O 1 0.9992930889129639
- O 1 0.9980332255363464
- O 1 0.9828413724899292
> O 0 0.4038502871990204
lysine O 0 0.0464361272752285
polymorphism O 0 0.03300884738564491
at O 0 0.02186831459403038
codon O 0 0.042195651680231094
1307 O 1 0.8153568506240845
( O 0 0.02172861620783806
I1307K O 0 0.0445745512843132
) O 0 0.012917383573949337
of O 0 0.011675795540213585
the O 0 0.013940599747002125
APC B-Disease 1 0.9998948574066162
gene O 0 0.01433231495320797
has O 0 0.010077816434204578
been O 0 0.007782944478094578
identified O 0 0.008137406781315804
in O 0 0.007738261949270964
6 O 0 0.013232655823230743
% O 0 0.010256072506308556
- O 0 0.016737982630729675
7 O 0 0.014728378504514694
% O 0 0.009793673641979694
of O 0 0.01045955065637827
the O 0 0.01484879944473505
Ashkenazi O 0 0.24054649472236633
Jewish O 0 0.030296694487333298
population O 0 0.02435995079576969
. O 0 0.04143660143017769

To O 0 0.026972809806466103
assess O 0 0.027916718274354935
the O 0 0.015710873529314995
risk O 0 0.015273422934114933
of O 0 0.009872927330434322
this O 0 0.008245513774454594
common O 0 0.012991647236049175
APC B-Disease 1 0.9999338388442993
allelic O 1 0.9992770552635193
variant O 1 0.9974289536476135
in O 1 0.9852361679077148
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 0.016981376335024834
we O 0 0.009863962419331074
have O 0 0.0074033853597939014
analyzed O 0 0.013524269685149193
a O 0 0.012196051888167858
large O 0 0.01285435352474451
cohort O 0 0.029358545318245888
of O 0 0.01502173114567995
unselected O 1 0.9545899629592896
Ashkenazi O 0 0.36810430884361267
Jewish O 0 0.02024860680103302
subjects O 0 0.021324828267097473
with O 0 0.018211999908089638
adenomatous B-Disease 1 1.0
polyps I-Disease 1 0.9999974966049194
and O 0 0.09155236929655075
. O 0 0.05094914138317108
or O 1 0.9995971322059631
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 0.0949554294347763
for O 0 0.017491184175014496
the O 0 0.038230787962675095
APC O 1 0.9999178647994995
I1307K O 1 0.9949595928192139
polymorphism O 0 0.10520239174365997
. O 0 0.06697027385234833

The O 0 0.062446773052215576
APC O 1 0.9990448355674744
I1307K O 1 0.9224098324775696
allele O 0 0.04546298459172249
was O 0 0.024624193087220192
identified O 0 0.015575236640870571
in O 0 0.0125235915184021
48 O 0 0.01920725591480732
( O 0 0.011164884082973003
10 O 0 0.01264280453324318
. O 0 0.009874777868390083
1 O 0 0.01563093438744545
% O 0 0.0135252820327878
) O 0 0.014979456551373005
of O 0 0.023197773844003677
476 O 1 0.9984368681907654
patients O 1 0.9905106425285339
. O 0 0.05064575374126434

Compared O 0 0.02975231409072876
with O 0 0.016504235565662384
the O 0 0.01292897667735815
frequency O 0 0.011695257388055325
in O 0 0.007869216613471508
two O 0 0.0062476471066474915
separate O 0 0.007381160277873278
population O 0 0.005989393685013056
control O 0 0.008784940466284752
groups O 0 0.005861163605004549
, O 0 0.00868899654597044
the O 0 0.012090049684047699
APC O 1 0.9999910593032837
I1307K O 1 0.9991449117660522
allele O 0 0.027772843837738037
is O 0 0.009130062535405159
associated O 0 0.008169303648173809
with O 0 0.0060139000415802
an O 0 0.008297835476696491
estimated O 0 0.011833231896162033
relative O 0 0.019123578444123268
risk O 0 0.024275826290249825
of O 0 0.017956839874386787
1 O 0 0.03605825826525688
. O 0 0.04256457835435867

5 O 0 0.08113425970077515
- O 0 0.34156402945518494
1 O 0 0.07556476444005966
. O 0 0.07011143118143082

7 O 0 0.06343554705381393
for O 0 0.054043520241975784
colorectal B-Disease 1 1.0
neoplasia I-Disease 1 0.9999995231628418
( O 0 0.02763822115957737
both O 0 0.02150297909975052
P O 1 0.9894117712974548
= O 0 0.1307898461818695
. O 0 0.0336906798183918
01 O 1 0.9996665716171265
) O 0 0.045730940997600555
. O 0 0.04892059415578842

Furthermore O 0 0.045158009976148605
, O 0 0.021412018686532974
compared O 0 0.021025171503424644
with O 0 0.01654331386089325
noncarriers O 1 0.9778677225112915
, O 0 0.027245838195085526
APC O 1 0.9999879598617554
I1307K O 1 0.9971368312835693
carriers O 0 0.027061201632022858
had O 0 0.013056276366114616
increased O 0 0.011104200966656208
numbers O 0 0.009662548080086708
of O 0 0.013069141656160355
adenomas B-Disease 1 0.9999943971633911
and O 1 0.9791143536567688
colorectal B-Disease 1 1.0
cancers I-Disease 1 0.9999997615814209
per O 0 0.01667446829378605
patient O 1 0.994127631187439
( O 0 0.016048600897192955
P O 1 0.8742000460624695
= O 0 0.022673774510622025
. O 0 0.011841123923659325
03 O 1 0.9935746788978577
) O 0 0.010796599090099335
, O 0 0.00847565196454525
as O 0 0.007226527668535709
well O 0 0.007939718663692474
as O 0 0.008317969739437103
a O 0 0.012973634526133537
younger O 0 0.02793293446302414
age O 0 0.027113666757941246
at O 0 0.041404757648706436
diagnosis O 1 0.9997106194496155
. O 0 0.046410419046878815

We O 0 0.026985865086317062
conclude O 0 0.029159503057599068
that O 0 0.011871038936078548
the O 0 0.017806433141231537
APC O 1 0.9994600415229797
I1307K O 1 0.9648177623748779
variant O 0 0.03414478898048401
leads O 0 0.0198302511125803
to O 0 0.013707980513572693
increased O 0 0.11577185243368149
adenoma B-Disease 1 1.0
formation O 0 0.27652573585510254
and O 0 0.012148262932896614
directly O 0 0.012122818268835545
contributes O 0 0.01559809222817421
to O 0 0.009254982694983482
3 O 0 0.013153504580259323
% O 0 0.010623147711157799
- O 0 0.017805056646466255
4 O 0 0.015256419777870178
% O 0 0.009697278961539268
of O 0 0.010387005284428596
all O 0 0.014571255072951317
Ashkenazi O 1 0.9984040856361389
Jewish O 1 0.9995740056037903
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.32833099365234375

The O 0 0.025992898270487785
estimated O 0 0.021577097475528717
relative O 0 0.020039381459355354
risk O 0 0.027895769104361534
for O 0 0.011273741722106934
carriers O 1 0.6053246259689331
may O 0 0.01084907352924347
justify O 0 0.015774549916386604
specific O 0 0.009933782741427422
clinical O 0 0.2644675076007843
screening O 0 0.014412627555429935
for O 0 0.0078065465204417706
the O 0 0.009629431180655956
360 O 0 0.0223075021058321
, O 0 0.013191276229918003
000 O 0 0.020780129358172417
Americans O 0 0.012180953286588192
expected O 0 0.011360825039446354
to O 0 0.011133883148431778
harbor O 0 0.024327991530299187
this O 0 0.009163199923932552
allele O 0 0.01710207760334015
, O 0 0.008801769465208054
and O 0 0.007711532060056925
genetic O 0 0.008732657879590988
testing O 0 0.008426672779023647
in O 0 0.0059012421406805515
the O 0 0.005764087662100792
setting O 0 0.007845785468816757
of O 0 0.006791842170059681
long O 0 0.010427234694361687
- O 0 0.289108544588089
term O 0 0.012180506251752377
- O 0 0.02188662625849247
outcome O 0 0.009698359295725822
studies O 0 0.007465231232345104
may O 0 0.00651125842705369
impact O 0 0.010238328017294407
significantly O 0 0.015028668567538261
on O 1 0.8705258965492249
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 1 0.9999997615814209
in O 0 0.01984281837940216
this O 0 0.017063230276107788
population O 0 0.022966764867305756
. O 0 0.038604751229286194

Localization O 0 0.06852052360773087
of O 0 0.02536870539188385
human O 0 0.021885475143790245
BRCA1 O 1 0.9721966981887817
and O 0 0.011296933516860008
its O 0 0.011429017409682274
loss O 0 0.018012039363384247
in O 0 0.00948962103575468
high O 0 0.022146644070744514
- O 1 0.5764152407646179
grade O 0 0.03260811045765877
, O 0 0.014325208030641079
non B-Disease 0 0.4109704792499542
- I-Disease 1 0.9999910593032837
inherited I-Disease 1 1.0
breast I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 0.190871924161911

Although O 0 0.021982362493872643
the O 0 0.01639505662024021
link O 0 0.01814797706902027
between O 0 0.011416524648666382
the O 0 0.016761356964707375
BRCA1 O 1 0.9999964237213135
tumour B-Disease 1 1.0
- O 1 0.9995848536491394
suppressor O 1 0.9980915188789368
gene O 0 0.014511384069919586
and O 0 0.015314362943172455
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 0.9999996423721313
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 0.41551634669303894
established O 0 0.04498699679970741
, O 0 0.009168344549834728
the O 0 0.008391120471060276
role O 0 0.009969751350581646
, O 0 0.008069091476500034
if O 0 0.006195808295160532
any O 0 0.0059544919058680534
, O 0 0.007553912699222565
of O 0 0.008455156348645687
BRCA1 O 1 0.7990052700042725
in O 0 0.011251550167798996
non B-Disease 1 0.8940675854682922
- I-Disease 1 0.9999985694885254
familial I-Disease 1 0.9999998807907104
cancers I-Disease 1 0.9999995231628418
is O 0 0.029267286881804466
unclear O 0 0.045687563717365265
. O 0 0.04902025684714317

BRCA1 O 1 0.99979168176651
mutations O 0 0.02556736394762993
are O 0 0.008656068705022335
rare O 0 0.013805084861814976
in O 0 0.010726682841777802
sporadic B-Disease 1 0.979986846446991
cancers I-Disease 1 0.999981164932251
, O 0 0.008295265026390553
but O 0 0.0065611740574240685
loss O 0 0.11454682052135468
of O 0 0.013184599578380585
BRCA1 O 1 0.9996558427810669
resulting O 0 0.012380648404359818
from O 0 0.007965346798300743
reduced O 0 0.012771038338541985
expression O 0 0.010409915819764137
or O 0 0.010862276889383793
incorrect O 0 0.019180450588464737
subcellular O 0 0.04168333113193512
localization O 0 0.037996020168066025
is O 0 0.011393418535590172
postulated O 0 0.017450887709856033
to O 0 0.007465779315680265
be O 0 0.00537129957228899
important O 0 0.005725320428609848
in O 0 0.006259787827730179
non B-Disease 0 0.06246371939778328
- I-Disease 1 0.9999969005584717
familial I-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 0.9999995231628418
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 0.45821383595466614

Epigenetic O 1 0.5583194494247437
loss O 1 0.7386537790298462
, O 0 0.017562348395586014
however O 0 0.011510860174894333
, O 0 0.009700438939034939
has O 0 0.008240987546741962
not O 0 0.006083620246499777
received O 0 0.009877076372504234
general O 0 0.014562501572072506
acceptance O 0 0.02073468081653118
due O 0 0.009308394975960255
to O 0 0.009822659194469452
controversy O 0 0.0168785247951746
regarding O 0 0.01325145922601223
the O 0 0.014076802879571915
subcellular O 0 0.036431849002838135
localization O 0 0.03215227648615837
of O 0 0.019065294414758682
BRCA1 O 1 0.9971550703048706
proteins O 0 0.012325398623943329
, O 0 0.008756191469728947
reports O 0 0.00873370561748743
of O 0 0.00686974823474884
which O 0 0.005903477780520916
have O 0 0.004907606169581413
ranged O 0 0.010918032377958298
from O 0 0.00693717272952199
exclusively O 0 0.010930073447525501
nuclear O 0 0.012975686229765415
, O 0 0.008080855011940002
to O 0 0.008420770987868309
conditionally O 0 0.023252632468938828
nuclear O 0 0.01567262038588524
, O 0 0.009017893113195896
to O 0 0.009886350482702255
the O 0 0.017212754115462303
ER O 1 0.9999972581863403
/ O 1 0.9990947246551514
golgi O 1 0.9728524684906006
, O 0 0.02245669811964035
to O 0 0.02199198119342327
cytoplasmic O 0 0.043825261294841766
invaginations O 0 0.06477300077676773
into O 0 0.025716064497828484
the O 0 0.030491579324007034
nucleus O 0 0.06466888636350632
. O 0 0.04740523919463158

In O 0 0.01859620027244091
an O 0 0.011994481086730957
attempt O 0 0.016547488048672676
to O 0 0.0105446120724082
resolve O 0 0.016767391934990883
this O 0 0.008860008791089058
issue O 0 0.013850968331098557
, O 0 0.009593917988240719
we O 0 0.00758109986782074
have O 0 0.00836249440908432
comprehensively O 0 0.03635485842823982
characterized O 0 0.024157896637916565
19 O 0 0.037543293088674545
anti O 1 0.9993663430213928
- O 1 0.9999948740005493
BRCA1 O 1 0.9999974966049194
antibodies O 1 0.9947779178619385
. O 0 0.0530678816139698

These O 0 0.0335809625685215
reagents O 0 0.06372534483671188
detect O 0 0.03738625347614288
a O 0 0.026632752269506454
220 O 0 0.05155707150697708
- O 1 0.9764401316642761
kD O 1 0.9983090162277222
protein O 0 0.028246968984603882
localized O 0 0.028792500495910645
in O 0 0.014657351188361645
discrete O 0 0.021798094734549522
nuclear O 0 0.02447626180946827
foci O 0 0.03669629991054535
in O 0 0.011474739760160446
all O 0 0.010346837341785431
epithelial O 1 0.999853253364563
cell O 0 0.4735287129878998
lines O 0 0.011990844272077084
, O 0 0.008107795380055904
including O 0 0.008591761812567711
those O 0 0.007537946570664644
derived O 0 0.013711540028452873
from O 0 0.024468272924423218
breast B-Disease 1 0.9999998807907104
malignancies I-Disease 1 0.9999977350234985
. O 0 0.05578326806426048

Immunohistochemical O 1 0.9988117218017578
staining O 0 0.21488289535045624
of O 0 0.026874452829360962
human O 0 0.22336828708648682
breast O 1 0.9999998807907104
specimens O 0 0.33283838629722595
also O 0 0.017305364832282066
revealed O 0 0.1894223392009735
BRCA1 O 1 0.9995403289794922
nuclear O 0 0.02856256440281868
foci O 1 0.9775351285934448
in O 0 0.020715994760394096
benign O 1 0.9999994039535522
breast O 1 1.0
, O 1 0.9865439534187317
invasive B-Disease 1 0.9999998807907104
lobular I-Disease 1 1.0
cancers I-Disease 1 0.9999998807907104
and O 1 0.5313391089439392
low B-Disease 1 0.9990732669830322
- I-Disease 1 0.9999967813491821
grade I-Disease 1 0.9999947547912598
ductal I-Disease 1 1.0
carcinomas I-Disease 1 0.9999996423721313
. O 0 0.0974065512418747

Conversely O 0 0.09062038362026215
, O 0 0.03473798558115959
BRCA1 O 1 0.9711701273918152
expression O 0 0.022096363827586174
was O 0 0.024437103420495987
reduced O 0 0.020066123455762863
or O 0 0.01040871161967516
undetectable O 0 0.11527827382087708
in O 0 0.00706879049539566
the O 0 0.0073511963710188866
majority O 0 0.006922190077602863
of O 0 0.007353424094617367
high O 0 0.1378796100616455
- O 1 0.9994947910308838
grade O 1 0.9987500905990601
, O 1 0.7248040437698364
ductal B-Disease 1 1.0
carcinomas I-Disease 1 0.9999998807907104
, O 0 0.01680576428771019
suggesting O 0 0.013817899860441685
that O 0 0.007287786807864904
absence O 0 0.014923213049769402
of O 0 0.020438779145479202
BRCA1 O 1 0.9999841451644897
may O 0 0.010296402499079704
contribute O 0 0.012596922926604748
to O 0 0.009225534275174141
the O 0 0.011355625465512276
pathogenesis O 1 0.978523850440979
of O 0 0.01023110281676054
a O 0 0.009798480197787285
significant O 0 0.010609648190438747
percentage O 0 0.013642622157931328
of O 0 0.016426613554358482
sporadic B-Disease 1 0.9998001456260681
breast I-Disease 1 1.0
cancers I-Disease 1 0.9999997615814209
. O 0 0.03469220548868179
. O 0 0.05064547061920166

